data_2k3a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.132 0.491 . . . . 75.140000000000001 111.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.46 110.03 13.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.176 -0.466 . . . . 54.399999999999999 111.758 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.72 -28.24 1.75 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.925 -0.655 . . . . 73.420000000000002 113.287 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.32 150.04 27.43 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.547 -0.384 . . . . 74.109999999999999 110.755 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 28.2 p -58.69 -34.18 70.99 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.143 0.497 . . . . 72.310000000000002 111.796 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.8 p -64.44 -25.75 68.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.24 -60.33 3.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.519 0.563 . . . . 73.340000000000003 112.519 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 25.0 p90 -64.35 -30.53 71.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.097 -0.377 . . . . 64.430000000000007 111.892 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 110' ' ' VAL . 59.4 t -62.53 -43.67 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.105 0.479 . . . . 64.299999999999997 110.583 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -58.54 -36.61 74.15 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.043 -0.526 . . . . 64.219999999999999 110.944 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.73 -43.31 37.82 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.406 -0.361 . . . . 65.0 111.132 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -59.19 -34.4 72.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.146 0.498 . . . . 71.209999999999994 111.816 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 99' ' ' ILE . 7.1 p -85.03 9.38 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.309 0.576 . . . . 70.219999999999999 111.815 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.18 14.59 68.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.389 -0.434 . . . . 37.32 113.556 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.77 17.9 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.167 -0.539 . . . . 73.239999999999995 114.129 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -80.09 11.24 3.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.466 0.633 . . . . 64.219999999999999 112.375 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 pt -117.04 153.0 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.374 -0.376 . . . . 74.420000000000002 110.687 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.05 126.69 8.02 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.806 -0.711 . . . . 61.420000000000002 113.968 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -62.33 -19.27 63.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.189 0.518 . . . . 60.109999999999999 111.364 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -70.05 8.25 0.78 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.361 0.875 . . . . 73.430000000000007 113.361 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -78.15 -46.02 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.99 -0.444 . . . . 72.319999999999993 112.047 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.94 9.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.945 -0.645 . . . . 60.43 113.377 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -85.53 162.57 18.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.14 0.495 . . . . 55.43 111.881 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -58.32 -27.78 64.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.849 -0.614 . . . . 73.239999999999995 112.079 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -63.23 -35.34 79.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.985 0.422 . . . . 74.239999999999995 111.173 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.93 -21.26 19.32 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.508 0.558 . . . . 75.450000000000003 112.508 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -38.95 -55.43 1.55 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.447 1.277 . . . . 74.409999999999997 114.447 -172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB1' HG12 ' A' ' 90' ' ' VAL . . . -62.67 -37.63 87.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.941 -0.475 . . . . 62.32 112.235 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -68.94 -47.74 64.96 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.932 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.82 92.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.131 -0.486 . . . . 63.219999999999999 111.156 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.96 -51.98 62.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.078 0.466 . . . . 53.409999999999997 110.938 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 m -58.24 -45.27 88.07 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.176 0.512 . . . . 64.319999999999993 110.713 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 t -66.86 -24.6 66.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.072 -0.513 . . . . 71.540000000000006 111.97 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.3 -13.07 33.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.114 0.412 . . . . 64.140000000000001 112.114 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.34 41.84 3.86 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.253 -0.499 . . . . 62.439999999999998 113.434 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -107.61 -178.6 3.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 74.340000000000003 111.522 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.0 m -110.05 108.06 18.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 111.291 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.477 HG23 HG13 ' A' ' 152' ' ' ILE . 39.0 t -116.81 110.99 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.082 0.467 . . . . 65.140000000000001 111.907 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 50.8 m-80 -139.17 155.6 47.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.385 -0.371 . . . . 72.319999999999993 110.369 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.64 13.71 1.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.008 0.373 . . . . 74.430000000000007 112.008 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.5 p -73.84 116.87 56.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.601 -0.272 . . . . 74.010000000000005 111.416 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 103.51 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.486 2.124 . . . . 53.539999999999999 112.241 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.541 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 36.9 tt0 -141.45 152.15 44.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.977 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.32 153.92 42.0 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.021 0.439 . . . . 71.319999999999993 111.905 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.54 34.05 63.53 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.074 -0.584 . . . . 63.020000000000003 112.691 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.5 m -136.78 158.8 43.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.299999999999997 111.067 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -107.95 127.53 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.597 -0.274 . . . . 64.530000000000001 110.448 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD11 ' CD2' ' A' ' 149' ' ' TYR . 1.7 pt? -95.63 130.37 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.937 -0.477 . . . . 64.200000000000003 111.127 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.487 ' HA ' HG13 ' A' ' 110' ' ' VAL . 41.8 tt0 -98.29 129.32 45.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.402 -0.363 . . . . 64.140000000000001 111.685 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 112.752 0.649 . . . . 71.310000000000002 112.752 178.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 113.584 0.193 . . . . 52.140000000000001 113.584 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -131.63 149.71 52.4 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.747 -0.267 . . . . 65.519999999999996 111.036 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 76' ' ' ALA . 11.8 m -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.138 0.494 . . . . 65.530000000000001 111.663 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.86 163.03 40.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 73.129999999999995 110.651 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -96.68 127.4 42.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.752 0.31 . . . . 75.420000000000002 111.376 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 124' ' ' VAL . 60.9 t -76.1 108.05 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.948 0.404 . . . . 71.420000000000002 112.031 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 138' ' ' GLU . 11.3 mm-40 -71.95 -45.86 59.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.055 -0.52 . . . . 71.349999999999994 111.504 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -163.6 149.37 11.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 111.517 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.451 HG22 HG11 ' A' ' 122' ' ' VAL . 57.9 t -120.65 128.91 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 61.340000000000003 110.535 177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -84.42 154.55 22.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.955 0.407 . . . . 70.400000000000006 111.925 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 t -57.61 -34.42 69.26 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.441 0.639 . . . . 75.019999999999996 110.078 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.2 -31.53 43.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.245 -0.889 . . . . 75.140000000000001 111.583 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.75 -19.35 21.4 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.369 -0.443 . . . . 54.509999999999998 112.669 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.3 p -61.62 125.7 24.72 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.329 0.585 . . . . 51.409999999999997 111.66 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.451 HG11 HG22 ' A' ' 116' ' ' VAL . 48.9 t -103.44 117.85 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.716 -0.675 . . . . 74.109999999999999 111.347 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.85 102.52 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.218 0.532 . . . . 72.340000000000003 111.464 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.532 HG12 HG22 ' A' ' 113' ' ' VAL . 35.5 m -106.42 123.49 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.449 0.643 . . . . 62.509999999999998 111.876 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 39.5 t -81.03 122.19 26.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.054 0.455 . . . . 72.209999999999994 111.841 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -133.31 137.59 46.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.492 . . . . 63.200000000000003 111.18 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 60' ' ' TYR . 50.2 ttm . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.016 0.436 . . . . 72.400000000000006 111.642 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 2.6 mp0 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.336 0.589 . . . . 64.140000000000001 111.366 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -70.04 109.3 4.48 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.504 -0.771 . . . . 64.420000000000002 111.895 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.8 m -85.33 98.26 10.44 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.95 0.405 . . . . 72.049999999999997 111.343 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.0 mt -88.52 144.34 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 111.549 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.8 m -68.85 148.32 50.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 111.293 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.92 42.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.072 0.767 . . . . 65.230000000000004 113.072 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.03 -48.74 77.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.419 -0.419 . . . . 71.340000000000003 113.434 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.22 -39.03 75.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.042 0.449 . . . . 71.409999999999997 111.544 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.46 77.81 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.074 0.398 . . . . 73.400000000000006 112.074 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.9 m -61.55 -14.47 30.06 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.091 0.472 . . . . 62.520000000000003 111.74 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -73.67 -8.49 56.18 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.338 -0.392 . . . . 37.32 111.762 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.407 ' CD2' HD11 ' A' ' 100' ' ' LEU . 53.1 m-85 -105.17 156.91 17.66 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.112 0.482 . . . . 74.329999999999998 112.064 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.0 115.69 24.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.36 -0.382 . . . . 73.450000000000003 111.028 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 82.5 m-85 -93.29 121.32 34.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.135 0.493 . . . . 74.519999999999996 112.053 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.477 HG13 HG23 ' A' ' 90' ' ' VAL . 3.4 mp -89.89 111.08 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.347 -0.388 . . . . 64.310000000000002 110.316 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.541 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 33.2 m-70 -98.52 136.77 38.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.41 -0.359 . . . . 73.150000000000006 110.984 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 29.7 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.156 0.503 . . . . 53.130000000000003 112.236 -178.698 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 120.997 0.427 . . . . 63.310000000000002 111.784 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 103.84 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 112.35 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.75 -28.17 2.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 112.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 59' ' ' TRP . 96.3 mt-30 -73.88 143.87 45.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.007 0.432 . . . . 72.420000000000002 111.899 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.0 m -57.11 -46.28 82.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.569 174.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.3 p -55.13 -41.21 71.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.795 -0.639 . . . . 71.030000000000001 111.547 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB3' ' O ' ' A' ' 56' ' ' GLN . 59.3 t90 -55.23 -55.68 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.57 -0.741 . . . . 75.310000000000002 111.76 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.477 ' OH ' ' HD3' ' A' ' 64' ' ' LYS . 47.1 t80 -62.75 -42.18 99.55 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.294 0.479 . . . . 75.109999999999999 112.294 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 110' ' ' VAL . 82.4 t -60.44 -38.27 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 111.946 0.35 . . . . 73.530000000000001 111.946 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 44.2 t80 -62.22 -34.82 77.22 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 111.388 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.95 -46.78 56.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.167 0.508 . . . . 55.350000000000001 110.318 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.477 ' HD3' ' OH ' ' A' ' 60' ' ' TYR . 25.5 mmmt -55.71 -40.58 72.6 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 112.3 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.51 9.5 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.077 0.465 . . . . 74.209999999999994 111.55 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.66 60.47 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.523 -0.37 . . . . 37.880000000000003 113.745 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.452 ' HA2' ' CE1' ' A' ' 62' ' ' TYR . . . 63.54 29.25 74.07 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.159 -0.543 . . . . 62.409999999999997 114.261 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -93.23 24.57 3.76 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.478 0.639 . . . . 71.430000000000007 112.214 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.82 155.5 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.03 0.443 . . . . 63.340000000000003 111.702 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.13 93.56 0.34 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.09 -0.576 . . . . 73.140000000000001 112.551 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.514 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 63.1 p -72.65 20.8 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.377 0.88 . . . . 37.880000000000003 113.377 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -90.0 -2.26 58.11 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.189 -0.319 . . . . 64.030000000000001 111.752 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -64.83 -38.18 90.12 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.56 0.578 . . . . 72.439999999999998 112.56 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.09 -111.09 3.24 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.071 -0.585 . . . . 60.229999999999997 113.445 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -53.63 134.05 41.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.926 0.393 . . . . 61.350000000000001 111.908 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -59.95 -39.31 85.14 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.507 0.558 . . . . 61.240000000000002 112.507 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -63.74 -9.82 16.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.48 0.548 . . . . 55.420000000000002 112.48 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -94.15 -16.65 23.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.497 0.319 . . . . 60.420000000000002 111.661 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -60.49 -42.26 95.95 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.129 0.789 . . . . 73.120000000000005 113.129 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -56.66 10.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.971 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -62.52 -44.51 96.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.91 0.386 . . . . 65.239999999999995 111.627 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.1 -47.94 83.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.566 -0.288 . . . . 72.109999999999999 111.728 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . . . -56.38 -49.0 75.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 111.404 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -58.76 -40.81 84.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 111.999 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -75.49 -39.14 58.94 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.959 0.409 . . . . 62.299999999999997 111.897 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.99 82.61 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.113 0.412 . . . . 71.120000000000005 112.113 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.11 17.85 1.58 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.948 -0.644 . . . . 52.350000000000001 113.383 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 58.7 m-85 -89.19 176.61 6.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.26 0.552 . . . . 72.400000000000006 111.061 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -104.59 91.37 3.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.133 -0.485 . . . . 75.140000000000001 111.173 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.69 117.52 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.029 0.442 . . . . 73.319999999999993 112.054 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -153.04 -179.46 7.7 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.902 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.15 10.1 30.8 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.083 0.401 . . . . 71.319999999999993 112.083 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -72.56 111.79 12.48 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 110.291 -0.263 . . . . 74.530000000000001 110.291 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.47 ' O ' HG21 ' A' ' 116' ' ' VAL . 91.8 Cg_endo -76.65 1.93 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.836 2.358 . . . . 62.520000000000003 115.065 -170.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.23 137.51 6.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.895 0.702 . . . . 60.43 112.895 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.51 174.16 1.84 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.396 0.888 . . . . 72.150000000000006 113.396 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.0 35.33 57.95 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.998 -0.547 . . . . 42.130000000000003 112.484 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.7 m -153.4 -176.96 6.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.571 0.348 . . . . 62.020000000000003 110.665 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mt -122.2 129.39 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.803 -0.18 . . . . 73.209999999999994 111.45 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -98.37 133.45 42.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.799 -0.563 . . . . 74.420000000000002 110.923 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.39 106.15 17.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.031 -0.531 . . . . 72.450000000000003 110.286 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 75.400000000000006 111.38 -176.945 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 CA-C-O 120.971 0.206 . . . . 72.409999999999997 113.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -142.44 110.55 5.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.456 -0.438 . . . . 64.0 111.095 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 76' ' ' ALA . 31.4 m -111.81 145.15 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.921 0.391 . . . . 72.140000000000001 111.397 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.39 157.81 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.989 0.423 . . . . 73.530000000000001 111.366 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -90.7 130.91 36.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.827 0.346 . . . . 74.409999999999997 110.878 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.555 ' HA ' HG11 ' A' ' 124' ' ' VAL . 39.9 t -83.49 114.72 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 45.229999999999997 112.124 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.457 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 10.9 mm-40 -78.78 -50.96 10.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.907 -0.588 . . . . 73.409999999999997 111.536 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -158.08 150.71 22.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 111.84 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 94' ' ' PRO . 98.5 t -126.92 127.63 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.912 -0.585 . . . . 64.239999999999995 110.39 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -91.98 148.29 22.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.881 0.372 . . . . 74.549999999999997 111.852 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 75.8 m -64.0 -16.01 60.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.368 -0.378 . . . . 73.409999999999997 111.743 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.11 -6.46 39.43 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 111.379 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 60.05 1.59 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.316 -0.468 . . . . 54.219999999999999 112.985 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.0 p -145.78 133.6 21.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.294 -0.533 . . . . 65.319999999999993 111.668 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.46 113.62 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.14 -0.482 . . . . 74.049999999999997 111.213 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 31.2 mt-10 -99.49 118.85 36.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.502 -0.317 . . . . 75.109999999999999 110.928 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 113' ' ' VAL . 16.1 m -129.38 147.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.371 0.508 . . . . 64.340000000000003 112.371 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 65.9 m -79.4 122.91 26.98 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.928 0.394 . . . . 73.349999999999994 112.054 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' CD ' ' HD2' ' A' ' 139' ' ' ARG . 44.3 mt-10 -116.62 143.94 45.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.275 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.741 0.305 . . . . 52.299999999999997 110.227 171.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.729 0.299 . . . . 73.540000000000006 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.51 ' HD2' ' CD ' ' A' ' 126' ' ' GLU . 11.3 ptm180 -87.46 151.59 22.92 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.117 -0.364 . . . . 71.510000000000005 110.633 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.4 ' HG1' ' HG2' ' A' ' 123' ' ' GLU . 52.4 m -114.8 102.59 10.14 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.123 0.487 . . . . 73.299999999999997 110.98 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 mt -86.43 131.0 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.854 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -71.26 149.11 46.52 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.814 -0.175 . . . . 72.140000000000001 110.94 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.99 61.53 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.701 0.63 . . . . 72.409999999999997 112.701 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.68 -23.63 55.66 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.459 -0.4 . . . . 71.510000000000005 113.809 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.24 -35.06 10.87 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.448 -0.442 . . . . 64.299999999999997 111.257 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.32 67.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.122 0.487 . . . . 61.409999999999997 111.8 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 148' ' ' SER . 69.1 m -60.83 143.79 54.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.221 -0.445 . . . . 65.340000000000003 110.859 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 147' ' ' SER . 31.3 t 83.56 -3.0 1.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.681 0.792 . . . . 71.140000000000001 112.241 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -93.61 127.99 39.55 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.972 -0.455 . . . . 75.439999999999998 110.272 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.89 118.48 30.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 111.707 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -92.17 113.22 25.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.951 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 152' ' ' ILE . 4.1 mp -80.22 114.92 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.501 -0.318 . . . . 73.120000000000005 110.35 174.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.57 146.93 28.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.667 0.27 . . . . 75.319999999999993 110.658 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 120.804 0.335 . . . . 75.230000000000004 111.414 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 120.774 0.321 . . . . 75.450000000000003 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.37 156.73 25.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.715 0.635 . . . . 74.409999999999997 112.715 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.77 -33.9 3.23 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.284 -0.416 . . . . 53.450000000000003 113.795 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -75.64 150.74 37.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.229 0.537 . . . . 75.340000000000003 112.274 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.41 -39.53 73.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.025 -0.534 . . . . 75.25 111.638 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.7 p -54.99 -42.96 73.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.941 0.401 . . . . 75.25 111.649 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -62.82 -50.32 71.45 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.408 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.1 -54.15 50.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.787 -0.642 . . . . 73.510000000000005 111.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.5 -34.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.781 0.324 . . . . 74.319999999999993 111.469 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -55.62 -47.69 76.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.519 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.19 -37.56 75.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.965 0.412 . . . . 74.439999999999998 110.884 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -61.24 -35.57 77.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.013 -0.539 . . . . 43.009999999999998 112.19 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.65 12.4 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.432 0.634 . . . . 63.399999999999999 110.997 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.67 18.38 59.05 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 114.179 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.02 67.14 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.115 -0.564 . . . . 51.119999999999997 113.792 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.01 37.76 0.44 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.231 -0.57 . . . . 63.439999999999998 111.89 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.3 pt -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.112 0.482 . . . . 73.209999999999994 111.455 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.8 1.26 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.071 -0.585 . . . . 44.520000000000003 112.315 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -52.82 -18.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.219 0.822 . . . . 64.420000000000002 113.219 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -94.43 18.93 10.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.576 0.584 . . . . 73.299999999999997 112.576 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -67.69 -37.0 81.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.074 0.398 . . . . 74.439999999999998 112.074 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.94 -134.62 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.072 -0.585 . . . . 63.149999999999999 113.715 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -63.17 151.02 41.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.312 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -55.65 -31.76 62.61 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.14 0.793 . . . . 74.540000000000006 113.14 -172.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -67.14 -21.62 65.82 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.494 0.553 . . . . 74.420000000000002 112.494 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.38 -14.21 29.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.109 0.411 . . . . 75.209999999999994 112.109 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -52.06 -65.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.202 0.816 . . . . 72.0 113.202 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.18 91.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.059 0.392 . . . . 53.539999999999999 112.059 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 m -54.97 -36.91 65.86 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.976 0.417 . . . . 73.340000000000003 111.613 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.2 -28.11 25.66 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.342 -0.39 . . . . 64.450000000000003 111.891 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.7 70.04 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.726 0.298 . . . . 70.450000000000003 111.372 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.4 p -58.88 -54.36 48.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.012 0.434 . . . . 65.530000000000001 111.106 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.8 t -55.56 -37.19 67.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.945 -0.571 . . . . 64.230000000000004 112.446 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.88 -10.46 59.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 111.999 0.37 . . . . 73.439999999999998 111.999 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 41.51 4.24 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.332 -0.461 . . . . 55.439999999999998 113.873 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -110.98 -179.07 3.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.005 0.431 . . . . 64.030000000000001 111.112 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.4 m -109.72 103.86 12.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.216 0.45 . . . . 75.25 112.216 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.28 99.81 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 63.329999999999998 110.882 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.17 156.07 34.46 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 111.29 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.78 -4.06 58.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.443 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.2 m -66.35 111.71 7.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.323 -0.398 . . . . 74.239999999999995 110.806 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -78.12 20.29 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.471 2.781 . . . . 73.409999999999997 114.56 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -48.65 141.53 7.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.556 0.576 . . . . 73.400000000000006 112.556 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.74 144.68 47.55 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.987 -0.551 . . . . 44.299999999999997 112.36 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.54 45.89 5.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.916 -0.659 . . . . 73.140000000000001 112.584 -175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -149.53 177.68 9.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 70.319999999999993 111.121 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.8 mt -122.83 121.21 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 110.708 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.6 pt? -92.7 139.4 30.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.02 0.438 . . . . 70.329999999999998 110.867 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -105.06 103.7 13.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.92 0.39 . . . . 64.349999999999994 111.408 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 66.2 m . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 121.406 0.622 . . . . 70.329999999999998 111.165 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.649 0 CA-C-O 121.083 0.268 . . . . 73.299999999999997 113.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 26.8 t60 -141.32 148.09 39.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.687 -0.302 . . . . 74.230000000000004 110.457 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 76' ' ' ALA . 11.9 m -139.43 144.2 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.146 0.498 . . . . 71.129999999999995 111.692 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.39 153.73 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.907 -0.588 . . . . 61.200000000000003 110.666 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -88.71 128.7 35.62 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.049 0.452 . . . . 71.200000000000003 111.129 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.74 106.38 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.27 -0.423 . . . . 62.25 111.665 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -74.81 -51.99 12.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.938 0.399 . . . . 64.239999999999995 111.384 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -148.88 145.78 27.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.293 0.568 . . . . 43.119999999999997 112.347 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.49 130.02 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.826 -0.625 . . . . 62.030000000000001 110.763 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -88.36 147.46 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.354 -0.385 . . . . 74.420000000000002 111.372 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -56.09 -37.33 69.21 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.908 0.385 . . . . 62.229999999999997 111.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -22.48 64.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 111.736 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.37 -20.66 8.34 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.412 -0.423 . . . . 63.509999999999998 113.587 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -58.63 126.25 26.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.131 0.419 . . . . 65.340000000000003 112.131 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.12 122.89 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.05 -0.523 . . . . 65.040000000000006 111.189 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -103.43 109.58 21.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.273 0.558 . . . . 73.519999999999996 110.978 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.62 160.43 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.961 -0.563 . . . . 61.420000000000002 111.534 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.8 p -107.83 124.8 50.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.214 0.531 . . . . 63.229999999999997 111.744 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -108.34 -176.58 3.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.819 -0.628 . . . . 75.219999999999999 111.207 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 39.0 tpp . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 116.381 -0.372 . . . . 71.140000000000001 111.48 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.327 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -108.45 121.04 44.13 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.856 -0.611 . . . . 72.349999999999994 111.432 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.4 m -94.98 103.72 15.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 111.458 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 111.309 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.4 m -67.02 144.77 55.99 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.494 -0.321 . . . . 72.120000000000005 111.419 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.69 -47.49 50.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.965 0.728 . . . . 64.510000000000005 112.965 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.85 -57.86 16.12 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.548 -0.358 . . . . 64.299999999999997 113.479 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.57 -41.66 98.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 71.519999999999996 110.971 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.31 69.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.892 -0.595 . . . . 54.329999999999998 112.176 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -64.08 -11.65 31.69 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.489 0.551 . . . . 73.140000000000001 112.489 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 44.4 t -83.0 -10.38 58.8 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.975 0.416 . . . . 73.340000000000003 111.178 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 26.2 m-85 -93.73 153.08 18.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.076 0.465 . . . . 71.310000000000002 111.285 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.27 112.58 20.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.286 -0.416 . . . . 75.530000000000001 111.335 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 89.6 m-85 -93.9 113.52 25.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.121 0.486 . . . . 63.350000000000001 111.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -80.12 128.38 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 54.219999999999999 110.933 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.09 144.82 48.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.436 -0.347 . . . . 73.140000000000001 110.568 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.175 0.512 . . . . 65.430000000000007 112.289 -173.685 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 HG23 ' OE1' ' A' ' 56' ' ' GLN . 8.8 t . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.971 0.36 . . . . 75.120000000000005 111.971 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 111.01 1.46 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.069 0.461 . . . . 73.450000000000003 111.124 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.65 -24.05 3.06 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.302 -0.475 . . . . 53.229999999999997 112.4 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' OE1' HG23 ' A' ' 53' ' ' THR . 51.4 mt-30 -83.18 138.94 33.43 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.748 -0.266 . . . . 62.109999999999999 110.793 175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.477 ' O ' HG21 ' A' ' 61' ' ' VAL . 29.1 p -61.54 -35.37 77.57 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.181 0.515 . . . . 72.019999999999996 109.994 174.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -54.87 -44.97 74.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.513 -0.767 . . . . 74.530000000000001 111.454 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -55.88 -50.09 71.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.903 -0.589 . . . . 72.329999999999998 111.77 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -63.04 -45.37 92.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.796 0.331 . . . . 74.219999999999999 111.667 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 57' ' ' CYS . 60.6 t -60.99 -36.18 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.95 0.405 . . . . 64.209999999999994 111.053 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -56.14 -43.17 78.01 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.011 -0.54 . . . . 75.129999999999995 110.81 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.35 -47.55 70.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.153 -0.476 . . . . 63.119999999999997 110.977 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -56.76 -37.92 71.72 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.07 -3.6 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 111.483 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.98 8.43 84.07 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.441 -0.409 . . . . 37.460000000000001 113.713 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.55 84.62 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 113.554 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -78.6 36.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.177 0.436 . . . . 73.150000000000006 112.177 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.6 pt -140.02 -178.28 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.989 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.81 108.83 3.43 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.996 -0.621 . . . . 53.130000000000003 112.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.1 p -63.1 -14.66 51.16 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.415 -0.462 . . . . 55.039999999999999 112.203 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 t -85.85 5.4 32.91 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.674 0.62 . . . . 73.439999999999998 112.674 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -67.21 -34.74 78.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.092 -0.38 . . . . 75.340000000000003 111.889 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.25 -118.46 5.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.199 -0.524 . . . . 71.439999999999998 114.045 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -58.16 134.58 56.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.085 0.402 . . . . 63.420000000000002 112.085 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -58.08 -25.18 60.97 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.549 0.574 . . . . 72.030000000000001 112.549 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.33 -9.97 59.15 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.798 0.332 . . . . 73.439999999999998 111.881 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -102.53 -4.94 24.55 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 111.916 0.339 . . . . 63.530000000000001 111.916 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -64.7 -43.67 92.75 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.626 0.602 . . . . 74.430000000000007 112.626 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.61 95.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.088 0.47 . . . . 44.109999999999999 111.343 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -65.48 -48.11 73.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 74.430000000000007 111.315 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.42 95.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.866 0.365 . . . . 61.119999999999997 111.358 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.14 -56.23 24.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 111.393 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.6 t -64.06 -29.72 70.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 111.646 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 t -75.71 -33.46 60.31 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.941 0.401 . . . . 75.120000000000005 111.645 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.46 -25.0 36.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.902 0.382 . . . . 65.420000000000002 111.6 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.65 6.72 12.68 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.057 -0.592 . . . . 55.020000000000003 113.321 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 96.8 m-85 -74.3 158.2 34.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.242 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 92.88 6.91 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.272 0.558 . . . . 45.240000000000002 111.998 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 152' ' ' ILE . 46.7 t -95.3 124.37 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.83 -0.623 . . . . 74.0 111.365 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -146.42 166.97 24.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 111.203 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -82.49 -5.57 58.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.261 -0.427 . . . . 74.540000000000006 111.47 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 113.04 6.77 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 116.599 -0.273 . . . . 60.539999999999999 110.674 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 116' ' ' VAL . 94.1 Cg_endo -82.14 20.82 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.106 2.537 . . . . 72.140000000000001 114.625 -170.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.8 147.63 22.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.1 0.778 . . . . 73.340000000000003 113.1 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -64.75 159.82 21.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.366 -0.833 . . . . 71.25 112.329 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.7 44.65 12.08 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.405 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -156.48 179.66 9.04 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.975 0.417 . . . . 71.349999999999994 111.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.62 122.87 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.209 -0.45 . . . . 73.040000000000006 110.726 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -97.85 134.21 41.3 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.131 0.491 . . . . 54.009999999999998 111.078 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -101.62 116.66 33.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.013 0.435 . . . . 73.319999999999993 112.069 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 115.824 -0.626 . . . . 71.150000000000006 110.11 173.644 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 113.485 0.154 . . . . 37.460000000000001 113.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -141.17 130.92 24.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.427 0.291 . . . . 75.510000000000005 110.989 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 76' ' ' ALA . 26.3 m -127.37 146.92 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.003 0.43 . . . . 74.420000000000002 111.441 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.53 156.47 45.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.095 -0.502 . . . . 43.409999999999997 111.088 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -87.15 127.13 35.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.86 0.362 . . . . 70.109999999999999 111.64 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 96' ' ' ALA . 60.1 t -77.85 105.17 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.303 -0.408 . . . . 53.049999999999997 111.151 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.12 -48.46 10.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 71.219999999999999 111.622 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -150.69 151.93 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.97 0.414 . . . . 74.340000000000003 111.585 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 94' ' ' PRO . 29.0 t -127.17 137.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.421 -0.354 . . . . 74.450000000000003 111.137 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 121' ' ' SER . 87.2 m-20 -77.63 164.22 25.53 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.909 0.385 . . . . 54.229999999999997 111.41 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 m -63.09 -31.22 72.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.878 0.325 . . . . 72.319999999999993 111.878 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.66 -39.21 64.62 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 111.837 0.31 . . . . 61.520000000000003 111.837 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.13 -12.22 2.57 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 113.85 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.438 ' HB2' HD21 ' A' ' 117' ' ' ASN . 67.4 m -55.26 128.55 34.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.239 0.543 . . . . 55.020000000000003 111.835 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 113' ' ' VAL . 48.4 t -106.56 119.35 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.503 -0.771 . . . . 72.129999999999995 111.763 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.89 107.52 19.27 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.92 0.391 . . . . 72.510000000000005 110.577 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.24 148.55 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.718 0.636 . . . . 65.040000000000006 112.718 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.8 p -99.21 112.45 24.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.795 -0.639 . . . . 74.120000000000005 111.376 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.44 -172.33 2.49 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.031 -0.531 . . . . 72.25 111.18 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.475 0.801 0 O-C-N 122.301 -0.25 . . . . 73.019999999999996 110.881 -179.506 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 121.018 0.437 . . . . 62.149999999999999 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -96.91 122.95 40.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 111.88 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 32.5 m -93.83 113.42 25.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.097 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.84 125.25 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.793 0.294 . . . . 71.140000000000001 111.793 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -62.23 145.14 54.42 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.684 0.278 . . . . 73.319999999999993 111.575 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.36 -43.03 61.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.775 0.657 . . . . 75.120000000000005 112.775 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.12 -22.25 28.11 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.252 -0.499 . . . . 74.340000000000003 113.707 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -101.69 -47.39 4.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 71.019999999999996 110.692 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HB2' ' OH ' ' A' ' 151' ' ' TYR . . . -60.83 -40.78 94.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 113.192 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.6 m -60.59 -16.62 40.04 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.927 0.714 . . . . 75.310000000000002 112.927 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.4 t -79.16 -25.31 42.87 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.962 0.41 . . . . 63.439999999999998 111.55 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.71 148.49 34.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.06 0.457 . . . . 75.010000000000005 111.608 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 150' ' ' ASN . 0.8 OUTLIER -83.76 115.78 22.38 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.237 -0.289 . . . . 51.399999999999999 111.358 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 69.8 m-85 -94.2 110.83 22.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.9 0.381 . . . . 73.019999999999996 111.847 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.485 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -81.37 113.38 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.293 -0.412 . . . . 75.510000000000005 110.695 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -104.29 135.98 44.73 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.691 0.281 . . . . 74.040000000000006 110.677 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.891 -175.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 120.984 0.421 . . . . 72.150000000000006 112.081 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.52 149.64 27.42 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.162 0.506 . . . . 64.400000000000006 112.338 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.64 -34.77 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.292 -0.413 . . . . 54.25 113.428 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.21 148.76 50.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.773 0.32 . . . . 71.510000000000005 111.545 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -56.8 -43.06 80.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.983 0.42 . . . . 70.319999999999993 111.12 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -55.73 -39.57 71.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.04 -0.527 . . . . 63.340000000000003 111.565 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.488 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 87.6 t90 -60.54 -52.29 65.8 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 111.44 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.06 -41.37 96.48 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.136 -0.353 . . . . 75.510000000000005 111.344 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 112' ' ' TYR . 65.7 t -63.23 -35.04 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.276 0.56 . . . . 75.400000000000006 110.69 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 59' ' ' TRP . 60.5 t80 -57.15 -46.51 82.67 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.589 -0.732 . . . . 63.329999999999998 111.136 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.6 -40.86 72.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.851 0.357 . . . . 62.329999999999998 111.726 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -61.33 -31.94 71.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.284 0.476 . . . . 71.329999999999998 112.284 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.92 6.49 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.279 0.562 . . . . 72.239999999999995 111.193 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 21.63 73.96 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.425 -0.417 . . . . 74.230000000000004 113.527 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.55 27.16 71.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 121.227 -0.511 . . . . 55.049999999999997 113.456 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -89.95 25.45 2.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.216 -0.579 . . . . 75.129999999999995 111.674 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.4 pt -131.57 176.52 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.788 0.435 . . . . 74.230000000000004 110.643 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 129.22 9.81 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.8 -0.714 . . . . 54.439999999999998 113.124 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.6 m -62.35 -23.18 66.64 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.466 -0.432 . . . . 75.349999999999994 112.117 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -60.31 -15.74 28.18 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.599 0.592 . . . . 74.310000000000002 112.599 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -60.48 -36.18 77.67 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.045 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.44 -122.99 24.38 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.661 0.624 . . . . 71.209999999999994 114.661 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -60.23 141.84 55.42 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.25 0.548 . . . . 60.200000000000003 112.062 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -59.57 -23.11 62.64 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.993 0.738 . . . . 64.450000000000003 112.993 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.01 -11.4 60.32 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 122.046 -0.409 . . . . 72.109999999999999 111.864 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -101.54 -26.22 13.62 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.442 0.534 . . . . 73.519999999999996 112.442 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -41.08 -59.16 1.56 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.48 1.289 . . . . 72.129999999999995 114.48 -173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.85 85.01 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.046 -0.409 . . . . 53.299999999999997 112.013 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 m -63.78 -43.28 96.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 111.261 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.06 99.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.928 0.394 . . . . 52.32 111.365 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.1 82.9 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.042 0.448 . . . . 65.209999999999994 110.998 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 m -61.39 -40.68 95.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 111.489 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -73.16 -36.88 66.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.13 0.419 . . . . 74.540000000000006 112.13 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.02 66.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.231 0.456 . . . . 75.129999999999995 112.231 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.59 0.87 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.93 -0.652 . . . . 38.770000000000003 113.448 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.51 179.47 4.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 73.209999999999994 111.445 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.9 m -108.88 94.58 5.13 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.948 0.404 . . . . 64.530000000000001 111.815 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.85 111.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.893 0.377 . . . . 71.230000000000004 111.181 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.78 176.77 7.56 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.018 0.437 . . . . 75.400000000000006 111.09 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.26 -1.87 57.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.672 0.272 . . . . 63.109999999999999 110.818 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 t -55.8 118.28 19.33 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 116.304 -0.407 . . . . 75.120000000000005 111.425 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -86.23 11.8 3.2 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.008 2.472 . . . . 70.519999999999996 113.942 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -59.06 143.57 48.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 112.138 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.69 163.36 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.774 -0.648 . . . . 74.239999999999995 112.627 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.97 16.17 75.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.128 -0.558 . . . . 61.039999999999999 112.762 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -124.69 165.99 16.96 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.74 0.305 . . . . 54.439999999999998 111.153 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.8 mp -112.96 128.73 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.25 -0.281 . . . . 72.530000000000001 110.553 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 111' ' ' ALA . 1.9 pt? -101.26 133.06 46.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.332 0.587 . . . . 70.340000000000003 111.296 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.546 ' HA ' HG11 ' A' ' 110' ' ' VAL . 43.2 tt0 -92.83 108.83 20.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.046 -0.524 . . . . 63.100000000000001 110.934 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 46.6 m . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 N-CA-C 111.987 -0.445 . . . . 38.770000000000003 111.987 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -166.83 141.22 4.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.076 0.438 . . . . 65.329999999999998 111.521 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 101' ' ' GLN . 16.9 m -146.18 153.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.29 0.636 . . . . 60.350000000000001 110.697 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' HB2' HD21 ' A' ' 100' ' ' LEU . . . -148.22 160.55 42.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.926 0.394 . . . . 52.25 111.278 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.413 ' HB2' HG11 ' A' ' 61' ' ' VAL . 70.9 t80 -98.62 127.79 44.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.937 0.399 . . . . 74.040000000000006 111.445 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 116.21 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.391 -0.368 . . . . 74.519999999999996 111.888 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -88.03 -38.83 15.14 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.116 0.413 . . . . 73.409999999999997 112.116 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -161.88 145.91 12.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.796 0.665 . . . . 73.530000000000001 112.796 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.99 150.4 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.888 -0.596 . . . . 63.240000000000002 110.573 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -113.11 168.73 9.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.479 0.548 . . . . 73.200000000000003 112.479 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.7 t -63.22 -31.84 73.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.086 0.47 . . . . 72.430000000000007 110.933 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.95 -12.36 54.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 111.723 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.62 -1.22 89.04 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.636 -0.585 . . . . 73.439999999999998 111.636 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 m -68.38 136.1 52.82 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.941 0.401 . . . . 61.340000000000003 111.608 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.92 122.03 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.056 -0.52 . . . . 73.120000000000005 111.884 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 75.420000000000002 111.082 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.01 149.22 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.116 -0.493 . . . . 73.420000000000002 112.224 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.4 t -97.37 109.39 22.16 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.005 -0.543 . . . . 70.239999999999995 111.55 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.18 171.05 7.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.003 -0.544 . . . . 62.140000000000001 110.295 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 111.935 178.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 120.979 0.418 . . . . 62.219999999999999 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -99.64 119.39 38.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.098 0.475 . . . . 72.450000000000003 111.544 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.2 m -95.63 94.34 7.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.257 -0.429 . . . . 71.239999999999995 110.77 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.7 mt -83.22 131.83 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.582 -0.281 . . . . 72.420000000000002 111.311 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.5 m -62.63 150.11 41.63 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.483 0.182 . . . . 71.420000000000002 111.485 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.58 -51.06 39.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.736 0.643 . . . . 74.200000000000003 112.736 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.66 70.3 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.286 -0.415 . . . . 73.0 113.504 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.14 -38.53 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.124 0.487 . . . . 74.540000000000006 111.266 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.405 ' HB2' ' OH ' ' A' ' 151' ' ' TYR . . . -63.67 -38.69 92.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.073 -0.512 . . . . 75.019999999999996 112.173 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.1 t -61.36 -12.17 12.95 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.345 0.498 . . . . 75.140000000000001 112.345 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.1 t -82.02 -13.96 56.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.739 0.304 . . . . 51.039999999999999 111.784 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.44 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 36.2 m-85 -97.05 151.35 19.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 111.992 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -89.81 115.53 27.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.351 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.405 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 96.3 m-85 -94.87 112.06 23.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.419 . . . . 72.540000000000006 111.86 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 152' ' ' ILE . 3.9 mp -79.36 121.25 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.249 -0.432 . . . . 74.409999999999997 110.706 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -112.6 136.12 52.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 109.971 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.6 mt . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.81 0.338 . . . . 72.109999999999999 111.697 -175.663 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 121.274 0.559 . . . . 71.019999999999996 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.69 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.678 -0.692 . . . . 61.140000000000001 111.051 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.83 -31.5 4.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.337 -0.459 . . . . 50.240000000000002 112.819 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -60.97 137.65 58.22 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.526 -0.396 . . . . 73.120000000000005 111.84 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.436 ' O ' HG22 ' A' ' 61' ' ' VAL . 57.2 m -50.59 -41.95 55.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 71.430000000000007 110.416 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -59.29 -39.19 82.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.267 -0.879 . . . . 74.019999999999996 112.182 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -60.81 -52.62 64.3 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.5 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.78 -49.21 78.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.949 0.404 . . . . 62.420000000000002 111.76 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 57' ' ' CYS . 67.5 t -59.87 -36.73 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.958 0.408 . . . . 61.009999999999998 111.348 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -58.46 -38.52 77.71 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.098 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.21 -46.68 69.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.378 -0.373 . . . . 71.230000000000004 111.174 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.65 -33.69 71.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.232 0.456 . . . . 73.5 112.232 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -88.98 12.12 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-O 121.31 0.576 . . . . 75.400000000000006 111.461 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.19 14.23 55.89 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.361 -0.381 . . . . 51.009999999999998 113.814 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.21 9.1 53.52 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 114.194 0.438 . . . . 72.019999999999996 114.194 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.4 -20.56 63.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.592 0.59 . . . . 74.299999999999997 112.592 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.452 HG23 HD23 ' A' ' 154' ' ' LEU . 34.2 pt -80.23 -35.9 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.895 0.702 . . . . 72.340000000000003 112.895 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 119.34 2.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.097 -0.573 . . . . 63.530000000000001 112.231 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -81.72 20.39 0.94 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.771 0.656 . . . . 70.209999999999994 112.771 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 t -90.81 12.3 19.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 74.439999999999998 111.97 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -83.42 -30.03 27.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.683 0.277 . . . . 60.509999999999998 111.72 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.66 -126.31 7.48 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.373 -0.442 . . . . 50.43 113.925 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -58.8 139.47 56.29 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.893 0.377 . . . . 44.009999999999998 111.73 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -54.62 -40.29 68.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.839 0.681 . . . . 72.519999999999996 112.839 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -71.81 -9.59 58.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.689 0.626 . . . . 74.150000000000006 112.689 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -97.19 -15.98 20.62 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.759 0.314 . . . . 74.409999999999997 111.263 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -49.79 -58.74 4.74 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.726 0.639 . . . . 74.120000000000005 112.726 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.43 -39.71 70.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 75.439999999999998 111.769 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -40.41 89.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.325 -0.398 . . . . 70.400000000000006 111.766 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.44 -45.84 24.49 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.012 0.434 . . . . 74.140000000000001 111.37 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.89 -56.58 11.62 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.38 0.511 . . . . 73.420000000000002 112.38 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m -67.55 -1.01 4.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.621 0.6 . . . . 75.349999999999994 112.621 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.0 t -116.93 -12.18 10.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.973 0.416 . . . . 52.119999999999997 111.54 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.05 8.54 38.82 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.17 0.433 . . . . 72.239999999999995 112.17 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.82 35.82 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.967 -0.635 . . . . 61.200000000000003 113.543 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.01 162.63 12.98 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.141 0.496 . . . . 71.510000000000005 111.355 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -111.28 99.08 7.97 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.879 0.371 . . . . 74.049999999999997 111.905 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG23 HG13 ' A' ' 152' ' ' ILE . 57.4 t -93.6 103.75 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.422 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 86.4 m-20 -134.8 137.92 43.79 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.061 -0.518 . . . . 75.209999999999994 109.956 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.58 -4.69 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.056 0.761 . . . . 74.25 113.056 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 m -55.71 112.81 4.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 122.597 0.359 . . . . 74.120000000000005 111.388 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.75 119.0 3.55 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.813 2.342 . . . . 71.200000000000003 113.166 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.9 145.16 30.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.703 -0.681 . . . . 73.019999999999996 111.146 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.43 133.11 54.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.917 0.389 . . . . 38.509999999999998 111.596 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.22 48.83 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.841 -0.695 . . . . 72.120000000000005 112.795 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.3 p -159.3 177.13 11.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.94 0.4 . . . . 63.420000000000002 110.657 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mt -123.7 122.75 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.872 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -98.59 123.52 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.547 0.689 . . . . 73.310000000000002 111.66 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 29.0 tt0 -82.37 106.45 14.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.94 -0.573 . . . . 73.030000000000001 111.45 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 44.2 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 110.734 173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.717 0 CA-C-O 120.838 0.132 . . . . 73.019999999999996 113.065 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 74.6 t60 -140.49 105.97 5.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.908 0.385 . . . . 65.049999999999997 110.652 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 76' ' ' ALA . 27.7 m -103.65 136.38 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.111 0.481 . . . . 71.409999999999997 111.649 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.88 159.52 41.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.929 -0.578 . . . . 71.540000000000006 110.737 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -93.14 123.98 36.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.879 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.61 112.29 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.021 0.439 . . . . 73.230000000000004 111.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.23 -49.36 13.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.021 -0.536 . . . . 74.209999999999994 111.459 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -164.96 139.57 5.14 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.963 0.411 . . . . 65.030000000000001 112.091 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.42 123.64 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.247 -0.433 . . . . 52.229999999999997 109.922 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -78.17 166.84 22.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.372 0.508 . . . . 75.010000000000005 112.372 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -47.26 -48.51 24.57 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.465 0.543 . . . . 65.299999999999997 112.465 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.72 -45.28 87.22 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.002 0.429 . . . . 71.450000000000003 111.769 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.42 -21.89 2.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.889 -0.672 . . . . 70.430000000000007 113.661 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.1 m -56.78 129.74 42.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.419 0.61 . . . . 74.329999999999998 111.426 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.2 t -103.74 120.97 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.81 -0.632 . . . . 74.0 112.033 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.45 122.76 33.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.428 -0.351 . . . . 73.340000000000003 110.843 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.89 149.9 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.378 0.51 . . . . 73.5 112.378 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 90.1 p -94.35 126.57 39.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.142 -0.481 . . . . 65.340000000000003 111.171 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.85 179.75 4.4 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.413 0.625 . . . . 61.240000000000002 111.962 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.4 ttm . . . . . 0 CA--C 1.535 0.391 0 CA-C-N 115.53 -0.759 . . . . 65.25 109.851 171.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.842 -0.059 . . . . 73.0 110.842 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -127.91 133.21 49.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 111.782 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.9 m -97.49 100.22 11.63 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.846 0.355 . . . . 71.5 110.717 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.0 mt -81.57 136.91 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.681 0.277 . . . . 74.409999999999997 111.426 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -63.72 147.42 51.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.603 0.239 . . . . 73.319999999999993 111.538 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.84 -45.8 71.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.372 0.508 . . . . 74.030000000000001 112.372 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.35 -49.96 71.23 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.286 -0.483 . . . . 61.130000000000003 113.3 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -44.15 91.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 110.856 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.451 ' HB1' ' HH ' ' A' ' 151' ' ' TYR . . . -60.49 -44.3 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.777 -0.647 . . . . 70.400000000000006 112.112 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 t -63.9 -16.34 61.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.101 0.477 . . . . 74.219999999999999 111.577 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.2 t -82.08 -6.22 59.0 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.385 -0.37 . . . . 72.219999999999999 111.731 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 22.3 m-85 -102.11 153.16 20.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 75.310000000000002 111.821 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 15.9 m-80 -92.04 107.25 19.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.447 -0.342 . . . . 72.0 111.518 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.8 m-85 -85.9 114.66 22.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.28 0.474 . . . . 73.239999999999995 112.28 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.524 HG13 HG23 ' A' ' 90' ' ' VAL . 3.8 mp -78.44 114.52 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.549 174.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -106.36 142.51 35.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.85 0.357 . . . . 72.239999999999995 110.961 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 69' ' ' ILE . 41.7 mt . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 120.851 0.358 . . . . 73.209999999999994 111.749 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 112.797 0.666 . . . . 74.209999999999994 112.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.0 142.34 58.41 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.876 -0.602 . . . . 75.409999999999997 111.917 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.92 32.35 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.23 -0.51 . . . . 71.140000000000001 112.29 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.76 139.68 31.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.244 -0.28 . . . . 75.120000000000005 110.244 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 49.0 m -54.87 -29.23 55.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.984 0.421 . . . . 72.409999999999997 112.043 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 p -60.15 -35.67 75.83 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.909 0.707 . . . . 74.530000000000001 112.909 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 48.6 t90 -61.91 -62.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.278 0.844 . . . . 74.420000000000002 113.278 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 32.5 p90 -68.01 -28.86 67.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.875 0.694 . . . . 73.299999999999997 112.875 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.68 -36.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.06 0.457 . . . . 72.420000000000002 111.018 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -59.41 -34.93 73.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.276 0.56 . . . . 75.120000000000005 110.964 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.71 -50.56 34.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.94 -0.573 . . . . 75.209999999999994 110.405 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.0 mmmt -55.3 -36.82 66.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.774 0.657 . . . . 73.530000000000001 112.774 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.42 HG22 HG21 ' A' ' 69' ' ' ILE . 8.0 p -82.33 -5.22 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 121.059 0.457 . . . . 74.200000000000003 111.929 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.57 24.43 76.21 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.283 -0.484 . . . . 54.420000000000002 113.55 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.12 23.2 72.95 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.203 -0.522 . . . . 73.540000000000006 113.895 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -89.26 19.9 4.09 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.311 0.486 . . . . 61.119999999999997 112.311 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 65' ' ' VAL . 34.7 pt -126.73 178.49 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.921 0.391 . . . . 74.239999999999995 111.537 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.28 125.65 7.26 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.315 -0.469 . . . . 65.140000000000001 113.043 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.7 p -80.55 -13.35 59.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.742 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -94.55 13.92 22.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.204 0.446 . . . . 75.439999999999998 112.204 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.43 -32.37 58.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 73.409999999999997 111.824 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.48 -118.63 6.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.297 -0.477 . . . . 74.540000000000006 113.665 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.3 137.74 56.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.097 0.406 . . . . 75.439999999999998 112.097 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -55.36 -42.68 74.22 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.355 0.502 . . . . 74.239999999999995 112.355 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -68.64 -2.99 10.35 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.568 0.581 . . . . 74.310000000000002 112.568 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -100.96 -10.24 20.77 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.785 0.326 . . . . 71.340000000000003 111.537 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -61.19 -36.56 80.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.042 0.756 . . . . 74.230000000000004 113.042 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.21 -50.14 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.12 0.486 . . . . 75.140000000000001 111.2 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -61.23 -46.48 90.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.065 -0.516 . . . . 65.439999999999998 111.27 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.24 -52.54 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.085 -0.507 . . . . 74.230000000000004 111.614 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.46 -47.41 69.77 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.831 0.348 . . . . 64.420000000000002 111.665 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -59.58 -50.99 71.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.18 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.0 t -69.28 -19.85 63.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.205 0.446 . . . . 61.039999999999999 112.205 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.41 -36.03 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.081 0.401 . . . . 71.140000000000001 112.081 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.16 8.04 5.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.992 -0.623 . . . . 75.420000000000002 113.181 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -80.07 -171.34 2.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.186 0.517 . . . . 71.450000000000003 111.176 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.0 m -121.94 91.25 3.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.064 0.459 . . . . 73.120000000000005 111.359 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.27 105.17 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.0 0.428 . . . . 74.109999999999999 111.315 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -127.2 161.31 28.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 111.212 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.41 7.24 20.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.136 0.493 . . . . 71.219999999999999 110.969 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 m -72.76 112.49 15.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.318 -0.401 . . . . 43.109999999999999 110.995 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.58 22.72 0.51 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.052 2.501 . . . . 54.539999999999999 114.47 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.535 ' HB3' ' HE1' ' A' ' 153' ' ' HIS . 36.4 tt0 -60.1 147.16 40.48 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.063 0.459 . . . . 62.109999999999999 111.851 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.34 166.55 21.39 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.22 0.822 . . . . 75.239999999999995 113.22 -173.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.06 31.02 44.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.703 -0.68 . . . . 71.230000000000004 112.93 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.1 m -146.75 170.63 16.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 111.273 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.4 mp -107.68 133.83 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 110.254 -0.276 . . . . 75.319999999999993 110.254 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -98.89 107.82 20.35 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.986 0.898 . . . . 73.420000000000002 111.049 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.518 ' HA ' HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -72.93 99.12 2.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 72.049999999999997 109.822 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.416 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 50.9 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.56 -0.746 . . . . 74.530000000000001 111.595 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 112.228 -0.349 . . . . 75.340000000000003 112.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -112.38 147.37 36.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 111.929 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' ' 101' ' ' GLN . 10.1 m -142.69 141.49 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.143 -0.481 . . . . 64.439999999999998 110.667 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.03 159.63 43.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.76 0.314 . . . . 73.319999999999993 110.509 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -94.32 125.73 39.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.945 0.403 . . . . 73.010000000000005 111.667 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.42 109.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.893 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.84 -61.18 2.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.044 -0.525 . . . . 65.129999999999995 111.771 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -148.56 145.43 27.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 62.140000000000001 111.949 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.2 t -103.11 125.77 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.595 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -95.36 141.07 29.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.748 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -60.36 -21.25 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.394 -0.366 . . . . 71.0 111.852 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.23 -12.89 56.12 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.863 0.363 . . . . 74.239999999999995 111.956 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.83 45.56 4.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.93 -0.468 . . . . 64.319999999999993 111.93 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.7 p -137.17 138.6 40.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.086 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.17 119.45 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.223 -0.444 . . . . 62.43 111.57 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.627 ' HG2' ' HG1' ' A' ' 140' ' ' THR . 54.2 mt-10 -88.44 112.27 22.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.86 0.362 . . . . 55.32 110.963 176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.97 137.91 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.195 0.521 . . . . 64.519999999999996 112.02 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.425 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 34.5 p -86.61 115.61 24.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.07 0.462 . . . . 75.400000000000006 111.883 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 11.5 pt-20 -133.43 -179.27 5.41 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.596 . . . . 75.120000000000005 111.387 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.437 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 49.0 ttm . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.905 0.383 . . . . 53.539999999999999 111.54 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 120.819 0.342 . . . . 64.430000000000007 111.375 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -82.52 120.97 26.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.171 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.627 ' HG1' ' HG2' ' A' ' 123' ' ' GLU . 71.4 m -85.81 106.56 17.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.042 0.448 . . . . 75.140000000000001 110.923 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -97.71 139.65 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.192 -0.458 . . . . 72.510000000000005 111.658 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -69.71 154.54 41.84 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.783 0.325 . . . . 61.020000000000003 111.233 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.87 80.99 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.605 0.595 . . . . 64.129999999999995 112.605 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.26 -49.12 82.02 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.293 -0.479 . . . . 63.020000000000003 112.996 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.55 -40.98 93.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.127 0.489 . . . . 61.119999999999997 110.861 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -56.57 -42.57 78.83 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 111.8 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.3 t -60.96 -19.83 61.51 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.106 0.479 . . . . 64.209999999999994 111.744 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 47.4 t -77.42 -17.72 57.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.929 0.395 . . . . 71.319999999999993 111.674 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.416 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 17.0 m-85 -101.01 157.87 16.43 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.229 0.538 . . . . 72.409999999999997 111.817 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -99.74 111.04 23.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 111.333 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.403 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 76.3 m-85 -87.98 106.2 17.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.063 0.459 . . . . 73.25 111.976 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.14 103.18 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.053 -0.521 . . . . 73.310000000000002 110.907 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.535 ' HE1' ' HB3' ' A' ' 95' ' ' GLU . 92.8 m-70 -85.16 143.09 29.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.364 . . . . 70.319999999999993 110.435 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 75.129999999999995 112.568 -166.424 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.404 0.52 . . . . 70.129999999999995 112.404 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.27 143.03 41.12 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.033 0.444 . . . . 43.219999999999999 111.946 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.95 58.19 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.086 -0.506 . . . . 45.210000000000001 113.295 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -83.52 141.59 31.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.904 0.352 . . . . 74.420000000000002 111.513 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 60' ' ' TYR . 56.6 m -59.97 -29.41 68.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.401 0.619 . . . . 45.240000000000002 111.075 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.1 p -76.08 -11.35 59.93 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.817 -0.629 . . . . 73.019999999999996 112.549 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -76.8 -62.71 1.55 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.657 0.614 . . . . 74.25 112.657 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HE2' ' HA ' ' A' ' 57' ' ' CYS . 50.5 p90 -63.72 -26.56 68.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.923 0.712 . . . . 73.109999999999999 112.923 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 110' ' ' VAL . 46.4 t -60.68 -31.96 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.897 0.38 . . . . 74.230000000000004 111.974 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.79 -44.53 95.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.883 0.373 . . . . 73.099999999999994 111.295 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -64.63 -41.06 96.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.286 0.565 . . . . 74.510000000000005 110.565 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.9 mmmt -62.18 -32.91 73.59 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.693 -0.685 . . . . 70.140000000000001 112.28 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 HG22 HD13 ' A' ' 154' ' ' LEU . 9.2 p -96.52 6.82 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 121.334 0.588 . . . . 72.219999999999999 111.961 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.53 8.62 76.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 45.409999999999997 114.237 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.87 3.07 66.79 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.038 0.775 . . . . 37.649999999999999 115.038 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.01 17.64 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.904 -0.762 . . . . 74.420000000000002 112.705 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 pt -106.32 -29.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 111.954 0.353 . . . . 64.340000000000003 111.954 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.87 98.77 1.1 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.044 -0.598 . . . . 71.319999999999993 112.884 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 p -73.02 83.85 1.26 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.229 -0.571 . . . . 75.340000000000003 111.522 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.7 t -154.79 17.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.09 0.471 . . . . 64.239999999999995 111.318 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -89.47 -4.12 58.09 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.26 0.467 . . . . 74.299999999999997 112.26 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.63 -137.76 22.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.054 -0.593 . . . . 64.109999999999999 113.329 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -70.24 155.39 40.71 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.502 -0.411 . . . . 73.219999999999999 111.57 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -56.84 -32.12 65.45 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.828 0.677 . . . . 60.140000000000001 112.828 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.93 -28.61 57.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.328 0.492 . . . . 75.319999999999993 112.328 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.33 -16.53 24.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.286 0.476 . . . . 73.239999999999995 112.286 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -50.22 -66.02 0.46 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.964 1.098 . . . . 73.340000000000003 113.964 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.5 -33.71 68.31 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.298 0.481 . . . . 52.399999999999999 112.298 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -67.31 -48.02 68.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.057 0.456 . . . . 74.109999999999999 110.835 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.52 96.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 111.357 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.96 44.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.298 -0.41 . . . . 73.329999999999998 111.105 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -61.07 -40.0 92.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.892 0.377 . . . . 62.539999999999999 110.939 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -63.62 -27.58 69.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.301 -0.408 . . . . 62.240000000000002 111.379 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.27 -12.18 41.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.945 0.402 . . . . 63.329999999999998 111.898 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.51 52.69 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.261 -0.495 . . . . 72.319999999999993 113.693 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -70.51 175.52 4.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.333 0.587 . . . . 74.219999999999999 112.012 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -101.01 92.03 4.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.053 -0.521 . . . . 72.140000000000001 111.506 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.8 93.48 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.916 0.389 . . . . 71.120000000000005 111.024 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -122.5 168.2 12.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.543 -0.299 . . . . 71.5 110.529 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.35 5.92 32.47 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.931 -0.481 . . . . 75.099999999999994 111.767 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 44.2 m -65.21 109.06 2.5 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 116.729 -0.214 . . . . 72.0 110.829 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 6.2 Cg_exo -79.14 8.85 3.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.302 2.668 . . . . 74.420000000000002 113.968 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.01 145.26 17.1 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.333 0.494 . . . . 75.120000000000005 112.333 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.72 46.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.877 -0.601 . . . . 54.149999999999999 112.587 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.28 55.5 1.69 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.001 -0.619 . . . . 70.420000000000002 111.803 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.6 t -163.01 165.35 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.305 0.574 . . . . 62.219999999999999 111.85 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 35.2 mt -116.58 125.38 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.644 -0.707 . . . . 65.400000000000006 110.479 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -99.43 133.14 44.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.928 0.394 . . . . 65.25 111.396 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -102.4 133.18 47.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.399 0.518 . . . . 73.140000000000001 112.399 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.473 0.684 0 CA-C-N 116.033 -0.53 . . . . 74.549999999999997 110.38 171.662 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.405 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.152 0.306 . . . . 63.229999999999997 113.038 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -140.73 137.27 33.33 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.857 -0.202 . . . . 75.120000000000005 110.817 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 76' ' ' ALA . 14.3 m -138.68 141.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.923 0.392 . . . . 71.040000000000006 111.499 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.09 22.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.96 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -101.37 133.73 45.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.44 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.41 110.1 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 111.646 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.43 -53.38 9.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.09 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -156.57 143.36 18.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.041 0.448 . . . . 64.120000000000005 112.135 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.71 135.0 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.386 -0.37 . . . . 74.310000000000002 110.926 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -92.17 154.7 18.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.369 -0.378 . . . . 63.43 111.304 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -59.18 -24.25 62.92 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.84 0.352 . . . . 65.430000000000007 111.688 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.17 -11.52 60.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.926 0.393 . . . . 71.329999999999998 111.717 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.65 56.47 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.385 -0.436 . . . . 42.219999999999999 112.968 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.1 m -64.84 126.43 27.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.11 0.481 . . . . 64.409999999999997 111.423 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.4 t -103.19 129.74 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.957 -0.565 . . . . 71.430000000000007 111.32 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.14 112.96 26.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.857 0.361 . . . . 75.099999999999994 111.415 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.0 162.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.964 0.412 . . . . 73.510000000000005 111.81 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.419 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 61.7 p -117.03 133.91 55.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.13 0.49 . . . . 72.230000000000004 111.614 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -129.51 152.09 49.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.12 -0.491 . . . . 53.119999999999997 111.047 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.0 ttm . . . . . 0 N--CA 1.466 0.336 0 O-C-N 121.902 -0.499 . . . . 61.450000000000003 109.96 172.11 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.605 0.24 . . . . 65.329999999999998 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.22 109.8 6.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 110.866 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 79.9 m -85.02 139.28 31.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.445 -0.343 . . . . 62.119999999999997 111.569 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.6 mt -123.52 149.08 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.758 0.423 . . . . 53.420000000000002 110.87 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 m -64.53 156.77 28.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.11 0.164 . . . . 61.039999999999999 110.838 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.67 -63.22 1.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.086 0.402 . . . . 73.109999999999999 112.086 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.66 -38.1 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.204 -0.522 . . . . 71.109999999999999 112.956 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.51 -36.26 80.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.006 0.522 . . . . 64.450000000000003 110.991 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -43.63 65.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.106 -0.497 . . . . 61.399999999999999 111.529 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 t -59.23 -15.73 16.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 111.965 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.7 t -70.07 -25.28 63.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.925 0.393 . . . . 73.310000000000002 111.575 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -87.4 154.56 20.57 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.242 0.544 . . . . 72.430000000000007 111.895 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -89.3 119.76 30.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.828 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 95.5 m-85 -100.91 117.07 34.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.634 0.605 . . . . 71.140000000000001 112.634 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -91.35 121.03 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.127 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -113.76 157.31 22.41 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.901 0.481 . . . . 71.439999999999998 110.96 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.474 HD13 HG22 ' A' ' 65' ' ' VAL . 34.2 mt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.49 0.552 . . . . 73.310000000000002 112.49 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 95.93 0.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.021 -0.536 . . . . 75.099999999999994 111.917 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.21 -22.74 0.87 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.955 -0.566 . . . . 52.149999999999999 112.679 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -80.31 146.89 31.37 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 111.713 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.406 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.6 m -57.87 -38.52 75.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.56 0.695 . . . . 70.219999999999999 110.448 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.9 p -62.7 -24.33 67.6 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.487 -0.779 . . . . 72.409999999999997 112.274 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -62.59 -65.28 0.71 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.334 0.494 . . . . 65.140000000000001 112.334 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -66.97 -29.08 68.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.537 0.569 . . . . 73.230000000000004 112.537 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 57' ' ' CYS . 61.1 t -61.37 -37.63 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 111.426 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -57.97 -47.82 81.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.978 0.418 . . . . 75.319999999999993 110.845 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.14 -38.69 72.25 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.944 0.35 . . . . 72.310000000000002 111.944 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -56.07 -38.39 70.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.998 0.428 . . . . 74.439999999999998 111.855 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG23 HD12 ' A' ' 99' ' ' ILE . 8.8 p -88.39 9.37 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 121.388 0.613 . . . . 51.329999999999998 111.456 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.68 -2.87 77.3 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.336 -0.393 . . . . 38.280000000000001 113.703 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.31 14.56 66.06 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.998 -0.62 . . . . 63.229999999999997 113.143 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.82 10.38 6.4 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.199 0.444 . . . . 73.129999999999995 112.199 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 pt -110.5 174.1 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.799 0.333 . . . . 53.409999999999997 111.118 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.6 124.31 6.76 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.93 -0.652 . . . . 54.329999999999998 114.013 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.3 p -65.5 -19.39 65.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.026 0.441 . . . . 75.400000000000006 111.13 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 t -78.58 -6.94 56.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.809 0.67 . . . . 71.239999999999995 112.809 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -61.33 -43.51 98.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.153 -0.342 . . . . 74.519999999999996 111.684 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.89 -116.29 5.92 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 114.246 0.458 . . . . 71.540000000000006 114.246 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -57.66 132.47 53.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.197 0.444 . . . . 72.0 112.197 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -57.96 -40.55 80.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.178 0.513 . . . . 65.200000000000003 111.885 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -66.91 -19.3 65.7 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.394 0.616 . . . . 72.530000000000001 110.767 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.9 -17.51 23.92 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.055 -0.521 . . . . 74.109999999999999 112.387 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -47.56 -47.07 28.4 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.345 0.868 . . . . 75.209999999999994 113.345 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' A' ' 101' ' ' GLN . . . -59.22 -46.48 88.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.83 0.348 . . . . 50.509999999999998 111.701 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.6 t -59.43 -38.91 81.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.004 0.43 . . . . 45.340000000000003 111.439 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.45 -59.51 2.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 111.277 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.65 36.26 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.685 0.624 . . . . 73.150000000000006 112.685 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 p -55.64 -53.52 55.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 111.998 0.37 . . . . 71.030000000000001 111.998 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -72.14 -22.1 61.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.233 0.457 . . . . 74.310000000000002 112.233 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.64 -17.55 50.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.197 0.443 . . . . 63.509999999999998 112.197 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 25.39 5.46 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.003 -0.617 . . . . 73.540000000000006 113.803 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.72 -176.38 3.17 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.446 -0.444 . . . . 74.519999999999996 110.732 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 63.8 m -109.19 93.0 4.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.741 0.305 . . . . 73.040000000000006 111.772 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.483 HG22 HG13 ' A' ' 152' ' ' ILE . 46.8 t -97.02 91.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.22 0.533 . . . . 73.219999999999999 111.018 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 163.94 19.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.004 -0.544 . . . . 62.530000000000001 110.531 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.87 -7.47 57.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.11 -0.369 . . . . 74.549999999999997 111.166 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -51.45 106.05 0.6 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 116.382 -0.372 . . . . 64.209999999999994 110.86 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -84.25 13.24 2.78 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.832 2.355 . . . . 63.520000000000003 114.796 -168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.24 151.46 36.21 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.929 0.714 . . . . 74.010000000000005 112.929 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.58 160.3 11.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.44 -0.8 . . . . 73.019999999999996 112.892 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.4 32.97 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.192 -0.528 . . . . 63.25 112.273 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -145.55 164.91 30.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.822 0.344 . . . . 54.020000000000003 110.715 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.9 mp -100.86 117.42 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.059 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -79.35 136.87 37.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 72.5 110.601 174.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.444 ' OE1' ' HB1' ' A' ' 80' ' ' ALA . 31.0 tt0 -120.06 104.54 10.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.835 0.35 . . . . 74.400000000000006 111.335 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 50.8 m . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.939 0.399 . . . . 74.340000000000003 110.811 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 N-CA-C 113.929 0.332 . . . . 72.25 113.929 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 46.7 t60 -138.42 149.73 45.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.819 0.447 . . . . 75.010000000000005 110.747 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 76' ' ' ALA . 14.0 m -141.17 143.95 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.439 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.67 23.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 111.681 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -80.64 133.68 35.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.246 -0.284 . . . . 75.430000000000007 110.989 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.46 114.34 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.025 0.441 . . . . 53.340000000000003 111.91 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -79.28 -41.49 27.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.912 -0.586 . . . . 75.319999999999993 111.686 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -167.85 151.95 6.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.909 0.385 . . . . 75.510000000000005 111.809 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.25 122.21 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.638 0.256 . . . . 71.239999999999995 110.685 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -83.05 160.97 21.84 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.15 0.426 . . . . 73.310000000000002 112.15 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -56.07 -22.5 28.05 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.029 0.443 . . . . 75.319999999999993 111.545 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.76 -9.11 17.9 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.135 -0.484 . . . . 71.25 112.0 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.54 89.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.338 -0.458 . . . . 74.340000000000003 112.272 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 m -88.45 131.48 34.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.147 0.498 . . . . 75.239999999999995 111.663 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.07 119.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.349 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.514 ' HG2' ' HG1' ' A' ' 140' ' ' THR . 38.0 mt-10 -98.59 107.91 20.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.687 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.429 HG12 HD13 ' A' ' 100' ' ' LEU . 34.4 m -105.2 161.87 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.551 0.574 . . . . 63.420000000000002 112.551 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.2 t -95.81 123.73 39.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.037 -0.529 . . . . 74.519999999999996 111.874 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -126.51 150.0 49.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.129 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.7 ttm . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.747 0.308 . . . . 72.109999999999999 110.234 175.431 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.116 0.484 . . . . 72.150000000000006 111.715 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.43 118.57 31.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.306 -0.407 . . . . 75.549999999999997 110.841 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.514 ' HG1' ' HG2' ' A' ' 123' ' ' GLU . 89.4 m -90.69 105.27 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.134 0.493 . . . . 75.019999999999996 111.866 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.51 133.54 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.073 0.549 . . . . 72.349999999999994 111.102 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -72.85 157.95 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.157 0.428 . . . . 75.099999999999994 112.157 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.46 72.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.688 0.625 . . . . 74.439999999999998 112.688 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.06 -45.88 86.2 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.305 -0.474 . . . . 60.039999999999999 112.997 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.61 -40.56 95.72 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.416 0.627 . . . . 71.430000000000007 110.878 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.68 ' HB3' ' HH ' ' A' ' 151' ' ' TYR . . . -68.93 -21.11 64.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.641 -0.708 . . . . 71.540000000000006 112.689 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.4 p -65.73 -13.16 58.79 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.317 0.488 . . . . 61.439999999999998 112.317 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 39.0 t -102.49 2.21 36.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 111.865 0.32 . . . . 70.450000000000003 111.865 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -103.68 146.09 29.1 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.21 -0.306 . . . . 75.150000000000006 110.94 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -94.23 139.59 30.85 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.539 0.209 . . . . 51.210000000000001 110.943 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.68 ' HH ' ' HB3' ' A' ' 146' ' ' ALA . 91.3 m-85 -117.22 116.98 28.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 73.450000000000003 111.797 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.3 mp -89.05 113.44 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.358 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 13.4 m-70 -99.97 136.06 40.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.082 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 112.481 0.549 . . . . 72.140000000000001 112.481 -177.18 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 111.998 0.37 . . . . 70.319999999999993 111.998 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.72 124.3 28.92 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.852 0.358 . . . . 74.349999999999994 111.871 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.54 21.39 5.12 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.43 -0.414 . . . . 70.109999999999999 113.1 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -129.72 152.38 49.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.568 -0.372 . . . . 70.099999999999994 111.215 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.4 p -63.1 -35.76 81.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.945 0.403 . . . . 70.030000000000001 110.615 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -61.5 -26.59 68.01 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.059 0.456 . . . . 74.329999999999998 111.397 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -78.91 -55.69 4.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.049 -0.523 . . . . 71.219999999999999 110.869 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.05 -52.77 63.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.883 -0.599 . . . . 73.540000000000006 112.499 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.4 t -58.99 -31.99 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.301 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.41 -35.95 82.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.151 0.501 . . . . 71.150000000000006 110.667 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.96 -44.18 73.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.797 -0.638 . . . . 75.019999999999996 111.142 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.282 0.475 . . . . 74.209999999999994 112.282 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG13 HG12 ' A' ' 69' ' ' ILE . 9.4 p -88.42 8.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 121.083 0.468 . . . . 71.030000000000001 111.563 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.05 67.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.403 -0.427 . . . . 72.400000000000006 113.814 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.15 15.15 64.92 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.18 -0.533 . . . . 37.640000000000001 113.477 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.38 -5.88 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.218 0.451 . . . . 73.109999999999999 112.218 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.4 HG12 HG13 ' A' ' 65' ' ' VAL . 35.5 pt -98.79 140.93 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.559 -0.291 . . . . 72.049999999999997 110.495 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.16 125.14 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.9 -0.667 . . . . 71.239999999999995 113.586 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -66.36 78.31 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.182 0.515 . . . . 63.030000000000001 111.355 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -151.96 13.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.385 0.612 . . . . 74.200000000000003 110.905 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.66 -34.32 12.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 111.446 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.36 -130.92 10.02 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.184 -0.531 . . . . 53.140000000000001 113.344 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -67.11 151.25 47.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.3 0.572 . . . . 63.030000000000001 111.757 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -57.01 -33.92 67.65 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.863 1.06 . . . . 64.519999999999996 113.863 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.09 -28.08 69.2 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.848 -0.532 . . . . 72.040000000000006 112.032 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -84.63 -14.56 48.3 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.685 0.279 . . . . 62.210000000000001 111.604 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -51.02 -62.54 1.55 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.114 0.783 . . . . 72.430000000000007 113.114 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.57 -43.55 72.16 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.271 0.471 . . . . 73.409999999999997 112.271 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -60.91 -48.47 81.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.14 0.495 . . . . 73.439999999999998 111.508 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.12 60.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.148 -0.478 . . . . 71.200000000000003 111.455 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.65 7.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.355 -0.384 . . . . 74.530000000000001 111.025 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 p -62.14 -37.32 84.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.132 0.492 . . . . 74.129999999999995 110.941 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -64.25 -38.33 90.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.004 -0.543 . . . . 61.240000000000002 111.951 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.42 -6.01 58.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.676 0.621 . . . . 71.349999999999994 112.676 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.83 -2.3 25.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.938 -0.649 . . . . 74.319999999999993 113.574 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -76.36 170.32 16.58 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.305 0.574 . . . . 74.219999999999999 111.087 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.9 m -115.43 103.57 10.9 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.216 0.451 . . . . 73.340000000000003 112.216 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 152' ' ' ILE . 46.6 t -102.16 119.41 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 70.209999999999994 111.84 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -143.62 168.57 19.57 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.135 -0.484 . . . . 72.310000000000002 110.329 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.48 12.59 9.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.825 0.345 . . . . 70.420000000000002 111.53 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -65.73 108.99 2.54 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 110.624 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.68 14.0 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.042 2.495 . . . . 72.329999999999998 114.419 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -61.69 149.56 39.22 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.179 0.514 . . . . 74.329999999999998 111.985 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.471 ' HA ' HG11 ' A' ' 113' ' ' VAL . . . -60.51 152.47 25.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.953 0.723 . . . . 51.340000000000003 112.953 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.58 23.79 38.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.164 -0.471 . . . . 62.240000000000002 113.192 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.3 p -131.25 159.28 38.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 111.112 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.3 mp -103.42 119.69 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.327 -0.397 . . . . 63.25 110.521 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 111' ' ' ALA . 1.9 pt? -96.07 130.22 43.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.56 124.29 39.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.056 -0.52 . . . . 71.219999999999999 112.159 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 115.877 -0.601 . . . . 72.109999999999999 110.734 171.011 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.646 0 CA-C-O 120.988 0.215 . . . . 63.100000000000001 113.141 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -147.84 149.18 31.81 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.374 -0.486 . . . . 72.310000000000002 111.032 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 76' ' ' ALA . 13.5 m -141.57 151.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.083 0.468 . . . . 73.519999999999996 111.779 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -149.26 167.79 25.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.992 -0.549 . . . . 71.109999999999999 110.996 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -102.94 129.76 49.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.25 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 96' ' ' ALA . 70.8 t -80.81 110.93 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 63.340000000000003 111.494 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -83.82 -45.58 13.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.08 0.4 . . . . 74.430000000000007 112.08 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -158.89 148.47 19.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.498 0.555 . . . . 73.25 112.498 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -109.71 134.7 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 63.310000000000002 110.638 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -94.96 160.87 14.38 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.297 0.48 . . . . 73.329999999999998 112.297 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -61.6 -22.4 65.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.103 -0.499 . . . . 62.439999999999998 111.413 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.64 -15.47 63.67 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.984 -0.553 . . . . 70.140000000000001 111.425 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.61 67.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.035 -0.426 . . . . 71.099999999999994 112.035 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 141.75 49.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.215 0.531 . . . . 74.430000000000007 111.894 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.32 128.32 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.857 -0.611 . . . . 72.129999999999995 111.981 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.28 117.27 29.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.941 0.4 . . . . 73.109999999999999 111.272 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.95 147.51 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.083 -0.508 . . . . 72.129999999999995 111.717 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.9 p -101.07 125.06 47.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.407 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 -179.68 5.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.384 0.611 . . . . 73.219999999999999 112.456 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 CA--C 1.537 0.46 0 CA-C-N 115.896 -0.593 . . . . 74.409999999999997 110.822 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 112.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.46 135.86 25.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.979 0.419 . . . . 73.439999999999998 111.526 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.3 m -95.05 99.76 11.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.075 0.464 . . . . 71.219999999999999 111.097 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.31 134.27 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.316 -0.402 . . . . 62.399999999999999 111.292 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 62.0 m -66.86 149.35 50.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.767 0.318 . . . . 61.219999999999999 111.562 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.85 66.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.582 0.586 . . . . 61.310000000000002 112.582 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.32 -38.47 86.77 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.408 -0.425 . . . . 54.240000000000002 113.564 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -83.09 -39.22 21.42 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.455 -0.438 . . . . 73.209999999999994 111.073 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.51 72.29 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.802 0.667 . . . . 63.409999999999997 112.802 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.8 m -66.42 -14.41 62.13 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.918 0.389 . . . . 73.030000000000001 111.978 -171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -85.28 -10.84 55.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.428 -0.351 . . . . 73.349999999999994 111.551 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.78 151.73 25.03 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.91 0.386 . . . . 72.140000000000001 111.175 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -89.09 112.91 23.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.544 -0.298 . . . . 55.439999999999998 111.337 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.13 117.44 29.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.899 0.381 . . . . 73.040000000000006 111.646 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.7 mp -84.79 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.963 0.411 . . . . 63.32 111.022 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -119.71 147.53 44.47 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.751 0.42 . . . . 73.409999999999997 110.667 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 112.709 0.633 . . . . 61.329999999999998 112.709 -174.518 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.995 0.739 . . . . 71.120000000000005 112.995 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.73 37.72 0.24 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.607 0.595 . . . . 75.129999999999995 112.607 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.24 16.9 1.9 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.615 -0.326 . . . . 64.040000000000006 112.845 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -124.26 137.36 54.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.391 0.276 . . . . 74.030000000000001 110.682 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 m -60.97 -17.82 53.83 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.235 0.54 . . . . 63.130000000000003 111.688 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.5 p -78.53 -26.94 45.9 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.253 0.549 . . . . 73.140000000000001 111.734 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.405 ' CZ3' ' HE2' ' A' ' 127' ' ' MET . 33.7 t90 -56.87 -67.17 0.34 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 41.1 p90 -62.83 -28.19 69.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.092 0.405 . . . . 72.439999999999998 112.092 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -71.56 -36.18 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.875 0.369 . . . . 64.5 111.604 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.73 -35.47 63.73 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.5 111.747 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.64 -43.34 38.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.81 0.338 . . . . 75.219999999999999 111.263 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.01 -29.97 70.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.095 0.406 . . . . 60.310000000000002 112.095 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 2.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.289 0.566 . . . . 74.420000000000002 111.491 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.08 22.78 77.36 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.35 -0.387 . . . . 73.140000000000001 113.686 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.43 21.9 55.14 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.769 0.667 . . . . 39.140000000000001 114.769 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -82.23 3.9 25.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.571 0.685 . . . . 63.119999999999997 112.222 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -111.98 144.83 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.756 0.312 . . . . 63.5 111.601 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.55 112.07 4.1 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.272 -0.49 . . . . 74.030000000000001 112.797 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.2 p -68.46 -7.55 32.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.506 0.558 . . . . 72.040000000000006 112.506 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 t -65.12 -2.86 3.13 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.947 0.721 . . . . 64.010000000000005 112.947 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -64.83 -27.25 68.75 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.912 0.387 . . . . 75.239999999999995 111.838 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.3 -130.85 10.5 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.205 -0.522 . . . . 75.409999999999997 112.896 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -82.31 168.28 17.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.316 0.579 . . . . 73.400000000000006 111.717 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.451 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -73.28 16.55 0.17 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.861 1.06 . . . . 72.200000000000003 113.861 -170.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.45 -28.08 12.77 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.969 0.414 . . . . 63.219999999999999 111.632 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.5 ' ND2' ' HB2' ' A' ' 82' ' ' ALA . 11.3 t30 -95.82 -3.0 46.4 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.33 0.492 . . . . 71.140000000000001 112.33 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -55.8 -56.48 20.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.842 0.682 . . . . 75.439999999999998 112.842 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.0 69.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.987 0.422 . . . . 75.319999999999993 112.016 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.1 t -66.86 -54.92 17.49 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.114 -0.494 . . . . 53.200000000000003 111.581 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . . . -62.91 -49.92 72.88 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.92 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -49.11 -57.22 7.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.609 0.364 . . . . 72.409999999999997 111.525 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.6 p -62.18 -39.67 93.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.973 0.416 . . . . 72.200000000000003 111.135 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -25.39 63.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.305 -0.407 . . . . 75.310000000000002 111.696 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.73 15.4 25.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.164 0.431 . . . . 61.219999999999999 112.164 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.55 -21.22 47.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.997 -0.621 . . . . 62.049999999999997 113.993 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.7 m-85 -63.6 154.98 31.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.476 0.638 . . . . 72.540000000000006 111.171 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 27.6 m -99.41 95.87 7.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.403 0.52 . . . . 72.430000000000007 112.403 -170.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.455 HG21 HG13 ' A' ' 152' ' ' ILE . 60.7 t -94.81 111.46 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.732 0.301 . . . . 72.049999999999997 111.383 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -133.29 174.77 10.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.603 -0.271 . . . . 72.519999999999996 111.161 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.64 0.52 52.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.968 0.413 . . . . 62.530000000000001 110.706 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.3 t -68.36 115.55 30.71 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.687 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -80.77 7.21 5.0 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.79 2.327 . . . . 73.310000000000002 113.276 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 137.74 5.41 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.171 0.434 . . . . 74.439999999999998 112.171 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.64 156.81 3.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.195 0.813 . . . . 65.219999999999999 113.195 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 26.01 57.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.93 -0.577 . . . . 71.420000000000002 113.016 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -129.38 175.99 8.32 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.272 0.558 . . . . 71.409999999999997 111.766 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.92 128.13 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 62.409999999999997 110.57 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -101.63 138.47 38.58 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.906 -0.496 . . . . 71.200000000000003 111.523 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -103.41 110.83 22.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 111.193 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.582 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 56.1 m . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 112.95 0.722 . . . . 63.109999999999999 112.95 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 111.064 -0.814 . . . . 74.430000000000007 111.064 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 59.4 t60 -168.2 134.87 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.651 0.725 . . . . 74.030000000000001 111.473 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 76' ' ' ALA . 30.1 m -141.67 143.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.007 -0.542 . . . . 64.420000000000002 110.927 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.77 156.51 45.0 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.734 0.302 . . . . 61.219999999999999 111.005 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -89.58 129.19 36.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.868 0.366 . . . . 75.030000000000001 111.336 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -75.32 116.83 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.03 0.443 . . . . 73.010000000000005 111.529 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -75.74 -54.95 6.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.914 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -158.28 164.89 35.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.239 0.542 . . . . 74.010000000000005 111.778 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.45 129.88 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.06 -0.518 . . . . 70.439999999999998 110.835 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -85.24 145.62 27.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.295 -0.253 . . . . 74.549999999999997 110.596 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.1 m -59.71 -21.82 61.16 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.031 0.443 . . . . 70.340000000000003 111.212 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.46 -23.8 67.1 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.015 -0.539 . . . . 75.319999999999993 111.723 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.6 -20.31 29.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 112.1 -0.4 . . . . 39.140000000000001 112.1 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.0 m -68.66 135.72 51.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.862 0.363 . . . . 62.299999999999997 111.527 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.45 136.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.362 -0.381 . . . . 73.549999999999997 111.701 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.99 117.68 32.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.539 -0.3 . . . . 72.420000000000002 110.588 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.33 156.94 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.956 0.408 . . . . 73.450000000000003 111.933 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 p -110.96 123.89 51.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.965 0.412 . . . . 73.430000000000007 111.191 177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 38.6 mt-10 -128.86 151.65 49.38 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.244 -0.434 . . . . 71.450000000000003 111.65 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.405 ' HE2' ' CZ3' ' A' ' 59' ' ' TRP . 44.4 tpp . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 120.926 0.393 . . . . 75.310000000000002 111.794 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.241 0.543 . . . . 75.040000000000006 112.077 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -149.9 128.05 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.975 -0.557 . . . . 74.209999999999994 110.59 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.1 m -99.87 113.37 25.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.434 -0.348 . . . . 71.030000000000001 110.707 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.85 134.24 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.708 0.289 . . . . 75.430000000000007 111.243 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -63.13 151.73 39.29 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.068 0.396 . . . . 73.400000000000006 112.068 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.82 61.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.718 0.636 . . . . 45.130000000000003 112.718 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.47 -37.91 56.82 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.506 -0.378 . . . . 62.25 113.808 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -94.96 -51.32 4.72 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.526 -0.397 . . . . 61.229999999999997 111.106 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.23 67.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.778 0.658 . . . . 63.32 112.778 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -64.19 -14.33 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.591 0.589 . . . . 64.120000000000005 112.591 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.2 t -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.057 0.456 . . . . 72.420000000000002 111.015 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 23.9 m-85 -72.59 152.33 41.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.859 -0.609 . . . . 72.129999999999995 112.127 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -84.67 117.63 23.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.467 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 97.3 m-85 -96.48 113.98 25.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 111.969 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.455 HG13 HG21 ' A' ' 90' ' ' VAL . 3.8 mp -79.29 129.54 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.448 -0.342 . . . . 71.040000000000006 110.447 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 50.8 m-70 -119.46 152.03 37.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.868 0.366 . . . . 73.239999999999995 110.865 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 57.1 mt . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 111.809 -177.625 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 111.864 0.32 . . . . 54.240000000000002 111.864 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.63 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.179 0.514 . . . . 63.219999999999999 112.004 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.72 -40.57 0.53 Allowed Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 112.763 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.57 144.54 56.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.754 0.311 . . . . 65.010000000000005 111.447 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 29.7 p -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.237 0.541 . . . . 73.450000000000003 110.974 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 p -66.01 -15.87 63.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.837 -0.619 . . . . 72.120000000000005 112.121 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -76.18 -60.83 2.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.007 0.373 . . . . 75.25 112.007 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 18.4 p90 -71.88 -30.6 65.57 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.75 0.648 . . . . 71.310000000000002 112.75 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.97 -32.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 110.469 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.2 -39.77 79.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.769 -0.651 . . . . 71.430000000000007 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.74 -37.51 76.5 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.341 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 125' ' ' SER . 30.4 mmmt -56.17 -33.58 65.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.913 0.387 . . . . 72.510000000000005 111.696 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 65' ' ' VAL . 10.7 p -102.34 15.37 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.602 0.715 . . . . 61.0 111.163 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.9 -1.3 17.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.25 -0.432 . . . . 72.040000000000006 113.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.03 10.8 77.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.351 -0.452 . . . . 61.25 113.361 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -79.28 38.1 0.35 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.312 0.486 . . . . 73.439999999999998 112.312 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.552 HG23 HD22 ' A' ' 154' ' ' LEU . 20.5 pt -134.78 -41.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.21 100.24 2.49 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.911 -0.661 . . . . 65.5 113.353 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.0 p -80.24 43.57 0.64 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.199 0.444 . . . . 63.539999999999999 112.199 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 t -126.28 18.46 7.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.957 0.408 . . . . 75.140000000000001 112.084 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -91.17 11.67 22.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.849 0.685 . . . . 75.420000000000002 112.849 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.05 -143.44 28.69 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 113.596 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.08 152.42 45.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.521 -0.4 . . . . 61.119999999999997 111.104 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.53 -38.43 59.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.514 0.561 . . . . 72.140000000000001 112.514 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -61.31 -25.97 67.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.346 0.499 . . . . 62.340000000000003 112.346 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -94.56 -5.81 45.07 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.25 -0.281 . . . . 43.25 111.508 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.16 -56.26 21.88 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.373 0.509 . . . . 75.319999999999993 112.373 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.92 96.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.861 0.363 . . . . 62.340000000000003 111.846 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -35.58 81.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.4 -0.363 . . . . 72.510000000000005 111.784 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.49 -45.9 24.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.615 0.228 . . . . 72.25 111.615 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.53 -55.42 25.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.936 0.398 . . . . 75.219999999999999 111.694 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 p -57.1 -49.41 75.97 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 111.283 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.7 t -65.7 -15.54 62.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.242 0.46 . . . . 62.439999999999998 112.242 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.84 3.47 54.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.924 0.392 . . . . 73.25 111.654 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.52 -4.44 73.03 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.3 -0.476 . . . . 75.109999999999999 113.657 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -75.15 170.4 16.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.435 0.636 . . . . 72.230000000000004 111.565 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -99.88 97.21 8.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 112.353 -170.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.38 91.98 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.146 0.498 . . . . 64.409999999999997 110.692 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.77 138.42 53.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.677 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -76.71 13.33 1.03 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.48 0.918 . . . . 73.349999999999994 113.48 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -65.85 114.02 14.51 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 110.02 -0.363 . . . . 71.200000000000003 110.02 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.14 22.19 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.942 2.428 . . . . 55.25 114.543 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 116' ' ' VAL . 44.5 mt-10 -74.44 159.81 31.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.529 0.681 . . . . 71.340000000000003 112.695 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.56 5.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.323 -0.853 . . . . 75.409999999999997 113.086 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.22 40.91 40.31 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.874 -0.603 . . . . 64.329999999999998 112.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.2 p -152.25 167.19 29.4 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.568 -0.372 . . . . 65.200000000000003 111.125 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.6 mp -112.78 122.95 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.602 -0.272 . . . . 72.5 110.351 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.41 138.36 31.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 64.010000000000005 110.893 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.37 109.4 19.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.355 -0.384 . . . . 63.149999999999999 110.561 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.472 0.669 0 CA-C-N 116.313 -0.403 . . . . 74.329999999999998 111.476 -179.163 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 CA-C-O 121.052 0.251 . . . . 74.099999999999994 112.94 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -148.98 143.55 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.511 -0.405 . . . . 74.109999999999999 111.421 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.77 153.92 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.048 0.451 . . . . 72.120000000000005 111.615 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.48 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.577 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -95.4 126.18 40.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.001 0.429 . . . . 64.109999999999999 111.627 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.99 108.21 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.068 -0.515 . . . . 74.239999999999995 111.682 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.75 -48.65 14.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.066 -0.515 . . . . 74.230000000000004 111.443 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -154.4 154.7 33.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.284 -0.417 . . . . 74.120000000000005 110.913 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 95' ' ' GLU . 45.2 t -123.65 111.0 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.874 0.368 . . . . 73.510000000000005 111.094 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -64.95 131.96 48.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.483 -0.326 . . . . 70.209999999999994 111.566 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.6 p -60.78 -19.01 58.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.835 0.35 . . . . 70.120000000000005 111.596 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 -16.72 64.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.882 0.372 . . . . 73.219999999999999 111.788 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.37 57.51 0.59 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.303 -0.475 . . . . 43.409999999999997 113.067 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -151.64 136.29 17.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.735 0.303 . . . . 74.030000000000001 111.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.93 116.1 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.269 -0.423 . . . . 63.140000000000001 110.912 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -90.22 104.85 17.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.874 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -108.51 132.84 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.154 0.502 . . . . 65.129999999999995 111.907 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.502 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 32.0 t -89.28 114.23 25.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.425 -0.352 . . . . 64.519999999999996 111.17 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -131.05 147.31 52.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.532 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 40.8 ttm . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 121.093 0.473 . . . . 71.349999999999994 110.863 173.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 121.331 0.586 . . . . 63.329999999999998 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -83.91 107.12 16.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.905 -0.589 . . . . 64.019999999999996 112.215 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.1 m -86.73 112.91 22.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 111.248 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.1 mt -111.87 139.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.391 -0.368 . . . . 75.430000000000007 111.568 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.5 m -58.45 133.81 56.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.621 0.248 . . . . 74.530000000000001 111.399 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.22 73.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.191 0.441 . . . . 52.009999999999998 112.191 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -52.25 40.04 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.203 -0.523 . . . . 71.109999999999999 112.965 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.48 -44.72 77.87 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.163 0.506 . . . . 55.43 110.859 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -60.84 -30.69 70.25 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.196 0.813 . . . . 38.07 113.196 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.9 t -58.49 -23.74 58.67 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.807 0.669 . . . . 63.530000000000001 112.807 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.5 t -76.17 -19.45 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.021 0.439 . . . . 71.25 111.79 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 11.0 m-85 -83.67 147.9 27.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.934 0.397 . . . . 75.219999999999999 110.965 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.8 121.41 33.4 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.333 -0.229 . . . . 75.340000000000003 111.274 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -98.21 121.85 40.65 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.132 0.492 . . . . 74.120000000000005 112.005 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.68 121.74 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.354 -0.385 . . . . 65.420000000000002 110.423 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -115.38 147.35 40.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.548 0.339 . . . . 75.409999999999997 110.57 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.552 HD22 HG23 ' A' ' 69' ' ' ILE . 86.9 mt . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.321 0.489 . . . . 73.310000000000002 112.321 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.28 86.5 0.41 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 112.078 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.29 -29.88 0.36 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.871 -0.681 . . . . 37.659999999999997 113.7 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.49 151.1 30.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 111.852 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.6 m -54.67 -40.95 69.59 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.834 -0.621 . . . . 71.209999999999994 112.248 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -62.82 -24.19 67.64 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 74.109999999999999 112.151 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -60.99 -47.89 84.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.222 0.453 . . . . 73.400000000000006 112.222 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 126' ' ' GLU . 25.0 p90 -80.63 -39.69 26.98 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.172 -0.33 . . . . 72.230000000000004 111.624 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 57' ' ' CYS . 45.6 t -57.23 -41.89 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.879 0.371 . . . . 74.319999999999993 111.74 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.01 -38.47 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.175 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.51 -39.58 37.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 111.003 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.506 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.2 mmmt -53.22 -44.81 68.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.928 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.95 -22.43 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 111.962 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.2 30.19 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.169 -0.538 . . . . 62.509999999999998 113.656 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.91 -14.89 35.09 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.321 -0.466 . . . . 75.030000000000001 114.144 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.41 68.81 4.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.303 -0.528 . . . . 74.310000000000002 112.118 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 70' ' ' GLY . 6.0 pt -146.96 -54.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.043 -0.526 . . . . 71.409999999999997 111.473 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 69' ' ' ILE . . . 142.28 102.27 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.722 -0.752 . . . . 73.530000000000001 113.37 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 84.4 p -55.34 -28.09 51.47 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.023 0.379 . . . . 71.450000000000003 112.023 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -62.96 -16.64 60.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.087 0.773 . . . . 75.340000000000003 113.087 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -61.87 -43.15 99.42 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.908 0.385 . . . . 73.349999999999994 111.294 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.68 -92.99 0.2 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.323 -0.465 . . . . 74.319999999999993 114.122 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.91 139.74 38.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.01 0.433 . . . . 72.430000000000007 111.915 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB1' HG12 ' A' ' 110' ' ' VAL . . . -60.44 -28.58 68.4 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.366 0.506 . . . . 73.010000000000005 112.366 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -67.51 -17.76 64.79 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.943 0.401 . . . . 72.519999999999996 111.78 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.4 -34.16 12.87 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.197 0.443 . . . . 74.519999999999996 112.197 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -35.58 -64.62 0.28 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.625 1.343 . . . . 75.099999999999994 114.625 -171.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.48 79.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.632 0.604 . . . . 74.219999999999999 112.632 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -68.23 -44.55 75.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.085 0.469 . . . . 75.099999999999994 111.336 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.45 83.1 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.209 -0.451 . . . . 75.120000000000005 111.046 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -59.62 5.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.038 -0.528 . . . . 63.140000000000001 111.105 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.4 p -58.25 -32.41 68.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.244 -0.434 . . . . 73.540000000000006 111.56 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -72.85 -41.95 64.23 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.229 0.455 . . . . 73.140000000000001 112.229 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.75 -8.39 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.643 0.609 . . . . 72.400000000000006 112.643 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.38 7.48 26.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.942 -0.647 . . . . 43.350000000000001 113.447 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -80.4 168.18 19.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.629 . . . . 74.430000000000007 111.744 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 m -104.86 102.24 11.79 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.813 -0.631 . . . . 63.020000000000003 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.76 111.26 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 61.539999999999999 111.404 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 58.6 m-80 -132.15 149.31 52.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.366 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.79 12.25 1.13 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.219 0.452 . . . . 62.310000000000002 112.219 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.5 t -73.54 116.85 55.55 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.733 -0.212 . . . . 55.509999999999998 111.24 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.76 104.24 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.39 2.06 . . . . 74.019999999999996 112.032 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -131.04 136.47 48.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.058 -0.519 . . . . 71.439999999999998 111.699 -174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.98 120.86 14.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.555 -0.293 . . . . 37.659999999999997 111.237 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.64 15.33 17.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.202 -0.523 . . . . 64.409999999999997 113.254 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -120.75 170.1 9.77 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.475 -0.426 . . . . 61.539999999999999 110.753 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.0 mp -113.24 123.04 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.617 -0.265 . . . . 75.230000000000004 110.71 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -93.71 133.29 37.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.073 0.463 . . . . 71.030000000000001 111.212 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -94.25 112.18 23.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.294 -0.412 . . . . 72.209999999999994 111.153 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 37.5 m . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 112.292 0.478 . . . . 74.209999999999994 112.292 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 CA-C-O 120.965 0.203 . . . . 73.010000000000005 113.322 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 39.6 t60 -136.0 142.78 44.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.709 0.29 . . . . 74.040000000000006 111.058 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.522 HG12 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -146.89 146.2 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.088 0.555 . . . . 64.510000000000005 110.397 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.7 37.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.961 0.41 . . . . 61.399999999999999 111.433 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.5 123.74 37.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.942 0.401 . . . . 72.230000000000004 111.054 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.86 106.04 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.966 0.412 . . . . 73.019999999999996 111.913 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.91 -51.59 53.47 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.121 0.486 . . . . 71.140000000000001 110.754 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -160.37 164.24 32.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.057 -0.52 . . . . 65.209999999999994 110.833 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.28 140.45 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.049 0.452 . . . . 64.219999999999999 111.198 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -89.54 147.91 23.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.728 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.0 t -62.54 -20.7 64.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.864 0.364 . . . . 71.340000000000003 111.908 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.82 -22.83 62.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.336 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.87 -17.87 10.72 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.302 -0.408 . . . . 64.25 113.073 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -64.07 126.25 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.951 0.405 . . . . 73.540000000000006 111.621 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.05 124.48 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.998 0.428 . . . . 73.409999999999997 111.967 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -93.23 113.85 26.18 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.939 0.4 . . . . 73.319999999999993 110.662 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.75 164.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.24 0.459 . . . . 74.540000000000006 112.24 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.506 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 48.6 p -117.17 140.61 49.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.462 -0.335 . . . . 72.349999999999994 111.715 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 59.8 mt-10 -138.65 159.06 43.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.05 0.54 . . . . 75.25 110.991 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.9 tpp . . . . . 0 N--CA 1.472 0.656 0 O-C-N 122.347 -0.221 . . . . 63.100000000000001 110.569 175.615 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 27.3 mt-10 . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 120.919 0.39 . . . . 65.340000000000003 111.755 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.2 ptp180 -157.73 173.15 17.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.477 -0.329 . . . . 63.329999999999998 111.118 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 72.8 m -127.73 123.51 35.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.963 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -94.73 137.42 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.876 0.37 . . . . 63.539999999999999 111.389 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -59.84 137.9 57.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.997 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.07 -42.62 60.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.545 0.572 . . . . 72.219999999999999 112.545 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.29 -27.99 61.15 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.316 -0.402 . . . . 37.659999999999997 113.637 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.82 -27.79 14.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.387 -0.478 . . . . 74.430000000000007 111.39 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.64 -29.02 61.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.087 0.773 . . . . 64.439999999999998 113.087 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t -78.19 -6.24 54.23 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.0 0.37 . . . . 73.400000000000006 112.0 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.5 m -85.88 -15.04 43.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.773 0.32 . . . . 72.349999999999994 111.797 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -93.69 144.92 24.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.053 0.454 . . . . 73.030000000000001 112.21 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -93.88 116.41 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.152 -0.476 . . . . 54.32 110.359 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 20.9 m-85 -95.49 122.91 38.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.933 0.397 . . . . 60.350000000000001 111.748 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.466 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.4 mp -83.63 123.38 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.388 -0.369 . . . . 74.420000000000002 110.604 175.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.34 136.94 52.43 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.516 0.327 . . . . 63.439999999999998 110.547 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 69' ' ' ILE . 74.4 mt . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 112.348 0.499 . . . . 51.149999999999999 112.348 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 112.257 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 112.76 4.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.928 -0.578 . . . . 74.030000000000001 111.804 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.55 7.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.345 -0.455 . . . . 55.039999999999999 112.703 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -115.5 144.47 43.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.123 0.487 . . . . 73.200000000000003 111.584 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.428 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.1 p -58.03 -46.24 85.64 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.311 -0.404 . . . . 54.109999999999999 111.541 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -51.52 -45.35 62.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.093 0.405 . . . . 75.019999999999996 112.093 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -54.79 -48.66 72.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.96 -0.564 . . . . 75.549999999999997 111.744 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -68.79 -49.84 55.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 112.096 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 57' ' ' CYS . 58.0 t -58.18 -40.5 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.57 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.97 -41.76 75.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 111.553 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.02 -43.0 68.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.372 -0.376 . . . . 71.019999999999996 111.447 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -61.32 -34.48 75.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.018 0.377 . . . . 70.25 112.018 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -86.22 6.55 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-O 121.358 0.599 . . . . 72.25 111.072 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.37 18.48 60.93 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 113.833 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 16.95 67.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.16 -0.543 . . . . 64.120000000000005 113.949 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -78.88 7.08 7.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 117.455 0.628 . . . . 72.430000000000007 112.463 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.29 -37.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.528 0.566 . . . . 72.400000000000006 112.528 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.17 102.56 2.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.967 -0.635 . . . . 71.109999999999999 112.013 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -61.34 -18.06 56.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.742 0.645 . . . . 74.310000000000002 112.742 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 t -57.24 -15.94 7.15 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.701 0.63 . . . . 74.25 112.701 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -57.97 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.255 0.55 . . . . 74.299999999999997 110.825 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.25 -103.21 0.56 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.805 -0.634 . . . . 63.350000000000001 114.613 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -57.37 134.91 56.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.112 0.412 . . . . 65.209999999999994 112.112 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.62 -11.78 47.54 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 51.200000000000003 113.04 -173.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.37 -10.97 36.21 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.957 174.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -93.35 -27.49 16.74 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.097 0.406 . . . . 75.120000000000005 112.097 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.468 ' HB2' ' NE2' ' A' ' 101' ' ' GLN . 11.9 m0 -41.34 -58.04 1.97 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.854 1.057 . . . . 74.530000000000001 113.854 -175.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.9 91.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.917 -0.49 . . . . 71.140000000000001 111.975 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -57.69 -51.81 68.01 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.168 0.509 . . . . 54.310000000000002 111.618 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.93 97.69 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.37 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.48 -57.02 11.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.953 0.406 . . . . 37.920000000000002 111.26 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 t -57.5 -44.41 84.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.082 0.468 . . . . 37.920000000000002 111.39 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 t -70.85 -21.21 62.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 112.225 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.79 -10.06 32.64 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.205 0.446 . . . . 42.030000000000001 112.205 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.65 8.73 29.96 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.919 -0.657 . . . . 70.530000000000001 113.827 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' HD2' ' HA ' ' A' ' 154' ' ' LEU . 71.3 m-85 -83.81 166.94 17.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.439 -0.447 . . . . 75.430000000000007 111.329 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 90.5 m -100.5 92.73 5.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.114 0.483 . . . . 62.039999999999999 111.923 -173.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.3 98.8 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 111.299 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -126.77 176.49 7.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.513 -0.312 . . . . 73.530000000000001 110.632 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -93.39 25.42 3.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.931 0.396 . . . . 62.520000000000003 111.275 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 t -81.89 108.14 10.44 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 111.458 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.5 19.11 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.04 2.494 . . . . 71.400000000000006 114.278 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -54.96 142.82 28.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 111.726 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.92 146.13 53.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.471 0.545 . . . . 71.140000000000001 112.471 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.98 10.09 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.17 -0.538 . . . . 73.430000000000007 113.031 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.4 p -136.62 169.08 18.29 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.5 -0.412 . . . . 73.310000000000002 111.167 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -110.14 134.6 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.626 -0.261 . . . . 71.140000000000001 110.302 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 111' ' ' ALA . 1.5 pt? -112.99 131.24 55.84 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.247 0.546 . . . . 72.409999999999997 111.443 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.468 ' NE2' ' HB2' ' A' ' 79' ' ' TRP . 36.0 tt0 -105.96 129.0 54.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.524 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 112.773 0.656 . . . . 75.140000000000001 112.773 -178.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.618 0 N-CA-C 113.5 0.16 . . . . 44.329999999999998 113.5 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -173.5 136.99 0.62 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.417 0.287 . . . . 71.299999999999997 110.92 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.9 151.52 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.33 -0.395 . . . . 51.340000000000003 111.408 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 100' ' ' LEU . . . -148.78 167.37 25.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.466 -0.333 . . . . 72.430000000000007 110.99 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -102.88 131.44 49.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.894 0.378 . . . . 70.450000000000003 111.202 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.462 ' HA ' HG11 ' A' ' 124' ' ' VAL . 60.9 t -81.89 112.29 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.297 -0.41 . . . . 74.450000000000003 111.539 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -80.13 -56.02 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.878 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.19 144.05 23.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.757 0.651 . . . . 63.310000000000002 112.757 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.47 136.25 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.745 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.663 ' N ' HD21 ' A' ' 117' ' ' ASN . 0.6 OUTLIER -98.17 147.33 24.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.399 -0.188 . . . . 51.420000000000002 110.925 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -57.71 -34.84 69.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.934 0.346 . . . . 65.109999999999999 111.934 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.59 -9.23 40.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.464 0.542 . . . . 64.209999999999994 112.464 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.56 0.41 46.47 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.367 -0.444 . . . . 74.230000000000004 113.757 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 m -77.53 142.07 39.26 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.747 0.308 . . . . 72.519999999999996 111.626 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.8 t -113.19 115.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 111.558 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.84 118.63 29.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.392 . . . . 63.119999999999997 111.326 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 113' ' ' VAL . 34.1 m -124.8 148.18 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.043 0.449 . . . . 62.409999999999997 111.924 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.0 m -102.89 116.04 31.78 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.068 0.461 . . . . 51.350000000000001 111.079 175.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.43 -168.24 1.29 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 111.246 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.948 0.404 . . . . 64.140000000000001 110.763 173.072 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 121.206 0.527 . . . . 75.0 112.373 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -152.1 130.85 12.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.466 . . . . 72.310000000000002 111.604 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 m -99.13 98.7 9.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.082 0.467 . . . . 71.310000000000002 110.209 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.72 134.76 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 112.231 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.8 m -67.99 148.59 50.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.598 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.87 -44.95 63.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.446 0.536 . . . . 53.32 112.446 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.75 76.56 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 73.519999999999996 113.017 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.97 -34.02 75.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.866 0.365 . . . . 70.430000000000007 111.557 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.82 66.79 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.174 0.511 . . . . 64.5 111.859 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 t -67.67 -3.64 9.72 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.403 0.52 . . . . 65.319999999999993 112.403 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -93.28 -0.3 56.78 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.965 0.412 . . . . 75.549999999999997 111.622 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -118.77 153.42 34.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.535 0.569 . . . . 75.409999999999997 112.535 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.2 m-80 -101.4 116.14 32.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.797 -0.638 . . . . 63.140000000000001 110.526 176.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -94.85 112.68 24.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.230000000000004 111.91 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -81.06 127.23 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.076 0.465 . . . . 53.149999999999999 111.345 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 62.0 m-70 -111.1 133.15 53.7 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.548 -0.538 . . . . 73.349999999999994 109.548 174.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 88' ' ' TYR . 48.0 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 112.248 0.462 . . . . 65.439999999999998 112.248 -171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 73.219999999999999 111.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.68 138.18 42.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 72.349999999999994 111.738 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.79 -28.51 13.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.283 -0.484 . . . . 71.549999999999997 112.753 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -80.3 136.73 36.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.269 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.412 ' O ' HG22 ' A' ' 61' ' ' VAL . 25.2 p -59.14 -41.28 87.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.073 171.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.5 p -52.57 -43.8 65.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.455 -0.793 . . . . 72.109999999999999 111.968 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -55.95 -52.31 64.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 112.022 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.63 -47.34 72.91 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.983 0.421 . . . . 72.010000000000005 111.702 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' CYS . 96.9 t -60.97 -34.52 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.555 -0.293 . . . . 71.450000000000003 111.706 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -54.69 -46.81 74.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 111.41 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 110.892 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 64' ' ' LYS . 29.3 mmmt -61.98 -31.73 72.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.155 -0.475 . . . . 63.509999999999998 112.202 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 154' ' ' LEU . 7.6 p -91.24 6.22 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.449 0.642 . . . . 55.350000000000001 111.164 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 10.26 72.04 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.299 -0.41 . . . . 64.120000000000005 113.959 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.14 15.75 72.43 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.002 -0.618 . . . . 64.200000000000003 114.032 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 154' ' ' LEU . 40.2 m-80 -82.79 28.28 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.316 0.558 . . . . 72.120000000000005 111.99 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.76 161.78 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.131 0.491 . . . . 61.509999999999998 111.523 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.1 78.03 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.999 -0.619 . . . . 52.43 112.558 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -49.18 -28.18 4.24 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.571 0.582 . . . . 53.219999999999999 112.571 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -60.73 -18.03 52.08 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.873 0.694 . . . . 65.120000000000005 112.873 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -56.05 -32.95 64.53 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.942 0.401 . . . . 74.099999999999994 111.617 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.9 2.02 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.261 -0.427 . . . . 62.409999999999997 114.092 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.88 133.78 48.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 71.319999999999993 112.452 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.41 61.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.228 0.825 . . . . 65.230000000000004 113.228 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -67.05 -34.47 77.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.939 0.4 . . . . 73.409999999999997 112.047 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -71.26 -29.34 64.97 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.337 0.495 . . . . 60.130000000000003 112.337 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -43.38 -60.27 1.78 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.619 0.97 . . . . 73.310000000000002 113.619 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.43 86.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.45 0.537 . . . . 73.329999999999998 112.45 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 t -65.03 -55.02 21.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.941 0.401 . . . . 61.450000000000003 111.438 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.77 74.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.443 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . . . -57.32 -49.02 77.44 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.629 -0.259 . . . . 62.509999999999998 111.291 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.7 p -66.51 -29.55 69.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.029 0.442 . . . . 74.319999999999993 111.119 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -76.79 -31.36 56.95 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.128 -0.487 . . . . 73.140000000000001 111.798 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.46 -24.48 24.12 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.156 0.428 . . . . 71.239999999999995 112.156 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.82 4.31 19.23 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.048 -0.596 . . . . 51.109999999999999 113.881 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 18.4 m-85 -69.23 168.49 14.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.467 . . . . 74.340000000000003 111.288 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.6 m -101.19 97.94 8.41 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.07 0.396 . . . . 75.120000000000005 112.07 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.548 HG23 HG13 ' A' ' 152' ' ' ILE . 41.6 t -102.49 96.52 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.002 0.429 . . . . 73.150000000000006 111.316 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -122.66 172.31 8.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.891 0.377 . . . . 72.530000000000001 110.96 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -86.56 2.52 47.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.654 0.264 . . . . 71.530000000000001 111.305 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -62.8 113.75 10.1 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 116.52 -0.309 . . . . 72.420000000000002 110.761 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.27 8.16 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.643 2.229 . . . . 72.519999999999996 113.973 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.32 138.62 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.328 0.492 . . . . 72.540000000000006 112.328 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.08 156.98 4.93 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.718 0.636 . . . . 70.430000000000007 112.718 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.46 33.38 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.111 -0.566 . . . . 74.349999999999994 112.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.2 p -138.31 176.64 8.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 73.010000000000005 111.115 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.71 121.78 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.36 -0.382 . . . . 53.32 110.889 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD23 ' HB1' ' A' ' 111' ' ' ALA . 1.9 pt? -100.62 136.66 40.15 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.692 -0.63 . . . . 71.129999999999995 111.636 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -101.99 124.99 48.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.868 -0.605 . . . . 75.230000000000004 111.46 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 31.2 t . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.246 0.461 . . . . 64.129999999999995 112.246 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 111.834 -0.506 . . . . 73.510000000000005 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 58.4 t60 -157.59 135.47 10.76 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.345 -0.503 . . . . 75.239999999999995 110.74 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.73 142.1 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.073 0.463 . . . . 52.229999999999997 111.389 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HB1' HD23 ' A' ' 100' ' ' LEU . . . -139.44 156.69 46.79 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.243 -0.435 . . . . 74.439999999999998 110.837 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.71 133.14 38.7 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.832 0.349 . . . . 74.209999999999994 111.279 -176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.45 116.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.858 0.361 . . . . 44.439999999999998 111.836 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.72 -54.96 3.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.957 0.408 . . . . 73.349999999999994 112.01 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.76 145.2 30.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.265 0.555 . . . . 72.239999999999995 112.004 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.61 133.74 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.03 -0.532 . . . . 64.109999999999999 111.464 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 121' ' ' SER . 33.9 m-80 -76.87 152.25 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.406 -0.361 . . . . 71.530000000000001 110.556 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.1 m -47.22 -40.73 16.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.337 0.866 . . . . 72.310000000000002 113.337 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.55 -23.39 61.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.37 0.507 . . . . 70.549999999999997 112.37 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.44 -0.94 9.54 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.163 -0.541 . . . . 63.420000000000002 113.38 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 19.2 m -65.41 118.78 9.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.168 0.509 . . . . 72.239999999999995 110.952 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.412 HG21 ' OH ' ' A' ' 151' ' ' TYR . 40.4 t -96.35 121.97 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.805 -0.634 . . . . 51.509999999999998 112.392 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -96.35 105.25 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.342 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 m -97.08 163.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.423 0.527 . . . . 73.109999999999999 112.423 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -115.51 119.19 35.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.922 -0.581 . . . . 64.140000000000001 111.028 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.8 177.2 6.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.024 0.44 . . . . 63.549999999999997 111.512 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.472 0.651 0 CA-C-N 116.497 -0.32 . . . . 63.399999999999999 110.45 176.733 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.191 0.519 . . . . 70.5 111.695 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.06 105.07 16.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.168 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 88.2 m -79.17 104.14 9.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.041 0.448 . . . . 71.120000000000005 110.65 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.401 HD13 ' CE2' ' A' ' 149' ' ' TYR . 73.2 mt -92.57 112.44 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.105 -0.498 . . . . 72.200000000000003 111.599 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.4 m -61.07 153.26 25.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.24 0.459 . . . . 75.109999999999999 112.24 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.79 -48.65 41.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.876 0.695 . . . . 74.430000000000007 112.876 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.14 -38.05 88.35 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.175 -0.536 . . . . 52.509999999999998 113.316 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -72.9 -37.35 67.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.963 0.411 . . . . 65.310000000000002 111.669 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.69 -23.91 67.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.911 0.708 . . . . 63.119999999999997 112.911 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 m -54.87 -17.29 3.42 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.845 1.054 . . . . 71.439999999999998 113.845 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.4 t -99.11 -13.94 19.6 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.155 0.798 . . . . 75.25 113.155 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.401 ' CE2' HD13 ' A' ' 141' ' ' ILE . 31.4 m-85 -88.7 143.74 26.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.564 0.697 . . . . 75.239999999999995 112.866 -173.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.09 116.35 31.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.613 -0.721 . . . . 72.040000000000006 111.071 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.412 ' OH ' HG21 ' A' ' 122' ' ' VAL . 64.0 m-85 -98.26 118.18 34.33 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.002 0.371 . . . . 65.329999999999998 112.002 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.548 HG13 HG23 ' A' ' 90' ' ' VAL . 3.7 mp -84.66 131.99 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.432 -0.349 . . . . 74.150000000000006 110.595 174.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -121.58 148.65 44.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.703 0.401 . . . . 70.099999999999994 110.056 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 65' ' ' VAL . 50.4 mt . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.406 0.622 . . . . 73.019999999999996 112.598 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 112.975 0.732 . . . . 73.420000000000002 112.975 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.99 152.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.175 0.512 . . . . 42.539999999999999 111.928 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.494 ' HA2' ' SD ' ' A' ' 127' ' ' MET . . . 82.82 -33.66 2.83 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.819 -0.705 . . . . 38.020000000000003 112.827 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.5 139.83 58.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.382 0.273 . . . . 65.319999999999993 110.96 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.0 p -54.03 -45.88 71.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.072 0.463 . . . . 73.239999999999995 110.967 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.3 p -53.19 -43.47 67.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 112.022 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.94 -48.59 77.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.22 0.533 . . . . 73.510000000000005 111.188 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.448 ' HB2' ' HE1' ' A' ' 127' ' ' MET . 65.5 t80 -63.66 -45.17 91.37 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.903 -0.59 . . . . 64.019999999999996 111.629 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 57' ' ' CYS . 64.3 t -60.46 -43.25 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.797 0.332 . . . . 71.299999999999997 111.415 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -55.04 -38.71 68.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.268 -0.423 . . . . 71.299999999999997 111.527 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.85 -48.81 34.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.834 0.35 . . . . 75.129999999999995 111.366 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -58.25 -36.52 73.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.362 0.505 . . . . 72.400000000000006 112.362 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 154' ' ' LEU . 9.6 p -80.8 11.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.415 0.626 . . . . 72.120000000000005 111.42 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.13 19.44 66.04 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.294 -0.412 . . . . 73.420000000000002 113.581 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.53 24.14 61.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.26 -0.495 . . . . 71.140000000000001 113.716 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -86.8 9.94 17.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.301 -0.529 . . . . 72.430000000000007 111.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.82 148.85 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.979 0.419 . . . . 71.319999999999993 111.428 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.97 84.95 0.16 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 53.5 112.933 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.1 p -51.68 -21.12 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.447 0.536 . . . . 51.5 112.447 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.1 t -66.62 -2.13 4.5 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.787 0.662 . . . . 53.32 112.787 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -63.53 -22.83 67.11 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.07 0.396 . . . . 74.420000000000002 112.07 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.42 -131.73 10.87 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.173 -0.537 . . . . 70.049999999999997 113.729 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.82 154.98 40.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.415 0.626 . . . . 62.399999999999999 111.972 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -72.37 31.03 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 113.965 1.098 . . . . 52.310000000000002 113.965 -171.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -111.61 -18.25 12.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.249 0.547 . . . . 74.040000000000006 110.287 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.64 -0.17 27.85 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.935 -0.575 . . . . 60.450000000000003 112.067 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -66.96 -58.44 4.96 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.093 -0.379 . . . . 71.129999999999995 111.953 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 152' ' ' ILE . . . -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 111.884 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.7 t -58.71 -51.37 70.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.945 0.402 . . . . 51.049999999999997 111.264 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.31 82.78 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.432 -0.349 . . . . 61.030000000000001 111.443 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -55.67 -52.88 62.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 74.400000000000006 111.273 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -62.78 -32.35 73.5 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.801 0.334 . . . . 65.109999999999999 111.602 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.9 t -76.48 -33.09 58.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.119 0.415 . . . . 74.510000000000005 112.119 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.88 -51.43 8.59 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.115 0.413 . . . . 72.129999999999995 112.115 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.29 24.7 0.08 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.831 -0.7 . . . . 63.109999999999999 113.818 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.504 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 28.5 m-85 -90.89 178.82 5.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.224 0.535 . . . . 75.430000000000007 111.293 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.525 HG22 ' OD1' ' A' ' 91' ' ' ASN . 84.2 m -109.26 89.6 3.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.055 -0.52 . . . . 70.329999999999998 111.051 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.86 111.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.93 0.395 . . . . 63.32 111.648 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' A' ' 89' ' ' THR . 6.0 m120 -135.61 177.14 8.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.99 0.424 . . . . 73.219999999999999 110.74 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.7 -0.05 57.29 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 110.815 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.5 m -67.86 114.24 19.16 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.195 -0.457 . . . . 73.329999999999998 110.802 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -85.75 12.35 3.07 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.074 2.516 . . . . 65.239999999999995 114.943 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.54 145.31 33.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.963 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.14 157.49 2.58 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.725 -0.67 . . . . 73.109999999999999 112.656 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.04 38.66 9.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.963 -0.637 . . . . 72.200000000000003 112.187 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.5 p -152.55 173.19 15.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.206 0.527 . . . . 51.420000000000002 111.79 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.16 124.38 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.636 -0.711 . . . . 72.129999999999995 110.786 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 1.6 pt? -91.81 137.38 32.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.932 -0.48 . . . . 52.229999999999997 111.244 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.402 ' HB3' ' OD1' ' A' ' 150' ' ' ASN . 27.3 tt0 -106.52 128.79 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.479 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 12.5 t . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 112.979 0.733 . . . . 73.400000000000006 112.979 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.388 0 N-CA-C 112.159 -0.377 . . . . 72.010000000000005 112.159 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 19.6 t60 -175.0 138.32 0.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.748 0.309 . . . . 72.209999999999994 110.782 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 76' ' ' ALA . 16.7 m -143.47 146.64 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 111.185 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.82 149.88 30.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.002 -0.545 . . . . 65.439999999999998 110.902 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -87.31 126.35 34.79 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.38 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.44 111.7 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.059 0.392 . . . . 74.409999999999997 112.059 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.04 -44.98 36.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.944 0.402 . . . . 75.329999999999998 111.648 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.5 164.03 29.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 111.946 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.33 108.8 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.899 -0.591 . . . . 75.120000000000005 110.307 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.99 157.47 33.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.09 0.472 . . . . 63.219999999999999 111.959 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.8 m -61.29 -12.82 14.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.449 0.537 . . . . 70.439999999999998 112.449 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.97 -6.48 52.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.887 0.375 . . . . 63.240000000000002 111.705 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.14 -16.5 59.5 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.402 -0.428 . . . . 75.329999999999998 112.514 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -66.51 131.9 47.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.95 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.72 124.82 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.56 . . . . 72.010000000000005 111.475 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.89 111.43 23.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.928 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.54 153.02 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.258 0.466 . . . . 74.129999999999995 112.258 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -101.13 121.74 42.37 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.195 0.521 . . . . 72.430000000000007 111.437 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -127.68 124.16 37.24 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.896 -0.593 . . . . 72.219999999999999 111.329 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.494 ' SD ' ' HA2' ' A' ' 55' ' ' GLY . 44.5 ttm . . . . . 0 N--CA 1.471 0.578 0 O-C-N 121.943 -0.473 . . . . 72.129999999999995 110.457 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 74.530000000000001 110.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -103.57 105.8 16.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 111.626 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.2 m -87.71 104.93 17.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.794 0.33 . . . . 75.299999999999997 111.2 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.4 mt -93.38 140.28 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 122.494 0.317 . . . . 75.530000000000001 111.633 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.0 m -64.12 146.8 53.6 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.645 -0.252 . . . . 75.040000000000006 111.317 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.58 64.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.66 0.615 . . . . 74.430000000000007 112.66 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.61 -34.95 65.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.518 -0.372 . . . . 60.340000000000003 113.876 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.55 -35.29 17.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.964 0.412 . . . . 75.209999999999994 111.361 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.95 80.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.435 -0.348 . . . . 65.310000000000002 111.673 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.5 p -67.14 -8.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.863 0.363 . . . . 74.510000000000005 111.888 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.1 t -78.8 -11.82 60.0 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.093 0.473 . . . . 52.310000000000002 110.805 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 34.3 m-85 -106.16 135.11 48.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.316 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 101' ' ' GLN . 4.2 p-10 -82.11 129.69 34.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.995 0.426 . . . . 63.240000000000002 111.89 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -100.05 123.76 44.65 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.61 0.596 . . . . 73.030000000000001 112.61 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD11 ' HB1' ' A' ' 80' ' ' ALA . 3.6 mp -86.5 123.95 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.135 -0.484 . . . . 72.120000000000005 110.576 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.2 149.64 35.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.547 0.339 . . . . 74.239999999999995 110.314 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.513 HD11 HG22 ' A' ' 65' ' ' VAL . 24.7 mt . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.165 0.507 . . . . 74.140000000000001 111.427 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.216 0.531 . . . . 54.049999999999997 112.148 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 140.67 45.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.986 -0.552 . . . . 63.399999999999999 112.062 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.54 -18.86 43.58 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.243 -0.503 . . . . 71.430000000000007 113.257 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.11 161.15 14.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.884 0.373 . . . . 75.430000000000007 111.754 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.438 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 59.6 m -63.22 -43.35 98.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.003 0.43 . . . . 73.219999999999999 111.878 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.3 p -61.1 -25.51 67.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.573 0.583 . . . . 75.219999999999999 112.573 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.45 -63.88 1.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 38.9 p90 -66.52 -29.12 69.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.064 0.394 . . . . 74.209999999999994 112.064 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 57' ' ' CYS . 59.2 t -62.12 -45.05 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.95 0.405 . . . . 54.109999999999999 110.874 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -56.4 -34.1 66.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 111.086 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.35 -46.43 22.86 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.207 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -57.74 -32.64 67.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.079 0.4 . . . . 72.329999999999998 112.079 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 65' ' ' VAL . 8.0 p -91.52 13.18 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.3 0.571 . . . . 71.310000000000002 111.455 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.98 22.67 58.14 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 113.936 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.86 22.21 64.2 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.326 0.49 . . . . 73.519999999999996 114.326 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -83.35 12.0 6.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.488 0.644 . . . . 73.510000000000005 112.284 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.85 176.34 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.966 0.412 . . . . 70.019999999999996 111.744 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.17 115.75 8.44 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.164 -0.541 . . . . 73.099999999999994 113.621 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 p -75.41 0.87 15.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.592 0.59 . . . . 72.409999999999997 112.592 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 t -119.76 20.45 12.28 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.014 0.376 . . . . 73.209999999999994 112.014 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.83 -37.76 73.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.08 0.467 . . . . 75.129999999999995 111.386 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.22 3.94 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.152 -0.477 . . . . 52.340000000000003 114.24 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.14 125.18 6.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.218 0.607 . . . . 71.519999999999996 112.522 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.12 60.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.287 0.477 . . . . 64.450000000000003 112.287 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -94.24 0.31 55.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.573 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.84 -12.9 16.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.545 0.338 . . . . 71.439999999999998 111.694 -176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -57.99 -33.69 69.18 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.463 0.912 . . . . 74.349999999999994 113.463 -172.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.79 64.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.898 0.38 . . . . 71.349999999999994 111.344 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -64.21 -43.72 94.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 111.128 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.11 96.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.413 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . . . -57.76 -52.38 65.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.0 0.429 . . . . 75.349999999999994 110.633 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.0 t -58.8 -34.06 71.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 111.649 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 t -74.99 -25.71 59.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.819 0.342 . . . . 43.32 111.908 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.62 2.43 41.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.074 0.398 . . . . 65.349999999999994 112.074 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 41.55 14.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.325 -0.464 . . . . 74.239999999999995 113.943 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 66.5 m-85 -103.78 169.68 8.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.319 -0.518 . . . . 71.450000000000003 111.815 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.4 m -97.07 98.84 10.39 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.052 -0.522 . . . . 74.120000000000005 112.367 -171.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.43 103.19 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.151 0.501 . . . . 65.209999999999994 112.283 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -139.06 162.57 34.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.307 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -86.46 3.84 42.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.408 0.521 . . . . 75.340000000000003 112.408 -177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.0 m -57.25 113.13 5.59 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 110.542 -0.17 . . . . 75.230000000000004 110.542 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.94 -1.52 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.737 2.291 . . . . 75.129999999999995 114.577 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.71 139.57 9.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.874 0.694 . . . . 63.219999999999999 112.874 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.91 162.99 2.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.406 -0.816 . . . . 72.109999999999999 112.937 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.06 33.04 27.53 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.092 -0.575 . . . . 61.549999999999997 112.276 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.1 p -147.1 168.53 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.505 0.322 . . . . 73.140000000000001 110.834 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -115.7 124.44 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.345 -0.222 . . . . 74.310000000000002 110.659 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -96.95 134.97 39.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.326 0.584 . . . . 63.210000000000001 111.703 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -97.72 101.59 13.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 110.976 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 26.5 t . . . . . 0 N--CA 1.47 0.535 0 CA-C-N 115.851 -0.613 . . . . 75.430000000000007 111.923 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 CA-C-O 121.08 0.267 . . . . 45.049999999999997 113.175 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -149.1 131.34 15.51 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.591 -0.358 . . . . 73.299999999999997 110.86 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.79 149.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 110.392 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.84 152.45 28.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.991 0.424 . . . . 62.530000000000001 111.984 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -80.8 129.08 34.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.272 -0.422 . . . . 73.120000000000005 110.811 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.24 102.68 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.216 0.531 . . . . 64.109999999999999 111.058 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.597 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 18.5 mm-40 -62.22 -58.1 9.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.459 -0.791 . . . . 71.420000000000002 111.289 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -161.67 148.47 14.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.846 -0.615 . . . . 75.310000000000002 111.361 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -115.15 137.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.309 . . . . 73.140000000000001 110.721 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -107.54 150.52 26.74 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.863 0.363 . . . . 61.43 111.762 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 m -61.53 -36.98 82.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.382 0.882 . . . . 75.310000000000002 113.382 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.19 -45.09 79.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.21 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.61 62.43 0.05 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.996 -0.621 . . . . 51.32 113.255 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.9 m -147.5 134.21 19.99 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.477 -0.425 . . . . 73.120000000000005 111.341 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 117.7 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.635 -0.711 . . . . 73.540000000000006 110.988 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.03 117.42 26.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.141 -0.481 . . . . 74.5 110.981 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.01 150.24 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.437 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 94.1 p -77.95 130.19 36.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.676 -0.693 . . . . 63.530000000000001 112.178 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -143.26 146.74 33.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.202 0.525 . . . . 75.239999999999995 112.306 174.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 57.3 tpp . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 116.077 -0.51 . . . . 72.540000000000006 110.264 175.121 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 30.9 mt-10 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.665 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -79.77 125.2 29.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.637 0.256 . . . . 64.530000000000001 110.631 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.9 m -91.33 99.54 12.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.99 0.424 . . . . 60.240000000000002 110.853 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.89 137.94 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.041 0.386 . . . . 73.120000000000005 112.041 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 52.5 m -61.6 151.5 33.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.941 0.4 . . . . 72.400000000000006 111.8 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.87 82.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.248 0.462 . . . . 72.439999999999998 112.248 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.13 74.79 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.418 -0.42 . . . . 51.530000000000001 113.426 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.96 -54.66 6.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.262 0.553 . . . . 72.430000000000007 111.129 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.46 94.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.783 0.66 . . . . 54.240000000000002 112.783 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.3 p -62.07 -16.13 49.89 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.125 0.417 . . . . 45.310000000000002 112.125 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.8 t -76.69 -17.83 58.89 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.952 0.406 . . . . 73.319999999999993 111.317 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.467 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 16.8 m-85 -93.06 152.95 18.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.21 0.529 . . . . 72.329999999999998 111.847 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.04 132.17 35.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.035 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 94.5 m-85 -106.84 129.83 54.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.781 0.8 . . . . 74.129999999999995 112.807 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.76 112.08 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.294 -0.866 . . . . 62.049999999999997 110.798 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -106.2 141.38 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.954 0.407 . . . . 71.129999999999995 111.543 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 CA--C 1.539 0.544 0 CA-C-N 116.088 -0.505 . . . . 54.100000000000001 111.181 179.591 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 111.787 0.292 . . . . 73.150000000000006 111.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 35.06 0.1 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.54 0.941 . . . . 63.149999999999999 113.54 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.68 4.72 1.27 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.221 -0.514 . . . . 63.229999999999997 113.556 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.69 147.04 42.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.997 0.399 . . . . 74.299999999999997 111.212 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 63.7 m -54.93 -31.52 60.44 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.209 0.528 . . . . 73.0 111.259 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.6 p -68.04 -18.15 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.039 0.755 . . . . 73.120000000000005 113.039 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -75.81 -71.22 0.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.942 0.719 . . . . 75.219999999999999 112.942 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 12.6 p90 -59.93 -18.42 45.08 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.384 0.883 . . . . 74.239999999999995 113.384 -171.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.13 -34.78 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.21 0.528 . . . . 74.019999999999996 110.749 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 72.7 t80 -56.94 -51.86 67.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.712 -0.676 . . . . 74.209999999999994 111.294 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.48 -42.77 92.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.324 -0.398 . . . . 71.340000000000003 111.602 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HZ1' ' CD ' ' A' ' 114' ' ' GLU . 14.4 mmmm -66.33 -31.96 73.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.326 0.491 . . . . 55.119999999999997 112.326 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.86 9.69 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.475 0.655 . . . . 71.319999999999993 111.402 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.5 14.83 65.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.426 -0.416 . . . . 65.430000000000007 113.671 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.39 7.73 64.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.41 0.524 . . . . 72.140000000000001 114.41 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -78.45 35.05 0.22 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.263 0.532 . . . . 75.129999999999995 112.371 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.8 pt -121.44 -30.46 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.134 0.42 . . . . 73.219999999999999 112.134 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.31 9.44 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.07 -0.586 . . . . 53.039999999999999 113.289 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.516 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 53.2 p 59.6 4.8 0.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.287 0.847 . . . . 72.439999999999998 113.287 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -84.95 9.6 14.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.165 0.507 . . . . 62.43 111.571 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.4 m0 -79.36 -36.67 38.97 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.322 -0.399 . . . . 72.519999999999996 111.593 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.36 -122.63 6.02 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.023 -0.608 . . . . 64.439999999999998 113.964 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -51.6 141.44 16.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.421 0.526 . . . . 71.209999999999994 112.421 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -31.9 72.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.195 0.442 . . . . 63.439999999999998 112.195 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.38 1.93 20.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.807 0.337 . . . . 74.420000000000002 111.661 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.95 -6.97 12.58 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.132 0.419 . . . . 63.109999999999999 112.132 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.39 -56.47 21.62 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.682 0.623 . . . . 73.409999999999997 112.682 -176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.51 75.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 71.040000000000006 111.552 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.5 m -60.69 -52.53 64.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.977 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.21 78.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 111.196 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -58.38 8.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.512 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.6 p -58.89 -37.09 75.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.836 0.351 . . . . 74.129999999999995 111.735 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -71.52 -39.81 70.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.383 -0.371 . . . . 61.340000000000003 111.392 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.5 10.57 5.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.664 0.616 . . . . 63.140000000000001 112.664 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.94 66.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.012 -0.613 . . . . 64.329999999999998 114.334 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -76.79 164.3 25.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.514 0.657 . . . . 63.219999999999999 110.999 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.4 m -100.5 100.35 11.08 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 111.671 -172.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 HG21 HG13 ' A' ' 152' ' ' ILE . 48.1 t -108.83 119.88 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.773 0.32 . . . . 71.430000000000007 111.572 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -140.13 -176.15 4.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 111.19 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -97.57 4.07 50.37 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.182 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.6 m -67.71 114.1 18.06 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.274 -0.421 . . . . 65.450000000000003 110.439 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.69 22.9 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.968 2.445 . . . . 61.140000000000001 114.584 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.08 149.69 36.3 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.959 0.726 . . . . 71.329999999999998 112.959 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.38 163.06 4.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.71 -0.677 . . . . 53.140000000000001 112.467 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.63 34.53 73.09 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.947 -0.644 . . . . 71.109999999999999 112.626 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.1 m -139.01 165.83 26.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.654 0.264 . . . . 52.109999999999999 111.105 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -116.86 127.56 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 110.446 -0.205 . . . . 71.019999999999996 110.446 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.7 pt? -99.83 144.94 28.31 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.848 -0.533 . . . . 75.129999999999995 110.993 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -121.62 133.56 54.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.4 0.619 . . . . 63.020000000000003 112.536 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 29.7 t . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 115.35 -0.841 . . . . 65.310000000000002 110.657 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 CA-C-O 121.003 0.224 . . . . 73.109999999999999 113.333 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 73.0 t60 -143.85 141.93 30.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.565 -0.374 . . . . 64.319999999999993 111.2 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 20.5 m -139.17 146.34 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.505 -0.316 . . . . 74.120000000000005 111.114 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -153.74 154.64 34.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.03 0.443 . . . . 71.099999999999994 112.125 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -91.18 121.21 32.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.252 -0.431 . . . . 72.439999999999998 111.535 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.65 114.33 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.03 0.381 . . . . 74.439999999999998 112.03 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 10.1 mm-40 -78.78 -56.69 4.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 111.635 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -149.46 141.66 24.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.411 0.523 . . . . 64.510000000000005 112.411 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.32 126.33 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 111.071 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -94.42 144.12 25.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.753 0.311 . . . . 72.519999999999996 111.093 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -60.91 -25.74 66.95 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.223 0.535 . . . . 75.340000000000003 111.549 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.49 -16.32 62.29 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.992 -0.549 . . . . 75.019999999999996 111.59 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.86 -14.98 37.67 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.28 -0.418 . . . . 42.219999999999999 112.952 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.1 m -66.68 120.99 14.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 64.409999999999997 111.499 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.57 116.93 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.306 0.574 . . . . 73.219999999999999 111.178 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.14 113.69 25.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 111.005 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.94 167.11 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.196 0.522 . . . . 74.439999999999998 112.146 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.1 t -108.01 105.59 15.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.096 -0.502 . . . . 71.329999999999998 111.088 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -141.69 118.58 11.16 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.27 -0.423 . . . . 53.130000000000003 111.382 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.1 ttm . . . . . 0 CA--C 1.534 0.361 0 O-C-N 122.218 -0.301 . . . . 62.399999999999999 110.703 174.786 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 42.2 mt-10 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 111.959 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -114.5 122.99 48.27 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.433 -0.348 . . . . 73.530000000000001 111.176 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.2 m -85.66 99.79 11.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.775 0.322 . . . . 75.109999999999999 110.505 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.9 mt -93.27 139.78 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.912 0.387 . . . . 73.530000000000001 111.925 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 m -69.17 150.78 47.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.338 -0.392 . . . . 71.409999999999997 111.734 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.93 -52.38 58.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.463 0.542 . . . . 74.310000000000002 112.463 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.28 -13.0 34.11 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.117 -0.492 . . . . 72.439999999999998 114.018 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -101.77 -49.81 3.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 110.959 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.42 72.56 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.621 0.6 . . . . 74.530000000000001 112.621 -175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 68.3 m -60.69 -9.52 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.064 0.764 . . . . 36.469999999999999 113.064 -177.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.0 t -83.37 -19.79 35.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.932 0.396 . . . . 64.230000000000004 111.548 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -85.91 161.58 18.98 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.155 0.502 . . . . 74.239999999999995 112.096 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.0 m-20 -89.29 117.76 28.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.493 -0.321 . . . . 73.430000000000007 111.265 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -99.89 113.1 25.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.299 0.481 . . . . 74.129999999999995 112.299 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.7 mp -83.06 134.73 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.374 -0.376 . . . . 71.409999999999997 110.272 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -122.99 142.79 50.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.967 0.413 . . . . 74.209999999999994 111.354 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 111.796 -179.908 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.188 0.518 . . . . 71.329999999999998 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 115.2 9.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 111.273 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.92 -13.22 7.2 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.172 -0.537 . . . . 65.200000000000003 112.887 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -100.03 144.99 28.42 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.787 0.327 . . . . 74.099999999999994 111.144 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.6 m -56.01 -25.87 46.27 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.117 0.414 . . . . 74.140000000000001 112.117 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.2 p -67.21 -27.22 67.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.275 0.472 . . . . 64.129999999999995 112.275 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -65.64 -64.07 0.95 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.806 0.669 . . . . 74.510000000000005 112.806 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HB3' ' SD ' ' A' ' 127' ' ' MET . 34.6 p90 -63.49 -32.48 73.94 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.048 0.388 . . . . 73.340000000000003 112.048 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 110' ' ' VAL . 66.1 t -62.62 -37.17 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.765 0.317 . . . . 72.319999999999993 111.442 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -59.15 -37.36 77.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.057 0.456 . . . . 75.109999999999999 110.84 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.11 -40.82 62.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.179 -0.464 . . . . 71.519999999999996 110.998 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.75 -44.88 86.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.093 0.473 . . . . 63.240000000000002 111.753 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.42 -3.14 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.106 0.479 . . . . 71.030000000000001 111.424 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.15 22.37 73.89 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.47 -0.395 . . . . 73.230000000000004 113.703 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.25 15.38 65.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 114.325 0.49 . . . . 37.799999999999997 114.325 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -79.68 2.65 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.644 0.609 . . . . 61.310000000000002 112.644 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.7 pt -109.43 149.56 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.166 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.36 110.5 3.2 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.826 -0.702 . . . . 37.799999999999997 112.674 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -64.47 -3.24 2.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 122.413 -0.463 . . . . 63.32 112.24 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 t -64.12 -13.33 47.17 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.256 0.465 . . . . 74.129999999999995 112.256 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -59.11 -50.07 75.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.96 0.409 . . . . 74.549999999999997 111.424 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.58 -128.26 9.33 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.162 -0.542 . . . . 61.140000000000001 113.38 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.71 140.47 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 111.83 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.99 -41.28 64.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.118 0.784 . . . . 73.209999999999994 113.118 -173.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.62 -22.62 65.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -84.54 -24.2 29.41 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.748 0.277 . . . . 72.450000000000003 111.748 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -45.37 -46.98 13.48 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.996 0.739 . . . . 75.430000000000007 112.996 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.46 81.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 63.439999999999998 112.181 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 t -80.4 -47.5 14.3 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 74.049999999999997 111.617 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.94 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.359 -0.382 . . . . 73.409999999999997 111.602 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -60.55 -53.78 53.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 53.310000000000002 111.327 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.0 p -59.77 -42.47 93.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.89 0.376 . . . . 73.049999999999997 111.225 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 t -65.61 -29.77 70.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.374 -0.376 . . . . 75.030000000000001 111.543 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.18 -4.34 59.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.435 0.531 . . . . 74.25 112.435 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.45 3.18 56.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.262 -0.494 . . . . 72.25 113.853 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.41 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 81.7 m-85 -72.3 173.79 8.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 111.423 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 35.4 m -106.24 84.85 2.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.09 0.404 . . . . 73.400000000000006 112.09 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 152' ' ' ILE . 49.5 t -93.9 111.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.85 0.357 . . . . 74.549999999999997 111.562 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -149.06 159.96 43.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 110.779 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.2 24.36 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.447 0.536 . . . . 75.209999999999994 112.447 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -81.04 108.64 10.8 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.387 0.275 . . . . 75.209999999999994 110.83 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.45 7.9 4.72 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.833 2.355 . . . . 62.340000000000003 114.395 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -51.59 143.07 13.02 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.158 0.429 . . . . 70.120000000000005 112.158 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 152.7 11.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.52 13.78 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.133 -0.556 . . . . 64.010000000000005 113.114 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.3 p -144.86 178.4 8.04 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 71.129999999999995 111.06 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 62.7 mt -124.58 120.06 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.551 -0.295 . . . . 74.430000000000007 111.211 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 149' ' ' TYR . 1.9 pt? -85.59 126.87 34.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 72.129999999999995 111.233 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 111.26 23.93 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.976 0.417 . . . . 73.310000000000002 109.927 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.437 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 21.4 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 114.238 1.199 . . . . 61.039999999999999 114.238 -169.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 113.938 0.335 . . . . 50.450000000000003 113.938 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -111.91 143.31 43.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.542 0.337 . . . . 75.5 111.038 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.519 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.7 m -141.17 150.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.08 0.467 . . . . 70.140000000000001 111.824 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.42 168.94 25.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.813 -0.63 . . . . 72.129999999999995 110.561 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -100.43 129.55 46.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 111.281 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.35 112.66 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.778 0.323 . . . . 60.25 111.689 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.29 -53.95 4.91 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.12 0.415 . . . . 70.329999999999998 112.12 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -143.18 150.43 39.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.993 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.19 131.98 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.886 -0.597 . . . . 70.239999999999995 110.757 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.57 156.3 16.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.475 -0.33 . . . . 53.299999999999997 111.302 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.8 p -64.66 -18.35 64.88 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.137 0.421 . . . . 63.229999999999997 112.137 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -69.47 -9.78 55.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.817 0.342 . . . . 74.049999999999997 111.443 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 0.07 67.57 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 112.214 -0.354 . . . . 70.439999999999998 112.214 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 m -67.89 120.73 14.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 110.926 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.4 t -105.22 119.19 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.659 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.55 107.12 19.49 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.191 0.519 . . . . 74.430000000000007 110.929 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.58 144.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.013 -0.54 . . . . 64.439999999999998 111.771 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 t -90.98 112.83 24.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.333 -0.394 . . . . 74.010000000000005 111.379 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.39 -173.08 2.3 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.037 -0.529 . . . . 63.219999999999999 110.964 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 60' ' ' TYR . 19.2 ptm . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.213 0.53 . . . . 71.340000000000003 110.77 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 111.945 0.35 . . . . 72.230000000000004 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -111.94 125.41 54.03 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.025 -0.422 . . . . 60.030000000000001 110.77 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.1 m -91.54 105.12 17.51 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.964 0.411 . . . . 64.0 111.619 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.18 139.93 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.375 -0.375 . . . . 71.219999999999999 111.555 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.2 m -72.36 155.31 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.681 0.277 . . . . 70.420000000000002 111.679 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.99 -48.19 73.63 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.535 0.569 . . . . 72.099999999999994 112.535 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.33 -41.08 92.88 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.478 -0.392 . . . . 62.25 113.41 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.51 -45.3 39.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.249 0.547 . . . . 64.230000000000004 111.236 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.1 89.85 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.837 0.68 . . . . 65.319999999999993 112.837 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -62.47 -15.63 50.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.615 0.598 . . . . 74.120000000000005 112.615 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -79.53 -28.35 41.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.904 0.383 . . . . 73.25 111.796 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.46 ' CD2' HD13 ' A' ' 100' ' ' LEU . 22.9 m-85 -74.14 147.84 42.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.163 0.506 . . . . 64.25 111.969 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -91.99 108.12 19.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.233 -0.439 . . . . 75.510000000000005 110.781 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 71.3 m-85 -88.22 119.08 28.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.948 0.404 . . . . 71.25 111.803 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.508 HG13 HG23 ' A' ' 90' ' ' VAL . 3.6 mp -82.21 130.18 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.731 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 46.4 m-70 -120.39 161.95 20.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.969 0.508 . . . . 74.129999999999995 109.87 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.754 0.65 . . . . 74.219999999999999 112.754 -172.275 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 121.052 0.453 . . . . 72.209999999999994 111.854 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.08 149.88 26.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.834 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.18 -23.33 35.16 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.132 -0.556 . . . . 74.239999999999995 113.252 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -89.41 142.19 27.88 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.559 -0.377 . . . . 71.019999999999996 111.294 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.27 -27.05 65.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.213 0.53 . . . . 73.329999999999998 111.469 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.4 p -73.37 -16.37 61.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 112.203 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.98 -54.43 47.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.265 0.626 . . . . 72.340000000000003 112.397 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.89 -34.95 51.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.167 0.432 . . . . 73.129999999999995 112.167 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.14 -42.59 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 111.853 0.316 . . . . 75.329999999999998 111.853 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -58.01 -36.84 73.24 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.77 -41.82 43.27 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.868 0.366 . . . . 71.140000000000001 110.929 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.24 -27.2 68.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.107 0.41 . . . . 73.049999999999997 112.107 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.8 3.27 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 121.277 0.56 . . . . 60.350000000000001 111.422 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.28 12.77 66.56 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.163 -0.541 . . . . 72.150000000000006 113.933 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.41 16.91 71.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 114.43 0.532 . . . . 74.450000000000003 114.43 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.95 30.19 0.52 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.343 0.571 . . . . 63.229999999999997 112.123 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.81 150.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.923 0.392 . . . . 74.519999999999996 111.603 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.65 98.25 0.28 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.321 -0.466 . . . . 72.450000000000003 113.363 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.0 p -59.36 -8.76 1.88 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.086 0.773 . . . . 71.430000000000007 113.086 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -66.57 -12.5 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.59 0.589 . . . . 63.140000000000001 112.59 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -63.15 -59.45 4.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.807 0.337 . . . . 75.310000000000002 111.779 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.62 -110.43 3.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.11 -0.567 . . . . 37.890000000000001 113.699 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.52 140.2 58.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.985 0.393 . . . . 73.299999999999997 111.316 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -52.19 -43.68 64.31 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.573 0.582 . . . . 41.119999999999997 112.573 -176.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -56.96 -21.14 27.96 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.774 0.657 . . . . 61.130000000000003 112.774 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -90.94 -23.81 20.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.824 0.305 . . . . 72.519999999999996 111.824 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 101' ' ' GLN . 9.4 m0 -50.52 -40.26 51.11 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.264 0.839 . . . . 73.319999999999993 113.264 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.63 -64.58 0.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.171 0.434 . . . . 70.239999999999995 112.171 -175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -63.82 -35.44 80.62 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 71.030000000000001 111.691 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.39 87.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.773 0.32 . . . . 72.430000000000007 111.377 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.031 0.443 . . . . 37.890000000000001 111.347 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 p -64.22 -28.51 69.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.423 -0.353 . . . . 65.140000000000001 111.897 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -77.9 -36.34 49.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.9 0.381 . . . . 72.230000000000004 111.767 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -22.03 59.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.267 0.469 . . . . 72.129999999999995 112.267 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.58 10.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.047 -0.597 . . . . 37.890000000000001 113.587 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -76.67 -173.79 2.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.195 0.521 . . . . 64.439999999999998 111.286 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.9 m -121.23 97.47 5.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.436 -0.347 . . . . 63.149999999999999 111.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.543 HG22 HG13 ' A' ' 152' ' ' ILE . 46.2 t -101.62 108.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.817 0.341 . . . . 74.430000000000007 111.847 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.65 147.74 39.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.51 -0.314 . . . . 74.219999999999999 110.932 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -72.76 -9.78 59.04 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.172 0.434 . . . . 73.239999999999995 112.172 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.9 m -56.53 119.79 31.48 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.519 0.2 . . . . 74.230000000000004 111.095 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.56 121.76 1.93 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.001 2.467 . . . . 73.140000000000001 113.78 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.49 156.87 35.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 111.099 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 151.66 46.04 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.077 0.465 . . . . 73.129999999999995 112.115 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.02 41.45 18.26 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.191 -0.528 . . . . 54.020000000000003 113.108 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.5 m -151.75 158.53 43.48 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.514 -0.404 . . . . 63.25 111.011 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.4 mp -103.26 126.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.335 -0.246 . . . . 74.109999999999999 110.335 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 149' ' ' TYR . 1.2 pt? -98.85 124.36 43.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.399 0.619 . . . . 65.230000000000004 110.836 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -111.8 124.17 51.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 111.434 -172.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.572 ' HB2' ' CD1' ' A' ' 149' ' ' TYR . 47.5 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.877 0.37 . . . . 71.019999999999996 111.795 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -159.52 142.25 13.93 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.494 0.647 . . . . 73.510000000000005 111.66 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 76' ' ' ALA . 12.8 m -141.09 141.43 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 111.716 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.16 156.67 41.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.38 -0.373 . . . . 73.209999999999994 110.905 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -96.0 128.64 43.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.881 0.372 . . . . 70.109999999999999 111.209 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.442 HG23 HG13 ' A' ' 124' ' ' VAL . 61.8 t -79.8 118.82 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.317 0.488 . . . . 63.530000000000001 112.317 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -83.92 -53.67 5.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.282 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.42 154.05 34.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.075 0.464 . . . . 64.519999999999996 111.605 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.28 129.09 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 111.009 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 117' ' ' ASN . 0.8 OUTLIER -77.46 160.0 29.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.869 0.366 . . . . 40.229999999999997 111.5 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.3 m -64.04 -20.42 65.91 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.784 0.326 . . . . 62.229999999999997 111.605 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.11 -22.92 66.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.071 0.463 . . . . 74.420000000000002 111.329 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.87 45.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.582 -0.607 . . . . 75.109999999999999 111.582 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -64.97 129.17 38.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.621 0.368 . . . . 74.239999999999995 110.909 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.465 HG21 ' OH ' ' A' ' 151' ' ' TYR . 61.0 t -106.7 111.36 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.201 0.524 . . . . 64.209999999999994 111.737 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.539 ' HG2' HG23 ' A' ' 140' ' ' THR . 37.9 mt-10 -90.32 107.31 19.06 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 110.716 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 113' ' ' VAL . 30.6 m -108.91 173.87 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.004 -0.543 . . . . 73.310000000000002 112.14 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.8 p -117.87 126.09 51.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.026 -0.534 . . . . 74.340000000000003 111.488 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -121.82 -172.68 2.49 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 111.268 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.1 tpp . . . . . 0 N--CA 1.471 0.619 0 O-C-N 121.904 -0.497 . . . . 45.32 111.338 177.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.634 0.254 . . . . 73.109999999999999 111.63 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 2.4 tpm_? -140.61 122.71 15.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.971 0.415 . . . . 74.400000000000006 111.923 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 123' ' ' GLU . 81.5 m -104.36 98.5 8.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.946 0.403 . . . . 60.399999999999999 110.739 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.66 128.88 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 54.43 111.775 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.1 m -67.29 147.25 53.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.549 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.72 -47.28 59.2 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.532 0.568 . . . . 52.219999999999999 112.532 -177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.66 64.55 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.225 -0.512 . . . . 71.200000000000003 113.246 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.32 -34.48 25.68 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.085 0.469 . . . . 73.439999999999998 111.06 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.93 18.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.707 0.632 . . . . 72.349999999999994 112.707 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -75.81 -21.6 57.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.328 0.492 . . . . 44.539999999999999 112.328 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 94.2 p -83.34 -33.28 25.91 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.355 0.502 . . . . 63.119999999999997 112.355 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 102' ' ' SER . 80.8 m-85 -70.8 145.82 50.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.251 0.548 . . . . 75.209999999999994 112.327 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -101.35 114.84 29.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.069 -0.514 . . . . 71.549999999999997 110.208 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.465 ' OH ' HG21 ' A' ' 122' ' ' VAL . 14.2 m-85 -90.91 114.96 27.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.283 0.475 . . . . 74.519999999999996 112.283 -174.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.543 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -82.02 107.75 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.752 -0.462 . . . . 74.510000000000005 109.752 173.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.81 125.36 40.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 60.310000000000002 111.239 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.986 0.422 . . . . 72.329999999999998 111.056 178.338 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 20.5 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 111.939 0.348 . . . . 62.240000000000002 111.939 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.1 mptp? 73.33 -50.65 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 112.971 0.73 . . . . 74.409999999999997 112.971 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -53.83 110.8 0.63 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.005 0.431 . . . . 74.319999999999993 111.809 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tt -92.2 122.87 35.09 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.073 -0.512 . . . . 75.099999999999994 110.799 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -75.56 95.31 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.973 0.416 . . . . 64.439999999999998 111.156 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.6 m -82.74 129.03 34.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 72.230000000000004 111.683 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.35 113.31 24.59 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.922 0.392 . . . . 63.130000000000003 111.39 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 75.5 p -84.9 18.43 2.45 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.465 0.543 . . . . 74.5 112.465 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 m -62.48 137.56 58.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.319 0.488 . . . . 75.510000000000005 112.319 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 10' ' ' LEU . 2.1 pt? -146.56 116.34 7.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 110.841 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -79.66 119.75 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.303 -0.408 . . . . 74.129999999999995 111.17 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.17 114.91 19.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 74.319999999999993 111.67 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.19 145.28 17.59 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.214 -0.517 . . . . 74.409999999999997 112.567 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.8 129.54 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 117.088 0.444 . . . . 72.409999999999997 111.784 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.03 -179.3 47.27 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 113.207 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.06 131.88 45.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.205 0.526 . . . . 72.329999999999998 112.282 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.24 84.62 7.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.098 0.475 . . . . 70.430000000000007 111.466 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.36 147.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.868 0.366 . . . . 72.299999999999997 111.443 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.7 t -123.16 143.73 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.024 0.379 . . . . 51.100000000000001 112.024 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.92 135.56 12.96 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.536 -0.364 . . . . 75.120000000000005 112.78 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.7 mm? -90.1 163.59 14.81 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.061 0.458 . . . . 74.219999999999999 111.724 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.38 130.33 47.56 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.013 0.435 . . . . 64.340000000000003 111.814 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -162.12 111.49 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.167 -0.47 . . . . 75.329999999999998 111.089 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -127.34 3.89 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.998 -0.62 . . . . 60.539999999999999 114.178 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.79 152.65 21.95 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.2 0.524 . . . . 71.140000000000001 112.222 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -93.35 177.75 5.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.118 -0.492 . . . . 73.299999999999997 111.904 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 165.41 12.03 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.803 0.668 . . . . 75.129999999999995 112.803 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -103.55 137.8 41.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.621 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 151.97 20.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.987 0.422 . . . . 75.420000000000002 111.943 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.03 -172.35 2.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.486 0.315 . . . . 65.530000000000001 111.301 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.9 128.65 12.44 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.242 0.544 . . . . 72.319999999999993 112.09 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -173.75 151.91 1.93 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.939 -0.573 . . . . 65.150000000000006 110.964 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.1 p -85.1 102.49 13.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.043 0.449 . . . . 65.030000000000001 110.708 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -150.41 99.5 3.2 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.131 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.36 90.96 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.749 2.299 . . . . 71.230000000000004 113.022 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 131.84 39.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.824 0.345 . . . . 74.310000000000002 111.316 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.86 -20.64 23.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.473 -0.33 . . . . 73.209999999999994 111.689 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -92.54 165.23 13.12 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.35 0.595 . . . . 72.200000000000003 112.296 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -78.92 101.53 7.77 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.197 0.522 . . . . 63.240000000000002 110.096 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.8 p -83.11 119.5 24.58 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.422 0.897 . . . . 74.010000000000005 113.422 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.8 m -67.61 133.09 48.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.872 -0.604 . . . . 74.209999999999994 109.957 169.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -52.55 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.566 0.58 . . . . 73.239999999999995 112.566 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 155' ' ' ASN . 22.5 m -133.12 152.8 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.795 0.331 . . . . 71.200000000000003 111.399 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.8 p -78.61 176.43 9.47 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.048 0.452 . . . . 74.230000000000004 111.554 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.4 p -135.27 93.98 3.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 73.349999999999994 112.287 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.91 64.73 1.73 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.141 -0.552 . . . . 70.209999999999994 111.999 173.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 68' ' ' ASN . 34.2 t -88.89 110.84 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.178 0.436 . . . . 62.350000000000001 112.178 -173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -149.49 158.03 43.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.25 -0.432 . . . . 72.329999999999998 111.321 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 160.12 5.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.695 0.283 . . . . 74.230000000000004 111.566 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.406 HD21 ' HB2' ' A' ' 63' ' ' ASP . 38.9 t-20 -59.7 106.4 0.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.025 0.44 . . . . 71.219999999999999 111.765 -176.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.32 9.52 42.57 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.074 -0.512 . . . . 72.430000000000007 111.928 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -94.85 159.48 15.03 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.084 -0.385 . . . . 73.519999999999996 111.128 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t -70.91 139.64 50.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.132 0.491 . . . . 75.140000000000001 111.916 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.46 110.03 13.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.176 -0.466 . . . . 54.399999999999999 111.758 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.72 -28.24 1.75 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.925 -0.655 . . . . 73.420000000000002 113.287 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.32 150.04 27.43 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.547 -0.384 . . . . 74.109999999999999 110.755 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.574 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 28.2 p -58.69 -34.18 70.99 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.143 0.497 . . . . 72.310000000000002 111.796 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.8 p -64.44 -25.75 68.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.24 -60.33 3.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.519 0.563 . . . . 73.340000000000003 112.519 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 25.0 p90 -64.35 -30.53 71.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.097 -0.377 . . . . 64.430000000000007 111.892 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 110' ' ' VAL . 59.4 t -62.53 -43.67 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.105 0.479 . . . . 64.299999999999997 110.583 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -58.54 -36.61 74.15 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.043 -0.526 . . . . 64.219999999999999 110.944 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.406 ' HB2' HD21 ' A' ' 50' ' ' ASN . 23.5 t70 -76.73 -43.31 37.82 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.406 -0.361 . . . . 65.0 111.132 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -59.19 -34.4 72.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.146 0.498 . . . . 71.209999999999994 111.816 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 99' ' ' ILE . 7.1 p -85.03 9.38 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.309 0.576 . . . . 70.219999999999999 111.815 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.18 14.59 68.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.389 -0.434 . . . . 37.32 113.556 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.77 17.9 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.167 -0.539 . . . . 73.239999999999995 114.129 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 59.8 m-80 -80.09 11.24 3.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.466 0.633 . . . . 64.219999999999999 112.375 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 pt -117.04 153.0 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.374 -0.376 . . . . 74.420000000000002 110.687 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.05 126.69 8.02 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.806 -0.711 . . . . 61.420000000000002 113.968 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -62.33 -19.27 63.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.189 0.518 . . . . 60.109999999999999 111.364 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -70.05 8.25 0.78 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.361 0.875 . . . . 73.430000000000007 113.361 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -78.15 -46.02 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.99 -0.444 . . . . 72.319999999999993 112.047 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.94 9.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.945 -0.645 . . . . 60.43 113.377 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -85.53 162.57 18.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.14 0.495 . . . . 55.43 111.881 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -58.32 -27.78 64.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.849 -0.614 . . . . 73.239999999999995 112.079 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -63.23 -35.34 79.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.985 0.422 . . . . 74.239999999999995 111.173 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.93 -21.26 19.32 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.508 0.558 . . . . 75.450000000000003 112.508 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -38.95 -55.43 1.55 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.447 1.277 . . . . 74.409999999999997 114.447 -172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB1' HG12 ' A' ' 90' ' ' VAL . . . -62.67 -37.63 87.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.941 -0.475 . . . . 62.32 112.235 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -68.94 -47.74 64.96 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.932 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.82 92.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.131 -0.486 . . . . 63.219999999999999 111.156 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.96 -51.98 62.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.078 0.466 . . . . 53.409999999999997 110.938 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 m -58.24 -45.27 88.07 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.176 0.512 . . . . 64.319999999999993 110.713 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 t -66.86 -24.6 66.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.072 -0.513 . . . . 71.540000000000006 111.97 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.3 -13.07 33.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.114 0.412 . . . . 64.140000000000001 112.114 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.34 41.84 3.86 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.253 -0.499 . . . . 62.439999999999998 113.434 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -107.61 -178.6 3.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 74.340000000000003 111.522 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.0 m -110.05 108.06 18.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 111.291 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.477 HG23 HG13 ' A' ' 152' ' ' ILE . 39.0 t -116.81 110.99 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.082 0.467 . . . . 65.140000000000001 111.907 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 50.8 m-80 -139.17 155.6 47.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.385 -0.371 . . . . 72.319999999999993 110.369 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.64 13.71 1.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.008 0.373 . . . . 74.430000000000007 112.008 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.5 p -73.84 116.87 56.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.601 -0.272 . . . . 74.010000000000005 111.416 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 103.51 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.486 2.124 . . . . 53.539999999999999 112.241 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.541 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 36.9 tt0 -141.45 152.15 44.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.977 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.32 153.92 42.0 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.021 0.439 . . . . 71.319999999999993 111.905 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.54 34.05 63.53 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.074 -0.584 . . . . 63.020000000000003 112.691 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.5 m -136.78 158.8 43.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.299999999999997 111.067 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -107.95 127.53 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.597 -0.274 . . . . 64.530000000000001 110.448 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD11 ' CD2' ' A' ' 149' ' ' TYR . 1.7 pt? -95.63 130.37 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.937 -0.477 . . . . 64.200000000000003 111.127 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.487 ' HA ' HG13 ' A' ' 110' ' ' VAL . 41.8 tt0 -98.29 129.32 45.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.402 -0.363 . . . . 64.140000000000001 111.685 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.5 t -95.38 -40.62 9.41 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.752 0.649 . . . . 71.310000000000002 112.752 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.3 p 66.59 -42.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.419 1.087 . . . . 75.200000000000003 113.47 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.17 9.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.212 0.529 . . . . 37.32 112.075 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.51 64.19 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.162 -0.542 . . . . 55.32 113.349 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.97 -84.14 0.36 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.398 -0.43 . . . . 65.140000000000001 113.038 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -87.7 1.85 52.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.955 0.407 . . . . 74.230000000000004 111.767 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.06 155.32 23.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.288 -0.482 . . . . 52.140000000000001 113.584 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -131.63 149.71 52.4 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.747 -0.267 . . . . 65.519999999999996 111.036 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 76' ' ' ALA . 11.8 m -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.138 0.494 . . . . 65.530000000000001 111.663 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.86 163.03 40.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 73.129999999999995 110.651 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -96.68 127.4 42.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.752 0.31 . . . . 75.420000000000002 111.376 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.532 HG22 HG12 ' A' ' 124' ' ' VAL . 60.9 t -76.1 108.05 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.948 0.404 . . . . 71.420000000000002 112.031 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 138' ' ' GLU . 11.3 mm-40 -71.95 -45.86 59.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.055 -0.52 . . . . 71.349999999999994 111.504 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -163.6 149.37 11.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 111.517 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.451 HG22 HG11 ' A' ' 122' ' ' VAL . 57.9 t -120.65 128.91 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 61.340000000000003 110.535 177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -84.42 154.55 22.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.955 0.407 . . . . 70.400000000000006 111.925 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 t -57.61 -34.42 69.26 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.441 0.639 . . . . 75.019999999999996 110.078 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.2 -31.53 43.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.245 -0.889 . . . . 75.140000000000001 111.583 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.75 -19.35 21.4 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.369 -0.443 . . . . 54.509999999999998 112.669 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.3 p -61.62 125.7 24.72 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.329 0.585 . . . . 51.409999999999997 111.66 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.451 HG11 HG22 ' A' ' 116' ' ' VAL . 48.9 t -103.44 117.85 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.716 -0.675 . . . . 74.109999999999999 111.347 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.85 102.52 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.218 0.532 . . . . 72.340000000000003 111.464 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.532 HG12 HG22 ' A' ' 113' ' ' VAL . 35.5 m -106.42 123.49 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.449 0.643 . . . . 62.509999999999998 111.876 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 39.5 t -81.03 122.19 26.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.054 0.455 . . . . 72.209999999999994 111.841 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -133.31 137.59 46.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.492 . . . . 63.200000000000003 111.18 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 50.2 ttm -80.58 122.14 26.68 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.016 0.436 . . . . 72.400000000000006 111.642 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.455 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER -83.23 -29.46 28.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 64.319999999999993 110.592 176.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.4 t80 71.38 -55.74 0.65 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.91 0.707 . . . . 63.009999999999998 112.91 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -50.38 93.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.066 0.46 . . . . 72.409999999999997 111.529 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.62 -38.05 1.48 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.99 -0.55 . . . . 54.130000000000003 112.683 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.02 167.17 40.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.597 -0.335 . . . . 37.32 112.834 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.06 -28.2 65.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.763 2.309 . . . . 64.340000000000003 113.169 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.29 28.07 8.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.668 0.271 . . . . 74.329999999999998 111.684 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.2 m -66.56 83.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.417 0.627 . . . . 55.240000000000002 111.044 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 22.0 t -109.29 155.25 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.832 -0.622 . . . . 61.43 110.821 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.7 m -145.21 136.85 25.36 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.072 0.463 . . . . 54.210000000000001 111.737 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 2.6 mp0 -84.35 94.08 8.39 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.336 0.589 . . . . 64.140000000000001 111.366 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -70.04 109.3 4.48 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.504 -0.771 . . . . 64.420000000000002 111.895 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.8 m -85.33 98.26 10.44 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.95 0.405 . . . . 72.049999999999997 111.343 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.0 mt -88.52 144.34 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 111.549 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.8 m -68.85 148.32 50.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 111.293 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.92 42.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.072 0.767 . . . . 65.230000000000004 113.072 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.03 -48.74 77.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.419 -0.419 . . . . 71.340000000000003 113.434 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.22 -39.03 75.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.042 0.449 . . . . 71.409999999999997 111.544 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.46 77.81 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.074 0.398 . . . . 73.400000000000006 112.074 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.9 m -61.55 -14.47 30.06 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.091 0.472 . . . . 62.520000000000003 111.74 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -73.67 -8.49 56.18 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.338 -0.392 . . . . 37.32 111.762 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.407 ' CD2' HD11 ' A' ' 100' ' ' LEU . 53.1 m-85 -105.17 156.91 17.66 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.112 0.482 . . . . 74.329999999999998 112.064 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.0 115.69 24.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.36 -0.382 . . . . 73.450000000000003 111.028 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 82.5 m-85 -93.29 121.32 34.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.135 0.493 . . . . 74.519999999999996 112.053 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.477 HG13 HG23 ' A' ' 90' ' ' VAL . 3.4 mp -89.89 111.08 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.347 -0.388 . . . . 64.310000000000002 110.316 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.541 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 33.2 m-70 -98.52 136.77 38.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.41 -0.359 . . . . 73.150000000000006 110.984 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.04 93.21 7.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.156 0.503 . . . . 53.130000000000003 112.236 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 155' ' ' ASN . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.107 0.479 . . . . 74.319999999999993 110.269 173.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.798 0.333 . . . . 64.439999999999998 111.19 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.1 150.04 20.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.25 0.547 . . . . 75.310000000000002 111.723 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -108.25 123.38 48.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.265 -0.425 . . . . 70.099999999999994 110.974 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.34 103.59 5.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.001 0.429 . . . . 74.420000000000002 111.997 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 m -87.29 38.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.45 0.643 . . . . 73.329999999999998 111.196 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.1 m -86.58 144.69 27.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.629 0.603 . . . . 74.400000000000006 112.629 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.21 126.91 38.54 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.7 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -136.92 105.16 5.7 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.668 0.271 . . . . 72.109999999999999 111.357 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 10' ' ' LEU . 25.4 m -88.3 157.38 18.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.983 0.42 . . . . 75.120000000000005 111.959 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 10' ' ' LEU . 1.9 mm? -102.83 22.8 13.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.688 0.395 . . . . 73.129999999999995 111.242 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t -61.58 152.48 30.36 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.608 0.596 . . . . 72.239999999999995 112.608 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.53 168.61 8.98 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.194 -0.457 . . . . 65.219999999999999 112.202 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.76 96.1 1.76 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.443 -0.408 . . . . 74.310000000000002 113.021 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.1 mt -94.92 120.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.61 -0.347 . . . . 71.019999999999996 111.503 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -139.62 10.77 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.304 -0.475 . . . . 62.109999999999999 113.331 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.65 119.67 3.37 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.61 -0.347 . . . . 71.319999999999993 111.357 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.33 101.66 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.993 0.425 . . . . 63.32 111.689 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 49' ' ' ALA . 35.1 mm -79.49 79.84 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.289 0.566 . . . . 62.210000000000001 110.918 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.97 124.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.196 -0.457 . . . . 64.340000000000003 110.967 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.73 84.85 0.08 OUTLIER Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 112.439 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -170.61 122.91 0.63 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.81 0.338 . . . . 73.230000000000004 111.1 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.57 95.21 2.88 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.847 0.356 . . . . 74.209999999999994 110.498 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 66.64 -4.25 0.77 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.66 0.615 . . . . 63.399999999999999 112.66 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.9 -1.46 84.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.263 -0.494 . . . . 43.240000000000002 113.732 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -72.17 -19.97 61.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.895 0.379 . . . . 72.450000000000003 111.873 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -107.86 131.66 54.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.038 0.447 . . . . 73.200000000000003 111.294 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.82 23.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.978 -0.555 . . . . 75.030000000000001 110.665 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.06 162.54 9.2 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.309 0.485 . . . . 70.519999999999996 112.309 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.05 9.23 23.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.5 0.555 . . . . 74.420000000000002 112.5 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.14 107.53 0.9 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 111.887 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.18 119.18 36.38 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.275 -0.42 . . . . 73.439999999999998 111.931 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HB3' HE22 ' A' ' 34' ' ' GLN . 98.8 mt-30 -93.18 117.86 30.56 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.928 0.394 . . . . 70.329999999999998 111.064 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.5 p -113.52 96.1 5.7 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.613 0.597 . . . . 72.450000000000003 112.613 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 32' ' ' GLN . 2.2 mp0 -118.63 112.79 36.8 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.394 -0.366 . . . . 72.049999999999997 110.939 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.57 100.45 0.41 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.772 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.7 p -118.89 157.41 27.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.186 0.517 . . . . 72.109999999999999 111.486 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -80.46 30.83 0.29 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.396 0.517 . . . . 75.340000000000003 112.396 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.32 7.68 15.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.924 0.342 . . . . 74.409999999999997 111.924 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -62.25 103.83 0.43 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.003 0.43 . . . . 43.210000000000001 111.491 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -139.5 158.21 44.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.37 -0.377 . . . . 45.240000000000002 111.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 m -84.15 92.16 7.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 52.020000000000003 110.198 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -104.83 146.59 28.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.096 0.474 . . . . 64.049999999999997 112.214 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.7 m -103.21 138.02 40.58 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.018 -0.537 . . . . 70.540000000000006 110.833 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -64.92 114.12 4.32 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.86 0.362 . . . . 75.219999999999999 111.908 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.5 p -114.17 -179.39 3.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.933 0.397 . . . . 75.340000000000003 111.375 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.5 -112.88 3.24 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.321 -0.466 . . . . 44.420000000000002 112.723 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.5 p 51.93 13.07 0.22 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 114.277 1.214 . . . . 75.209999999999994 114.277 174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.8 m -98.8 157.34 16.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.078 0.466 . . . . 73.510000000000005 111.701 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 18' ' ' ILE . . . -74.61 -74.03 0.21 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.266 0.555 . . . . 65.439999999999998 111.898 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -165.12 90.32 0.5 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.94 -0.573 . . . . 72.530000000000001 110.055 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.43 31.53 0.58 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.138 0.494 . . . . 71.040000000000006 112.198 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -140.51 -177.93 5.27 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.607 0.363 . . . . 71.209999999999994 110.527 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -114.85 149.87 36.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.997 0.427 . . . . 63.310000000000002 111.784 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 103.84 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 112.35 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.75 -28.17 2.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 112.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 59' ' ' TRP . 96.3 mt-30 -73.88 143.87 45.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.007 0.432 . . . . 72.420000000000002 111.899 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.0 m -57.11 -46.28 82.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.569 174.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.3 p -55.13 -41.21 71.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.795 -0.639 . . . . 71.030000000000001 111.547 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB3' ' O ' ' A' ' 56' ' ' GLN . 59.3 t90 -55.23 -55.68 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.57 -0.741 . . . . 75.310000000000002 111.76 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.477 ' OH ' ' HD3' ' A' ' 64' ' ' LYS . 47.1 t80 -62.75 -42.18 99.55 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.294 0.479 . . . . 75.109999999999999 112.294 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 110' ' ' VAL . 82.4 t -60.44 -38.27 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 111.946 0.35 . . . . 73.530000000000001 111.946 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.514 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 44.2 t80 -62.22 -34.82 77.22 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 111.388 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.95 -46.78 56.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.167 0.508 . . . . 55.350000000000001 110.318 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.477 ' HD3' ' OH ' ' A' ' 60' ' ' TYR . 25.5 mmmt -55.71 -40.58 72.6 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 112.3 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.51 9.5 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.077 0.465 . . . . 74.209999999999994 111.55 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.66 60.47 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.523 -0.37 . . . . 37.880000000000003 113.745 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.452 ' HA2' ' CE1' ' A' ' 62' ' ' TYR . . . 63.54 29.25 74.07 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.159 -0.543 . . . . 62.409999999999997 114.261 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -93.23 24.57 3.76 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.478 0.639 . . . . 71.430000000000007 112.214 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.82 155.5 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.03 0.443 . . . . 63.340000000000003 111.702 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.13 93.56 0.34 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.09 -0.576 . . . . 73.140000000000001 112.551 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.514 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 63.1 p -72.65 20.8 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.377 0.88 . . . . 37.880000000000003 113.377 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -90.0 -2.26 58.11 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.189 -0.319 . . . . 64.030000000000001 111.752 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -64.83 -38.18 90.12 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.56 0.578 . . . . 72.439999999999998 112.56 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.09 -111.09 3.24 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.071 -0.585 . . . . 60.229999999999997 113.445 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -53.63 134.05 41.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.926 0.393 . . . . 61.350000000000001 111.908 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -59.95 -39.31 85.14 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.507 0.558 . . . . 61.240000000000002 112.507 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -63.74 -9.82 16.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.48 0.548 . . . . 55.420000000000002 112.48 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -94.15 -16.65 23.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.497 0.319 . . . . 60.420000000000002 111.661 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -60.49 -42.26 95.95 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.129 0.789 . . . . 73.120000000000005 113.129 -170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -56.66 10.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.971 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -62.52 -44.51 96.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.91 0.386 . . . . 65.239999999999995 111.627 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.1 -47.94 83.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.566 -0.288 . . . . 72.109999999999999 111.728 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . . . -56.38 -49.0 75.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 111.404 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -58.76 -40.81 84.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 111.999 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -75.49 -39.14 58.94 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.959 0.409 . . . . 62.299999999999997 111.897 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.99 82.61 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.113 0.412 . . . . 71.120000000000005 112.113 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.11 17.85 1.58 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.948 -0.644 . . . . 52.350000000000001 113.383 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 58.7 m-85 -89.19 176.61 6.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.26 0.552 . . . . 72.400000000000006 111.061 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -104.59 91.37 3.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.133 -0.485 . . . . 75.140000000000001 111.173 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.69 117.52 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.029 0.442 . . . . 73.319999999999993 112.054 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -153.04 -179.46 7.7 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.902 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.15 10.1 30.8 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.083 0.401 . . . . 71.319999999999993 112.083 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -72.56 111.79 12.48 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 110.291 -0.263 . . . . 74.530000000000001 110.291 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.47 ' O ' HG21 ' A' ' 116' ' ' VAL . 91.8 Cg_endo -76.65 1.93 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.836 2.358 . . . . 62.520000000000003 115.065 -170.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.23 137.51 6.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.895 0.702 . . . . 60.43 112.895 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.51 174.16 1.84 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.396 0.888 . . . . 72.150000000000006 113.396 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.0 35.33 57.95 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.998 -0.547 . . . . 42.130000000000003 112.484 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.7 m -153.4 -176.96 6.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.571 0.348 . . . . 62.020000000000003 110.665 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mt -122.2 129.39 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.803 -0.18 . . . . 73.209999999999994 111.45 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -98.37 133.45 42.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.799 -0.563 . . . . 74.420000000000002 110.923 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.39 106.15 17.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.031 -0.531 . . . . 72.450000000000003 110.286 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -99.29 116.16 30.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 75.400000000000006 111.38 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 48.2 p -77.35 2.75 14.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.661 0.615 . . . . 63.439999999999998 112.661 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.48 58.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.087 0.47 . . . . 72.25 111.624 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.03 168.76 37.95 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.23 -0.51 . . . . 63.030000000000001 113.073 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.44 99.04 0.22 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.303 -0.475 . . . . 71.340000000000003 112.933 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 66.22 27.23 10.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.504 0.668 . . . . 75.420000000000002 110.833 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.26 162.01 30.55 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.411 -0.813 . . . . 72.409999999999997 113.021 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -142.44 110.55 5.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.456 -0.438 . . . . 64.0 111.095 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 76' ' ' ALA . 31.4 m -111.81 145.15 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.921 0.391 . . . . 72.140000000000001 111.397 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.39 157.81 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.989 0.423 . . . . 73.530000000000001 111.366 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -90.7 130.91 36.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.827 0.346 . . . . 74.409999999999997 110.878 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.555 ' HA ' HG11 ' A' ' 124' ' ' VAL . 39.9 t -83.49 114.72 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 45.229999999999997 112.124 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.457 ' CD ' ' HZ3' ' A' ' 64' ' ' LYS . 10.9 mm-40 -78.78 -50.96 10.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.907 -0.588 . . . . 73.409999999999997 111.536 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -158.08 150.71 22.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 111.84 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 94' ' ' PRO . 98.5 t -126.92 127.63 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.912 -0.585 . . . . 64.239999999999995 110.39 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -91.98 148.29 22.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.881 0.372 . . . . 74.549999999999997 111.852 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 75.8 m -64.0 -16.01 60.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.368 -0.378 . . . . 73.409999999999997 111.743 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.11 -6.46 39.43 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 111.379 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 60.05 1.59 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.316 -0.468 . . . . 54.219999999999999 112.985 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.0 p -145.78 133.6 21.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.294 -0.533 . . . . 65.319999999999993 111.668 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.46 113.62 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.14 -0.482 . . . . 74.049999999999997 111.213 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 31.2 mt-10 -99.49 118.85 36.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.502 -0.317 . . . . 75.109999999999999 110.928 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 113' ' ' VAL . 16.1 m -129.38 147.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.371 0.508 . . . . 64.340000000000003 112.371 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 65.9 m -79.4 122.91 26.98 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.928 0.394 . . . . 73.349999999999994 112.054 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' CD ' ' HD2' ' A' ' 139' ' ' ARG . 44.3 mt-10 -116.62 143.94 45.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.275 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 tpp -93.77 103.99 16.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.741 0.305 . . . . 52.299999999999997 110.227 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 76.46 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.3 0.571 . . . . 63.409999999999997 111.896 -177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -60.01 -23.55 63.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.815 -0.629 . . . . 75.439999999999998 111.846 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.5 -29.66 68.01 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.126 0.489 . . . . 71.209999999999994 111.086 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.73 -50.44 1.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.835 -0.506 . . . . 53.140000000000001 111.835 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.69 120.81 0.95 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.357 -0.449 . . . . 73.239999999999995 112.517 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.41 5.46 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.015 2.477 . . . . 74.510000000000005 113.878 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -115.26 3.72 14.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.848 0.356 . . . . 72.049999999999997 111.118 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 m -115.93 132.55 56.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 111.365 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG12 ' OH ' ' A' ' 60' ' ' TYR . 43.2 t -113.48 140.24 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.528 0.566 . . . . 73.530000000000001 112.528 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 t -136.83 134.88 37.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.95 -0.568 . . . . 72.019999999999996 111.144 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -91.43 119.9 31.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.729 0.299 . . . . 73.540000000000006 111.413 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.51 ' HD2' ' CD ' ' A' ' 126' ' ' GLU . 11.3 ptm180 -87.46 151.59 22.92 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.117 -0.364 . . . . 71.510000000000005 110.633 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.4 ' HG1' ' HG2' ' A' ' 123' ' ' GLU . 52.4 m -114.8 102.59 10.14 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.123 0.487 . . . . 73.299999999999997 110.98 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 mt -86.43 131.0 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.854 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -71.26 149.11 46.52 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.814 -0.175 . . . . 72.140000000000001 110.94 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.99 61.53 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.701 0.63 . . . . 72.409999999999997 112.701 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.68 -23.63 55.66 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.459 -0.4 . . . . 71.510000000000005 113.809 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.24 -35.06 10.87 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.448 -0.442 . . . . 64.299999999999997 111.257 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.32 67.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.122 0.487 . . . . 61.409999999999997 111.8 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 148' ' ' SER . 69.1 m -60.83 143.79 54.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.221 -0.445 . . . . 65.340000000000003 110.859 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 147' ' ' SER . 31.3 t 83.56 -3.0 1.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.681 0.792 . . . . 71.140000000000001 112.241 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -93.61 127.99 39.55 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.972 -0.455 . . . . 75.439999999999998 110.272 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.89 118.48 30.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 111.707 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -92.17 113.22 25.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.951 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -80.22 114.92 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.501 -0.318 . . . . 73.120000000000005 110.35 174.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.57 146.93 28.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.667 0.27 . . . . 75.319999999999993 110.658 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.7 mt -102.47 127.81 49.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.804 0.335 . . . . 75.230000000000004 111.414 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.877 0.37 . . . . 61.219999999999999 111.012 178.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.009 0.374 . . . . 73.439999999999998 112.009 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -97.39 151.57 19.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.871 0.367 . . . . 64.129999999999995 110.518 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -87.33 94.01 9.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.937 0.398 . . . . 74.209999999999994 110.877 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -156.27 161.78 40.19 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.166 0.508 . . . . 74.129999999999995 112.257 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.07 141.86 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.962 -0.563 . . . . 73.109999999999999 110.474 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.3 m -83.71 106.4 15.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 110.902 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.9 150.06 34.14 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.328 0.492 . . . . 71.430000000000007 112.328 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -162.18 167.42 24.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.246 -0.434 . . . . 54.340000000000003 111.187 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.9 m -150.35 126.19 10.42 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.747 0.308 . . . . 74.430000000000007 111.145 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD21 ' N ' ' A' ' 10' ' ' LEU . 1.6 pt? -132.07 139.99 48.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.164 0.507 . . . . 65.25 111.667 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -164.53 104.49 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.731 -0.668 . . . . 71.420000000000002 110.798 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.13 112.56 24.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.188 0.44 . . . . 65.400000000000006 112.188 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.59 116.91 5.35 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 112.387 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -110.2 144.2 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.026 0.441 . . . . 74.120000000000005 111.768 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.27 140.64 12.45 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.364 -0.446 . . . . 73.030000000000001 113.073 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.03 137.04 38.13 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.488 -0.419 . . . . 53.119999999999997 111.775 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.42 113.72 25.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.406 -0.361 . . . . 72.439999999999998 111.53 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -96.43 142.2 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.117 0.484 . . . . 74.329999999999998 112.037 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.1 153.66 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.355 -0.384 . . . . 62.100000000000001 111.406 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.23 118.0 0.84 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.877 -0.677 . . . . 64.319999999999993 113.873 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 22' ' ' ASP . 7.9 tt -144.63 138.62 27.49 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' N ' HD22 ' A' ' 21' ' ' LEU . 16.1 m-20 -121.83 161.19 23.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.862 0.69 . . . . 72.239999999999995 112.862 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -163.73 99.61 0.89 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.502 -0.772 . . . . 75.5 110.565 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.41 172.95 51.83 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.217 -0.516 . . . . 63.130000000000003 114.369 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -77.92 112.78 15.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.233 0.539 . . . . 73.329999999999998 111.321 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.1 143.38 30.59 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.219 0.822 . . . . 74.319999999999993 113.219 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.9 178.8 5.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 55.399999999999999 109.919 166.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -141.02 140.09 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 112.104 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.16 110.35 18.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.999 0.428 . . . . 70.230000000000004 110.486 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.82 89.7 6.34 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.247 0.832 . . . . 63.009999999999998 113.247 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.86 127.66 33.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.883 -0.784 . . . . 71.519999999999996 108.883 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.77 103.54 0.08 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.646 0.736 . . . . 71.310000000000002 111.553 -176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 t -68.14 86.18 0.26 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.428 -0.806 . . . . 40.020000000000003 112.424 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -129.11 140.34 38.35 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.038 -0.528 . . . . 62.299999999999997 110.747 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.54 104.82 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.45 2.1 . . . . 64.430000000000007 112.774 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -96.75 -41.48 8.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.353 0.501 . . . . 71.319999999999993 112.353 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -99.72 139.07 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.168 0.509 . . . . 64.510000000000005 111.951 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -93.05 -30.73 15.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.036 -0.529 . . . . 71.109999999999999 111.723 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.16 33.33 0.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.589 0.589 . . . . 72.219999999999999 112.589 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.6 p -85.78 89.57 7.79 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.272 0.558 . . . . 75.209999999999994 112.004 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.5 p -115.45 131.19 57.01 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.237 -0.438 . . . . 63.210000000000001 110.561 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.08 103.08 2.2 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.104 0.478 . . . . 71.109999999999999 112.059 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.6 m -76.33 75.87 3.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.014 0.435 . . . . 70.530000000000001 110.216 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.1 t -66.36 81.06 0.09 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.847 0.832 . . . . 73.310000000000002 112.389 -173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -175.95 -48.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.343 -0.844 . . . . 51.340000000000003 110.691 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.66 -162.58 52.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.195 -0.526 . . . . 72.219999999999999 113.058 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.6 t -103.43 149.56 24.69 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.283 -0.539 . . . . 74.299999999999997 111.595 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.0 t -128.67 -0.53 5.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.826 -0.625 . . . . 74.439999999999998 111.412 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.86 175.2 14.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.183 0.516 . . . . 52.109999999999999 112.235 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -90.07 117.32 28.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.249 -0.432 . . . . 71.129999999999995 110.441 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 71' ' ' SER . 3.9 mm? -96.01 15.46 20.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.04 0.385 . . . . 74.420000000000002 112.04 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -110.32 178.8 4.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.936 0.398 . . . . 74.329999999999998 111.27 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -116.8 150.1 38.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.403 -0.362 . . . . 75.450000000000003 111.61 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.37 156.73 25.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.715 0.635 . . . . 74.409999999999997 112.715 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.77 -33.9 3.23 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.284 -0.416 . . . . 53.450000000000003 113.795 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -75.64 150.74 37.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.229 0.537 . . . . 75.340000000000003 112.274 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.41 -39.53 73.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.025 -0.534 . . . . 75.25 111.638 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.7 p -54.99 -42.96 73.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.941 0.401 . . . . 75.25 111.649 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -62.82 -50.32 71.45 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.408 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.1 -54.15 50.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.787 -0.642 . . . . 73.510000000000005 111.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.5 -34.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.781 0.324 . . . . 74.319999999999993 111.469 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -55.62 -47.69 76.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.519 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.19 -37.56 75.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.965 0.412 . . . . 74.439999999999998 110.884 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -61.24 -35.57 77.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.013 -0.539 . . . . 43.009999999999998 112.19 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.65 12.4 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.432 0.634 . . . . 63.399999999999999 110.997 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.67 18.38 59.05 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 114.179 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.02 67.14 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.115 -0.564 . . . . 51.119999999999997 113.792 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.01 37.76 0.44 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.231 -0.57 . . . . 63.439999999999998 111.89 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.3 pt -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.112 0.482 . . . . 73.209999999999994 111.455 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.8 1.26 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.071 -0.585 . . . . 44.520000000000003 112.315 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 6.2 m -52.82 -18.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.219 0.822 . . . . 64.420000000000002 113.219 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -94.43 18.93 10.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.576 0.584 . . . . 73.299999999999997 112.576 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -67.69 -37.0 81.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.074 0.398 . . . . 74.439999999999998 112.074 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.94 -134.62 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.072 -0.585 . . . . 63.149999999999999 113.715 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -63.17 151.02 41.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.312 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -55.65 -31.76 62.61 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.14 0.793 . . . . 74.540000000000006 113.14 -172.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -67.14 -21.62 65.82 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.494 0.553 . . . . 74.420000000000002 112.494 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.38 -14.21 29.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.109 0.411 . . . . 75.209999999999994 112.109 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -52.06 -65.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.202 0.816 . . . . 72.0 113.202 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.18 91.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.059 0.392 . . . . 53.539999999999999 112.059 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 m -54.97 -36.91 65.86 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.976 0.417 . . . . 73.340000000000003 111.613 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.2 -28.11 25.66 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.342 -0.39 . . . . 64.450000000000003 111.891 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.7 70.04 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.726 0.298 . . . . 70.450000000000003 111.372 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.4 p -58.88 -54.36 48.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.012 0.434 . . . . 65.530000000000001 111.106 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.8 t -55.56 -37.19 67.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.945 -0.571 . . . . 64.230000000000004 112.446 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.88 -10.46 59.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 111.999 0.37 . . . . 73.439999999999998 111.999 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 41.51 4.24 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.332 -0.461 . . . . 55.439999999999998 113.873 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -110.98 -179.07 3.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.005 0.431 . . . . 64.030000000000001 111.112 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.4 m -109.72 103.86 12.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.216 0.45 . . . . 75.25 112.216 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.28 99.81 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 63.329999999999998 110.882 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.17 156.07 34.46 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 111.29 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.78 -4.06 58.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.443 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.2 m -66.35 111.71 7.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.323 -0.398 . . . . 74.239999999999995 110.806 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -78.12 20.29 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.471 2.781 . . . . 73.409999999999997 114.56 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -48.65 141.53 7.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.556 0.576 . . . . 73.400000000000006 112.556 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.74 144.68 47.55 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.987 -0.551 . . . . 44.299999999999997 112.36 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.54 45.89 5.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.916 -0.659 . . . . 73.140000000000001 112.584 -175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -149.53 177.68 9.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 70.319999999999993 111.121 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.8 mt -122.83 121.21 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 110.708 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.6 pt? -92.7 139.4 30.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.02 0.438 . . . . 70.329999999999998 110.867 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -105.06 103.7 13.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.92 0.39 . . . . 64.349999999999994 111.408 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 66.2 m -74.6 97.27 3.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.406 0.622 . . . . 70.329999999999998 111.165 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.6 p -88.24 11.68 15.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.879 -0.601 . . . . 72.329999999999998 112.203 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.33 -27.59 68.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.466 0.543 . . . . 64.25 112.466 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 156.36 -174.47 34.17 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.911 -0.661 . . . . 63.140000000000001 113.599 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.41 41.54 94.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.324 -0.465 . . . . 64.109999999999999 113.407 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.39 17.39 8.32 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.026 0.531 . . . . 74.409999999999997 112.046 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.38 156.2 29.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.08 -0.581 . . . . 73.299999999999997 113.436 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 26.8 t60 -141.32 148.09 39.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.687 -0.302 . . . . 74.230000000000004 110.457 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 76' ' ' ALA . 11.9 m -139.43 144.2 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.146 0.498 . . . . 71.129999999999995 111.692 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.39 153.73 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.907 -0.588 . . . . 61.200000000000003 110.666 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -88.71 128.7 35.62 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.049 0.452 . . . . 71.200000000000003 111.129 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.74 106.38 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.27 -0.423 . . . . 62.25 111.665 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -74.81 -51.99 12.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.938 0.399 . . . . 64.239999999999995 111.384 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -148.88 145.78 27.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.293 0.568 . . . . 43.119999999999997 112.347 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.49 130.02 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.826 -0.625 . . . . 62.030000000000001 110.763 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -88.36 147.46 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.354 -0.385 . . . . 74.420000000000002 111.372 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -56.09 -37.33 69.21 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.908 0.385 . . . . 62.229999999999997 111.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -22.48 64.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 111.736 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.37 -20.66 8.34 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.412 -0.423 . . . . 63.509999999999998 113.587 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -58.63 126.25 26.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.131 0.419 . . . . 65.340000000000003 112.131 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.12 122.89 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.05 -0.523 . . . . 65.040000000000006 111.189 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -103.43 109.58 21.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.273 0.558 . . . . 73.519999999999996 110.978 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.62 160.43 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.961 -0.563 . . . . 61.420000000000002 111.534 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.8 p -107.83 124.8 50.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.214 0.531 . . . . 63.229999999999997 111.744 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -108.34 -176.58 3.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.819 -0.628 . . . . 75.219999999999999 111.207 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 39.0 tpp -141.35 134.44 29.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.381 -0.372 . . . . 71.140000000000001 111.48 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 t30 60.22 29.17 18.78 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.313 0.578 . . . . 42.509999999999998 111.921 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -79.05 -168.53 1.5 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.791 -0.448 . . . . 74.409999999999997 109.791 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.64 96.09 0.08 Allowed 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.619 -0.676 . . . . 64.540000000000006 111.829 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.95 -63.01 0.13 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.039 -0.528 . . . . 71.109999999999999 112.82 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -174.64 154.66 19.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.796 -0.716 . . . . 64.109999999999999 113.469 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.26 140.91 41.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.633 2.222 . . . . 73.420000000000002 112.925 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 64.86 12.78 8.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.888 -0.596 . . . . 74.209999999999994 112.019 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.1 t -99.53 139.87 34.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.665 0.269 . . . . 75.310000000000002 111.032 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.58 118.36 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.16 0.505 . . . . 72.310000000000002 111.622 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 49.4 m -98.65 107.28 19.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.063 0.459 . . . . 72.140000000000001 111.218 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.96 110.01 16.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.327 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -108.45 121.04 44.13 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.856 -0.611 . . . . 72.349999999999994 111.432 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.4 m -94.98 103.72 15.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 111.458 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 111.309 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.4 m -67.02 144.77 55.99 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.494 -0.321 . . . . 72.120000000000005 111.419 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.69 -47.49 50.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.965 0.728 . . . . 64.510000000000005 112.965 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.85 -57.86 16.12 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.548 -0.358 . . . . 64.299999999999997 113.479 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.57 -41.66 98.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 71.519999999999996 110.971 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.31 69.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.892 -0.595 . . . . 54.329999999999998 112.176 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -64.08 -11.65 31.69 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.489 0.551 . . . . 73.140000000000001 112.489 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 44.4 t -83.0 -10.38 58.8 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.975 0.416 . . . . 73.340000000000003 111.178 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 26.2 m-85 -93.73 153.08 18.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.076 0.465 . . . . 71.310000000000002 111.285 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.27 112.58 20.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.286 -0.416 . . . . 75.530000000000001 111.335 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 89.6 m-85 -93.9 113.52 25.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.121 0.486 . . . . 63.350000000000001 111.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -80.12 128.38 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 54.219999999999999 110.933 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.09 144.82 48.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.436 -0.347 . . . . 73.140000000000001 110.568 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 59.8 mt -98.55 129.35 45.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.175 0.512 . . . . 65.430000000000007 112.289 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.787 0 CA-C-N 116.132 -0.486 . . . . 75.099999999999994 111.534 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.669 0.271 . . . . 73.5 111.136 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -89.54 103.41 16.05 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.421 . . . . 54.229999999999997 111.246 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.05 155.68 23.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.876 0.37 . . . . 72.409999999999997 111.292 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.6 mt -78.95 113.3 16.95 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 110.151 -0.314 . . . . 75.430000000000007 110.151 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.74 -38.32 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.96 0.356 . . . . 75.099999999999994 111.96 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.8 m 50.92 82.05 0.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.097 0.475 . . . . 71.109999999999999 111.159 -176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.08 158.15 43.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.746 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 11' ' ' THR . 81.7 m -61.05 95.99 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.228 0.537 . . . . 73.310000000000002 111.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.8 m -111.68 114.34 27.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 111.299 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.61 28.67 17.81 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.535 0.683 . . . . 73.439999999999998 110.959 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.52 ' HB ' HG22 ' A' ' 8' ' ' THR . 79.2 m -120.38 128.74 53.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.667 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.94 -30.62 0.87 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.217 0.451 . . . . 74.0 112.217 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.08 65.85 1.76 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.971 -0.633 . . . . 51.32 112.759 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 14' ' ' ILE . 2.4 mp -74.42 84.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 73.519999999999996 110.997 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.06 139.43 3.95 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.665 -0.698 . . . . 61.530000000000001 112.623 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.7 106.9 1.11 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.923 0.392 . . . . 41.149999999999999 111.436 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.35 68.95 4.47 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.432 0.635 . . . . 52.399999999999999 111.81 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 tt -83.36 -20.56 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.01 -0.541 . . . . 62.5 111.471 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.77 102.42 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.523 0.677 . . . . 70.230000000000004 112.141 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -149.91 51.03 0.54 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.852 -0.613 . . . . 73.340000000000003 112.574 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.46 168.74 20.45 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 111.752 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -101.87 -77.28 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.467 0.543 . . . . 64.030000000000001 112.467 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -179.63 -33.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.577 0.351 . . . . 71.409999999999997 111.568 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.04 -66.79 3.83 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.088 -0.577 . . . . 74.109999999999999 113.356 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.82 171.14 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.387 0.514 . . . . 62.399999999999999 112.387 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -138.23 144.32 40.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.09 -0.505 . . . . 64.439999999999998 111.907 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.65 92.92 9.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.967 0.413 . . . . 74.019999999999996 110.04 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.94 -148.52 0.05 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.054 0.761 . . . . 61.32 113.054 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 92.62 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.156 0.799 . . . . 73.200000000000003 113.156 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.47 134.31 53.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.064 -0.516 . . . . 64.230000000000004 110.244 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -34.52 35.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.007 0.432 . . . . 72.140000000000001 111.489 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.66 86.44 2.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.01 0.433 . . . . 74.030000000000001 110.092 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 t -152.66 115.56 4.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.604 . . . . 63.299999999999997 112.123 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -113.73 123.0 33.78 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 110.343 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.42 91.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.53 2.153 . . . . 74.519999999999996 112.782 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 38' ' ' GLN . 46.0 p -133.08 -19.72 2.22 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.683 -0.69 . . . . 71.409999999999997 111.566 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 38' ' ' GLN . 5.2 p30 48.79 -70.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.73 1.212 . . . . 72.340000000000003 113.941 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' THR . 36.0 tt0 72.68 -65.07 0.37 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.825 0.45 . . . . 72.329999999999998 111.816 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.7 p -86.75 170.71 11.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.004 0.431 . . . . 72.420000000000002 111.26 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -107.17 -17.52 14.13 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.063 0.458 . . . . 75.230000000000004 111.655 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.8 m -123.67 107.48 11.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.438 -0.346 . . . . 74.540000000000006 110.446 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -91.04 106.73 18.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.352 0.501 . . . . 73.409999999999997 112.352 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.623 ' HB2' ' HA3' ' A' ' 87' ' ' GLY . 73.0 m -123.5 117.17 24.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.056 -0.52 . . . . 75.329999999999998 110.087 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.2 m -139.27 144.59 38.44 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.124 0.487 . . . . 72.239999999999995 112.089 -174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.1 t -140.81 93.0 2.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.947 -0.57 . . . . 53.109999999999999 110.324 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.97 103.79 3.05 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.142 -0.551 . . . . 75.420000000000002 112.975 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.8 p -92.93 128.95 38.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.499 -0.412 . . . . 73.349999999999994 111.32 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -86.48 -16.21 37.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.944 0.402 . . . . 62.210000000000001 111.639 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.02 104.22 13.91 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 63.439999999999998 111.75 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -72.46 110.79 7.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.449 -0.342 . . . . 61.32 110.742 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' H ' ' HB2' ' A' ' 71' ' ' SER . 89.9 mt -93.67 17.38 11.92 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.191 0.441 . . . . 72.129999999999995 112.191 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -104.79 177.5 4.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.086 0.47 . . . . 74.340000000000003 111.177 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 HG23 ' OE1' ' A' ' 56' ' ' GLN . 8.8 t -124.18 148.99 46.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.404 -0.362 . . . . 75.120000000000005 111.971 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 111.01 1.46 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.069 0.461 . . . . 73.450000000000003 111.124 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.65 -24.05 3.06 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.302 -0.475 . . . . 53.229999999999997 112.4 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' OE1' HG23 ' A' ' 53' ' ' THR . 51.4 mt-30 -83.18 138.94 33.43 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.748 -0.266 . . . . 62.109999999999999 110.793 175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.477 ' O ' HG21 ' A' ' 61' ' ' VAL . 29.1 p -61.54 -35.37 77.57 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.181 0.515 . . . . 72.019999999999996 109.994 174.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -54.87 -44.97 74.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.513 -0.767 . . . . 74.530000000000001 111.454 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -55.88 -50.09 71.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.903 -0.589 . . . . 72.329999999999998 111.77 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -63.04 -45.37 92.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.796 0.331 . . . . 74.219999999999999 111.667 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 57' ' ' CYS . 60.6 t -60.99 -36.18 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.95 0.405 . . . . 64.209999999999994 111.053 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -56.14 -43.17 78.01 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.011 -0.54 . . . . 75.129999999999995 110.81 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.35 -47.55 70.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.153 -0.476 . . . . 63.119999999999997 110.977 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -56.76 -37.92 71.72 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.07 -3.6 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 111.483 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.98 8.43 84.07 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.441 -0.409 . . . . 37.460000000000001 113.713 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.55 84.62 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 113.554 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -78.6 36.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.177 0.436 . . . . 73.150000000000006 112.177 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.6 pt -140.02 -178.28 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.989 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.81 108.83 3.43 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.996 -0.621 . . . . 53.130000000000003 112.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.468 ' HB2' ' H ' ' A' ' 51' ' ' LEU . 80.1 p -63.1 -14.66 51.16 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.415 -0.462 . . . . 55.039999999999999 112.203 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 t -85.85 5.4 32.91 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.674 0.62 . . . . 73.439999999999998 112.674 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -67.21 -34.74 78.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.092 -0.38 . . . . 75.340000000000003 111.889 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.25 -118.46 5.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.199 -0.524 . . . . 71.439999999999998 114.045 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -58.16 134.58 56.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.085 0.402 . . . . 63.420000000000002 112.085 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -58.08 -25.18 60.97 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.549 0.574 . . . . 72.030000000000001 112.549 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.33 -9.97 59.15 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.798 0.332 . . . . 73.439999999999998 111.881 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -102.53 -4.94 24.55 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 111.916 0.339 . . . . 63.530000000000001 111.916 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -64.7 -43.67 92.75 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.626 0.602 . . . . 74.430000000000007 112.626 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.61 95.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.088 0.47 . . . . 44.109999999999999 111.343 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -65.48 -48.11 73.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 74.430000000000007 111.315 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.42 95.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.866 0.365 . . . . 61.119999999999997 111.358 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.14 -56.23 24.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 111.393 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.6 t -64.06 -29.72 70.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 111.646 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 t -75.71 -33.46 60.31 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.941 0.401 . . . . 75.120000000000005 111.645 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.46 -25.0 36.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.902 0.382 . . . . 65.420000000000002 111.6 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.623 ' HA3' ' HB2' ' A' ' 43' ' ' SER . . . 117.65 6.72 12.68 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.057 -0.592 . . . . 55.020000000000003 113.321 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 96.8 m-85 -74.3 158.2 34.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.242 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 92.88 6.91 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.272 0.558 . . . . 45.240000000000002 111.998 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 152' ' ' ILE . 46.7 t -95.3 124.37 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.83 -0.623 . . . . 74.0 111.365 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -146.42 166.97 24.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 111.203 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -82.49 -5.57 58.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.261 -0.427 . . . . 74.540000000000006 111.47 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 113.04 6.77 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 116.599 -0.273 . . . . 60.539999999999999 110.674 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 116' ' ' VAL . 94.1 Cg_endo -82.14 20.82 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.106 2.537 . . . . 72.140000000000001 114.625 -170.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.8 147.63 22.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.1 0.778 . . . . 73.340000000000003 113.1 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -64.75 159.82 21.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.366 -0.833 . . . . 71.25 112.329 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.7 44.65 12.08 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.405 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -156.48 179.66 9.04 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.975 0.417 . . . . 71.349999999999994 111.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.62 122.87 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.209 -0.45 . . . . 73.040000000000006 110.726 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -97.85 134.21 41.3 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.131 0.491 . . . . 54.009999999999998 111.078 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -101.62 116.66 33.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.013 0.435 . . . . 73.319999999999993 112.069 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -101.98 115.68 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.824 -0.626 . . . . 71.150000000000006 110.11 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 p -76.23 66.93 2.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.396 0.617 . . . . 62.420000000000002 111.747 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.28 168.84 18.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.735 -0.666 . . . . 44.409999999999997 112.042 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.16 -26.66 67.89 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.545 . . . . 60.539999999999999 114.001 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.02 49.25 3.17 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.092 -0.575 . . . . 74.109999999999999 113.771 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 59.03 27.83 16.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 73.239999999999995 111.967 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.52 152.36 29.25 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.152 -0.476 . . . . 37.460000000000001 113.485 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -141.17 130.92 24.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.427 0.291 . . . . 75.510000000000005 110.989 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 76' ' ' ALA . 26.3 m -127.37 146.92 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.003 0.43 . . . . 74.420000000000002 111.441 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.53 156.47 45.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.095 -0.502 . . . . 43.409999999999997 111.088 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -87.15 127.13 35.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.86 0.362 . . . . 70.109999999999999 111.64 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 96' ' ' ALA . 60.1 t -77.85 105.17 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.303 -0.408 . . . . 53.049999999999997 111.151 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.12 -48.46 10.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 71.219999999999999 111.622 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -150.69 151.93 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.97 0.414 . . . . 74.340000000000003 111.585 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 94' ' ' PRO . 29.0 t -127.17 137.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.421 -0.354 . . . . 74.450000000000003 111.137 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 121' ' ' SER . 87.2 m-20 -77.63 164.22 25.53 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.909 0.385 . . . . 54.229999999999997 111.41 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 m -63.09 -31.22 72.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.878 0.325 . . . . 72.319999999999993 111.878 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.66 -39.21 64.62 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 111.837 0.31 . . . . 61.520000000000003 111.837 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.13 -12.22 2.57 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 113.85 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.438 ' HB2' HD21 ' A' ' 117' ' ' ASN . 67.4 m -55.26 128.55 34.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.239 0.543 . . . . 55.020000000000003 111.835 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 113' ' ' VAL . 48.4 t -106.56 119.35 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.503 -0.771 . . . . 72.129999999999995 111.763 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.89 107.52 19.27 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.92 0.391 . . . . 72.510000000000005 110.577 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.24 148.55 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.718 0.636 . . . . 65.040000000000006 112.718 -174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.8 p -99.21 112.45 24.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.795 -0.639 . . . . 74.120000000000005 111.376 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 137' ' ' SER . 5.3 pt-20 -123.44 -172.33 2.49 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.031 -0.531 . . . . 72.25 111.18 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.567 ' HE1' ' O ' ' A' ' 134' ' ' PHE . 59.8 ttm -138.48 141.54 39.42 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.301 -0.25 . . . . 73.019999999999996 110.881 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -129.71 -71.49 0.61 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.234 0.457 . . . . 65.010000000000005 112.234 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.5 ' HB3' ' HG ' ' A' ' 135' ' ' SER . 36.5 t80 -72.46 97.6 2.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.426 0.631 . . . . 74.439999999999998 112.626 -171.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -68.99 88.29 0.39 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.518 0.675 . . . . 74.239999999999995 110.658 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.14 -42.31 0.07 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.744 . . . . 63.439999999999998 111.827 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.66 160.34 47.04 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.971 -0.633 . . . . 37.460000000000001 111.942 173.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.2 -28.94 81.7 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.742 2.295 . . . . 71.540000000000006 113.531 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' O ' ' HE1' ' A' ' 127' ' ' MET . 29.2 p90 -135.78 -46.92 0.67 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.876 0.324 . . . . 71.040000000000006 111.876 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.5 ' HG ' ' HB3' ' A' ' 129' ' ' TYR . 43.0 t 46.67 63.66 1.82 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.297 0.57 . . . . 72.409999999999997 111.966 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 134' ' ' PHE . 58.5 t -88.9 128.33 41.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 70.010000000000005 111.7 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.566 ' HB3' ' HG3' ' A' ' 126' ' ' GLU . 15.3 t -101.69 127.17 48.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.139 -0.482 . . . . 64.310000000000002 110.939 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.11 92.53 4.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.018 0.437 . . . . 62.149999999999999 109.935 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -96.91 122.95 40.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 111.88 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 32.5 m -93.83 113.42 25.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.097 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.84 125.25 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.793 0.294 . . . . 71.140000000000001 111.793 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -62.23 145.14 54.42 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.684 0.278 . . . . 73.319999999999993 111.575 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.36 -43.03 61.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.775 0.657 . . . . 75.120000000000005 112.775 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.12 -22.25 28.11 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.252 -0.499 . . . . 74.340000000000003 113.707 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -101.69 -47.39 4.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 71.019999999999996 110.692 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HB2' ' OH ' ' A' ' 151' ' ' TYR . . . -60.83 -40.78 94.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 113.192 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.6 m -60.59 -16.62 40.04 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.927 0.714 . . . . 75.310000000000002 112.927 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.4 t -79.16 -25.31 42.87 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.962 0.41 . . . . 63.439999999999998 111.55 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.71 148.49 34.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.06 0.457 . . . . 75.010000000000005 111.608 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 150' ' ' ASN . 0.8 OUTLIER -83.76 115.78 22.38 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.237 -0.289 . . . . 51.399999999999999 111.358 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 69.8 m-85 -94.2 110.83 22.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.9 0.381 . . . . 73.019999999999996 111.847 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.485 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -81.37 113.38 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.293 -0.412 . . . . 75.510000000000005 110.695 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -104.29 135.98 44.73 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.691 0.281 . . . . 74.040000000000006 110.677 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.6 mt -99.83 123.36 44.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.891 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.263 0.554 . . . . 74.439999999999998 110.573 176.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.687 0.254 . . . . 75.230000000000004 111.687 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.94 116.01 29.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.059 0.392 . . . . 74.230000000000004 112.059 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.96 101.26 1.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.181 0.515 . . . . 65.549999999999997 111.4 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.6 mt -121.17 91.88 3.63 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.75 0.31 . . . . 62.109999999999999 111.294 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.58 150.48 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.788 0.328 . . . . 75.299999999999997 111.616 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -158.69 140.4 13.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.806 0.336 . . . . 72.420000000000002 111.531 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.7 104.74 8.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.055 0.455 . . . . 70.409999999999997 111.691 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.3 p -99.69 136.51 39.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.259 -0.428 . . . . 43.530000000000001 111.345 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -129.62 23.17 5.45 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.554 0.576 . . . . 74.340000000000003 112.554 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 10' ' ' LEU . 5.9 mp -75.63 86.44 2.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.091 0.472 . . . . 62.240000000000002 110.606 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -123.36 17.14 9.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.217 0.451 . . . . 64.019999999999996 112.217 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 122.17 17.06 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.395 0.517 . . . . 73.019999999999996 112.395 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.41 59.72 0.47 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.358 -0.383 . . . . 64.25 112.506 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 14' ' ' ILE . 2.1 mp -77.3 141.4 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 111.893 0.331 . . . . 73.540000000000006 111.893 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.31 117.69 0.52 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.357 -0.383 . . . . 38.770000000000003 112.469 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.95 165.64 27.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.069 0.461 . . . . 42.399999999999999 112.038 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.98 148.83 32.11 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.377 0.51 . . . . 74.530000000000001 112.377 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.6 pt -133.37 156.77 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.091 -0.504 . . . . 72.129999999999995 111.108 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.9 141.34 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.897 0.379 . . . . 72.109999999999999 111.164 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.16 96.12 0.5 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.001 -0.618 . . . . 74.310000000000002 113.92 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' N ' HD11 ' A' ' 21' ' ' LEU . 6.9 mp -83.3 91.01 7.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.855 0.36 . . . . 73.120000000000005 110.957 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.3 113.02 19.13 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.074 0.464 . . . . 74.019999999999996 111.523 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -143.31 173.13 11.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.371 -0.377 . . . . 74.239999999999995 110.82 177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.67 114.89 3.56 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.918 -0.658 . . . . 73.019999999999996 113.541 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -110.79 -164.91 0.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 122.51 0.324 . . . . 73.239999999999995 111.037 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.79 178.43 9.14 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.007 0.432 . . . . 70.549999999999997 111.287 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.48 -178.84 3.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.22 -0.445 . . . . 64.430000000000007 110.832 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.32 -3.76 53.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.742 0.306 . . . . 73.409999999999997 111.727 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.48 109.61 10.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.258 0.466 . . . . 65.140000000000001 112.258 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.31 168.2 24.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.138 -0.483 . . . . 55.32 111.29 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -131.93 141.97 49.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.98 0.419 . . . . 74.530000000000001 111.764 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -72.56 83.65 1.13 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.996 0.427 . . . . 70.540000000000006 111.542 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -170.92 172.34 5.59 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.237 -0.438 . . . . 61.310000000000002 111.171 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.83 94.62 17.67 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.609 -0.269 . . . . 73.140000000000001 111.351 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.14 145.51 84.75 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.664 2.243 . . . . 71.430000000000007 112.429 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 t -63.19 108.92 1.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.536 0.684 . . . . 74.409999999999997 112.315 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -85.38 68.5 10.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.099 0.476 . . . . 70.319999999999993 110.983 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -65.2 -63.71 1.04 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.967 0.413 . . . . 74.310000000000002 111.327 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.8 m -88.14 135.28 33.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.358 -0.383 . . . . 61.119999999999997 111.228 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -80.91 27.63 0.38 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.019 0.438 . . . . 53.210000000000001 112.144 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.9 m -152.21 115.38 4.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.576 0.35 . . . . 72.430000000000007 110.793 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -179.59 3.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.997 0.427 . . . . 74.310000000000002 111.728 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -115.78 139.25 50.35 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.989 0.423 . . . . 74.340000000000003 111.453 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.7 p -138.91 29.34 2.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.071 0.462 . . . . 75.340000000000003 110.949 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.1 m -82.21 77.79 8.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.014 0.435 . . . . 52.100000000000001 111.398 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.21 109.63 2.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.289 -0.482 . . . . 54.109999999999999 112.832 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.3 p -80.84 103.11 10.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.048 0.451 . . . . 63.450000000000003 110.885 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 m -74.25 -30.12 61.99 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.123 0.416 . . . . 74.420000000000002 112.123 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.93 161.01 29.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.824 0.345 . . . . 64.450000000000003 111.522 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.95 103.57 15.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.982 -0.449 . . . . 73.510000000000005 111.736 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.1 0.46 43.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.66 -0.245 . . . . 73.329999999999998 111.638 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.4 160.6 18.96 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.171 -0.33 . . . . 72.200000000000003 111.602 -173.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t -71.93 145.06 48.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.984 0.421 . . . . 72.150000000000006 112.081 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.52 149.64 27.42 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.162 0.506 . . . . 64.400000000000006 112.338 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.64 -34.77 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.292 -0.413 . . . . 54.25 113.428 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.21 148.76 50.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.773 0.32 . . . . 71.510000000000005 111.545 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.3 p -56.8 -43.06 80.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.983 0.42 . . . . 70.319999999999993 111.12 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -55.73 -39.57 71.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.04 -0.527 . . . . 63.340000000000003 111.565 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.488 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 87.6 t90 -60.54 -52.29 65.8 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 111.44 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.06 -41.37 96.48 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.136 -0.353 . . . . 75.510000000000005 111.344 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 112' ' ' TYR . 65.7 t -63.23 -35.04 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.276 0.56 . . . . 75.400000000000006 110.69 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 59' ' ' TRP . 60.5 t80 -57.15 -46.51 82.67 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.589 -0.732 . . . . 63.329999999999998 111.136 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.6 -40.86 72.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.851 0.357 . . . . 62.329999999999998 111.726 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -61.33 -31.94 71.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.284 0.476 . . . . 71.329999999999998 112.284 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.92 6.49 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.279 0.562 . . . . 72.239999999999995 111.193 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 21.63 73.96 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.425 -0.417 . . . . 74.230000000000004 113.527 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.55 27.16 71.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 121.227 -0.511 . . . . 55.049999999999997 113.456 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -89.95 25.45 2.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.216 -0.579 . . . . 75.129999999999995 111.674 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.4 pt -131.57 176.52 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.788 0.435 . . . . 74.230000000000004 110.643 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 129.22 9.81 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.8 -0.714 . . . . 54.439999999999998 113.124 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.6 m -62.35 -23.18 66.64 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.466 -0.432 . . . . 75.349999999999994 112.117 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -60.31 -15.74 28.18 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.599 0.592 . . . . 74.310000000000002 112.599 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -60.48 -36.18 77.67 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.045 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.44 -122.99 24.38 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.661 0.624 . . . . 71.209999999999994 114.661 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -60.23 141.84 55.42 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.25 0.548 . . . . 60.200000000000003 112.062 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -59.57 -23.11 62.64 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.993 0.738 . . . . 64.450000000000003 112.993 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.01 -11.4 60.32 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 122.046 -0.409 . . . . 72.109999999999999 111.864 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -101.54 -26.22 13.62 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.442 0.534 . . . . 73.519999999999996 112.442 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -41.08 -59.16 1.56 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.48 1.289 . . . . 72.129999999999995 114.48 -173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.85 85.01 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.046 -0.409 . . . . 53.299999999999997 112.013 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 m -63.78 -43.28 96.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 111.261 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.06 99.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.928 0.394 . . . . 52.32 111.365 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.1 82.9 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.042 0.448 . . . . 65.209999999999994 110.998 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 m -61.39 -40.68 95.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 111.489 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -73.16 -36.88 66.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.13 0.419 . . . . 74.540000000000006 112.13 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.02 66.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.231 0.456 . . . . 75.129999999999995 112.231 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.59 0.87 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.93 -0.652 . . . . 38.770000000000003 113.448 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.51 179.47 4.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 73.209999999999994 111.445 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.9 m -108.88 94.58 5.13 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.948 0.404 . . . . 64.530000000000001 111.815 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.85 111.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.893 0.377 . . . . 71.230000000000004 111.181 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.78 176.77 7.56 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.018 0.437 . . . . 75.400000000000006 111.09 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.26 -1.87 57.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.672 0.272 . . . . 63.109999999999999 110.818 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 t -55.8 118.28 19.33 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 116.304 -0.407 . . . . 75.120000000000005 111.425 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -86.23 11.8 3.2 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.008 2.472 . . . . 70.519999999999996 113.942 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -59.06 143.57 48.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 112.138 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.69 163.36 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.774 -0.648 . . . . 74.239999999999995 112.627 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.97 16.17 75.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.128 -0.558 . . . . 61.039999999999999 112.762 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -124.69 165.99 16.96 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.74 0.305 . . . . 54.439999999999998 111.153 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.8 mp -112.96 128.73 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.25 -0.281 . . . . 72.530000000000001 110.553 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 111' ' ' ALA . 1.9 pt? -101.26 133.06 46.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.332 0.587 . . . . 70.340000000000003 111.296 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.546 ' HA ' HG11 ' A' ' 110' ' ' VAL . 43.2 tt0 -92.83 108.83 20.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.046 -0.524 . . . . 63.100000000000001 110.934 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 46.6 m -87.92 -34.74 18.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.7 p 56.23 17.03 2.58 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.082 0.771 . . . . 51.149999999999999 113.082 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.63 86.52 2.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.995 0.426 . . . . 71.120000000000005 112.123 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.87 179.84 17.04 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.113 -0.565 . . . . 60.32 113.382 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.87 -48.59 74.98 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 72.019999999999996 113.515 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -78.7 -19.83 51.51 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.395 0.617 . . . . 75.340000000000003 110.48 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.57 -164.65 22.09 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.691 -0.686 . . . . 38.770000000000003 111.987 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -166.83 141.22 4.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.076 0.438 . . . . 65.329999999999998 111.521 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 101' ' ' GLN . 16.9 m -146.18 153.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.29 0.636 . . . . 60.350000000000001 110.697 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' HB2' HD21 ' A' ' 100' ' ' LEU . . . -148.22 160.55 42.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.926 0.394 . . . . 52.25 111.278 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.413 ' HB2' HG11 ' A' ' 61' ' ' VAL . 70.9 t80 -98.62 127.79 44.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.937 0.399 . . . . 74.040000000000006 111.445 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 116.21 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.391 -0.368 . . . . 74.519999999999996 111.888 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -88.03 -38.83 15.14 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.116 0.413 . . . . 73.409999999999997 112.116 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -161.88 145.91 12.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.796 0.665 . . . . 73.530000000000001 112.796 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.99 150.4 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.888 -0.596 . . . . 63.240000000000002 110.573 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -113.11 168.73 9.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.479 0.548 . . . . 73.200000000000003 112.479 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.7 t -63.22 -31.84 73.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.086 0.47 . . . . 72.430000000000007 110.933 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.95 -12.36 54.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 111.723 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.62 -1.22 89.04 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.636 -0.585 . . . . 73.439999999999998 111.636 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 m -68.38 136.1 52.82 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.941 0.401 . . . . 61.340000000000003 111.608 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.92 122.03 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.056 -0.52 . . . . 73.120000000000005 111.884 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 75.420000000000002 111.082 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.01 149.22 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.116 -0.493 . . . . 73.420000000000002 112.224 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.4 t -97.37 109.39 22.16 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.005 -0.543 . . . . 70.239999999999995 111.55 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.18 171.05 7.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.003 -0.544 . . . . 62.140000000000001 110.295 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 34.7 ttm -110.26 124.55 51.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 111.935 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.79 89.71 4.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.744 -0.662 . . . . 71.540000000000006 110.635 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -72.98 10.33 0.94 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.512 0.56 . . . . 75.420000000000002 112.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -94.0 85.12 4.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.082 0.468 . . . . 71.030000000000001 110.879 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.64 60.2 6.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.251 -0.499 . . . . 74.450000000000003 113.465 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 164.98 94.23 0.1 OUTLIER Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.083 -0.58 . . . . 52.240000000000002 113.445 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.19 -13.26 34.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.733 2.289 . . . . 75.340000000000003 113.414 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -118.9 1.58 11.51 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.819 0.342 . . . . 71.540000000000006 111.073 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -70.38 123.76 22.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.19 0.519 . . . . 72.450000000000003 111.164 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.27 147.61 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.43 -0.35 . . . . 65.109999999999999 111.349 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.9 t -130.87 120.19 23.28 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.107 0.48 . . . . 71.530000000000001 110.91 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.68 113.25 25.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.916 -0.584 . . . . 62.219999999999999 110.818 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -99.64 119.39 38.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.098 0.475 . . . . 72.450000000000003 111.544 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.2 m -95.63 94.34 7.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.257 -0.429 . . . . 71.239999999999995 110.77 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.7 mt -83.22 131.83 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.582 -0.281 . . . . 72.420000000000002 111.311 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.5 m -62.63 150.11 41.63 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.483 0.182 . . . . 71.420000000000002 111.485 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.58 -51.06 39.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.736 0.643 . . . . 74.200000000000003 112.736 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.66 70.3 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.286 -0.415 . . . . 73.0 113.504 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.14 -38.53 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.124 0.487 . . . . 74.540000000000006 111.266 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.405 ' HB2' ' OH ' ' A' ' 151' ' ' TYR . . . -63.67 -38.69 92.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.073 -0.512 . . . . 75.019999999999996 112.173 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.1 t -61.36 -12.17 12.95 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.345 0.498 . . . . 75.140000000000001 112.345 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.1 t -82.02 -13.96 56.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.739 0.304 . . . . 51.039999999999999 111.784 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.44 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 36.2 m-85 -97.05 151.35 19.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 111.992 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -89.81 115.53 27.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.351 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.405 ' OH ' ' HB2' ' A' ' 146' ' ' ALA . 96.3 m-85 -94.87 112.06 23.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.419 . . . . 72.540000000000006 111.86 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 152' ' ' ILE . 3.9 mp -79.36 121.25 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.249 -0.432 . . . . 74.409999999999997 110.706 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -112.6 136.12 52.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 109.971 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.98 129.38 34.86 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.81 0.338 . . . . 72.109999999999999 111.697 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 p30 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.188 0.518 . . . . 71.420000000000002 111.192 179.586 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 112.102 0.408 . . . . 70.439999999999998 112.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -79.12 76.75 5.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.75 0.786 . . . . 64.530000000000001 112.157 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -140.88 106.2 5.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 71.209999999999994 110.407 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 tt 56.31 87.8 0.05 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.232 0.539 . . . . 74.209999999999994 110.532 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.44 141.77 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.974 0.416 . . . . 73.200000000000003 111.633 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 m -76.17 98.84 4.51 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.004 0.43 . . . . 74.120000000000005 111.279 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.55 146.97 26.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.872 0.368 . . . . 70.049999999999997 111.813 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.5 p -123.5 112.95 18.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.394 -0.366 . . . . 74.230000000000004 111.431 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -89.0 126.68 35.52 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.85 0.357 . . . . 73.409999999999997 111.571 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.25 95.57 5.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.95 0.405 . . . . 61.520000000000003 111.295 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -105.69 110.51 22.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.507 -0.315 . . . . 72.209999999999994 110.974 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.24 150.07 51.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.363 0.505 . . . . 73.530000000000001 112.363 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 106.1 0.29 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.937 -0.574 . . . . 54.409999999999997 112.594 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 pp -82.73 156.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.661 0.615 . . . . 64.329999999999998 112.661 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.05 138.28 6.39 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.015 -0.539 . . . . 74.239999999999995 113.121 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.4 124.13 5.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.425 0.29 . . . . 74.239999999999995 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.74 116.97 32.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.836 0.351 . . . . 73.439999999999998 111.833 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -110.14 122.43 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.586 -0.279 . . . . 52.439999999999998 111.148 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 p -167.44 141.35 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.714 0.292 . . . . 72.230000000000004 111.559 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.245 -0.502 . . . . 71.439999999999998 113.039 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.4 mt -97.68 165.64 11.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.119 0.485 . . . . 75.319999999999993 112.129 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.57 152.1 39.17 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.224 -0.443 . . . . 74.129999999999995 111.952 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -176.12 147.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.764 0.426 . . . . 74.310000000000002 111.445 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.83 96.84 0.3 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.192 -0.528 . . . . 44.140000000000001 113.68 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.85 119.97 26.77 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 122.427 -0.455 . . . . 72.530000000000001 111.489 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.91 140.46 49.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.572 0.225 . . . . 71.299999999999997 111.002 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.23 7.83 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.066 0.395 . . . . 70.140000000000001 112.066 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -163.16 147.59 11.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.672 0.272 . . . . 73.129999999999995 110.671 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.8 117.98 29.62 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.92 0.391 . . . . 61.409999999999997 111.889 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.18 145.08 23.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.904 0.383 . . . . 52.210000000000001 111.668 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -143.17 119.67 11.01 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.843 0.354 . . . . 74.019999999999996 110.552 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -150.71 141.08 22.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.915 0.388 . . . . 75.540000000000006 111.416 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.2 t -139.92 98.79 3.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.057 0.456 . . . . 75.310000000000002 111.457 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -83.36 115.06 57.27 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 122.262 -0.274 . . . . 62.340000000000003 111.315 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.98 98.05 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.343 2.028 . . . . 72.519999999999996 113.304 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -110.62 104.79 13.52 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.57 -0.286 . . . . 73.109999999999999 111.03 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -91.37 110.56 21.87 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 110.818 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 80' ' ' ALA . 6.5 tp-100 -76.01 138.36 40.85 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.456 -0.338 . . . . 64.439999999999998 111.439 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 p -67.28 109.44 3.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.13 0.49 . . . . 52.420000000000002 110.767 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 84' ' ' SER . 30.5 p -74.4 156.7 36.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.845 0.683 . . . . 73.310000000000002 112.845 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -116.23 136.27 53.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.944 -0.571 . . . . 74.530000000000001 111.359 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -7.92 57.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.147 0.425 . . . . 75.040000000000006 112.147 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -66.23 125.67 26.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.901 0.382 . . . . 51.030000000000001 111.663 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 t -114.33 175.08 5.63 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.028 0.442 . . . . 63.450000000000003 111.811 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -170.95 168.67 6.96 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.319 -0.4 . . . . 74.420000000000002 111.385 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.08 32.48 2.34 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.181 -0.533 . . . . 45.140000000000001 113.319 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 t -90.24 122.61 33.32 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.551 -0.382 . . . . 71.409999999999997 111.627 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.4 m -97.84 -16.2 19.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.94 0.348 . . . . 74.129999999999995 111.94 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.28 148.29 41.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.785 0.326 . . . . 74.340000000000003 111.818 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.68 94.63 0.21 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.891 0.377 . . . . 74.010000000000005 111.497 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 72' ' ' THR . 69.3 mt -70.67 -18.06 62.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.079 0.4 . . . . 74.219999999999999 112.079 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -80.22 178.14 8.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.853 0.358 . . . . 72.010000000000005 111.45 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.4 p -111.11 154.15 24.7 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.274 0.559 . . . . 71.019999999999996 112.504 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.69 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.678 -0.692 . . . . 61.140000000000001 111.051 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.83 -31.5 4.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.337 -0.459 . . . . 50.240000000000002 112.819 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -60.97 137.65 58.22 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.526 -0.396 . . . . 73.120000000000005 111.84 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.436 ' O ' HG22 ' A' ' 61' ' ' VAL . 57.2 m -50.59 -41.95 55.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 71.430000000000007 110.416 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -59.29 -39.19 82.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.267 -0.879 . . . . 74.019999999999996 112.182 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -60.81 -52.62 64.3 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.5 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.78 -49.21 78.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.949 0.404 . . . . 62.420000000000002 111.76 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 57' ' ' CYS . 67.5 t -59.87 -36.73 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.958 0.408 . . . . 61.009999999999998 111.348 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -58.46 -38.52 77.71 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.098 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.21 -46.68 69.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.378 -0.373 . . . . 71.230000000000004 111.174 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.65 -33.69 71.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.232 0.456 . . . . 73.5 112.232 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -88.98 12.12 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-O 121.31 0.576 . . . . 75.400000000000006 111.461 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.19 14.23 55.89 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.361 -0.381 . . . . 51.009999999999998 113.814 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.21 9.1 53.52 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 114.194 0.438 . . . . 72.019999999999996 114.194 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.4 -20.56 63.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.592 0.59 . . . . 74.299999999999997 112.592 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.452 HG23 HD23 ' A' ' 154' ' ' LEU . 34.2 pt -80.23 -35.9 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.895 0.702 . . . . 72.340000000000003 112.895 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 119.34 2.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.097 -0.573 . . . . 63.530000000000001 112.231 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -81.72 20.39 0.94 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.771 0.656 . . . . 70.209999999999994 112.771 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.5 t -90.81 12.3 19.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 74.439999999999998 111.97 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -83.42 -30.03 27.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.683 0.277 . . . . 60.509999999999998 111.72 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.66 -126.31 7.48 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.373 -0.442 . . . . 50.43 113.925 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -58.8 139.47 56.29 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.893 0.377 . . . . 44.009999999999998 111.73 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -54.62 -40.29 68.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.839 0.681 . . . . 72.519999999999996 112.839 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.543 ' OD1' ' HA ' ' A' ' 103' ' ' THR . 96.1 m-20 -71.81 -9.59 58.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.689 0.626 . . . . 74.150000000000006 112.689 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -97.19 -15.98 20.62 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.759 0.314 . . . . 74.409999999999997 111.263 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -49.79 -58.74 4.74 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.726 0.639 . . . . 74.120000000000005 112.726 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . . . -55.43 -39.71 70.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 75.439999999999998 111.769 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -40.41 89.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.325 -0.398 . . . . 70.400000000000006 111.766 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.44 -45.84 24.49 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.012 0.434 . . . . 74.140000000000001 111.37 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.89 -56.58 11.62 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.38 0.511 . . . . 73.420000000000002 112.38 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.459 ' HB2' HG23 ' A' ' 40' ' ' THR . 68.9 m -67.55 -1.01 4.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.621 0.6 . . . . 75.349999999999994 112.621 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 40' ' ' THR . 38.0 t -116.93 -12.18 10.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.973 0.416 . . . . 52.119999999999997 111.54 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.05 8.54 38.82 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.17 0.433 . . . . 72.239999999999995 112.17 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.82 35.82 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.967 -0.635 . . . . 61.200000000000003 113.543 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.01 162.63 12.98 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.141 0.496 . . . . 71.510000000000005 111.355 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -111.28 99.08 7.97 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.879 0.371 . . . . 74.049999999999997 111.905 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG23 HG13 ' A' ' 152' ' ' ILE . 57.4 t -93.6 103.75 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.422 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 86.4 m-20 -134.8 137.92 43.79 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.061 -0.518 . . . . 75.209999999999994 109.956 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.58 -4.69 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.056 0.761 . . . . 74.25 113.056 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 m -55.71 112.81 4.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 122.597 0.359 . . . . 74.120000000000005 111.388 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.75 119.0 3.55 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.813 2.342 . . . . 71.200000000000003 113.166 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.9 145.16 30.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.703 -0.681 . . . . 73.019999999999996 111.146 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.43 133.11 54.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.917 0.389 . . . . 38.509999999999998 111.596 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.22 48.83 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.841 -0.695 . . . . 72.120000000000005 112.795 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.3 p -159.3 177.13 11.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.94 0.4 . . . . 63.420000000000002 110.657 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mt -123.7 122.75 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.872 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -98.59 123.52 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.547 0.689 . . . . 73.310000000000002 111.66 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 29.0 tt0 -82.37 106.45 14.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.94 -0.573 . . . . 73.030000000000001 111.45 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 44.2 m -84.2 92.86 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 110.734 173.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.543 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 39.3 p -69.44 -8.86 50.53 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.112 0.482 . . . . 64.409999999999997 111.532 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.51 -35.14 71.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.001 -0.545 . . . . 75.200000000000003 112.022 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.77 38.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.356 -0.45 . . . . 74.329999999999998 112.865 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.49 -40.33 69.08 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.757 -0.258 . . . . 61.439999999999998 113.605 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -109.81 0.42 18.78 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.234 0.54 . . . . 73.030000000000001 110.636 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 76' ' ' ALA . . . 99.68 155.26 28.27 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.788 -0.642 . . . . 73.019999999999996 113.065 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 74.6 t60 -140.49 105.97 5.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.908 0.385 . . . . 65.049999999999997 110.652 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 76' ' ' ALA . 27.7 m -103.65 136.38 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.111 0.481 . . . . 71.409999999999997 111.649 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.88 159.52 41.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.929 -0.578 . . . . 71.540000000000006 110.737 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -93.14 123.98 36.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.879 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.61 112.29 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.021 0.439 . . . . 73.230000000000004 111.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.23 -49.36 13.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.021 -0.536 . . . . 74.209999999999994 111.459 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -164.96 139.57 5.14 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.963 0.411 . . . . 65.030000000000001 112.091 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.42 123.64 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.247 -0.433 . . . . 52.229999999999997 109.922 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -78.17 166.84 22.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.372 0.508 . . . . 75.010000000000005 112.372 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -47.26 -48.51 24.57 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.465 0.543 . . . . 65.299999999999997 112.465 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.72 -45.28 87.22 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.002 0.429 . . . . 71.450000000000003 111.769 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.42 -21.89 2.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.889 -0.672 . . . . 70.430000000000007 113.661 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.1 m -56.78 129.74 42.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.419 0.61 . . . . 74.329999999999998 111.426 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.2 t -103.74 120.97 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.81 -0.632 . . . . 74.0 112.033 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.45 122.76 33.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.428 -0.351 . . . . 73.340000000000003 110.843 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.89 149.9 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.378 0.51 . . . . 73.5 112.378 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 90.1 p -94.35 126.57 39.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.142 -0.481 . . . . 65.340000000000003 111.171 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.85 179.75 4.4 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.413 0.625 . . . . 61.240000000000002 111.962 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.4 ttm -138.44 108.08 6.23 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.53 -0.759 . . . . 65.25 109.851 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER -98.13 -2.58 39.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.018 0.377 . . . . 73.209999999999994 112.018 -177.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.1 t80 56.44 37.97 29.28 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.417 0.627 . . . . 75.040000000000006 111.179 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -75.46 -67.47 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.136 -0.483 . . . . 70.329999999999998 111.285 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.86 -15.54 78.98 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.144 -0.55 . . . . 75.200000000000003 113.854 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 161.89 -158.94 30.93 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.035 -0.603 . . . . 60.140000000000001 113.147 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.68 -64.23 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.174 2.583 . . . . 72.019999999999996 113.702 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -86.75 37.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.069 0.461 . . . . 74.129999999999995 111.801 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.9 t -75.27 93.64 2.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.266 0.555 . . . . 74.540000000000006 111.035 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 137' ' ' SER . 45.9 t -80.31 161.73 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.837 -0.619 . . . . 73.409999999999997 111.657 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' HG11 ' A' ' 136' ' ' VAL . 75.0 m -143.4 156.47 44.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.382 -0.372 . . . . 73.209999999999994 110.433 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -130.86 121.07 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.901 -0.136 . . . . 73.0 110.842 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -127.91 133.21 49.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 111.782 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.9 m -97.49 100.22 11.63 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.846 0.355 . . . . 71.5 110.717 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.0 mt -81.57 136.91 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.681 0.277 . . . . 74.409999999999997 111.426 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -63.72 147.42 51.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.603 0.239 . . . . 73.319999999999993 111.538 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.84 -45.8 71.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.372 0.508 . . . . 74.030000000000001 112.372 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.35 -49.96 71.23 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.286 -0.483 . . . . 61.130000000000003 113.3 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -44.15 91.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 110.856 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' HB1' ' HH ' ' A' ' 151' ' ' TYR . . . -60.49 -44.3 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.777 -0.647 . . . . 70.400000000000006 112.112 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 t -63.9 -16.34 61.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.101 0.477 . . . . 74.219999999999999 111.577 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.2 t -82.08 -6.22 59.0 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.385 -0.37 . . . . 72.219999999999999 111.731 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 22.3 m-85 -102.11 153.16 20.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 75.310000000000002 111.821 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 15.9 m-80 -92.04 107.25 19.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.447 -0.342 . . . . 72.0 111.518 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.8 m-85 -85.9 114.66 22.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.28 0.474 . . . . 73.239999999999995 112.28 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.524 HG13 HG23 ' A' ' 90' ' ' VAL . 3.8 mp -78.44 114.52 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.549 174.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -106.36 142.51 35.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.85 0.357 . . . . 72.239999999999995 110.961 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 69' ' ' ILE . 41.7 mt -104.2 91.5 3.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.851 0.358 . . . . 73.209999999999994 111.749 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.017 0.437 . . . . 72.530000000000001 111.23 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.538 0.209 . . . . 71.239999999999995 111.065 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -105.66 80.92 1.61 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.016 0.436 . . . . 75.409999999999997 110.831 177.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.75 ' HB3' ' HZ3' ' A' ' 3' ' ' LYS . 5.0 mmmp? -145.67 117.96 8.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.183 -0.462 . . . . 63.509999999999998 110.872 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.32 168.46 25.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.005 0.431 . . . . 74.420000000000002 111.962 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.03 143.61 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.298 -0.41 . . . . 71.230000000000004 110.835 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -90.38 25.02 2.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.961 0.41 . . . . 75.200000000000003 112.03 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.37 126.37 21.03 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.56 0.578 . . . . 73.329999999999998 112.56 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -149.31 164.05 35.97 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.024 -0.534 . . . . 71.310000000000002 110.941 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -147.72 155.89 42.19 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.064 0.459 . . . . 73.310000000000002 112.095 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD11 ' N ' ' A' ' 10' ' ' LEU . 5.1 mp -120.86 109.95 15.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.274 -0.421 . . . . 72.420000000000002 111.272 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -98.03 -176.93 3.58 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.772 -0.195 . . . . 43.240000000000002 111.342 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.1 -49.33 0.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.084 0.772 . . . . 73.319999999999993 113.084 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 32.11 1.98 Allowed Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.266 -0.492 . . . . 70.439999999999998 114.319 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -99.18 108.67 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.247 -0.56 . . . . 71.329999999999998 110.774 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.09 121.85 0.59 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.459 -0.401 . . . . 75.150000000000006 112.765 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.82 146.57 46.41 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.46 -0.436 . . . . 73.239999999999995 111.761 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.46 131.27 35.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.945 0.402 . . . . 62.310000000000002 111.908 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.9 mt -92.29 131.28 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.354 -0.385 . . . . 73.340000000000003 111.466 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.86 177.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.181 0.515 . . . . 73.540000000000006 112.05 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 103.72 2.54 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.301 -0.476 . . . . 41.539999999999999 113.744 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.2 pt? -164.64 132.16 3.21 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.985 0.422 . . . . 62.439999999999998 111.495 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -147.6 132.05 17.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.895 0.379 . . . . 64.420000000000002 111.437 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -144.2 151.66 39.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.69 0.281 . . . . 73.200000000000003 111.533 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.36 84.0 0.24 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.346 0.499 . . . . 52.210000000000001 114.346 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -126.1 134.0 51.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.967 0.413 . . . . 64.129999999999995 111.387 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -81.22 -174.26 4.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.637 0.606 . . . . 72.109999999999999 112.637 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.68 105.16 1.4 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.106 -0.497 . . . . 73.200000000000003 111.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.06 104.28 7.46 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.668 0.271 . . . . 71.200000000000003 111.301 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.55 95.92 10.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.787 0.327 . . . . 75.129999999999995 111.345 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.15 118.44 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.4 -0.364 . . . . 70.140000000000001 111.457 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.15 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.955 0.407 . . . . 53.509999999999998 111.963 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -126.16 153.88 43.99 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.87 0.366 . . . . 71.099999999999994 111.403 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.0 m -148.25 92.43 2.03 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.033 0.444 . . . . 62.299999999999997 111.5 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -155.05 75.39 5.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 121.249 0.547 . . . . 74.209999999999994 111.606 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.03 42.95 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.2 2.6 . . . . 73.430000000000007 112.447 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.9 m -116.27 91.11 3.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.819 0.342 . . . . 70.200000000000003 111.666 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.25 131.52 34.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 75.540000000000006 111.23 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -90.8 100.76 13.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.059 0.457 . . . . 73.200000000000003 111.437 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.1 p -83.7 93.87 8.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.012 0.434 . . . . 73.030000000000001 111.739 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -165.26 151.88 10.27 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.21 0.448 . . . . 64.340000000000003 112.21 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 p -85.6 103.16 14.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.207 -0.451 . . . . 65.430000000000007 110.6 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -69.26 107.24 3.17 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.472 0.653 . . . . 75.530000000000001 112.022 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m -122.59 92.96 3.83 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.026 -0.534 . . . . 70.099999999999994 111.048 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 p -113.17 135.74 53.49 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.366 -0.208 . . . . 64.219999999999999 111.417 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.457 ' HB2' ' OH ' ' A' ' 88' ' ' TYR . 74.6 m -72.81 148.6 44.37 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.027 0.441 . . . . 63.450000000000003 111.253 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.98 117.63 1.2 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.24 -0.505 . . . . 71.230000000000004 112.364 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 m -153.03 107.52 3.14 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.597 -0.355 . . . . 72.340000000000003 110.95 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.8 m -69.86 -21.76 63.32 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.287 0.477 . . . . 71.409999999999997 112.287 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.69 125.83 27.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.808 0.337 . . . . 54.030000000000001 111.559 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -91.9 105.99 18.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 61.509999999999998 111.001 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' SER . 4.0 mm? -88.6 26.76 1.41 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 111.967 0.358 . . . . 62.229999999999997 111.967 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.72 -168.99 1.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.283 0.233 . . . . 75.209999999999994 110.564 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -136.6 148.25 47.38 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.797 0.666 . . . . 74.209999999999994 112.797 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.0 142.34 58.41 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.876 -0.602 . . . . 75.409999999999997 111.917 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.92 32.35 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.23 -0.51 . . . . 71.140000000000001 112.29 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.76 139.68 31.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.244 -0.28 . . . . 75.120000000000005 110.244 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 49.0 m -54.87 -29.23 55.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.984 0.421 . . . . 72.409999999999997 112.043 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 p -60.15 -35.67 75.83 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.909 0.707 . . . . 74.530000000000001 112.909 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 48.6 t90 -61.91 -62.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.278 0.844 . . . . 74.420000000000002 113.278 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 32.5 p90 -68.01 -28.86 67.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.875 0.694 . . . . 73.299999999999997 112.875 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.68 -36.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.06 0.457 . . . . 72.420000000000002 111.018 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -59.41 -34.93 73.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.276 0.56 . . . . 75.120000000000005 110.964 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.71 -50.56 34.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.94 -0.573 . . . . 75.209999999999994 110.405 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.0 mmmt -55.3 -36.82 66.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.774 0.657 . . . . 73.530000000000001 112.774 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG22 HG21 ' A' ' 69' ' ' ILE . 8.0 p -82.33 -5.22 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 121.059 0.457 . . . . 74.200000000000003 111.929 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.57 24.43 76.21 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.283 -0.484 . . . . 54.420000000000002 113.55 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.12 23.2 72.95 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.203 -0.522 . . . . 73.540000000000006 113.895 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -89.26 19.9 4.09 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.311 0.486 . . . . 61.119999999999997 112.311 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 65' ' ' VAL . 34.7 pt -126.73 178.49 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.921 0.391 . . . . 74.239999999999995 111.537 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.28 125.65 7.26 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.315 -0.469 . . . . 65.140000000000001 113.043 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 51' ' ' LEU . 75.7 p -80.55 -13.35 59.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.742 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -94.55 13.92 22.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.204 0.446 . . . . 75.439999999999998 112.204 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.43 -32.37 58.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 73.409999999999997 111.824 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.48 -118.63 6.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.297 -0.477 . . . . 74.540000000000006 113.665 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.3 137.74 56.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.097 0.406 . . . . 75.439999999999998 112.097 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -55.36 -42.68 74.22 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.355 0.502 . . . . 74.239999999999995 112.355 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -68.64 -2.99 10.35 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.568 0.581 . . . . 74.310000000000002 112.568 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -100.96 -10.24 20.77 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.785 0.326 . . . . 71.340000000000003 111.537 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -61.19 -36.56 80.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.042 0.756 . . . . 74.230000000000004 113.042 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.21 -50.14 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.12 0.486 . . . . 75.140000000000001 111.2 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -61.23 -46.48 90.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.065 -0.516 . . . . 65.439999999999998 111.27 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.24 -52.54 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.085 -0.507 . . . . 74.230000000000004 111.614 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.46 -47.41 69.77 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.831 0.348 . . . . 64.420000000000002 111.665 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -59.58 -50.99 71.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.18 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.0 t -69.28 -19.85 63.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.205 0.446 . . . . 61.039999999999999 112.205 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.41 -36.03 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.081 0.401 . . . . 71.140000000000001 112.081 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.16 8.04 5.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.992 -0.623 . . . . 75.420000000000002 113.181 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.457 ' OH ' ' HB2' ' A' ' 45' ' ' SER . 14.2 m-85 -80.07 -171.34 2.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.186 0.517 . . . . 71.450000000000003 111.176 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.0 m -121.94 91.25 3.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.064 0.459 . . . . 73.120000000000005 111.359 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.27 105.17 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.0 0.428 . . . . 74.109999999999999 111.315 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -127.2 161.31 28.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 111.212 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.41 7.24 20.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.136 0.493 . . . . 71.219999999999999 110.969 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 m -72.76 112.49 15.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.318 -0.401 . . . . 43.109999999999999 110.995 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.58 22.72 0.51 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.052 2.501 . . . . 54.539999999999999 114.47 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' HB3' ' HE1' ' A' ' 153' ' ' HIS . 36.4 tt0 -60.1 147.16 40.48 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.063 0.459 . . . . 62.109999999999999 111.851 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.34 166.55 21.39 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.22 0.822 . . . . 75.239999999999995 113.22 -173.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.06 31.02 44.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.703 -0.68 . . . . 71.230000000000004 112.93 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.1 m -146.75 170.63 16.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 111.273 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 99' ' ' ILE . 3.4 mp -107.68 133.83 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 110.254 -0.276 . . . . 75.319999999999993 110.254 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -98.89 107.82 20.35 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.986 0.898 . . . . 73.420000000000002 111.049 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.518 ' HA ' HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -72.93 99.12 2.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 72.049999999999997 109.822 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 50.9 m -93.77 104.88 16.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.56 -0.746 . . . . 74.530000000000001 111.595 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 p -81.12 24.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.244 0.461 . . . . 72.230000000000004 112.244 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -106.16 96.96 6.84 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.154 0.428 . . . . 63.130000000000003 112.154 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.76 -176.2 29.33 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.151 0.42 . . . . 72.549999999999997 114.151 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.76 22.41 57.08 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 114.032 0.373 . . . . 38.25 114.032 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 57.77 19.6 5.76 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.91 0.386 . . . . 72.310000000000002 111.297 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.1 111.8 3.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.428 -0.415 . . . . 75.340000000000003 112.228 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -112.38 147.37 36.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 111.929 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' ' 101' ' ' GLN . 10.1 m -142.69 141.49 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.143 -0.481 . . . . 64.439999999999998 110.667 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.03 159.63 43.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.76 0.314 . . . . 73.319999999999993 110.509 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -94.32 125.73 39.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.945 0.403 . . . . 73.010000000000005 111.667 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.42 109.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.893 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.84 -61.18 2.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.044 -0.525 . . . . 65.129999999999995 111.771 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -148.56 145.43 27.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 62.140000000000001 111.949 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.2 t -103.11 125.77 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.595 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -95.36 141.07 29.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.748 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -60.36 -21.25 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.394 -0.366 . . . . 71.0 111.852 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.23 -12.89 56.12 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.863 0.363 . . . . 74.239999999999995 111.956 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.83 45.56 4.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.93 -0.468 . . . . 64.319999999999993 111.93 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.7 p -137.17 138.6 40.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.086 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.17 119.45 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.223 -0.444 . . . . 62.43 111.57 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.627 ' HG2' ' HG1' ' A' ' 140' ' ' THR . 54.2 mt-10 -88.44 112.27 22.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.86 0.362 . . . . 55.32 110.963 176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.97 137.91 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.195 0.521 . . . . 64.519999999999996 112.02 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.425 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 34.5 p -86.61 115.61 24.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.07 0.462 . . . . 75.400000000000006 111.883 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 11.5 pt-20 -133.43 -179.27 5.41 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.596 . . . . 75.120000000000005 111.387 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.437 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 49.0 ttm -135.18 128.54 32.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.905 0.383 . . . . 53.539999999999999 111.54 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -83.4 90.03 7.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.239 0.542 . . . . 75.129999999999995 111.046 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -62.94 152.27 37.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.782 -0.645 . . . . 63.439999999999998 111.85 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 70.88 -67.72 0.24 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.527 0.731 . . . . 64.019999999999996 111.993 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.23 7.78 50.37 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.146 -0.549 . . . . 71.430000000000007 113.718 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -155.82 159.84 29.57 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.136 -0.554 . . . . 63.32 112.873 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 135' ' ' SER . 97.7 Cg_endo -82.91 -156.22 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.742 2.295 . . . . 74.010000000000005 112.525 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -68.58 13.33 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.882 0.697 . . . . 75.099999999999994 112.882 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 133' ' ' PRO . 34.0 t -76.71 114.61 15.65 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.032 0.444 . . . . 65.109999999999999 111.75 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.5 t -81.0 124.42 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.958 0.409 . . . . 74.099999999999994 111.406 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.8 p -114.55 142.14 46.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.431 -0.35 . . . . 65.040000000000006 111.399 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -92.8 104.54 16.78 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.819 0.342 . . . . 64.430000000000007 111.375 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -82.52 120.97 26.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.171 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.627 ' HG1' ' HG2' ' A' ' 123' ' ' GLU . 71.4 m -85.81 106.56 17.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.042 0.448 . . . . 75.140000000000001 110.923 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -97.71 139.65 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.192 -0.458 . . . . 72.510000000000005 111.658 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -69.71 154.54 41.84 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.783 0.325 . . . . 61.020000000000003 111.233 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.87 80.99 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.605 0.595 . . . . 64.129999999999995 112.605 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.26 -49.12 82.02 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.293 -0.479 . . . . 63.020000000000003 112.996 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.55 -40.98 93.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.127 0.489 . . . . 61.119999999999997 110.861 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -56.57 -42.57 78.83 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 111.8 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.3 t -60.96 -19.83 61.51 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.106 0.479 . . . . 64.209999999999994 111.744 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 47.4 t -77.42 -17.72 57.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.929 0.395 . . . . 71.319999999999993 111.674 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.416 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 17.0 m-85 -101.01 157.87 16.43 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.229 0.538 . . . . 72.409999999999997 111.817 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -99.74 111.04 23.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 111.333 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.403 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 76.3 m-85 -87.98 106.2 17.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.063 0.459 . . . . 73.25 111.976 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -77.14 103.18 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.053 -0.521 . . . . 73.310000000000002 110.907 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' HE1' ' HB3' ' A' ' 95' ' ' GLU . 92.8 m-70 -85.16 143.09 29.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.364 . . . . 70.319999999999993 110.435 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.92 9.76 38.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 75.129999999999995 112.568 -166.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 121.498 0.666 . . . . 61.100000000000001 110.644 -176.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.662 0.268 . . . . 71.209999999999994 111.252 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -119.57 130.15 55.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 112.009 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -127.4 113.12 15.8 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.788 -0.642 . . . . 72.540000000000006 109.767 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.55 159.43 26.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.122 0.487 . . . . 70.120000000000005 112.034 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 7' ' ' ALA . 12.1 p -140.59 138.77 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.118 0.485 . . . . 64.340000000000003 111.293 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.6 p -107.98 27.14 9.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.864 0.364 . . . . 74.230000000000004 111.56 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -63.13 92.03 0.05 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.37 0.508 . . . . 55.119999999999997 112.37 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -141.21 154.01 45.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.888 -0.596 . . . . 75.25 110.606 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -120.39 113.89 21.01 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.444 0.535 . . . . 61.219999999999999 112.444 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.74 111.26 7.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.265 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.94 144.32 31.38 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.501 -0.318 . . . . 74.299999999999997 110.996 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.78 161.3 36.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.94 0.4 . . . . 62.329999999999998 111.887 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.49 145.95 4.58 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.35 -0.452 . . . . 75.450000000000003 113.043 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -136.26 127.97 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.255 0.55 . . . . 61.049999999999997 111.705 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.54 118.53 6.19 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.292 -0.48 . . . . 74.310000000000002 112.716 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 138.9 31.5 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.413 -0.463 . . . . 75.439999999999998 112.017 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.87 109.76 19.03 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.821 0.343 . . . . 75.430000000000007 110.913 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.07 141.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.272 0.471 . . . . 71.019999999999996 112.272 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.46 140.77 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.39 -0.368 . . . . 74.120000000000005 111.049 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.8 113.34 1.31 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.104 -0.569 . . . . 60.140000000000001 113.177 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.39 150.23 36.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.026 0.441 . . . . 74.219999999999999 111.594 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.82 146.48 27.32 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.244 -0.435 . . . . 73.349999999999994 111.295 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -129.48 163.64 25.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.933 0.397 . . . . 65.510000000000005 111.349 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.79 78.3 1.05 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.209 -0.45 . . . . 62.520000000000003 112.409 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -122.65 118.63 28.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.085 0.469 . . . . 72.450000000000003 111.688 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.74 160.48 22.83 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.845 0.683 . . . . 70.299999999999997 112.845 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.95 104.66 6.67 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.848 -0.614 . . . . 71.340000000000003 111.006 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.01 157.2 35.29 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.519999999999996 111.428 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.14 143.38 5.29 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.53 0.567 . . . . 61.530000000000001 112.53 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.9 17.07 6.22 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.085 1.143 . . . . 62.439999999999998 114.085 171.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.84 78.12 9.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.657 -0.652 . . . . 73.219999999999999 111.653 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -133.04 -4.9 3.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.622 0.725 . . . . 74.409999999999997 110.598 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.6 t -91.12 90.94 8.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.841 -0.618 . . . . 71.219999999999999 112.026 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.8 121.98 83.3 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.371 -0.377 . . . . 63.329999999999998 110.926 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.11 66.88 1.38 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.786 2.324 . . . . 74.200000000000003 113.071 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -71.78 90.53 1.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.03 0.443 . . . . 72.319999999999993 111.94 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -132.07 172.7 12.04 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.071 0.462 . . . . 72.129999999999995 111.329 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -108.4 -0.02 20.85 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.764 -0.653 . . . . 70.109999999999999 110.396 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.4 p -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.108 0.48 . . . . 74.450000000000003 111.997 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -143.75 116.0 8.48 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.982 -0.554 . . . . 60.119999999999997 110.748 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.2 p -115.24 114.72 25.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.441 0.534 . . . . 75.030000000000001 112.441 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -104.63 92.05 4.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.35 0.595 . . . . 74.400000000000006 111.239 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.9 p -110.07 98.02 7.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.904 -0.589 . . . . 73.319999999999993 110.97 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -94.15 -26.0 16.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.806 0.336 . . . . 73.439999999999998 111.808 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -69.18 82.95 0.35 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.415 0.626 . . . . 60.420000000000002 111.206 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.86 -179.04 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.346 -0.843 . . . . 65.030000000000001 111.745 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -179.36 -179.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.219 0.51 . . . . 73.140000000000001 111.736 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.7 m -90.62 -7.19 53.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.685 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.37 86.31 1.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.049 0.452 . . . . 70.140000000000001 111.545 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -73.59 112.36 9.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.145 0.498 . . . . 55.539999999999999 111.33 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.81 -9.5 58.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.715 0.635 . . . . 71.120000000000005 112.715 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.71 176.35 9.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.051 -0.406 . . . . 74.439999999999998 110.882 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -121.92 152.28 39.82 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.404 0.52 . . . . 70.129999999999995 112.404 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.27 143.03 41.12 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.033 0.444 . . . . 43.219999999999999 111.946 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.95 58.19 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.086 -0.506 . . . . 45.210000000000001 113.295 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -83.52 141.59 31.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.904 0.352 . . . . 74.420000000000002 111.513 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 60' ' ' TYR . 56.6 m -59.97 -29.41 68.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.401 0.619 . . . . 45.240000000000002 111.075 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.1 p -76.08 -11.35 59.93 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.817 -0.629 . . . . 73.019999999999996 112.549 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -76.8 -62.71 1.55 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.657 0.614 . . . . 74.25 112.657 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' HE2' ' HA ' ' A' ' 57' ' ' CYS . 50.5 p90 -63.72 -26.56 68.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.923 0.712 . . . . 73.109999999999999 112.923 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 110' ' ' VAL . 46.4 t -60.68 -31.96 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.897 0.38 . . . . 74.230000000000004 111.974 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.79 -44.53 95.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.883 0.373 . . . . 73.099999999999994 111.295 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -64.63 -41.06 96.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.286 0.565 . . . . 74.510000000000005 110.565 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.9 mmmt -62.18 -32.91 73.59 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.693 -0.685 . . . . 70.140000000000001 112.28 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG22 HD13 ' A' ' 154' ' ' LEU . 9.2 p -96.52 6.82 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 121.334 0.588 . . . . 72.219999999999999 111.961 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.53 8.62 76.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 45.409999999999997 114.237 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.87 3.07 66.79 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.038 0.775 . . . . 37.649999999999999 115.038 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.01 17.64 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.904 -0.762 . . . . 74.420000000000002 112.705 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 pt -106.32 -29.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 111.954 0.353 . . . . 64.340000000000003 111.954 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.87 98.77 1.1 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.044 -0.598 . . . . 71.319999999999993 112.884 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 p -73.02 83.85 1.26 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.229 -0.571 . . . . 75.340000000000003 111.522 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.7 t -154.79 17.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.09 0.471 . . . . 64.239999999999995 111.318 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -89.47 -4.12 58.09 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.26 0.467 . . . . 74.299999999999997 112.26 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.63 -137.76 22.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.054 -0.593 . . . . 64.109999999999999 113.329 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -70.24 155.39 40.71 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.502 -0.411 . . . . 73.219999999999999 111.57 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.509 ' HB2' HG12 ' A' ' 110' ' ' VAL . . . -56.84 -32.12 65.45 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.828 0.677 . . . . 60.140000000000001 112.828 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 103' ' ' THR . 91.8 m-20 -55.93 -28.61 57.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.328 0.492 . . . . 75.319999999999993 112.328 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.33 -16.53 24.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.286 0.476 . . . . 73.239999999999995 112.286 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -50.22 -66.02 0.46 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.964 1.098 . . . . 73.340000000000003 113.964 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.5 -33.71 68.31 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.298 0.481 . . . . 52.399999999999999 112.298 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -67.31 -48.02 68.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.057 0.456 . . . . 74.109999999999999 110.835 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.52 96.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.214 -0.448 . . . . 74.120000000000005 111.357 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.96 44.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.298 -0.41 . . . . 73.329999999999998 111.105 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -61.07 -40.0 92.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.892 0.377 . . . . 62.539999999999999 110.939 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -63.62 -27.58 69.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.301 -0.408 . . . . 62.240000000000002 111.379 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.27 -12.18 41.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.945 0.402 . . . . 63.329999999999998 111.898 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.51 52.69 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.261 -0.495 . . . . 72.319999999999993 113.693 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -70.51 175.52 4.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.333 0.587 . . . . 74.219999999999999 112.012 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -101.01 92.03 4.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.053 -0.521 . . . . 72.140000000000001 111.506 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.8 93.48 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.916 0.389 . . . . 71.120000000000005 111.024 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -122.5 168.2 12.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.543 -0.299 . . . . 71.5 110.529 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.35 5.92 32.47 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.931 -0.481 . . . . 75.099999999999994 111.767 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 44.2 m -65.21 109.06 2.5 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 116.729 -0.214 . . . . 72.0 110.829 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 6.2 Cg_exo -79.14 8.85 3.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.302 2.668 . . . . 74.420000000000002 113.968 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.01 145.26 17.1 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.333 0.494 . . . . 75.120000000000005 112.333 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.72 46.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.877 -0.601 . . . . 54.149999999999999 112.587 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.28 55.5 1.69 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.001 -0.619 . . . . 70.420000000000002 111.803 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.6 t -163.01 165.35 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.305 0.574 . . . . 62.219999999999999 111.85 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 35.2 mt -116.58 125.38 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.644 -0.707 . . . . 65.400000000000006 110.479 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -99.43 133.14 44.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.928 0.394 . . . . 65.25 111.396 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -102.4 133.18 47.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.399 0.518 . . . . 73.140000000000001 112.399 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -124.32 107.92 11.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.033 -0.53 . . . . 74.549999999999997 110.38 171.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 80.2 p -78.56 -14.61 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.357 0.503 . . . . 61.310000000000002 112.357 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.49 -27.83 68.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.845 0.684 . . . . 63.229999999999997 112.845 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.72 57.48 3.85 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 121.243 -0.503 . . . . 72.209999999999994 114.177 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.31 -86.68 0.02 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.166 0.483 . . . . 60.140000000000001 113.819 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.83 11.06 26.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.51 0.671 . . . . 72.430000000000007 110.624 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.405 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . 86.84 163.13 38.32 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.339 -0.846 . . . . 63.229999999999997 113.038 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -140.73 137.27 33.33 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.857 -0.202 . . . . 75.120000000000005 110.817 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 76' ' ' ALA . 14.3 m -138.68 141.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.923 0.392 . . . . 71.040000000000006 111.499 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.09 22.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.96 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -101.37 133.73 45.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.44 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.41 110.1 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 111.646 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.43 -53.38 9.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.09 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -156.57 143.36 18.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.041 0.448 . . . . 64.120000000000005 112.135 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.71 135.0 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.386 -0.37 . . . . 74.310000000000002 110.926 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -92.17 154.7 18.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.369 -0.378 . . . . 63.43 111.304 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -59.18 -24.25 62.92 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.84 0.352 . . . . 65.430000000000007 111.688 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.17 -11.52 60.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.926 0.393 . . . . 71.329999999999998 111.717 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.65 56.47 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.385 -0.436 . . . . 42.219999999999999 112.968 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.1 m -64.84 126.43 27.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.11 0.481 . . . . 64.409999999999997 111.423 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.4 t -103.19 129.74 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.957 -0.565 . . . . 71.430000000000007 111.32 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.14 112.96 26.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.857 0.361 . . . . 75.099999999999994 111.415 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.0 162.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.964 0.412 . . . . 73.510000000000005 111.81 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.419 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 61.7 p -117.03 133.91 55.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.13 0.49 . . . . 72.230000000000004 111.614 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -129.51 152.09 49.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.12 -0.491 . . . . 53.119999999999997 111.047 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.0 ttm -92.08 110.28 21.64 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.902 -0.499 . . . . 61.450000000000003 109.96 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.41 72.74 2.45 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 111.423 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 45.4 p90 -60.0 -20.16 56.3 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.679 0.622 . . . . 74.099999999999994 112.679 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -93.34 16.18 13.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.937 0.399 . . . . 73.510000000000005 111.924 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.77 -53.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 116.407 -0.36 . . . . 71.340000000000003 112.238 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.25 87.26 0.4 Allowed Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.566 -0.613 . . . . 71.439999999999998 111.566 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 44.2 Cg_exo -56.44 -17.07 20.22 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.23 2.62 . . . . 73.219999999999999 114.644 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.93 16.73 9.34 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.183 -0.323 . . . . 71.129999999999995 111.478 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.3 t -123.27 150.02 44.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.349 0.595 . . . . 60.299999999999997 112.273 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.12 126.29 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.821 -0.627 . . . . 71.310000000000002 111.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.6 t -109.55 167.35 10.2 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.371 -0.377 . . . . 71.030000000000001 111.199 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -101.07 144.55 29.85 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.235 -0.439 . . . . 65.329999999999998 111.152 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.22 109.8 6.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 110.866 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 79.9 m -85.02 139.28 31.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.445 -0.343 . . . . 62.119999999999997 111.569 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.6 mt -123.52 149.08 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.758 0.423 . . . . 53.420000000000002 110.87 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 m -64.53 156.77 28.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.11 0.164 . . . . 61.039999999999999 110.838 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.67 -63.22 1.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.086 0.402 . . . . 73.109999999999999 112.086 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.66 -38.1 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.204 -0.522 . . . . 71.109999999999999 112.956 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.51 -36.26 80.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.006 0.522 . . . . 64.450000000000003 110.991 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -43.63 65.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.106 -0.497 . . . . 61.399999999999999 111.529 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 t -59.23 -15.73 16.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 111.965 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.7 t -70.07 -25.28 63.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.925 0.393 . . . . 73.310000000000002 111.575 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -87.4 154.56 20.57 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.242 0.544 . . . . 72.430000000000007 111.895 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -89.3 119.76 30.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.828 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 95.5 m-85 -100.91 117.07 34.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.634 0.605 . . . . 71.140000000000001 112.634 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -91.35 121.03 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.127 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -113.76 157.31 22.41 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.901 0.481 . . . . 71.439999999999998 110.96 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.474 HD13 HG22 ' A' ' 65' ' ' VAL . 34.2 mt -102.26 -33.89 9.44 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.49 0.552 . . . . 73.310000000000002 112.49 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 121.413 0.625 . . . . 75.140000000000001 111.701 -177.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.6 mtp . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 112.059 0.392 . . . . 71.010000000000005 112.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -82.77 119.09 23.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.684 0.278 . . . . 72.239999999999995 111.23 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -119.63 123.84 44.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.722 0.296 . . . . 75.129999999999995 110.913 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 pp -158.03 160.07 37.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.24 0.543 . . . . 72.530000000000001 111.914 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.47 145.19 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 110.935 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.6 p -107.1 86.58 2.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 111.244 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.56 24.66 12.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.269 -0.423 . . . . 74.329999999999998 112.133 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -87.12 110.63 20.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 73.019999999999996 112.406 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -166.08 133.43 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.757 -0.656 . . . . 64.450000000000003 110.46 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -136.01 149.2 48.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.053 0.454 . . . . 72.040000000000006 112.169 -173.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -100.35 146.31 27.12 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.376 -0.375 . . . . 72.230000000000004 110.768 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 175.71 9.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.013 0.435 . . . . 65.120000000000005 111.93 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.05 72.58 1.28 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.187 -0.53 . . . . 40.520000000000003 113.987 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.2 pt -136.91 -178.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.724 0.297 . . . . 63.020000000000003 110.885 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.93 161.76 37.05 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.049 -0.596 . . . . 74.450000000000003 114.087 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.51 153.97 5.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.963 0.505 . . . . 55.509999999999998 110.659 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.23 154.49 25.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.899 0.381 . . . . 75.150000000000006 111.604 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.84 22.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.931 0.345 . . . . 74.430000000000007 111.931 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.85 94.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.197 0.523 . . . . 64.409999999999997 111.851 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.92 93.93 0.09 OUTLIER Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.823 -0.626 . . . . 73.099999999999994 112.173 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 pp -138.78 157.47 46.01 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.535 0.568 . . . . 73.299999999999997 112.535 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.14 106.72 1.36 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 111.281 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -150.51 13.87 0.75 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.002 0.43 . . . . 74.530000000000001 111.596 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.32 69.51 0.42 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.782 -0.723 . . . . 64.420000000000002 113.559 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -112.99 91.94 3.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.418 0.628 . . . . 73.519999999999996 111.564 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.12 149.84 32.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.884 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -170.46 154.87 4.84 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.448 . . . . 43.420000000000002 112.208 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -136.81 136.82 39.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 110.592 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.47 16.72 15.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.407 0.521 . . . . 43.439999999999998 112.407 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.48 132.47 43.9 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 38.280000000000001 111.47 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -70.82 127.76 33.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.571 -0.286 . . . . 72.310000000000002 110.664 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.99 115.75 13.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.044 0.45 . . . . 74.349999999999994 111.78 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -128.55 148.35 50.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.401 -0.363 . . . . 72.310000000000002 110.24 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -120.94 143.23 36.31 Favored Pre-proline 0 N--CA 1.467 0.421 0 O-C-N 122.341 -0.224 . . . . 72.25 111.493 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.75 125.46 15.87 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.41 2.073 . . . . 74.430000000000007 112.466 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.7 p -48.05 -73.2 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.078 0.77 . . . . 75.400000000000006 113.078 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -170.15 127.04 0.83 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.76 0.314 . . . . 72.439999999999998 111.413 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.35 125.42 6.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.2 0.524 . . . . 75.230000000000004 111.51 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.9 p -66.12 105.61 1.42 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.999 -0.546 . . . . 51.340000000000003 111.487 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.0 p -133.09 124.75 28.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.287 -0.415 . . . . 62.409999999999997 111.427 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.5 m -76.83 96.17 4.23 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.194 0.521 . . . . 51.32 110.943 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.69 126.5 38.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.093 -0.503 . . . . 62.43 111.101 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 t -144.97 166.39 25.43 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.119 0.485 . . . . 72.209999999999994 111.716 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.7 p -91.62 16.58 10.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.91 -0.586 . . . . 74.150000000000006 111.337 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 m -64.2 100.19 0.32 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.069 -0.514 . . . . 75.319999999999993 112.011 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.4 118.8 1.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 116.481 -0.327 . . . . 63.420000000000002 112.582 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -101.41 104.02 14.97 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.318 -0.519 . . . . 75.239999999999995 111.84 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -88.51 91.95 9.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.809 0.338 . . . . 71.430000000000007 111.106 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 96.24 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.036 0.446 . . . . 71.219999999999999 111.169 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.57 98.25 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.133 0.492 . . . . 73.349999999999994 111.037 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -87.1 4.98 39.97 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.066 -0.516 . . . . 72.230000000000004 112.298 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 90.5 m-85 -84.85 -178.92 6.97 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.8 0.333 . . . . 63.140000000000001 110.985 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t -111.74 147.07 36.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 112.153 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 95.93 0.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.021 -0.536 . . . . 75.099999999999994 111.917 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.21 -22.74 0.87 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.955 -0.566 . . . . 52.149999999999999 112.679 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -80.31 146.89 31.37 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 111.713 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.406 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.6 m -57.87 -38.52 75.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.56 0.695 . . . . 70.219999999999999 110.448 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.9 p -62.7 -24.33 67.6 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.487 -0.779 . . . . 72.409999999999997 112.274 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -62.59 -65.28 0.71 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.334 0.494 . . . . 65.140000000000001 112.334 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -66.97 -29.08 68.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.537 0.569 . . . . 73.230000000000004 112.537 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 57' ' ' CYS . 61.1 t -61.37 -37.63 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 111.426 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -57.97 -47.82 81.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.978 0.418 . . . . 75.319999999999993 110.845 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.14 -38.69 72.25 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.944 0.35 . . . . 72.310000000000002 111.944 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -56.07 -38.39 70.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.998 0.428 . . . . 74.439999999999998 111.855 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG23 HD12 ' A' ' 99' ' ' ILE . 8.8 p -88.39 9.37 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 121.388 0.613 . . . . 51.329999999999998 111.456 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.68 -2.87 77.3 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.336 -0.393 . . . . 38.280000000000001 113.703 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.31 14.56 66.06 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.998 -0.62 . . . . 63.229999999999997 113.143 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.82 10.38 6.4 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.199 0.444 . . . . 73.129999999999995 112.199 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 pt -110.5 174.1 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.799 0.333 . . . . 53.409999999999997 111.118 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.6 124.31 6.76 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.93 -0.652 . . . . 54.329999999999998 114.013 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.3 p -65.5 -19.39 65.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.026 0.441 . . . . 75.400000000000006 111.13 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 t -78.58 -6.94 56.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.809 0.67 . . . . 71.239999999999995 112.809 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -61.33 -43.51 98.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.153 -0.342 . . . . 74.519999999999996 111.684 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 71.89 -116.29 5.92 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 114.246 0.458 . . . . 71.540000000000006 114.246 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -57.66 132.47 53.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.197 0.444 . . . . 72.0 112.197 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -57.96 -40.55 80.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.178 0.513 . . . . 65.200000000000003 111.885 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -66.91 -19.3 65.7 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.394 0.616 . . . . 72.530000000000001 110.767 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.9 -17.51 23.92 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.055 -0.521 . . . . 74.109999999999999 112.387 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -47.56 -47.07 28.4 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.345 0.868 . . . . 75.209999999999994 113.345 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' A' ' 101' ' ' GLN . . . -59.22 -46.48 88.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.83 0.348 . . . . 50.509999999999998 111.701 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.6 t -59.43 -38.91 81.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.004 0.43 . . . . 45.340000000000003 111.439 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.45 -59.51 2.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 111.277 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.65 36.26 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.685 0.624 . . . . 73.150000000000006 112.685 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 p -55.64 -53.52 55.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 111.998 0.37 . . . . 71.030000000000001 111.998 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -72.14 -22.1 61.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.233 0.457 . . . . 74.310000000000002 112.233 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.64 -17.55 50.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.197 0.443 . . . . 63.509999999999998 112.197 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 25.39 5.46 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.003 -0.617 . . . . 73.540000000000006 113.803 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.72 -176.38 3.17 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.446 -0.444 . . . . 74.519999999999996 110.732 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 63.8 m -109.19 93.0 4.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.741 0.305 . . . . 73.040000000000006 111.772 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.483 HG22 HG13 ' A' ' 152' ' ' ILE . 46.8 t -97.02 91.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.22 0.533 . . . . 73.219999999999999 111.018 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.58 163.94 19.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.004 -0.544 . . . . 62.530000000000001 110.531 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.87 -7.47 57.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.11 -0.369 . . . . 74.549999999999997 111.166 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -51.45 106.05 0.6 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 116.382 -0.372 . . . . 64.209999999999994 110.86 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -84.25 13.24 2.78 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.832 2.355 . . . . 63.520000000000003 114.796 -168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.24 151.46 36.21 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.929 0.714 . . . . 74.010000000000005 112.929 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.58 160.3 11.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.44 -0.8 . . . . 73.019999999999996 112.892 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.4 32.97 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.192 -0.528 . . . . 63.25 112.273 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -145.55 164.91 30.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.822 0.344 . . . . 54.020000000000003 110.715 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.9 mp -100.86 117.42 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.059 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -79.35 136.87 37.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 72.5 110.601 174.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.444 ' OE1' ' HB1' ' A' ' 80' ' ' ALA . 31.0 tt0 -120.06 104.54 10.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.835 0.35 . . . . 74.400000000000006 111.335 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 50.8 m -84.51 85.03 7.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.939 0.399 . . . . 74.340000000000003 110.811 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.4 p -65.97 -40.09 90.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.219 0.533 . . . . 75.439999999999998 110.853 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.17 102.42 4.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.874 -0.603 . . . . 75.439999999999998 111.362 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.61 -143.6 9.67 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.874 -0.679 . . . . 74.319999999999993 113.105 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.66 71.93 1.56 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.558 -0.354 . . . . 65.150000000000006 113.711 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 62.86 8.92 3.35 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.564 0.95 . . . . 75.140000000000001 113.564 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.31 129.44 3.57 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.99 -0.624 . . . . 72.25 113.929 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 46.7 t60 -138.42 149.73 45.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.819 0.447 . . . . 75.010000000000005 110.747 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 76' ' ' ALA . 14.0 m -141.17 143.95 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.439 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.67 23.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 111.681 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -80.64 133.68 35.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.246 -0.284 . . . . 75.430000000000007 110.989 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.46 114.34 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.025 0.441 . . . . 53.340000000000003 111.91 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -79.28 -41.49 27.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.912 -0.586 . . . . 75.319999999999993 111.686 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -167.85 151.95 6.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.909 0.385 . . . . 75.510000000000005 111.809 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.25 122.21 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.638 0.256 . . . . 71.239999999999995 110.685 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -83.05 160.97 21.84 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.15 0.426 . . . . 73.310000000000002 112.15 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -56.07 -22.5 28.05 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.029 0.443 . . . . 75.319999999999993 111.545 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.76 -9.11 17.9 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.135 -0.484 . . . . 71.25 112.0 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.54 89.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.338 -0.458 . . . . 74.340000000000003 112.272 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 m -88.45 131.48 34.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.147 0.498 . . . . 75.239999999999995 111.663 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.07 119.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.349 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.514 ' HG2' ' HG1' ' A' ' 140' ' ' THR . 38.0 mt-10 -98.59 107.91 20.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.687 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.429 HG12 HD13 ' A' ' 100' ' ' LEU . 34.4 m -105.2 161.87 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.551 0.574 . . . . 63.420000000000002 112.551 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.2 t -95.81 123.73 39.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.037 -0.529 . . . . 74.519999999999996 111.874 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -126.51 150.0 49.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.129 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.7 ttm -100.06 131.59 45.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.747 0.308 . . . . 72.109999999999999 110.234 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -97.45 -68.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.747 0.647 . . . . 74.439999999999998 112.747 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.54 125.85 32.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.179 0.437 . . . . 72.439999999999998 112.179 -170.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.01 -46.15 78.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.241 0.46 . . . . 71.349999999999994 112.241 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -86.62 17.99 36.67 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.092 -0.575 . . . . 63.240000000000002 113.169 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -132.58 80.87 0.32 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.55 -0.357 . . . . 64.019999999999996 112.654 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.52 -2.15 6.88 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 122.726 2.284 . . . . 75.209999999999994 113.055 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -112.63 3.32 16.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.997 0.427 . . . . 73.430000000000007 111.186 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -87.98 86.79 7.18 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.28 0.562 . . . . 61.210000000000001 110.977 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 75.7 t -109.18 148.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.139 -0.482 . . . . 62.43 111.605 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.3 m -143.35 136.58 28.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.044 0.449 . . . . 74.150000000000006 111.253 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -83.65 120.11 25.59 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.116 0.484 . . . . 72.150000000000006 111.715 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.43 118.57 31.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.306 -0.407 . . . . 75.549999999999997 110.841 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.514 ' HG1' ' HG2' ' A' ' 123' ' ' GLU . 89.4 m -90.69 105.27 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.134 0.493 . . . . 75.019999999999996 111.866 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.51 133.54 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.073 0.549 . . . . 72.349999999999994 111.102 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -72.85 157.95 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.157 0.428 . . . . 75.099999999999994 112.157 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.46 72.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.688 0.625 . . . . 74.439999999999998 112.688 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.06 -45.88 86.2 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.305 -0.474 . . . . 60.039999999999999 112.997 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.61 -40.56 95.72 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.416 0.627 . . . . 71.430000000000007 110.878 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.68 ' HB3' ' HH ' ' A' ' 151' ' ' TYR . . . -68.93 -21.11 64.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.641 -0.708 . . . . 71.540000000000006 112.689 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.4 p -65.73 -13.16 58.79 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.317 0.488 . . . . 61.439999999999998 112.317 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 39.0 t -102.49 2.21 36.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 111.865 0.32 . . . . 70.450000000000003 111.865 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -103.68 146.09 29.1 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.21 -0.306 . . . . 75.150000000000006 110.94 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -94.23 139.59 30.85 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.539 0.209 . . . . 51.210000000000001 110.943 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.68 ' HH ' ' HB3' ' A' ' 146' ' ' ALA . 91.3 m-85 -117.22 116.98 28.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 73.450000000000003 111.797 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.3 mp -89.05 113.44 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.358 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 13.4 m-70 -99.97 136.06 40.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.082 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.12 -29.82 13.87 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.481 0.549 . . . . 72.140000000000001 112.481 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 121.079 0.466 . . . . 71.439999999999998 112.129 177.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.955 0.354 . . . . 75.030000000000001 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -139.01 -156.76 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.408 0.283 . . . . 74.140000000000001 110.848 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 71.39 23.12 4.02 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.034 0.753 . . . . 63.350000000000001 113.034 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.34 157.51 33.85 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.153 0.502 . . . . 63.140000000000001 111.813 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.78 122.2 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.175 0.512 . . . . 50.539999999999999 111.978 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.9 p -85.76 150.58 24.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.942 0.401 . . . . 55.240000000000002 111.44 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.71 152.67 28.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.963 0.411 . . . . 73.25 111.733 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 159.81 42.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.953 0.406 . . . . 74.510000000000005 111.594 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.6 m -151.31 124.69 8.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 111.415 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt -120.76 121.72 38.82 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.304 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -77.77 122.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.44 -0.345 . . . . 70.439999999999998 111.36 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.89 0.376 . . . . 73.109999999999999 111.975 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.27 84.14 1.59 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.306 -0.473 . . . . 62.43 112.934 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.6 pt -85.47 178.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.2 0.524 . . . . 73.310000000000002 112.038 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.42 161.23 10.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 51.439999999999998 112.779 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.33 153.23 31.3 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 122.508 -0.407 . . . . 73.230000000000004 111.822 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.91 104.51 4.0 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.141 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.93 129.01 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.203 0.525 . . . . 74.319999999999993 111.974 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.18 143.8 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.885 -0.598 . . . . 62.350000000000001 111.08 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.12 127.41 1.86 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.246 -0.502 . . . . 37.640000000000001 113.0 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.4 mt -133.83 157.73 45.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.498 -0.413 . . . . 73.209999999999994 111.356 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -90.43 136.76 32.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.307 0.575 . . . . 74.329999999999998 111.592 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -93.99 -25.44 17.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.862 -0.608 . . . . 74.409999999999997 111.526 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.16 73.41 0.56 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.918 -0.658 . . . . 50.539999999999999 112.722 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.84 129.63 34.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.885 0.374 . . . . 73.209999999999994 111.179 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -105.4 -175.79 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.915 0.709 . . . . 62.130000000000003 112.915 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 179.31 120.61 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.804 -1.089 . . . . 52.409999999999997 109.872 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.4 t70 -71.99 159.85 33.51 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.638 0.256 . . . . 43.020000000000003 110.829 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.27 32.44 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.79 0.293 . . . . 74.099999999999994 111.79 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.06 93.89 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.031 0.752 . . . . 71.150000000000006 113.031 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -81.55 105.53 12.78 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.345 0.593 . . . . 74.420000000000002 111.144 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.24 -73.73 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.165 -0.471 . . . . 72.340000000000003 112.213 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -160.72 172.4 17.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.678 0.275 . . . . 71.5 111.334 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -120.0 109.77 37.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.593 -0.276 . . . . 74.439999999999998 111.516 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.92 99.54 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.432 2.088 . . . . 54.140000000000001 111.54 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.9 p -70.96 109.4 5.06 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 75.040000000000006 113.366 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' C ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -127.78 171.96 11.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.603 -0.726 . . . . 74.340000000000003 110.674 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.47 90.2 2.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.391 0.615 . . . . 74.099999999999994 111.393 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -97.05 158.2 15.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.844 -0.616 . . . . 75.019999999999996 111.758 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -78.64 154.55 30.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.365 -0.38 . . . . 70.299999999999997 111.28 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.25 66.77 4.79 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.699 0.629 . . . . 72.0 112.699 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.67 99.62 3.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.882 0.372 . . . . 74.209999999999994 110.814 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.9 m -79.77 146.72 32.17 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.21 0.528 . . . . 70.340000000000003 112.34 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 t -107.92 168.77 9.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.951 -0.568 . . . . 73.430000000000007 111.008 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -106.83 -30.68 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.863 0.363 . . . . 74.040000000000006 111.278 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 -150.94 42.22 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.058 -0.591 . . . . 55.32 112.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 t -174.86 116.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.575 0.35 . . . . 74.420000000000002 110.576 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.8 m -70.41 155.76 40.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.197 -0.314 . . . . 71.530000000000001 110.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 70.13 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.807 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.84 131.39 50.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.345 0.498 . . . . 64.299999999999997 112.345 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 71' ' ' SER . 84.2 mt -103.98 35.96 2.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.343 -0.389 . . . . 74.120000000000005 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -123.69 -86.54 0.64 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 111.627 0.232 . . . . 75.25 111.627 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -178.48 149.83 0.52 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 111.998 0.37 . . . . 70.319999999999993 111.998 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.72 124.3 28.92 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.852 0.358 . . . . 74.349999999999994 111.871 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.54 21.39 5.12 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.43 -0.414 . . . . 70.109999999999999 113.1 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -129.72 152.38 49.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.568 -0.372 . . . . 70.099999999999994 111.215 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.4 p -63.1 -35.76 81.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.945 0.403 . . . . 70.030000000000001 110.615 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -61.5 -26.59 68.01 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.059 0.456 . . . . 74.329999999999998 111.397 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -78.91 -55.69 4.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.049 -0.523 . . . . 71.219999999999999 110.869 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.05 -52.77 63.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.883 -0.599 . . . . 73.540000000000006 112.499 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.4 t -58.99 -31.99 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.301 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.41 -35.95 82.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.151 0.501 . . . . 71.150000000000006 110.667 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.96 -44.18 73.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.797 -0.638 . . . . 75.019999999999996 111.142 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.282 0.475 . . . . 74.209999999999994 112.282 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG13 HG12 ' A' ' 69' ' ' ILE . 9.4 p -88.42 8.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 121.083 0.468 . . . . 71.030000000000001 111.563 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 28' ' ' ASP . . . 67.16 17.05 67.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.403 -0.427 . . . . 72.400000000000006 113.814 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.15 15.15 64.92 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.18 -0.533 . . . . 37.640000000000001 113.477 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.38 -5.88 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.218 0.451 . . . . 73.109999999999999 112.218 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.4 HG12 HG13 ' A' ' 65' ' ' VAL . 35.5 pt -98.79 140.93 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.559 -0.291 . . . . 72.049999999999997 110.495 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.16 125.14 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.9 -0.667 . . . . 71.239999999999995 113.586 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.509 ' HB2' HD13 ' A' ' 51' ' ' LEU . 57.7 m -66.36 78.31 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.182 0.515 . . . . 63.030000000000001 111.355 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -151.96 13.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.385 0.612 . . . . 74.200000000000003 110.905 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.66 -34.32 12.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 111.446 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.36 -130.92 10.02 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.184 -0.531 . . . . 53.140000000000001 113.344 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -67.11 151.25 47.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.3 0.572 . . . . 63.030000000000001 111.757 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -57.01 -33.92 67.65 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.863 1.06 . . . . 64.519999999999996 113.863 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.09 -28.08 69.2 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.848 -0.532 . . . . 72.040000000000006 112.032 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -84.63 -14.56 48.3 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.685 0.279 . . . . 62.210000000000001 111.604 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -51.02 -62.54 1.55 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.114 0.783 . . . . 72.430000000000007 113.114 -177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.57 -43.55 72.16 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.271 0.471 . . . . 73.409999999999997 112.271 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -60.91 -48.47 81.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.14 0.495 . . . . 73.439999999999998 111.508 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.12 60.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.148 -0.478 . . . . 71.200000000000003 111.455 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.65 7.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.355 -0.384 . . . . 74.530000000000001 111.025 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 p -62.14 -37.32 84.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.132 0.492 . . . . 74.129999999999995 110.941 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -64.25 -38.33 90.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.004 -0.543 . . . . 61.240000000000002 111.951 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.42 -6.01 58.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.676 0.621 . . . . 71.349999999999994 112.676 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.83 -2.3 25.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.938 -0.649 . . . . 74.319999999999993 113.574 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -76.36 170.32 16.58 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.305 0.574 . . . . 74.219999999999999 111.087 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.9 m -115.43 103.57 10.9 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.216 0.451 . . . . 73.340000000000003 112.216 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 152' ' ' ILE . 46.6 t -102.16 119.41 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 70.209999999999994 111.84 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -143.62 168.57 19.57 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.135 -0.484 . . . . 72.310000000000002 110.329 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.48 12.59 9.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.825 0.345 . . . . 70.420000000000002 111.53 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -65.73 108.99 2.54 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 110.624 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.68 14.0 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.042 2.495 . . . . 72.329999999999998 114.419 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -61.69 149.56 39.22 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.179 0.514 . . . . 74.329999999999998 111.985 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.471 ' HA ' HG11 ' A' ' 113' ' ' VAL . . . -60.51 152.47 25.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.953 0.723 . . . . 51.340000000000003 112.953 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.58 23.79 38.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.164 -0.471 . . . . 62.240000000000002 113.192 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.3 p -131.25 159.28 38.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 111.112 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.3 mp -103.42 119.69 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.327 -0.397 . . . . 63.25 110.521 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 111' ' ' ALA . 1.9 pt? -96.07 130.22 43.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -95.56 124.29 39.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.056 -0.52 . . . . 71.219999999999999 112.159 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -103.55 107.71 18.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.877 -0.601 . . . . 72.109999999999999 110.734 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.1 p -79.76 2.55 22.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.014 0.376 . . . . 74.25 112.014 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.81 -20.59 59.71 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.788 0.662 . . . . 63.32 112.788 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.24 159.69 19.96 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.95 -0.643 . . . . 55.43 113.65 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 107' ' ' TYR . . . -63.71 129.02 38.69 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.271 -0.49 . . . . 63.329999999999998 112.24 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 93.6 m-85 70.6 5.16 5.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 111.117 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . 76.37 172.77 35.23 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.256 -0.429 . . . . 63.100000000000001 113.141 -176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -147.84 149.18 31.81 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.374 -0.486 . . . . 72.310000000000002 111.032 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 76' ' ' ALA . 13.5 m -141.57 151.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.083 0.468 . . . . 73.519999999999996 111.779 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 100' ' ' LEU . . . -149.26 167.79 25.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.992 -0.549 . . . . 71.109999999999999 110.996 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -102.94 129.76 49.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.25 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 96' ' ' ALA . 70.8 t -80.81 110.93 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 63.340000000000003 111.494 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -83.82 -45.58 13.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.08 0.4 . . . . 74.430000000000007 112.08 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -158.89 148.47 19.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.498 0.555 . . . . 73.25 112.498 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -109.71 134.7 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 63.310000000000002 110.638 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -94.96 160.87 14.38 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.297 0.48 . . . . 73.329999999999998 112.297 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -61.6 -22.4 65.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.103 -0.499 . . . . 62.439999999999998 111.413 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.64 -15.47 63.67 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.984 -0.553 . . . . 70.140000000000001 111.425 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.61 67.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.035 -0.426 . . . . 71.099999999999994 112.035 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 141.75 49.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.215 0.531 . . . . 74.430000000000007 111.894 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.32 128.32 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.857 -0.611 . . . . 72.129999999999995 111.981 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.28 117.27 29.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.941 0.4 . . . . 73.109999999999999 111.272 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.95 147.51 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.083 -0.508 . . . . 72.129999999999995 111.717 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.506 ' HB2' HG11 ' A' ' 136' ' ' VAL . 91.9 p -101.07 125.06 47.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.407 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 -179.68 5.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.384 0.611 . . . . 73.219999999999999 112.456 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 47.3 ttm -137.59 118.41 14.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.896 -0.593 . . . . 74.409999999999997 110.822 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -123.98 -64.37 1.14 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.97 0.359 . . . . 60.399999999999999 111.97 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -156.76 -55.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.786 0.327 . . . . 75.420000000000002 111.223 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -52.16 117.18 2.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.246 -0.434 . . . . 75.140000000000001 111.499 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.72 -80.25 0.36 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.147 -0.549 . . . . 50.329999999999998 113.22 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.96 -163.56 31.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.984 -0.626 . . . . 41.100000000000001 113.666 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.14 -32.46 87.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.376 2.717 . . . . 52.219999999999999 114.2 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -134.09 22.05 3.8 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.592 0.59 . . . . 73.349999999999994 112.592 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -96.48 158.49 15.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.887 0.375 . . . . 73.209999999999994 110.957 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 125' ' ' SER . 25.0 t -120.78 158.36 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 113.206 0.817 . . . . 74.319999999999993 113.206 -169.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.42 ' N ' HG13 ' A' ' 136' ' ' VAL . 33.1 t -138.88 131.87 29.53 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.885 -0.598 . . . . 74.219999999999999 109.975 169.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -93.59 155.68 17.16 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 112.029 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.46 135.86 25.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.979 0.419 . . . . 73.439999999999998 111.526 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.3 m -95.05 99.76 11.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.075 0.464 . . . . 71.219999999999999 111.097 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.31 134.27 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.316 -0.402 . . . . 62.399999999999999 111.292 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 62.0 m -66.86 149.35 50.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.767 0.318 . . . . 61.219999999999999 111.562 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.85 66.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.582 0.586 . . . . 61.310000000000002 112.582 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.32 -38.47 86.77 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.408 -0.425 . . . . 54.240000000000002 113.564 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -83.09 -39.22 21.42 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.455 -0.438 . . . . 73.209999999999994 111.073 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.51 72.29 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.802 0.667 . . . . 63.409999999999997 112.802 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.8 m -66.42 -14.41 62.13 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.918 0.389 . . . . 73.030000000000001 111.978 -171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -85.28 -10.84 55.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.428 -0.351 . . . . 73.349999999999994 111.551 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.78 151.73 25.03 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.91 0.386 . . . . 72.140000000000001 111.175 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -89.09 112.91 23.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.544 -0.298 . . . . 55.439999999999998 111.337 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.13 117.44 29.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.899 0.381 . . . . 73.040000000000006 111.646 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.7 mp -84.79 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.963 0.411 . . . . 63.32 111.022 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -119.71 147.53 44.47 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.751 0.42 . . . . 73.409999999999997 110.667 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.5 mt -101.52 135.39 43.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.709 0.633 . . . . 61.329999999999998 112.709 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 167.013 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 pmm? . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.31 0.1 . . . . 72.319999999999993 111.041 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 24.9 pttm -60.52 91.11 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.447 0.642 . . . . 72.530000000000001 111.798 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -74.24 -54.16 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.178 -0.465 . . . . 75.5 111.483 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.74 100.39 10.74 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.952 0.405 . . . . 61.310000000000002 110.922 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.31 99.8 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.119 0.485 . . . . 74.349999999999994 111.121 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t -105.26 169.15 8.61 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.109 -0.496 . . . . 64.319999999999993 111.371 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.41 162.37 16.97 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.926 0.393 . . . . 52.539999999999999 111.662 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -102.29 21.05 15.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.372 0.606 . . . . 75.310000000000002 110.935 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 HG23 ' HG ' ' A' ' 10' ' ' LEU . 43.9 m -113.19 120.86 42.68 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.128 -0.487 . . . . 74.420000000000002 111.784 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.511 ' HG ' HG23 ' A' ' 9' ' ' THR . 88.6 mt 63.3 21.73 12.96 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.762 0.653 . . . . 72.510000000000005 112.762 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -104.03 160.56 14.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 111.778 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.86 8.71 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.276 0.56 . . . . 75.420000000000002 112.379 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.45 -47.14 3.25 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.295 -0.479 . . . . 51.119999999999997 113.559 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.455 ' O ' HG12 ' A' ' 14' ' ' ILE . 14.0 tt -98.18 22.54 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.684 0.754 . . . . 72.099999999999994 111.442 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.83 75.05 1.3 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.98 -0.628 . . . . 73.430000000000007 113.317 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.65 113.04 25.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.566 -0.373 . . . . 71.230000000000004 111.7 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.72 154.4 20.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.855 0.359 . . . . 71.409999999999997 111.91 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.008 0.432 . . . . 73.200000000000003 111.578 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.49 126.16 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.475 -0.33 . . . . 74.140000000000001 111.081 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.81 112.47 0.69 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.087 -0.577 . . . . 64.230000000000004 112.661 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.444 ' N ' HD11 ' A' ' 21' ' ' LEU . 7.1 mp -73.72 159.57 32.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.004 0.43 . . . . 74.010000000000005 111.498 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.67 167.65 11.33 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 111.752 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.09 105.8 11.77 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.069 0.461 . . . . 75.099999999999994 110.663 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.13 117.06 10.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.34 -0.457 . . . . 75.409999999999997 113.979 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -92.6 128.58 38.5 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.453 -0.439 . . . . 75.140000000000001 111.016 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -99.48 117.83 34.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.851 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.17 156.5 45.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.279 -0.419 . . . . 72.519999999999996 110.914 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -122.06 177.88 5.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.101 0.477 . . . . 74.430000000000007 111.668 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.65 132.3 52.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.094 0.474 . . . . 65.340000000000003 111.839 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.53 179.32 4.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 111.279 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.29 156.49 43.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.206 0.527 . . . . 73.109999999999999 111.654 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -132.92 -174.07 3.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.577 -0.738 . . . . 72.409999999999997 110.211 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -69.27 173.97 5.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.42 . . . . 73.120000000000005 111.027 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.9 102.45 35.51 Favored Pre-proline 0 CA--C 1.54 0.589 0 O-C-N 122.137 -0.352 . . . . 71.140000000000001 110.968 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.05 89.28 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.424 2.082 . . . . 74.329999999999998 112.917 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -78.8 70.8 5.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.584 . . . . 75.430000000000007 111.681 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -80.19 95.45 6.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.119 0.485 . . . . 62.350000000000001 110.446 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.96 -4.36 43.57 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.8 0.667 . . . . 60.520000000000003 112.8 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.7 p -83.78 97.9 9.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.349 0.595 . . . . 72.420000000000002 111.515 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.8 m -88.55 80.39 7.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.153 0.501 . . . . 75.010000000000005 110.811 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 p -89.93 140.36 29.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.338 -0.392 . . . . 71.349999999999994 111.144 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -91.3 22.66 3.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.554 0.692 . . . . 72.040000000000006 110.551 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.8 p -73.85 92.92 2.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.992 -0.549 . . . . 73.040000000000006 111.722 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -93.24 161.51 14.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.307 -0.406 . . . . 74.109999999999999 111.658 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -78.72 131.88 36.76 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.722 0.296 . . . . 70.109999999999999 111.092 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.66 9.49 76.87 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.953 -0.642 . . . . 73.219999999999999 113.432 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.7 t -154.56 106.64 2.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.198 0.499 . . . . 74.129999999999995 111.513 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -97.39 1.0 48.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.159 0.504 . . . . 72.519999999999996 111.381 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.36 18.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.256 -0.429 . . . . 44.32 110.95 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -100.8 134.9 43.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.764 0.316 . . . . 71.25 110.786 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.25 -11.59 20.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.072 0.768 . . . . 72.219999999999999 113.072 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -107.25 164.25 12.34 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.809 0.67 . . . . 75.219999999999999 112.809 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -80.69 165.22 22.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.547 -0.751 . . . . 71.120000000000005 112.995 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.73 37.72 0.24 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.607 0.595 . . . . 75.129999999999995 112.607 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.24 16.9 1.9 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.615 -0.326 . . . . 64.040000000000006 112.845 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -124.26 137.36 54.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.391 0.276 . . . . 74.030000000000001 110.682 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 m -60.97 -17.82 53.83 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.235 0.54 . . . . 63.130000000000003 111.688 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.5 p -78.53 -26.94 45.9 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.253 0.549 . . . . 73.140000000000001 111.734 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.405 ' CZ3' ' HE2' ' A' ' 127' ' ' MET . 33.7 t90 -56.87 -67.17 0.34 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 41.1 p90 -62.83 -28.19 69.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.092 0.405 . . . . 72.439999999999998 112.092 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -71.56 -36.18 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.875 0.369 . . . . 64.5 111.604 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.73 -35.47 63.73 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.5 111.747 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.64 -43.34 38.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.81 0.338 . . . . 75.219999999999999 111.263 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.01 -29.97 70.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.095 0.406 . . . . 60.310000000000002 112.095 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 2.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.289 0.566 . . . . 74.420000000000002 111.491 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.08 22.78 77.36 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.35 -0.387 . . . . 73.140000000000001 113.686 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.43 21.9 55.14 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.769 0.667 . . . . 39.140000000000001 114.769 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -82.23 3.9 25.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.571 0.685 . . . . 63.119999999999997 112.222 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -111.98 144.83 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.756 0.312 . . . . 63.5 111.601 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.55 112.07 4.1 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.272 -0.49 . . . . 74.030000000000001 112.797 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.2 p -68.46 -7.55 32.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.506 0.558 . . . . 72.040000000000006 112.506 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 t -65.12 -2.86 3.13 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.947 0.721 . . . . 64.010000000000005 112.947 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -64.83 -27.25 68.75 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.912 0.387 . . . . 75.239999999999995 111.838 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.3 -130.85 10.5 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.205 -0.522 . . . . 75.409999999999997 112.896 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 15.8 m120 -82.31 168.28 17.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.316 0.579 . . . . 73.400000000000006 111.717 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.451 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -73.28 16.55 0.17 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.861 1.06 . . . . 72.200000000000003 113.861 -170.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.45 -28.08 12.77 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.969 0.414 . . . . 63.219999999999999 111.632 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.5 ' ND2' ' HB2' ' A' ' 82' ' ' ALA . 11.3 t30 -95.82 -3.0 46.4 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.33 0.492 . . . . 71.140000000000001 112.33 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -55.8 -56.48 20.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.842 0.682 . . . . 75.439999999999998 112.842 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.0 69.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.987 0.422 . . . . 75.319999999999993 112.016 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.1 t -66.86 -54.92 17.49 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.114 -0.494 . . . . 53.200000000000003 111.581 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . . . -62.91 -49.92 72.88 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.92 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -49.11 -57.22 7.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.609 0.364 . . . . 72.409999999999997 111.525 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.6 p -62.18 -39.67 93.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.973 0.416 . . . . 72.200000000000003 111.135 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -25.39 63.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.305 -0.407 . . . . 75.310000000000002 111.696 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.73 15.4 25.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.164 0.431 . . . . 61.219999999999999 112.164 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.55 -21.22 47.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.997 -0.621 . . . . 62.049999999999997 113.993 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.7 m-85 -63.6 154.98 31.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.476 0.638 . . . . 72.540000000000006 111.171 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 27.6 m -99.41 95.87 7.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.403 0.52 . . . . 72.430000000000007 112.403 -170.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG21 HG13 ' A' ' 152' ' ' ILE . 60.7 t -94.81 111.46 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.732 0.301 . . . . 72.049999999999997 111.383 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -133.29 174.77 10.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.603 -0.271 . . . . 72.519999999999996 111.161 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.64 0.52 52.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.968 0.413 . . . . 62.530000000000001 110.706 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.3 t -68.36 115.55 30.71 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.687 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -80.77 7.21 5.0 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.79 2.327 . . . . 73.310000000000002 113.276 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 137.74 5.41 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.171 0.434 . . . . 74.439999999999998 112.171 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.64 156.81 3.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.195 0.813 . . . . 65.219999999999999 113.195 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 26.01 57.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.93 -0.577 . . . . 71.420000000000002 113.016 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -129.38 175.99 8.32 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.272 0.558 . . . . 71.409999999999997 111.766 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 55.0 mt -129.92 128.13 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 62.409999999999997 110.57 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -101.63 138.47 38.58 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.906 -0.496 . . . . 71.200000000000003 111.523 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -103.41 110.83 22.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 111.193 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.582 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 56.1 m -84.13 -29.83 26.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.95 0.722 . . . . 63.109999999999999 112.95 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.0 p 67.12 -24.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.983 1.105 . . . . 73.319999999999993 113.983 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 102' ' ' SER . . . -68.09 84.89 0.24 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.521 0.934 . . . . 73.420000000000002 113.521 -173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.37 134.78 1.39 Allowed Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.974 0.75 . . . . 74.299999999999997 114.974 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.99 49.36 1.93 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.484 -0.389 . . . . 73.150000000000006 113.665 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.569 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 84.5 m-85 57.7 30.92 19.65 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.243 0.544 . . . . 74.439999999999998 110.67 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.71 -165.53 25.88 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.064 -0.814 . . . . 74.430000000000007 111.064 -170.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 59.4 t60 -168.2 134.87 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.651 0.725 . . . . 74.030000000000001 111.473 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 76' ' ' ALA . 30.1 m -141.67 143.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.007 -0.542 . . . . 64.420000000000002 110.927 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.77 156.51 45.0 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.734 0.302 . . . . 61.219999999999999 111.005 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -89.58 129.19 36.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.868 0.366 . . . . 75.030000000000001 111.336 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -75.32 116.83 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.03 0.443 . . . . 73.010000000000005 111.529 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -75.74 -54.95 6.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.914 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -158.28 164.89 35.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.239 0.542 . . . . 74.010000000000005 111.778 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.45 129.88 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.06 -0.518 . . . . 70.439999999999998 110.835 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -85.24 145.62 27.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.295 -0.253 . . . . 74.549999999999997 110.596 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.1 m -59.71 -21.82 61.16 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.031 0.443 . . . . 70.340000000000003 111.212 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.46 -23.8 67.1 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.015 -0.539 . . . . 75.319999999999993 111.723 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.6 -20.31 29.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 112.1 -0.4 . . . . 39.140000000000001 112.1 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.0 m -68.66 135.72 51.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.862 0.363 . . . . 62.299999999999997 111.527 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.45 136.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.362 -0.381 . . . . 73.549999999999997 111.701 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.99 117.68 32.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.539 -0.3 . . . . 72.420000000000002 110.588 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.33 156.94 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.956 0.408 . . . . 73.450000000000003 111.933 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 p -110.96 123.89 51.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.965 0.412 . . . . 73.430000000000007 111.191 177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 38.6 mt-10 -128.86 151.65 49.38 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.244 -0.434 . . . . 71.450000000000003 111.65 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.405 ' HE2' ' CZ3' ' A' ' 59' ' ' TRP . 44.4 tpp -74.57 109.51 8.11 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.926 0.393 . . . . 75.310000000000002 111.794 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.82 -35.41 24.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.274 -0.421 . . . . 71.530000000000001 110.65 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 63.9 t80 71.7 -18.37 0.3 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.889 0.7 . . . . 73.099999999999994 112.889 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -78.21 129.79 35.52 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.89 -0.506 . . . . 71.299999999999997 111.055 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.7 -106.44 3.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.124 -0.56 . . . . 64.120000000000005 112.548 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.73 164.7 53.31 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.379 -0.438 . . . . 75.340000000000003 113.504 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.81 -53.56 3.13 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.624 2.216 . . . . 72.019999999999996 112.857 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -98.43 45.28 1.01 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 74.129999999999995 110.709 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.2 t -68.25 84.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.227 0.537 . . . . 70.030000000000001 111.663 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.74 117.14 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.247 -0.433 . . . . 74.150000000000006 110.923 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.3 m -104.4 174.07 6.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.934 0.397 . . . . 71.049999999999997 111.652 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.46 156.03 19.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.241 0.543 . . . . 75.040000000000006 112.077 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -149.9 128.05 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.975 -0.557 . . . . 74.209999999999994 110.59 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.1 m -99.87 113.37 25.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.434 -0.348 . . . . 71.030000000000001 110.707 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.85 134.24 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.708 0.289 . . . . 75.430000000000007 111.243 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -63.13 151.73 39.29 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.068 0.396 . . . . 73.400000000000006 112.068 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.82 61.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.718 0.636 . . . . 45.130000000000003 112.718 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.47 -37.91 56.82 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.506 -0.378 . . . . 62.25 113.808 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -94.96 -51.32 4.72 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.526 -0.397 . . . . 61.229999999999997 111.106 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.23 67.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.778 0.658 . . . . 63.32 112.778 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -64.19 -14.33 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.591 0.589 . . . . 64.120000000000005 112.591 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.2 t -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.057 0.456 . . . . 72.420000000000002 111.015 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 23.9 m-85 -72.59 152.33 41.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.859 -0.609 . . . . 72.129999999999995 112.127 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -84.67 117.63 23.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.467 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 97.3 m-85 -96.48 113.98 25.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 111.969 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.455 HG13 HG21 ' A' ' 90' ' ' VAL . 3.8 mp -79.29 129.54 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.448 -0.342 . . . . 71.040000000000006 110.447 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 50.8 m-70 -119.46 152.03 37.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.868 0.366 . . . . 73.239999999999995 110.865 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.49 -43.88 5.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 111.809 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.152 0.501 . . . . 73.129999999999995 111.453 -174.309 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.374 0.131 . . . . 73.420000000000002 110.801 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 3.7 mppt? -76.17 103.5 6.23 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.879 0.371 . . . . 73.129999999999995 111.398 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.599 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -112.8 30.88 6.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.248 0.547 . . . . 73.049999999999997 111.417 178.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.26 93.54 4.01 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 70.319999999999993 111.824 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG21 ' H ' ' A' ' 7' ' ' ALA . 12.5 p -80.33 145.86 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.264 -0.425 . . . . 64.420000000000002 110.615 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.6 p -101.25 6.52 42.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.04 0.385 . . . . 74.439999999999998 112.04 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.637 ' H ' HG21 ' A' ' 5' ' ' VAL . . . -67.11 106.26 1.93 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.9 0.704 . . . . 74.329999999999998 112.9 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -147.87 137.75 22.65 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.012 -0.54 . . . . 75.219999999999999 110.205 171.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.2 m -84.04 133.64 34.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.914 0.709 . . . . 74.400000000000006 112.914 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 10' ' ' LEU . 2.2 pt? -152.34 151.62 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.426 -0.807 . . . . 62.049999999999997 110.301 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 t -163.67 179.69 7.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 122.142 -0.349 . . . . 74.150000000000006 111.873 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.43 173.91 13.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.505 0.322 . . . . 72.430000000000007 111.096 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.61 97.22 2.45 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.164 -0.541 . . . . 65.010000000000005 113.452 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 14' ' ' ILE . 2.0 pp -87.84 128.82 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.174 0.511 . . . . 62.310000000000002 111.85 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.27 -157.44 23.81 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.273 -0.489 . . . . 51.109999999999999 113.621 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.89 129.19 17.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.612 -0.346 . . . . 70.230000000000004 111.184 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.82 157.09 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.163 0.506 . . . . 63.219999999999999 112.273 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.9 tt -77.19 143.9 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 116.096 -0.502 . . . . 51.299999999999997 111.551 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.8 p -106.45 120.96 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.174 0.512 . . . . 72.120000000000005 111.523 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.93 59.95 4.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 74.150000000000006 112.254 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 110.36 1.34 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.16 0.43 . . . . 73.209999999999994 112.16 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.33 155.03 24.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.315 -0.402 . . . . 73.329999999999998 111.74 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -134.17 15.52 3.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.186 0.81 . . . . 74.209999999999994 113.186 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.75 144.19 5.08 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.566 -0.826 . . . . 42.350000000000001 113.965 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 71.3 -15.45 0.42 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.014 0.746 . . . . 64.349999999999994 113.014 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -61.0 142.35 56.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.969 0.414 . . . . 75.219999999999999 112.04 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.97 167.59 20.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.273 0.559 . . . . 74.420000000000002 112.476 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.39 94.89 3.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.275 -0.42 . . . . 74.109999999999999 110.584 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.15 112.88 23.9 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.461 0.541 . . . . 65.219999999999999 112.461 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.71 114.63 12.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.29 -0.414 . . . . 62.020000000000003 110.777 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -14.58 54.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.298 0.481 . . . . 73.420000000000002 112.298 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.38 111.1 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.95 0.405 . . . . 51.329999999999998 111.311 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -153.27 161.19 42.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.99 0.424 . . . . 62.009999999999998 111.26 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -112.82 106.0 55.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.017 0.436 . . . . 74.299999999999997 110.173 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.7 92.15 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 62.310000000000002 114.316 -173.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -76.67 -28.13 55.86 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.616 0.722 . . . . 73.019999999999996 109.965 168.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -89.89 150.0 22.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.398 -0.819 . . . . 73.129999999999995 110.821 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -72.43 143.86 48.34 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.01 0.433 . . . . 72.209999999999994 111.507 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.7 m -69.62 116.23 9.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.3 -0.409 . . . . 74.239999999999995 112.036 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.5 t -153.14 150.0 28.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.883 0.373 . . . . 75.219999999999999 111.563 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -139.56 137.47 35.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.288 -0.414 . . . . 72.299999999999997 110.124 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -160.93 -158.33 0.58 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.371 0.508 . . . . 74.430000000000007 112.371 -171.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -80.16 31.11 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.186 0.81 . . . . 61.049999999999997 113.186 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.4 p -69.41 99.54 1.24 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.115 -0.366 . . . . 54.109999999999999 111.557 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 m -130.23 71.14 1.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.935 0.398 . . . . 72.530000000000001 111.713 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.18 163.55 39.58 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.165 -0.54 . . . . 75.439999999999998 113.326 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.0 m -69.96 153.99 42.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.884 0.373 . . . . 63.520000000000003 111.597 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -94.54 -63.6 1.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.041 0.448 . . . . 52.049999999999997 111.766 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.06 172.63 12.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.107 0.78 . . . . 41.310000000000002 113.107 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -80.34 104.6 11.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.713 -0.676 . . . . 73.540000000000006 110.982 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.89 -17.41 50.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.085 0.402 . . . . 70.150000000000006 112.085 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -81.69 -170.29 2.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.126 0.488 . . . . 71.5 111.941 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -117.89 154.15 32.35 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.349 -0.387 . . . . 54.240000000000002 111.864 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.63 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.179 0.514 . . . . 63.219999999999999 112.004 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.72 -40.57 0.53 Allowed Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 112.763 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.57 144.54 56.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.754 0.311 . . . . 65.010000000000005 111.447 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 29.7 p -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.237 0.541 . . . . 73.450000000000003 110.974 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 p -66.01 -15.87 63.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.837 -0.619 . . . . 72.120000000000005 112.121 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -76.18 -60.83 2.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.007 0.373 . . . . 75.25 112.007 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 18.4 p90 -71.88 -30.6 65.57 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.75 0.648 . . . . 71.310000000000002 112.75 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.97 -32.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 110.469 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.2 -39.77 79.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.769 -0.651 . . . . 71.430000000000007 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.74 -37.51 76.5 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.341 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 125' ' ' SER . 30.4 mmmt -56.17 -33.58 65.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.913 0.387 . . . . 72.510000000000005 111.696 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 65' ' ' VAL . 10.7 p -102.34 15.37 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.602 0.715 . . . . 61.0 111.163 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.9 -1.3 17.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.25 -0.432 . . . . 72.040000000000006 113.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.03 10.8 77.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.351 -0.452 . . . . 61.25 113.361 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -79.28 38.1 0.35 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.312 0.486 . . . . 73.439999999999998 112.312 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.552 HG23 HD22 ' A' ' 154' ' ' LEU . 20.5 pt -134.78 -41.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.21 100.24 2.49 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.911 -0.661 . . . . 65.5 113.353 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.0 p -80.24 43.57 0.64 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.199 0.444 . . . . 63.539999999999999 112.199 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 t -126.28 18.46 7.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.957 0.408 . . . . 75.140000000000001 112.084 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -91.17 11.67 22.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.849 0.685 . . . . 75.420000000000002 112.849 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.05 -143.44 28.69 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 113.596 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.08 152.42 45.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.521 -0.4 . . . . 61.119999999999997 111.104 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.53 -38.43 59.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.514 0.561 . . . . 72.140000000000001 112.514 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -61.31 -25.97 67.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.346 0.499 . . . . 62.340000000000003 112.346 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -94.56 -5.81 45.07 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.25 -0.281 . . . . 43.25 111.508 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.16 -56.26 21.88 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.373 0.509 . . . . 75.319999999999993 112.373 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.92 96.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.861 0.363 . . . . 62.340000000000003 111.846 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -35.58 81.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.4 -0.363 . . . . 72.510000000000005 111.784 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.49 -45.9 24.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.615 0.228 . . . . 72.25 111.615 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.53 -55.42 25.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.936 0.398 . . . . 75.219999999999999 111.694 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 p -57.1 -49.41 75.97 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 111.283 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.7 t -65.7 -15.54 62.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.242 0.46 . . . . 62.439999999999998 112.242 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.84 3.47 54.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.924 0.392 . . . . 73.25 111.654 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.52 -4.44 73.03 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.3 -0.476 . . . . 75.109999999999999 113.657 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -75.15 170.4 16.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.435 0.636 . . . . 72.230000000000004 111.565 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -99.88 97.21 8.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 112.353 -170.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.38 91.98 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.146 0.498 . . . . 64.409999999999997 110.692 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.77 138.42 53.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.677 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -76.71 13.33 1.03 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.48 0.918 . . . . 73.349999999999994 113.48 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -65.85 114.02 14.51 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 110.02 -0.363 . . . . 71.200000000000003 110.02 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.14 22.19 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.942 2.428 . . . . 55.25 114.543 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.471 ' HA ' HG23 ' A' ' 116' ' ' VAL . 44.5 mt-10 -74.44 159.81 31.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.529 0.681 . . . . 71.340000000000003 112.695 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.56 5.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.323 -0.853 . . . . 75.409999999999997 113.086 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.22 40.91 40.31 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.874 -0.603 . . . . 64.329999999999998 112.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.2 p -152.25 167.19 29.4 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.568 -0.372 . . . . 65.200000000000003 111.125 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.6 mp -112.78 122.95 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.602 -0.272 . . . . 72.5 110.351 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -86.41 138.36 31.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 64.010000000000005 110.893 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.37 109.4 19.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.355 -0.384 . . . . 63.149999999999999 110.561 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.5 t -105.81 133.22 50.9 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.313 -0.403 . . . . 74.329999999999998 111.476 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.7 p -112.78 22.45 14.48 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.755 0.312 . . . . 71.439999999999998 111.787 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.52 -53.02 48.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.195 0.443 . . . . 72.299999999999997 112.195 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.5 -178.25 29.54 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.862 -0.685 . . . . 71.200000000000003 113.675 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.72 30.48 72.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.572 -0.347 . . . . 41.119999999999997 113.825 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 57.47 27.79 14.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.222 0.534 . . . . 75.140000000000001 111.775 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.7 151.85 23.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 116.004 -0.544 . . . . 74.099999999999994 112.94 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -148.98 143.55 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.511 -0.405 . . . . 74.109999999999999 111.421 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.77 153.92 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.048 0.451 . . . . 72.120000000000005 111.615 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.48 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.577 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -95.4 126.18 40.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.001 0.429 . . . . 64.109999999999999 111.627 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.99 108.21 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.068 -0.515 . . . . 74.239999999999995 111.682 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.75 -48.65 14.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.066 -0.515 . . . . 74.230000000000004 111.443 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -154.4 154.7 33.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.284 -0.417 . . . . 74.120000000000005 110.913 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 95' ' ' GLU . 45.2 t -123.65 111.0 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.874 0.368 . . . . 73.510000000000005 111.094 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -64.95 131.96 48.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.483 -0.326 . . . . 70.209999999999994 111.566 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.6 p -60.78 -19.01 58.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.835 0.35 . . . . 70.120000000000005 111.596 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 -16.72 64.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.882 0.372 . . . . 73.219999999999999 111.788 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.37 57.51 0.59 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.303 -0.475 . . . . 43.409999999999997 113.067 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -151.64 136.29 17.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.735 0.303 . . . . 74.030000000000001 111.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.93 116.1 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.269 -0.423 . . . . 63.140000000000001 110.912 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -90.22 104.85 17.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.874 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -108.51 132.84 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.154 0.502 . . . . 65.129999999999995 111.907 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.502 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 32.0 t -89.28 114.23 25.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.425 -0.352 . . . . 64.519999999999996 111.17 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -131.05 147.31 52.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.532 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.574 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 40.8 ttm -81.02 107.73 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.093 0.473 . . . . 71.349999999999994 110.863 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.35 -21.41 24.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.918 -0.583 . . . . 75.439999999999998 110.983 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.56 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 9.0 t80 59.5 62.68 1.7 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.782 -0.644 . . . . 74.040000000000006 110.992 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -79.36 -64.26 1.23 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.888 -0.596 . . . . 74.319999999999993 110.828 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -126.23 -53.89 0.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.248 -0.501 . . . . 72.540000000000006 113.348 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.61 148.39 35.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.108 -0.568 . . . . 74.120000000000005 113.38 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.49 -14.87 37.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.953 2.436 . . . . 72.040000000000006 113.296 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -120.81 25.98 9.37 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.258 0.551 . . . . 74.120000000000005 110.604 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.56 ' HB3' ' HA ' ' A' ' 129' ' ' TYR . 43.2 t -59.45 97.56 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.983 0.734 . . . . 52.240000000000002 112.983 -175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 63.0 t -104.19 127.34 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.962 0.41 . . . . 73.349999999999994 110.866 175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.4 t -112.62 136.54 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.352 -0.385 . . . . 72.340000000000003 111.257 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -82.63 97.0 8.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.331 0.586 . . . . 63.329999999999998 110.025 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -83.91 107.12 16.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.905 -0.589 . . . . 64.019999999999996 112.215 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.1 m -86.73 112.91 22.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 111.248 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.1 mt -111.87 139.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.391 -0.368 . . . . 75.430000000000007 111.568 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.5 m -58.45 133.81 56.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.621 0.248 . . . . 74.530000000000001 111.399 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.22 73.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.191 0.441 . . . . 52.009999999999998 112.191 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -52.25 40.04 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.203 -0.523 . . . . 71.109999999999999 112.965 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.48 -44.72 77.87 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.163 0.506 . . . . 55.43 110.859 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -60.84 -30.69 70.25 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.196 0.813 . . . . 38.07 113.196 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.9 t -58.49 -23.74 58.67 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.807 0.669 . . . . 63.530000000000001 112.807 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.5 t -76.17 -19.45 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.021 0.439 . . . . 71.25 111.79 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 11.0 m-85 -83.67 147.9 27.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.934 0.397 . . . . 75.219999999999999 110.965 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.8 121.41 33.4 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.333 -0.229 . . . . 75.340000000000003 111.274 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -98.21 121.85 40.65 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.132 0.492 . . . . 74.120000000000005 112.005 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.68 121.74 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.354 -0.385 . . . . 65.420000000000002 110.423 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -115.38 147.35 40.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.548 0.339 . . . . 75.409999999999997 110.57 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.552 HD22 HG23 ' A' ' 69' ' ' ILE . 86.9 mt -110.64 116.89 32.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.321 0.489 . . . . 73.310000000000002 112.321 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 109.895 -0.409 . . . . 71.540000000000006 109.895 172.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.474 0.178 . . . . 61.200000000000003 111.201 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.69 93.04 0.1 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.056 0.455 . . . . 75.340000000000003 111.39 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.73 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 9.7 mtmp? -121.15 120.67 35.93 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 111.784 -176.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.86 96.58 7.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.179 0.514 . . . . 72.25 110.566 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 5' ' ' VAL . 17.6 m -74.05 104.65 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.54 0.686 . . . . 74.200000000000003 112.072 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 t -156.04 135.95 12.72 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.912 -0.585 . . . . 71.319999999999993 110.757 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.69 115.24 26.78 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.103 0.409 . . . . 55.109999999999999 112.103 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.7 m -63.01 88.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.352 0.596 . . . . 74.140000000000001 110.723 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 m -107.63 134.94 49.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.977 -0.556 . . . . 72.540000000000006 111.395 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.29 178.16 6.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.066 0.46 . . . . 64.319999999999993 111.724 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -158.1 150.13 21.87 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.085 -0.507 . . . . 72.310000000000002 111.064 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.28 179.54 4.22 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.261 0.467 . . . . 73.0 112.261 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.9 119.52 0.53 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.228 -0.51 . . . . 51.030000000000001 113.134 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 tt -166.13 -42.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.371 0.878 . . . . 71.420000000000002 113.371 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.86 166.17 13.48 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.684 -0.769 . . . . 37.659999999999997 114.632 -171.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 161.07 36.54 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.608 0.363 . . . . 40.530000000000001 111.275 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.69 162.9 13.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.83 0.678 . . . . 74.040000000000006 112.83 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -83.18 156.21 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.026 -0.533 . . . . 70.239999999999995 111.291 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.9 t -93.52 -66.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.822 0.675 . . . . 53.329999999999998 112.822 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 77.9 0.44 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.614 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 22' ' ' ASP . 3.6 tt -96.82 133.56 41.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 75.230000000000004 110.851 -174.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' N ' HD22 ' A' ' 21' ' ' LEU . 7.5 m-20 -81.22 88.55 6.03 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.947 0.403 . . . . 63.43 111.173 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -153.66 128.28 9.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.702 0.287 . . . . 64.400000000000006 111.683 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.68 -83.72 0.99 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.445 -0.407 . . . . 74.219999999999999 112.914 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -143.7 -69.66 0.32 Allowed 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.445 -0.444 . . . . 62.140000000000001 111.433 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.68 160.31 34.65 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.614 0.245 . . . . 75.019999999999996 111.595 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.67 105.26 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.153 0.427 . . . . 64.120000000000005 112.153 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.64 144.76 9.06 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.268 -0.424 . . . . 74.450000000000003 110.777 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.532 ' H ' ' NE2' ' A' ' 32' ' ' GLN . . . -160.21 150.12 18.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.648 0.261 . . . . 71.319999999999993 111.373 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.42 -8.74 57.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.987 0.736 . . . . 61.329999999999998 112.987 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.38 -9.5 38.51 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.818 0.342 . . . . 65.340000000000003 111.865 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 29' ' ' ALA . 21.2 pt20 -85.54 176.58 8.14 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.384 0.611 . . . . 74.120000000000005 112.315 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.5 p -86.24 138.09 32.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.807 -0.633 . . . . 62.43 111.564 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.47 82.5 3.04 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 120.964 0.411 . . . . 54.039999999999999 111.175 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -97.48 172.83 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.387 2.725 . . . . 70.319999999999993 113.291 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 t -72.37 -25.36 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.096 0.474 . . . . 74.219999999999999 111.159 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -70.94 109.61 5.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.085 0.469 . . . . 73.519999999999996 111.798 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.32 82.67 2.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.103 0.478 . . . . 71.129999999999995 109.721 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.3 t -113.36 -179.12 3.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.42 0.526 . . . . 75.200000000000003 112.42 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.1 p -133.48 22.72 4.01 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.274 -0.421 . . . . 74.329999999999998 112.125 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.1 p -98.18 -175.64 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.859 0.361 . . . . 64.109999999999999 111.821 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.06 149.45 50.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 74.340000000000003 112.955 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.3 m -133.01 149.05 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.666 -0.697 . . . . 75.409999999999997 110.337 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.0 p -122.6 167.61 13.19 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.288 0.566 . . . . 72.030000000000001 112.523 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -96.79 126.26 41.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.965 -0.561 . . . . 74.219999999999999 110.196 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.93 -172.76 48.53 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.934 -0.65 . . . . 73.519999999999996 114.567 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.539 ' HB3' ' HH ' ' A' ' 62' ' ' TYR . 33.4 t -125.75 -177.93 4.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.763 0.425 . . . . 65.099999999999994 110.321 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -149.42 13.9 0.85 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.666 0.987 . . . . 73.140000000000001 113.666 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.42 117.53 23.12 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.56 0.578 . . . . 70.540000000000006 112.56 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.475 HD22 ' HB2' ' A' ' 63' ' ' ASP . 1.6 m-20 -76.73 86.92 3.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 110.848 176.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.85 50.32 1.97 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.016 0.436 . . . . 63.210000000000001 111.893 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 80.1 m-85 -116.25 -159.52 0.72 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.782 0.325 . . . . 72.409999999999997 111.371 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t -117.25 144.49 44.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 111.199 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.28 86.5 0.41 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 112.078 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.29 -29.88 0.36 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.871 -0.681 . . . . 37.659999999999997 113.7 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.49 151.1 30.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 111.852 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.6 m -54.67 -40.95 69.59 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.834 -0.621 . . . . 71.209999999999994 112.248 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -62.82 -24.19 67.64 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 74.109999999999999 112.151 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -60.99 -47.89 84.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.222 0.453 . . . . 73.400000000000006 112.222 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 126' ' ' GLU . 25.0 p90 -80.63 -39.69 26.98 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.172 -0.33 . . . . 72.230000000000004 111.624 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 57' ' ' CYS . 45.6 t -57.23 -41.89 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.879 0.371 . . . . 74.319999999999993 111.74 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.539 ' HH ' ' HB3' ' A' ' 47' ' ' SER . 13.0 t80 -56.01 -38.47 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.175 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.475 ' HB2' HD22 ' A' ' 50' ' ' ASN . 31.1 t70 -78.51 -39.58 37.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 111.003 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.506 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.2 mmmt -53.22 -44.81 68.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.928 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.95 -22.43 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 111.962 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.2 30.19 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.169 -0.538 . . . . 62.509999999999998 113.656 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.91 -14.89 35.09 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.321 -0.466 . . . . 75.030000000000001 114.144 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.41 68.81 4.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.303 -0.528 . . . . 74.310000000000002 112.118 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 70' ' ' GLY . 6.0 pt -146.96 -54.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.043 -0.526 . . . . 71.409999999999997 111.473 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 69' ' ' ILE . . . 142.28 102.27 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.722 -0.752 . . . . 73.530000000000001 113.37 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 84.4 p -55.34 -28.09 51.47 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.023 0.379 . . . . 71.450000000000003 112.023 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -62.96 -16.64 60.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.087 0.773 . . . . 75.340000000000003 113.087 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -61.87 -43.15 99.42 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.908 0.385 . . . . 73.349999999999994 111.294 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 66.68 -92.99 0.2 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.323 -0.465 . . . . 74.319999999999993 114.122 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.91 139.74 38.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.01 0.433 . . . . 72.430000000000007 111.915 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB1' HG12 ' A' ' 110' ' ' VAL . . . -60.44 -28.58 68.4 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.366 0.506 . . . . 73.010000000000005 112.366 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -67.51 -17.76 64.79 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.943 0.401 . . . . 72.519999999999996 111.78 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.4 -34.16 12.87 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.197 0.443 . . . . 74.519999999999996 112.197 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -35.58 -64.62 0.28 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.625 1.343 . . . . 75.099999999999994 114.625 -171.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.48 79.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.632 0.604 . . . . 74.219999999999999 112.632 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -68.23 -44.55 75.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.085 0.469 . . . . 75.099999999999994 111.336 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.45 83.1 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.209 -0.451 . . . . 75.120000000000005 111.046 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -59.62 5.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.038 -0.528 . . . . 63.140000000000001 111.105 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.4 p -58.25 -32.41 68.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.244 -0.434 . . . . 73.540000000000006 111.56 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -72.85 -41.95 64.23 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.229 0.455 . . . . 73.140000000000001 112.229 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.75 -8.39 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.643 0.609 . . . . 72.400000000000006 112.643 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.38 7.48 26.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.942 -0.647 . . . . 43.350000000000001 113.447 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -80.4 168.18 19.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.629 . . . . 74.430000000000007 111.744 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 m -104.86 102.24 11.79 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.813 -0.631 . . . . 63.020000000000003 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.76 111.26 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 61.539999999999999 111.404 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 58.6 m-80 -132.15 149.31 52.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.366 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.79 12.25 1.13 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.219 0.452 . . . . 62.310000000000002 112.219 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.5 t -73.54 116.85 55.55 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.733 -0.212 . . . . 55.509999999999998 111.24 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.76 104.24 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.39 2.06 . . . . 74.019999999999996 112.032 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -131.04 136.47 48.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.058 -0.519 . . . . 71.439999999999998 111.699 -174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.98 120.86 14.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.555 -0.293 . . . . 37.659999999999997 111.237 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.64 15.33 17.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.202 -0.523 . . . . 64.409999999999997 113.254 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -120.75 170.1 9.77 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.475 -0.426 . . . . 61.539999999999999 110.753 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.0 mp -113.24 123.04 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.617 -0.265 . . . . 75.230000000000004 110.71 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -93.71 133.29 37.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.073 0.463 . . . . 71.030000000000001 111.212 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -94.25 112.18 23.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.294 -0.412 . . . . 72.209999999999994 111.153 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 37.5 m -93.9 -17.41 23.04 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.292 0.478 . . . . 74.209999999999994 112.292 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.4 p 47.41 21.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.476 0.917 . . . . 73.510000000000005 113.476 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.58 105.02 3.49 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.12 0.785 . . . . 75.519999999999996 113.12 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.75 97.34 0.6 Allowed Glycine 0 CA--C 1.531 1.044 0 N-CA-C 115.278 0.871 . . . . 37.659999999999997 115.278 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.04 -86.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.638 0.615 . . . . 62.200000000000003 114.638 171.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -69.39 -28.61 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.227 0.537 . . . . 75.400000000000006 110.859 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.02 176.54 33.44 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.874 -0.603 . . . . 73.010000000000005 113.322 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 39.6 t60 -136.0 142.78 44.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.709 0.29 . . . . 74.040000000000006 111.058 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.522 HG12 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -146.89 146.2 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.088 0.555 . . . . 64.510000000000005 110.397 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.84 161.7 37.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.961 0.41 . . . . 61.399999999999999 111.433 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.5 123.74 37.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.942 0.401 . . . . 72.230000000000004 111.054 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.86 106.04 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.966 0.412 . . . . 73.019999999999996 111.913 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.91 -51.59 53.47 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.121 0.486 . . . . 71.140000000000001 110.754 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -160.37 164.24 32.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.057 -0.52 . . . . 65.209999999999994 110.833 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.28 140.45 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.049 0.452 . . . . 64.219999999999999 111.198 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -89.54 147.91 23.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.728 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.0 t -62.54 -20.7 64.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.864 0.364 . . . . 71.340000000000003 111.908 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.82 -22.83 62.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.336 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.87 -17.87 10.72 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.302 -0.408 . . . . 64.25 113.073 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -64.07 126.25 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.951 0.405 . . . . 73.540000000000006 111.621 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.05 124.48 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.998 0.428 . . . . 73.409999999999997 111.967 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -93.23 113.85 26.18 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.939 0.4 . . . . 73.319999999999993 110.662 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.75 164.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.24 0.459 . . . . 74.540000000000006 112.24 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.506 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 48.6 p -117.17 140.61 49.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.462 -0.335 . . . . 72.349999999999994 111.715 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 59.8 mt-10 -138.65 159.06 43.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.05 0.54 . . . . 75.25 110.991 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.9 tpp -82.5 136.29 34.92 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.347 -0.221 . . . . 63.100000000000001 110.569 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.556 0.576 . . . . 71.0 112.556 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.94 164.95 37.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.395 0.617 . . . . 74.340000000000003 112.23 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.06 116.03 4.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.552 -0.749 . . . . 63.520000000000003 111.578 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.6 30.6 26.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 43.210000000000001 112.558 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.08 -170.63 36.46 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.46 -0.4 . . . . 54.299999999999997 113.788 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.6 -178.59 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.978 2.452 . . . . 72.129999999999995 113.341 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.66 -19.51 65.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.07 0.462 . . . . 73.450000000000003 111.421 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.8 m -72.28 107.24 4.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.265 -0.425 . . . . 74.019999999999996 111.331 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.489 HG21 ' HD3' ' A' ' 64' ' ' LYS . 76.6 t -89.82 127.7 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.861 0.362 . . . . 65.349999999999994 111.535 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.5 t -68.24 174.61 3.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.086 0.469 . . . . 73.040000000000006 111.884 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 27.3 mt-10 -144.6 158.07 43.93 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.919 0.39 . . . . 65.340000000000003 111.755 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.2 ptp180 -157.73 173.15 17.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.477 -0.329 . . . . 63.329999999999998 111.118 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 72.8 m -127.73 123.51 35.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.963 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -94.73 137.42 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.876 0.37 . . . . 63.539999999999999 111.389 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -59.84 137.9 57.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.997 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.07 -42.62 60.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.545 0.572 . . . . 72.219999999999999 112.545 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.29 -27.99 61.15 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.316 -0.402 . . . . 37.659999999999997 113.637 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.82 -27.79 14.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.387 -0.478 . . . . 74.430000000000007 111.39 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.64 -29.02 61.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.087 0.773 . . . . 64.439999999999998 113.087 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t -78.19 -6.24 54.23 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.0 0.37 . . . . 73.400000000000006 112.0 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.5 m -85.88 -15.04 43.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.773 0.32 . . . . 72.349999999999994 111.797 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -93.69 144.92 24.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.053 0.454 . . . . 73.030000000000001 112.21 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -93.88 116.41 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.152 -0.476 . . . . 54.32 110.359 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 20.9 m-85 -95.49 122.91 38.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.933 0.397 . . . . 60.350000000000001 111.748 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.63 123.38 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.388 -0.369 . . . . 74.420000000000002 110.604 175.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.34 136.94 52.43 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.516 0.327 . . . . 63.439999999999998 110.547 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.432 HD21 HG23 ' A' ' 69' ' ' ILE . 74.4 mt -97.92 102.94 14.83 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.348 0.499 . . . . 51.149999999999999 112.348 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.214 0.531 . . . . 73.420000000000002 110.813 173.264 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.547 0.213 . . . . 73.200000000000003 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 2' ' ' LYS . 9.5 mtpm? -71.66 93.83 1.29 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.253 0.549 . . . . 73.219999999999999 110.204 175.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -124.46 124.52 42.49 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.288 -0.415 . . . . 75.030000000000001 111.092 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 4' ' ' LEU . 2.9 mm? -80.87 84.96 6.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.318 0.58 . . . . 73.140000000000001 110.81 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -102.06 94.79 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 115.869 -0.605 . . . . 63.350000000000001 111.098 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.5 m -133.83 97.16 3.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.49 -0.323 . . . . 73.329999999999998 110.871 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.13 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.869 0.322 . . . . 74.439999999999998 111.869 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -175.12 163.6 3.19 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.236 -0.438 . . . . 75.319999999999993 110.951 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -133.35 168.7 18.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.083 0.468 . . . . 63.240000000000002 111.988 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 10' ' ' LEU . 1.7 mp -103.93 119.64 39.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.02 -0.536 . . . . 65.200000000000003 111.56 -173.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -78.17 121.46 24.37 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.495 -0.321 . . . . 73.010000000000005 111.694 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.22 -174.35 2.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.495 -0.32 . . . . 74.219999999999999 111.393 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.61 128.09 0.97 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.154 -0.546 . . . . 65.209999999999994 113.156 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -98.48 108.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.581 -0.364 . . . . 73.450000000000003 111.516 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.41 74.8 0.57 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.311 -0.471 . . . . 51.350000000000001 113.409 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.68 96.69 10.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.539 -0.389 . . . . 75.010000000000005 110.977 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.97 97.4 7.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.176 0.512 . . . . 75.129999999999995 112.348 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 pt -76.28 142.9 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.12 -0.491 . . . . 74.510000000000005 111.405 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.79 168.79 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.787 0.327 . . . . 74.319999999999993 111.374 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.49 -18.13 3.47 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.89 -0.671 . . . . 37.920000000000002 113.82 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.53 117.45 16.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.333 0.587 . . . . 71.010000000000005 111.638 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.6 123.53 35.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.216 -0.447 . . . . 73.150000000000006 111.426 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -141.38 164.57 29.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.972 0.415 . . . . 44.229999999999997 111.582 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.04 123.5 2.72 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.289 -0.482 . . . . 64.040000000000006 113.435 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -132.56 138.72 47.56 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.529 -0.395 . . . . 73.409999999999997 111.022 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.5 122.03 23.25 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.011 0.434 . . . . 74.239999999999995 111.642 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.27 124.46 3.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.048 0.451 . . . . 75.430000000000007 112.094 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.29 46.15 1.4 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.049 -0.523 . . . . 73.150000000000006 110.826 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.42 29.58 15.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.394 0.616 . . . . 72.109999999999999 111.042 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 19.56 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.883 0.697 . . . . 53.530000000000001 112.883 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -91.23 23.52 3.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.176 0.512 . . . . 74.540000000000006 110.677 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -75.37 159.06 31.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.421 0.629 . . . . 72.109999999999999 112.482 -176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 t -150.2 115.82 5.53 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.661 -0.7 . . . . 74.099999999999994 110.419 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -155.62 116.28 2.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.501 -0.318 . . . . 74.430000000000007 111.848 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.11 105.22 1.79 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.283 1.988 . . . . 73.310000000000002 112.131 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -60.58 128.33 36.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 74.230000000000004 111.342 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -53.36 140.88 25.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.97 0.414 . . . . 64.340000000000003 111.628 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -67.83 86.88 0.23 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.443 0.639 . . . . 72.549999999999997 111.858 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -75.73 114.24 14.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.697 -0.683 . . . . 65.230000000000004 111.204 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 p -68.97 -28.92 67.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.197 0.522 . . . . 74.019999999999996 110.976 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -152.04 137.77 17.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.969 -0.559 . . . . 74.400000000000006 111.523 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -96.72 8.87 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.14 0.495 . . . . 74.129999999999995 111.195 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -83.32 13.16 4.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 75.25 112.01 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 t -148.42 163.35 37.4 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.296 0.238 . . . . 74.319999999999993 111.16 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -153.86 -52.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.913 0.387 . . . . 65.420000000000002 111.932 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.67 88.16 1.7 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.114 -0.565 . . . . 71.349999999999994 112.792 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -84.54 116.46 23.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.604 -0.351 . . . . 73.239999999999995 110.928 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.428 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 69.9 m -145.33 142.02 29.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 73.420000000000002 112.651 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 51' ' ' LEU . . . -167.24 125.8 1.33 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.581 -0.736 . . . . 63.240000000000002 109.855 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -60.07 94.59 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.135 0.493 . . . . 60.32 111.725 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 49' ' ' ALA . 85.6 mt -95.94 20.86 9.39 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.775 -0.648 . . . . 71.109999999999999 111.242 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.89 -179.68 3.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.576 0.227 . . . . 73.420000000000002 111.111 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t -127.54 151.17 49.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 112.257 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 112.76 4.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.928 -0.578 . . . . 74.030000000000001 111.804 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.55 7.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.345 -0.455 . . . . 55.039999999999999 112.703 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -115.5 144.47 43.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.123 0.487 . . . . 73.200000000000003 111.584 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.428 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.1 p -58.03 -46.24 85.64 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.311 -0.404 . . . . 54.109999999999999 111.541 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -51.52 -45.35 62.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.093 0.405 . . . . 75.019999999999996 112.093 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -54.79 -48.66 72.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.96 -0.564 . . . . 75.549999999999997 111.744 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -68.79 -49.84 55.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 112.096 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 57' ' ' CYS . 58.0 t -58.18 -40.5 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.57 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' A' ' 48' ' ' SER . 92.4 t80 -55.97 -41.76 75.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 111.553 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.02 -43.0 68.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.372 -0.376 . . . . 71.019999999999996 111.447 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -61.32 -34.48 75.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.018 0.377 . . . . 70.25 112.018 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -86.22 6.55 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-O 121.358 0.599 . . . . 72.25 111.072 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.37 18.48 60.93 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 113.833 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 16.95 67.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.16 -0.543 . . . . 64.120000000000005 113.949 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -78.88 7.08 7.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 117.455 0.628 . . . . 72.430000000000007 112.463 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.29 -37.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.528 0.566 . . . . 72.400000000000006 112.528 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.17 102.56 2.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.967 -0.635 . . . . 71.109999999999999 112.013 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -61.34 -18.06 56.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.742 0.645 . . . . 74.310000000000002 112.742 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 t -57.24 -15.94 7.15 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.701 0.63 . . . . 74.25 112.701 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -57.97 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.255 0.55 . . . . 74.299999999999997 110.825 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.25 -103.21 0.56 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.805 -0.634 . . . . 63.350000000000001 114.613 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -57.37 134.91 56.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.112 0.412 . . . . 65.209999999999994 112.112 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.62 -11.78 47.54 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 51.200000000000003 113.04 -173.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.37 -10.97 36.21 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.957 174.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -93.35 -27.49 16.74 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.097 0.406 . . . . 75.120000000000005 112.097 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.468 ' HB2' ' NE2' ' A' ' 101' ' ' GLN . 11.9 m0 -41.34 -58.04 1.97 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.854 1.057 . . . . 74.530000000000001 113.854 -175.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.9 91.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.917 -0.49 . . . . 71.140000000000001 111.975 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -57.69 -51.81 68.01 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.168 0.509 . . . . 54.310000000000002 111.618 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.93 97.69 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.37 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.48 -57.02 11.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.953 0.406 . . . . 37.920000000000002 111.26 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 t -57.5 -44.41 84.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.082 0.468 . . . . 37.920000000000002 111.39 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 t -70.85 -21.21 62.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 112.225 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.79 -10.06 32.64 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.205 0.446 . . . . 42.030000000000001 112.205 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.65 8.73 29.96 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.919 -0.657 . . . . 70.530000000000001 113.827 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' HD2' ' HA ' ' A' ' 154' ' ' LEU . 71.3 m-85 -83.81 166.94 17.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.439 -0.447 . . . . 75.430000000000007 111.329 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 90.5 m -100.5 92.73 5.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.114 0.483 . . . . 62.039999999999999 111.923 -173.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.3 98.8 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 111.299 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -126.77 176.49 7.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.513 -0.312 . . . . 73.530000000000001 110.632 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -93.39 25.42 3.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.931 0.396 . . . . 62.520000000000003 111.275 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 t -81.89 108.14 10.44 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 111.458 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.5 19.11 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.04 2.494 . . . . 71.400000000000006 114.278 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -54.96 142.82 28.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 111.726 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.92 146.13 53.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.471 0.545 . . . . 71.140000000000001 112.471 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.98 10.09 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.17 -0.538 . . . . 73.430000000000007 113.031 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.4 p -136.62 169.08 18.29 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.5 -0.412 . . . . 73.310000000000002 111.167 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -110.14 134.6 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.626 -0.261 . . . . 71.140000000000001 110.302 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 111' ' ' ALA . 1.5 pt? -112.99 131.24 55.84 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.247 0.546 . . . . 72.409999999999997 111.443 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.468 ' NE2' ' HB2' ' A' ' 79' ' ' TRP . 36.0 tt0 -105.96 129.0 54.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.524 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -91.58 -37.82 12.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.773 0.656 . . . . 75.140000000000001 112.773 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 101' ' ' GLN . 26.3 p 60.58 10.35 2.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 113.128 0.788 . . . . 70.230000000000004 113.128 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.28 -67.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.147 0.795 . . . . 52.450000000000003 113.147 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.13 176.57 37.69 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.795 -0.717 . . . . 61.340000000000003 113.132 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.02 52.57 52.02 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.451 -0.404 . . . . 52.219999999999999 113.44 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 65.84 17.54 10.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.767 0.427 . . . . 74.120000000000005 112.113 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.69 -161.44 22.9 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.317 -0.468 . . . . 44.329999999999998 113.5 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -173.5 136.99 0.62 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.417 0.287 . . . . 71.299999999999997 110.92 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.9 151.52 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.33 -0.395 . . . . 51.340000000000003 111.408 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 100' ' ' LEU . . . -148.78 167.37 25.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.466 -0.333 . . . . 72.430000000000007 110.99 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -102.88 131.44 49.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.894 0.378 . . . . 70.450000000000003 111.202 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.462 ' HA ' HG11 ' A' ' 124' ' ' VAL . 60.9 t -81.89 112.29 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.297 -0.41 . . . . 74.450000000000003 111.539 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -80.13 -56.02 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.878 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.19 144.05 23.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.757 0.651 . . . . 63.310000000000002 112.757 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.47 136.25 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.745 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.663 ' N ' HD21 ' A' ' 117' ' ' ASN . 0.6 OUTLIER -98.17 147.33 24.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.399 -0.188 . . . . 51.420000000000002 110.925 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -57.71 -34.84 69.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.934 0.346 . . . . 65.109999999999999 111.934 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.59 -9.23 40.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.464 0.542 . . . . 64.209999999999994 112.464 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.56 0.41 46.47 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.367 -0.444 . . . . 74.230000000000004 113.757 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 m -77.53 142.07 39.26 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.747 0.308 . . . . 72.519999999999996 111.626 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.8 t -113.19 115.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 111.558 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.84 118.63 29.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.392 . . . . 63.119999999999997 111.326 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 113' ' ' VAL . 34.1 m -124.8 148.18 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.043 0.449 . . . . 62.409999999999997 111.924 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.0 m -102.89 116.04 31.78 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.068 0.461 . . . . 51.350000000000001 111.079 175.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.43 -168.24 1.29 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 111.246 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.0 ttm -144.48 114.41 7.33 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.948 0.404 . . . . 64.140000000000001 110.763 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -130.62 -79.35 0.54 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.384 -0.371 . . . . 63.329999999999998 111.122 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -152.28 116.67 5.0 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.198 0.444 . . . . 64.140000000000001 112.198 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 135' ' ' SER . 9.5 p30 171.96 151.23 0.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 71.230000000000004 110.213 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.46 -95.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.464 -0.398 . . . . 71.129999999999995 113.996 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.22 -169.53 14.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.626 -0.321 . . . . 74.099999999999994 112.968 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.88 0.36 5.1 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.962 2.441 . . . . 74.430000000000007 113.664 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -122.16 0.15 9.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.692 0.282 . . . . 70.400000000000006 111.42 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 130' ' ' ASN . 68.6 m -81.34 141.68 33.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.363 0.601 . . . . 64.510000000000005 111.799 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.91 146.16 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.941 -0.572 . . . . 73.209999999999994 112.27 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -118.42 117.49 29.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.317 -0.401 . . . . 64.299999999999997 109.972 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.95 156.35 18.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.206 0.527 . . . . 75.0 112.373 -172.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -152.1 130.85 12.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.466 . . . . 72.310000000000002 111.604 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 m -99.13 98.7 9.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.082 0.467 . . . . 71.310000000000002 110.209 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.72 134.76 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 112.231 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.8 m -67.99 148.59 50.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.598 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.87 -44.95 63.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.446 0.536 . . . . 53.32 112.446 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.75 76.56 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 73.519999999999996 113.017 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.97 -34.02 75.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.866 0.365 . . . . 70.430000000000007 111.557 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.82 66.79 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.174 0.511 . . . . 64.5 111.859 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 t -67.67 -3.64 9.72 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.403 0.52 . . . . 65.319999999999993 112.403 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -93.28 -0.3 56.78 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.965 0.412 . . . . 75.549999999999997 111.622 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -118.77 153.42 34.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.535 0.569 . . . . 75.409999999999997 112.535 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.2 m-80 -101.4 116.14 32.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.797 -0.638 . . . . 63.140000000000001 110.526 176.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -94.85 112.68 24.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.230000000000004 111.91 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -81.06 127.23 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.076 0.465 . . . . 53.149999999999999 111.345 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 62.0 m-70 -111.1 133.15 53.7 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.548 -0.538 . . . . 73.349999999999994 109.548 174.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 88' ' ' TYR . 48.0 mt -84.29 -15.71 45.71 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.248 0.462 . . . . 65.439999999999998 112.248 -171.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 122.99 0.516 . . . . 37.920000000000002 111.929 -175.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.414 0.524 . . . . 65.010000000000005 112.414 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.58 148.45 46.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.996 0.427 . . . . 71.409999999999997 112.06 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.57 101.14 13.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.163 -0.471 . . . . 74.239999999999995 111.396 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.34 18.58 9.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.3 0.572 . . . . 71.040000000000006 110.583 175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.78 122.43 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.762 -0.653 . . . . 73.420000000000002 111.253 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -135.91 91.05 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.909 0.385 . . . . 65.109999999999999 110.866 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.58 106.04 16.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.057 0.456 . . . . 70.439999999999998 111.55 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.4 t -156.79 178.69 10.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.961 0.41 . . . . 73.129999999999995 111.679 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -142.77 146.65 34.46 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.234 -0.439 . . . . 72.310000000000002 111.666 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.33 170.68 5.64 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.25 -0.432 . . . . 71.049999999999997 111.348 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.2 m -72.93 91.92 1.58 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.889 0.376 . . . . 74.5 110.862 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 83.89 1.41 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.297 0.57 . . . . 74.239999999999995 111.69 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.55 83.97 1.21 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.088 -0.577 . . . . 74.219999999999999 112.878 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -61.59 110.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.384 0.612 . . . . 72.030000000000001 111.041 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 67.23 3.19 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.202 -0.523 . . . . 60.119999999999997 113.32 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.42 26.64 4.23 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.843 0.354 . . . . 75.540000000000006 111.757 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.4 100.08 10.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.028 0.381 . . . . 71.219999999999999 112.028 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.92 125.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.439 -0.346 . . . . 71.510000000000005 110.561 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.73 130.63 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.450000000000003 111.586 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.03 110.12 0.73 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.507 -0.377 . . . . 75.209999999999994 112.856 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pp -95.89 171.66 8.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.069 0.461 . . . . 71.310000000000002 111.97 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.56 164.27 30.68 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.236 0.541 . . . . 74.430000000000007 112.189 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -114.31 136.45 52.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.105 -0.498 . . . . 75.200000000000003 110.589 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.24 133.78 7.17 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.721 -0.752 . . . . 75.450000000000003 113.625 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 50.09 85.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.19 0.596 . . . . 75.239999999999995 112.558 176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.39 100.67 9.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 111.423 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.78 147.86 13.72 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.231 -0.441 . . . . 43.310000000000002 111.63 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -152.32 158.08 42.24 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.96 0.409 . . . . 75.340000000000003 111.336 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.92 109.15 4.47 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 110.543 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.54 107.54 7.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.57 0.582 . . . . 62.399999999999999 112.57 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -76.16 86.75 3.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.225 0.536 . . . . 75.25 109.805 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -171.28 -179.82 2.76 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.852 -0.613 . . . . 71.439999999999998 111.19 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.3 p -64.44 131.24 46.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.266 -0.424 . . . . 65.25 110.064 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.38 145.95 85.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.647 -0.251 . . . . 73.049999999999997 111.512 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.09 95.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.819 2.346 . . . . 74.340000000000003 113.203 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 p -86.88 77.2 9.3 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.332 0.587 . . . . 73.030000000000001 111.284 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -78.05 107.67 10.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 110.393 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' NE2' ' H ' ' A' ' 38' ' ' GLN . 1.9 mp0 -50.21 -42.31 51.31 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.205 0.446 . . . . 71.120000000000005 112.205 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -105.62 97.01 6.9 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.752 0.311 . . . . 64.140000000000001 110.884 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.1 m -60.5 90.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.159 0.504 . . . . 61.210000000000001 111.674 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -162.05 178.15 9.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.312 -0.404 . . . . 71.230000000000004 111.148 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -173.27 3.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.864 0.364 . . . . 75.239999999999995 111.536 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.0 p -157.49 -177.69 6.78 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.917 0.389 . . . . 74.040000000000006 111.426 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -78.94 104.13 9.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.917 0.389 . . . . 73.299999999999997 111.237 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.0 p -87.0 119.13 26.88 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.008 0.433 . . . . 72.25 111.777 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.21 -104.07 1.49 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.312 -0.471 . . . . 63.149999999999999 113.097 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -121.26 173.63 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.259 0.552 . . . . 71.200000000000003 111.698 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 p -100.52 -39.68 7.81 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.002 -0.544 . . . . 74.310000000000002 111.329 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.69 165.58 23.4 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.393 -0.367 . . . . 75.019999999999996 111.665 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -66.63 111.19 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.247 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.61 -13.58 59.76 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.293 0.479 . . . . 64.340000000000003 112.293 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -86.08 179.2 7.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.067 0.46 . . . . 72.140000000000001 111.909 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.4 t -129.35 151.66 49.74 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 73.219999999999999 111.934 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.68 138.18 42.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 72.349999999999994 111.738 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.79 -28.51 13.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.283 -0.484 . . . . 71.549999999999997 112.753 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -80.3 136.73 36.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.269 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.412 ' O ' HG22 ' A' ' 61' ' ' VAL . 25.2 p -59.14 -41.28 87.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.073 171.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.5 p -52.57 -43.8 65.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.455 -0.793 . . . . 72.109999999999999 111.968 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -55.95 -52.31 64.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 112.022 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.63 -47.34 72.91 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.983 0.421 . . . . 72.010000000000005 111.702 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' CYS . 96.9 t -60.97 -34.52 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.555 -0.293 . . . . 71.450000000000003 111.706 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -54.69 -46.81 74.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 111.41 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 110.892 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 64' ' ' LYS . 29.3 mmmt -61.98 -31.73 72.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.155 -0.475 . . . . 63.509999999999998 112.202 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 154' ' ' LEU . 7.6 p -91.24 6.22 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.449 0.642 . . . . 55.350000000000001 111.164 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 10.26 72.04 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.299 -0.41 . . . . 64.120000000000005 113.959 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.14 15.75 72.43 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.002 -0.618 . . . . 64.200000000000003 114.032 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.411 ' HB2' HD12 ' A' ' 154' ' ' LEU . 40.2 m-80 -82.79 28.28 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.316 0.558 . . . . 72.120000000000005 111.99 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.76 161.78 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.131 0.491 . . . . 61.509999999999998 111.523 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.1 78.03 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.999 -0.619 . . . . 52.43 112.558 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -49.18 -28.18 4.24 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.571 0.582 . . . . 53.219999999999999 112.571 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -60.73 -18.03 52.08 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.873 0.694 . . . . 65.120000000000005 112.873 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -56.05 -32.95 64.53 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.942 0.401 . . . . 74.099999999999994 111.617 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.9 2.02 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.261 -0.427 . . . . 62.409999999999997 114.092 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.88 133.78 48.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 71.319999999999993 112.452 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.41 61.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.228 0.825 . . . . 65.230000000000004 113.228 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -67.05 -34.47 77.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.939 0.4 . . . . 73.409999999999997 112.047 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -71.26 -29.34 64.97 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.337 0.495 . . . . 60.130000000000003 112.337 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -43.38 -60.27 1.78 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.619 0.97 . . . . 73.310000000000002 113.619 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.43 86.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.45 0.537 . . . . 73.329999999999998 112.45 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 t -65.03 -55.02 21.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.941 0.401 . . . . 61.450000000000003 111.438 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.77 74.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.443 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . . . -57.32 -49.02 77.44 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.629 -0.259 . . . . 62.509999999999998 111.291 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.7 p -66.51 -29.55 69.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.029 0.442 . . . . 74.319999999999993 111.119 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -76.79 -31.36 56.95 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.128 -0.487 . . . . 73.140000000000001 111.798 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.46 -24.48 24.12 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.156 0.428 . . . . 71.239999999999995 112.156 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.82 4.31 19.23 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.048 -0.596 . . . . 51.109999999999999 113.881 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 18.4 m-85 -69.23 168.49 14.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.467 . . . . 74.340000000000003 111.288 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.6 m -101.19 97.94 8.41 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.07 0.396 . . . . 75.120000000000005 112.07 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.548 HG23 HG13 ' A' ' 152' ' ' ILE . 41.6 t -102.49 96.52 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.002 0.429 . . . . 73.150000000000006 111.316 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -122.66 172.31 8.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.891 0.377 . . . . 72.530000000000001 110.96 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -86.56 2.52 47.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.654 0.264 . . . . 71.530000000000001 111.305 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -62.8 113.75 10.1 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 116.52 -0.309 . . . . 72.420000000000002 110.761 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.27 8.16 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.643 2.229 . . . . 72.519999999999996 113.973 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.32 138.62 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.328 0.492 . . . . 72.540000000000006 112.328 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.08 156.98 4.93 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.718 0.636 . . . . 70.430000000000007 112.718 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.46 33.38 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.111 -0.566 . . . . 74.349999999999994 112.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.2 p -138.31 176.64 8.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 73.010000000000005 111.115 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.71 121.78 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.36 -0.382 . . . . 53.32 110.889 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD23 ' HB1' ' A' ' 111' ' ' ALA . 1.9 pt? -100.62 136.66 40.15 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.692 -0.63 . . . . 71.129999999999995 111.636 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -101.99 124.99 48.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.868 -0.605 . . . . 75.230000000000004 111.46 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 31.2 t -90.09 -22.4 21.81 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.246 0.461 . . . . 64.129999999999995 112.246 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 p 66.82 -59.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.23 1.012 . . . . 74.420000000000002 113.639 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.89 10.81 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.555 1.317 . . . . 70.519999999999996 114.555 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.63 43.02 3.19 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.726 -0.609 . . . . 71.349999999999994 113.391 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 -77.7 0.4 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.527 -0.368 . . . . 55.32 113.127 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -97.24 20.45 11.44 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.293 0.568 . . . . 74.030000000000001 110.316 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.02 171.88 44.69 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.881 -0.6 . . . . 73.510000000000005 111.834 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 58.4 t60 -157.59 135.47 10.76 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.345 -0.503 . . . . 75.239999999999995 110.74 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.73 142.1 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.073 0.463 . . . . 52.229999999999997 111.389 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HB1' HD23 ' A' ' 100' ' ' LEU . . . -139.44 156.69 46.79 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.243 -0.435 . . . . 74.439999999999998 110.837 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.71 133.14 38.7 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.832 0.349 . . . . 74.209999999999994 111.279 -176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.45 116.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.858 0.361 . . . . 44.439999999999998 111.836 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.72 -54.96 3.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.957 0.408 . . . . 73.349999999999994 112.01 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.76 145.2 30.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.265 0.555 . . . . 72.239999999999995 112.004 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.61 133.74 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.03 -0.532 . . . . 64.109999999999999 111.464 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 121' ' ' SER . 33.9 m-80 -76.87 152.25 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.406 -0.361 . . . . 71.530000000000001 110.556 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.1 m -47.22 -40.73 16.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.337 0.866 . . . . 72.310000000000002 113.337 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.55 -23.39 61.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.37 0.507 . . . . 70.549999999999997 112.37 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.44 -0.94 9.54 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.163 -0.541 . . . . 63.420000000000002 113.38 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 19.2 m -65.41 118.78 9.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.168 0.509 . . . . 72.239999999999995 110.952 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.412 HG21 ' OH ' ' A' ' 151' ' ' TYR . 40.4 t -96.35 121.97 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.805 -0.634 . . . . 51.509999999999998 112.392 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -96.35 105.25 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.342 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 m -97.08 163.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.423 0.527 . . . . 73.109999999999999 112.423 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -115.51 119.19 35.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.922 -0.581 . . . . 64.140000000000001 111.028 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.8 177.2 6.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.024 0.44 . . . . 63.549999999999997 111.512 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.5 ttm -138.23 149.72 46.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.497 -0.32 . . . . 63.399999999999999 110.45 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 74.39 -27.67 0.19 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.352 0.661 . . . . 72.439999999999998 112.172 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.73 -175.42 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.933 0.493 . . . . 75.150000000000006 110.154 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -44.96 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.173 0.511 . . . . 73.319999999999993 112.237 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 165.16 -52.36 0.27 Allowed Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.848 -0.614 . . . . 37.579999999999998 112.818 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.83 175.45 14.65 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.979 -0.629 . . . . 61.140000000000001 113.925 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 135' ' ' SER . 38.9 Cg_endo -65.58 128.69 20.65 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.982 2.455 . . . . 72.239999999999995 112.411 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.84 -23.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.758 0.651 . . . . 73.239999999999995 112.758 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 133' ' ' PRO . 67.2 m -69.46 141.28 54.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.293 0.568 . . . . 61.32 111.438 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.56 122.09 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.864 -0.607 . . . . 74.430000000000007 112.045 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.0 t -91.92 151.87 20.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.794 -0.639 . . . . 71.099999999999994 110.634 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -125.69 103.76 8.0 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.191 0.519 . . . . 70.5 111.695 -174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.06 105.07 16.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.168 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 88.2 m -79.17 104.14 9.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.041 0.448 . . . . 71.120000000000005 110.65 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.401 HD13 ' CE2' ' A' ' 149' ' ' TYR . 73.2 mt -92.57 112.44 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.105 -0.498 . . . . 72.200000000000003 111.599 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.4 m -61.07 153.26 25.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.24 0.459 . . . . 75.109999999999999 112.24 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.79 -48.65 41.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.876 0.695 . . . . 74.430000000000007 112.876 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.14 -38.05 88.35 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.175 -0.536 . . . . 52.509999999999998 113.316 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -72.9 -37.35 67.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.963 0.411 . . . . 65.310000000000002 111.669 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.69 -23.91 67.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.911 0.708 . . . . 63.119999999999997 112.911 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 m -54.87 -17.29 3.42 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.845 1.054 . . . . 71.439999999999998 113.845 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.4 t -99.11 -13.94 19.6 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.155 0.798 . . . . 75.25 113.155 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.401 ' CE2' HD13 ' A' ' 141' ' ' ILE . 31.4 m-85 -88.7 143.74 26.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.564 0.697 . . . . 75.239999999999995 112.866 -173.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -100.09 116.35 31.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.613 -0.721 . . . . 72.040000000000006 111.071 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.412 ' OH ' HG21 ' A' ' 122' ' ' VAL . 64.0 m-85 -98.26 118.18 34.33 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.002 0.371 . . . . 65.329999999999998 112.002 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.548 HG13 HG23 ' A' ' 90' ' ' VAL . 3.7 mp -84.66 131.99 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.432 -0.349 . . . . 74.150000000000006 110.595 174.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -121.58 148.65 44.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.703 0.401 . . . . 70.099999999999994 110.056 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 65' ' ' VAL . 50.4 mt -93.17 132.08 37.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.406 0.622 . . . . 73.019999999999996 112.598 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 CA--C 1.545 0.78 0 CA-C-N 115.912 -0.585 . . . . 64.519999999999996 112.174 177.129 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.969 0.414 . . . . 72.109999999999999 111.209 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -145.25 134.96 23.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.848 0.356 . . . . 72.420000000000002 110.662 -178.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -114.54 98.99 7.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.309 0.576 . . . . 73.040000000000006 112.4 -174.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tt -104.59 101.0 10.66 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.112 -0.699 . . . . 73.040000000000006 109.112 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.08 115.01 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.29 0.567 . . . . 74.340000000000003 111.594 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -81.62 50.07 1.43 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.324 0.583 . . . . 72.239999999999995 111.483 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.87 67.02 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 62.329999999999998 111.739 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -105.23 93.56 4.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.044 0.449 . . . . 63.240000000000002 110.616 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -93.1 139.63 30.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.249 -0.432 . . . . 72.200000000000003 110.833 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.0 mp -92.61 38.11 1.01 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 111.808 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 m -66.26 94.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.459 -0.337 . . . . 62.240000000000002 111.59 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.48 125.24 0.5 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.386 -0.37 . . . . 72.310000000000002 111.397 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.5 101.87 0.17 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 113.035 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 14' ' ' ILE . 2.5 mp -86.6 123.21 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.847 0.356 . . . . 73.209999999999994 110.888 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.62 18.92 7.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.392 -0.432 . . . . 64.230000000000004 112.839 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.76 102.69 10.94 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.993 0.368 . . . . 63.530000000000001 111.993 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.58 90.69 0.95 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.986 0.422 . . . . 55.539999999999999 111.301 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -92.56 156.06 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 60.240000000000002 111.743 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.96 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.932 0.396 . . . . 72.340000000000003 111.107 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.45 93.17 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.267 -0.492 . . . . 52.200000000000003 112.969 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.76 82.9 2.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.215 0.531 . . . . 73.25 110.691 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -83.26 169.37 15.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.108 -0.497 . . . . 72.430000000000007 111.918 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.94 176.83 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.897 0.38 . . . . 74.010000000000005 111.9 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.03 78.97 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.899 -0.667 . . . . 64.430000000000007 113.321 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -94.27 95.38 8.88 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.481 -0.423 . . . . 65.010000000000005 110.561 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.66 113.73 13.94 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.233 0.457 . . . . 73.230000000000004 112.233 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.67 92.09 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.714 0.293 . . . . 62.409999999999997 111.781 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.75 138.92 39.01 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.87 0.366 . . . . 73.140000000000001 111.311 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 0.92 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.894 0.378 . . . . 62.25 111.859 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.84 88.75 2.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.995 0.426 . . . . 75.200000000000003 111.144 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -96.8 123.95 40.64 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.233 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -117.17 123.27 46.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.846 0.355 . . . . 73.129999999999995 111.477 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.0 m -157.15 114.27 3.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.751 0.31 . . . . 64.239999999999995 111.558 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 76.2 mt-30 -115.56 132.43 23.13 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 120.637 0.256 . . . . 63.140000000000001 111.583 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 17.0 Cg_exo -68.01 125.35 12.95 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.705 2.27 . . . . 60.509999999999998 111.847 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.2 p -51.53 -68.05 0.2 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.688 0.996 . . . . 65.430000000000007 113.688 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.7 125.91 29.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.247 0.546 . . . . 74.140000000000001 112.351 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.78 106.28 16.74 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.043 -0.526 . . . . 74.109999999999999 110.757 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m -102.56 32.12 3.76 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.843 0.312 . . . . 65.319999999999993 111.843 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.8 m -127.09 154.97 44.03 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.701 0.286 . . . . 72.329999999999998 111.37 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -56.7 126.43 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.805 0.442 . . . . 72.120000000000005 111.974 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -92.37 41.64 1.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.974 0.361 . . . . 72.219999999999999 111.974 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.3 m -76.88 89.66 3.48 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.417 0.627 . . . . 54.100000000000001 111.012 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -80.88 74.25 7.87 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.546 0.573 . . . . 61.310000000000002 112.546 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.9 p -134.51 8.83 3.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.508 0.559 . . . . 72.329999999999998 112.508 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.36 146.63 30.54 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.204 -0.522 . . . . 64.239999999999995 113.288 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.7 p -82.85 79.45 9.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.394 -0.474 . . . . 54.109999999999999 111.772 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -90.53 84.68 5.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.8 0.334 . . . . 75.200000000000003 110.45 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.02 137.71 8.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.174 0.512 . . . . 38.020000000000003 112.06 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -81.58 95.82 7.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.195 -0.457 . . . . 65.439999999999998 110.815 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.41 31.29 1.34 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.26 0.467 . . . . 74.109999999999999 112.26 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB3' ' OE1' ' A' ' 56' ' ' GLN . 20.0 m-85 -128.33 176.45 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.274 -0.266 . . . . 65.319999999999993 111.5 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.6 t -111.43 19.13 18.51 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.975 0.732 . . . . 73.420000000000002 112.975 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.99 152.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.175 0.512 . . . . 42.539999999999999 111.928 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.494 ' HA2' ' SD ' ' A' ' 127' ' ' MET . . . 82.82 -33.66 2.83 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.819 -0.705 . . . . 38.020000000000003 112.827 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.508 ' OE1' ' HB3' ' A' ' 52' ' ' TYR . 95.5 mt-30 -62.5 139.83 58.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.382 0.273 . . . . 65.319999999999993 110.96 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.493 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.0 p -54.03 -45.88 71.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.072 0.463 . . . . 73.239999999999995 110.967 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.3 p -53.19 -43.47 67.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 112.022 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.411 ' HD1' ' HB2' ' A' ' 52' ' ' TYR . 89.1 t90 -56.94 -48.59 77.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.22 0.533 . . . . 73.510000000000005 111.188 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.448 ' HB2' ' HE1' ' A' ' 127' ' ' MET . 65.5 t80 -63.66 -45.17 91.37 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.903 -0.59 . . . . 64.019999999999996 111.629 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 57' ' ' CYS . 64.3 t -60.46 -43.25 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.797 0.332 . . . . 71.299999999999997 111.415 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -55.04 -38.71 68.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.268 -0.423 . . . . 71.299999999999997 111.527 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.85 -48.81 34.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.834 0.35 . . . . 75.129999999999995 111.366 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -58.25 -36.52 73.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.362 0.505 . . . . 72.400000000000006 112.362 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 154' ' ' LEU . 9.6 p -80.8 11.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.415 0.626 . . . . 72.120000000000005 111.42 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.13 19.44 66.04 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.294 -0.412 . . . . 73.420000000000002 113.581 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.53 24.14 61.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.26 -0.495 . . . . 71.140000000000001 113.716 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -86.8 9.94 17.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.301 -0.529 . . . . 72.430000000000007 111.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.82 148.85 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.979 0.419 . . . . 71.319999999999993 111.428 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.97 84.95 0.16 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 53.5 112.933 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.1 p -51.68 -21.12 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.447 0.536 . . . . 51.5 112.447 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.1 t -66.62 -2.13 4.5 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.787 0.662 . . . . 53.32 112.787 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -63.53 -22.83 67.11 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.07 0.396 . . . . 74.420000000000002 112.07 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.42 -131.73 10.87 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.173 -0.537 . . . . 70.049999999999997 113.729 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.82 154.98 40.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.415 0.626 . . . . 62.399999999999999 111.972 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB2' HG11 ' A' ' 110' ' ' VAL . . . -72.37 31.03 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 113.965 1.098 . . . . 52.310000000000002 113.965 -171.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -111.61 -18.25 12.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.249 0.547 . . . . 74.040000000000006 110.287 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.64 -0.17 27.85 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.935 -0.575 . . . . 60.450000000000003 112.067 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -66.96 -58.44 4.96 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.093 -0.379 . . . . 71.129999999999995 111.953 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 152' ' ' ILE . . . -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 111.884 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.7 t -58.71 -51.37 70.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.945 0.402 . . . . 51.049999999999997 111.264 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.31 82.78 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.432 -0.349 . . . . 61.030000000000001 111.443 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -55.67 -52.88 62.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 74.400000000000006 111.273 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -62.78 -32.35 73.5 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.801 0.334 . . . . 65.109999999999999 111.602 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.9 t -76.48 -33.09 58.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.119 0.415 . . . . 74.510000000000005 112.119 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.88 -51.43 8.59 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.115 0.413 . . . . 72.129999999999995 112.115 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.29 24.7 0.08 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.831 -0.7 . . . . 63.109999999999999 113.818 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.504 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 28.5 m-85 -90.89 178.82 5.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.224 0.535 . . . . 75.430000000000007 111.293 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.525 HG22 ' OD1' ' A' ' 91' ' ' ASN . 84.2 m -109.26 89.6 3.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.055 -0.52 . . . . 70.329999999999998 111.051 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.86 111.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.93 0.395 . . . . 63.32 111.648 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' A' ' 89' ' ' THR . 6.0 m120 -135.61 177.14 8.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.99 0.424 . . . . 73.219999999999999 110.74 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.7 -0.05 57.29 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 110.815 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.5 m -67.86 114.24 19.16 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.195 -0.457 . . . . 73.329999999999998 110.802 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -85.75 12.35 3.07 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.074 2.516 . . . . 65.239999999999995 114.943 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.54 145.31 33.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.963 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.14 157.49 2.58 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.725 -0.67 . . . . 73.109999999999999 112.656 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.04 38.66 9.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.963 -0.637 . . . . 72.200000000000003 112.187 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.5 p -152.55 173.19 15.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.206 0.527 . . . . 51.420000000000002 111.79 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.16 124.38 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.636 -0.711 . . . . 72.129999999999995 110.786 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 1.6 pt? -91.81 137.38 32.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.932 -0.48 . . . . 52.229999999999997 111.244 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.402 ' HB3' ' OD1' ' A' ' 150' ' ' ASN . 27.3 tt0 -106.52 128.79 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.479 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 12.5 t -80.09 -56.87 3.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.979 0.733 . . . . 73.400000000000006 112.979 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 p 68.16 -53.46 0.53 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.221 1.008 . . . . 60.409999999999997 112.565 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.01 -28.91 26.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.973 0.731 . . . . 71.040000000000006 112.973 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.17 -2.27 13.17 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 114.413 0.525 . . . . 74.519999999999996 114.413 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.44 -65.63 3.82 Favored Glycine 0 CA--C 1.525 0.675 0 O-C-N 122.199 -0.589 . . . . 65.010000000000005 112.914 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.8 -0.4 13.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.994 0.426 . . . . 75.219999999999999 110.914 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.93 177.19 35.57 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.195 -0.526 . . . . 72.010000000000005 112.159 -170.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 19.6 t60 -175.0 138.32 0.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.748 0.309 . . . . 72.209999999999994 110.782 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 76' ' ' ALA . 16.7 m -143.47 146.64 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 111.185 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.82 149.88 30.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.002 -0.545 . . . . 65.439999999999998 110.902 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -87.31 126.35 34.79 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.38 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.44 111.7 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.059 0.392 . . . . 74.409999999999997 112.059 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.04 -44.98 36.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.944 0.402 . . . . 75.329999999999998 111.648 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.5 164.03 29.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 111.946 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.33 108.8 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.899 -0.591 . . . . 75.120000000000005 110.307 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.99 157.47 33.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.09 0.472 . . . . 63.219999999999999 111.959 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.8 m -61.29 -12.82 14.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.449 0.537 . . . . 70.439999999999998 112.449 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.97 -6.48 52.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.887 0.375 . . . . 63.240000000000002 111.705 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.14 -16.5 59.5 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.402 -0.428 . . . . 75.329999999999998 112.514 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -66.51 131.9 47.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.95 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.72 124.82 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.56 . . . . 72.010000000000005 111.475 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.89 111.43 23.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.928 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.54 153.02 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.258 0.466 . . . . 74.129999999999995 112.258 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -101.13 121.74 42.37 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.195 0.521 . . . . 72.430000000000007 111.437 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -127.68 124.16 37.24 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.896 -0.593 . . . . 72.219999999999999 111.329 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.494 ' SD ' ' HA2' ' A' ' 55' ' ' GLY . 44.5 ttm -65.82 112.41 3.73 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.943 -0.473 . . . . 72.129999999999995 110.457 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -138.24 -40.19 0.53 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.995 0.426 . . . . 64.319999999999993 111.765 -172.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.23 161.01 31.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.965 0.412 . . . . 73.0 111.579 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.87 116.79 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.442 -0.345 . . . . 73.25 111.034 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.85 -57.12 0.06 OUTLIER Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.831 -0.699 . . . . 75.329999999999998 113.086 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 164.56 -153.39 23.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.726 -0.75 . . . . 75.230000000000004 113.251 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.12 -21.31 21.6 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.039 2.493 . . . . 72.299999999999997 113.99 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.0 26.86 6.46 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.968 0.729 . . . . 72.299999999999997 112.968 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -86.74 72.36 10.19 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.162 0.982 . . . . 74.200000000000003 109.86 170.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 137' ' ' SER . 38.3 t -106.57 163.17 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.994 -1.003 . . . . 74.209999999999994 112.261 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.485 ' N ' HG11 ' A' ' 136' ' ' VAL . 88.5 p -122.38 140.43 52.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.833 -0.621 . . . . 74.329999999999998 110.288 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -96.14 103.88 15.8 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 74.530000000000001 110.161 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -103.57 105.8 16.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 111.626 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.2 m -87.71 104.93 17.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.794 0.33 . . . . 75.299999999999997 111.2 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.4 mt -93.38 140.28 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 122.494 0.317 . . . . 75.530000000000001 111.633 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.0 m -64.12 146.8 53.6 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.645 -0.252 . . . . 75.040000000000006 111.317 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.58 64.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.66 0.615 . . . . 74.430000000000007 112.66 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.61 -34.95 65.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.518 -0.372 . . . . 60.340000000000003 113.876 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.55 -35.29 17.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.964 0.412 . . . . 75.209999999999994 111.361 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.95 80.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.435 -0.348 . . . . 65.310000000000002 111.673 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.5 p -67.14 -8.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.863 0.363 . . . . 74.510000000000005 111.888 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.1 t -78.8 -11.82 60.0 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.093 0.473 . . . . 52.310000000000002 110.805 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 34.3 m-85 -106.16 135.11 48.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.054 -0.521 . . . . 73.129999999999995 110.316 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 101' ' ' GLN . 4.2 p-10 -82.11 129.69 34.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.995 0.426 . . . . 63.240000000000002 111.89 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -100.05 123.76 44.65 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.61 0.596 . . . . 73.030000000000001 112.61 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD11 ' HB1' ' A' ' 80' ' ' ALA . 3.6 mp -86.5 123.95 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.135 -0.484 . . . . 72.120000000000005 110.576 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.2 149.64 35.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.547 0.339 . . . . 74.239999999999995 110.314 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.513 HD11 HG22 ' A' ' 65' ' ' VAL . 24.7 mt -92.47 128.27 38.26 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.165 0.507 . . . . 74.140000000000001 111.427 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 111.834 -178.446 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 112.279 0.474 . . . . 74.420000000000002 112.279 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 56.17 83.63 0.09 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.307 0.575 . . . . 60.030000000000001 111.434 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -130.76 123.76 29.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.647 -0.706 . . . . 70.310000000000002 110.369 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -126.1 142.13 51.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.297 0.57 . . . . 70.310000000000002 112.173 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.41 -42.25 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 111.05 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.2 m 73.19 -55.01 0.69 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.269 0.627 . . . . 51.229999999999997 112.589 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.27 94.4 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.011 0.434 . . . . 72.430000000000007 111.368 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.5 p -87.85 124.51 33.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.007 0.432 . . . . 71.400000000000006 111.805 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 m -62.23 102.86 0.33 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.166 0.508 . . . . 61.32 111.457 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.88 174.86 6.74 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 111.956 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.4 m -136.4 128.22 29.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.565 -0.289 . . . . 63.240000000000002 111.41 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.49 143.41 32.55 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.934 0.397 . . . . 62.310000000000002 111.405 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.06 -109.6 0.41 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.169 -0.539 . . . . 74.129999999999995 113.027 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 pt 42.82 25.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 113.992 1.108 . . . . 60.25 113.992 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.82 98.23 1.97 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.069 -0.586 . . . . 72.450000000000003 112.86 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.29 135.86 8.22 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.591 -0.358 . . . . 75.420000000000002 111.818 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.19 147.91 13.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 72.340000000000003 111.937 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 pt -133.92 150.15 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.879 0.371 . . . . 72.439999999999998 111.699 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.27 163.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.109 0.48 . . . . 75.299999999999997 111.984 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.08 151.8 19.96 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 116.083 -0.508 . . . . 71.040000000000006 112.4 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.65 119.53 38.99 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.203 -0.586 . . . . 71.329999999999998 111.968 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.61 155.64 21.05 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 112.051 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -148.67 149.6 31.76 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.2 -0.455 . . . . 74.0 111.227 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.07 -132.97 1.42 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.257 -0.497 . . . . 38.380000000000003 112.844 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -163.26 -175.21 4.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.759 0.314 . . . . 63.200000000000003 111.436 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.68 -90.44 0.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 111.708 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.72 62.92 1.13 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.766 0.793 . . . . 54.409999999999997 109.998 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.14 9.12 2.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.342 -0.845 . . . . 75.150000000000006 112.817 -171.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 123.37 22.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.797 0.332 . . . . 73.540000000000006 111.022 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 92.72 2.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.134 0.492 . . . . 72.099999999999994 111.837 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.11 83.03 7.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.594 0.711 . . . . 74.209999999999994 111.517 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -86.03 3.67 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.528 -0.76 . . . . 51.039999999999999 110.784 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -95.51 156.48 16.31 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.08 0.467 . . . . 74.310000000000002 112.144 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.63 100.15 0.96 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.987 -0.551 . . . . 70.430000000000007 110.632 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.92 105.72 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.469 2.113 . . . . 43.149999999999999 113.063 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 t -86.74 -8.29 57.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.908 0.385 . . . . 70.409999999999997 111.478 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -70.72 141.46 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 70.239999999999995 111.501 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.04 -1.83 38.69 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.321 0.489 . . . . 63.450000000000003 112.321 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.6 p -68.36 90.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.029 0.442 . . . . 74.109999999999999 111.136 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.5 m 61.65 84.24 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.826 -0.625 . . . . 71.219999999999999 111.853 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 p -92.23 126.81 37.46 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.253 -0.431 . . . . 64.200000000000003 111.694 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.05 -48.8 69.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.726 0.298 . . . . 73.150000000000006 111.509 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.3 t -70.19 85.76 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.95 0.405 . . . . 72.209999999999994 111.077 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -90.69 121.26 32.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.324 -0.398 . . . . 74.019999999999996 110.972 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 98.9 p -66.44 140.46 58.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.999 0.428 . . . . 74.5 111.797 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.67 61.11 3.67 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.035 -0.603 . . . . 41.210000000000001 112.802 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -78.93 97.14 5.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.961 0.41 . . . . 71.099999999999994 110.746 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.8 t -108.0 110.18 21.83 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.113 0.482 . . . . 55.119999999999997 111.612 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.84 135.46 16.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.156 -0.475 . . . . 53.32 110.668 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -71.98 98.82 2.13 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.102 0.477 . . . . 54.25 110.603 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.89 18.74 1.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.619 0.599 . . . . 74.310000000000002 112.619 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.21 -174.72 2.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.268 0.556 . . . . 75.109999999999999 111.292 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -105.41 143.27 33.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.216 0.531 . . . . 54.049999999999997 112.148 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 140.67 45.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.986 -0.552 . . . . 63.399999999999999 112.062 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.54 -18.86 43.58 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.243 -0.503 . . . . 71.430000000000007 113.257 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.11 161.15 14.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.884 0.373 . . . . 75.430000000000007 111.754 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.438 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 59.6 m -63.22 -43.35 98.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.003 0.43 . . . . 73.219999999999999 111.878 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.3 p -61.1 -25.51 67.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.573 0.583 . . . . 75.219999999999999 112.573 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.45 -63.88 1.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 38.9 p90 -66.52 -29.12 69.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.064 0.394 . . . . 74.209999999999994 112.064 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 57' ' ' CYS . 59.2 t -62.12 -45.05 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.95 0.405 . . . . 54.109999999999999 110.874 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -56.4 -34.1 66.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 111.086 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.35 -46.43 22.86 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.207 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 136' ' ' VAL . 28.9 mmmt -57.74 -32.64 67.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.079 0.4 . . . . 72.329999999999998 112.079 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 65' ' ' VAL . 8.0 p -91.52 13.18 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.3 0.571 . . . . 71.310000000000002 111.455 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.98 22.67 58.14 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 113.936 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.86 22.21 64.2 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.326 0.49 . . . . 73.519999999999996 114.326 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -83.35 12.0 6.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.488 0.644 . . . . 73.510000000000005 112.284 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.85 176.34 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.966 0.412 . . . . 70.019999999999996 111.744 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.17 115.75 8.44 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.164 -0.541 . . . . 73.099999999999994 113.621 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 p -75.41 0.87 15.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.592 0.59 . . . . 72.409999999999997 112.592 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 t -119.76 20.45 12.28 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.014 0.376 . . . . 73.209999999999994 112.014 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.83 -37.76 73.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.08 0.467 . . . . 75.129999999999995 111.386 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 -111.22 3.94 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.152 -0.477 . . . . 52.340000000000003 114.24 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.14 125.18 6.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.218 0.607 . . . . 71.519999999999996 112.522 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.12 60.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.287 0.477 . . . . 64.450000000000003 112.287 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -94.24 0.31 55.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.573 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.84 -12.9 16.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.545 0.338 . . . . 71.439999999999998 111.694 -176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -57.99 -33.69 69.18 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.463 0.912 . . . . 74.349999999999994 113.463 -172.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.79 64.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.898 0.38 . . . . 71.349999999999994 111.344 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -64.21 -43.72 94.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 111.128 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.11 96.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.413 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 88' ' ' TYR . . . -57.76 -52.38 65.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.0 0.429 . . . . 75.349999999999994 110.633 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.0 t -58.8 -34.06 71.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 111.649 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 t -74.99 -25.71 59.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.819 0.342 . . . . 43.32 111.908 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.62 2.43 41.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.074 0.398 . . . . 65.349999999999994 112.074 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 41.55 14.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.325 -0.464 . . . . 74.239999999999995 113.943 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 66.5 m-85 -103.78 169.68 8.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.319 -0.518 . . . . 71.450000000000003 111.815 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.4 m -97.07 98.84 10.39 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.052 -0.522 . . . . 74.120000000000005 112.367 -171.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.43 103.19 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.151 0.501 . . . . 65.209999999999994 112.283 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -139.06 162.57 34.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.307 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -86.46 3.84 42.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.408 0.521 . . . . 75.340000000000003 112.408 -177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.0 m -57.25 113.13 5.59 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 110.542 -0.17 . . . . 75.230000000000004 110.542 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.94 -1.52 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.737 2.291 . . . . 75.129999999999995 114.577 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.71 139.57 9.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.874 0.694 . . . . 63.219999999999999 112.874 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.91 162.99 2.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.406 -0.816 . . . . 72.109999999999999 112.937 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.06 33.04 27.53 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.092 -0.575 . . . . 61.549999999999997 112.276 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.1 p -147.1 168.53 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.505 0.322 . . . . 73.140000000000001 110.834 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -115.7 124.44 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.345 -0.222 . . . . 74.310000000000002 110.659 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -96.95 134.97 39.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.326 0.584 . . . . 63.210000000000001 111.703 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -97.72 101.59 13.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 110.976 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 26.5 t -77.97 -30.07 50.08 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.851 -0.613 . . . . 75.430000000000007 111.923 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.475 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 30.2 p 67.54 -28.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.105 0.962 . . . . 72.209999999999994 113.444 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.47 102.8 1.51 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.815 -0.553 . . . . 61.539999999999999 111.872 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 155.05 45.99 0.02 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.936 -0.649 . . . . 62.229999999999997 113.613 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.56 -85.29 0.19 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.004 -0.617 . . . . 53.509999999999998 113.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -85.05 6.15 26.59 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.286 0.565 . . . . 74.409999999999997 110.973 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . 104.69 178.97 24.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.886 -0.597 . . . . 45.049999999999997 113.175 -178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -149.1 131.34 15.51 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.591 -0.358 . . . . 73.299999999999997 110.86 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.79 149.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 110.392 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.84 152.45 28.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.991 0.424 . . . . 62.530000000000001 111.984 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -80.8 129.08 34.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.272 -0.422 . . . . 73.120000000000005 110.811 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.24 102.68 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.216 0.531 . . . . 64.109999999999999 111.058 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.597 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 18.5 mm-40 -62.22 -58.1 9.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.459 -0.791 . . . . 71.420000000000002 111.289 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -161.67 148.47 14.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.846 -0.615 . . . . 75.310000000000002 111.361 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -115.15 137.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.309 . . . . 73.140000000000001 110.721 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -107.54 150.52 26.74 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.863 0.363 . . . . 61.43 111.762 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 m -61.53 -36.98 82.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.382 0.882 . . . . 75.310000000000002 113.382 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.19 -45.09 79.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.21 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.61 62.43 0.05 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.996 -0.621 . . . . 51.32 113.255 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.9 m -147.5 134.21 19.99 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.477 -0.425 . . . . 73.120000000000005 111.341 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 117.7 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.635 -0.711 . . . . 73.540000000000006 110.988 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.03 117.42 26.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.141 -0.481 . . . . 74.5 110.981 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.01 150.24 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.437 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.437 ' HB2' ' CG1' ' A' ' 136' ' ' VAL . 94.1 p -77.95 130.19 36.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.676 -0.693 . . . . 63.530000000000001 112.178 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -143.26 146.74 33.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.202 0.525 . . . . 75.239999999999995 112.306 174.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 57.3 tpp -99.54 156.48 17.03 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.077 -0.51 . . . . 72.540000000000006 110.264 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.31 40.63 21.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.447 0.642 . . . . 73.409999999999997 110.954 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 12.9 t80 -126.72 -171.23 2.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.06 -0.518 . . . . 74.329999999999998 110.563 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -43.86 100.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.951 0.723 . . . . 64.340000000000003 112.951 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 40.53 59.13 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 113.525 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.61 76.98 0.13 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.36 -0.924 . . . . 62.43 114.284 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.8 -42.49 0.32 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.414 2.076 . . . . 71.120000000000005 112.181 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -116.99 17.32 14.97 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.012 -0.54 . . . . 75.129999999999995 110.314 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.4 t -133.76 147.24 51.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.844 -0.616 . . . . 74.510000000000005 110.609 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 125' ' ' SER . 41.1 t -78.76 107.8 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.14 0.495 . . . . 63.130000000000003 111.95 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 129' ' ' TYR . 46.9 t -83.08 175.35 10.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.066 -0.515 . . . . 62.140000000000001 111.481 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 30.9 mt-10 -128.1 102.94 6.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.477 -0.329 . . . . 72.340000000000003 111.665 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -79.77 125.2 29.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.637 0.256 . . . . 64.530000000000001 110.631 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.9 m -91.33 99.54 12.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.99 0.424 . . . . 60.240000000000002 110.853 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.89 137.94 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.041 0.386 . . . . 73.120000000000005 112.041 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 52.5 m -61.6 151.5 33.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.941 0.4 . . . . 72.400000000000006 111.8 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.87 82.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.248 0.462 . . . . 72.439999999999998 112.248 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.13 74.79 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.418 -0.42 . . . . 51.530000000000001 113.426 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.96 -54.66 6.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.262 0.553 . . . . 72.430000000000007 111.129 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.46 94.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.783 0.66 . . . . 54.240000000000002 112.783 -176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.3 p -62.07 -16.13 49.89 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.125 0.417 . . . . 45.310000000000002 112.125 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.8 t -76.69 -17.83 58.89 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.952 0.406 . . . . 73.319999999999993 111.317 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.467 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 16.8 m-85 -93.06 152.95 18.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.21 0.529 . . . . 72.329999999999998 111.847 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.04 132.17 35.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.035 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 94.5 m-85 -106.84 129.83 54.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.781 0.8 . . . . 74.129999999999995 112.807 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.76 112.08 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.294 -0.866 . . . . 62.049999999999997 110.798 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -106.2 141.38 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.954 0.407 . . . . 71.129999999999995 111.543 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.62 -40.61 8.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.088 -0.505 . . . . 54.100000000000001 111.181 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 . . . . . 0 N--CA 1.477 0.917 0 C-N-CA 123.031 0.532 . . . . 74.219999999999999 112.349 178.711 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.489 0.185 . . . . 52.420000000000002 111.464 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -76.1 104.99 6.89 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 72.409999999999997 110.856 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HG3' ' HG ' ' A' ' 4' ' ' LEU . 5.2 tppp? -84.91 -61.73 1.71 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.345 -0.388 . . . . 54.409999999999997 111.678 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.494 ' HG ' ' HG3' ' A' ' 3' ' ' LYS . 93.2 mt -129.65 155.52 45.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.912 0.387 . . . . 63.420000000000002 111.331 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.46 131.03 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.993 0.425 . . . . 72.430000000000007 111.4 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.4 m -124.97 132.5 53.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 111.941 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.43 112.25 22.02 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.805 0.336 . . . . 62.009999999999998 110.684 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.0 p -108.53 -32.87 7.22 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.898 0.703 . . . . 72.219999999999999 112.898 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 t -87.67 134.52 33.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.862 0.689 . . . . 62.130000000000003 112.862 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.16 147.06 46.63 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.372 -0.376 . . . . 70.319999999999993 110.605 173.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.6 m -70.01 102.2 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 74.549999999999997 111.943 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.63 114.95 9.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.881 0.372 . . . . 52.450000000000003 111.164 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.83 -144.05 3.89 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.294 -0.479 . . . . 52.32 112.601 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 14' ' ' ILE . 20.6 pt -140.22 96.73 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.342 0.591 . . . . 71.450000000000003 111.707 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.19 54.65 1.56 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.002 -0.618 . . . . 62.420000000000002 113.316 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 119.61 19.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.903 0.334 . . . . 55.200000000000003 111.903 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.86 138.51 21.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.036 0.384 . . . . 73.510000000000005 112.036 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -129.95 128.17 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.543 0.337 . . . . 73.230000000000004 111.142 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.71 -78.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.896 0.702 . . . . 65.310000000000002 112.896 -174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.51 73.83 1.24 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.969 -0.634 . . . . 54.219999999999999 113.074 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -87.73 137.65 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.321 0.489 . . . . 72.299999999999997 112.321 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -169.7 132.67 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.081 -0.508 . . . . 61.140000000000001 110.933 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -171.07 136.31 1.07 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.826 0.346 . . . . 74.140000000000001 111.639 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 116.33 3.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.162 -0.542 . . . . 36.469999999999999 113.594 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -150.94 133.31 15.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.334 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -142.41 143.06 32.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.882 0.372 . . . . 55.329999999999998 111.315 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 90.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.945 0.402 . . . . 71.299999999999997 112.012 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -80.44 171.55 14.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 111.679 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.87 156.63 39.34 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.011 0.375 . . . . 61.130000000000003 112.011 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.84 86.8 0.05 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.873 0.368 . . . . 65.519999999999996 111.744 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.66 119.29 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.189 -0.319 . . . . 70.319999999999993 110.893 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -127.31 152.12 47.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.105 0.478 . . . . 73.120000000000005 111.804 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.3 p -111.72 150.96 29.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.082 -0.508 . . . . 71.140000000000001 110.87 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -130.68 159.79 69.39 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.486 -0.324 . . . . 73.310000000000002 111.249 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -72.8 30.47 0.29 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 122.752 2.301 . . . . 74.349999999999994 113.509 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.9 p -78.39 -171.66 2.53 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 72.319999999999993 110.975 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -73.42 -174.71 1.73 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 122.14 -0.35 . . . . 72.219999999999999 110.877 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 38' ' ' GLN . 4.2 pm0 -132.84 101.96 5.46 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.786 0.661 . . . . 73.420000000000002 112.786 -173.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.8 m -79.58 160.73 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.202 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.6 t -87.76 143.83 26.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.397 -0.365 . . . . 61.140000000000001 110.048 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p 54.25 95.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.349 0.595 . . . . 62.520000000000003 111.37 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' H ' ' NE2' ' A' ' 42' ' ' GLN . 1.2 mp0 -81.47 165.4 21.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.966 0.412 . . . . 71.209999999999994 111.982 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.7 m -60.94 123.52 17.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.331 -0.395 . . . . 75.319999999999993 110.691 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.8 p -57.62 -63.93 1.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.691 0.626 . . . . 74.120000000000005 112.691 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -161.33 135.92 7.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.912 0.387 . . . . 74.549999999999997 111.952 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.74 -178.27 50.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.264 -0.493 . . . . 62.109999999999999 112.207 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.0 m -143.12 148.46 36.65 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.151 -0.617 . . . . 74.25 111.641 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 m -90.33 -22.27 21.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.468 -0.333 . . . . 72.129999999999995 111.631 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 95.51 0.16 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.19 0.441 . . . . 73.430000000000007 112.19 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -88.36 142.06 28.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.902 0.382 . . . . 61.219999999999999 111.199 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.8 mt -94.76 15.79 17.46 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.307 0.484 . . . . 51.340000000000003 112.307 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 41.4 m-85 -114.51 -174.21 2.44 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.067 0.46 . . . . 75.140000000000001 111.719 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 t -129.67 160.75 32.38 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.32 -0.4 . . . . 73.150000000000006 111.787 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 35.06 0.1 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.54 0.941 . . . . 63.149999999999999 113.54 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.68 4.72 1.27 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.221 -0.514 . . . . 63.229999999999997 113.556 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.69 147.04 42.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.997 0.399 . . . . 74.299999999999997 111.212 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 63.7 m -54.93 -31.52 60.44 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.209 0.528 . . . . 73.0 111.259 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.6 p -68.04 -18.15 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.039 0.755 . . . . 73.120000000000005 113.039 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -75.81 -71.22 0.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.942 0.719 . . . . 75.219999999999999 112.942 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 12.6 p90 -59.93 -18.42 45.08 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.384 0.883 . . . . 74.239999999999995 113.384 -171.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.13 -34.78 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.21 0.528 . . . . 74.019999999999996 110.749 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 72.7 t80 -56.94 -51.86 67.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.712 -0.676 . . . . 74.209999999999994 111.294 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.48 -42.77 92.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.324 -0.398 . . . . 71.340000000000003 111.602 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' HZ1' ' CD ' ' A' ' 114' ' ' GLU . 14.4 mmmm -66.33 -31.96 73.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.326 0.491 . . . . 55.119999999999997 112.326 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.86 9.69 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.475 0.655 . . . . 71.319999999999993 111.402 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.5 14.83 65.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.426 -0.416 . . . . 65.430000000000007 113.671 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.39 7.73 64.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.41 0.524 . . . . 72.140000000000001 114.41 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -78.45 35.05 0.22 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.263 0.532 . . . . 75.129999999999995 112.371 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.8 pt -121.44 -30.46 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.134 0.42 . . . . 73.219999999999999 112.134 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.31 9.44 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.07 -0.586 . . . . 53.039999999999999 113.289 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.516 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 53.2 p 59.6 4.8 0.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.287 0.847 . . . . 72.439999999999998 113.287 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -84.95 9.6 14.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.165 0.507 . . . . 62.43 111.571 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.4 m0 -79.36 -36.67 38.97 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.322 -0.399 . . . . 72.519999999999996 111.593 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 85.36 -122.63 6.02 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.023 -0.608 . . . . 64.439999999999998 113.964 174.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -51.6 141.44 16.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.421 0.526 . . . . 71.209999999999994 112.421 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -31.9 72.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.195 0.442 . . . . 63.439999999999998 112.195 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.38 1.93 20.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.807 0.337 . . . . 74.420000000000002 111.661 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.95 -6.97 12.58 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.132 0.419 . . . . 63.109999999999999 112.132 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.39 -56.47 21.62 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.682 0.623 . . . . 73.409999999999997 112.682 -176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.51 75.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 71.040000000000006 111.552 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.5 m -60.69 -52.53 64.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.977 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.21 78.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 111.196 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -58.38 8.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.512 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.6 p -58.89 -37.09 75.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.836 0.351 . . . . 74.129999999999995 111.735 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -71.52 -39.81 70.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.383 -0.371 . . . . 61.340000000000003 111.392 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.5 10.57 5.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.664 0.616 . . . . 63.140000000000001 112.664 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.94 66.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.012 -0.613 . . . . 64.329999999999998 114.334 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -76.79 164.3 25.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.514 0.657 . . . . 63.219999999999999 110.999 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.4 m -100.5 100.35 11.08 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 111.671 -172.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 HG21 HG13 ' A' ' 152' ' ' ILE . 48.1 t -108.83 119.88 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.773 0.32 . . . . 71.430000000000007 111.572 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -140.13 -176.15 4.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 111.19 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -97.57 4.07 50.37 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.182 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.6 m -67.71 114.1 18.06 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.274 -0.421 . . . . 65.450000000000003 110.439 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.69 22.9 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.968 2.445 . . . . 61.140000000000001 114.584 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.08 149.69 36.3 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.959 0.726 . . . . 71.329999999999998 112.959 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.38 163.06 4.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.71 -0.677 . . . . 53.140000000000001 112.467 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.63 34.53 73.09 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.947 -0.644 . . . . 71.109999999999999 112.626 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.1 m -139.01 165.83 26.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.654 0.264 . . . . 52.109999999999999 111.105 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -116.86 127.56 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 110.446 -0.205 . . . . 71.019999999999996 110.446 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.7 pt? -99.83 144.94 28.31 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.848 -0.533 . . . . 75.129999999999995 110.993 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -121.62 133.56 54.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.4 0.619 . . . . 63.020000000000003 112.536 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 29.7 t -112.36 115.58 28.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.35 -0.841 . . . . 65.310000000000002 110.657 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.7 p -91.99 13.9 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 52.43 111.593 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.39 -44.34 58.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.538 0.569 . . . . 65.030000000000001 112.538 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -96.34 72.11 0.83 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.184 -0.531 . . . . 74.219999999999999 114.295 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 48.31 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.736 0.654 . . . . 62.329999999999998 114.736 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.25 -23.75 65.88 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.095 0.558 . . . . 71.519999999999996 111.649 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.21 171.23 33.66 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.137 -0.554 . . . . 73.109999999999999 113.333 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 73.0 t60 -143.85 141.93 30.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.565 -0.374 . . . . 64.319999999999993 111.2 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 20.5 m -139.17 146.34 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.505 -0.316 . . . . 74.120000000000005 111.114 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -153.74 154.64 34.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.03 0.443 . . . . 71.099999999999994 112.125 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -91.18 121.21 32.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.252 -0.431 . . . . 72.439999999999998 111.535 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.65 114.33 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.03 0.381 . . . . 74.439999999999998 112.03 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 10.1 mm-40 -78.78 -56.69 4.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 111.635 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -149.46 141.66 24.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.411 0.523 . . . . 64.510000000000005 112.411 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.32 126.33 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 111.071 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -94.42 144.12 25.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.753 0.311 . . . . 72.519999999999996 111.093 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -60.91 -25.74 66.95 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.223 0.535 . . . . 75.340000000000003 111.549 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.49 -16.32 62.29 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.992 -0.549 . . . . 75.019999999999996 111.59 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.86 -14.98 37.67 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.28 -0.418 . . . . 42.219999999999999 112.952 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.1 m -66.68 120.99 14.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 64.409999999999997 111.499 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.57 116.93 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.306 0.574 . . . . 73.219999999999999 111.178 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.14 113.69 25.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 111.005 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.94 167.11 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.196 0.522 . . . . 74.439999999999998 112.146 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.1 t -108.01 105.59 15.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.096 -0.502 . . . . 71.329999999999998 111.088 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 137' ' ' SER . 5.8 pt-20 -141.69 118.58 11.16 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.27 -0.423 . . . . 53.130000000000003 111.382 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.1 ttm -67.4 117.19 9.04 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.218 -0.301 . . . . 62.399999999999999 110.703 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -114.69 -76.58 0.58 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 72.439999999999998 111.794 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -118.78 -52.3 2.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.408 -0.36 . . . . 74.129999999999995 111.535 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -124.11 148.9 46.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.624 -0.262 . . . . 70.299999999999997 110.72 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 163.26 -64.41 0.25 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.223 -0.513 . . . . 54.399999999999999 112.45 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.6 154.83 6.44 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.291 -0.48 . . . . 42.539999999999999 112.263 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.68 -36.37 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.749 2.299 . . . . 74.439999999999998 113.472 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -116.36 -5.84 11.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.906 0.384 . . . . 63.130000000000003 111.5 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -100.23 128.2 46.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.335 -0.393 . . . . 60.030000000000001 111.102 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 60' ' ' TYR . 14.7 t -95.11 139.53 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.839 0.352 . . . . 65.049999999999997 111.874 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 1.5 m -75.6 175.06 8.94 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.499 -0.318 . . . . 72.349999999999994 110.821 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 42.2 mt-10 -133.29 133.9 43.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 111.959 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -114.5 122.99 48.27 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.433 -0.348 . . . . 73.530000000000001 111.176 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.2 m -85.66 99.79 11.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.775 0.322 . . . . 75.109999999999999 110.505 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.9 mt -93.27 139.78 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.912 0.387 . . . . 73.530000000000001 111.925 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 m -69.17 150.78 47.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.338 -0.392 . . . . 71.409999999999997 111.734 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.93 -52.38 58.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.463 0.542 . . . . 74.310000000000002 112.463 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.28 -13.0 34.11 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.117 -0.492 . . . . 72.439999999999998 114.018 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -101.77 -49.81 3.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 110.959 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.42 72.56 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.621 0.6 . . . . 74.530000000000001 112.621 -175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 68.3 m -60.69 -9.52 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.064 0.764 . . . . 36.469999999999999 113.064 -177.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.0 t -83.37 -19.79 35.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.932 0.396 . . . . 64.230000000000004 111.548 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -85.91 161.58 18.98 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.155 0.502 . . . . 74.239999999999995 112.096 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.0 m-20 -89.29 117.76 28.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.493 -0.321 . . . . 73.430000000000007 111.265 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -99.89 113.1 25.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.299 0.481 . . . . 74.129999999999995 112.299 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 152' ' ' ILE . 3.7 mp -83.06 134.73 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.374 -0.376 . . . . 71.409999999999997 110.272 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -122.99 142.79 50.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.967 0.413 . . . . 74.209999999999994 111.354 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.7 mt -110.68 -37.69 5.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 111.796 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 63.530000000000001 111.579 -173.833 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ptp . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 112.352 0.501 . . . . 72.219999999999999 112.352 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -92.01 142.59 27.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.224 0.535 . . . . 63.350000000000001 112.257 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -123.68 171.25 9.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.986 -0.552 . . . . 75.420000000000002 110.334 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.7 175.15 11.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 75.140000000000001 112.125 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.05 161.33 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.066 -0.516 . . . . 65.019999999999996 111.653 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.5 p -82.88 94.2 7.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.831 0.348 . . . . 62.310000000000002 111.165 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.33 117.35 32.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.503 0.557 . . . . 37.799999999999997 112.503 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -151.48 178.71 9.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.28 -0.418 . . . . 72.329999999999998 110.826 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -123.92 133.5 53.71 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 111.642 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.523 ' O ' HD12 ' A' ' 10' ' ' LEU . 2.6 pp -134.85 133.77 40.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.18 0.514 . . . . 63.219999999999999 110.696 173.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -107.01 123.71 48.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.372 0.508 . . . . 74.129999999999995 112.372 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 139.15 40.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.428 -0.351 . . . . 52.43 111.138 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 63.35 0.31 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.995 -0.621 . . . . 62.450000000000003 113.286 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.0 pt -96.74 155.03 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.506 -0.408 . . . . 75.510000000000005 111.531 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.3 92.23 0.09 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.868 -0.682 . . . . 71.340000000000003 113.24 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.99 107.31 19.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.973 0.416 . . . . 73.439999999999998 111.816 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.87 151.69 22.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 111.591 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.16 163.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.93 0.395 . . . . 73.450000000000003 111.583 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -97.39 100.14 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.892 0.377 . . . . 70.25 110.723 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.2 122.54 6.55 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.146 -0.55 . . . . 62.219999999999999 113.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.79 115.46 9.09 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.87 0.366 . . . . 71.420000000000002 110.157 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.15 136.9 32.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.903 0.382 . . . . 65.230000000000004 111.051 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -151.34 145.05 25.03 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.054 0.454 . . . . 71.120000000000005 112.086 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.61 167.1 26.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.056 -0.52 . . . . 63.509999999999998 112.515 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -151.73 112.91 4.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.396 0.517 . . . . 42.32 112.396 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -150.11 133.23 16.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.349 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.46 112.22 6.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 111.998 0.37 . . . . 64.010000000000005 111.998 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.86 112.64 24.31 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.913 0.387 . . . . 71.0 111.448 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.1 47.59 1.8 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.089 0.471 . . . . 54.109999999999999 110.553 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.62 109.1 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.836 -0.62 . . . . 62.520000000000003 112.408 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.59 87.06 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.01 -0.541 . . . . 72.329999999999998 111.32 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.57 95.64 10.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.1 -0.5 . . . . 63.350000000000001 111.103 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -89.65 1.36 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.266 0.555 . . . . 71.230000000000004 110.962 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 57.37 78.85 0.35 Allowed Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.336 -0.847 . . . . 74.230000000000004 112.238 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.72 100.21 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.638 2.225 . . . . 64.109999999999999 112.323 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.5 p -92.94 151.83 19.71 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 71.200000000000003 111.754 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.18 164.56 24.2 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.259 -0.428 . . . . 71.540000000000006 111.232 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -69.15 -40.02 78.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.863 0.363 . . . . 71.519999999999996 111.494 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -165.76 115.36 1.01 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.436 -0.347 . . . . 62.210000000000001 110.704 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -74.48 72.87 1.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.849 0.833 . . . . 75.510000000000005 111.712 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.5 m -143.41 90.86 2.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.691 -0.686 . . . . 73.200000000000003 110.385 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 111.8 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.0 m -74.85 75.39 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.06 0.457 . . . . 51.229999999999997 111.773 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -78.64 -52.3 8.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.552 0.692 . . . . 73.510000000000005 109.74 172.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 68' ' ' ASN . 33.9 t -106.12 86.4 2.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.215 -0.902 . . . . 72.120000000000005 110.445 171.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.64 -31.01 0.79 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.318 -0.468 . . . . 70.120000000000005 113.004 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -77.43 81.26 3.91 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.354 0.597 . . . . 72.400000000000006 111.677 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -71.86 85.73 0.96 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.881 -0.6 . . . . 63.200000000000003 111.198 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.37 119.18 30.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 37.799999999999997 111.55 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -82.71 94.27 7.56 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 73.200000000000003 111.179 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 3.4 mm? -68.67 -18.34 64.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.787 0.327 . . . . 71.310000000000002 111.443 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -73.48 174.23 8.51 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.454 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t -105.93 149.33 26.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.188 0.518 . . . . 71.329999999999998 111.945 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 115.2 9.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 111.273 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.92 -13.22 7.2 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.172 -0.537 . . . . 65.200000000000003 112.887 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -100.03 144.99 28.42 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.787 0.327 . . . . 74.099999999999994 111.144 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.6 m -56.01 -25.87 46.27 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.117 0.414 . . . . 74.140000000000001 112.117 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.2 p -67.21 -27.22 67.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.275 0.472 . . . . 64.129999999999995 112.275 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -65.64 -64.07 0.95 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.806 0.669 . . . . 74.510000000000005 112.806 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.474 ' HB3' ' SD ' ' A' ' 127' ' ' MET . 34.6 p90 -63.49 -32.48 73.94 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.048 0.388 . . . . 73.340000000000003 112.048 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 110' ' ' VAL . 66.1 t -62.62 -37.17 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.765 0.317 . . . . 72.319999999999993 111.442 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -59.15 -37.36 77.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.057 0.456 . . . . 75.109999999999999 110.84 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.11 -40.82 62.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.179 -0.464 . . . . 71.519999999999996 110.998 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.75 -44.88 86.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.093 0.473 . . . . 63.240000000000002 111.753 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.42 -3.14 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.106 0.479 . . . . 71.030000000000001 111.424 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.15 22.37 73.89 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.47 -0.395 . . . . 73.230000000000004 113.703 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.25 15.38 65.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 114.325 0.49 . . . . 37.799999999999997 114.325 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.44 ' HA ' ' OG ' ' A' ' 45' ' ' SER . 49.6 m-80 -79.68 2.65 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.644 0.609 . . . . 61.310000000000002 112.644 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.7 pt -109.43 149.56 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.166 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.36 110.5 3.2 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.826 -0.702 . . . . 37.799999999999997 112.674 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.432 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 28.7 t -64.47 -3.24 2.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 122.413 -0.463 . . . . 63.32 112.24 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 t -64.12 -13.33 47.17 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.256 0.465 . . . . 74.129999999999995 112.256 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -59.11 -50.07 75.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.96 0.409 . . . . 74.549999999999997 111.424 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.58 -128.26 9.33 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.162 -0.542 . . . . 61.140000000000001 113.38 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.71 140.47 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 111.83 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.99 -41.28 64.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.118 0.784 . . . . 73.209999999999994 113.118 -173.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.62 -22.62 65.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -84.54 -24.2 29.41 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.748 0.277 . . . . 72.450000000000003 111.748 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -45.37 -46.98 13.48 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.996 0.739 . . . . 75.430000000000007 112.996 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.46 81.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 63.439999999999998 112.181 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 t -80.4 -47.5 14.3 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 74.049999999999997 111.617 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.94 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.359 -0.382 . . . . 73.409999999999997 111.602 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -60.55 -53.78 53.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 53.310000000000002 111.327 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.0 p -59.77 -42.47 93.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.89 0.376 . . . . 73.049999999999997 111.225 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 t -65.61 -29.77 70.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.374 -0.376 . . . . 75.030000000000001 111.543 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.18 -4.34 59.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.435 0.531 . . . . 74.25 112.435 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.45 3.18 56.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.262 -0.494 . . . . 72.25 113.853 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.41 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 81.7 m-85 -72.3 173.79 8.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 111.423 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 35.4 m -106.24 84.85 2.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.09 0.404 . . . . 73.400000000000006 112.09 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG23 HG13 ' A' ' 152' ' ' ILE . 49.5 t -93.9 111.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.85 0.357 . . . . 74.549999999999997 111.562 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -149.06 159.96 43.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 110.779 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.2 24.36 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.447 0.536 . . . . 75.209999999999994 112.447 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -81.04 108.64 10.8 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.387 0.275 . . . . 75.209999999999994 110.83 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.45 7.9 4.72 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.833 2.355 . . . . 62.340000000000003 114.395 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -51.59 143.07 13.02 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.158 0.429 . . . . 70.120000000000005 112.158 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 152.7 11.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.52 13.78 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.133 -0.556 . . . . 64.010000000000005 113.114 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.3 p -144.86 178.4 8.04 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 71.129999999999995 111.06 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 62.7 mt -124.58 120.06 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.551 -0.295 . . . . 74.430000000000007 111.211 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 149' ' ' TYR . 1.9 pt? -85.59 126.87 34.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 72.129999999999995 111.233 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 111.26 23.93 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.976 0.417 . . . . 73.310000000000002 109.927 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.437 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 21.4 t -66.02 -55.86 14.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.238 1.199 . . . . 61.039999999999999 114.238 -169.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.7 p 59.63 -1.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.639 0.977 . . . . 65.319999999999993 113.639 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.91 115.71 5.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.341 0.497 . . . . 73.409999999999997 112.341 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.41 -44.19 3.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.291 -0.48 . . . . 43.229999999999997 113.566 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 150.07 -45.97 0.65 Allowed Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 112.587 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -64.68 85.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.468 0.651 . . . . 71.209999999999994 110.811 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 76' ' ' ALA . . . -51.02 113.38 2.15 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.215 -0.902 . . . . 50.450000000000003 113.938 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -111.91 143.31 43.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.542 0.337 . . . . 75.5 111.038 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.519 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.7 m -141.17 150.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.08 0.467 . . . . 70.140000000000001 111.824 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.42 168.94 25.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.813 -0.63 . . . . 72.129999999999995 110.561 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -100.43 129.55 46.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 111.281 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.35 112.66 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.778 0.323 . . . . 60.25 111.689 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.29 -53.95 4.91 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.12 0.415 . . . . 70.329999999999998 112.12 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -143.18 150.43 39.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.993 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.19 131.98 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.886 -0.597 . . . . 70.239999999999995 110.757 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.57 156.3 16.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.475 -0.33 . . . . 53.299999999999997 111.302 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.8 p -64.66 -18.35 64.88 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.137 0.421 . . . . 63.229999999999997 112.137 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -69.47 -9.78 55.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.817 0.342 . . . . 74.049999999999997 111.443 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 0.07 67.57 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 112.214 -0.354 . . . . 70.439999999999998 112.214 -174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 m -67.89 120.73 14.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 110.926 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.4 t -105.22 119.19 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.659 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.55 107.12 19.49 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.191 0.519 . . . . 74.430000000000007 110.929 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.58 144.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.013 -0.54 . . . . 64.439999999999998 111.771 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 t -90.98 112.83 24.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.333 -0.394 . . . . 74.010000000000005 111.379 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.39 -173.08 2.3 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.037 -0.529 . . . . 63.219999999999999 110.964 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 60' ' ' TYR . 19.2 ptm -133.9 124.76 26.96 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.213 0.53 . . . . 71.340000000000003 110.77 173.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.86 42.66 0.87 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.139 -0.351 . . . . 71.530000000000001 111.748 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -53.11 -33.6 52.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.007 0.432 . . . . 63.549999999999997 111.759 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -66.91 -27.31 67.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 112.007 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.03 -58.07 0.76 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.484 -0.388 . . . . 64.230000000000004 112.788 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.41 172.46 14.22 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.585 -0.34 . . . . 73.209999999999994 113.493 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.25 96.94 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.843 2.362 . . . . 73.209999999999994 113.372 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.6 p90 43.37 24.45 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.943 1.09 . . . . 74.299999999999997 113.943 174.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.6 t -71.6 130.48 41.31 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.143 0.423 . . . . 74.540000000000006 112.143 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 77.1 t -95.43 125.4 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.772 0.32 . . . . 74.549999999999997 111.108 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -141.79 167.05 23.06 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.261 0.467 . . . . 75.219999999999999 112.261 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -99.12 137.06 38.19 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.163 -0.471 . . . . 72.230000000000004 111.945 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -111.94 125.41 54.03 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.025 -0.422 . . . . 60.030000000000001 110.77 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.1 m -91.54 105.12 17.51 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.964 0.411 . . . . 64.0 111.619 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.18 139.93 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.375 -0.375 . . . . 71.219999999999999 111.555 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.2 m -72.36 155.31 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.681 0.277 . . . . 70.420000000000002 111.679 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.99 -48.19 73.63 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.535 0.569 . . . . 72.099999999999994 112.535 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.33 -41.08 92.88 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.478 -0.392 . . . . 62.25 113.41 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.51 -45.3 39.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.249 0.547 . . . . 64.230000000000004 111.236 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.1 89.85 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.837 0.68 . . . . 65.319999999999993 112.837 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -62.47 -15.63 50.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.615 0.598 . . . . 74.120000000000005 112.615 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -79.53 -28.35 41.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.904 0.383 . . . . 73.25 111.796 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.46 ' CD2' HD13 ' A' ' 100' ' ' LEU . 22.9 m-85 -74.14 147.84 42.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.163 0.506 . . . . 64.25 111.969 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -91.99 108.12 19.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.233 -0.439 . . . . 75.510000000000005 110.781 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 71.3 m-85 -88.22 119.08 28.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.948 0.404 . . . . 71.25 111.803 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.508 HG13 HG23 ' A' ' 90' ' ' VAL . 3.6 mp -82.21 130.18 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.731 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 46.4 m-70 -120.39 161.95 20.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.969 0.508 . . . . 74.129999999999995 109.87 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.87 141.67 36.89 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.754 0.65 . . . . 74.219999999999999 112.754 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 CA--C 1.544 0.713 0 CA-C-N 115.7 -0.682 . . . . 71.299999999999997 111.026 179.42 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.867 0.365 . . . . 72.400000000000006 111.155 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 9.2 mmpt? -142.36 149.71 39.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.79 0.436 . . . . 75.25 110.446 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -153.26 120.5 5.83 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.599 0.592 . . . . 75.310000000000002 112.599 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.89 148.72 43.66 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.724 -0.671 . . . . 72.340000000000003 110.011 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -162.32 144.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.389 0.514 . . . . 74.129999999999995 112.389 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.573 HG23 HG22 ' A' ' 8' ' ' THR . 54.2 m -95.84 97.11 9.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.081 0.467 . . . . 75.409999999999997 110.348 173.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.02 2.66 38.02 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.034 1.124 . . . . 75.420000000000002 114.034 -169.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.573 HG22 HG23 ' A' ' 6' ' ' THR . 11.8 t -71.16 162.42 29.45 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.661 0.615 . . . . 74.030000000000001 112.661 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.9 m -152.78 139.36 18.74 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.711 -0.677 . . . . 74.030000000000001 111.016 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -106.75 113.08 26.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.329 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.2 m -124.56 107.38 10.99 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.366 -0.209 . . . . 73.129999999999995 111.44 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.22 140.99 0.9 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.771 0.319 . . . . 53.409999999999997 111.641 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.16 111.01 0.26 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.377 -0.44 . . . . 63.420000000000002 112.873 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 tt -106.34 136.0 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.1 0.476 . . . . 72.040000000000006 112.265 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.04 83.02 0.34 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.388 -0.434 . . . . 65.209999999999994 112.577 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.92 135.65 33.23 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.415 -0.462 . . . . 72.5 112.051 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.6 103.56 0.71 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.697 0.284 . . . . 63.450000000000003 111.688 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.41 178.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.2 0.444 . . . . 53.520000000000003 112.2 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -116.11 140.07 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.861 0.363 . . . . 73.219999999999999 111.797 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.16 115.45 0.63 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.262 -0.426 . . . . 65.510000000000005 112.568 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 21' ' ' LEU . 2.6 mm? -114.36 141.44 47.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.098 0.449 . . . . 75.430000000000007 111.902 -176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.5 146.45 38.47 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.93 0.395 . . . . 65.299999999999997 110.709 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -148.51 112.56 5.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.954 0.407 . . . . 62.439999999999998 111.742 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.5 23.25 12.4 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.128 -0.558 . . . . 54.549999999999997 113.29 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.32 166.41 12.31 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.51 -0.406 . . . . 63.32 111.856 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.52 177.81 7.16 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.352 -0.386 . . . . 71.310000000000002 111.348 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -172.6 168.45 5.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.902 0.382 . . . . 74.239999999999995 111.397 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.13 127.18 33.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.072 0.463 . . . . 63.409999999999997 110.542 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.88 138.84 33.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.977 0.418 . . . . 72.340000000000003 111.892 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.22 165.56 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.746 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -82.91 23.36 0.84 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.7 0.259 . . . . 64.209999999999994 111.7 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 54.56 42.64 31.17 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.362 0.601 . . . . 73.140000000000001 111.297 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -76.46 77.94 3.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.913 -0.585 . . . . 73.310000000000002 111.4 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 65.79 111.73 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 64.409999999999997 112.26 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.14 74.56 0.73 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.101 1.868 . . . . 73.219999999999999 112.125 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.3 m -71.49 109.23 5.32 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.178 -0.465 . . . . 71.019999999999996 112.064 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 t30 54.92 83.19 0.09 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.846 0.684 . . . . 75.340000000000003 112.846 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -125.49 -57.72 1.46 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.278 -0.419 . . . . 75.439999999999998 110.927 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -153.71 113.98 3.95 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.066 0.46 . . . . 73.430000000000007 111.565 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -110.96 -31.97 6.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.276 0.56 . . . . 74.439999999999998 111.003 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.3 p -83.42 73.67 10.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.281 0.562 . . . . 54.240000000000002 111.019 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.42 -15.93 53.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.222 -0.445 . . . . 61.149999999999999 111.601 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -82.57 160.07 22.63 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.222 -0.299 . . . . 72.430000000000007 110.467 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p 50.62 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.134 0.574 . . . . 64.430000000000007 111.762 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 93.0 p -159.53 152.88 22.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.026 -0.534 . . . . 71.510000000000005 110.863 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.39 -94.87 1.45 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.215 -0.517 . . . . 61.25 112.664 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -149.77 -167.28 2.78 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.843 0.321 . . . . 40.350000000000001 111.176 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.6 p -147.4 138.92 23.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.839 0.352 . . . . 37.890000000000001 110.799 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.17 164.81 4.85 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.46 -0.336 . . . . 71.25 110.891 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.38 105.31 14.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.96 0.409 . . . . 60.229999999999997 110.662 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.36 -0.95 11.36 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.566 0.58 . . . . 64.219999999999999 112.566 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 72.8 m-85 -99.27 -177.58 3.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 111.729 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.4 t -121.68 157.39 31.0 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.052 0.453 . . . . 72.209999999999994 111.854 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.08 149.88 26.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.834 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.18 -23.33 35.16 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.132 -0.556 . . . . 74.239999999999995 113.252 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -89.41 142.19 27.88 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.559 -0.377 . . . . 71.019999999999996 111.294 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.27 -27.05 65.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.213 0.53 . . . . 73.329999999999998 111.469 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.4 p -73.37 -16.37 61.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 112.203 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.98 -54.43 47.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.265 0.626 . . . . 72.340000000000003 112.397 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.89 -34.95 51.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.167 0.432 . . . . 73.129999999999995 112.167 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.14 -42.59 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 111.853 0.316 . . . . 75.329999999999998 111.853 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -58.01 -36.84 73.24 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.77 -41.82 43.27 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.868 0.366 . . . . 71.140000000000001 110.929 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.24 -27.2 68.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.107 0.41 . . . . 73.049999999999997 112.107 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.8 3.27 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 121.277 0.56 . . . . 60.350000000000001 111.422 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.28 12.77 66.56 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.163 -0.541 . . . . 72.150000000000006 113.933 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.41 16.91 71.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 114.43 0.532 . . . . 74.450000000000003 114.43 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.95 30.19 0.52 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.343 0.571 . . . . 63.229999999999997 112.123 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.81 150.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.923 0.392 . . . . 74.519999999999996 111.603 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.65 98.25 0.28 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.321 -0.466 . . . . 72.450000000000003 113.363 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.0 p -59.36 -8.76 1.88 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.086 0.773 . . . . 71.430000000000007 113.086 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -66.57 -12.5 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.59 0.589 . . . . 63.140000000000001 112.59 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -63.15 -59.45 4.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.807 0.337 . . . . 75.310000000000002 111.779 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.549 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 88.62 -110.43 3.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.11 -0.567 . . . . 37.890000000000001 113.699 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.52 140.2 58.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.985 0.393 . . . . 73.299999999999997 111.316 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -52.19 -43.68 64.31 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.573 0.582 . . . . 41.119999999999997 112.573 -176.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -56.96 -21.14 27.96 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.774 0.657 . . . . 61.130000000000003 112.774 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -90.94 -23.81 20.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.824 0.305 . . . . 72.519999999999996 111.824 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.414 ' HB2' ' HG3' ' A' ' 101' ' ' GLN . 9.4 m0 -50.52 -40.26 51.11 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.264 0.839 . . . . 73.319999999999993 113.264 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.63 -64.58 0.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.171 0.434 . . . . 70.239999999999995 112.171 -175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -63.82 -35.44 80.62 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 71.030000000000001 111.691 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.39 87.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.773 0.32 . . . . 72.430000000000007 111.377 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.031 0.443 . . . . 37.890000000000001 111.347 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 p -64.22 -28.51 69.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.423 -0.353 . . . . 65.140000000000001 111.897 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -77.9 -36.34 49.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.9 0.381 . . . . 72.230000000000004 111.767 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -22.03 59.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.267 0.469 . . . . 72.129999999999995 112.267 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.58 10.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.047 -0.597 . . . . 37.890000000000001 113.587 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -76.67 -173.79 2.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.195 0.521 . . . . 64.439999999999998 111.286 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.9 m -121.23 97.47 5.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.436 -0.347 . . . . 63.149999999999999 111.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.543 HG22 HG13 ' A' ' 152' ' ' ILE . 46.2 t -101.62 108.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.817 0.341 . . . . 74.430000000000007 111.847 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.65 147.74 39.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.51 -0.314 . . . . 74.219999999999999 110.932 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -72.76 -9.78 59.04 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.172 0.434 . . . . 73.239999999999995 112.172 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.9 m -56.53 119.79 31.48 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.519 0.2 . . . . 74.230000000000004 111.095 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.56 121.76 1.93 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.001 2.467 . . . . 73.140000000000001 113.78 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.49 156.87 35.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 111.099 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 151.66 46.04 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.077 0.465 . . . . 73.129999999999995 112.115 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.02 41.45 18.26 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.191 -0.528 . . . . 54.020000000000003 113.108 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.5 m -151.75 158.53 43.48 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.514 -0.404 . . . . 63.25 111.011 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 99' ' ' ILE . 3.4 mp -103.26 126.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.335 -0.246 . . . . 74.109999999999999 110.335 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 149' ' ' TYR . 1.2 pt? -98.85 124.36 43.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.399 0.619 . . . . 65.230000000000004 110.836 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' HG3' ' HB2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -111.8 124.17 51.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 111.434 -172.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.572 ' HB2' ' CD1' ' A' ' 149' ' ' TYR . 47.5 t -109.13 112.84 25.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.877 0.37 . . . . 71.019999999999996 111.795 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -81.76 71.4 8.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.703 0.763 . . . . 73.239999999999995 111.531 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.39 -25.97 59.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.576 -0.738 . . . . 63.539999999999999 111.626 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.67 160.09 11.57 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.057 -0.519 . . . . 37.890000000000001 112.836 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.14 -77.05 0.24 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.546 -0.359 . . . . 72.25 113.344 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -106.25 -42.83 4.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.984 0.421 . . . . 75.409999999999997 111.629 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.1 -165.68 30.51 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 -169.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -159.52 142.25 13.93 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.494 0.647 . . . . 73.510000000000005 111.66 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 76' ' ' ALA . 12.8 m -141.09 141.43 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 111.716 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.16 156.67 41.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.38 -0.373 . . . . 73.209999999999994 110.905 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -96.0 128.64 43.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.881 0.372 . . . . 70.109999999999999 111.209 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG23 HG13 ' A' ' 124' ' ' VAL . 61.8 t -79.8 118.82 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.317 0.488 . . . . 63.530000000000001 112.317 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -83.92 -53.67 5.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.282 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.42 154.05 34.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.075 0.464 . . . . 64.519999999999996 111.605 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.28 129.09 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 111.009 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 117' ' ' ASN . 0.8 OUTLIER -77.46 160.0 29.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.869 0.366 . . . . 40.229999999999997 111.5 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.3 m -64.04 -20.42 65.91 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.784 0.326 . . . . 62.229999999999997 111.605 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.11 -22.92 66.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.071 0.463 . . . . 74.420000000000002 111.329 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.87 45.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.582 -0.607 . . . . 75.109999999999999 111.582 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -64.97 129.17 38.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.621 0.368 . . . . 74.239999999999995 110.909 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.465 HG21 ' OH ' ' A' ' 151' ' ' TYR . 61.0 t -106.7 111.36 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.201 0.524 . . . . 64.209999999999994 111.737 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.539 ' HG2' HG23 ' A' ' 140' ' ' THR . 37.9 mt-10 -90.32 107.31 19.06 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 110.716 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 113' ' ' VAL . 30.6 m -108.91 173.87 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.004 -0.543 . . . . 73.310000000000002 112.14 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.466 ' HB2' HG12 ' A' ' 136' ' ' VAL . 54.8 p -117.87 126.09 51.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.026 -0.534 . . . . 74.340000000000003 111.488 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 136' ' ' VAL . 48.5 mt-10 -121.82 -172.68 2.49 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 111.268 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.1 tpp -130.88 133.24 45.72 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.904 -0.497 . . . . 45.32 111.338 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -89.4 -45.48 9.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.086 0.47 . . . . 75.329999999999998 111.488 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -89.21 110.79 21.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.913 0.387 . . . . 75.409999999999997 111.74 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -46.5 -38.97 10.0 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.353 0.871 . . . . 72.450000000000003 113.353 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -139.05 46.22 0.98 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.072 -0.585 . . . . 54.030000000000001 112.973 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -103.19 -153.31 24.0 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.268 -0.492 . . . . 73.049999999999997 113.509 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.902 2.402 . . . . 63.0 113.191 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -82.71 20.61 1.12 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.577 0.584 . . . . 73.109999999999999 112.577 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 m -71.44 83.56 0.8 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.194 0.521 . . . . 71.420000000000002 111.445 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 125' ' ' SER . 79.7 t -77.1 137.8 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.017 -0.538 . . . . 72.540000000000006 112.261 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.1 t -91.13 139.38 30.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.023 -0.535 . . . . 71.450000000000003 111.031 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.65 137.23 32.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.545 -0.298 . . . . 73.109999999999999 111.63 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 2.4 tpm_? -140.61 122.71 15.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.971 0.415 . . . . 74.400000000000006 111.923 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 123' ' ' GLU . 81.5 m -104.36 98.5 8.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.946 0.403 . . . . 60.399999999999999 110.739 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.66 128.88 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 54.43 111.775 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.1 m -67.29 147.25 53.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.549 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.72 -47.28 59.2 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.532 0.568 . . . . 52.219999999999999 112.532 -177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.66 64.55 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.225 -0.512 . . . . 71.200000000000003 113.246 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.32 -34.48 25.68 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.085 0.469 . . . . 73.439999999999998 111.06 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.93 18.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.707 0.632 . . . . 72.349999999999994 112.707 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -75.81 -21.6 57.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.328 0.492 . . . . 44.539999999999999 112.328 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 94.2 p -83.34 -33.28 25.91 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.355 0.502 . . . . 63.119999999999997 112.355 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 102' ' ' SER . 80.8 m-85 -70.8 145.82 50.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.251 0.548 . . . . 75.209999999999994 112.327 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -101.35 114.84 29.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.069 -0.514 . . . . 71.549999999999997 110.208 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.465 ' OH ' HG21 ' A' ' 122' ' ' VAL . 14.2 m-85 -90.91 114.96 27.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.283 0.475 . . . . 74.519999999999996 112.283 -174.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.543 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -82.02 107.75 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.752 -0.462 . . . . 74.510000000000005 109.752 173.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.81 125.36 40.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 60.310000000000002 111.239 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.94 95.74 10.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.986 0.422 . . . . 72.329999999999998 111.056 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.544 0.747 0 CA-C-O 120.876 0.37 . . . . 74.140000000000001 111.695 178.18 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.132 0.491 . . . . 75.140000000000001 111.916 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.46 110.03 13.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.176 -0.466 . . . . 54.399999999999999 111.758 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.72 -28.24 1.75 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.925 -0.655 . . . . 73.420000000000002 113.287 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.32 150.04 27.43 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.547 -0.384 . . . . 74.109999999999999 110.755 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 28.2 p -58.69 -34.18 70.99 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.143 0.497 . . . . 72.310000000000002 111.796 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.404 ' HB ' ' CZ2' ' A' ' 79' ' ' TRP . 49.8 p -64.44 -25.75 68.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.24 -60.33 3.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.519 0.563 . . . . 73.340000000000003 112.519 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 25.0 p90 -64.35 -30.53 71.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.097 -0.377 . . . . 64.430000000000007 111.892 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HG23 ' A' ' 110' ' ' VAL . 59.4 t -62.53 -43.67 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.105 0.479 . . . . 61.409999999999997 110.583 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -58.54 -36.61 74.15 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.043 -0.526 . . . . 63.229999999999997 110.944 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.73 -43.31 37.82 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.406 -0.361 . . . . 64.530000000000001 111.132 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -59.19 -34.4 72.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.146 0.498 . . . . 71.209999999999994 111.816 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 99' ' ' ILE . 7.1 p -85.03 9.38 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.309 0.576 . . . . 70.219999999999999 111.815 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.18 14.59 68.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.389 -0.434 . . . . 34.329999999999998 113.556 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.77 17.9 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.167 -0.539 . . . . 73.239999999999995 114.129 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -80.09 11.24 3.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.466 0.633 . . . . 64.219999999999999 112.375 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 pt -117.04 153.0 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.374 -0.376 . . . . 74.319999999999993 110.687 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.05 126.69 8.02 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.806 -0.711 . . . . 61.420000000000002 113.968 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -62.33 -19.27 63.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.189 0.518 . . . . 60.109999999999999 111.364 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -70.05 8.25 0.78 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.361 0.875 . . . . 73.430000000000007 113.361 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -78.15 -46.02 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.99 -0.444 . . . . 72.319999999999993 112.047 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.94 9.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.945 -0.645 . . . . 60.43 113.377 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -85.53 162.57 18.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.14 0.495 . . . . 55.43 111.881 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.32 -27.78 64.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.849 -0.614 . . . . 73.239999999999995 112.079 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -63.23 -35.34 79.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.985 0.422 . . . . 74.239999999999995 111.173 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.93 -21.26 19.32 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.508 0.558 . . . . 75.450000000000003 112.508 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.404 ' CZ2' ' HB ' ' A' ' 58' ' ' THR . 4.9 m0 -38.95 -55.43 1.55 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.447 1.277 . . . . 73.510000000000005 114.447 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -62.67 -37.63 87.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.941 -0.475 . . . . 62.32 112.235 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -68.94 -47.74 64.96 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.932 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.82 92.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.131 -0.486 . . . . 63.219999999999999 111.156 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.96 -51.98 62.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.078 0.466 . . . . 53.409999999999997 110.938 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 m -58.24 -45.27 88.07 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.176 0.512 . . . . 64.319999999999993 110.713 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 t -66.86 -24.6 66.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.072 -0.513 . . . . 64.299999999999997 111.97 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.3 -13.07 33.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.114 0.412 . . . . 64.140000000000001 112.114 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.34 41.84 3.86 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.253 -0.499 . . . . 62.439999999999998 113.434 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -107.61 -178.6 3.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 74.340000000000003 111.522 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.0 m -110.05 108.06 18.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.291 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 152' ' ' ILE . 39.0 t -116.81 110.99 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.082 0.467 . . . . 65.140000000000001 111.907 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 50.8 m-80 -139.17 155.6 47.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.385 -0.371 . . . . 72.319999999999993 110.369 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.64 13.71 1.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.008 0.373 . . . . 74.430000000000007 112.008 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.5 p -73.84 116.87 56.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.601 -0.272 . . . . 74.010000000000005 111.416 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 103.51 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.486 2.124 . . . . 53.539999999999999 112.241 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 36.9 tt0 -141.45 152.15 44.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.977 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.32 153.92 42.0 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.021 0.439 . . . . 71.319999999999993 111.905 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.54 34.05 63.53 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.074 -0.584 . . . . 63.020000000000003 112.691 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.5 m -136.78 158.8 43.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.299999999999997 111.067 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -107.95 127.53 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.597 -0.274 . . . . 64.530000000000001 110.448 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.7 pt? -95.63 130.37 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.937 -0.477 . . . . 42.329999999999998 111.127 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HA ' HG12 ' A' ' 110' ' ' VAL . 41.8 tt0 -98.29 129.32 45.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.402 -0.363 . . . . 64.140000000000001 111.685 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 112.752 0.649 . . . . 71.310000000000002 112.752 178.84 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 113.584 0.193 . . . . 52.140000000000001 113.584 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -131.63 149.71 52.4 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.747 -0.267 . . . . 65.519999999999996 111.036 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.8 m -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.138 0.494 . . . . 65.530000000000001 111.663 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.86 163.03 40.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 73.129999999999995 110.651 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -96.68 127.4 42.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.752 0.31 . . . . 73.340000000000003 111.376 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 124' ' ' VAL . 60.9 t -76.1 108.05 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.948 0.404 . . . . 43.539999999999999 112.031 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 138' ' ' GLU . 11.3 mm-40 -71.95 -45.86 59.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.055 -0.52 . . . . 71.349999999999994 111.504 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -163.6 149.37 11.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 111.517 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 122' ' ' VAL . 57.9 t -120.65 128.91 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 52.119999999999997 110.535 177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.42 154.55 22.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.955 0.407 . . . . 70.400000000000006 111.925 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 t -57.61 -34.42 69.26 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.441 0.639 . . . . 75.019999999999996 110.078 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.2 -31.53 43.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.245 -0.889 . . . . 75.140000000000001 111.583 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 112.75 -19.35 21.4 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.369 -0.443 . . . . 54.509999999999998 112.669 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.3 p -61.62 125.7 24.72 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.329 0.585 . . . . 51.409999999999997 111.66 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 116' ' ' VAL . 48.9 t -103.44 117.85 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.716 -0.675 . . . . 74.109999999999999 111.347 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.85 102.52 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.218 0.532 . . . . 72.340000000000003 111.464 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.562 HG12 HG22 ' A' ' 113' ' ' VAL . 35.5 m -106.42 123.49 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.449 0.643 . . . . 60.340000000000003 111.876 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 39.5 t -81.03 122.19 26.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.054 0.455 . . . . 72.209999999999994 111.841 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -133.31 137.59 46.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.492 . . . . 63.200000000000003 111.18 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.5 ' HB3' ' CD2' ' A' ' 60' ' ' TYR . 50.2 ttm . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.016 0.436 . . . . 72.400000000000006 111.642 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 2.6 mp0 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.336 0.589 . . . . 64.140000000000001 111.366 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -70.04 109.3 4.48 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.504 -0.771 . . . . 64.420000000000002 111.895 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.8 m -85.33 98.26 10.44 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.95 0.405 . . . . 60.340000000000003 111.343 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.0 mt -88.52 144.34 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 111.549 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.8 m -68.85 148.32 50.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 111.293 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.404 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -49.36 -49.92 42.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.072 0.767 . . . . 65.230000000000004 113.072 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.03 -48.74 77.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.419 -0.419 . . . . 71.340000000000003 113.434 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.22 -39.03 75.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.042 0.449 . . . . 54.539999999999999 111.544 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.46 77.81 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.074 0.398 . . . . 73.400000000000006 112.074 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.9 m -61.55 -14.47 30.06 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.091 0.472 . . . . 62.520000000000003 111.74 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -73.67 -8.49 56.18 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.338 -0.392 . . . . 34.140000000000001 111.762 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 100' ' ' LEU . 53.1 m-85 -105.17 156.91 17.66 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.112 0.482 . . . . 74.329999999999998 112.064 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 91.7 m-20 -87.0 115.69 24.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.36 -0.382 . . . . 73.450000000000003 111.028 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 82.5 m-85 -93.29 121.32 34.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.053 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -89.89 111.08 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.347 -0.388 . . . . 64.310000000000002 110.316 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 33.2 m-70 -98.52 136.77 38.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.41 -0.359 . . . . 65.010000000000005 110.984 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 29.7 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.156 0.503 . . . . 53.130000000000003 112.236 -178.698 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 120.997 0.427 . . . . 63.310000000000002 111.784 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 103.84 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 112.35 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.75 -28.17 2.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 112.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 59' ' ' TRP . 96.3 mt-30 -73.88 143.87 45.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.007 0.432 . . . . 71.439999999999998 111.899 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.5 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.0 m -57.11 -46.28 82.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.569 174.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.3 p -55.13 -41.21 71.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.795 -0.639 . . . . 52.420000000000002 111.547 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 56' ' ' GLN . 59.3 t90 -55.23 -55.68 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.57 -0.741 . . . . 73.329999999999998 111.76 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.481 ' OH ' ' HD3' ' A' ' 64' ' ' LYS . 47.1 t80 -62.75 -42.18 99.55 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.294 0.479 . . . . 75.109999999999999 112.294 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 110' ' ' VAL . 82.4 t -60.44 -38.27 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 111.946 0.35 . . . . 73.530000000000001 111.946 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 44.2 t80 -62.22 -34.82 77.22 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 111.388 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.95 -46.78 56.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.167 0.508 . . . . 55.350000000000001 110.318 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HD3' ' OH ' ' A' ' 60' ' ' TYR . 25.5 mmmt -55.71 -40.58 72.6 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 112.3 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.51 9.5 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.077 0.465 . . . . 74.209999999999994 111.55 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.66 60.47 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.523 -0.37 . . . . 31.52 113.745 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA2' ' CE1' ' A' ' 62' ' ' TYR . . . 63.54 29.25 74.07 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.159 -0.543 . . . . 62.409999999999997 114.261 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -93.23 24.57 3.76 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.478 0.639 . . . . 71.430000000000007 112.214 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.82 155.5 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.03 0.443 . . . . 61.140000000000001 111.702 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.13 93.56 0.34 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.09 -0.576 . . . . 73.140000000000001 112.551 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 63.1 p -72.65 20.8 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.377 0.88 . . . . 35.329999999999998 113.377 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -90.0 -2.26 58.11 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.189 -0.319 . . . . 64.030000000000001 111.752 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -64.83 -38.18 90.12 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.56 0.578 . . . . 72.439999999999998 112.56 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.09 -111.09 3.24 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.071 -0.585 . . . . 60.229999999999997 113.445 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -53.63 134.05 41.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.926 0.393 . . . . 41.119999999999997 111.908 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.95 -39.31 85.14 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.507 0.558 . . . . 61.240000000000002 112.507 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -63.74 -9.82 16.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.48 0.548 . . . . 55.420000000000002 112.48 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -94.15 -16.65 23.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.497 0.319 . . . . 60.420000000000002 111.661 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 11.6 m0 -60.49 -42.26 95.95 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.129 0.789 . . . . 73.120000000000005 113.129 -170.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -66.1 -56.66 10.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.971 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -62.52 -44.51 96.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.91 0.386 . . . . 65.239999999999995 111.627 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.1 -47.94 83.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.566 -0.288 . . . . 54.009999999999998 111.728 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -56.38 -49.0 75.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 111.404 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -58.76 -40.81 84.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 111.999 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -75.49 -39.14 58.94 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.959 0.409 . . . . 62.299999999999997 111.897 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.99 82.61 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.113 0.412 . . . . 71.120000000000005 112.113 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.11 17.85 1.58 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.948 -0.644 . . . . 52.350000000000001 113.383 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 58.7 m-85 -89.19 176.61 6.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.26 0.552 . . . . 72.400000000000006 111.061 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -104.59 91.37 3.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.133 -0.485 . . . . 75.140000000000001 111.173 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 152' ' ' ILE . 62.1 t -103.69 117.52 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.029 0.442 . . . . 71.120000000000005 112.054 -176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -153.04 -179.46 7.7 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.902 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.15 10.1 30.8 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.083 0.401 . . . . 71.319999999999993 112.083 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -72.56 111.79 12.48 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 110.291 -0.263 . . . . 74.530000000000001 110.291 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.479 ' O ' HG21 ' A' ' 116' ' ' VAL . 91.8 Cg_endo -76.65 1.93 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.836 2.358 . . . . 62.520000000000003 115.065 -170.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.23 137.51 6.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.895 0.702 . . . . 60.43 112.895 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.51 174.16 1.84 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.396 0.888 . . . . 72.150000000000006 113.396 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.0 35.33 57.95 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.998 -0.547 . . . . 42.130000000000003 112.484 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.7 m -153.4 -176.96 6.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.571 0.348 . . . . 62.020000000000003 110.665 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mt -122.2 129.39 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.803 -0.18 . . . . 52.409999999999997 111.45 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.4 pt? -98.37 133.45 42.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.799 -0.563 . . . . 74.420000000000002 110.923 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -101.39 106.15 17.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.031 -0.531 . . . . 72.450000000000003 110.286 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 75.400000000000006 111.38 -176.945 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 CA-C-O 120.971 0.206 . . . . 72.409999999999997 113.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -142.44 110.55 5.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.456 -0.438 . . . . 64.0 111.095 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG13 ' HB1' ' A' ' 76' ' ' ALA . 31.4 m -111.81 145.15 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.921 0.391 . . . . 72.140000000000001 111.397 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.39 157.81 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.989 0.423 . . . . 73.530000000000001 111.366 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -90.7 130.91 36.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.827 0.346 . . . . 73.319999999999993 110.878 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' HA ' HG12 ' A' ' 124' ' ' VAL . 39.9 t -83.49 114.72 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 45.229999999999997 112.124 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.78 -50.96 10.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.907 -0.588 . . . . 73.409999999999997 111.536 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -158.08 150.71 22.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 111.84 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 94' ' ' PRO . 98.5 t -126.92 127.63 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.912 -0.585 . . . . 64.239999999999995 110.39 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -91.98 148.29 22.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.881 0.372 . . . . 74.549999999999997 111.852 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 75.8 m -64.0 -16.01 60.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.368 -0.378 . . . . 73.409999999999997 111.743 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.11 -6.46 39.43 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 111.379 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 60.05 1.59 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.316 -0.468 . . . . 54.219999999999999 112.985 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.0 p -145.78 133.6 21.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.294 -0.533 . . . . 64.109999999999999 111.668 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.46 113.62 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.213 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 31.2 mt-10 -99.49 118.85 36.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.502 -0.317 . . . . 75.109999999999999 110.928 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 113' ' ' VAL . 16.1 m -129.38 147.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.371 0.508 . . . . 64.340000000000003 112.371 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 65.9 m -79.4 122.91 26.98 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.928 0.394 . . . . 53.329999999999998 112.054 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.518 ' CD ' ' HD2' ' A' ' 139' ' ' ARG . 44.3 mt-10 -116.62 143.94 45.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.275 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.741 0.305 . . . . 52.299999999999997 110.227 171.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.729 0.299 . . . . 70.540000000000006 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HD2' ' CD ' ' A' ' 126' ' ' GLU . 11.3 ptm180 -87.46 151.59 22.92 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.117 -0.364 . . . . 71.510000000000005 110.633 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.422 HG23 ' HG2' ' A' ' 123' ' ' GLU . 52.4 m -114.8 102.59 10.14 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.123 0.487 . . . . 72.120000000000005 110.98 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 mt -86.43 131.0 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.854 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -71.26 149.11 46.52 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.814 -0.175 . . . . 72.140000000000001 110.94 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.99 61.53 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.701 0.63 . . . . 65.109999999999999 112.701 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.68 -23.63 55.66 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.459 -0.4 . . . . 71.510000000000005 113.809 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.24 -35.06 10.87 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.448 -0.442 . . . . 64.299999999999997 111.257 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.32 67.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.122 0.487 . . . . 61.409999999999997 111.8 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 148' ' ' SER . 69.1 m -60.83 143.79 54.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.221 -0.445 . . . . 24.050000000000001 110.859 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 147' ' ' SER . 31.3 t 83.56 -3.0 1.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.681 0.792 . . . . 65.010000000000005 112.241 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -93.61 127.99 39.55 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.972 -0.455 . . . . 75.439999999999998 110.272 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.89 118.48 30.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 111.707 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -92.17 113.22 25.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.951 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -80.22 114.92 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.501 -0.318 . . . . 73.120000000000005 110.35 174.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.57 146.93 28.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.667 0.27 . . . . 75.319999999999993 110.658 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 120.804 0.335 . . . . 75.049999999999997 111.414 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 5.1 t . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 120.774 0.321 . . . . 61.119999999999997 111.61 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.37 156.73 25.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.715 0.635 . . . . 74.409999999999997 112.715 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.77 -33.9 3.23 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.284 -0.416 . . . . 53.450000000000003 113.795 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -75.64 150.74 37.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.229 0.537 . . . . 75.340000000000003 112.274 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.406 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.7 p -56.41 -39.53 73.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.025 -0.534 . . . . 75.25 111.638 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.7 p -54.99 -42.96 73.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.941 0.401 . . . . 63.219999999999999 111.649 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' THR . 86.7 t90 -62.82 -50.32 71.45 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.408 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.1 -54.15 50.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.787 -0.642 . . . . 63.310000000000002 111.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.8 t -60.5 -34.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.469 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -55.62 -47.69 76.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.519 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.19 -37.56 75.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.965 0.412 . . . . 74.439999999999998 110.884 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -61.24 -35.57 77.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.013 -0.539 . . . . 43.009999999999998 112.19 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.65 12.4 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.432 0.634 . . . . 63.399999999999999 110.997 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.67 18.38 59.05 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 114.179 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.02 67.14 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.115 -0.564 . . . . 51.119999999999997 113.792 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.01 37.76 0.44 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.231 -0.57 . . . . 62.420000000000002 111.89 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.3 pt -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.112 0.482 . . . . 64.310000000000002 111.455 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.8 1.26 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.071 -0.585 . . . . 44.520000000000003 112.315 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -52.82 -18.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.219 0.822 . . . . 64.420000000000002 113.219 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -94.43 18.93 10.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.576 0.584 . . . . 73.299999999999997 112.576 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -67.69 -37.0 81.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.074 0.398 . . . . 72.519999999999996 112.074 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.94 -134.62 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.072 -0.585 . . . . 63.149999999999999 113.715 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -63.17 151.02 41.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.312 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.65 -31.76 62.61 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.14 0.793 . . . . 73.099999999999994 113.14 -172.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -67.14 -21.62 65.82 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.494 0.553 . . . . 61.210000000000001 112.494 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.38 -14.21 29.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.109 0.411 . . . . 75.209999999999994 112.109 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -52.06 -65.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.202 0.816 . . . . 72.0 113.202 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.18 91.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.059 0.392 . . . . 44.329999999999998 112.059 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 m -54.97 -36.91 65.86 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.976 0.417 . . . . 73.340000000000003 111.613 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.2 -28.11 25.66 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.342 -0.39 . . . . 64.450000000000003 111.891 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.7 70.04 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.726 0.298 . . . . 70.450000000000003 111.372 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.4 p -58.88 -54.36 48.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.012 0.434 . . . . 65.530000000000001 111.106 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.8 t -55.56 -37.19 67.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.945 -0.571 . . . . 64.230000000000004 112.446 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.88 -10.46 59.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 111.999 0.37 . . . . 73.439999999999998 111.999 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 41.51 4.24 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.332 -0.461 . . . . 55.439999999999998 113.873 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -110.98 -179.07 3.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.005 0.431 . . . . 64.030000000000001 111.112 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.4 m -109.72 103.86 12.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.216 0.45 . . . . 63.130000000000003 112.216 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.28 99.81 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 63.329999999999998 110.882 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -122.17 156.07 34.46 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 111.29 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.78 -4.06 58.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.443 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.2 m -66.35 111.71 7.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.323 -0.398 . . . . 74.239999999999995 110.806 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -78.12 20.29 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.471 2.781 . . . . 64.409999999999997 114.56 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -48.65 141.53 7.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.556 0.576 . . . . 73.400000000000006 112.556 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.74 144.68 47.55 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.987 -0.551 . . . . 44.299999999999997 112.36 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.54 45.89 5.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.916 -0.659 . . . . 73.140000000000001 112.584 -175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -149.53 177.68 9.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 70.319999999999993 111.121 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.8 mt -122.83 121.21 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 110.708 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.6 pt? -92.7 139.4 30.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.02 0.438 . . . . 70.329999999999998 110.867 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -105.06 103.7 13.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.92 0.39 . . . . 62.399999999999999 111.408 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 66.2 m . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 121.406 0.622 . . . . 70.329999999999998 111.165 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.649 0 CA-C-O 121.083 0.268 . . . . 73.299999999999997 113.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 26.8 t60 -141.32 148.09 39.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.687 -0.302 . . . . 74.230000000000004 110.457 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.493 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -139.43 144.2 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.146 0.498 . . . . 71.129999999999995 111.692 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.39 153.73 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.907 -0.588 . . . . 61.200000000000003 110.666 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -88.71 128.7 35.62 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.049 0.452 . . . . 71.200000000000003 111.129 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.74 106.38 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.27 -0.423 . . . . 62.25 111.665 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -74.81 -51.99 12.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.938 0.399 . . . . 64.239999999999995 111.384 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -148.88 145.78 27.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.293 0.568 . . . . 40.200000000000003 112.347 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.49 130.02 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.826 -0.625 . . . . 61.530000000000001 110.763 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -88.36 147.46 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.354 -0.385 . . . . 74.420000000000002 111.372 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -56.09 -37.33 69.21 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.908 0.385 . . . . 62.229999999999997 111.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -22.48 64.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 111.736 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.37 -20.66 8.34 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.412 -0.423 . . . . 63.509999999999998 113.587 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -58.63 126.25 26.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.131 0.419 . . . . 65.340000000000003 112.131 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.12 122.89 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.05 -0.523 . . . . 65.040000000000006 111.189 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -103.43 109.58 21.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.273 0.558 . . . . 73.519999999999996 110.978 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.62 160.43 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.961 -0.563 . . . . 54.43 111.534 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.8 p -107.83 124.8 50.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.214 0.531 . . . . 63.229999999999997 111.744 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -108.34 -176.58 3.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.819 -0.628 . . . . 75.219999999999999 111.207 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 39.0 tpp . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 116.381 -0.372 . . . . 54.32 111.48 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.327 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -108.45 121.04 44.13 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.856 -0.611 . . . . 72.349999999999994 111.432 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.4 m -94.98 103.72 15.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 111.458 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 111.309 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.4 m -67.02 144.77 55.99 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.494 -0.321 . . . . 72.120000000000005 111.419 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.69 -47.49 50.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.965 0.728 . . . . 64.510000000000005 112.965 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.85 -57.86 16.12 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.548 -0.358 . . . . 64.299999999999997 113.479 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.57 -41.66 98.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 71.519999999999996 110.971 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.31 69.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.892 -0.595 . . . . 54.329999999999998 112.176 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -64.08 -11.65 31.69 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.489 0.551 . . . . 73.140000000000001 112.489 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 44.4 t -83.0 -10.38 58.8 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.975 0.416 . . . . 73.340000000000003 111.178 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 26.2 m-85 -93.73 153.08 18.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.076 0.465 . . . . 71.310000000000002 111.285 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.27 112.58 20.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.286 -0.416 . . . . 75.530000000000001 111.335 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 89.6 m-85 -93.9 113.52 25.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.121 0.486 . . . . 62.420000000000002 111.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -80.12 128.38 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 54.219999999999999 110.933 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.09 144.82 48.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.436 -0.347 . . . . 71.25 110.568 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.175 0.512 . . . . 63.439999999999998 112.289 -173.685 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.413 HG22 ' OE1' ' A' ' 56' ' ' GLN . 8.8 t . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.971 0.36 . . . . 75.120000000000005 111.971 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 111.01 1.46 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.069 0.461 . . . . 55.130000000000003 111.124 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.65 -24.05 3.06 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.302 -0.475 . . . . 53.229999999999997 112.4 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 53' ' ' THR . 51.4 mt-30 -83.18 138.94 33.43 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.748 -0.266 . . . . 62.109999999999999 110.793 175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.1 p -61.54 -35.37 77.57 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.181 0.515 . . . . 72.019999999999996 109.994 174.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -54.87 -44.97 74.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.513 -0.767 . . . . 74.530000000000001 111.454 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -55.88 -50.09 71.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.903 -0.589 . . . . 72.329999999999998 111.77 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -63.04 -45.37 92.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.796 0.331 . . . . 73.150000000000006 111.667 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.6 t -60.99 -36.18 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.95 0.405 . . . . 42.32 111.053 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -56.14 -43.17 78.01 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 110.81 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.35 -47.55 70.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.153 -0.476 . . . . 63.119999999999997 110.977 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -56.76 -37.92 71.72 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.07 -3.6 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 111.483 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.98 8.43 84.07 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.441 -0.409 . . . . 23.32 113.713 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.55 84.62 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 113.554 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -78.6 36.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.177 0.436 . . . . 73.150000000000006 112.177 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.6 pt -140.02 -178.28 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.989 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.81 108.83 3.43 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.996 -0.621 . . . . 53.130000000000003 112.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.1 p -63.1 -14.66 51.16 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.415 -0.462 . . . . 53.109999999999999 112.203 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 t -85.85 5.4 32.91 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.674 0.62 . . . . 72.349999999999994 112.674 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -67.21 -34.74 78.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.092 -0.38 . . . . 75.340000000000003 111.889 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.25 -118.46 5.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.199 -0.524 . . . . 71.439999999999998 114.045 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -58.16 134.58 56.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.085 0.402 . . . . 55.520000000000003 112.085 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.08 -25.18 60.97 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.549 0.574 . . . . 72.030000000000001 112.549 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -77.33 -9.97 59.15 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.798 0.332 . . . . 73.129999999999995 111.881 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -102.53 -4.94 24.55 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 111.916 0.339 . . . . 54.020000000000003 111.916 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -64.7 -43.67 92.75 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.626 0.602 . . . . 73.340000000000003 112.626 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.61 95.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.088 0.47 . . . . 44.109999999999999 111.343 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -65.48 -48.11 73.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 64.329999999999998 111.315 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.42 95.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.866 0.365 . . . . 61.119999999999997 111.358 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.14 -56.23 24.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 111.393 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.6 t -64.06 -29.72 70.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 111.646 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 t -75.71 -33.46 60.31 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.941 0.401 . . . . 75.109999999999999 111.645 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.46 -25.0 36.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.902 0.382 . . . . 65.420000000000002 111.6 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.65 6.72 12.68 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.057 -0.592 . . . . 55.020000000000003 113.321 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 96.8 m-85 -74.3 158.2 34.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.242 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 92.88 6.91 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.272 0.558 . . . . 45.240000000000002 111.998 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 152' ' ' ILE . 46.7 t -95.3 124.37 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.83 -0.623 . . . . 74.0 111.365 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -146.42 166.97 24.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 111.203 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -82.49 -5.57 58.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.261 -0.427 . . . . 74.540000000000006 111.47 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 113.04 6.77 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 116.599 -0.273 . . . . 60.539999999999999 110.674 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.471 ' O ' HG21 ' A' ' 116' ' ' VAL . 94.1 Cg_endo -82.14 20.82 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.106 2.537 . . . . 72.140000000000001 114.625 -170.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.8 147.63 22.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.1 0.778 . . . . 73.340000000000003 113.1 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -64.75 159.82 21.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.366 -0.833 . . . . 64.519999999999996 112.329 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.7 44.65 12.08 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.405 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -156.48 179.66 9.04 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.975 0.417 . . . . 71.019999999999996 111.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.62 122.87 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.209 -0.45 . . . . 73.040000000000006 110.726 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -97.85 134.21 41.3 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.131 0.491 . . . . 54.009999999999998 111.078 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -101.62 116.66 33.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.013 0.435 . . . . 73.319999999999993 112.069 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 115.824 -0.626 . . . . 70.219999999999999 110.11 173.644 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 113.485 0.154 . . . . 33.340000000000003 113.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -141.17 130.92 24.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.427 0.291 . . . . 54.240000000000002 110.989 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.511 HG13 ' HB1' ' A' ' 76' ' ' ALA . 26.3 m -127.37 146.92 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.003 0.43 . . . . 74.420000000000002 111.441 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.53 156.47 45.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.095 -0.502 . . . . 43.409999999999997 111.088 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -87.15 127.13 35.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.86 0.362 . . . . 52.450000000000003 111.64 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 122' ' ' VAL . 60.1 t -77.85 105.17 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.303 -0.408 . . . . 53.049999999999997 111.151 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.12 -48.46 10.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.622 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -150.69 151.93 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.97 0.414 . . . . 74.340000000000003 111.585 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 94' ' ' PRO . 29.0 t -127.17 137.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.421 -0.354 . . . . 74.450000000000003 111.137 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -77.63 164.22 25.53 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.909 0.385 . . . . 54.229999999999997 111.41 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 m -63.09 -31.22 72.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.878 0.325 . . . . 72.319999999999993 111.878 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.66 -39.21 64.62 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 111.837 0.31 . . . . 61.520000000000003 111.837 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 142.13 -12.22 2.57 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 113.85 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.4 m -55.26 128.55 34.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.239 0.543 . . . . 55.020000000000003 111.835 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 113' ' ' VAL . 48.4 t -106.56 119.35 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.503 -0.771 . . . . 72.129999999999995 111.763 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.89 107.52 19.27 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.92 0.391 . . . . 72.510000000000005 110.577 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 122' ' ' VAL . 32.9 m -112.24 148.55 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.718 0.636 . . . . 65.040000000000006 112.718 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.8 p -99.21 112.45 24.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.795 -0.639 . . . . 74.120000000000005 111.376 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.44 -172.33 2.49 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.031 -0.531 . . . . 72.25 111.18 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.475 0.801 0 O-C-N 122.301 -0.25 . . . . 73.019999999999996 110.881 -179.506 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 121.018 0.437 . . . . 62.149999999999999 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -96.91 122.95 40.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 111.88 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 32.5 m -93.83 113.42 25.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.097 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.84 125.25 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.793 0.294 . . . . 71.140000000000001 111.793 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -62.23 145.14 54.42 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.684 0.278 . . . . 73.319999999999993 111.575 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.431 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -51.36 -43.03 61.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.775 0.657 . . . . 75.120000000000005 112.775 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.12 -22.25 28.11 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.252 -0.499 . . . . 74.340000000000003 113.707 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -101.69 -47.39 4.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 71.019999999999996 110.692 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.549 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.83 -40.78 94.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 113.192 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.6 m -60.59 -16.62 40.04 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.927 0.714 . . . . 75.310000000000002 112.927 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.4 t -79.16 -25.31 42.87 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.962 0.41 . . . . 63.439999999999998 111.55 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.71 148.49 34.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.06 0.457 . . . . 72.340000000000003 111.608 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.548 HD22 ' N ' ' A' ' 150' ' ' ASN . 0.8 OUTLIER -83.76 115.78 22.38 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.237 -0.289 . . . . 51.399999999999999 111.358 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 69.8 m-85 -94.2 110.83 22.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.847 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -81.37 113.38 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.293 -0.412 . . . . 75.510000000000005 110.695 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -104.29 135.98 44.73 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.691 0.281 . . . . 64.209999999999994 110.677 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.891 -175.793 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 120.984 0.421 . . . . 72.150000000000006 112.081 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.52 149.64 27.42 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.162 0.506 . . . . 64.400000000000006 112.338 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.64 -34.77 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.292 -0.413 . . . . 54.25 113.428 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.21 148.76 50.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.773 0.32 . . . . 71.510000000000005 111.545 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.3 p -56.8 -43.06 80.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.983 0.42 . . . . 70.319999999999993 111.12 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -55.73 -39.57 71.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.04 -0.527 . . . . 63.340000000000003 111.565 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.504 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 87.6 t90 -60.54 -52.29 65.8 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 111.44 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.06 -41.37 96.48 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.136 -0.353 . . . . 75.510000000000005 111.344 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 112' ' ' TYR . 65.7 t -63.23 -35.04 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.276 0.56 . . . . 75.400000000000006 110.69 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 59' ' ' TRP . 60.5 t80 -57.15 -46.51 82.67 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.589 -0.732 . . . . 63.329999999999998 111.136 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.6 -40.86 72.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.851 0.357 . . . . 55.009999999999998 111.726 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -61.33 -31.94 71.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.284 0.476 . . . . 71.329999999999998 112.284 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 65' ' ' VAL . 7.5 p -84.92 6.49 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.279 0.562 . . . . 72.239999999999995 111.193 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 21.63 73.96 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.425 -0.417 . . . . 74.230000000000004 113.527 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.55 27.16 71.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 121.227 -0.511 . . . . 55.049999999999997 113.456 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -89.95 25.45 2.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.216 -0.579 . . . . 75.129999999999995 111.674 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.4 pt -131.57 176.52 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.788 0.435 . . . . 74.230000000000004 110.643 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 129.22 9.81 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.8 -0.714 . . . . 54.439999999999998 113.124 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.6 m -62.35 -23.18 66.64 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.466 -0.432 . . . . 75.349999999999994 112.117 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -60.31 -15.74 28.18 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.599 0.592 . . . . 74.310000000000002 112.599 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -60.48 -36.18 77.67 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.045 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.44 -122.99 24.38 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.661 0.624 . . . . 71.209999999999994 114.661 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -60.23 141.84 55.42 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.25 0.548 . . . . 55.409999999999997 112.062 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.57 -23.11 62.64 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.993 0.738 . . . . 64.450000000000003 112.993 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.01 -11.4 60.32 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 122.046 -0.409 . . . . 72.109999999999999 111.864 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -101.54 -26.22 13.62 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.442 0.534 . . . . 73.519999999999996 112.442 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -41.08 -59.16 1.56 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.48 1.289 . . . . 72.129999999999995 114.48 -173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.85 85.01 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.046 -0.409 . . . . 53.299999999999997 112.013 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 m -63.78 -43.28 96.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 111.261 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.06 99.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.928 0.394 . . . . 52.32 111.365 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.1 82.9 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.042 0.448 . . . . 65.209999999999994 110.998 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 m -61.39 -40.68 95.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.133 -0.485 . . . . 65.230000000000004 111.489 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -73.16 -36.88 66.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.13 0.419 . . . . 74.540000000000006 112.13 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.02 66.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.231 0.456 . . . . 75.129999999999995 112.231 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.59 0.87 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.93 -0.652 . . . . 32.210000000000001 113.448 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.51 179.47 4.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 73.209999999999994 111.445 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.9 m -108.88 94.58 5.13 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.948 0.404 . . . . 64.530000000000001 111.815 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.85 111.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.893 0.377 . . . . 43.049999999999997 111.181 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.78 176.77 7.56 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.018 0.437 . . . . 75.400000000000006 111.09 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -90.26 -1.87 57.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.672 0.272 . . . . 44.210000000000001 110.818 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 t -55.8 118.28 19.33 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 116.304 -0.407 . . . . 75.120000000000005 111.425 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -86.23 11.8 3.2 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.008 2.472 . . . . 70.519999999999996 113.942 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -59.06 143.57 48.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 112.138 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.69 163.36 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.774 -0.648 . . . . 74.239999999999995 112.627 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.97 16.17 75.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.128 -0.558 . . . . 61.039999999999999 112.762 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -124.69 165.99 16.96 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.74 0.305 . . . . 52.329999999999998 111.153 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -112.96 128.73 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.25 -0.281 . . . . 72.530000000000001 110.553 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -101.26 133.06 46.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.332 0.587 . . . . 70.340000000000003 111.296 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.556 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.2 tt0 -92.83 108.83 20.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.046 -0.524 . . . . 63.100000000000001 110.934 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 46.6 m . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 N-CA-C 111.987 -0.445 . . . . 30.539999999999999 111.987 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -166.83 141.22 4.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.076 0.438 . . . . 65.329999999999998 111.521 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 101' ' ' GLN . 16.9 m -146.18 153.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.29 0.636 . . . . 60.350000000000001 110.697 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.22 160.55 42.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.926 0.394 . . . . 52.25 111.278 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' HB2' HG13 ' A' ' 61' ' ' VAL . 70.9 t80 -98.62 127.79 44.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.937 0.399 . . . . 74.040000000000006 111.445 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 116.21 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.391 -0.368 . . . . 74.519999999999996 111.888 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -88.03 -38.83 15.14 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.116 0.413 . . . . 73.409999999999997 112.116 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -161.88 145.91 12.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.796 0.665 . . . . 73.530000000000001 112.796 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.99 150.4 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.888 -0.596 . . . . 63.240000000000002 110.573 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -113.11 168.73 9.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.479 0.548 . . . . 73.200000000000003 112.479 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.7 t -63.22 -31.84 73.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.086 0.47 . . . . 72.430000000000007 110.933 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.95 -12.36 54.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 111.723 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.62 -1.22 89.04 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.636 -0.585 . . . . 73.439999999999998 111.636 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 m -68.38 136.1 52.82 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.941 0.401 . . . . 61.340000000000003 111.608 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.92 122.03 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.056 -0.52 . . . . 73.120000000000005 111.884 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 75.420000000000002 111.082 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.01 149.22 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.116 -0.493 . . . . 73.420000000000002 112.224 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.4 t -97.37 109.39 22.16 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.005 -0.543 . . . . 70.239999999999995 111.55 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.18 171.05 7.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.003 -0.544 . . . . 62.140000000000001 110.295 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 111.935 178.78 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 120.979 0.418 . . . . 60.229999999999997 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -99.64 119.39 38.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.098 0.475 . . . . 72.450000000000003 111.544 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.2 m -95.63 94.34 7.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.257 -0.429 . . . . 71.239999999999995 110.77 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.7 mt -83.22 131.83 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.582 -0.281 . . . . 72.420000000000002 111.311 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.5 m -62.63 150.11 41.63 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.483 0.182 . . . . 60.130000000000003 111.485 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.58 -51.06 39.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.736 0.643 . . . . 74.200000000000003 112.736 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.66 70.3 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.286 -0.415 . . . . 73.0 113.504 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.14 -38.53 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.124 0.487 . . . . 74.540000000000006 111.266 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -63.67 -38.69 92.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.073 -0.512 . . . . 75.019999999999996 112.173 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.1 t -61.36 -12.17 12.95 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.345 0.498 . . . . 75.140000000000001 112.345 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.1 t -82.02 -13.96 56.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.739 0.304 . . . . 45.140000000000001 111.784 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.44 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 36.2 m-85 -97.05 151.35 19.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 111.992 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -89.81 115.53 27.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.351 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.418 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 96.3 m-85 -94.87 112.06 23.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.419 . . . . 72.540000000000006 111.86 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.9 mp -79.36 121.25 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.706 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -112.6 136.12 52.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 109.971 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.6 mt . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.81 0.338 . . . . 72.109999999999999 111.697 -175.663 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 121.274 0.559 . . . . 71.019999999999996 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.69 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.678 -0.692 . . . . 61.140000000000001 111.051 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.83 -31.5 4.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.337 -0.459 . . . . 50.240000000000002 112.819 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -60.97 137.65 58.22 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.526 -0.396 . . . . 72.010000000000005 111.84 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.459 ' O ' HG23 ' A' ' 61' ' ' VAL . 57.2 m -50.59 -41.95 55.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 71.430000000000007 110.416 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -59.29 -39.19 82.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.267 -0.879 . . . . 71.049999999999997 112.182 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -60.81 -52.62 64.3 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.5 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.78 -49.21 78.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.949 0.404 . . . . 62.420000000000002 111.76 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' CYS . 67.5 t -59.87 -36.73 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.958 0.408 . . . . 61.009999999999998 111.348 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -58.46 -38.52 77.71 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.098 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.21 -46.68 69.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.378 -0.373 . . . . 71.230000000000004 111.174 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.65 -33.69 71.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.232 0.456 . . . . 73.5 112.232 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -88.98 12.12 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-O 121.31 0.576 . . . . 75.400000000000006 111.461 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.19 14.23 55.89 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.361 -0.381 . . . . 51.009999999999998 113.814 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.21 9.1 53.52 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 114.194 0.438 . . . . 72.019999999999996 114.194 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.4 -20.56 63.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.592 0.59 . . . . 74.299999999999997 112.592 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 154' ' ' LEU . 34.2 pt -80.23 -35.9 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.895 0.702 . . . . 72.340000000000003 112.895 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 119.34 2.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.097 -0.573 . . . . 63.530000000000001 112.231 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -81.72 20.39 0.94 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.771 0.656 . . . . 70.209999999999994 112.771 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 t -90.81 12.3 19.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 74.439999999999998 111.97 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -83.42 -30.03 27.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.683 0.277 . . . . 60.509999999999998 111.72 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.66 -126.31 7.48 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.373 -0.442 . . . . 50.43 113.925 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -58.8 139.47 56.29 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.893 0.377 . . . . 44.009999999999998 111.73 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -54.62 -40.29 68.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.839 0.681 . . . . 42.310000000000002 112.839 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -71.81 -9.59 58.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.689 0.626 . . . . 74.150000000000006 112.689 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -97.19 -15.98 20.62 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.759 0.314 . . . . 41.25 111.263 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -49.79 -58.74 4.74 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.726 0.639 . . . . 74.120000000000005 112.726 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.43 -39.71 70.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 75.439999999999998 111.769 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -40.41 89.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.325 -0.398 . . . . 70.400000000000006 111.766 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.44 -45.84 24.49 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.012 0.434 . . . . 74.140000000000001 111.37 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.89 -56.58 11.62 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.38 0.511 . . . . 71.409999999999997 112.38 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m -67.55 -1.01 4.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.621 0.6 . . . . 75.349999999999994 112.621 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.0 t -116.93 -12.18 10.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.973 0.416 . . . . 52.119999999999997 111.54 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.05 8.54 38.82 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.17 0.433 . . . . 72.239999999999995 112.17 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.82 35.82 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.967 -0.635 . . . . 61.200000000000003 113.543 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.01 162.63 12.98 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.141 0.496 . . . . 51.140000000000001 111.355 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -111.28 99.08 7.97 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.879 0.371 . . . . 74.049999999999997 111.905 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 152' ' ' ILE . 57.4 t -93.6 103.75 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.422 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 86.4 m-20 -134.8 137.92 43.79 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.061 -0.518 . . . . 75.209999999999994 109.956 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.58 -4.69 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.056 0.761 . . . . 74.25 113.056 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 m -55.71 112.81 4.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 122.597 0.359 . . . . 74.120000000000005 111.388 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.75 119.0 3.55 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.813 2.342 . . . . 71.200000000000003 113.166 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.9 145.16 30.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.703 -0.681 . . . . 73.019999999999996 111.146 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.43 133.11 54.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.917 0.389 . . . . 20.420000000000002 111.596 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.22 48.83 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.841 -0.695 . . . . 72.120000000000005 112.795 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.3 p -159.3 177.13 11.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.94 0.4 . . . . 63.420000000000002 110.657 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mt -123.7 122.75 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.872 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -98.59 123.52 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.547 0.689 . . . . 73.310000000000002 111.66 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 19.9 tt0 -82.37 106.45 14.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.94 -0.573 . . . . 73.030000000000001 111.45 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 44.2 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 110.734 173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 CA-C-O 120.838 0.132 . . . . 73.019999999999996 113.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 74.6 t60 -140.49 105.97 5.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.908 0.385 . . . . 65.049999999999997 110.652 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG13 ' HB1' ' A' ' 76' ' ' ALA . 27.7 m -103.65 136.38 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.111 0.481 . . . . 71.409999999999997 111.649 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.88 159.52 41.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.929 -0.578 . . . . 71.540000000000006 110.737 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -93.14 123.98 36.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.879 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.61 112.29 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.021 0.439 . . . . 73.230000000000004 111.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.23 -49.36 13.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.021 -0.536 . . . . 72.530000000000001 111.459 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -164.96 139.57 5.14 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.963 0.411 . . . . 64.239999999999995 112.091 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.42 123.64 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.247 -0.433 . . . . 52.229999999999997 109.922 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -78.17 166.84 22.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.372 0.508 . . . . 75.010000000000005 112.372 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -47.26 -48.51 24.57 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.465 0.543 . . . . 65.299999999999997 112.465 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.72 -45.28 87.22 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.002 0.429 . . . . 71.450000000000003 111.769 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.42 -21.89 2.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.889 -0.672 . . . . 70.430000000000007 113.661 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.1 m -56.78 129.74 42.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.419 0.61 . . . . 74.329999999999998 111.426 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.2 t -103.74 120.97 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.81 -0.632 . . . . 74.0 112.033 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.45 122.76 33.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.428 -0.351 . . . . 73.340000000000003 110.843 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.89 149.9 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.378 0.51 . . . . 73.5 112.378 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 90.1 p -94.35 126.57 39.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 111.171 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.85 179.75 4.4 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.413 0.625 . . . . 61.240000000000002 111.962 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.4 ttm . . . . . 0 CA--C 1.535 0.391 0 CA-C-N 115.53 -0.759 . . . . 65.25 109.851 171.813 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.842 -0.059 . . . . 73.0 110.842 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -127.91 133.21 49.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 111.782 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.9 m -97.49 100.22 11.63 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.846 0.355 . . . . 64.099999999999994 110.717 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.0 mt -81.57 136.91 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.681 0.277 . . . . 74.409999999999997 111.426 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -63.72 147.42 51.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.603 0.239 . . . . 73.319999999999993 111.538 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.84 -45.8 71.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.372 0.508 . . . . 63.0 112.372 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.35 -49.96 71.23 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.286 -0.483 . . . . 61.130000000000003 113.3 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -44.15 91.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 110.856 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.449 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.49 -44.3 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.777 -0.647 . . . . 70.400000000000006 112.112 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 t -63.9 -16.34 61.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.101 0.477 . . . . 74.140000000000001 111.577 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.2 t -82.08 -6.22 59.0 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.385 -0.37 . . . . 62.119999999999997 111.731 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 22.3 m-85 -102.11 153.16 20.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 73.030000000000001 111.821 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 10.5 m120 -92.04 107.25 19.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.447 -0.342 . . . . 72.0 111.518 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.8 m-85 -85.9 114.66 22.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.28 0.474 . . . . 73.239999999999995 112.28 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -78.44 114.52 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.549 174.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -106.36 142.51 35.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.85 0.357 . . . . 64.430000000000007 110.961 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.485 HD21 HG22 ' A' ' 69' ' ' ILE . 41.7 mt . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 120.851 0.358 . . . . 72.150000000000006 111.749 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 112.797 0.666 . . . . 74.209999999999994 112.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.0 142.34 58.41 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.876 -0.602 . . . . 75.409999999999997 111.917 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.92 32.35 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.23 -0.51 . . . . 71.140000000000001 112.29 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.76 139.68 31.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.244 -0.28 . . . . 75.120000000000005 110.244 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 49.0 m -54.87 -29.23 55.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.984 0.421 . . . . 72.409999999999997 112.043 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 p -60.15 -35.67 75.83 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.909 0.707 . . . . 74.530000000000001 112.909 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 48.6 t90 -61.91 -62.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.278 0.844 . . . . 72.319999999999993 113.278 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 32.5 p90 -68.01 -28.86 67.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.875 0.694 . . . . 73.299999999999997 112.875 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.68 -36.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.06 0.457 . . . . 72.420000000000002 111.018 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -59.41 -34.93 73.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.276 0.56 . . . . 64.129999999999995 110.964 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.71 -50.56 34.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.94 -0.573 . . . . 75.209999999999994 110.405 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.0 mmmt -55.3 -36.82 66.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.774 0.657 . . . . 73.530000000000001 112.774 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.448 HG21 HG23 ' A' ' 69' ' ' ILE . 8.0 p -82.33 -5.22 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 121.059 0.457 . . . . 74.200000000000003 111.929 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.57 24.43 76.21 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.283 -0.484 . . . . 54.420000000000002 113.55 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.12 23.2 72.95 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.203 -0.522 . . . . 73.540000000000006 113.895 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -89.26 19.9 4.09 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.311 0.486 . . . . 61.119999999999997 112.311 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 65' ' ' VAL . 34.7 pt -126.73 178.49 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.921 0.391 . . . . 74.239999999999995 111.537 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.28 125.65 7.26 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.315 -0.469 . . . . 65.140000000000001 113.043 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.7 p -80.55 -13.35 59.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.742 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -94.55 13.92 22.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.204 0.446 . . . . 72.540000000000006 112.204 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.43 -32.37 58.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 73.409999999999997 111.824 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.48 -118.63 6.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.297 -0.477 . . . . 74.540000000000006 113.665 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.3 137.74 56.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.097 0.406 . . . . 75.439999999999998 112.097 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.36 -42.68 74.22 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.355 0.502 . . . . 62.25 112.355 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -68.64 -2.99 10.35 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.568 0.581 . . . . 74.310000000000002 112.568 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -100.96 -10.24 20.77 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.785 0.326 . . . . 60.109999999999999 111.537 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -61.19 -36.56 80.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.042 0.756 . . . . 70.349999999999994 113.042 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.21 -50.14 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.12 0.486 . . . . 75.140000000000001 111.2 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -61.23 -46.48 90.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.065 -0.516 . . . . 65.439999999999998 111.27 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.24 -52.54 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.085 -0.507 . . . . 62.109999999999999 111.614 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.46 -47.41 69.77 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.831 0.348 . . . . 64.420000000000002 111.665 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -59.58 -50.99 71.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.18 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.0 t -69.28 -19.85 63.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.205 0.446 . . . . 54.049999999999997 112.205 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.41 -36.03 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.081 0.401 . . . . 71.140000000000001 112.081 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.16 8.04 5.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.992 -0.623 . . . . 75.420000000000002 113.181 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -80.07 -171.34 2.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.186 0.517 . . . . 63.119999999999997 111.176 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.0 m -121.94 91.25 3.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.064 0.459 . . . . 63.109999999999999 111.359 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.27 105.17 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.0 0.428 . . . . 74.109999999999999 111.315 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -127.2 161.31 28.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 111.212 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.41 7.24 20.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.136 0.493 . . . . 71.219999999999999 110.969 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 m -72.76 112.49 15.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.318 -0.401 . . . . 41.219999999999999 110.995 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.58 22.72 0.51 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.052 2.501 . . . . 54.539999999999999 114.47 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 153' ' ' HIS . 36.4 tt0 -60.1 147.16 40.48 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.063 0.459 . . . . 62.109999999999999 111.851 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.34 166.55 21.39 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.22 0.822 . . . . 75.239999999999995 113.22 -173.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.06 31.02 44.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.703 -0.68 . . . . 71.230000000000004 112.93 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.1 m -146.75 170.63 16.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 111.273 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -107.68 133.83 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 110.254 -0.276 . . . . 75.319999999999993 110.254 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -98.89 107.82 20.35 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.986 0.898 . . . . 73.420000000000002 111.049 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -72.93 99.12 2.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 72.049999999999997 109.822 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 50.9 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.56 -0.746 . . . . 74.530000000000001 111.595 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 112.228 -0.349 . . . . 75.340000000000003 112.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -112.38 147.37 36.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 111.929 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 101' ' ' GLN . 10.1 m -142.69 141.49 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.143 -0.481 . . . . 64.439999999999998 110.667 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.03 159.63 43.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.76 0.314 . . . . 63.229999999999997 110.509 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -94.32 125.73 39.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.945 0.403 . . . . 51.149999999999999 111.667 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.42 109.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.893 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.84 -61.18 2.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.044 -0.525 . . . . 65.129999999999995 111.771 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -148.56 145.43 27.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 62.140000000000001 111.949 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.2 t -103.11 125.77 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.595 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -95.36 141.07 29.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.748 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -60.36 -21.25 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.394 -0.366 . . . . 53.420000000000002 111.852 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.23 -12.89 56.12 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.863 0.363 . . . . 74.239999999999995 111.956 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.83 45.56 4.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.93 -0.468 . . . . 64.319999999999993 111.93 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.7 p -137.17 138.6 40.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.086 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.17 119.45 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.223 -0.444 . . . . 62.43 111.57 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -88.44 112.27 22.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.86 0.362 . . . . 55.32 110.963 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.97 137.91 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.195 0.521 . . . . 64.519999999999996 112.02 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 34.5 p -86.61 115.61 24.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.07 0.462 . . . . 64.310000000000002 111.883 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.42 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 11.5 pt-20 -133.43 -179.27 5.41 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.596 . . . . 75.120000000000005 111.387 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.451 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 49.0 ttm . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.905 0.383 . . . . 53.539999999999999 111.54 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 120.819 0.342 . . . . 63.509999999999998 111.375 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -82.52 120.97 26.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.171 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 71.4 m -85.81 106.56 17.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.042 0.448 . . . . 75.140000000000001 110.923 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -97.71 139.65 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.192 -0.458 . . . . 72.510000000000005 111.658 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -69.71 154.54 41.84 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.783 0.325 . . . . 61.020000000000003 111.233 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.87 80.99 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.605 0.595 . . . . 64.129999999999995 112.605 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.26 -49.12 82.02 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.293 -0.479 . . . . 63.020000000000003 112.996 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.55 -40.98 93.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.127 0.489 . . . . 51.399999999999999 110.861 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.57 -42.57 78.83 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 111.8 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.3 t -60.96 -19.83 61.51 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.106 0.479 . . . . 64.209999999999994 111.744 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 47.4 t -77.42 -17.72 57.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.929 0.395 . . . . 71.319999999999993 111.674 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 17.0 m-85 -101.01 157.87 16.43 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.229 0.538 . . . . 72.409999999999997 111.817 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -99.74 111.04 23.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 111.333 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -87.98 106.2 17.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.063 0.459 . . . . 72.010000000000005 111.976 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.433 HD12 ' H ' ' A' ' 152' ' ' ILE . 4.1 mp -77.14 103.18 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.053 -0.521 . . . . 73.310000000000002 110.907 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' A' ' 95' ' ' GLU . 92.8 m-70 -85.16 143.09 29.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.364 . . . . 70.319999999999993 110.435 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 75.129999999999995 112.568 -166.424 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.404 0.52 . . . . 70.019999999999996 112.404 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.27 143.03 41.12 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.033 0.444 . . . . 43.219999999999999 111.946 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.95 58.19 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.086 -0.506 . . . . 45.210000000000001 113.295 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -83.52 141.59 31.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.904 0.352 . . . . 74.420000000000002 111.513 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 60' ' ' TYR . 56.6 m -59.97 -29.41 68.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.401 0.619 . . . . 45.240000000000002 111.075 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.1 p -76.08 -11.35 59.93 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.817 -0.629 . . . . 73.019999999999996 112.549 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -76.8 -62.71 1.55 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.657 0.614 . . . . 72.430000000000007 112.657 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HE2' ' HA ' ' A' ' 57' ' ' CYS . 50.5 p90 -63.72 -26.56 68.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.923 0.712 . . . . 73.109999999999999 112.923 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.465 HG21 HG23 ' A' ' 110' ' ' VAL . 46.4 t -60.68 -31.96 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.897 0.38 . . . . 74.230000000000004 111.974 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.79 -44.53 95.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.883 0.373 . . . . 72.439999999999998 111.295 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -64.63 -41.06 96.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.286 0.565 . . . . 74.510000000000005 110.565 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.9 mmmt -62.18 -32.91 73.59 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.693 -0.685 . . . . 70.140000000000001 112.28 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 HD11 ' A' ' 154' ' ' LEU . 9.2 p -96.52 6.82 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 121.334 0.588 . . . . 72.219999999999999 111.961 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.53 8.62 76.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 45.409999999999997 114.237 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.87 3.07 66.79 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.038 0.775 . . . . 34.25 115.038 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.01 17.64 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.904 -0.762 . . . . 74.420000000000002 112.705 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 pt -106.32 -29.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 111.954 0.353 . . . . 64.340000000000003 111.954 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.87 98.77 1.1 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.044 -0.598 . . . . 71.319999999999993 112.884 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 p -73.02 83.85 1.26 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.229 -0.571 . . . . 75.340000000000003 111.522 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.7 t -154.79 17.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.09 0.471 . . . . 64.239999999999995 111.318 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -89.47 -4.12 58.09 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.26 0.467 . . . . 74.299999999999997 112.26 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.63 -137.76 22.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.054 -0.593 . . . . 64.109999999999999 113.329 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -70.24 155.39 40.71 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.502 -0.411 . . . . 73.219999999999999 111.57 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -56.84 -32.12 65.45 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.828 0.677 . . . . 60.140000000000001 112.828 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.93 -28.61 57.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.328 0.492 . . . . 75.319999999999993 112.328 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.33 -16.53 24.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.286 0.476 . . . . 73.239999999999995 112.286 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 6.6 m0 -50.22 -66.02 0.46 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.964 1.098 . . . . 73.340000000000003 113.964 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.5 -33.71 68.31 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.298 0.481 . . . . 52.399999999999999 112.298 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -67.31 -48.02 68.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.057 0.456 . . . . 74.109999999999999 110.835 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.52 96.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.357 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.96 44.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.298 -0.41 . . . . 73.329999999999998 111.105 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -61.07 -40.0 92.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.892 0.377 . . . . 62.539999999999999 110.939 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -63.62 -27.58 69.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.301 -0.408 . . . . 62.240000000000002 111.379 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.27 -12.18 41.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.945 0.402 . . . . 63.329999999999998 111.898 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.51 52.69 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.261 -0.495 . . . . 72.319999999999993 113.693 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -70.51 175.52 4.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.333 0.587 . . . . 74.219999999999999 112.012 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -101.01 92.03 4.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.053 -0.521 . . . . 64.200000000000003 111.506 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 152' ' ' ILE . 22.0 t -99.8 93.48 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.916 0.389 . . . . 71.120000000000005 111.024 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -122.5 168.2 12.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.543 -0.299 . . . . 71.5 110.529 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.35 5.92 32.47 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.931 -0.481 . . . . 75.099999999999994 111.767 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 44.2 m -65.21 109.06 2.5 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 116.729 -0.214 . . . . 65.099999999999994 110.829 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 6.2 Cg_exo -79.14 8.85 3.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.302 2.668 . . . . 74.420000000000002 113.968 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.01 145.26 17.1 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.333 0.494 . . . . 75.120000000000005 112.333 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.72 46.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.877 -0.601 . . . . 54.149999999999999 112.587 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.28 55.5 1.69 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.001 -0.619 . . . . 70.420000000000002 111.803 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.6 t -163.01 165.35 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.305 0.574 . . . . 50.509999999999998 111.85 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 35.2 mt -116.58 125.38 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.644 -0.707 . . . . 65.400000000000006 110.479 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.8 pt? -99.43 133.14 44.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.928 0.394 . . . . 65.25 111.396 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -102.4 133.18 47.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.399 0.518 . . . . 73.140000000000001 112.399 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.473 0.684 0 CA-C-N 116.033 -0.53 . . . . 74.549999999999997 110.38 171.662 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.152 0.306 . . . . 63.229999999999997 113.038 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -140.73 137.27 33.33 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.857 -0.202 . . . . 65.150000000000006 110.817 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.3 m -138.68 141.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.923 0.392 . . . . 54.130000000000003 111.499 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.09 22.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.96 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -101.37 133.73 45.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.02 0.438 . . . . 71.019999999999996 111.44 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.41 110.1 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 111.646 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.43 -53.38 9.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.09 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -156.57 143.36 18.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.041 0.448 . . . . 61.450000000000003 112.135 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.71 135.0 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.386 -0.37 . . . . 63.25 110.926 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -92.17 154.7 18.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.369 -0.378 . . . . 63.43 111.304 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -59.18 -24.25 62.92 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.84 0.352 . . . . 65.430000000000007 111.688 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.17 -11.52 60.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.926 0.393 . . . . 71.329999999999998 111.717 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.65 56.47 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.385 -0.436 . . . . 42.219999999999999 112.968 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.1 m -64.84 126.43 27.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.11 0.481 . . . . 64.409999999999997 111.423 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.4 t -103.19 129.74 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.957 -0.565 . . . . 50.009999999999998 111.32 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.14 112.96 26.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.857 0.361 . . . . 75.099999999999994 111.415 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.0 162.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.964 0.412 . . . . 73.510000000000005 111.81 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.42 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 61.7 p -117.03 133.91 55.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.13 0.49 . . . . 72.230000000000004 111.614 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -129.51 152.09 49.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.12 -0.491 . . . . 53.119999999999997 111.047 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.0 ttm . . . . . 0 N--CA 1.466 0.336 0 O-C-N 121.902 -0.499 . . . . 61.450000000000003 109.96 172.11 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.605 0.24 . . . . 65.329999999999998 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.22 109.8 6.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 110.866 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 79.9 m -85.02 139.28 31.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.445 -0.343 . . . . 53.310000000000002 111.569 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.6 mt -123.52 149.08 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.758 0.423 . . . . 43.310000000000002 110.87 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 m -64.53 156.77 28.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.11 0.164 . . . . 61.039999999999999 110.838 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.67 -63.22 1.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.086 0.402 . . . . 64.439999999999998 112.086 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.66 -38.1 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.204 -0.522 . . . . 71.109999999999999 112.956 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.51 -36.26 80.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.006 0.522 . . . . 64.450000000000003 110.991 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.41 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -71.62 -43.63 65.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.106 -0.497 . . . . 61.399999999999999 111.529 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 t -59.23 -15.73 16.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 111.965 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.7 t -70.07 -25.28 63.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.925 0.393 . . . . 64.010000000000005 111.575 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -87.4 154.56 20.57 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.242 0.544 . . . . 72.430000000000007 111.895 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -89.3 119.76 30.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.952 -0.567 . . . . 64.409999999999997 110.828 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 95.5 m-85 -100.91 117.07 34.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.634 0.605 . . . . 55.549999999999997 112.634 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -91.35 121.03 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.127 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -113.76 157.31 22.41 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.901 0.481 . . . . 71.439999999999998 110.96 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.499 HD11 HG22 ' A' ' 65' ' ' VAL . 34.2 mt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.49 0.552 . . . . 73.310000000000002 112.49 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 95.93 0.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.021 -0.536 . . . . 75.099999999999994 111.917 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.21 -22.74 0.87 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.955 -0.566 . . . . 52.149999999999999 112.679 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -80.31 146.89 31.37 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 111.713 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.6 m -57.87 -38.52 75.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.56 0.695 . . . . 64.340000000000003 110.448 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.9 p -62.7 -24.33 67.6 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.487 -0.779 . . . . 72.409999999999997 112.274 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -62.59 -65.28 0.71 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.334 0.494 . . . . 65.140000000000001 112.334 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -66.97 -29.08 68.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.537 0.569 . . . . 73.230000000000004 112.537 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 57' ' ' CYS . 61.1 t -61.37 -37.63 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 111.426 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -57.97 -47.82 81.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.978 0.418 . . . . 75.319999999999993 110.845 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.14 -38.69 72.25 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.944 0.35 . . . . 62.32 111.944 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -56.07 -38.39 70.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.998 0.428 . . . . 72.319999999999993 111.855 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' ILE . 8.8 p -88.39 9.37 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 121.388 0.613 . . . . 51.329999999999998 111.456 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.68 -2.87 77.3 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.336 -0.393 . . . . 33.439999999999998 113.703 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.31 14.56 66.06 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.998 -0.62 . . . . 63.229999999999997 113.143 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.82 10.38 6.4 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.199 0.444 . . . . 73.129999999999995 112.199 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 pt -110.5 174.1 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.799 0.333 . . . . 53.409999999999997 111.118 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.6 124.31 6.76 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.93 -0.652 . . . . 54.329999999999998 114.013 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.3 p -65.5 -19.39 65.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.026 0.441 . . . . 75.400000000000006 111.13 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 t -78.58 -6.94 56.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.809 0.67 . . . . 64.140000000000001 112.809 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -61.33 -43.51 98.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.153 -0.342 . . . . 74.519999999999996 111.684 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.89 -116.29 5.92 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 114.246 0.458 . . . . 71.540000000000006 114.246 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -57.66 132.47 53.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.197 0.444 . . . . 72.0 112.197 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.96 -40.55 80.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.178 0.513 . . . . 41.399999999999999 111.885 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -66.91 -19.3 65.7 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.394 0.616 . . . . 72.530000000000001 110.767 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.9 -17.51 23.92 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.055 -0.521 . . . . 74.109999999999999 112.387 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.401 ' CZ3' HG21 ' A' ' 99' ' ' ILE . 10.7 m0 -47.56 -47.07 28.4 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.345 0.868 . . . . 73.530000000000001 113.345 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.415 ' H ' ' NE2' ' A' ' 101' ' ' GLN . . . -59.22 -46.48 88.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.83 0.348 . . . . 50.509999999999998 111.701 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.6 t -59.43 -38.91 81.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.004 0.43 . . . . 41.310000000000002 111.439 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.45 -59.51 2.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 111.277 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -50.47 -52.65 36.26 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.685 0.624 . . . . 73.150000000000006 112.685 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 p -55.64 -53.52 55.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 111.998 0.37 . . . . 71.030000000000001 111.998 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -72.14 -22.1 61.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.233 0.457 . . . . 74.310000000000002 112.233 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.64 -17.55 50.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.197 0.443 . . . . 63.509999999999998 112.197 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 25.39 5.46 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.003 -0.617 . . . . 73.540000000000006 113.803 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.412 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 65.6 m-85 -100.72 -176.38 3.17 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.446 -0.444 . . . . 70.310000000000002 110.732 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 63.8 m -109.19 93.0 4.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.741 0.305 . . . . 73.040000000000006 111.772 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 152' ' ' ILE . 46.8 t -97.02 91.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.22 0.533 . . . . 73.219999999999999 111.018 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -122.58 163.94 19.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.004 -0.544 . . . . 62.340000000000003 110.531 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.87 -7.47 57.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.11 -0.369 . . . . 74.549999999999997 111.166 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -51.45 106.05 0.6 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 116.382 -0.372 . . . . 64.209999999999994 110.86 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -84.25 13.24 2.78 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.832 2.355 . . . . 63.520000000000003 114.796 -168.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.24 151.46 36.21 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.929 0.714 . . . . 74.010000000000005 112.929 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.58 160.3 11.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.44 -0.8 . . . . 73.019999999999996 112.892 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.4 32.97 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.192 -0.528 . . . . 63.25 112.273 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -145.55 164.91 30.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.822 0.344 . . . . 53.409999999999997 110.715 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -100.86 117.42 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.059 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD13 HG11 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -79.35 136.87 37.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 72.5 110.601 174.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' NE2' ' H ' ' A' ' 80' ' ' ALA . 31.0 tt0 -120.06 104.54 10.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.835 0.35 . . . . 74.400000000000006 111.335 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 50.8 m . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.939 0.399 . . . . 74.340000000000003 110.811 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 N-CA-C 113.929 0.332 . . . . 72.25 113.929 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 46.7 t60 -138.42 149.73 45.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.819 0.447 . . . . 75.010000000000005 110.747 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.504 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.0 m -141.17 143.95 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.439 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.67 23.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 111.681 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -80.64 133.68 35.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.246 -0.284 . . . . 75.430000000000007 110.989 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.46 114.34 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.025 0.441 . . . . 53.340000000000003 111.91 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -79.28 -41.49 27.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.912 -0.586 . . . . 75.319999999999993 111.686 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -167.85 151.95 6.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.909 0.385 . . . . 72.109999999999999 111.809 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.25 122.21 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.638 0.256 . . . . 71.239999999999995 110.685 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -83.05 160.97 21.84 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.15 0.426 . . . . 73.310000000000002 112.15 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -56.07 -22.5 28.05 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.029 0.443 . . . . 75.319999999999993 111.545 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.76 -9.11 17.9 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.135 -0.484 . . . . 71.25 112.0 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.54 89.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.338 -0.458 . . . . 74.340000000000003 112.272 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 m -88.45 131.48 34.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.147 0.498 . . . . 75.239999999999995 111.663 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.07 119.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.349 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.59 107.91 20.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.687 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 100' ' ' LEU . 34.4 m -105.2 161.87 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.551 0.574 . . . . 63.420000000000002 112.551 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.2 t -95.81 123.73 39.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.037 -0.529 . . . . 72.329999999999998 111.874 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -126.51 150.0 49.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.129 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.7 ttm . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.747 0.308 . . . . 72.109999999999999 110.234 175.431 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.116 0.484 . . . . 72.150000000000006 111.715 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.43 118.57 31.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.306 -0.407 . . . . 75.549999999999997 110.841 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.4 m -90.69 105.27 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.134 0.493 . . . . 75.019999999999996 111.866 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.51 133.54 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.073 0.549 . . . . 72.349999999999994 111.102 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -72.85 157.95 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.157 0.428 . . . . 75.099999999999994 112.157 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.46 72.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.688 0.625 . . . . 53.109999999999999 112.688 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.06 -45.88 86.2 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.305 -0.474 . . . . 60.039999999999999 112.997 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.61 -40.56 95.72 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.416 0.627 . . . . 71.430000000000007 110.878 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.93 -21.11 64.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.641 -0.708 . . . . 71.540000000000006 112.689 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.4 p -65.73 -13.16 58.79 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.317 0.488 . . . . 61.439999999999998 112.317 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 39.0 t -102.49 2.21 36.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 111.865 0.32 . . . . 70.450000000000003 111.865 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -103.68 146.09 29.1 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.21 -0.306 . . . . 70.329999999999998 110.94 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -94.23 139.59 30.85 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.539 0.209 . . . . 51.210000000000001 110.943 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 100' ' ' LEU . 91.3 m-85 -117.22 116.98 28.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 73.450000000000003 111.797 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.3 mp -89.05 113.44 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.358 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 13.4 m-70 -99.97 136.06 40.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.082 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 112.481 0.549 . . . . 72.140000000000001 112.481 -177.18 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 111.998 0.37 . . . . 51.140000000000001 111.998 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.72 124.3 28.92 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.852 0.358 . . . . 74.349999999999994 111.871 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.54 21.39 5.12 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.43 -0.414 . . . . 70.109999999999999 113.1 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -129.72 152.38 49.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.568 -0.372 . . . . 70.099999999999994 111.215 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.4 p -63.1 -35.76 81.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.945 0.403 . . . . 70.030000000000001 110.615 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -61.5 -26.59 68.01 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.059 0.456 . . . . 70.209999999999994 111.397 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -78.91 -55.69 4.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.049 -0.523 . . . . 65.430000000000007 110.869 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.05 -52.77 63.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.883 -0.599 . . . . 73.540000000000006 112.499 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.4 t -58.99 -31.99 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.301 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.41 -35.95 82.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.151 0.501 . . . . 65.329999999999998 110.667 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.96 -44.18 73.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.797 -0.638 . . . . 75.019999999999996 111.142 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.282 0.475 . . . . 74.209999999999994 112.282 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HG12 ' A' ' 69' ' ' ILE . 9.4 p -88.42 8.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 121.083 0.468 . . . . 71.030000000000001 111.563 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.05 67.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.403 -0.427 . . . . 72.400000000000006 113.814 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.15 15.15 64.92 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.18 -0.533 . . . . 32.210000000000001 113.477 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.38 -5.88 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.218 0.451 . . . . 73.109999999999999 112.218 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.405 HG12 HG11 ' A' ' 65' ' ' VAL . 35.5 pt -98.79 140.93 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.559 -0.291 . . . . 72.049999999999997 110.495 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.16 125.14 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.9 -0.667 . . . . 71.239999999999995 113.586 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -66.36 78.31 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.182 0.515 . . . . 63.030000000000001 111.355 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -151.96 13.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.385 0.612 . . . . 74.200000000000003 110.905 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.66 -34.32 12.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.911 -0.586 . . . . 55.340000000000003 111.446 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.36 -130.92 10.02 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.184 -0.531 . . . . 53.140000000000001 113.344 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -67.11 151.25 47.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.3 0.572 . . . . 63.030000000000001 111.757 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.01 -33.92 67.65 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.863 1.06 . . . . 64.519999999999996 113.863 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.09 -28.08 69.2 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.848 -0.532 . . . . 72.040000000000006 112.032 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -84.63 -14.56 48.3 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.685 0.279 . . . . 62.210000000000001 111.604 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.409 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 8.2 m0 -51.02 -62.54 1.55 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.114 0.783 . . . . 72.430000000000007 113.114 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.57 -43.55 72.16 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.271 0.471 . . . . 73.409999999999997 112.271 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -60.91 -48.47 81.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.14 0.495 . . . . 73.439999999999998 111.508 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.12 60.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.148 -0.478 . . . . 71.200000000000003 111.455 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.65 7.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.355 -0.384 . . . . 74.530000000000001 111.025 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 p -62.14 -37.32 84.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.132 0.492 . . . . 55.240000000000002 110.941 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -64.25 -38.33 90.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.004 -0.543 . . . . 61.240000000000002 111.951 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.42 -6.01 58.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.676 0.621 . . . . 71.349999999999994 112.676 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.83 -2.3 25.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.938 -0.649 . . . . 74.319999999999993 113.574 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -76.36 170.32 16.58 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.305 0.574 . . . . 71.540000000000006 111.087 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.9 m -115.43 103.57 10.9 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.216 0.451 . . . . 73.340000000000003 112.216 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 152' ' ' ILE . 46.6 t -102.16 119.41 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 70.209999999999994 111.84 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -143.62 168.57 19.57 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.135 -0.484 . . . . 72.310000000000002 110.329 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.48 12.59 9.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.825 0.345 . . . . 70.420000000000002 111.53 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -65.73 108.99 2.54 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 110.624 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.68 14.0 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.042 2.495 . . . . 72.329999999999998 114.419 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -61.69 149.56 39.22 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.179 0.514 . . . . 74.329999999999998 111.985 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -60.51 152.47 25.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.953 0.723 . . . . 51.340000000000003 112.953 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.58 23.79 38.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.164 -0.471 . . . . 62.240000000000002 113.192 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.3 p -131.25 159.28 38.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 111.112 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.3 mp -103.42 119.69 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.327 -0.397 . . . . 63.25 110.521 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -96.07 130.22 43.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 30.1 tt0 -95.56 124.29 39.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.056 -0.52 . . . . 71.219999999999999 112.159 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 115.877 -0.601 . . . . 72.109999999999999 110.734 171.011 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 CA-C-O 120.988 0.215 . . . . 63.100000000000001 113.141 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -147.84 149.18 31.81 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.374 -0.486 . . . . 72.310000000000002 111.032 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.541 HG13 ' HB1' ' A' ' 76' ' ' ALA . 13.5 m -141.57 151.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.083 0.468 . . . . 73.519999999999996 111.779 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -149.26 167.79 25.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.992 -0.549 . . . . 71.109999999999999 110.996 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -102.94 129.76 49.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.25 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 96' ' ' ALA . 70.8 t -80.81 110.93 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 63.340000000000003 111.494 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -83.82 -45.58 13.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.08 0.4 . . . . 74.430000000000007 112.08 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -158.89 148.47 19.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.498 0.555 . . . . 73.25 112.498 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -109.71 134.7 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 63.310000000000002 110.638 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.96 160.87 14.38 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.297 0.48 . . . . 73.329999999999998 112.297 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -61.6 -22.4 65.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.103 -0.499 . . . . 62.439999999999998 111.413 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.64 -15.47 63.67 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.984 -0.553 . . . . 70.140000000000001 111.425 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.61 67.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.035 -0.426 . . . . 71.099999999999994 112.035 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 141.75 49.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.215 0.531 . . . . 74.430000000000007 111.894 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.32 128.32 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.857 -0.611 . . . . 72.129999999999995 111.981 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.28 117.27 29.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.941 0.4 . . . . 73.109999999999999 111.272 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.95 147.51 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 111.717 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.9 p -101.07 125.06 47.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.407 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 -179.68 5.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.384 0.611 . . . . 73.219999999999999 112.456 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 CA--C 1.537 0.46 0 CA-C-N 115.896 -0.593 . . . . 74.409999999999997 110.822 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 112.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.46 135.86 25.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.979 0.419 . . . . 73.439999999999998 111.526 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.3 m -95.05 99.76 11.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.075 0.464 . . . . 71.219999999999999 111.097 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.31 134.27 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.316 -0.402 . . . . 62.399999999999999 111.292 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 62.0 m -66.86 149.35 50.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.767 0.318 . . . . 61.219999999999999 111.562 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.85 66.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.582 0.586 . . . . 61.310000000000002 112.582 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.32 -38.47 86.77 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.408 -0.425 . . . . 54.240000000000002 113.564 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -83.09 -39.22 21.42 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.455 -0.438 . . . . 73.209999999999994 111.073 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -70.19 -42.51 72.29 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.802 0.667 . . . . 63.409999999999997 112.802 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.8 m -66.42 -14.41 62.13 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.918 0.389 . . . . 73.030000000000001 111.978 -171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -85.28 -10.84 55.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.428 -0.351 . . . . 61.130000000000003 111.551 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.428 ' CD2' HD12 ' A' ' 100' ' ' LEU . 25.4 m-85 -83.78 151.73 25.03 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.91 0.386 . . . . 72.140000000000001 111.175 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 81.5 m-20 -89.09 112.91 23.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.544 -0.298 . . . . 55.439999999999998 111.337 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.13 117.44 29.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.899 0.381 . . . . 60.140000000000001 111.646 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.7 mp -84.79 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.963 0.411 . . . . 63.32 111.022 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.71 147.53 44.47 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.751 0.42 . . . . 73.409999999999997 110.667 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 112.709 0.633 . . . . 44.219999999999999 112.709 -174.518 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.995 0.739 . . . . 71.120000000000005 112.995 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.73 37.72 0.24 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.607 0.595 . . . . 75.129999999999995 112.607 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.24 16.9 1.9 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.615 -0.326 . . . . 64.040000000000006 112.845 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -124.26 137.36 54.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.391 0.276 . . . . 74.030000000000001 110.682 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 m -60.97 -17.82 53.83 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.235 0.54 . . . . 53.509999999999998 111.688 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.5 p -78.53 -26.94 45.9 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.253 0.549 . . . . 73.140000000000001 111.734 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -56.87 -67.17 0.34 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 41.1 p90 -62.83 -28.19 69.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.092 0.405 . . . . 62.020000000000003 112.092 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -71.56 -36.18 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.875 0.369 . . . . 64.5 111.604 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.73 -35.47 63.73 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.5 111.747 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.64 -43.34 38.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.81 0.338 . . . . 75.219999999999999 111.263 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.01 -29.97 70.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.095 0.406 . . . . 60.310000000000002 112.095 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 2.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.289 0.566 . . . . 74.420000000000002 111.491 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.08 22.78 77.36 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.35 -0.387 . . . . 73.140000000000001 113.686 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.43 21.9 55.14 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.769 0.667 . . . . 32.549999999999997 114.769 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -82.23 3.9 25.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.571 0.685 . . . . 63.119999999999997 112.222 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -111.98 144.83 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.756 0.312 . . . . 60.100000000000001 111.601 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.55 112.07 4.1 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.272 -0.49 . . . . 74.030000000000001 112.797 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.2 p -68.46 -7.55 32.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.506 0.558 . . . . 72.040000000000006 112.506 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 t -65.12 -2.86 3.13 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.947 0.721 . . . . 64.010000000000005 112.947 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -64.83 -27.25 68.75 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.912 0.387 . . . . 73.109999999999999 111.838 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.3 -130.85 10.5 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.205 -0.522 . . . . 75.409999999999997 112.896 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -82.31 168.28 17.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.316 0.579 . . . . 64.450000000000003 111.717 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -73.28 16.55 0.17 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.861 1.06 . . . . 72.200000000000003 113.861 -170.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -101.45 -28.08 12.77 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.969 0.414 . . . . 63.219999999999999 111.632 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -95.82 -3.0 46.4 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.33 0.492 . . . . 71.140000000000001 112.33 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.408 ' HZ3' HD13 ' A' ' 99' ' ' ILE . 10.2 m0 -55.8 -56.48 20.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.842 0.682 . . . . 75.439999999999998 112.842 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.0 69.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.987 0.422 . . . . 75.319999999999993 112.016 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.1 t -66.86 -54.92 17.49 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.114 -0.494 . . . . 53.200000000000003 111.581 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.92 72.88 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.92 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -49.11 -57.22 7.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.609 0.364 . . . . 71.510000000000005 111.525 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.6 p -62.18 -39.67 93.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.973 0.416 . . . . 72.200000000000003 111.135 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -25.39 63.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.305 -0.407 . . . . 75.310000000000002 111.696 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.73 15.4 25.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.164 0.431 . . . . 61.219999999999999 112.164 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.55 -21.22 47.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.997 -0.621 . . . . 62.049999999999997 113.993 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.433 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.7 m-85 -63.6 154.98 31.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.476 0.638 . . . . 72.540000000000006 111.171 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 27.6 m -99.41 95.87 7.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.403 0.52 . . . . 72.430000000000007 112.403 -170.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.463 HG22 HG13 ' A' ' 152' ' ' ILE . 60.7 t -94.81 111.46 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.732 0.301 . . . . 72.049999999999997 111.383 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -133.29 174.77 10.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.603 -0.271 . . . . 72.019999999999996 111.161 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.64 0.52 52.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.968 0.413 . . . . 62.530000000000001 110.706 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.3 t -68.36 115.55 30.71 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.687 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -80.77 7.21 5.0 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.79 2.327 . . . . 73.310000000000002 113.276 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 137.74 5.41 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.171 0.434 . . . . 74.439999999999998 112.171 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.64 156.81 3.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.195 0.813 . . . . 42.520000000000003 113.195 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 26.01 57.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.93 -0.577 . . . . 71.420000000000002 113.016 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -129.38 175.99 8.32 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.272 0.558 . . . . 71.409999999999997 111.766 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 55.0 mt -129.92 128.13 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 62.409999999999997 110.57 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -101.63 138.47 38.58 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.906 -0.496 . . . . 71.200000000000003 111.523 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -103.41 110.83 22.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 111.193 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.59 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 56.1 m . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 112.95 0.722 . . . . 63.109999999999999 112.95 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 111.064 -0.814 . . . . 74.430000000000007 111.064 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 59.4 t60 -168.2 134.87 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.651 0.725 . . . . 52.100000000000001 111.473 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG13 ' HB1' ' A' ' 76' ' ' ALA . 30.1 m -141.67 143.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.007 -0.542 . . . . 52.020000000000003 110.927 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.77 156.51 45.0 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.734 0.302 . . . . 61.219999999999999 111.005 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -89.58 129.19 36.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.868 0.366 . . . . 63.549999999999997 111.336 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -75.32 116.83 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.03 0.443 . . . . 63.43 111.529 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -75.74 -54.95 6.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.914 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -158.28 164.89 35.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.239 0.542 . . . . 73.340000000000003 111.778 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.45 129.88 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.06 -0.518 . . . . 64.319999999999993 110.835 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -85.24 145.62 27.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.295 -0.253 . . . . 74.549999999999997 110.596 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.1 m -59.71 -21.82 61.16 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.031 0.443 . . . . 70.340000000000003 111.212 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.46 -23.8 67.1 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.015 -0.539 . . . . 75.319999999999993 111.723 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.6 -20.31 29.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 112.1 -0.4 . . . . 24.52 112.1 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.0 m -68.66 135.72 51.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.862 0.363 . . . . 61.030000000000001 111.527 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.45 136.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.362 -0.381 . . . . 54.450000000000003 111.701 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.99 117.68 32.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.539 -0.3 . . . . 72.420000000000002 110.588 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.33 156.94 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.956 0.408 . . . . 73.450000000000003 111.933 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 p -110.96 123.89 51.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.965 0.412 . . . . 73.430000000000007 111.191 177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 38.6 mt-10 -128.86 151.65 49.38 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.244 -0.434 . . . . 71.450000000000003 111.65 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.4 tpp . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 120.926 0.393 . . . . 75.310000000000002 111.794 -178.155 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.241 0.543 . . . . 75.040000000000006 112.077 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -149.9 128.05 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.975 -0.557 . . . . 74.209999999999994 110.59 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.1 m -99.87 113.37 25.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.434 -0.348 . . . . 71.030000000000001 110.707 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.85 134.24 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.708 0.289 . . . . 75.430000000000007 111.243 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -63.13 151.73 39.29 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.068 0.396 . . . . 73.400000000000006 112.068 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.82 61.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.718 0.636 . . . . 43.310000000000002 112.718 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.47 -37.91 56.82 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.506 -0.378 . . . . 62.25 113.808 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -94.96 -51.32 4.72 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.526 -0.397 . . . . 61.229999999999997 111.106 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.23 67.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.778 0.658 . . . . 63.32 112.778 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -64.19 -14.33 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.591 0.589 . . . . 62.340000000000003 112.591 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.2 t -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.057 0.456 . . . . 72.420000000000002 111.015 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 23.9 m-85 -72.59 152.33 41.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.859 -0.609 . . . . 65.099999999999994 112.127 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -84.67 117.63 23.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.467 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 97.3 m-85 -96.48 113.98 25.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 111.969 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.8 mp -79.29 129.54 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.448 -0.342 . . . . 71.040000000000006 110.447 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 50.8 m-70 -119.46 152.03 37.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 110.865 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 57.1 mt . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 111.809 -177.625 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 111.864 0.32 . . . . 54.240000000000002 111.864 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.63 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.179 0.514 . . . . 63.219999999999999 112.004 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.72 -40.57 0.53 Allowed Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 112.763 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.57 144.54 56.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.754 0.311 . . . . 65.010000000000005 111.447 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 29.7 p -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.237 0.541 . . . . 73.450000000000003 110.974 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 p -66.01 -15.87 63.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.837 -0.619 . . . . 72.120000000000005 112.121 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -76.18 -60.83 2.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.007 0.373 . . . . 74.400000000000006 112.007 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 18.4 p90 -71.88 -30.6 65.57 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.75 0.648 . . . . 71.230000000000004 112.75 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.97 -32.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 110.469 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.2 -39.77 79.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.769 -0.651 . . . . 71.430000000000007 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.74 -37.51 76.5 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.341 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 125' ' ' SER . 30.4 mmmt -56.17 -33.58 65.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.913 0.387 . . . . 72.510000000000005 111.696 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.7 p -102.34 15.37 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.602 0.715 . . . . 61.0 111.163 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.9 -1.3 17.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.25 -0.432 . . . . 72.040000000000006 113.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.03 10.8 77.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.351 -0.452 . . . . 61.25 113.361 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -79.28 38.1 0.35 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.312 0.486 . . . . 73.439999999999998 112.312 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD21 ' A' ' 154' ' ' LEU . 20.5 pt -134.78 -41.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.21 100.24 2.49 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.911 -0.661 . . . . 65.5 113.353 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.0 p -80.24 43.57 0.64 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.199 0.444 . . . . 63.539999999999999 112.199 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 t -126.28 18.46 7.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.957 0.408 . . . . 71.329999999999998 112.084 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -91.17 11.67 22.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.849 0.685 . . . . 63.119999999999997 112.849 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.05 -143.44 28.69 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 113.596 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.08 152.42 45.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.521 -0.4 . . . . 61.119999999999997 111.104 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.53 -38.43 59.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.514 0.561 . . . . 52.240000000000002 112.514 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -61.31 -25.97 67.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.346 0.499 . . . . 62.340000000000003 112.346 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -94.56 -5.81 45.07 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.25 -0.281 . . . . 43.25 111.508 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.16 -56.26 21.88 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.373 0.509 . . . . 75.319999999999993 112.373 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.417 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -61.78 -40.92 96.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.861 0.363 . . . . 62.340000000000003 111.846 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -35.58 81.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.4 -0.363 . . . . 72.510000000000005 111.784 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.49 -45.9 24.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.615 0.228 . . . . 72.25 111.615 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.53 -55.42 25.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.936 0.398 . . . . 75.219999999999999 111.694 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 p -57.1 -49.41 75.97 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 111.283 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.7 t -65.7 -15.54 62.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.242 0.46 . . . . 51.409999999999997 112.242 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.84 3.47 54.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.924 0.392 . . . . 73.25 111.654 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.52 -4.44 73.03 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.3 -0.476 . . . . 75.109999999999999 113.657 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -75.15 170.4 16.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 111.565 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -99.88 97.21 8.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 112.353 -170.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.38 91.98 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.146 0.498 . . . . 64.409999999999997 110.692 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.77 138.42 53.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.677 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -76.71 13.33 1.03 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.48 0.918 . . . . 52.409999999999997 113.48 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -65.85 114.02 14.51 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 110.02 -0.363 . . . . 71.129999999999995 110.02 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.14 22.19 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.942 2.428 . . . . 55.25 114.543 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.5 mt-10 -74.44 159.81 31.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.529 0.681 . . . . 71.340000000000003 112.695 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.56 5.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.323 -0.853 . . . . 75.409999999999997 113.086 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.22 40.91 40.31 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.874 -0.603 . . . . 64.329999999999998 112.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.2 p -152.25 167.19 29.4 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.568 -0.372 . . . . 65.200000000000003 111.125 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.6 mp -112.78 122.95 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.602 -0.272 . . . . 72.5 110.351 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 149' ' ' TYR . 1.7 pt? -86.41 138.36 31.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 64.010000000000005 110.893 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -112.37 109.4 19.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.355 -0.384 . . . . 63.149999999999999 110.561 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.472 0.669 0 CA-C-N 116.313 -0.403 . . . . 74.329999999999998 111.476 -179.163 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 CA-C-O 121.052 0.251 . . . . 74.099999999999994 112.94 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -148.98 143.55 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.511 -0.405 . . . . 74.109999999999999 111.421 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.77 153.92 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.048 0.451 . . . . 72.120000000000005 111.615 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.48 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.577 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -95.4 126.18 40.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.001 0.429 . . . . 64.109999999999999 111.627 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.403 HG22 HG12 ' A' ' 124' ' ' VAL . 42.6 t -74.99 108.21 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.068 -0.515 . . . . 74.239999999999995 111.682 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.75 -48.65 14.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.066 -0.515 . . . . 74.230000000000004 111.443 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -154.4 154.7 33.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.284 -0.417 . . . . 74.120000000000005 110.913 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 95' ' ' GLU . 45.2 t -123.65 111.0 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.874 0.368 . . . . 55.049999999999997 111.094 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -64.95 131.96 48.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.483 -0.326 . . . . 70.209999999999994 111.566 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.6 p -60.78 -19.01 58.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.835 0.35 . . . . 53.119999999999997 111.596 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 -16.72 64.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.882 0.372 . . . . 73.219999999999999 111.788 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.37 57.51 0.59 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.303 -0.475 . . . . 43.409999999999997 113.067 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -151.64 136.29 17.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.735 0.303 . . . . 74.030000000000001 111.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.93 116.1 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.269 -0.423 . . . . 61.210000000000001 110.912 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -90.22 104.85 17.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.874 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 113' ' ' VAL . 33.2 m -108.51 132.84 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.154 0.502 . . . . 55.439999999999998 111.907 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.505 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 32.0 t -89.28 114.23 25.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.425 -0.352 . . . . 64.519999999999996 111.17 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -131.05 147.31 52.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.532 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.41 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 40.8 ttm . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 121.093 0.473 . . . . 71.349999999999994 110.863 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 121.331 0.586 . . . . 63.109999999999999 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -83.91 107.12 16.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.905 -0.589 . . . . 64.019999999999996 112.215 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.1 m -86.73 112.91 22.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 111.248 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.1 mt -111.87 139.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.391 -0.368 . . . . 75.430000000000007 111.568 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.5 m -58.45 133.81 56.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.621 0.248 . . . . 74.530000000000001 111.399 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.22 73.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.191 0.441 . . . . 52.009999999999998 112.191 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -52.25 40.04 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.203 -0.523 . . . . 71.109999999999999 112.965 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.48 -44.72 77.87 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.163 0.506 . . . . 55.43 110.859 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.438 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.84 -30.69 70.25 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.196 0.813 . . . . 34.149999999999999 113.196 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.9 t -58.49 -23.74 58.67 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.807 0.669 . . . . 63.530000000000001 112.807 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.5 t -76.17 -19.45 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.021 0.439 . . . . 71.25 111.79 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 11.0 m-85 -83.67 147.9 27.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.934 0.397 . . . . 75.219999999999999 110.965 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.8 121.41 33.4 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.333 -0.229 . . . . 75.340000000000003 111.274 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.438 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 54.4 m-85 -98.21 121.85 40.65 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.132 0.492 . . . . 74.120000000000005 112.005 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.68 121.74 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.354 -0.385 . . . . 65.420000000000002 110.423 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -115.38 147.35 40.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.548 0.339 . . . . 75.409999999999997 110.57 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 HG22 ' A' ' 69' ' ' ILE . 86.9 mt . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.321 0.489 . . . . 73.310000000000002 112.321 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.28 86.5 0.41 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 112.078 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.29 -29.88 0.36 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.871 -0.681 . . . . 15.43 113.7 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.49 151.1 30.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 111.852 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.6 m -54.67 -40.95 69.59 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.834 -0.621 . . . . 71.209999999999994 112.248 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -62.82 -24.19 67.64 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 74.109999999999999 112.151 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -60.99 -47.89 84.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.222 0.453 . . . . 73.400000000000006 112.222 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 126' ' ' GLU . 25.0 p90 -80.63 -39.69 26.98 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.172 -0.33 . . . . 72.230000000000004 111.624 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 57' ' ' CYS . 45.6 t -57.23 -41.89 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.879 0.371 . . . . 74.319999999999993 111.74 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.01 -38.47 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.175 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.51 -39.58 37.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 111.003 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.2 mmmt -53.22 -44.81 68.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.928 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.95 -22.43 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 111.962 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.2 30.19 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.169 -0.538 . . . . 62.509999999999998 113.656 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.91 -14.89 35.09 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.321 -0.466 . . . . 75.030000000000001 114.144 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.41 68.81 4.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.303 -0.528 . . . . 74.310000000000002 112.118 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 70' ' ' GLY . 6.0 pt -146.96 -54.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.043 -0.526 . . . . 71.409999999999997 111.473 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG13 ' A' ' 69' ' ' ILE . . . 142.28 102.27 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.722 -0.752 . . . . 73.530000000000001 113.37 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 84.4 p -55.34 -28.09 51.47 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.023 0.379 . . . . 71.450000000000003 112.023 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -62.96 -16.64 60.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.087 0.773 . . . . 75.340000000000003 113.087 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -61.87 -43.15 99.42 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.908 0.385 . . . . 73.349999999999994 111.294 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.68 -92.99 0.2 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.323 -0.465 . . . . 74.319999999999993 114.122 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.91 139.74 38.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.01 0.433 . . . . 72.430000000000007 111.915 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -60.44 -28.58 68.4 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.366 0.506 . . . . 73.010000000000005 112.366 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -67.51 -17.76 64.79 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.943 0.401 . . . . 72.519999999999996 111.78 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.4 -34.16 12.87 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.197 0.443 . . . . 73.140000000000001 112.197 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -35.58 -64.62 0.28 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.625 1.343 . . . . 75.099999999999994 114.625 -171.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.48 79.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.632 0.604 . . . . 74.219999999999999 112.632 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -68.23 -44.55 75.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.085 0.469 . . . . 75.099999999999994 111.336 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.45 83.1 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.209 -0.451 . . . . 75.120000000000005 111.046 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -59.62 5.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.038 -0.528 . . . . 63.140000000000001 111.105 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.4 p -58.25 -32.41 68.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 111.56 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -72.85 -41.95 64.23 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.229 0.455 . . . . 44.119999999999997 112.229 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.75 -8.39 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.643 0.609 . . . . 54.009999999999998 112.643 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.38 7.48 26.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.942 -0.647 . . . . 43.350000000000001 113.447 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -80.4 168.18 19.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.629 . . . . 74.430000000000007 111.744 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 m -104.86 102.24 11.79 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.813 -0.631 . . . . 52.329999999999998 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.76 111.26 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 61.539999999999999 111.404 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 30.9 m120 -132.15 149.31 52.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.366 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.79 12.25 1.13 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.219 0.452 . . . . 62.310000000000002 112.219 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.5 t -73.54 116.85 55.55 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.733 -0.212 . . . . 52.340000000000003 111.24 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.76 104.24 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.39 2.06 . . . . 74.019999999999996 112.032 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -131.04 136.47 48.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.058 -0.519 . . . . 71.439999999999998 111.699 -174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.98 120.86 14.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.555 -0.293 . . . . 32.509999999999998 111.237 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.64 15.33 17.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.202 -0.523 . . . . 64.409999999999997 113.254 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -120.75 170.1 9.77 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.475 -0.426 . . . . 61.539999999999999 110.753 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.0 mp -113.24 123.04 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.617 -0.265 . . . . 75.230000000000004 110.71 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -93.71 133.29 37.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.073 0.463 . . . . 71.030000000000001 111.212 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.426 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.8 tt0 -94.25 112.18 23.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.294 -0.412 . . . . 72.209999999999994 111.153 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 37.5 m . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 112.292 0.478 . . . . 74.209999999999994 112.292 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 CA-C-O 120.965 0.203 . . . . 73.010000000000005 113.322 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 39.6 t60 -136.0 142.78 44.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.709 0.29 . . . . 73.319999999999993 111.058 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.552 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -146.89 146.2 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.088 0.555 . . . . 64.340000000000003 110.397 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -143.84 161.7 37.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.961 0.41 . . . . 61.399999999999999 111.433 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.5 123.74 37.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.942 0.401 . . . . 72.230000000000004 111.054 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.86 106.04 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.966 0.412 . . . . 73.019999999999996 111.913 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.91 -51.59 53.47 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.121 0.486 . . . . 71.140000000000001 110.754 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -160.37 164.24 32.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.057 -0.52 . . . . 65.209999999999994 110.833 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.28 140.45 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.049 0.452 . . . . 64.219999999999999 111.198 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -89.54 147.91 23.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.728 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.0 t -62.54 -20.7 64.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.864 0.364 . . . . 44.240000000000002 111.908 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.82 -22.83 62.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.336 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.87 -17.87 10.72 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.302 -0.408 . . . . 64.25 113.073 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -64.07 126.25 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.951 0.405 . . . . 73.540000000000006 111.621 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.05 124.48 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.998 0.428 . . . . 73.409999999999997 111.967 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -93.23 113.85 26.18 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.939 0.4 . . . . 73.319999999999993 110.662 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.75 164.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.24 0.459 . . . . 74.540000000000006 112.24 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.518 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 48.6 p -117.17 140.61 49.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.462 -0.335 . . . . 71.409999999999997 111.715 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 59.8 mt-10 -138.65 159.06 43.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.05 0.54 . . . . 75.25 110.991 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.9 tpp . . . . . 0 N--CA 1.472 0.656 0 O-C-N 122.347 -0.221 . . . . 63.100000000000001 110.569 175.615 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 27.3 mt-10 . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 120.919 0.39 . . . . 65.340000000000003 111.755 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.2 ptp180 -157.73 173.15 17.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.477 -0.329 . . . . 54.439999999999998 111.118 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 72.8 m -127.73 123.51 35.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.963 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -94.73 137.42 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.876 0.37 . . . . 63.539999999999999 111.389 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -59.84 137.9 57.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.154 -0.476 . . . . 40.43 111.997 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.07 -42.62 60.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.545 0.572 . . . . 72.219999999999999 112.545 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.29 -27.99 61.15 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.316 -0.402 . . . . 34.340000000000003 113.637 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.82 -27.79 14.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.387 -0.478 . . . . 74.430000000000007 111.39 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.64 -29.02 61.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.087 0.773 . . . . 64.439999999999998 113.087 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t -78.19 -6.24 54.23 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.0 0.37 . . . . 73.400000000000006 112.0 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.5 m -85.88 -15.04 43.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.773 0.32 . . . . 72.349999999999994 111.797 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -93.69 144.92 24.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.053 0.454 . . . . 71.340000000000003 112.21 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -93.88 116.41 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.152 -0.476 . . . . 54.32 110.359 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 20.9 m-85 -95.49 122.91 38.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.933 0.397 . . . . 60.350000000000001 111.748 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.63 123.38 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.388 -0.369 . . . . 74.420000000000002 110.604 175.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.34 136.94 52.43 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.516 0.327 . . . . 63.439999999999998 110.547 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 69' ' ' ILE . 74.4 mt . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 112.348 0.499 . . . . 51.149999999999999 112.348 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 112.257 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 112.76 4.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.928 -0.578 . . . . 74.030000000000001 111.804 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.55 7.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.345 -0.455 . . . . 55.039999999999999 112.703 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -115.5 144.47 43.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.123 0.487 . . . . 73.200000000000003 111.584 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.1 p -58.03 -46.24 85.64 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.311 -0.404 . . . . 24.530000000000001 111.541 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -51.52 -45.35 62.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.093 0.405 . . . . 75.019999999999996 112.093 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -54.79 -48.66 72.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.96 -0.564 . . . . 75.549999999999997 111.744 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -68.79 -49.84 55.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 112.096 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 57' ' ' CYS . 58.0 t -58.18 -40.5 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.57 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.97 -41.76 75.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.175 -0.466 . . . . 70.299999999999997 111.553 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.02 -43.0 68.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.372 -0.376 . . . . 71.019999999999996 111.447 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -61.32 -34.48 75.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.018 0.377 . . . . 70.25 112.018 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -86.22 6.55 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-O 121.358 0.599 . . . . 72.25 111.072 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.37 18.48 60.93 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 113.833 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 16.95 67.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.16 -0.543 . . . . 64.120000000000005 113.949 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -78.88 7.08 7.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 117.455 0.628 . . . . 72.430000000000007 112.463 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.29 -37.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.528 0.566 . . . . 72.400000000000006 112.528 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.17 102.56 2.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.967 -0.635 . . . . 71.109999999999999 112.013 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -61.34 -18.06 56.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.742 0.645 . . . . 74.310000000000002 112.742 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 t -57.24 -15.94 7.15 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.701 0.63 . . . . 62.119999999999997 112.701 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -57.97 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.255 0.55 . . . . 74.299999999999997 110.825 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.25 -103.21 0.56 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.805 -0.634 . . . . 63.350000000000001 114.613 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -57.37 134.91 56.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.112 0.412 . . . . 65.209999999999994 112.112 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.62 -11.78 47.54 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 51.200000000000003 113.04 -173.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.37 -10.97 36.21 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.957 174.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -93.35 -27.49 16.74 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.097 0.406 . . . . 75.120000000000005 112.097 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -41.34 -58.04 1.97 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.854 1.057 . . . . 74.530000000000001 113.854 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.9 91.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.917 -0.49 . . . . 52.32 111.975 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -57.69 -51.81 68.01 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.168 0.509 . . . . 54.310000000000002 111.618 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.93 97.69 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.37 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.48 -57.02 11.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.953 0.406 . . . . 35.520000000000003 111.26 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 t -57.5 -44.41 84.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.082 0.468 . . . . 33.32 111.39 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 t -70.85 -21.21 62.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 112.225 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.79 -10.06 32.64 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.205 0.446 . . . . 42.030000000000001 112.205 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.65 8.73 29.96 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.919 -0.657 . . . . 70.530000000000001 113.827 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HD2' ' HA ' ' A' ' 154' ' ' LEU . 71.3 m-85 -83.81 166.94 17.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.439 -0.447 . . . . 72.329999999999998 111.329 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 90.5 m -100.5 92.73 5.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.114 0.483 . . . . 62.039999999999999 111.923 -173.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.3 98.8 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 111.299 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -126.77 176.49 7.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.513 -0.312 . . . . 73.530000000000001 110.632 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -93.39 25.42 3.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.931 0.396 . . . . 62.520000000000003 111.275 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 t -81.89 108.14 10.44 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 111.458 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.5 19.11 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.04 2.494 . . . . 71.400000000000006 114.278 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -54.96 142.82 28.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 111.726 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.92 146.13 53.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.471 0.545 . . . . 71.140000000000001 112.471 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.98 10.09 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.17 -0.538 . . . . 73.430000000000007 113.031 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.4 p -136.62 169.08 18.29 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.5 -0.412 . . . . 73.310000000000002 111.167 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -110.14 134.6 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.626 -0.261 . . . . 71.140000000000001 110.302 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.5 pt? -112.99 131.24 55.84 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.247 0.546 . . . . 72.409999999999997 111.443 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -105.96 129.0 54.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.524 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 112.773 0.656 . . . . 75.140000000000001 112.773 -178.476 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.618 0 N-CA-C 113.5 0.16 . . . . 44.329999999999998 113.5 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -173.5 136.99 0.62 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.417 0.287 . . . . 71.299999999999997 110.92 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.9 151.52 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.33 -0.395 . . . . 51.340000000000003 111.408 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.78 167.37 25.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.466 -0.333 . . . . 72.430000000000007 110.99 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -102.88 131.44 49.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.894 0.378 . . . . 60.439999999999998 111.202 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 124' ' ' VAL . 60.9 t -81.89 112.29 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.297 -0.41 . . . . 74.450000000000003 111.539 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -80.13 -56.02 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.878 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.19 144.05 23.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.757 0.651 . . . . 63.310000000000002 112.757 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.47 136.25 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.745 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.17 147.33 24.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.399 -0.188 . . . . 41.340000000000003 110.925 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -57.71 -34.84 69.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.934 0.346 . . . . 65.109999999999999 111.934 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.59 -9.23 40.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.464 0.542 . . . . 64.209999999999994 112.464 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.56 0.41 46.47 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.367 -0.444 . . . . 74.230000000000004 113.757 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 m -77.53 142.07 39.26 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.747 0.308 . . . . 72.519999999999996 111.626 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.8 t -113.19 115.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 111.558 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.84 118.63 29.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.392 . . . . 63.119999999999997 111.326 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 113' ' ' VAL . 34.1 m -124.8 148.18 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.043 0.449 . . . . 62.409999999999997 111.924 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.0 m -102.89 116.04 31.78 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.068 0.461 . . . . 51.350000000000001 111.079 175.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.43 -168.24 1.29 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 111.246 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.948 0.404 . . . . 64.140000000000001 110.763 173.072 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 121.206 0.527 . . . . 75.0 112.373 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -152.1 130.85 12.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.466 . . . . 71.209999999999994 111.604 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 m -99.13 98.7 9.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.082 0.467 . . . . 71.310000000000002 110.209 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.72 134.76 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 112.231 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.8 m -67.99 148.59 50.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.598 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.87 -44.95 63.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.446 0.536 . . . . 50.140000000000001 112.446 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.75 76.56 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 73.519999999999996 113.017 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.97 -34.02 75.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.866 0.365 . . . . 70.430000000000007 111.557 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.82 66.79 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.174 0.511 . . . . 64.5 111.859 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 t -67.67 -3.64 9.72 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.403 0.52 . . . . 65.319999999999993 112.403 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -93.28 -0.3 56.78 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.965 0.412 . . . . 75.549999999999997 111.622 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -118.77 153.42 34.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.535 0.569 . . . . 75.409999999999997 112.535 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.2 m-80 -101.4 116.14 32.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.797 -0.638 . . . . 63.140000000000001 110.526 176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -94.85 112.68 24.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.230000000000004 111.91 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -81.06 127.23 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.076 0.465 . . . . 53.149999999999999 111.345 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 62.0 m-70 -111.1 133.15 53.7 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.548 -0.538 . . . . 73.349999999999994 109.548 174.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 88' ' ' TYR . 48.0 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 112.248 0.462 . . . . 65.439999999999998 112.248 -171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 73.219999999999999 111.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.68 138.18 42.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 72.349999999999994 111.738 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.79 -28.51 13.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.283 -0.484 . . . . 71.549999999999997 112.753 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -80.3 136.73 36.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.269 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.2 p -59.14 -41.28 87.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.073 171.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.5 p -52.57 -43.8 65.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.455 -0.793 . . . . 72.109999999999999 111.968 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -55.95 -52.31 64.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 112.022 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.63 -47.34 72.91 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.983 0.421 . . . . 72.010000000000005 111.702 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 57' ' ' CYS . 96.9 t -60.97 -34.52 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.555 -0.293 . . . . 65.219999999999999 111.706 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -54.69 -46.81 74.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 111.41 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 110.892 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 64' ' ' LYS . 29.3 mmmt -61.98 -31.73 72.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.155 -0.475 . . . . 63.509999999999998 112.202 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 154' ' ' LEU . 7.6 p -91.24 6.22 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.449 0.642 . . . . 55.350000000000001 111.164 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 10.26 72.04 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.299 -0.41 . . . . 64.120000000000005 113.959 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.14 15.75 72.43 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.002 -0.618 . . . . 64.200000000000003 114.032 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.43 ' HB2' HD13 ' A' ' 154' ' ' LEU . 40.2 m-80 -82.79 28.28 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.316 0.558 . . . . 72.120000000000005 111.99 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.76 161.78 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.131 0.491 . . . . 61.509999999999998 111.523 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.1 78.03 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.999 -0.619 . . . . 52.43 112.558 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -49.18 -28.18 4.24 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.571 0.582 . . . . 43.219999999999999 112.571 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -60.73 -18.03 52.08 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.873 0.694 . . . . 53.130000000000003 112.873 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -56.05 -32.95 64.53 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.942 0.401 . . . . 74.099999999999994 111.617 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.9 2.02 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.261 -0.427 . . . . 62.409999999999997 114.092 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.88 133.78 48.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 71.319999999999993 112.452 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.41 61.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.228 0.825 . . . . 65.230000000000004 113.228 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -67.05 -34.47 77.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.939 0.4 . . . . 73.409999999999997 112.047 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -71.26 -29.34 64.97 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.337 0.495 . . . . 60.130000000000003 112.337 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -43.38 -60.27 1.78 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.619 0.97 . . . . 73.310000000000002 113.619 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.43 86.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.45 0.537 . . . . 73.329999999999998 112.45 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 t -65.03 -55.02 21.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.941 0.401 . . . . 61.450000000000003 111.438 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.77 74.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.443 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.32 -49.02 77.44 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.629 -0.259 . . . . 62.509999999999998 111.291 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.7 p -66.51 -29.55 69.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.029 0.442 . . . . 74.319999999999993 111.119 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -76.79 -31.36 56.95 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.128 -0.487 . . . . 44.420000000000002 111.798 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.46 -24.48 24.12 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.156 0.428 . . . . 71.239999999999995 112.156 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.82 4.31 19.23 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.048 -0.596 . . . . 51.109999999999999 113.881 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.546 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 18.4 m-85 -69.23 168.49 14.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.467 . . . . 74.340000000000003 111.288 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.6 m -101.19 97.94 8.41 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.07 0.396 . . . . 75.120000000000005 112.07 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 152' ' ' ILE . 41.6 t -102.49 96.52 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.002 0.429 . . . . 73.150000000000006 111.316 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -122.66 172.31 8.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.891 0.377 . . . . 72.530000000000001 110.96 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -86.56 2.52 47.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.654 0.264 . . . . 71.530000000000001 111.305 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -62.8 113.75 10.1 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 116.52 -0.309 . . . . 72.420000000000002 110.761 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.415 ' HB2' HG22 ' A' ' 122' ' ' VAL . 90.0 Cg_endo -82.27 8.16 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.643 2.229 . . . . 72.519999999999996 113.973 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.32 138.62 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.328 0.492 . . . . 53.329999999999998 112.328 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.08 156.98 4.93 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.718 0.636 . . . . 70.430000000000007 112.718 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.46 33.38 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.111 -0.566 . . . . 74.349999999999994 112.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.2 p -138.31 176.64 8.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 73.010000000000005 111.115 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.71 121.78 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.36 -0.382 . . . . 53.32 110.889 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -100.62 136.66 40.15 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.692 -0.63 . . . . 71.129999999999995 111.636 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -101.99 124.99 48.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.868 -0.605 . . . . 75.230000000000004 111.46 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 31.2 t . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.246 0.461 . . . . 52.549999999999997 112.246 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 111.834 -0.506 . . . . 73.510000000000005 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 58.4 t60 -157.59 135.47 10.76 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.345 -0.503 . . . . 75.239999999999995 110.74 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.73 142.1 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.073 0.463 . . . . 44.100000000000001 111.389 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -139.44 156.69 46.79 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.243 -0.435 . . . . 43.450000000000003 110.837 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.71 133.14 38.7 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.832 0.349 . . . . 63.109999999999999 111.279 -176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.45 116.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.858 0.361 . . . . 44.439999999999998 111.836 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.72 -54.96 3.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.957 0.408 . . . . 71.319999999999993 112.01 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.76 145.2 30.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.265 0.555 . . . . 72.239999999999995 112.004 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.61 133.74 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.03 -0.532 . . . . 42.299999999999997 111.464 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' SER . 33.9 m-80 -76.87 152.25 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.406 -0.361 . . . . 63.240000000000002 110.556 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.1 m -47.22 -40.73 16.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.337 0.866 . . . . 72.310000000000002 113.337 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.55 -23.39 61.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.37 0.507 . . . . 70.549999999999997 112.37 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.44 -0.94 9.54 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.163 -0.541 . . . . 63.420000000000002 113.38 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 19.2 m -65.41 118.78 9.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.168 0.509 . . . . 72.239999999999995 110.952 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.42 HG21 ' OH ' ' A' ' 151' ' ' TYR . 40.4 t -96.35 121.97 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.805 -0.634 . . . . 51.509999999999998 112.392 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -96.35 105.25 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.342 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 m -97.08 163.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.423 0.527 . . . . 73.109999999999999 112.423 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -115.51 119.19 35.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.922 -0.581 . . . . 64.140000000000001 111.028 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.8 177.2 6.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.024 0.44 . . . . 63.549999999999997 111.512 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.472 0.651 0 CA-C-N 116.497 -0.32 . . . . 63.399999999999999 110.45 176.733 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.191 0.519 . . . . 70.5 111.695 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.06 105.07 16.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.168 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 88.2 m -79.17 104.14 9.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.041 0.448 . . . . 64.340000000000003 110.65 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 149' ' ' TYR . 73.2 mt -92.57 112.44 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.105 -0.498 . . . . 72.200000000000003 111.599 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.4 m -61.07 153.26 25.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.24 0.459 . . . . 75.109999999999999 112.24 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.79 -48.65 41.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.876 0.695 . . . . 74.430000000000007 112.876 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.14 -38.05 88.35 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.175 -0.536 . . . . 52.509999999999998 113.316 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -72.9 -37.35 67.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.963 0.411 . . . . 65.310000000000002 111.669 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.69 -23.91 67.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.911 0.708 . . . . 63.119999999999997 112.911 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 m -54.87 -17.29 3.42 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.845 1.054 . . . . 71.439999999999998 113.845 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.4 t -99.11 -13.94 19.6 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.155 0.798 . . . . 75.25 113.155 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 141' ' ' ILE . 31.4 m-85 -88.7 143.74 26.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.564 0.697 . . . . 75.239999999999995 112.866 -173.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 86.8 m-20 -100.09 116.35 31.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.613 -0.721 . . . . 72.040000000000006 111.071 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' A' ' 122' ' ' VAL . 64.0 m-85 -98.26 118.18 34.33 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.002 0.371 . . . . 64.299999999999997 112.002 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.573 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -84.66 131.99 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.432 -0.349 . . . . 74.150000000000006 110.595 174.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -121.58 148.65 44.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.703 0.401 . . . . 70.099999999999994 110.056 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.583 HD11 HG22 ' A' ' 65' ' ' VAL . 50.4 mt . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.406 0.622 . . . . 71.430000000000007 112.598 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 112.975 0.732 . . . . 73.420000000000002 112.975 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.99 152.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.175 0.512 . . . . 42.539999999999999 111.928 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.486 ' HA2' ' SD ' ' A' ' 127' ' ' MET . . . 82.82 -33.66 2.83 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.819 -0.705 . . . . 32.240000000000002 112.827 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.5 139.83 58.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.382 0.273 . . . . 65.319999999999993 110.96 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.0 p -54.03 -45.88 71.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.072 0.463 . . . . 63.229999999999997 110.967 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.3 p -53.19 -43.47 67.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 112.022 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.94 -48.59 77.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.22 0.533 . . . . 72.019999999999996 111.188 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.66 -45.17 91.37 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.903 -0.59 . . . . 64.019999999999996 111.629 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 57' ' ' CYS . 64.3 t -60.46 -43.25 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.797 0.332 . . . . 71.299999999999997 111.415 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -55.04 -38.71 68.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.268 -0.423 . . . . 71.299999999999997 111.527 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.85 -48.81 34.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.834 0.35 . . . . 75.129999999999995 111.366 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -58.25 -36.52 73.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.362 0.505 . . . . 72.400000000000006 112.362 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 HD11 ' A' ' 154' ' ' LEU . 9.6 p -80.8 11.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.415 0.626 . . . . 72.120000000000005 111.42 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.13 19.44 66.04 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.294 -0.412 . . . . 73.420000000000002 113.581 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.53 24.14 61.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.26 -0.495 . . . . 71.140000000000001 113.716 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -86.8 9.94 17.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.301 -0.529 . . . . 72.430000000000007 111.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.82 148.85 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.979 0.419 . . . . 71.319999999999993 111.428 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.97 84.95 0.16 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 53.5 112.933 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.1 p -51.68 -21.12 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.447 0.536 . . . . 51.5 112.447 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.1 t -66.62 -2.13 4.5 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.787 0.662 . . . . 53.32 112.787 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -63.53 -22.83 67.11 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.07 0.396 . . . . 72.129999999999995 112.07 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.42 -131.73 10.87 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.173 -0.537 . . . . 70.049999999999997 113.729 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.82 154.98 40.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.415 0.626 . . . . 62.399999999999999 111.972 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -72.37 31.03 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 113.965 1.098 . . . . 52.310000000000002 113.965 -171.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -111.61 -18.25 12.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.249 0.547 . . . . 74.040000000000006 110.287 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -104.64 -0.17 27.85 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.935 -0.575 . . . . 60.450000000000003 112.067 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -66.96 -58.44 4.96 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.093 -0.379 . . . . 71.129999999999995 111.953 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 111.884 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.7 t -58.71 -51.37 70.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.945 0.402 . . . . 51.049999999999997 111.264 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.31 82.78 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.432 -0.349 . . . . 61.030000000000001 111.443 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -55.67 -52.88 62.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.519999999999996 111.273 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -62.78 -32.35 73.5 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.801 0.334 . . . . 65.109999999999999 111.602 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.9 t -76.48 -33.09 58.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.119 0.415 . . . . 74.510000000000005 112.119 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.88 -51.43 8.59 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.115 0.413 . . . . 72.129999999999995 112.115 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.29 24.7 0.08 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.831 -0.7 . . . . 63.109999999999999 113.818 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 28.5 m-85 -90.89 178.82 5.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.224 0.535 . . . . 75.430000000000007 111.293 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 91' ' ' ASN . 84.2 m -109.26 89.6 3.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.055 -0.52 . . . . 70.209999999999994 111.051 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.86 111.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.93 0.395 . . . . 63.32 111.648 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 89' ' ' THR . 6.0 m120 -135.61 177.14 8.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.99 0.424 . . . . 73.219999999999999 110.74 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.7 -0.05 57.29 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 110.815 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.5 m -67.86 114.24 19.16 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.802 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -85.75 12.35 3.07 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.074 2.516 . . . . 64.230000000000004 114.943 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.54 145.31 33.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.963 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.14 157.49 2.58 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.725 -0.67 . . . . 73.109999999999999 112.656 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.04 38.66 9.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.963 -0.637 . . . . 72.200000000000003 112.187 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.5 p -152.55 173.19 15.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.206 0.527 . . . . 51.130000000000003 111.79 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.16 124.38 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.636 -0.711 . . . . 71.439999999999998 110.786 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 1.6 pt? -91.81 137.38 32.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.932 -0.48 . . . . 52.020000000000003 111.244 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' OD1' ' A' ' 150' ' ' ASN . 27.3 tt0 -106.52 128.79 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.479 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 12.5 t . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 112.979 0.733 . . . . 73.400000000000006 112.979 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.388 0 N-CA-C 112.159 -0.377 . . . . 72.010000000000005 112.159 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 19.6 t60 -175.0 138.32 0.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.748 0.309 . . . . 72.209999999999994 110.782 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.449 HG13 ' HB1' ' A' ' 76' ' ' ALA . 16.7 m -143.47 146.64 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 111.185 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.82 149.88 30.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.002 -0.545 . . . . 55.340000000000003 110.902 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -87.31 126.35 34.79 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.38 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 124' ' ' VAL . 54.4 t -70.44 111.7 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.059 0.392 . . . . 74.409999999999997 112.059 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.04 -44.98 36.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.944 0.402 . . . . 75.329999999999998 111.648 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.5 164.03 29.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 111.946 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.33 108.8 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.899 -0.591 . . . . 61.219999999999999 110.307 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.99 157.47 33.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.09 0.472 . . . . 63.219999999999999 111.959 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.8 m -61.29 -12.82 14.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.449 0.537 . . . . 70.439999999999998 112.449 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.97 -6.48 52.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.887 0.375 . . . . 63.240000000000002 111.705 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.14 -16.5 59.5 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.402 -0.428 . . . . 75.329999999999998 112.514 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -66.51 131.9 47.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.95 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.72 124.82 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.56 . . . . 72.010000000000005 111.475 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.89 111.43 23.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.928 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 113' ' ' VAL . 33.6 m -114.54 153.02 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.258 0.466 . . . . 74.109999999999999 112.258 -177.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -101.13 121.74 42.37 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.195 0.521 . . . . 53.520000000000003 111.437 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -127.68 124.16 37.24 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.896 -0.593 . . . . 72.219999999999999 111.329 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.486 ' SD ' ' HA2' ' A' ' 55' ' ' GLY . 44.5 ttm . . . . . 0 N--CA 1.471 0.578 0 O-C-N 121.943 -0.473 . . . . 72.129999999999995 110.457 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 74.209999999999994 110.161 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -103.57 105.8 16.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 111.626 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.2 m -87.71 104.93 17.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.794 0.33 . . . . 75.299999999999997 111.2 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.4 mt -93.38 140.28 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 122.494 0.317 . . . . 75.530000000000001 111.633 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.0 m -64.12 146.8 53.6 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.645 -0.252 . . . . 75.040000000000006 111.317 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.58 64.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.66 0.615 . . . . 74.430000000000007 112.66 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.61 -34.95 65.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.518 -0.372 . . . . 60.340000000000003 113.876 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.55 -35.29 17.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.964 0.412 . . . . 75.209999999999994 111.361 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.95 80.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.435 -0.348 . . . . 65.310000000000002 111.673 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.5 p -67.14 -8.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.863 0.363 . . . . 74.510000000000005 111.888 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.1 t -78.8 -11.82 60.0 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.093 0.473 . . . . 52.149999999999999 110.805 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 34.3 m-85 -106.16 135.11 48.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.054 -0.521 . . . . 72.400000000000006 110.316 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 101' ' ' GLN . 4.2 p-10 -82.11 129.69 34.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.995 0.426 . . . . 63.240000000000002 111.89 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -100.05 123.76 44.65 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.61 0.596 . . . . 73.030000000000001 112.61 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 80' ' ' ALA . 3.6 mp -86.5 123.95 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.135 -0.484 . . . . 72.120000000000005 110.576 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.2 149.64 35.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.547 0.339 . . . . 74.239999999999995 110.314 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 65' ' ' VAL . 24.7 mt . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.165 0.507 . . . . 72.340000000000003 111.427 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.216 0.531 . . . . 52.310000000000002 112.148 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 140.67 45.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.986 -0.552 . . . . 63.399999999999999 112.062 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.54 -18.86 43.58 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.243 -0.503 . . . . 71.430000000000007 113.257 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.11 161.15 14.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.884 0.373 . . . . 75.430000000000007 111.754 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.452 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 59.6 m -63.22 -43.35 98.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.003 0.43 . . . . 73.219999999999999 111.878 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 74' ' ' GLY . 72.3 p -61.1 -25.51 67.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.573 0.583 . . . . 75.219999999999999 112.573 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.45 -63.88 1.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 38.9 p90 -66.52 -29.12 69.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.064 0.394 . . . . 71.549999999999997 112.064 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 57' ' ' CYS . 59.2 t -62.12 -45.05 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.95 0.405 . . . . 54.109999999999999 110.874 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -56.4 -34.1 66.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 111.086 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.35 -46.43 22.86 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.207 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -57.74 -32.64 67.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.079 0.4 . . . . 72.329999999999998 112.079 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 65' ' ' VAL . 8.0 p -91.52 13.18 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.3 0.571 . . . . 71.310000000000002 111.455 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.98 22.67 58.14 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 113.936 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.86 22.21 64.2 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.326 0.49 . . . . 73.519999999999996 114.326 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -83.35 12.0 6.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.488 0.644 . . . . 73.510000000000005 112.284 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.85 176.34 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.966 0.412 . . . . 70.019999999999996 111.744 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.17 115.75 8.44 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.164 -0.541 . . . . 73.099999999999994 113.621 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 p -75.41 0.87 15.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.592 0.59 . . . . 72.409999999999997 112.592 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 t -119.76 20.45 12.28 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.014 0.376 . . . . 73.209999999999994 112.014 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.83 -37.76 73.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.08 0.467 . . . . 75.129999999999995 111.386 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 58' ' ' THR . . . 67.29 -111.22 3.94 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.152 -0.477 . . . . 52.340000000000003 114.24 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.14 125.18 6.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.218 0.607 . . . . 71.519999999999996 112.522 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.12 60.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.287 0.477 . . . . 64.450000000000003 112.287 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -94.24 0.31 55.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.573 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.84 -12.9 16.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.545 0.338 . . . . 71.439999999999998 111.694 -176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -57.99 -33.69 69.18 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.463 0.912 . . . . 74.349999999999994 113.463 -172.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.79 64.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.898 0.38 . . . . 71.109999999999999 111.344 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -64.21 -43.72 94.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 111.128 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.11 96.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.413 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.76 -52.38 65.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.0 0.429 . . . . 75.349999999999994 110.633 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.0 t -58.8 -34.06 71.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 111.649 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 t -74.99 -25.71 59.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.819 0.342 . . . . 43.32 111.908 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.62 2.43 41.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.074 0.398 . . . . 65.349999999999994 112.074 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 41.55 14.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.325 -0.464 . . . . 74.239999999999995 113.943 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.448 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.5 m-85 -103.78 169.68 8.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.319 -0.518 . . . . 71.450000000000003 111.815 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.4 m -97.07 98.84 10.39 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.052 -0.522 . . . . 73.409999999999997 112.367 -171.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.43 103.19 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.151 0.501 . . . . 65.209999999999994 112.283 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -139.06 162.57 34.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.307 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -86.46 3.84 42.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.408 0.521 . . . . 75.340000000000003 112.408 -177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.0 m -57.25 113.13 5.59 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 110.542 -0.17 . . . . 73.430000000000007 110.542 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.94 -1.52 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.737 2.291 . . . . 75.129999999999995 114.577 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.71 139.57 9.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.874 0.694 . . . . 63.219999999999999 112.874 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.91 162.99 2.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.406 -0.816 . . . . 72.109999999999999 112.937 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.06 33.04 27.53 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.092 -0.575 . . . . 61.549999999999997 112.276 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.1 p -147.1 168.53 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.505 0.322 . . . . 71.430000000000007 110.834 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -115.7 124.44 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.345 -0.222 . . . . 74.310000000000002 110.659 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -96.95 134.97 39.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.326 0.584 . . . . 63.210000000000001 111.703 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -97.72 101.59 13.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 110.976 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 26.5 t . . . . . 0 N--CA 1.47 0.535 0 CA-C-N 115.851 -0.613 . . . . 64.409999999999997 111.923 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 CA-C-O 121.08 0.267 . . . . 45.049999999999997 113.175 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -149.1 131.34 15.51 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.591 -0.358 . . . . 64.510000000000005 110.86 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.79 149.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.171 -0.468 . . . . 71.510000000000005 110.392 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 61' ' ' VAL . . . -155.84 152.45 28.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.991 0.424 . . . . 62.530000000000001 111.984 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -80.8 129.08 34.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.272 -0.422 . . . . 63.149999999999999 110.811 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.24 102.68 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.216 0.531 . . . . 64.109999999999999 111.058 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.59 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 18.5 mm-40 -62.22 -58.1 9.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.459 -0.791 . . . . 71.420000000000002 111.289 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -161.67 148.47 14.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.846 -0.615 . . . . 75.310000000000002 111.361 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -115.15 137.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.309 . . . . 73.140000000000001 110.721 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -107.54 150.52 26.74 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.863 0.363 . . . . 61.43 111.762 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 m -61.53 -36.98 82.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.382 0.882 . . . . 61.219999999999999 113.382 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.19 -45.09 79.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.21 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.61 62.43 0.05 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.996 -0.621 . . . . 51.32 113.255 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.9 m -147.5 134.21 19.99 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.477 -0.425 . . . . 73.120000000000005 111.341 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 117.7 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.635 -0.711 . . . . 73.540000000000006 110.988 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.03 117.42 26.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.141 -0.481 . . . . 74.5 110.981 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.01 150.24 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.437 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 94.1 p -77.95 130.19 36.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.676 -0.693 . . . . 63.530000000000001 112.178 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -143.26 146.74 33.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.202 0.525 . . . . 75.239999999999995 112.306 174.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 57.3 tpp . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 116.077 -0.51 . . . . 72.540000000000006 110.264 175.121 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 30.9 mt-10 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.665 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -79.77 125.2 29.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.637 0.256 . . . . 64.530000000000001 110.631 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.9 m -91.33 99.54 12.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.99 0.424 . . . . 60.240000000000002 110.853 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.89 137.94 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.041 0.386 . . . . 73.120000000000005 112.041 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 52.5 m -61.6 151.5 33.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.941 0.4 . . . . 72.400000000000006 111.8 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.87 82.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.248 0.462 . . . . 72.439999999999998 112.248 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.13 74.79 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.418 -0.42 . . . . 51.530000000000001 113.426 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.96 -54.66 6.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.262 0.553 . . . . 71.150000000000006 111.129 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -61.48 -40.46 94.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.783 0.66 . . . . 54.240000000000002 112.783 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.3 p -62.07 -16.13 49.89 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.125 0.417 . . . . 43.210000000000001 112.125 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.8 t -76.69 -17.83 58.89 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.952 0.406 . . . . 73.319999999999993 111.317 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 16.8 m-85 -93.06 152.95 18.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.21 0.529 . . . . 71.120000000000005 111.847 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.04 132.17 35.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.035 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 94.5 m-85 -106.84 129.83 54.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.781 0.8 . . . . 74.129999999999995 112.807 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.76 112.08 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.294 -0.866 . . . . 62.049999999999997 110.798 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -106.2 141.38 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.954 0.407 . . . . 71.129999999999995 111.543 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 CA--C 1.539 0.544 0 CA-C-N 116.088 -0.505 . . . . 54.100000000000001 111.181 179.591 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 111.787 0.292 . . . . 73.150000000000006 111.787 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 35.06 0.1 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.54 0.941 . . . . 63.149999999999999 113.54 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.68 4.72 1.27 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.221 -0.514 . . . . 63.229999999999997 113.556 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.69 147.04 42.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.997 0.399 . . . . 74.299999999999997 111.212 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 63.7 m -54.93 -31.52 60.44 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.209 0.528 . . . . 64.5 111.259 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.6 p -68.04 -18.15 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.039 0.755 . . . . 73.120000000000005 113.039 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -75.81 -71.22 0.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.942 0.719 . . . . 75.219999999999999 112.942 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.493 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 12.6 p90 -59.93 -18.42 45.08 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.384 0.883 . . . . 74.239999999999995 113.384 -171.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.13 -34.78 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.21 0.528 . . . . 73.209999999999994 110.749 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 72.7 t80 -56.94 -51.86 67.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.712 -0.676 . . . . 62.439999999999998 111.294 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.48 -42.77 92.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.324 -0.398 . . . . 71.340000000000003 111.602 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -66.33 -31.96 73.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.326 0.491 . . . . 55.119999999999997 112.326 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.86 9.69 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.475 0.655 . . . . 71.319999999999993 111.402 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.5 14.83 65.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.426 -0.416 . . . . 65.430000000000007 113.671 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.39 7.73 64.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.41 0.524 . . . . 72.140000000000001 114.41 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -78.45 35.05 0.22 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.263 0.532 . . . . 75.129999999999995 112.371 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.8 pt -121.44 -30.46 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.134 0.42 . . . . 73.219999999999999 112.134 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.31 9.44 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.07 -0.586 . . . . 53.039999999999999 113.289 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.526 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 53.2 p 59.6 4.8 0.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.287 0.847 . . . . 72.439999999999998 113.287 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -84.95 9.6 14.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.165 0.507 . . . . 55.219999999999999 111.571 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.4 m0 -79.36 -36.67 38.97 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.322 -0.399 . . . . 72.519999999999996 111.593 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.36 -122.63 6.02 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.023 -0.608 . . . . 64.439999999999998 113.964 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -51.6 141.44 16.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.421 0.526 . . . . 71.209999999999994 112.421 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -31.9 72.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.195 0.442 . . . . 63.439999999999998 112.195 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.38 1.93 20.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.807 0.337 . . . . 74.420000000000002 111.661 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.95 -6.97 12.58 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.132 0.419 . . . . 54.109999999999999 112.132 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.39 -56.47 21.62 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.682 0.623 . . . . 73.409999999999997 112.682 -176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.51 75.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 71.040000000000006 111.552 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.5 m -60.69 -52.53 64.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.977 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.21 78.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 111.196 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -58.38 8.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.512 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.6 p -58.89 -37.09 75.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.836 0.351 . . . . 70.030000000000001 111.735 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -71.52 -39.81 70.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.383 -0.371 . . . . 61.340000000000003 111.392 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.5 10.57 5.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.664 0.616 . . . . 54.450000000000003 112.664 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.94 66.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.012 -0.613 . . . . 64.329999999999998 114.334 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -76.79 164.3 25.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.514 0.657 . . . . 63.219999999999999 110.999 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.401 HG22 ' OD1' ' A' ' 91' ' ' ASN . 85.4 m -100.5 100.35 11.08 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 111.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 152' ' ' ILE . 48.1 t -108.83 119.88 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.773 0.32 . . . . 71.430000000000007 111.572 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 89' ' ' THR . 7.5 m120 -140.13 -176.15 4.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 111.19 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -97.57 4.07 50.37 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.182 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.6 m -67.71 114.1 18.06 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.274 -0.421 . . . . 65.450000000000003 110.439 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.69 22.9 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.968 2.445 . . . . 50.350000000000001 114.584 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.08 149.69 36.3 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.959 0.726 . . . . 71.329999999999998 112.959 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.38 163.06 4.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.71 -0.677 . . . . 53.140000000000001 112.467 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.63 34.53 73.09 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.947 -0.644 . . . . 71.109999999999999 112.626 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.1 m -139.01 165.83 26.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.654 0.264 . . . . 52.109999999999999 111.105 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -116.86 127.56 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 110.446 -0.205 . . . . 71.019999999999996 110.446 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.7 pt? -99.83 144.94 28.31 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.848 -0.533 . . . . 75.129999999999995 110.993 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -121.62 133.56 54.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.4 0.619 . . . . 63.020000000000003 112.536 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 29.7 t . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 115.35 -0.841 . . . . 65.310000000000002 110.657 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 CA-C-O 121.003 0.224 . . . . 73.109999999999999 113.333 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 73.0 t60 -143.85 141.93 30.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.565 -0.374 . . . . 64.319999999999993 111.2 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 20.5 m -139.17 146.34 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.505 -0.316 . . . . 74.120000000000005 111.114 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.498 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -153.74 154.64 34.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.03 0.443 . . . . 71.099999999999994 112.125 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -91.18 121.21 32.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 111.535 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.65 114.33 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.03 0.381 . . . . 74.439999999999998 112.03 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 10.1 mm-40 -78.78 -56.69 4.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 111.635 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -149.46 141.66 24.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.411 0.523 . . . . 64.510000000000005 112.411 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.32 126.33 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 111.071 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -94.42 144.12 25.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.753 0.311 . . . . 72.519999999999996 111.093 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -60.91 -25.74 66.95 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.223 0.535 . . . . 75.340000000000003 111.549 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.49 -16.32 62.29 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.992 -0.549 . . . . 75.019999999999996 111.59 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.86 -14.98 37.67 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.28 -0.418 . . . . 42.219999999999999 112.952 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.1 m -66.68 120.99 14.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 64.409999999999997 111.499 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.57 116.93 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.306 0.574 . . . . 54.119999999999997 111.178 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.14 113.69 25.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 111.005 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.94 167.11 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.196 0.522 . . . . 65.109999999999999 112.146 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.1 t -108.01 105.59 15.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.096 -0.502 . . . . 44.329999999999998 111.088 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -141.69 118.58 11.16 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.27 -0.423 . . . . 53.130000000000003 111.382 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.1 ttm . . . . . 0 CA--C 1.534 0.361 0 O-C-N 122.218 -0.301 . . . . 53.530000000000001 110.703 174.786 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 42.2 mt-10 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 111.959 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -114.5 122.99 48.27 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.433 -0.348 . . . . 71.299999999999997 111.176 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.2 m -85.66 99.79 11.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.775 0.322 . . . . 64.019999999999996 110.505 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.9 mt -93.27 139.78 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.912 0.387 . . . . 73.530000000000001 111.925 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 m -69.17 150.78 47.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.338 -0.392 . . . . 71.409999999999997 111.734 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.93 -52.38 58.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.463 0.542 . . . . 74.310000000000002 112.463 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.28 -13.0 34.11 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.117 -0.492 . . . . 72.439999999999998 114.018 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -101.77 -49.81 3.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 110.959 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -56.88 -50.42 72.56 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.621 0.6 . . . . 74.530000000000001 112.621 -175.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 68.3 m -60.69 -9.52 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.064 0.764 . . . . 35.140000000000001 113.064 -177.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.0 t -83.37 -19.79 35.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.932 0.396 . . . . 64.230000000000004 111.548 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -85.91 161.58 18.98 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.155 0.502 . . . . 74.239999999999995 112.096 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.0 m-20 -89.29 117.76 28.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.493 -0.321 . . . . 73.430000000000007 111.265 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.417 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 93.7 m-85 -99.89 113.1 25.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.299 0.481 . . . . 74.129999999999995 112.299 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.7 mp -83.06 134.73 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.374 -0.376 . . . . 71.409999999999997 110.272 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -122.99 142.79 50.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.967 0.413 . . . . 63.130000000000003 111.354 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 111.796 -179.908 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.188 0.518 . . . . 71.329999999999998 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 115.2 9.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.915 -0.584 . . . . 65.209999999999994 111.273 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.92 -13.22 7.2 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.172 -0.537 . . . . 65.200000000000003 112.887 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -100.03 144.99 28.42 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.787 0.327 . . . . 74.099999999999994 111.144 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.6 m -56.01 -25.87 46.27 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.117 0.414 . . . . 74.140000000000001 112.117 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.2 p -67.21 -27.22 67.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.275 0.472 . . . . 51.409999999999997 112.275 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -65.64 -64.07 0.95 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.806 0.669 . . . . 74.510000000000005 112.806 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB3' ' SD ' ' A' ' 127' ' ' MET . 34.6 p90 -63.49 -32.48 73.94 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.048 0.388 . . . . 64.140000000000001 112.048 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 110' ' ' VAL . 66.1 t -62.62 -37.17 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.765 0.317 . . . . 72.319999999999993 111.442 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -59.15 -37.36 77.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.057 0.456 . . . . 74.540000000000006 110.84 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.11 -40.82 62.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.179 -0.464 . . . . 71.519999999999996 110.998 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.75 -44.88 86.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.093 0.473 . . . . 63.240000000000002 111.753 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.42 -3.14 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.106 0.479 . . . . 71.030000000000001 111.424 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.15 22.37 73.89 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.47 -0.395 . . . . 73.230000000000004 113.703 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.25 15.38 65.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 114.325 0.49 . . . . 25.039999999999999 114.325 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -79.68 2.65 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.644 0.609 . . . . 61.310000000000002 112.644 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.7 pt -109.43 149.56 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.166 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.36 110.5 3.2 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.826 -0.702 . . . . 31.539999999999999 112.674 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -64.47 -3.24 2.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 122.413 -0.463 . . . . 63.32 112.24 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 t -64.12 -13.33 47.17 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.256 0.465 . . . . 70.439999999999998 112.256 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -59.11 -50.07 75.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.96 0.409 . . . . 65.319999999999993 111.424 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.58 -128.26 9.33 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.162 -0.542 . . . . 61.140000000000001 113.38 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.71 140.47 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 111.83 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.99 -41.28 64.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.118 0.784 . . . . 73.209999999999994 113.118 -173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.62 -22.62 65.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -84.54 -24.2 29.41 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.748 0.277 . . . . 72.450000000000003 111.748 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -45.37 -46.98 13.48 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.996 0.739 . . . . 75.430000000000007 112.996 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.46 81.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 63.439999999999998 112.181 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 t -80.4 -47.5 14.3 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 74.049999999999997 111.617 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.94 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.359 -0.382 . . . . 73.409999999999997 111.602 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -60.55 -53.78 53.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 53.310000000000002 111.327 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.0 p -59.77 -42.47 93.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.89 0.376 . . . . 72.010000000000005 111.225 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 t -65.61 -29.77 70.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.374 -0.376 . . . . 75.030000000000001 111.543 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.18 -4.34 59.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.435 0.531 . . . . 74.25 112.435 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.45 3.18 56.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.262 -0.494 . . . . 72.25 113.853 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 81.7 m-85 -72.3 173.79 8.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 111.423 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 35.4 m -106.24 84.85 2.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.09 0.404 . . . . 73.400000000000006 112.09 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 152' ' ' ILE . 49.5 t -93.9 111.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.85 0.357 . . . . 74.549999999999997 111.562 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -149.06 159.96 43.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 110.779 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.2 24.36 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.447 0.536 . . . . 75.209999999999994 112.447 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -81.04 108.64 10.8 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.387 0.275 . . . . 75.209999999999994 110.83 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.45 7.9 4.72 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.833 2.355 . . . . 62.340000000000003 114.395 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -51.59 143.07 13.02 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.158 0.429 . . . . 70.120000000000005 112.158 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 152.7 11.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.52 13.78 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.133 -0.556 . . . . 64.010000000000005 113.114 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.3 p -144.86 178.4 8.04 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 71.129999999999995 111.06 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 62.7 mt -124.58 120.06 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.551 -0.295 . . . . 74.430000000000007 111.211 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.9 pt? -85.59 126.87 34.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 72.129999999999995 111.233 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 111.26 23.93 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.976 0.417 . . . . 73.310000000000002 109.927 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 21.4 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 114.238 1.199 . . . . 61.039999999999999 114.238 -169.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 113.938 0.335 . . . . 50.450000000000003 113.938 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -111.91 143.31 43.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.542 0.337 . . . . 73.340000000000003 111.038 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.531 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.7 m -141.17 150.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.08 0.467 . . . . 70.140000000000001 111.824 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.415 ' H ' HD23 ' A' ' 100' ' ' LEU . . . -156.42 168.94 25.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.813 -0.63 . . . . 63.200000000000003 110.561 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -100.43 129.55 46.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 111.281 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.35 112.66 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.778 0.323 . . . . 60.25 111.689 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.29 -53.95 4.91 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.12 0.415 . . . . 70.329999999999998 112.12 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -143.18 150.43 39.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.993 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.19 131.98 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.886 -0.597 . . . . 70.239999999999995 110.757 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.57 156.3 16.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.475 -0.33 . . . . 53.299999999999997 111.302 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.8 p -64.66 -18.35 64.88 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.137 0.421 . . . . 55.049999999999997 112.137 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -69.47 -9.78 55.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.817 0.342 . . . . 73.519999999999996 111.443 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 93.5 0.07 67.57 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 112.214 -0.354 . . . . 70.439999999999998 112.214 -174.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 m -67.89 120.73 14.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 110.926 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.4 t -105.22 119.19 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.659 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.55 107.12 19.49 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.191 0.519 . . . . 74.400000000000006 110.929 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.58 144.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.013 -0.54 . . . . 55.219999999999999 111.771 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 t -90.98 112.83 24.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.333 -0.394 . . . . 74.010000000000005 111.379 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.39 -173.08 2.3 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.037 -0.529 . . . . 63.219999999999999 110.964 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' A' ' 60' ' ' TYR . 19.2 ptm . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.213 0.53 . . . . 64.409999999999997 110.77 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 111.945 0.35 . . . . 71.150000000000006 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -111.94 125.41 54.03 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.025 -0.422 . . . . 60.030000000000001 110.77 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.1 m -91.54 105.12 17.51 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.964 0.411 . . . . 64.0 111.619 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.18 139.93 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.375 -0.375 . . . . 70.310000000000002 111.555 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.2 m -72.36 155.31 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.681 0.277 . . . . 70.420000000000002 111.679 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -54.99 -48.19 73.63 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.535 0.569 . . . . 72.099999999999994 112.535 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.33 -41.08 92.88 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.478 -0.392 . . . . 62.25 113.41 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.51 -45.3 39.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.249 0.547 . . . . 64.230000000000004 111.236 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -64.81 -38.1 89.85 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.837 0.68 . . . . 65.319999999999993 112.837 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -62.47 -15.63 50.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.615 0.598 . . . . 74.120000000000005 112.615 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -79.53 -28.35 41.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.904 0.383 . . . . 73.25 111.796 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 100' ' ' LEU . 22.9 m-85 -74.14 147.84 42.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.163 0.506 . . . . 64.25 111.969 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -91.99 108.12 19.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.233 -0.439 . . . . 75.510000000000005 110.781 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 71.3 m-85 -88.22 119.08 28.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.948 0.404 . . . . 71.25 111.803 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 90' ' ' VAL . 3.6 mp -82.21 130.18 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.731 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.46 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 46.4 m-70 -120.39 161.95 20.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.969 0.508 . . . . 74.129999999999995 109.87 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.754 0.65 . . . . 62.219999999999999 112.754 -172.275 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 121.052 0.453 . . . . 72.209999999999994 111.854 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.08 149.88 26.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.834 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.18 -23.33 35.16 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.132 -0.556 . . . . 74.239999999999995 113.252 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -89.41 142.19 27.88 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.559 -0.377 . . . . 71.019999999999996 111.294 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.27 -27.05 65.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.213 0.53 . . . . 60.299999999999997 111.469 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.4 p -73.37 -16.37 61.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 112.203 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.98 -54.43 47.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.265 0.626 . . . . 72.340000000000003 112.397 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 39.4 p90 -77.89 -34.95 51.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.167 0.432 . . . . 73.129999999999995 112.167 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.14 -42.59 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 111.853 0.316 . . . . 75.329999999999998 111.853 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -58.01 -36.84 73.24 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.77 -41.82 43.27 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.868 0.366 . . . . 71.140000000000001 110.929 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.24 -27.2 68.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.107 0.41 . . . . 64.040000000000006 112.107 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.8 3.27 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 121.277 0.56 . . . . 60.350000000000001 111.422 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.28 12.77 66.56 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.163 -0.541 . . . . 72.150000000000006 113.933 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.41 16.91 71.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 114.43 0.532 . . . . 74.450000000000003 114.43 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.95 30.19 0.52 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.343 0.571 . . . . 63.229999999999997 112.123 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.81 150.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.923 0.392 . . . . 74.519999999999996 111.603 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.65 98.25 0.28 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.321 -0.466 . . . . 72.450000000000003 113.363 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.0 p -59.36 -8.76 1.88 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.086 0.773 . . . . 71.430000000000007 113.086 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -66.57 -12.5 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.59 0.589 . . . . 63.140000000000001 112.59 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -63.15 -59.45 4.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.807 0.337 . . . . 70.239999999999995 111.779 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.62 -110.43 3.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.11 -0.567 . . . . 32.130000000000003 113.699 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.52 140.2 58.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.985 0.393 . . . . 73.299999999999997 111.316 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.19 -43.68 64.31 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.573 0.582 . . . . 41.119999999999997 112.573 -176.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -56.96 -21.14 27.96 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.774 0.657 . . . . 61.130000000000003 112.774 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -90.94 -23.81 20.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.824 0.305 . . . . 72.030000000000001 111.824 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 101' ' ' GLN . 9.4 m0 -50.52 -40.26 51.11 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.264 0.839 . . . . 73.319999999999993 113.264 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.63 -64.58 0.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.171 0.434 . . . . 70.239999999999995 112.171 -175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -63.82 -35.44 80.62 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 71.030000000000001 111.691 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.39 87.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.773 0.32 . . . . 72.430000000000007 111.377 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.031 0.443 . . . . 34.210000000000001 111.347 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 p -64.22 -28.51 69.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.423 -0.353 . . . . 65.140000000000001 111.897 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -77.9 -36.34 49.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.9 0.381 . . . . 54.420000000000002 111.767 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -22.03 59.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.267 0.469 . . . . 72.129999999999995 112.267 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.58 10.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.047 -0.597 . . . . 23.23 113.587 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -76.67 -173.79 2.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.195 0.521 . . . . 54.329999999999998 111.286 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.9 m -121.23 97.47 5.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.436 -0.347 . . . . 63.149999999999999 111.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 152' ' ' ILE . 46.2 t -101.62 108.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.817 0.341 . . . . 74.430000000000007 111.847 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.65 147.74 39.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.51 -0.314 . . . . 74.219999999999999 110.932 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -72.76 -9.78 59.04 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.172 0.434 . . . . 72.319999999999993 112.172 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.9 m -56.53 119.79 31.48 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.519 0.2 . . . . 74.230000000000004 111.095 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.56 121.76 1.93 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.001 2.467 . . . . 73.140000000000001 113.78 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.49 156.87 35.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 111.099 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 151.66 46.04 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.077 0.465 . . . . 72.439999999999998 112.115 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.02 41.45 18.26 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.191 -0.528 . . . . 54.020000000000003 113.108 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.5 m -151.75 158.53 43.48 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.514 -0.404 . . . . 63.25 111.011 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -103.26 126.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.335 -0.246 . . . . 74.109999999999999 110.335 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 149' ' ' TYR . 1.2 pt? -98.85 124.36 43.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.399 0.619 . . . . 65.230000000000004 110.836 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -111.8 124.17 51.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 111.434 -172.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.585 ' HB2' ' CD1' ' A' ' 149' ' ' TYR . 47.5 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.877 0.37 . . . . 54.310000000000002 111.795 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -159.52 142.25 13.93 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.494 0.647 . . . . 73.510000000000005 111.66 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' HB1' ' A' ' 76' ' ' ALA . 12.8 m -141.09 141.43 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 111.716 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.16 156.67 41.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.38 -0.373 . . . . 73.209999999999994 110.905 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -96.0 128.64 43.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.881 0.372 . . . . 70.109999999999999 111.209 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 124' ' ' VAL . 61.8 t -79.8 118.82 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.317 0.488 . . . . 63.530000000000001 112.317 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -83.92 -53.67 5.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.282 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.42 154.05 34.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.075 0.464 . . . . 64.519999999999996 111.605 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.28 129.09 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 111.009 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.46 160.0 29.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.869 0.366 . . . . 40.229999999999997 111.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.3 m -64.04 -20.42 65.91 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.784 0.326 . . . . 62.200000000000003 111.605 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.11 -22.92 66.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.071 0.463 . . . . 74.420000000000002 111.329 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.87 45.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.582 -0.607 . . . . 75.109999999999999 111.582 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -64.97 129.17 38.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.621 0.368 . . . . 74.239999999999995 110.909 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.469 HG21 ' OH ' ' A' ' 151' ' ' TYR . 61.0 t -106.7 111.36 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.201 0.524 . . . . 64.209999999999994 111.737 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 140' ' ' THR . 37.9 mt-10 -90.32 107.31 19.06 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 110.716 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 113' ' ' VAL . 30.6 m -108.91 173.87 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.004 -0.543 . . . . 73.310000000000002 112.14 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.8 p -117.87 126.09 51.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.026 -0.534 . . . . 74.340000000000003 111.488 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 48.5 mt-10 -121.82 -172.68 2.49 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 111.268 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.1 tpp . . . . . 0 N--CA 1.471 0.619 0 O-C-N 121.904 -0.497 . . . . 45.32 111.338 177.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.634 0.254 . . . . 73.109999999999999 111.63 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 2.4 tpm_? -140.61 122.71 15.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.971 0.415 . . . . 50.229999999999997 111.923 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 123' ' ' GLU . 81.5 m -104.36 98.5 8.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.946 0.403 . . . . 60.399999999999999 110.739 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.66 128.88 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 54.43 111.775 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.1 m -67.29 147.25 53.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.549 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.72 -47.28 59.2 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.532 0.568 . . . . 52.219999999999999 112.532 -177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.66 64.55 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.225 -0.512 . . . . 71.200000000000003 113.246 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.32 -34.48 25.68 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.085 0.469 . . . . 73.439999999999998 111.06 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 149' ' ' TYR . . . -63.3 -10.93 18.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.707 0.632 . . . . 63.229999999999997 112.707 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -75.81 -21.6 57.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.328 0.492 . . . . 44.539999999999999 112.328 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 94.2 p -83.34 -33.28 25.91 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.355 0.502 . . . . 60.329999999999998 112.355 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 102' ' ' SER . 80.8 m-85 -70.8 145.82 50.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.251 0.548 . . . . 75.209999999999994 112.327 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -101.35 114.84 29.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.069 -0.514 . . . . 71.549999999999997 110.208 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.469 ' OH ' HG21 ' A' ' 122' ' ' VAL . 14.2 m-85 -90.91 114.96 27.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.283 0.475 . . . . 61.340000000000003 112.283 -174.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.558 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -82.02 107.75 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.752 -0.462 . . . . 74.510000000000005 109.752 173.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.81 125.36 40.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 52.539999999999999 111.239 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.986 0.422 . . . . 72.329999999999998 111.056 178.338 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 20.5 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 111.939 0.348 . . . . 62.240000000000002 111.939 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.1 mptp? 73.33 -50.65 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 112.971 0.73 . . . . 74.409999999999997 112.971 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -53.83 110.8 0.63 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.005 0.431 . . . . 74.319999999999993 111.809 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tt -92.2 122.87 35.09 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.073 -0.512 . . . . 75.099999999999994 110.799 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -75.56 95.31 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.973 0.416 . . . . 54.310000000000002 111.156 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.6 m -82.74 129.03 34.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 72.230000000000004 111.683 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.35 113.31 24.59 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.922 0.392 . . . . 63.130000000000003 111.39 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 75.5 p -84.9 18.43 2.45 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.465 0.543 . . . . 73.209999999999994 112.465 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 m -62.48 137.56 58.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.319 0.488 . . . . 75.510000000000005 112.319 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 10' ' ' LEU . 2.1 pt? -146.56 116.34 7.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 110.841 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -79.66 119.75 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.303 -0.408 . . . . 71.430000000000007 111.17 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.17 114.91 19.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 45.310000000000002 111.67 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.19 145.28 17.59 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.214 -0.517 . . . . 74.409999999999997 112.567 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.8 129.54 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 117.088 0.444 . . . . 72.409999999999997 111.784 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.03 -179.3 47.27 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 113.207 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.06 131.88 45.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.205 0.526 . . . . 72.329999999999998 112.282 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.24 84.62 7.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.098 0.475 . . . . 70.430000000000007 111.466 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -89.36 147.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.868 0.366 . . . . 72.299999999999997 111.443 178.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.7 t -123.16 143.73 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.024 0.379 . . . . 51.100000000000001 112.024 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.92 135.56 12.96 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.536 -0.364 . . . . 75.120000000000005 112.78 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.7 mm? -90.1 163.59 14.81 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.061 0.458 . . . . 74.219999999999999 111.724 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.38 130.33 47.56 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.013 0.435 . . . . 64.340000000000003 111.814 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -162.12 111.49 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.167 -0.47 . . . . 70.340000000000003 111.089 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -127.34 3.89 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.998 -0.62 . . . . 60.539999999999999 114.178 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.79 152.65 21.95 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.2 0.524 . . . . 71.140000000000001 112.222 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -93.35 177.75 5.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.118 -0.492 . . . . 73.299999999999997 111.904 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 165.41 12.03 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.803 0.668 . . . . 75.129999999999995 112.803 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -103.55 137.8 41.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.621 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 151.97 20.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.987 0.422 . . . . 75.420000000000002 111.943 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.03 -172.35 2.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.486 0.315 . . . . 41.100000000000001 111.301 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.9 128.65 12.44 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.242 0.544 . . . . 72.319999999999993 112.09 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -173.75 151.91 1.93 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.939 -0.573 . . . . 65.150000000000006 110.964 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.1 p -85.1 102.49 13.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.043 0.449 . . . . 65.030000000000001 110.708 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -150.41 99.5 3.2 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.131 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.36 90.96 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.749 2.299 . . . . 71.230000000000004 113.022 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 131.84 39.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.824 0.345 . . . . 52.450000000000003 111.316 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.86 -20.64 23.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.473 -0.33 . . . . 72.430000000000007 111.689 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -92.54 165.23 13.12 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.35 0.595 . . . . 72.200000000000003 112.296 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -78.92 101.53 7.77 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.197 0.522 . . . . 63.240000000000002 110.096 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.8 p -83.11 119.5 24.58 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.422 0.897 . . . . 54.43 113.422 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.8 m -67.61 133.09 48.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.872 -0.604 . . . . 74.209999999999994 109.957 169.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -52.55 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.566 0.58 . . . . 73.239999999999995 112.566 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 155' ' ' ASN . 22.5 m -133.12 152.8 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.795 0.331 . . . . 71.200000000000003 111.399 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.8 p -78.61 176.43 9.47 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.048 0.452 . . . . 74.230000000000004 111.554 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.4 p -135.27 93.98 3.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 62.530000000000001 112.287 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.91 64.73 1.73 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.141 -0.552 . . . . 70.209999999999994 111.999 173.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 68' ' ' ASN . 34.2 t -88.89 110.84 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.178 0.436 . . . . 62.350000000000001 112.178 -173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -149.49 158.03 43.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.25 -0.432 . . . . 72.329999999999998 111.321 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 160.12 5.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.695 0.283 . . . . 74.230000000000004 111.566 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 63' ' ' ASP . 38.9 t-20 -59.7 106.4 0.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.025 0.44 . . . . 71.219999999999999 111.765 -176.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.32 9.52 42.57 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.074 -0.512 . . . . 72.430000000000007 111.928 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -94.85 159.48 15.03 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.084 -0.385 . . . . 72.150000000000006 111.128 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t -70.91 139.64 50.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.132 0.491 . . . . 75.140000000000001 111.916 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.46 110.03 13.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.176 -0.466 . . . . 54.399999999999999 111.758 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.72 -28.24 1.75 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.925 -0.655 . . . . 73.420000000000002 113.287 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.32 150.04 27.43 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.547 -0.384 . . . . 74.109999999999999 110.755 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 28.2 p -58.69 -34.18 70.99 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.143 0.497 . . . . 72.310000000000002 111.796 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.404 ' HB ' ' CZ2' ' A' ' 79' ' ' TRP . 49.8 p -64.44 -25.75 68.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.24 -60.33 3.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.519 0.563 . . . . 73.340000000000003 112.519 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 25.0 p90 -64.35 -30.53 71.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.097 -0.377 . . . . 64.430000000000007 111.892 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HG23 ' A' ' 110' ' ' VAL . 59.4 t -62.53 -43.67 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.105 0.479 . . . . 61.409999999999997 110.583 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -58.54 -36.61 74.15 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.043 -0.526 . . . . 63.229999999999997 110.944 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB2' HD22 ' A' ' 50' ' ' ASN . 23.5 t70 -76.73 -43.31 37.82 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.406 -0.361 . . . . 64.530000000000001 111.132 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -59.19 -34.4 72.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.146 0.498 . . . . 71.209999999999994 111.816 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 99' ' ' ILE . 7.1 p -85.03 9.38 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.309 0.576 . . . . 70.219999999999999 111.815 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.18 14.59 68.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.389 -0.434 . . . . 34.329999999999998 113.556 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.77 17.9 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.167 -0.539 . . . . 73.239999999999995 114.129 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 59.8 m-80 -80.09 11.24 3.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.466 0.633 . . . . 64.219999999999999 112.375 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 pt -117.04 153.0 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.374 -0.376 . . . . 74.319999999999993 110.687 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.05 126.69 8.02 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.806 -0.711 . . . . 61.420000000000002 113.968 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -62.33 -19.27 63.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.189 0.518 . . . . 60.109999999999999 111.364 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -70.05 8.25 0.78 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.361 0.875 . . . . 73.430000000000007 113.361 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -78.15 -46.02 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.99 -0.444 . . . . 72.319999999999993 112.047 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.94 9.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.945 -0.645 . . . . 60.43 113.377 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -85.53 162.57 18.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.14 0.495 . . . . 55.43 111.881 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.32 -27.78 64.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.849 -0.614 . . . . 73.239999999999995 112.079 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -63.23 -35.34 79.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.985 0.422 . . . . 74.239999999999995 111.173 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.93 -21.26 19.32 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.508 0.558 . . . . 75.450000000000003 112.508 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.404 ' CZ2' ' HB ' ' A' ' 58' ' ' THR . 4.9 m0 -38.95 -55.43 1.55 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.447 1.277 . . . . 73.510000000000005 114.447 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -62.67 -37.63 87.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.941 -0.475 . . . . 62.32 112.235 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -68.94 -47.74 64.96 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.932 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.82 92.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.131 -0.486 . . . . 63.219999999999999 111.156 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.96 -51.98 62.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.078 0.466 . . . . 53.409999999999997 110.938 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 m -58.24 -45.27 88.07 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.176 0.512 . . . . 64.319999999999993 110.713 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 t -66.86 -24.6 66.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.072 -0.513 . . . . 64.299999999999997 111.97 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.3 -13.07 33.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.114 0.412 . . . . 64.140000000000001 112.114 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.34 41.84 3.86 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.253 -0.499 . . . . 62.439999999999998 113.434 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -107.61 -178.6 3.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 74.340000000000003 111.522 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.0 m -110.05 108.06 18.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.291 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 152' ' ' ILE . 39.0 t -116.81 110.99 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.082 0.467 . . . . 65.140000000000001 111.907 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 50.8 m-80 -139.17 155.6 47.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.385 -0.371 . . . . 72.319999999999993 110.369 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.64 13.71 1.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.008 0.373 . . . . 74.430000000000007 112.008 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.5 p -73.84 116.87 56.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.601 -0.272 . . . . 74.010000000000005 111.416 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 103.51 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.486 2.124 . . . . 53.539999999999999 112.241 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 36.9 tt0 -141.45 152.15 44.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.977 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.32 153.92 42.0 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.021 0.439 . . . . 71.319999999999993 111.905 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.54 34.05 63.53 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.074 -0.584 . . . . 63.020000000000003 112.691 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.5 m -136.78 158.8 43.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.299999999999997 111.067 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -107.95 127.53 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.597 -0.274 . . . . 64.530000000000001 110.448 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.7 pt? -95.63 130.37 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.937 -0.477 . . . . 42.329999999999998 111.127 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HA ' HG12 ' A' ' 110' ' ' VAL . 41.8 tt0 -98.29 129.32 45.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.402 -0.363 . . . . 64.140000000000001 111.685 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.5 t -95.38 -40.62 9.41 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.752 0.649 . . . . 71.310000000000002 112.752 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.3 p 66.59 -42.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.419 1.087 . . . . 75.200000000000003 113.47 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.17 9.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.212 0.529 . . . . 33.219999999999999 112.075 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.51 64.19 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.162 -0.542 . . . . 55.32 113.349 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.97 -84.14 0.36 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.398 -0.43 . . . . 65.140000000000001 113.038 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -87.7 1.85 52.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.955 0.407 . . . . 54.030000000000001 111.767 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.06 155.32 23.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.288 -0.482 . . . . 52.140000000000001 113.584 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -131.63 149.71 52.4 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.747 -0.267 . . . . 65.519999999999996 111.036 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.8 m -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.138 0.494 . . . . 65.530000000000001 111.663 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.86 163.03 40.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 73.129999999999995 110.651 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -96.68 127.4 42.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.752 0.31 . . . . 73.340000000000003 111.376 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 124' ' ' VAL . 60.9 t -76.1 108.05 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.948 0.404 . . . . 43.539999999999999 112.031 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 138' ' ' GLU . 11.3 mm-40 -71.95 -45.86 59.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.055 -0.52 . . . . 71.349999999999994 111.504 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -163.6 149.37 11.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 111.517 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 122' ' ' VAL . 57.9 t -120.65 128.91 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 52.119999999999997 110.535 177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.42 154.55 22.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.955 0.407 . . . . 70.400000000000006 111.925 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 t -57.61 -34.42 69.26 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.441 0.639 . . . . 75.019999999999996 110.078 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.2 -31.53 43.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.245 -0.889 . . . . 75.140000000000001 111.583 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 112.75 -19.35 21.4 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.369 -0.443 . . . . 54.509999999999998 112.669 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.3 p -61.62 125.7 24.72 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.329 0.585 . . . . 51.409999999999997 111.66 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 116' ' ' VAL . 48.9 t -103.44 117.85 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.716 -0.675 . . . . 74.109999999999999 111.347 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.85 102.52 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.218 0.532 . . . . 72.340000000000003 111.464 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.562 HG12 HG22 ' A' ' 113' ' ' VAL . 35.5 m -106.42 123.49 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.449 0.643 . . . . 60.340000000000003 111.876 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 39.5 t -81.03 122.19 26.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.054 0.455 . . . . 72.209999999999994 111.841 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -133.31 137.59 46.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.492 . . . . 63.200000000000003 111.18 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.579 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 50.2 ttm -80.58 122.14 26.68 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.016 0.436 . . . . 72.400000000000006 111.642 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -83.23 -29.46 28.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 64.319999999999993 110.592 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.4 t80 71.38 -55.74 0.65 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.91 0.707 . . . . 60.299999999999997 112.91 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -50.38 93.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.066 0.46 . . . . 72.409999999999997 111.529 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.62 -38.05 1.48 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.99 -0.55 . . . . 54.130000000000003 112.683 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.02 167.17 40.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.597 -0.335 . . . . 33.149999999999999 112.834 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.06 -28.2 65.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.763 2.309 . . . . 64.340000000000003 113.169 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.29 28.07 8.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.668 0.271 . . . . 73.329999999999998 111.684 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.2 m -66.56 83.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.417 0.627 . . . . 52.229999999999997 111.044 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 22.0 t -109.29 155.25 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.832 -0.622 . . . . 54.149999999999999 110.821 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.7 m -145.21 136.85 25.36 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.072 0.463 . . . . 54.210000000000001 111.737 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 2.6 mp0 -84.35 94.08 8.39 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.336 0.589 . . . . 64.140000000000001 111.366 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -70.04 109.3 4.48 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.504 -0.771 . . . . 64.420000000000002 111.895 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.8 m -85.33 98.26 10.44 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.95 0.405 . . . . 60.340000000000003 111.343 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.0 mt -88.52 144.34 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 111.549 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.8 m -68.85 148.32 50.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 111.293 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.404 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -49.36 -49.92 42.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.072 0.767 . . . . 65.230000000000004 113.072 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.03 -48.74 77.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.419 -0.419 . . . . 71.340000000000003 113.434 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.22 -39.03 75.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.042 0.449 . . . . 54.539999999999999 111.544 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.46 77.81 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.074 0.398 . . . . 73.400000000000006 112.074 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.9 m -61.55 -14.47 30.06 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.091 0.472 . . . . 62.520000000000003 111.74 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -73.67 -8.49 56.18 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.338 -0.392 . . . . 34.140000000000001 111.762 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 100' ' ' LEU . 53.1 m-85 -105.17 156.91 17.66 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.112 0.482 . . . . 74.329999999999998 112.064 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 91.7 m-20 -87.0 115.69 24.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.36 -0.382 . . . . 73.450000000000003 111.028 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 82.5 m-85 -93.29 121.32 34.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.053 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -89.89 111.08 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.347 -0.388 . . . . 64.310000000000002 110.316 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 33.2 m-70 -98.52 136.77 38.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.41 -0.359 . . . . 65.010000000000005 110.984 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.04 93.21 7.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.156 0.503 . . . . 53.130000000000003 112.236 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 155' ' ' ASN . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.107 0.479 . . . . 74.319999999999993 110.269 173.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.798 0.333 . . . . 64.439999999999998 111.19 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.1 150.04 20.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.25 0.547 . . . . 75.310000000000002 111.723 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -108.25 123.38 48.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.265 -0.425 . . . . 70.099999999999994 110.974 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.34 103.59 5.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.001 0.429 . . . . 72.409999999999997 111.997 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 m -87.29 38.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.45 0.643 . . . . 73.329999999999998 111.196 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.1 m -86.58 144.69 27.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.629 0.603 . . . . 74.400000000000006 112.629 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.21 126.91 38.54 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.7 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -136.92 105.16 5.7 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.668 0.271 . . . . 62.109999999999999 111.357 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 10' ' ' LEU . 25.4 m -88.3 157.38 18.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.983 0.42 . . . . 75.120000000000005 111.959 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.9 mm? -102.83 22.8 13.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.688 0.395 . . . . 73.129999999999995 111.242 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t -61.58 152.48 30.36 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.608 0.596 . . . . 71.400000000000006 112.608 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.53 168.61 8.98 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.194 -0.457 . . . . 50.119999999999997 112.202 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.76 96.1 1.76 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.443 -0.408 . . . . 74.310000000000002 113.021 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.1 mt -94.92 120.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.61 -0.347 . . . . 71.019999999999996 111.503 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -139.62 10.77 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.304 -0.475 . . . . 62.109999999999999 113.331 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.65 119.67 3.37 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.61 -0.347 . . . . 71.319999999999993 111.357 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.33 101.66 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.993 0.425 . . . . 63.32 111.689 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' A' ' 49' ' ' ALA . 35.1 mm -79.49 79.84 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.289 0.566 . . . . 62.210000000000001 110.918 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.97 124.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.196 -0.457 . . . . 64.340000000000003 110.967 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.73 84.85 0.08 OUTLIER Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 112.439 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -170.61 122.91 0.63 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.81 0.338 . . . . 73.230000000000004 111.1 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.57 95.21 2.88 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.847 0.356 . . . . 74.209999999999994 110.498 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 66.64 -4.25 0.77 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.66 0.615 . . . . 63.399999999999999 112.66 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.9 -1.46 84.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.263 -0.494 . . . . 43.240000000000002 113.732 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -72.17 -19.97 61.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.895 0.379 . . . . 72.450000000000003 111.873 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -107.86 131.66 54.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.038 0.447 . . . . 73.200000000000003 111.294 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.82 23.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.978 -0.555 . . . . 75.030000000000001 110.665 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.06 162.54 9.2 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.309 0.485 . . . . 70.519999999999996 112.309 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.05 9.23 23.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.5 0.555 . . . . 74.420000000000002 112.5 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.14 107.53 0.9 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 111.887 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.18 119.18 36.38 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.275 -0.42 . . . . 73.439999999999998 111.931 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -93.18 117.86 30.56 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.928 0.394 . . . . 70.329999999999998 111.064 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.5 p -113.52 96.1 5.7 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.613 0.597 . . . . 72.450000000000003 112.613 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -118.63 112.79 36.8 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.394 -0.366 . . . . 64.310000000000002 110.939 173.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.57 100.45 0.41 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.772 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.7 p -118.89 157.41 27.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.186 0.517 . . . . 64.439999999999998 111.486 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -80.46 30.83 0.29 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.396 0.517 . . . . 75.340000000000003 112.396 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.32 7.68 15.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.924 0.342 . . . . 74.349999999999994 111.924 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -62.25 103.83 0.43 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.003 0.43 . . . . 43.210000000000001 111.491 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -139.5 158.21 44.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.37 -0.377 . . . . 45.109999999999999 111.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 m -84.15 92.16 7.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 52.020000000000003 110.198 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -104.83 146.59 28.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.096 0.474 . . . . 52.329999999999998 112.214 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.7 m -103.21 138.02 40.58 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.018 -0.537 . . . . 61.420000000000002 110.833 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -64.92 114.12 4.32 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.86 0.362 . . . . 75.219999999999999 111.908 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.5 p -114.17 -179.39 3.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.933 0.397 . . . . 62.25 111.375 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.5 -112.88 3.24 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.321 -0.466 . . . . 44.420000000000002 112.723 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.5 p 51.93 13.07 0.22 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 114.277 1.214 . . . . 75.209999999999994 114.277 174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.8 m -98.8 157.34 16.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.078 0.466 . . . . 73.510000000000005 111.701 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -74.61 -74.03 0.21 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.266 0.555 . . . . 65.439999999999998 111.898 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -165.12 90.32 0.5 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.94 -0.573 . . . . 72.530000000000001 110.055 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.43 31.53 0.58 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.138 0.494 . . . . 71.040000000000006 112.198 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -140.51 -177.93 5.27 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.607 0.363 . . . . 71.209999999999994 110.527 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -114.85 149.87 36.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.997 0.427 . . . . 63.310000000000002 111.784 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 103.84 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 112.35 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.75 -28.17 2.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 112.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 59' ' ' TRP . 96.3 mt-30 -73.88 143.87 45.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.007 0.432 . . . . 71.439999999999998 111.899 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.5 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.0 m -57.11 -46.28 82.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.569 174.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.3 p -55.13 -41.21 71.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.795 -0.639 . . . . 52.420000000000002 111.547 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 56' ' ' GLN . 59.3 t90 -55.23 -55.68 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.57 -0.741 . . . . 73.329999999999998 111.76 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.483 ' OH ' HG11 ' A' ' 136' ' ' VAL . 47.1 t80 -62.75 -42.18 99.55 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.294 0.479 . . . . 75.109999999999999 112.294 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 110' ' ' VAL . 82.4 t -60.44 -38.27 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 111.946 0.35 . . . . 73.530000000000001 111.946 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 44.2 t80 -62.22 -34.82 77.22 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 111.388 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.95 -46.78 56.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.167 0.508 . . . . 55.350000000000001 110.318 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HD3' ' OH ' ' A' ' 60' ' ' TYR . 25.5 mmmt -55.71 -40.58 72.6 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 112.3 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.51 9.5 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.077 0.465 . . . . 74.209999999999994 111.55 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.66 60.47 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.523 -0.37 . . . . 31.52 113.745 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA2' ' CE1' ' A' ' 62' ' ' TYR . . . 63.54 29.25 74.07 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.159 -0.543 . . . . 62.409999999999997 114.261 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -93.23 24.57 3.76 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.478 0.639 . . . . 71.430000000000007 112.214 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.82 155.5 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.03 0.443 . . . . 61.140000000000001 111.702 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.13 93.56 0.34 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.09 -0.576 . . . . 73.140000000000001 112.551 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 63.1 p -72.65 20.8 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.377 0.88 . . . . 35.329999999999998 113.377 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -90.0 -2.26 58.11 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.189 -0.319 . . . . 64.030000000000001 111.752 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -64.83 -38.18 90.12 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.56 0.578 . . . . 72.439999999999998 112.56 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.09 -111.09 3.24 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.071 -0.585 . . . . 60.229999999999997 113.445 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -53.63 134.05 41.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.926 0.393 . . . . 41.119999999999997 111.908 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.95 -39.31 85.14 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.507 0.558 . . . . 61.240000000000002 112.507 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -63.74 -9.82 16.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.48 0.548 . . . . 55.420000000000002 112.48 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -94.15 -16.65 23.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.497 0.319 . . . . 60.420000000000002 111.661 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 11.6 m0 -60.49 -42.26 95.95 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.129 0.789 . . . . 73.120000000000005 113.129 -170.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -66.1 -56.66 10.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.971 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -62.52 -44.51 96.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.91 0.386 . . . . 65.239999999999995 111.627 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.1 -47.94 83.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.566 -0.288 . . . . 54.009999999999998 111.728 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -56.38 -49.0 75.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 111.404 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -58.76 -40.81 84.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 111.999 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -75.49 -39.14 58.94 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.959 0.409 . . . . 62.299999999999997 111.897 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.99 82.61 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.113 0.412 . . . . 71.120000000000005 112.113 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.11 17.85 1.58 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.948 -0.644 . . . . 52.350000000000001 113.383 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 58.7 m-85 -89.19 176.61 6.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.26 0.552 . . . . 72.400000000000006 111.061 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -104.59 91.37 3.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.133 -0.485 . . . . 75.140000000000001 111.173 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 152' ' ' ILE . 62.1 t -103.69 117.52 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.029 0.442 . . . . 71.120000000000005 112.054 -176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -153.04 -179.46 7.7 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.902 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.15 10.1 30.8 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.083 0.401 . . . . 71.319999999999993 112.083 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -72.56 111.79 12.48 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 110.291 -0.263 . . . . 74.530000000000001 110.291 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.479 ' O ' HG21 ' A' ' 116' ' ' VAL . 91.8 Cg_endo -76.65 1.93 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.836 2.358 . . . . 62.520000000000003 115.065 -170.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.23 137.51 6.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.895 0.702 . . . . 60.43 112.895 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.51 174.16 1.84 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.396 0.888 . . . . 72.150000000000006 113.396 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.0 35.33 57.95 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.998 -0.547 . . . . 42.130000000000003 112.484 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.7 m -153.4 -176.96 6.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.571 0.348 . . . . 62.020000000000003 110.665 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mt -122.2 129.39 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.803 -0.18 . . . . 52.409999999999997 111.45 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.4 pt? -98.37 133.45 42.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.799 -0.563 . . . . 74.420000000000002 110.923 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -101.39 106.15 17.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.031 -0.531 . . . . 72.450000000000003 110.286 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -99.29 116.16 30.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 75.400000000000006 111.38 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 48.2 p -77.35 2.75 14.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.661 0.615 . . . . 63.439999999999998 112.661 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.48 58.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.087 0.47 . . . . 65.319999999999993 111.624 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.03 168.76 37.95 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.23 -0.51 . . . . 63.030000000000001 113.073 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.44 99.04 0.22 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.303 -0.475 . . . . 71.340000000000003 112.933 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 66.22 27.23 10.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.504 0.668 . . . . 75.420000000000002 110.833 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.26 162.01 30.55 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.411 -0.813 . . . . 72.409999999999997 113.021 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -142.44 110.55 5.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.456 -0.438 . . . . 64.0 111.095 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG13 ' HB1' ' A' ' 76' ' ' ALA . 31.4 m -111.81 145.15 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.921 0.391 . . . . 72.140000000000001 111.397 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.39 157.81 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.989 0.423 . . . . 73.530000000000001 111.366 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -90.7 130.91 36.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.827 0.346 . . . . 73.319999999999993 110.878 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' HA ' HG12 ' A' ' 124' ' ' VAL . 39.9 t -83.49 114.72 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 45.229999999999997 112.124 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.78 -50.96 10.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.907 -0.588 . . . . 73.409999999999997 111.536 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -158.08 150.71 22.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 111.84 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 94' ' ' PRO . 98.5 t -126.92 127.63 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.912 -0.585 . . . . 64.239999999999995 110.39 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -91.98 148.29 22.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.881 0.372 . . . . 74.549999999999997 111.852 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 75.8 m -64.0 -16.01 60.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.368 -0.378 . . . . 73.409999999999997 111.743 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.11 -6.46 39.43 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 111.379 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 60.05 1.59 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.316 -0.468 . . . . 54.219999999999999 112.985 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.0 p -145.78 133.6 21.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.294 -0.533 . . . . 64.109999999999999 111.668 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.46 113.62 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.213 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 31.2 mt-10 -99.49 118.85 36.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.502 -0.317 . . . . 75.109999999999999 110.928 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 113' ' ' VAL . 16.1 m -129.38 147.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.371 0.508 . . . . 64.340000000000003 112.371 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 65.9 m -79.4 122.91 26.98 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.928 0.394 . . . . 53.329999999999998 112.054 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' CD ' ' HD2' ' A' ' 139' ' ' ARG . 44.3 mt-10 -116.62 143.94 45.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.275 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 tpp -93.77 103.99 16.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.741 0.305 . . . . 52.299999999999997 110.227 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -77.55 76.46 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.3 0.571 . . . . 63.409999999999997 111.896 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -60.01 -23.55 63.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.815 -0.629 . . . . 75.439999999999998 111.846 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.5 -29.66 68.01 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.126 0.489 . . . . 71.209999999999994 111.086 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.73 -50.44 1.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.835 -0.506 . . . . 53.140000000000001 111.835 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.69 120.81 0.95 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.357 -0.449 . . . . 73.239999999999995 112.517 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.41 5.46 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.015 2.477 . . . . 74.510000000000005 113.878 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -115.26 3.72 14.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.848 0.356 . . . . 72.049999999999997 111.118 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 m -115.93 132.55 56.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 111.365 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG11 ' OH ' ' A' ' 60' ' ' TYR . 43.2 t -113.48 140.24 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.528 0.566 . . . . 55.329999999999998 112.528 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 t -136.83 134.88 37.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.95 -0.568 . . . . 72.019999999999996 111.144 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -91.43 119.9 31.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.729 0.299 . . . . 70.540000000000006 111.413 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HD2' ' CD ' ' A' ' 126' ' ' GLU . 11.3 ptm180 -87.46 151.59 22.92 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.117 -0.364 . . . . 71.510000000000005 110.633 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.422 HG23 ' HG2' ' A' ' 123' ' ' GLU . 52.4 m -114.8 102.59 10.14 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.123 0.487 . . . . 72.120000000000005 110.98 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 mt -86.43 131.0 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.854 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -71.26 149.11 46.52 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.814 -0.175 . . . . 72.140000000000001 110.94 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.99 61.53 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.701 0.63 . . . . 65.109999999999999 112.701 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.68 -23.63 55.66 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.459 -0.4 . . . . 71.510000000000005 113.809 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.24 -35.06 10.87 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.448 -0.442 . . . . 64.299999999999997 111.257 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.32 67.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.122 0.487 . . . . 61.409999999999997 111.8 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 148' ' ' SER . 69.1 m -60.83 143.79 54.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.221 -0.445 . . . . 24.050000000000001 110.859 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 147' ' ' SER . 31.3 t 83.56 -3.0 1.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.681 0.792 . . . . 65.010000000000005 112.241 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -93.61 127.99 39.55 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.972 -0.455 . . . . 75.439999999999998 110.272 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.89 118.48 30.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 111.707 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -92.17 113.22 25.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.951 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -80.22 114.92 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.501 -0.318 . . . . 73.120000000000005 110.35 174.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.57 146.93 28.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.667 0.27 . . . . 75.319999999999993 110.658 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.7 mt -102.47 127.81 49.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.804 0.335 . . . . 75.049999999999997 111.414 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.877 0.37 . . . . 61.219999999999999 111.012 178.933 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.009 0.374 . . . . 73.439999999999998 112.009 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -97.39 151.57 19.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.871 0.367 . . . . 64.129999999999995 110.518 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -87.33 94.01 9.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.937 0.398 . . . . 74.209999999999994 110.877 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -156.27 161.78 40.19 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.166 0.508 . . . . 74.129999999999995 112.257 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.07 141.86 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.962 -0.563 . . . . 73.109999999999999 110.474 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.3 m -83.71 106.4 15.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 110.902 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.9 150.06 34.14 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.328 0.492 . . . . 71.430000000000007 112.328 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -162.18 167.42 24.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.246 -0.434 . . . . 54.340000000000003 111.187 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.9 m -150.35 126.19 10.42 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.747 0.308 . . . . 74.430000000000007 111.145 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -132.07 139.99 48.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.164 0.507 . . . . 65.25 111.667 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -164.53 104.49 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.731 -0.668 . . . . 71.420000000000002 110.798 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.13 112.56 24.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.188 0.44 . . . . 65.400000000000006 112.188 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.59 116.91 5.35 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 112.387 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -110.2 144.2 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.026 0.441 . . . . 73.450000000000003 111.768 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.27 140.64 12.45 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.364 -0.446 . . . . 73.030000000000001 113.073 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.03 137.04 38.13 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.488 -0.419 . . . . 53.119999999999997 111.775 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.42 113.72 25.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.406 -0.361 . . . . 72.439999999999998 111.53 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -96.43 142.2 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.117 0.484 . . . . 74.329999999999998 112.037 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.1 153.66 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.355 -0.384 . . . . 62.100000000000001 111.406 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.23 118.0 0.84 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.877 -0.677 . . . . 64.319999999999993 113.873 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 22' ' ' ASP . 7.9 tt -144.63 138.62 27.49 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 21' ' ' LEU . 16.1 m-20 -121.83 161.19 23.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.862 0.69 . . . . 72.239999999999995 112.862 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -163.73 99.61 0.89 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.502 -0.772 . . . . 75.5 110.565 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.41 172.95 51.83 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.217 -0.516 . . . . 63.130000000000003 114.369 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -77.92 112.78 15.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.233 0.539 . . . . 73.329999999999998 111.321 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.1 143.38 30.59 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.219 0.822 . . . . 74.319999999999993 113.219 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.9 178.8 5.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 55.399999999999999 109.919 166.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -141.02 140.09 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 112.104 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.16 110.35 18.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.999 0.428 . . . . 70.230000000000004 110.486 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.82 89.7 6.34 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.247 0.832 . . . . 62.0 113.247 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.86 127.66 33.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.883 -0.784 . . . . 71.519999999999996 108.883 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.77 103.54 0.08 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.646 0.736 . . . . 71.310000000000002 111.553 -176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 t -68.14 86.18 0.26 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.428 -0.806 . . . . 40.020000000000003 112.424 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -129.11 140.34 38.35 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.038 -0.528 . . . . 62.299999999999997 110.747 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.54 104.82 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.45 2.1 . . . . 64.430000000000007 112.774 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -96.75 -41.48 8.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.353 0.501 . . . . 71.319999999999993 112.353 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -99.72 139.07 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.168 0.509 . . . . 64.510000000000005 111.951 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -93.05 -30.73 15.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.036 -0.529 . . . . 71.109999999999999 111.723 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.16 33.33 0.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.589 0.589 . . . . 72.219999999999999 112.589 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.6 p -85.78 89.57 7.79 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.272 0.558 . . . . 61.520000000000003 112.004 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.5 p -115.45 131.19 57.01 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.237 -0.438 . . . . 63.210000000000001 110.561 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.08 103.08 2.2 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.104 0.478 . . . . 71.109999999999999 112.059 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.6 m -76.33 75.87 3.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.014 0.435 . . . . 44.520000000000003 110.216 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' THR . 7.1 t -66.36 81.06 0.09 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.847 0.832 . . . . 72.540000000000006 112.389 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -175.95 -48.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.343 -0.844 . . . . 34.439999999999998 110.691 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.66 -162.58 52.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.195 -0.526 . . . . 72.219999999999999 113.058 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.6 t -103.43 149.56 24.69 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.283 -0.539 . . . . 74.299999999999997 111.595 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.0 t -128.67 -0.53 5.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.826 -0.625 . . . . 74.439999999999998 111.412 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.86 175.2 14.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.183 0.516 . . . . 52.109999999999999 112.235 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -90.07 117.32 28.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.249 -0.432 . . . . 53.43 110.441 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 71' ' ' SER . 3.9 mm? -96.01 15.46 20.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.04 0.385 . . . . 74.329999999999998 112.04 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -110.32 178.8 4.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.936 0.398 . . . . 74.329999999999998 111.27 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 5.1 t -116.8 150.1 38.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.403 -0.362 . . . . 61.119999999999997 111.61 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.37 156.73 25.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.715 0.635 . . . . 74.409999999999997 112.715 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.77 -33.9 3.23 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.284 -0.416 . . . . 53.450000000000003 113.795 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -75.64 150.74 37.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.229 0.537 . . . . 75.340000000000003 112.274 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.406 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.7 p -56.41 -39.53 73.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.025 -0.534 . . . . 75.25 111.638 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.7 p -54.99 -42.96 73.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.941 0.401 . . . . 63.219999999999999 111.649 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' THR . 86.7 t90 -62.82 -50.32 71.45 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.408 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.1 -54.15 50.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.787 -0.642 . . . . 63.310000000000002 111.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.8 t -60.5 -34.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.469 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -55.62 -47.69 76.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.519 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.19 -37.56 75.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.965 0.412 . . . . 74.439999999999998 110.884 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -61.24 -35.57 77.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.013 -0.539 . . . . 43.009999999999998 112.19 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.65 12.4 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.432 0.634 . . . . 63.399999999999999 110.997 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.67 18.38 59.05 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 114.179 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.02 67.14 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.115 -0.564 . . . . 51.119999999999997 113.792 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.01 37.76 0.44 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.231 -0.57 . . . . 62.420000000000002 111.89 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.3 pt -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.112 0.482 . . . . 64.310000000000002 111.455 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.8 1.26 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.071 -0.585 . . . . 44.520000000000003 112.315 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 6.2 m -52.82 -18.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.219 0.822 . . . . 64.420000000000002 113.219 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -94.43 18.93 10.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.576 0.584 . . . . 73.299999999999997 112.576 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -67.69 -37.0 81.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.074 0.398 . . . . 72.519999999999996 112.074 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.94 -134.62 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.072 -0.585 . . . . 63.149999999999999 113.715 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -63.17 151.02 41.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.312 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.65 -31.76 62.61 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.14 0.793 . . . . 73.099999999999994 113.14 -172.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -67.14 -21.62 65.82 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.494 0.553 . . . . 61.210000000000001 112.494 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.38 -14.21 29.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.109 0.411 . . . . 75.209999999999994 112.109 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -52.06 -65.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.202 0.816 . . . . 72.0 113.202 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.18 91.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.059 0.392 . . . . 44.329999999999998 112.059 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 m -54.97 -36.91 65.86 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.976 0.417 . . . . 73.340000000000003 111.613 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.2 -28.11 25.66 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.342 -0.39 . . . . 64.450000000000003 111.891 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.7 70.04 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.726 0.298 . . . . 70.450000000000003 111.372 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.4 p -58.88 -54.36 48.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.012 0.434 . . . . 65.530000000000001 111.106 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.8 t -55.56 -37.19 67.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.945 -0.571 . . . . 64.230000000000004 112.446 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.88 -10.46 59.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 111.999 0.37 . . . . 73.439999999999998 111.999 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 41.51 4.24 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.332 -0.461 . . . . 55.439999999999998 113.873 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -110.98 -179.07 3.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.005 0.431 . . . . 64.030000000000001 111.112 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.4 m -109.72 103.86 12.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.216 0.45 . . . . 63.130000000000003 112.216 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.6 t -94.28 99.81 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 63.329999999999998 110.882 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -122.17 156.07 34.46 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 111.29 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.78 -4.06 58.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.443 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.2 m -66.35 111.71 7.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.323 -0.398 . . . . 74.239999999999995 110.806 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -78.12 20.29 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.471 2.781 . . . . 64.409999999999997 114.56 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -48.65 141.53 7.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.556 0.576 . . . . 73.400000000000006 112.556 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.74 144.68 47.55 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.987 -0.551 . . . . 44.299999999999997 112.36 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.54 45.89 5.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.916 -0.659 . . . . 73.140000000000001 112.584 -175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -149.53 177.68 9.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 70.319999999999993 111.121 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.8 mt -122.83 121.21 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 110.708 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.6 pt? -92.7 139.4 30.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.02 0.438 . . . . 70.329999999999998 110.867 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -105.06 103.7 13.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.92 0.39 . . . . 62.399999999999999 111.408 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 66.2 m -74.6 97.27 3.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.406 0.622 . . . . 70.329999999999998 111.165 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.6 p -88.24 11.68 15.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.879 -0.601 . . . . 72.329999999999998 112.203 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.33 -27.59 68.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.466 0.543 . . . . 64.25 112.466 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 156.36 -174.47 34.17 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.911 -0.661 . . . . 63.140000000000001 113.599 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.41 41.54 94.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.324 -0.465 . . . . 64.109999999999999 113.407 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.39 17.39 8.32 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.026 0.531 . . . . 73.200000000000003 112.046 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.38 156.2 29.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.08 -0.581 . . . . 73.299999999999997 113.436 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 26.8 t60 -141.32 148.09 39.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.687 -0.302 . . . . 74.230000000000004 110.457 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.493 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -139.43 144.2 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.146 0.498 . . . . 71.129999999999995 111.692 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.39 153.73 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.907 -0.588 . . . . 61.200000000000003 110.666 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -88.71 128.7 35.62 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.049 0.452 . . . . 71.200000000000003 111.129 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.74 106.38 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.27 -0.423 . . . . 62.25 111.665 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -74.81 -51.99 12.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.938 0.399 . . . . 64.239999999999995 111.384 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -148.88 145.78 27.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.293 0.568 . . . . 40.200000000000003 112.347 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.49 130.02 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.826 -0.625 . . . . 61.530000000000001 110.763 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -88.36 147.46 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.354 -0.385 . . . . 74.420000000000002 111.372 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -56.09 -37.33 69.21 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.908 0.385 . . . . 62.229999999999997 111.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -22.48 64.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 111.736 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.37 -20.66 8.34 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.412 -0.423 . . . . 63.509999999999998 113.587 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -58.63 126.25 26.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.131 0.419 . . . . 65.340000000000003 112.131 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.12 122.89 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.05 -0.523 . . . . 65.040000000000006 111.189 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -103.43 109.58 21.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.273 0.558 . . . . 73.519999999999996 110.978 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.62 160.43 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.961 -0.563 . . . . 54.43 111.534 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.8 p -107.83 124.8 50.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.214 0.531 . . . . 63.229999999999997 111.744 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 48.4 mt-10 -108.34 -176.58 3.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.819 -0.628 . . . . 75.219999999999999 111.207 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 39.0 tpp -141.35 134.44 29.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.381 -0.372 . . . . 54.32 111.48 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 t30 60.22 29.17 18.78 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.313 0.578 . . . . 42.509999999999998 111.921 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -79.05 -168.53 1.5 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.791 -0.448 . . . . 54.399999999999999 109.791 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.64 96.09 0.08 Allowed 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.619 -0.676 . . . . 64.540000000000006 111.829 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.95 -63.01 0.13 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.039 -0.528 . . . . 71.109999999999999 112.82 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -174.64 154.66 19.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.796 -0.716 . . . . 64.109999999999999 113.469 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.26 140.91 41.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.633 2.222 . . . . 73.420000000000002 112.925 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 64.86 12.78 8.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.888 -0.596 . . . . 65.019999999999996 112.019 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.1 t -99.53 139.87 34.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.665 0.269 . . . . 75.310000000000002 111.032 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.58 118.36 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.16 0.505 . . . . 72.310000000000002 111.622 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 126' ' ' GLU . 49.4 m -98.65 107.28 19.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.063 0.459 . . . . 72.140000000000001 111.218 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.96 110.01 16.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.327 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -108.45 121.04 44.13 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.856 -0.611 . . . . 72.349999999999994 111.432 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.4 m -94.98 103.72 15.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 111.458 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 111.309 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.4 m -67.02 144.77 55.99 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.494 -0.321 . . . . 72.120000000000005 111.419 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.69 -47.49 50.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.965 0.728 . . . . 64.510000000000005 112.965 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.85 -57.86 16.12 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.548 -0.358 . . . . 64.299999999999997 113.479 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.57 -41.66 98.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 71.519999999999996 110.971 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.31 69.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.892 -0.595 . . . . 54.329999999999998 112.176 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -64.08 -11.65 31.69 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.489 0.551 . . . . 73.140000000000001 112.489 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 44.4 t -83.0 -10.38 58.8 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.975 0.416 . . . . 73.340000000000003 111.178 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 26.2 m-85 -93.73 153.08 18.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.076 0.465 . . . . 71.310000000000002 111.285 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.27 112.58 20.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.286 -0.416 . . . . 75.530000000000001 111.335 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 89.6 m-85 -93.9 113.52 25.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.121 0.486 . . . . 62.420000000000002 111.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -80.12 128.38 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 54.219999999999999 110.933 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.09 144.82 48.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.436 -0.347 . . . . 71.25 110.568 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 59.8 mt -98.55 129.35 45.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.175 0.512 . . . . 63.439999999999998 112.289 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.787 0 CA-C-N 116.132 -0.486 . . . . 75.099999999999994 111.534 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.669 0.271 . . . . 73.5 111.136 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -89.54 103.41 16.05 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.421 . . . . 54.229999999999997 111.246 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.05 155.68 23.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.876 0.37 . . . . 72.409999999999997 111.292 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.6 mt -78.95 113.3 16.95 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 110.151 -0.314 . . . . 74.109999999999999 110.151 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.74 -38.32 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.96 0.356 . . . . 75.099999999999994 111.96 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.8 m 50.92 82.05 0.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.097 0.475 . . . . 62.020000000000003 111.159 -176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.08 158.15 43.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.746 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.548 HG23 ' HB ' ' A' ' 11' ' ' THR . 81.7 m -61.05 95.99 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.228 0.537 . . . . 63.130000000000003 111.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.8 m -111.68 114.34 27.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 50.299999999999997 111.299 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.61 28.67 17.81 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.535 0.683 . . . . 73.439999999999998 110.959 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.548 ' HB ' HG23 ' A' ' 8' ' ' THR . 79.2 m -120.38 128.74 53.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.667 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.94 -30.62 0.87 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.217 0.451 . . . . 74.0 112.217 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.08 65.85 1.76 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.971 -0.633 . . . . 51.32 112.759 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.4 mp -74.42 84.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 73.519999999999996 110.997 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.06 139.43 3.95 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.665 -0.698 . . . . 61.530000000000001 112.623 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.7 106.9 1.11 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.923 0.392 . . . . 32.43 111.436 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.35 68.95 4.47 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.432 0.635 . . . . 52.399999999999999 111.81 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 tt -83.36 -20.56 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.01 -0.541 . . . . 62.5 111.471 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.77 102.42 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.523 0.677 . . . . 70.230000000000004 112.141 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -149.91 51.03 0.54 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.852 -0.613 . . . . 73.340000000000003 112.574 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.46 168.74 20.45 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 111.752 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -101.87 -77.28 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.467 0.543 . . . . 64.030000000000001 112.467 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -179.63 -33.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.577 0.351 . . . . 71.409999999999997 111.568 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.04 -66.79 3.83 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.088 -0.577 . . . . 74.109999999999999 113.356 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.82 171.14 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.387 0.514 . . . . 62.399999999999999 112.387 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -138.23 144.32 40.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.09 -0.505 . . . . 64.439999999999998 111.907 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.65 92.92 9.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.967 0.413 . . . . 74.019999999999996 110.04 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.94 -148.52 0.05 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.054 0.761 . . . . 61.32 113.054 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 92.62 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.156 0.799 . . . . 73.200000000000003 113.156 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.47 134.31 53.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.064 -0.516 . . . . 64.230000000000004 110.244 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -34.52 35.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.007 0.432 . . . . 65.230000000000004 111.489 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.66 86.44 2.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.01 0.433 . . . . 74.030000000000001 110.092 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 t -152.66 115.56 4.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.604 . . . . 61.140000000000001 112.123 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -113.73 123.0 33.78 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.158 -0.474 . . . . 72.400000000000006 110.343 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.42 91.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.53 2.153 . . . . 74.519999999999996 112.782 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 38' ' ' GLN . 46.0 p -133.08 -19.72 2.22 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.683 -0.69 . . . . 71.409999999999997 111.566 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 38' ' ' GLN . 5.2 p30 48.79 -70.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.73 1.212 . . . . 72.340000000000003 113.941 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' THR . 36.0 tt0 72.68 -65.07 0.37 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.825 0.45 . . . . 63.439999999999998 111.816 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.7 p -86.75 170.71 11.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.004 0.431 . . . . 72.420000000000002 111.26 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -107.17 -17.52 14.13 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.063 0.458 . . . . 75.230000000000004 111.655 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.8 m -123.67 107.48 11.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.438 -0.346 . . . . 74.540000000000006 110.446 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -91.04 106.73 18.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.352 0.501 . . . . 73.409999999999997 112.352 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.638 ' HB2' ' HA3' ' A' ' 87' ' ' GLY . 73.0 m -123.5 117.17 24.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.056 -0.52 . . . . 75.329999999999998 110.087 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.2 m -139.27 144.59 38.44 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.124 0.487 . . . . 72.0 112.089 -174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.1 t -140.81 93.0 2.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.947 -0.57 . . . . 53.109999999999999 110.324 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.97 103.79 3.05 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.142 -0.551 . . . . 75.420000000000002 112.975 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.8 p -92.93 128.95 38.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.499 -0.412 . . . . 73.349999999999994 111.32 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -86.48 -16.21 37.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.944 0.402 . . . . 62.210000000000001 111.639 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.02 104.22 13.91 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 52.100000000000001 111.75 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -72.46 110.79 7.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.449 -0.342 . . . . 50.520000000000003 110.742 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' H ' ' HB2' ' A' ' 71' ' ' SER . 89.9 mt -93.67 17.38 11.92 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.191 0.441 . . . . 72.129999999999995 112.191 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -104.79 177.5 4.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.086 0.47 . . . . 74.340000000000003 111.177 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.413 HG22 ' OE1' ' A' ' 56' ' ' GLN . 8.8 t -124.18 148.99 46.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.404 -0.362 . . . . 75.120000000000005 111.971 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 111.01 1.46 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.069 0.461 . . . . 55.130000000000003 111.124 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.65 -24.05 3.06 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.302 -0.475 . . . . 53.229999999999997 112.4 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 53' ' ' THR . 51.4 mt-30 -83.18 138.94 33.43 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.748 -0.266 . . . . 62.109999999999999 110.793 175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.1 p -61.54 -35.37 77.57 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.181 0.515 . . . . 72.019999999999996 109.994 174.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -54.87 -44.97 74.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.513 -0.767 . . . . 74.530000000000001 111.454 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -55.88 -50.09 71.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.903 -0.589 . . . . 72.329999999999998 111.77 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -63.04 -45.37 92.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.796 0.331 . . . . 73.150000000000006 111.667 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.6 t -60.99 -36.18 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.95 0.405 . . . . 42.32 111.053 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -56.14 -43.17 78.01 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 110.81 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.35 -47.55 70.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.153 -0.476 . . . . 63.119999999999997 110.977 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -56.76 -37.92 71.72 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.07 -3.6 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 111.483 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.98 8.43 84.07 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.441 -0.409 . . . . 23.32 113.713 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.55 84.62 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 113.554 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -78.6 36.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.177 0.436 . . . . 73.150000000000006 112.177 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.6 pt -140.02 -178.28 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.989 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.81 108.83 3.43 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.996 -0.621 . . . . 53.130000000000003 112.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 51' ' ' LEU . 80.1 p -63.1 -14.66 51.16 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.415 -0.462 . . . . 53.109999999999999 112.203 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 t -85.85 5.4 32.91 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.674 0.62 . . . . 72.349999999999994 112.674 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -67.21 -34.74 78.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.092 -0.38 . . . . 75.340000000000003 111.889 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.25 -118.46 5.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.199 -0.524 . . . . 71.439999999999998 114.045 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -58.16 134.58 56.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.085 0.402 . . . . 55.520000000000003 112.085 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.08 -25.18 60.97 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.549 0.574 . . . . 72.030000000000001 112.549 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.33 -9.97 59.15 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.798 0.332 . . . . 73.129999999999995 111.881 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -102.53 -4.94 24.55 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 111.916 0.339 . . . . 54.020000000000003 111.916 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -64.7 -43.67 92.75 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.626 0.602 . . . . 73.340000000000003 112.626 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.61 95.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.088 0.47 . . . . 44.109999999999999 111.343 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -65.48 -48.11 73.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 64.329999999999998 111.315 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.42 95.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.866 0.365 . . . . 61.119999999999997 111.358 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.14 -56.23 24.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 111.393 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.6 t -64.06 -29.72 70.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 111.646 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 t -75.71 -33.46 60.31 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.941 0.401 . . . . 75.109999999999999 111.645 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.46 -25.0 36.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.902 0.382 . . . . 65.420000000000002 111.6 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 43' ' ' SER . . . 117.65 6.72 12.68 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.057 -0.592 . . . . 55.020000000000003 113.321 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 96.8 m-85 -74.3 158.2 34.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.242 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 92.88 6.91 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.272 0.558 . . . . 45.240000000000002 111.998 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 152' ' ' ILE . 46.7 t -95.3 124.37 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.83 -0.623 . . . . 74.0 111.365 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -146.42 166.97 24.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 111.203 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -82.49 -5.57 58.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.261 -0.427 . . . . 74.540000000000006 111.47 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 113.04 6.77 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 116.599 -0.273 . . . . 60.539999999999999 110.674 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.471 ' O ' HG21 ' A' ' 116' ' ' VAL . 94.1 Cg_endo -82.14 20.82 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.106 2.537 . . . . 72.140000000000001 114.625 -170.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.8 147.63 22.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.1 0.778 . . . . 73.340000000000003 113.1 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -64.75 159.82 21.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.366 -0.833 . . . . 64.519999999999996 112.329 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.7 44.65 12.08 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.405 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -156.48 179.66 9.04 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.975 0.417 . . . . 71.019999999999996 111.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.62 122.87 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.209 -0.45 . . . . 73.040000000000006 110.726 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -97.85 134.21 41.3 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.131 0.491 . . . . 54.009999999999998 111.078 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -101.62 116.66 33.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.013 0.435 . . . . 73.319999999999993 112.069 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -101.98 115.68 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.824 -0.626 . . . . 70.219999999999999 110.11 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 p -76.23 66.93 2.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.396 0.617 . . . . 62.420000000000002 111.747 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.28 168.84 18.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.735 -0.666 . . . . 42.520000000000003 112.042 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.16 -26.66 67.89 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.545 . . . . 60.539999999999999 114.001 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.02 49.25 3.17 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.092 -0.575 . . . . 74.109999999999999 113.771 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 59.03 27.83 16.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 73.239999999999995 111.967 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.52 152.36 29.25 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.152 -0.476 . . . . 33.340000000000003 113.485 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -141.17 130.92 24.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.427 0.291 . . . . 54.240000000000002 110.989 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.511 HG13 ' HB1' ' A' ' 76' ' ' ALA . 26.3 m -127.37 146.92 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.003 0.43 . . . . 74.420000000000002 111.441 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.53 156.47 45.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.095 -0.502 . . . . 43.409999999999997 111.088 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -87.15 127.13 35.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.86 0.362 . . . . 52.450000000000003 111.64 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 122' ' ' VAL . 60.1 t -77.85 105.17 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.303 -0.408 . . . . 53.049999999999997 111.151 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.12 -48.46 10.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.622 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -150.69 151.93 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.97 0.414 . . . . 74.340000000000003 111.585 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 94' ' ' PRO . 29.0 t -127.17 137.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.421 -0.354 . . . . 74.450000000000003 111.137 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -77.63 164.22 25.53 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.909 0.385 . . . . 54.229999999999997 111.41 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 m -63.09 -31.22 72.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.878 0.325 . . . . 72.319999999999993 111.878 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.66 -39.21 64.62 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 111.837 0.31 . . . . 61.520000000000003 111.837 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 142.13 -12.22 2.57 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 113.85 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.4 m -55.26 128.55 34.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.239 0.543 . . . . 55.020000000000003 111.835 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 113' ' ' VAL . 48.4 t -106.56 119.35 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.503 -0.771 . . . . 72.129999999999995 111.763 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.89 107.52 19.27 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.92 0.391 . . . . 72.510000000000005 110.577 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 122' ' ' VAL . 32.9 m -112.24 148.55 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.718 0.636 . . . . 65.040000000000006 112.718 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.8 p -99.21 112.45 24.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.795 -0.639 . . . . 74.120000000000005 111.376 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.562 ' HG3' ' HB3' ' A' ' 137' ' ' SER . 5.3 pt-20 -123.44 -172.33 2.49 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.031 -0.531 . . . . 72.25 111.18 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.8 ttm -138.48 141.54 39.42 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.301 -0.25 . . . . 73.019999999999996 110.881 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -129.71 -71.49 0.61 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.234 0.457 . . . . 65.010000000000005 112.234 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.485 ' HB3' ' OG ' ' A' ' 135' ' ' SER . 36.5 t80 -72.46 97.6 2.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.426 0.631 . . . . 74.439999999999998 112.626 -171.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -68.99 88.29 0.39 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.518 0.675 . . . . 74.239999999999995 110.658 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.14 -42.31 0.07 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.744 . . . . 63.439999999999998 111.827 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.66 160.34 47.04 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.971 -0.633 . . . . 34.0 111.942 173.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.2 -28.94 81.7 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.742 2.295 . . . . 71.540000000000006 113.531 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.486 ' HD2' HG23 ' A' ' 136' ' ' VAL . 29.2 p90 -135.78 -46.92 0.67 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.876 0.324 . . . . 70.25 111.876 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 129' ' ' TYR . 43.0 t 46.67 63.66 1.82 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.297 0.57 . . . . 72.409999999999997 111.966 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG23 ' HD2' ' A' ' 134' ' ' PHE . 58.5 t -88.9 128.33 41.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 70.010000000000005 111.7 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.562 ' HB3' ' HG3' ' A' ' 126' ' ' GLU . 15.3 t -101.69 127.17 48.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.139 -0.482 . . . . 64.310000000000002 110.939 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.11 92.53 4.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.018 0.437 . . . . 62.149999999999999 109.935 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -96.91 122.95 40.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 111.88 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 32.5 m -93.83 113.42 25.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.097 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.84 125.25 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.793 0.294 . . . . 71.140000000000001 111.793 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -62.23 145.14 54.42 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.684 0.278 . . . . 73.319999999999993 111.575 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.431 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -51.36 -43.03 61.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.775 0.657 . . . . 75.120000000000005 112.775 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.12 -22.25 28.11 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.252 -0.499 . . . . 74.340000000000003 113.707 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -101.69 -47.39 4.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 71.019999999999996 110.692 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.549 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.83 -40.78 94.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 113.192 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.6 m -60.59 -16.62 40.04 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.927 0.714 . . . . 75.310000000000002 112.927 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.4 t -79.16 -25.31 42.87 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.962 0.41 . . . . 63.439999999999998 111.55 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.71 148.49 34.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.06 0.457 . . . . 72.340000000000003 111.608 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 150' ' ' ASN . 0.8 OUTLIER -83.76 115.78 22.38 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.237 -0.289 . . . . 51.399999999999999 111.358 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 69.8 m-85 -94.2 110.83 22.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.847 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -81.37 113.38 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.293 -0.412 . . . . 75.510000000000005 110.695 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -104.29 135.98 44.73 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.691 0.281 . . . . 64.209999999999994 110.677 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.6 mt -99.83 123.36 44.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.891 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.263 0.554 . . . . 74.439999999999998 110.573 176.921 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.687 0.254 . . . . 75.230000000000004 111.687 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.94 116.01 29.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.059 0.392 . . . . 74.230000000000004 112.059 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.96 101.26 1.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.181 0.515 . . . . 65.549999999999997 111.4 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.6 mt -121.17 91.88 3.63 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.75 0.31 . . . . 62.109999999999999 111.294 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.58 150.48 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 111.616 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -158.69 140.4 13.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.806 0.336 . . . . 72.420000000000002 111.531 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.7 104.74 8.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.055 0.455 . . . . 70.409999999999997 111.691 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.3 p -99.69 136.51 39.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.259 -0.428 . . . . 43.530000000000001 111.345 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -129.62 23.17 5.45 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.554 0.576 . . . . 74.340000000000003 112.554 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.9 mp -75.63 86.44 2.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.091 0.472 . . . . 62.240000000000002 110.606 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -123.36 17.14 9.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.217 0.451 . . . . 52.439999999999998 112.217 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 122.17 17.06 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.395 0.517 . . . . 73.019999999999996 112.395 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.41 59.72 0.47 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.358 -0.383 . . . . 64.25 112.506 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 14' ' ' ILE . 2.1 mp -77.3 141.4 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 111.893 0.331 . . . . 73.540000000000006 111.893 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.31 117.69 0.52 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.357 -0.383 . . . . 33.399999999999999 112.469 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.95 165.64 27.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.069 0.461 . . . . 42.399999999999999 112.038 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.98 148.83 32.11 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.377 0.51 . . . . 72.25 112.377 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.6 pt -133.37 156.77 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.091 -0.504 . . . . 72.129999999999995 111.108 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.9 141.34 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.897 0.379 . . . . 72.109999999999999 111.164 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.16 96.12 0.5 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.001 -0.618 . . . . 74.310000000000002 113.92 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 21' ' ' LEU . 6.9 mp -83.3 91.01 7.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.855 0.36 . . . . 73.120000000000005 110.957 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.3 113.02 19.13 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.074 0.464 . . . . 74.019999999999996 111.523 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -143.31 173.13 11.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.371 -0.377 . . . . 64.409999999999997 110.82 177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.67 114.89 3.56 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.918 -0.658 . . . . 73.019999999999996 113.541 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -110.79 -164.91 0.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 122.51 0.324 . . . . 73.239999999999995 111.037 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.79 178.43 9.14 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.007 0.432 . . . . 70.549999999999997 111.287 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.48 -178.84 3.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.22 -0.445 . . . . 64.430000000000007 110.832 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.32 -3.76 53.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.742 0.306 . . . . 73.409999999999997 111.727 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.48 109.61 10.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.258 0.466 . . . . 65.140000000000001 112.258 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.31 168.2 24.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.138 -0.483 . . . . 55.32 111.29 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -131.93 141.97 49.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.98 0.419 . . . . 74.530000000000001 111.764 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -72.56 83.65 1.13 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.996 0.427 . . . . 70.540000000000006 111.542 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -170.92 172.34 5.59 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.237 -0.438 . . . . 61.310000000000002 111.171 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.83 94.62 17.67 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.609 -0.269 . . . . 73.140000000000001 111.351 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.14 145.51 84.75 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.664 2.243 . . . . 71.430000000000007 112.429 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 t -63.19 108.92 1.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.536 0.684 . . . . 74.409999999999997 112.315 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -85.38 68.5 10.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.099 0.476 . . . . 70.319999999999993 110.983 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -65.2 -63.71 1.04 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.967 0.413 . . . . 74.310000000000002 111.327 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.8 m -88.14 135.28 33.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.358 -0.383 . . . . 61.119999999999997 111.228 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -80.91 27.63 0.38 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.019 0.438 . . . . 53.210000000000001 112.144 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.9 m -152.21 115.38 4.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.576 0.35 . . . . 72.430000000000007 110.793 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -179.59 3.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.997 0.427 . . . . 74.310000000000002 111.728 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -115.78 139.25 50.35 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.989 0.423 . . . . 72.5 111.453 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.7 p -138.91 29.34 2.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.071 0.462 . . . . 75.340000000000003 110.949 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.1 m -82.21 77.79 8.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.014 0.435 . . . . 52.100000000000001 111.398 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.21 109.63 2.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.289 -0.482 . . . . 54.109999999999999 112.832 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.3 p -80.84 103.11 10.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.048 0.451 . . . . 63.450000000000003 110.885 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 21.3 m -74.25 -30.12 61.99 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.123 0.416 . . . . 74.420000000000002 112.123 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.93 161.01 29.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.824 0.345 . . . . 64.450000000000003 111.522 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.95 103.57 15.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.982 -0.449 . . . . 73.510000000000005 111.736 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.1 mm? -99.1 0.46 43.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.66 -0.245 . . . . 73.329999999999998 111.638 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' HE2' ' HA2' ' A' ' 74' ' ' GLY . 3.6 t80 -114.4 160.6 18.96 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.171 -0.33 . . . . 64.200000000000003 111.602 -173.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t -71.93 145.06 48.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.984 0.421 . . . . 72.150000000000006 112.081 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.52 149.64 27.42 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.162 0.506 . . . . 64.400000000000006 112.338 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.64 -34.77 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.292 -0.413 . . . . 54.25 113.428 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.21 148.76 50.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.773 0.32 . . . . 71.510000000000005 111.545 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.3 p -56.8 -43.06 80.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.983 0.42 . . . . 70.319999999999993 111.12 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -55.73 -39.57 71.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.04 -0.527 . . . . 63.340000000000003 111.565 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.504 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 87.6 t90 -60.54 -52.29 65.8 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 111.44 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.06 -41.37 96.48 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.136 -0.353 . . . . 75.510000000000005 111.344 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 112' ' ' TYR . 65.7 t -63.23 -35.04 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.276 0.56 . . . . 75.400000000000006 110.69 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 59' ' ' TRP . 60.5 t80 -57.15 -46.51 82.67 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.589 -0.732 . . . . 63.329999999999998 111.136 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.6 -40.86 72.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.851 0.357 . . . . 55.009999999999998 111.726 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -61.33 -31.94 71.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.284 0.476 . . . . 71.329999999999998 112.284 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 65' ' ' VAL . 7.5 p -84.92 6.49 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.279 0.562 . . . . 72.239999999999995 111.193 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 21.63 73.96 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.425 -0.417 . . . . 74.230000000000004 113.527 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 48' ' ' SER . . . 64.55 27.16 71.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 121.227 -0.511 . . . . 55.049999999999997 113.456 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -89.95 25.45 2.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.216 -0.579 . . . . 75.129999999999995 111.674 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.4 pt -131.57 176.52 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.788 0.435 . . . . 74.230000000000004 110.643 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 129.22 9.81 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.8 -0.714 . . . . 54.439999999999998 113.124 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 59.6 m -62.35 -23.18 66.64 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.466 -0.432 . . . . 75.349999999999994 112.117 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -60.31 -15.74 28.18 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.599 0.592 . . . . 74.310000000000002 112.599 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -60.48 -36.18 77.67 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.045 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' HA2' ' HE2' ' A' ' 52' ' ' TYR . . . 65.44 -122.99 24.38 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.661 0.624 . . . . 71.209999999999994 114.661 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -60.23 141.84 55.42 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.25 0.548 . . . . 55.409999999999997 112.062 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.57 -23.11 62.64 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.993 0.738 . . . . 64.450000000000003 112.993 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.01 -11.4 60.32 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 122.046 -0.409 . . . . 72.109999999999999 111.864 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -101.54 -26.22 13.62 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.442 0.534 . . . . 73.519999999999996 112.442 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -41.08 -59.16 1.56 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.48 1.289 . . . . 72.129999999999995 114.48 -173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.85 85.01 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.046 -0.409 . . . . 53.299999999999997 112.013 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 m -63.78 -43.28 96.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 111.261 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.06 99.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.928 0.394 . . . . 52.32 111.365 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.1 82.9 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.042 0.448 . . . . 65.209999999999994 110.998 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 m -61.39 -40.68 95.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.133 -0.485 . . . . 65.230000000000004 111.489 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -73.16 -36.88 66.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.13 0.419 . . . . 74.540000000000006 112.13 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.02 66.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.231 0.456 . . . . 75.129999999999995 112.231 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.59 0.87 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.93 -0.652 . . . . 32.210000000000001 113.448 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.51 179.47 4.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 73.209999999999994 111.445 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.9 m -108.88 94.58 5.13 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.948 0.404 . . . . 64.530000000000001 111.815 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.85 111.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.893 0.377 . . . . 43.049999999999997 111.181 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.78 176.77 7.56 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.018 0.437 . . . . 75.400000000000006 111.09 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -90.26 -1.87 57.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.672 0.272 . . . . 44.210000000000001 110.818 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 t -55.8 118.28 19.33 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 116.304 -0.407 . . . . 75.120000000000005 111.425 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -86.23 11.8 3.2 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.008 2.472 . . . . 70.519999999999996 113.942 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -59.06 143.57 48.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 112.138 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.69 163.36 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.774 -0.648 . . . . 74.239999999999995 112.627 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.97 16.17 75.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.128 -0.558 . . . . 61.039999999999999 112.762 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -124.69 165.99 16.96 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.74 0.305 . . . . 52.329999999999998 111.153 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -112.96 128.73 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.25 -0.281 . . . . 72.530000000000001 110.553 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -101.26 133.06 46.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.332 0.587 . . . . 70.340000000000003 111.296 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.556 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.2 tt0 -92.83 108.83 20.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.046 -0.524 . . . . 63.100000000000001 110.934 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 46.6 m -87.92 -34.74 18.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.7 p 56.23 17.03 2.58 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.082 0.771 . . . . 51.149999999999999 113.082 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.63 86.52 2.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.995 0.426 . . . . 71.120000000000005 112.123 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.87 179.84 17.04 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.113 -0.565 . . . . 60.32 113.382 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.87 -48.59 74.98 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 72.019999999999996 113.515 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -78.7 -19.83 51.51 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.395 0.617 . . . . 71.129999999999995 110.48 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.57 -164.65 22.09 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.691 -0.686 . . . . 30.539999999999999 111.987 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -166.83 141.22 4.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.076 0.438 . . . . 65.329999999999998 111.521 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 101' ' ' GLN . 16.9 m -146.18 153.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.29 0.636 . . . . 60.350000000000001 110.697 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.22 160.55 42.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.926 0.394 . . . . 52.25 111.278 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' HB2' HG13 ' A' ' 61' ' ' VAL . 70.9 t80 -98.62 127.79 44.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.937 0.399 . . . . 74.040000000000006 111.445 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 116.21 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.391 -0.368 . . . . 74.519999999999996 111.888 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -88.03 -38.83 15.14 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.116 0.413 . . . . 73.409999999999997 112.116 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -161.88 145.91 12.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.796 0.665 . . . . 73.530000000000001 112.796 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.99 150.4 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.888 -0.596 . . . . 63.240000000000002 110.573 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -113.11 168.73 9.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.479 0.548 . . . . 73.200000000000003 112.479 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.7 t -63.22 -31.84 73.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.086 0.47 . . . . 72.430000000000007 110.933 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.95 -12.36 54.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 111.723 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.62 -1.22 89.04 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.636 -0.585 . . . . 73.439999999999998 111.636 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 m -68.38 136.1 52.82 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.941 0.401 . . . . 61.340000000000003 111.608 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.92 122.03 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.056 -0.52 . . . . 73.120000000000005 111.884 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 75.420000000000002 111.082 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.01 149.22 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.116 -0.493 . . . . 73.420000000000002 112.224 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.4 t -97.37 109.39 22.16 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.005 -0.543 . . . . 70.239999999999995 111.55 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.18 171.05 7.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.003 -0.544 . . . . 62.140000000000001 110.295 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 34.7 ttm -110.26 124.55 51.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 111.935 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.79 89.71 4.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.744 -0.662 . . . . 71.540000000000006 110.635 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -72.98 10.33 0.94 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.512 0.56 . . . . 75.420000000000002 112.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -94.0 85.12 4.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.082 0.468 . . . . 71.030000000000001 110.879 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.64 60.2 6.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.251 -0.499 . . . . 74.450000000000003 113.465 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 164.98 94.23 0.1 OUTLIER Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.083 -0.58 . . . . 52.240000000000002 113.445 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.19 -13.26 34.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.733 2.289 . . . . 75.340000000000003 113.414 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -118.9 1.58 11.51 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.819 0.342 . . . . 70.239999999999995 111.073 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -70.38 123.76 22.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.19 0.519 . . . . 72.450000000000003 111.164 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.27 147.61 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.43 -0.35 . . . . 65.109999999999999 111.349 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.9 t -130.87 120.19 23.28 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.107 0.48 . . . . 71.530000000000001 110.91 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.68 113.25 25.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.916 -0.584 . . . . 60.229999999999997 110.818 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -99.64 119.39 38.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.098 0.475 . . . . 72.450000000000003 111.544 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.2 m -95.63 94.34 7.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.257 -0.429 . . . . 71.239999999999995 110.77 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.7 mt -83.22 131.83 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.582 -0.281 . . . . 72.420000000000002 111.311 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.5 m -62.63 150.11 41.63 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.483 0.182 . . . . 60.130000000000003 111.485 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.58 -51.06 39.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.736 0.643 . . . . 74.200000000000003 112.736 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.66 70.3 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.286 -0.415 . . . . 73.0 113.504 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.14 -38.53 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.124 0.487 . . . . 74.540000000000006 111.266 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -63.67 -38.69 92.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.073 -0.512 . . . . 75.019999999999996 112.173 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.1 t -61.36 -12.17 12.95 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.345 0.498 . . . . 75.140000000000001 112.345 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.1 t -82.02 -13.96 56.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.739 0.304 . . . . 45.140000000000001 111.784 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.44 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 36.2 m-85 -97.05 151.35 19.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 111.992 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -89.81 115.53 27.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.351 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.418 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 96.3 m-85 -94.87 112.06 23.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.419 . . . . 72.540000000000006 111.86 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.9 mp -79.36 121.25 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.706 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -112.6 136.12 52.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 109.971 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.98 129.38 34.86 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.81 0.338 . . . . 72.109999999999999 111.697 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 p30 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.188 0.518 . . . . 71.420000000000002 111.192 179.586 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 112.102 0.408 . . . . 70.439999999999998 112.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -79.12 76.75 5.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.75 0.786 . . . . 64.530000000000001 112.157 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -140.88 106.2 5.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 71.209999999999994 110.407 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 tt 56.31 87.8 0.05 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.232 0.539 . . . . 74.209999999999994 110.532 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.44 141.77 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.974 0.416 . . . . 52.310000000000002 111.633 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 m -76.17 98.84 4.51 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.004 0.43 . . . . 74.120000000000005 111.279 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.55 146.97 26.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.872 0.368 . . . . 52.219999999999999 111.813 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.5 p -123.5 112.95 18.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.394 -0.366 . . . . 63.340000000000003 111.431 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -89.0 126.68 35.52 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.85 0.357 . . . . 72.439999999999998 111.571 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.25 95.57 5.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.95 0.405 . . . . 50.329999999999998 111.295 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -105.69 110.51 22.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.507 -0.315 . . . . 55.420000000000002 110.974 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.24 150.07 51.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.363 0.505 . . . . 55.240000000000002 112.363 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 106.1 0.29 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.937 -0.574 . . . . 54.409999999999997 112.594 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 14' ' ' ILE . 2.8 pp -82.73 156.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.661 0.615 . . . . 64.329999999999998 112.661 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.05 138.28 6.39 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.015 -0.539 . . . . 74.239999999999995 113.121 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.4 124.13 5.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.425 0.29 . . . . 74.239999999999995 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.74 116.97 32.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.836 0.351 . . . . 73.439999999999998 111.833 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -110.14 122.43 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.586 -0.279 . . . . 41.219999999999999 111.148 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 p -167.44 141.35 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.714 0.292 . . . . 72.230000000000004 111.559 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.245 -0.502 . . . . 71.439999999999998 113.039 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.4 mt -97.68 165.64 11.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.119 0.485 . . . . 75.319999999999993 112.129 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.57 152.1 39.17 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.224 -0.443 . . . . 74.129999999999995 111.952 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -176.12 147.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.764 0.426 . . . . 73.510000000000005 111.445 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.83 96.84 0.3 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.192 -0.528 . . . . 44.140000000000001 113.68 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -127.85 119.97 26.77 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 122.427 -0.455 . . . . 72.530000000000001 111.489 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.91 140.46 49.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.572 0.225 . . . . 71.299999999999997 111.002 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.23 7.83 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.066 0.395 . . . . 70.140000000000001 112.066 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -163.16 147.59 11.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.672 0.272 . . . . 73.129999999999995 110.671 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.8 117.98 29.62 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.92 0.391 . . . . 61.409999999999997 111.889 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.18 145.08 23.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.904 0.383 . . . . 52.210000000000001 111.668 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -143.17 119.67 11.01 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.843 0.354 . . . . 74.019999999999996 110.552 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -150.71 141.08 22.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.915 0.388 . . . . 75.540000000000006 111.416 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.2 t -139.92 98.79 3.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.057 0.456 . . . . 65.219999999999999 111.457 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -83.36 115.06 57.27 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 122.262 -0.274 . . . . 62.340000000000003 111.315 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.98 98.05 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.343 2.028 . . . . 72.349999999999994 113.304 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -110.62 104.79 13.52 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.57 -0.286 . . . . 73.109999999999999 111.03 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -91.37 110.56 21.87 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.986 0.422 . . . . 73.510000000000005 110.818 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 80' ' ' ALA . 6.5 tp-100 -76.01 138.36 40.85 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.456 -0.338 . . . . 64.439999999999998 111.439 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 p -67.28 109.44 3.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.13 0.49 . . . . 32.32 110.767 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 84' ' ' SER . 30.5 p -74.4 156.7 36.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.845 0.683 . . . . 73.310000000000002 112.845 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -116.23 136.27 53.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.944 -0.571 . . . . 70.299999999999997 111.359 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -7.92 57.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.147 0.425 . . . . 75.040000000000006 112.147 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -66.23 125.67 26.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.901 0.382 . . . . 51.030000000000001 111.663 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 t -114.33 175.08 5.63 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.028 0.442 . . . . 63.450000000000003 111.811 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB3' HG21 ' A' ' 72' ' ' THR . 30.0 t -170.95 168.67 6.96 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.319 -0.4 . . . . 74.420000000000002 111.385 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.08 32.48 2.34 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.181 -0.533 . . . . 45.140000000000001 113.319 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 t -90.24 122.61 33.32 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.551 -0.382 . . . . 63.520000000000003 111.627 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.4 m -97.84 -16.2 19.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.94 0.348 . . . . 74.129999999999995 111.94 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.28 148.29 41.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.785 0.326 . . . . 74.340000000000003 111.818 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.68 94.63 0.21 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.891 0.377 . . . . 74.010000000000005 111.497 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 72' ' ' THR . 69.3 mt -70.67 -18.06 62.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.079 0.4 . . . . 74.219999999999999 112.079 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -80.22 178.14 8.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.853 0.358 . . . . 72.010000000000005 111.45 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.4 p -111.11 154.15 24.7 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.274 0.559 . . . . 71.019999999999996 112.504 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.69 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.678 -0.692 . . . . 61.140000000000001 111.051 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.83 -31.5 4.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.337 -0.459 . . . . 50.240000000000002 112.819 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -60.97 137.65 58.22 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.526 -0.396 . . . . 72.010000000000005 111.84 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.459 ' O ' HG23 ' A' ' 61' ' ' VAL . 57.2 m -50.59 -41.95 55.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 71.430000000000007 110.416 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -59.29 -39.19 82.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.267 -0.879 . . . . 71.049999999999997 112.182 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -60.81 -52.62 64.3 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.5 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.78 -49.21 78.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.949 0.404 . . . . 62.420000000000002 111.76 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' CYS . 67.5 t -59.87 -36.73 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.958 0.408 . . . . 61.009999999999998 111.348 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -58.46 -38.52 77.71 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.098 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.21 -46.68 69.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.378 -0.373 . . . . 71.230000000000004 111.174 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.65 -33.69 71.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.232 0.456 . . . . 73.5 112.232 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -88.98 12.12 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-O 121.31 0.576 . . . . 75.400000000000006 111.461 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.19 14.23 55.89 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.361 -0.381 . . . . 51.009999999999998 113.814 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.21 9.1 53.52 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 114.194 0.438 . . . . 72.019999999999996 114.194 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.4 -20.56 63.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.592 0.59 . . . . 74.299999999999997 112.592 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 154' ' ' LEU . 34.2 pt -80.23 -35.9 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.895 0.702 . . . . 72.340000000000003 112.895 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 119.34 2.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.097 -0.573 . . . . 63.530000000000001 112.231 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -81.72 20.39 0.94 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.771 0.656 . . . . 70.209999999999994 112.771 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.5 t -90.81 12.3 19.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 74.439999999999998 111.97 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -83.42 -30.03 27.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.683 0.277 . . . . 60.509999999999998 111.72 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.66 -126.31 7.48 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.373 -0.442 . . . . 50.43 113.925 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -58.8 139.47 56.29 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.893 0.377 . . . . 44.009999999999998 111.73 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -54.62 -40.29 68.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.839 0.681 . . . . 42.310000000000002 112.839 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.546 ' OD1' ' HA ' ' A' ' 103' ' ' THR . 96.1 m-20 -71.81 -9.59 58.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.689 0.626 . . . . 74.150000000000006 112.689 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -97.19 -15.98 20.62 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.759 0.314 . . . . 41.25 111.263 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -49.79 -58.74 4.74 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.726 0.639 . . . . 74.120000000000005 112.726 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . . . -55.43 -39.71 70.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 75.439999999999998 111.769 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -40.41 89.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.325 -0.398 . . . . 70.400000000000006 111.766 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.44 -45.84 24.49 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.012 0.434 . . . . 74.140000000000001 111.37 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.89 -56.58 11.62 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.38 0.511 . . . . 71.409999999999997 112.38 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB2' HG22 ' A' ' 40' ' ' THR . 68.9 m -67.55 -1.01 4.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.621 0.6 . . . . 75.349999999999994 112.621 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 40' ' ' THR . 38.0 t -116.93 -12.18 10.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.973 0.416 . . . . 52.119999999999997 111.54 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.05 8.54 38.82 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.17 0.433 . . . . 72.239999999999995 112.17 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.82 35.82 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.967 -0.635 . . . . 61.200000000000003 113.543 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.01 162.63 12.98 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.141 0.496 . . . . 51.140000000000001 111.355 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -111.28 99.08 7.97 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.879 0.371 . . . . 74.049999999999997 111.905 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 152' ' ' ILE . 57.4 t -93.6 103.75 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.422 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 86.4 m-20 -134.8 137.92 43.79 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.061 -0.518 . . . . 75.209999999999994 109.956 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.58 -4.69 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.056 0.761 . . . . 74.25 113.056 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 m -55.71 112.81 4.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 122.597 0.359 . . . . 74.120000000000005 111.388 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.75 119.0 3.55 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.813 2.342 . . . . 71.200000000000003 113.166 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.9 145.16 30.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.703 -0.681 . . . . 73.019999999999996 111.146 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.43 133.11 54.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.917 0.389 . . . . 20.420000000000002 111.596 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.22 48.83 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.841 -0.695 . . . . 72.120000000000005 112.795 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.3 p -159.3 177.13 11.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.94 0.4 . . . . 63.420000000000002 110.657 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mt -123.7 122.75 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.872 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -98.59 123.52 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.547 0.689 . . . . 73.310000000000002 111.66 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 29.0 tt0 -82.37 106.45 14.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.94 -0.573 . . . . 73.030000000000001 111.45 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 44.2 m -84.2 92.86 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 110.734 173.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.546 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 39.3 p -69.44 -8.86 50.53 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.112 0.482 . . . . 64.409999999999997 111.532 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.51 -35.14 71.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.001 -0.545 . . . . 75.200000000000003 112.022 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.77 38.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.356 -0.45 . . . . 74.329999999999998 112.865 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.49 -40.33 69.08 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.757 -0.258 . . . . 61.439999999999998 113.605 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -109.81 0.42 18.78 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.234 0.54 . . . . 62.32 110.636 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.68 155.26 28.27 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.788 -0.642 . . . . 73.019999999999996 113.065 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 74.6 t60 -140.49 105.97 5.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.908 0.385 . . . . 65.049999999999997 110.652 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG13 ' HB1' ' A' ' 76' ' ' ALA . 27.7 m -103.65 136.38 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.111 0.481 . . . . 71.409999999999997 111.649 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.88 159.52 41.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.929 -0.578 . . . . 71.540000000000006 110.737 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -93.14 123.98 36.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.879 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.61 112.29 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.021 0.439 . . . . 73.230000000000004 111.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.23 -49.36 13.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.021 -0.536 . . . . 72.530000000000001 111.459 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -164.96 139.57 5.14 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.963 0.411 . . . . 64.239999999999995 112.091 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.42 123.64 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.247 -0.433 . . . . 52.229999999999997 109.922 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -78.17 166.84 22.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.372 0.508 . . . . 75.010000000000005 112.372 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -47.26 -48.51 24.57 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.465 0.543 . . . . 65.299999999999997 112.465 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.72 -45.28 87.22 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.002 0.429 . . . . 71.450000000000003 111.769 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.42 -21.89 2.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.889 -0.672 . . . . 70.430000000000007 113.661 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.1 m -56.78 129.74 42.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.419 0.61 . . . . 74.329999999999998 111.426 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.2 t -103.74 120.97 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.81 -0.632 . . . . 74.0 112.033 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.45 122.76 33.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.428 -0.351 . . . . 73.340000000000003 110.843 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.89 149.9 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.378 0.51 . . . . 73.5 112.378 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 90.1 p -94.35 126.57 39.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 111.171 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.85 179.75 4.4 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.413 0.625 . . . . 61.240000000000002 111.962 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.4 ttm -138.44 108.08 6.23 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.53 -0.759 . . . . 65.25 109.851 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -98.13 -2.58 39.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.018 0.377 . . . . 73.209999999999994 112.018 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.4 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 17.1 t80 56.44 37.97 29.28 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.417 0.627 . . . . 75.040000000000006 111.179 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -75.46 -67.47 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.136 -0.483 . . . . 70.329999999999998 111.285 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.86 -15.54 78.98 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.144 -0.55 . . . . 75.200000000000003 113.854 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 161.89 -158.94 30.93 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.035 -0.603 . . . . 60.140000000000001 113.147 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.68 -64.23 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.174 2.583 . . . . 72.019999999999996 113.702 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -86.75 37.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.069 0.461 . . . . 64.230000000000004 111.801 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 129' ' ' TYR . 47.9 t -75.27 93.64 2.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.266 0.555 . . . . 74.540000000000006 111.035 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 137' ' ' SER . 45.9 t -80.31 161.73 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.837 -0.619 . . . . 70.5 111.657 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.464 ' N ' HG12 ' A' ' 136' ' ' VAL . 75.0 m -143.4 156.47 44.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.382 -0.372 . . . . 53.229999999999997 110.433 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -130.86 121.07 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.901 -0.136 . . . . 73.0 110.842 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -127.91 133.21 49.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 111.782 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.9 m -97.49 100.22 11.63 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.846 0.355 . . . . 64.099999999999994 110.717 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.0 mt -81.57 136.91 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.681 0.277 . . . . 74.409999999999997 111.426 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -63.72 147.42 51.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.603 0.239 . . . . 73.319999999999993 111.538 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.84 -45.8 71.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.372 0.508 . . . . 63.0 112.372 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.35 -49.96 71.23 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.286 -0.483 . . . . 61.130000000000003 113.3 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -44.15 91.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 110.856 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.449 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.49 -44.3 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.777 -0.647 . . . . 70.400000000000006 112.112 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 t -63.9 -16.34 61.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.101 0.477 . . . . 74.140000000000001 111.577 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.2 t -82.08 -6.22 59.0 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.385 -0.37 . . . . 62.119999999999997 111.731 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 22.3 m-85 -102.11 153.16 20.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 73.030000000000001 111.821 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 15.9 m-80 -92.04 107.25 19.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.447 -0.342 . . . . 72.0 111.518 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.8 m-85 -85.9 114.66 22.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.28 0.474 . . . . 73.239999999999995 112.28 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -78.44 114.52 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.549 174.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -106.36 142.51 35.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.85 0.357 . . . . 64.430000000000007 110.961 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.485 HD21 HG22 ' A' ' 69' ' ' ILE . 41.7 mt -104.2 91.5 3.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.851 0.358 . . . . 72.150000000000006 111.749 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.017 0.437 . . . . 72.530000000000001 111.23 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.538 0.209 . . . . 71.239999999999995 111.065 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -105.66 80.92 1.61 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.016 0.436 . . . . 75.409999999999997 110.831 177.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 5.0 mmmp? -145.67 117.96 8.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.183 -0.462 . . . . 63.509999999999998 110.872 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.32 168.46 25.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.005 0.431 . . . . 74.420000000000002 111.962 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.03 143.61 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.298 -0.41 . . . . 71.230000000000004 110.835 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -90.38 25.02 2.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.961 0.41 . . . . 75.200000000000003 112.03 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.37 126.37 21.03 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.56 0.578 . . . . 73.329999999999998 112.56 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -149.31 164.05 35.97 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.024 -0.534 . . . . 71.310000000000002 110.941 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -147.72 155.89 42.19 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.064 0.459 . . . . 64.5 112.095 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.1 mp -120.86 109.95 15.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.274 -0.421 . . . . 72.420000000000002 111.272 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -98.03 -176.93 3.58 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.772 -0.195 . . . . 43.240000000000002 111.342 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.1 -49.33 0.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.084 0.772 . . . . 73.319999999999993 113.084 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 32.11 1.98 Allowed Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.266 -0.492 . . . . 70.439999999999998 114.319 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -99.18 108.67 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.247 -0.56 . . . . 71.329999999999998 110.774 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.09 121.85 0.59 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.459 -0.401 . . . . 75.150000000000006 112.765 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.82 146.57 46.41 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.46 -0.436 . . . . 73.239999999999995 111.761 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.46 131.27 35.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.945 0.402 . . . . 62.310000000000002 111.908 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.9 mt -92.29 131.28 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.354 -0.385 . . . . 73.340000000000003 111.466 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.86 177.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.181 0.515 . . . . 73.540000000000006 112.05 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 103.72 2.54 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.301 -0.476 . . . . 41.539999999999999 113.744 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.2 pt? -164.64 132.16 3.21 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.985 0.422 . . . . 62.439999999999998 111.495 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -147.6 132.05 17.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.895 0.379 . . . . 64.420000000000002 111.437 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -144.2 151.66 39.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.69 0.281 . . . . 73.200000000000003 111.533 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.36 84.0 0.24 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.346 0.499 . . . . 52.210000000000001 114.346 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -126.1 134.0 51.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.967 0.413 . . . . 64.129999999999995 111.387 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -81.22 -174.26 4.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.637 0.606 . . . . 72.109999999999999 112.637 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.68 105.16 1.4 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.106 -0.497 . . . . 73.200000000000003 111.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.06 104.28 7.46 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.668 0.271 . . . . 71.200000000000003 111.301 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.55 95.92 10.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.787 0.327 . . . . 53.25 111.345 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.15 118.44 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.4 -0.364 . . . . 55.100000000000001 111.457 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.15 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.955 0.407 . . . . 53.509999999999998 111.963 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -126.16 153.88 43.99 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.87 0.366 . . . . 71.099999999999994 111.403 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.0 m -148.25 92.43 2.03 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.033 0.444 . . . . 62.299999999999997 111.5 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -155.05 75.39 5.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 121.249 0.547 . . . . 74.209999999999994 111.606 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.03 42.95 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.2 2.6 . . . . 73.430000000000007 112.447 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.9 m -116.27 91.11 3.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.819 0.342 . . . . 70.200000000000003 111.666 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.25 131.52 34.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.140000000000001 111.23 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -90.8 100.76 13.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.059 0.457 . . . . 73.200000000000003 111.437 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.1 p -83.7 93.87 8.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.012 0.434 . . . . 73.030000000000001 111.739 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -165.26 151.88 10.27 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.21 0.448 . . . . 63.439999999999998 112.21 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 p -85.6 103.16 14.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.207 -0.451 . . . . 65.430000000000007 110.6 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -69.26 107.24 3.17 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.472 0.653 . . . . 75.530000000000001 112.022 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m -122.59 92.96 3.83 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.026 -0.534 . . . . 63.32 111.048 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 p -113.17 135.74 53.49 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.366 -0.208 . . . . 53.350000000000001 111.417 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' ' OH ' ' A' ' 88' ' ' TYR . 74.6 m -72.81 148.6 44.37 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.027 0.441 . . . . 63.450000000000003 111.253 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.98 117.63 1.2 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.24 -0.505 . . . . 71.230000000000004 112.364 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 m -153.03 107.52 3.14 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.597 -0.355 . . . . 72.340000000000003 110.95 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.8 m -69.86 -21.76 63.32 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.287 0.477 . . . . 71.409999999999997 112.287 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.69 125.83 27.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.808 0.337 . . . . 54.030000000000001 111.559 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -91.9 105.99 18.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 61.509999999999998 111.001 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 71' ' ' SER . 4.0 mm? -88.6 26.76 1.41 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 111.967 0.358 . . . . 62.229999999999997 111.967 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.72 -168.99 1.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.283 0.233 . . . . 75.209999999999994 110.564 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -136.6 148.25 47.38 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.797 0.666 . . . . 74.209999999999994 112.797 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.0 142.34 58.41 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.876 -0.602 . . . . 75.409999999999997 111.917 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.92 32.35 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.23 -0.51 . . . . 71.140000000000001 112.29 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.76 139.68 31.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.244 -0.28 . . . . 75.120000000000005 110.244 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 49.0 m -54.87 -29.23 55.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.984 0.421 . . . . 72.409999999999997 112.043 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 p -60.15 -35.67 75.83 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.909 0.707 . . . . 74.530000000000001 112.909 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 48.6 t90 -61.91 -62.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.278 0.844 . . . . 72.319999999999993 113.278 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 32.5 p90 -68.01 -28.86 67.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.875 0.694 . . . . 73.299999999999997 112.875 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.68 -36.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.06 0.457 . . . . 72.420000000000002 111.018 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -59.41 -34.93 73.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.276 0.56 . . . . 64.129999999999995 110.964 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.71 -50.56 34.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.94 -0.573 . . . . 75.209999999999994 110.405 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.0 mmmt -55.3 -36.82 66.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.774 0.657 . . . . 73.530000000000001 112.774 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.448 HG21 HG23 ' A' ' 69' ' ' ILE . 8.0 p -82.33 -5.22 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 121.059 0.457 . . . . 74.200000000000003 111.929 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.57 24.43 76.21 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.283 -0.484 . . . . 54.420000000000002 113.55 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.12 23.2 72.95 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.203 -0.522 . . . . 73.540000000000006 113.895 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -89.26 19.9 4.09 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.311 0.486 . . . . 61.119999999999997 112.311 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 65' ' ' VAL . 34.7 pt -126.73 178.49 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.921 0.391 . . . . 74.239999999999995 111.537 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.28 125.65 7.26 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.315 -0.469 . . . . 65.140000000000001 113.043 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 51' ' ' LEU . 75.7 p -80.55 -13.35 59.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.742 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -94.55 13.92 22.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.204 0.446 . . . . 72.540000000000006 112.204 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.43 -32.37 58.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 73.409999999999997 111.824 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.48 -118.63 6.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.297 -0.477 . . . . 74.540000000000006 113.665 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.3 137.74 56.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.097 0.406 . . . . 75.439999999999998 112.097 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.36 -42.68 74.22 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.355 0.502 . . . . 62.25 112.355 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -68.64 -2.99 10.35 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.568 0.581 . . . . 74.310000000000002 112.568 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -100.96 -10.24 20.77 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.785 0.326 . . . . 60.109999999999999 111.537 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -61.19 -36.56 80.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.042 0.756 . . . . 70.349999999999994 113.042 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.21 -50.14 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.12 0.486 . . . . 75.140000000000001 111.2 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -61.23 -46.48 90.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.065 -0.516 . . . . 65.439999999999998 111.27 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.24 -52.54 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.085 -0.507 . . . . 62.109999999999999 111.614 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.46 -47.41 69.77 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.831 0.348 . . . . 64.420000000000002 111.665 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -59.58 -50.99 71.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.18 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.0 t -69.28 -19.85 63.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.205 0.446 . . . . 54.049999999999997 112.205 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.41 -36.03 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.081 0.401 . . . . 71.140000000000001 112.081 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.16 8.04 5.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.992 -0.623 . . . . 75.420000000000002 113.181 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.454 ' OH ' ' HB2' ' A' ' 45' ' ' SER . 14.2 m-85 -80.07 -171.34 2.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.186 0.517 . . . . 63.119999999999997 111.176 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.0 m -121.94 91.25 3.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.064 0.459 . . . . 63.109999999999999 111.359 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.27 105.17 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.0 0.428 . . . . 74.109999999999999 111.315 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -127.2 161.31 28.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 111.212 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.41 7.24 20.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.136 0.493 . . . . 71.219999999999999 110.969 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 m -72.76 112.49 15.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.318 -0.401 . . . . 41.219999999999999 110.995 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.58 22.72 0.51 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.052 2.501 . . . . 54.539999999999999 114.47 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 153' ' ' HIS . 36.4 tt0 -60.1 147.16 40.48 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.063 0.459 . . . . 62.109999999999999 111.851 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.34 166.55 21.39 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.22 0.822 . . . . 75.239999999999995 113.22 -173.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.06 31.02 44.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.703 -0.68 . . . . 71.230000000000004 112.93 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.1 m -146.75 170.63 16.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 111.273 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -107.68 133.83 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 110.254 -0.276 . . . . 75.319999999999993 110.254 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -98.89 107.82 20.35 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.986 0.898 . . . . 73.420000000000002 111.049 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -72.93 99.12 2.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 72.049999999999997 109.822 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 50.9 m -93.77 104.88 16.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.56 -0.746 . . . . 74.530000000000001 111.595 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 p -81.12 24.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.244 0.461 . . . . 72.230000000000004 112.244 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -106.16 96.96 6.84 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.154 0.428 . . . . 63.130000000000003 112.154 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.76 -176.2 29.33 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.151 0.42 . . . . 72.549999999999997 114.151 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.76 22.41 57.08 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 114.032 0.373 . . . . 23.43 114.032 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 57.77 19.6 5.76 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.91 0.386 . . . . 72.310000000000002 111.297 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.1 111.8 3.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.428 -0.415 . . . . 75.340000000000003 112.228 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -112.38 147.37 36.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 111.929 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 101' ' ' GLN . 10.1 m -142.69 141.49 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.143 -0.481 . . . . 64.439999999999998 110.667 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.03 159.63 43.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.76 0.314 . . . . 63.229999999999997 110.509 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -94.32 125.73 39.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.945 0.403 . . . . 51.149999999999999 111.667 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.42 109.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.893 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.84 -61.18 2.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.044 -0.525 . . . . 65.129999999999995 111.771 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -148.56 145.43 27.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 62.140000000000001 111.949 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.2 t -103.11 125.77 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.595 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -95.36 141.07 29.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.748 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -60.36 -21.25 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.394 -0.366 . . . . 53.420000000000002 111.852 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.23 -12.89 56.12 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.863 0.363 . . . . 74.239999999999995 111.956 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.83 45.56 4.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.93 -0.468 . . . . 64.319999999999993 111.93 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.7 p -137.17 138.6 40.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.086 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.17 119.45 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.223 -0.444 . . . . 62.43 111.57 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -88.44 112.27 22.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.86 0.362 . . . . 55.32 110.963 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.97 137.91 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.195 0.521 . . . . 64.519999999999996 112.02 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 34.5 p -86.61 115.61 24.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.07 0.462 . . . . 64.310000000000002 111.883 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.42 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 11.5 pt-20 -133.43 -179.27 5.41 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.596 . . . . 75.120000000000005 111.387 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.451 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 49.0 ttm -135.18 128.54 32.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.905 0.383 . . . . 53.539999999999999 111.54 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -83.4 90.03 7.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.239 0.542 . . . . 75.129999999999995 111.046 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -62.94 152.27 37.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.782 -0.645 . . . . 63.439999999999998 111.85 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.1 m120 70.88 -67.72 0.24 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.527 0.731 . . . . 64.019999999999996 111.993 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.23 7.78 50.37 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.146 -0.549 . . . . 71.430000000000007 113.718 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -155.82 159.84 29.57 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.136 -0.554 . . . . 63.32 112.873 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.91 -156.22 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.742 2.295 . . . . 74.010000000000005 112.525 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -68.58 13.33 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.882 0.697 . . . . 75.099999999999994 112.882 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.0 t -76.71 114.61 15.65 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.032 0.444 . . . . 54.119999999999997 111.75 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.5 t -81.0 124.42 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.958 0.409 . . . . 74.099999999999994 111.406 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.8 p -114.55 142.14 46.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.431 -0.35 . . . . 53.509999999999998 111.399 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -92.8 104.54 16.78 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.819 0.342 . . . . 63.509999999999998 111.375 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -82.52 120.97 26.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.171 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 71.4 m -85.81 106.56 17.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.042 0.448 . . . . 75.140000000000001 110.923 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -97.71 139.65 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.192 -0.458 . . . . 72.510000000000005 111.658 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -69.71 154.54 41.84 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.783 0.325 . . . . 61.020000000000003 111.233 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.87 80.99 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.605 0.595 . . . . 64.129999999999995 112.605 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.26 -49.12 82.02 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.293 -0.479 . . . . 63.020000000000003 112.996 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.55 -40.98 93.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.127 0.489 . . . . 51.399999999999999 110.861 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.57 -42.57 78.83 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 111.8 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.3 t -60.96 -19.83 61.51 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.106 0.479 . . . . 64.209999999999994 111.744 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 47.4 t -77.42 -17.72 57.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.929 0.395 . . . . 71.319999999999993 111.674 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 17.0 m-85 -101.01 157.87 16.43 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.229 0.538 . . . . 72.409999999999997 111.817 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -99.74 111.04 23.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 111.333 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -87.98 106.2 17.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.063 0.459 . . . . 72.010000000000005 111.976 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -77.14 103.18 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.053 -0.521 . . . . 73.310000000000002 110.907 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' A' ' 95' ' ' GLU . 92.8 m-70 -85.16 143.09 29.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.364 . . . . 70.319999999999993 110.435 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.92 9.76 38.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 75.129999999999995 112.568 -166.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 121.498 0.666 . . . . 53.299999999999997 110.644 -176.499 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.662 0.268 . . . . 71.209999999999994 111.252 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -119.57 130.15 55.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 112.009 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -127.4 113.12 15.8 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.788 -0.642 . . . . 72.540000000000006 109.767 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.55 159.43 26.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.122 0.487 . . . . 54.229999999999997 112.034 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.1 p -140.59 138.77 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.118 0.485 . . . . 64.340000000000003 111.293 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.6 p -107.98 27.14 9.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.864 0.364 . . . . 74.230000000000004 111.56 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.568 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -63.13 92.03 0.05 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.37 0.508 . . . . 54.409999999999997 112.37 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -141.21 154.01 45.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.888 -0.596 . . . . 75.25 110.606 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -120.39 113.89 21.01 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.444 0.535 . . . . 61.219999999999999 112.444 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.74 111.26 7.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.265 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.94 144.32 31.38 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.501 -0.318 . . . . 74.299999999999997 110.996 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.78 161.3 36.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.94 0.4 . . . . 62.329999999999998 111.887 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.49 145.95 4.58 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.35 -0.452 . . . . 75.450000000000003 113.043 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -136.26 127.97 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.255 0.55 . . . . 61.049999999999997 111.705 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.54 118.53 6.19 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.292 -0.48 . . . . 74.310000000000002 112.716 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 138.9 31.5 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.413 -0.463 . . . . 75.439999999999998 112.017 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.87 109.76 19.03 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.821 0.343 . . . . 75.430000000000007 110.913 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.07 141.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.272 0.471 . . . . 71.019999999999996 112.272 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.46 140.77 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.39 -0.368 . . . . 72.439999999999998 111.049 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.8 113.34 1.31 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.104 -0.569 . . . . 60.140000000000001 113.177 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.39 150.23 36.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.026 0.441 . . . . 63.409999999999997 111.594 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.82 146.48 27.32 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.244 -0.435 . . . . 73.349999999999994 111.295 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -129.48 163.64 25.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.933 0.397 . . . . 62.240000000000002 111.349 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.79 78.3 1.05 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.209 -0.45 . . . . 62.520000000000003 112.409 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -122.65 118.63 28.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.085 0.469 . . . . 72.450000000000003 111.688 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.74 160.48 22.83 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.845 0.683 . . . . 70.299999999999997 112.845 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.95 104.66 6.67 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.848 -0.614 . . . . 71.340000000000003 111.006 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.01 157.2 35.29 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.519999999999996 111.428 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.14 143.38 5.29 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.53 0.567 . . . . 61.530000000000001 112.53 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.9 17.07 6.22 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.085 1.143 . . . . 62.439999999999998 114.085 171.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.84 78.12 9.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.657 -0.652 . . . . 73.219999999999999 111.653 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -133.04 -4.9 3.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.622 0.725 . . . . 74.409999999999997 110.598 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.6 t -91.12 90.94 8.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.841 -0.618 . . . . 71.219999999999999 112.026 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.8 121.98 83.3 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.371 -0.377 . . . . 63.329999999999998 110.926 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.11 66.88 1.38 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.786 2.324 . . . . 74.200000000000003 113.071 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -71.78 90.53 1.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.03 0.443 . . . . 72.319999999999993 111.94 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -132.07 172.7 12.04 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.071 0.462 . . . . 72.129999999999995 111.329 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -108.4 -0.02 20.85 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.764 -0.653 . . . . 64.420000000000002 110.396 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.4 p -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.108 0.48 . . . . 74.450000000000003 111.997 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -143.75 116.0 8.48 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.982 -0.554 . . . . 60.119999999999997 110.748 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.2 p -115.24 114.72 25.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.441 0.534 . . . . 75.030000000000001 112.441 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -104.63 92.05 4.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.35 0.595 . . . . 74.400000000000006 111.239 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.9 p -110.07 98.02 7.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.904 -0.589 . . . . 73.319999999999993 110.97 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -94.15 -26.0 16.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.806 0.336 . . . . 73.439999999999998 111.808 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -69.18 82.95 0.35 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.415 0.626 . . . . 60.420000000000002 111.206 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.86 -179.04 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.346 -0.843 . . . . 65.030000000000001 111.745 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -179.36 -179.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.219 0.51 . . . . 51.43 111.736 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.7 m -90.62 -7.19 53.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.219 -0.446 . . . . 44.409999999999997 110.685 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.37 86.31 1.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.049 0.452 . . . . 70.140000000000001 111.545 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -73.59 112.36 9.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.145 0.498 . . . . 55.539999999999999 111.33 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.81 -9.5 58.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.715 0.635 . . . . 71.120000000000005 112.715 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.71 176.35 9.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.051 -0.406 . . . . 74.129999999999995 110.882 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -121.92 152.28 39.82 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.404 0.52 . . . . 70.019999999999996 112.404 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.27 143.03 41.12 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.033 0.444 . . . . 43.219999999999999 111.946 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.95 58.19 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.086 -0.506 . . . . 45.210000000000001 113.295 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -83.52 141.59 31.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.904 0.352 . . . . 74.420000000000002 111.513 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 60' ' ' TYR . 56.6 m -59.97 -29.41 68.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.401 0.619 . . . . 45.240000000000002 111.075 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.1 p -76.08 -11.35 59.93 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.817 -0.629 . . . . 73.019999999999996 112.549 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -76.8 -62.71 1.55 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.657 0.614 . . . . 72.430000000000007 112.657 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HE2' ' HA ' ' A' ' 57' ' ' CYS . 50.5 p90 -63.72 -26.56 68.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.923 0.712 . . . . 73.109999999999999 112.923 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.465 HG21 HG23 ' A' ' 110' ' ' VAL . 46.4 t -60.68 -31.96 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.897 0.38 . . . . 74.230000000000004 111.974 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.79 -44.53 95.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.883 0.373 . . . . 72.439999999999998 111.295 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -64.63 -41.06 96.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.286 0.565 . . . . 74.510000000000005 110.565 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.9 mmmt -62.18 -32.91 73.59 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.693 -0.685 . . . . 70.140000000000001 112.28 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 HD11 ' A' ' 154' ' ' LEU . 9.2 p -96.52 6.82 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 121.334 0.588 . . . . 72.219999999999999 111.961 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.53 8.62 76.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 45.409999999999997 114.237 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.87 3.07 66.79 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.038 0.775 . . . . 34.25 115.038 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.01 17.64 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.904 -0.762 . . . . 74.420000000000002 112.705 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 pt -106.32 -29.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 111.954 0.353 . . . . 64.340000000000003 111.954 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.87 98.77 1.1 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.044 -0.598 . . . . 71.319999999999993 112.884 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 p -73.02 83.85 1.26 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.229 -0.571 . . . . 75.340000000000003 111.522 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.7 t -154.79 17.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.09 0.471 . . . . 64.239999999999995 111.318 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -89.47 -4.12 58.09 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.26 0.467 . . . . 74.299999999999997 112.26 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.63 -137.76 22.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.054 -0.593 . . . . 64.109999999999999 113.329 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -70.24 155.39 40.71 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.502 -0.411 . . . . 73.219999999999999 111.57 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -56.84 -32.12 65.45 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.828 0.677 . . . . 60.140000000000001 112.828 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 103' ' ' THR . 91.8 m-20 -55.93 -28.61 57.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.328 0.492 . . . . 75.319999999999993 112.328 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.33 -16.53 24.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.286 0.476 . . . . 73.239999999999995 112.286 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 6.6 m0 -50.22 -66.02 0.46 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.964 1.098 . . . . 73.340000000000003 113.964 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.5 -33.71 68.31 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.298 0.481 . . . . 52.399999999999999 112.298 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -67.31 -48.02 68.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.057 0.456 . . . . 74.109999999999999 110.835 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.52 96.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.357 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.96 44.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.298 -0.41 . . . . 73.329999999999998 111.105 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -61.07 -40.0 92.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.892 0.377 . . . . 62.539999999999999 110.939 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -63.62 -27.58 69.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.301 -0.408 . . . . 62.240000000000002 111.379 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.27 -12.18 41.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.945 0.402 . . . . 63.329999999999998 111.898 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.51 52.69 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.261 -0.495 . . . . 72.319999999999993 113.693 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -70.51 175.52 4.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.333 0.587 . . . . 74.219999999999999 112.012 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -101.01 92.03 4.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.053 -0.521 . . . . 64.200000000000003 111.506 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 152' ' ' ILE . 22.0 t -99.8 93.48 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.916 0.389 . . . . 71.120000000000005 111.024 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -122.5 168.2 12.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.543 -0.299 . . . . 71.5 110.529 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.35 5.92 32.47 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.931 -0.481 . . . . 75.099999999999994 111.767 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 44.2 m -65.21 109.06 2.5 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 116.729 -0.214 . . . . 65.099999999999994 110.829 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 6.2 Cg_exo -79.14 8.85 3.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.302 2.668 . . . . 74.420000000000002 113.968 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.01 145.26 17.1 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.333 0.494 . . . . 75.120000000000005 112.333 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.72 46.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.877 -0.601 . . . . 54.149999999999999 112.587 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.28 55.5 1.69 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.001 -0.619 . . . . 70.420000000000002 111.803 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.6 t -163.01 165.35 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.305 0.574 . . . . 50.509999999999998 111.85 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 35.2 mt -116.58 125.38 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.644 -0.707 . . . . 65.400000000000006 110.479 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.8 pt? -99.43 133.14 44.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.928 0.394 . . . . 65.25 111.396 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -102.4 133.18 47.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.399 0.518 . . . . 73.140000000000001 112.399 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -124.32 107.92 11.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.033 -0.53 . . . . 74.549999999999997 110.38 171.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.507 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 80.2 p -78.56 -14.61 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.357 0.503 . . . . 50.210000000000001 112.357 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.49 -27.83 68.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.845 0.684 . . . . 63.229999999999997 112.845 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.72 57.48 3.85 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 121.243 -0.503 . . . . 72.209999999999994 114.177 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.31 -86.68 0.02 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.166 0.483 . . . . 60.140000000000001 113.819 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.83 11.06 26.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.51 0.671 . . . . 72.430000000000007 110.624 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . 86.84 163.13 38.32 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.339 -0.846 . . . . 63.229999999999997 113.038 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -140.73 137.27 33.33 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.857 -0.202 . . . . 65.150000000000006 110.817 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.3 m -138.68 141.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.923 0.392 . . . . 54.130000000000003 111.499 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.09 22.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.96 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -101.37 133.73 45.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.02 0.438 . . . . 71.019999999999996 111.44 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.41 110.1 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 111.646 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.43 -53.38 9.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.09 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -156.57 143.36 18.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.041 0.448 . . . . 61.450000000000003 112.135 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.71 135.0 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.386 -0.37 . . . . 63.25 110.926 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -92.17 154.7 18.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.369 -0.378 . . . . 63.43 111.304 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -59.18 -24.25 62.92 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.84 0.352 . . . . 65.430000000000007 111.688 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.17 -11.52 60.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.926 0.393 . . . . 71.329999999999998 111.717 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.65 56.47 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.385 -0.436 . . . . 42.219999999999999 112.968 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.1 m -64.84 126.43 27.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.11 0.481 . . . . 64.409999999999997 111.423 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.4 t -103.19 129.74 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.957 -0.565 . . . . 50.009999999999998 111.32 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.14 112.96 26.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.857 0.361 . . . . 75.099999999999994 111.415 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.0 162.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.964 0.412 . . . . 73.510000000000005 111.81 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.42 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 61.7 p -117.03 133.91 55.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.13 0.49 . . . . 72.230000000000004 111.614 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -129.51 152.09 49.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.12 -0.491 . . . . 53.119999999999997 111.047 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.0 ttm -92.08 110.28 21.64 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.902 -0.499 . . . . 61.450000000000003 109.96 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.41 72.74 2.45 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 111.423 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 45.4 p90 -60.0 -20.16 56.3 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.679 0.622 . . . . 73.420000000000002 112.679 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -93.34 16.18 13.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.937 0.399 . . . . 73.510000000000005 111.924 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.77 -53.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 116.407 -0.36 . . . . 71.340000000000003 112.238 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.25 87.26 0.4 Allowed Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.566 -0.613 . . . . 71.439999999999998 111.566 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 44.2 Cg_exo -56.44 -17.07 20.22 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.23 2.62 . . . . 64.230000000000004 114.644 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.93 16.73 9.34 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.183 -0.323 . . . . 65.340000000000003 111.478 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.3 t -123.27 150.02 44.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.349 0.595 . . . . 60.299999999999997 112.273 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.12 126.29 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.821 -0.627 . . . . 71.310000000000002 111.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.6 t -109.55 167.35 10.2 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.371 -0.377 . . . . 65.230000000000004 111.199 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -101.07 144.55 29.85 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.235 -0.439 . . . . 65.329999999999998 111.152 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.22 109.8 6.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 110.866 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 79.9 m -85.02 139.28 31.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.445 -0.343 . . . . 53.310000000000002 111.569 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.6 mt -123.52 149.08 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.758 0.423 . . . . 43.310000000000002 110.87 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 m -64.53 156.77 28.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.11 0.164 . . . . 61.039999999999999 110.838 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.67 -63.22 1.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.086 0.402 . . . . 64.439999999999998 112.086 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.66 -38.1 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.204 -0.522 . . . . 71.109999999999999 112.956 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.51 -36.26 80.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.006 0.522 . . . . 64.450000000000003 110.991 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.41 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -71.62 -43.63 65.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.106 -0.497 . . . . 61.399999999999999 111.529 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 t -59.23 -15.73 16.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 111.965 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.7 t -70.07 -25.28 63.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.925 0.393 . . . . 64.010000000000005 111.575 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -87.4 154.56 20.57 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.242 0.544 . . . . 72.430000000000007 111.895 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -89.3 119.76 30.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.952 -0.567 . . . . 64.409999999999997 110.828 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 95.5 m-85 -100.91 117.07 34.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.634 0.605 . . . . 55.549999999999997 112.634 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -91.35 121.03 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.127 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -113.76 157.31 22.41 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.901 0.481 . . . . 71.439999999999998 110.96 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.499 HD11 HG22 ' A' ' 65' ' ' VAL . 34.2 mt -102.26 -33.89 9.44 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.49 0.552 . . . . 73.310000000000002 112.49 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 121.413 0.625 . . . . 75.140000000000001 111.701 -177.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.6 mtp . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 112.059 0.392 . . . . 71.010000000000005 112.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -82.77 119.09 23.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.684 0.278 . . . . 72.239999999999995 111.23 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -119.63 123.84 44.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.722 0.296 . . . . 75.129999999999995 110.913 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 pp -158.03 160.07 37.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.24 0.543 . . . . 72.530000000000001 111.914 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.47 145.19 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 110.935 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.6 p -107.1 86.58 2.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 111.244 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.56 24.66 12.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.269 -0.423 . . . . 74.329999999999998 112.133 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -87.12 110.63 20.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 73.019999999999996 112.406 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -166.08 133.43 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.757 -0.656 . . . . 64.450000000000003 110.46 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -136.01 149.2 48.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.053 0.454 . . . . 72.040000000000006 112.169 -173.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -100.35 146.31 27.12 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.376 -0.375 . . . . 72.230000000000004 110.768 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 175.71 9.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.013 0.435 . . . . 64.219999999999999 111.93 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.05 72.58 1.28 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.187 -0.53 . . . . 40.520000000000003 113.987 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.2 pt -136.91 -178.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.724 0.297 . . . . 61.030000000000001 110.885 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.93 161.76 37.05 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.049 -0.596 . . . . 74.450000000000003 114.087 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.51 153.97 5.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.963 0.505 . . . . 55.509999999999998 110.659 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.23 154.49 25.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.899 0.381 . . . . 75.150000000000006 111.604 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.84 22.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.931 0.345 . . . . 74.430000000000007 111.931 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.85 94.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.197 0.523 . . . . 64.409999999999997 111.851 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.92 93.93 0.09 OUTLIER Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.823 -0.626 . . . . 73.099999999999994 112.173 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 pp -138.78 157.47 46.01 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.535 0.568 . . . . 73.299999999999997 112.535 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.14 106.72 1.36 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 111.281 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -150.51 13.87 0.75 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 111.596 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.32 69.51 0.42 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.782 -0.723 . . . . 64.420000000000002 113.559 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -112.99 91.94 3.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.418 0.628 . . . . 70.519999999999996 111.564 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.12 149.84 32.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.884 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -170.46 154.87 4.84 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.448 . . . . 43.420000000000002 112.208 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -136.81 136.82 39.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 110.592 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.47 16.72 15.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.407 0.521 . . . . 21.34 112.407 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.48 132.47 43.9 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 33.450000000000003 111.47 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -70.82 127.76 33.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.571 -0.286 . . . . 72.310000000000002 110.664 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.99 115.75 13.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.044 0.45 . . . . 74.349999999999994 111.78 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -128.55 148.35 50.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.401 -0.363 . . . . 65.120000000000005 110.24 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -120.94 143.23 36.31 Favored Pre-proline 0 N--CA 1.467 0.421 0 O-C-N 122.341 -0.224 . . . . 72.25 111.493 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.75 125.46 15.87 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.41 2.073 . . . . 74.430000000000007 112.466 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.7 p -48.05 -73.2 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.078 0.77 . . . . 75.400000000000006 113.078 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -170.15 127.04 0.83 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.76 0.314 . . . . 71.519999999999996 111.413 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.35 125.42 6.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.2 0.524 . . . . 75.230000000000004 111.51 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.9 p -66.12 105.61 1.42 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.999 -0.546 . . . . 51.340000000000003 111.487 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.0 p -133.09 124.75 28.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.287 -0.415 . . . . 62.409999999999997 111.427 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.5 m -76.83 96.17 4.23 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.194 0.521 . . . . 44.340000000000003 110.943 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.69 126.5 38.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.093 -0.503 . . . . 62.43 111.101 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 t -144.97 166.39 25.43 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.119 0.485 . . . . 60.210000000000001 111.716 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.7 p -91.62 16.58 10.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.91 -0.586 . . . . 74.150000000000006 111.337 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 m -64.2 100.19 0.32 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.069 -0.514 . . . . 75.319999999999993 112.011 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.4 118.8 1.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 116.481 -0.327 . . . . 63.420000000000002 112.582 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -101.41 104.02 14.97 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.318 -0.519 . . . . 72.519999999999996 111.84 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -88.51 91.95 9.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.809 0.338 . . . . 60.340000000000003 111.106 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 96.24 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.036 0.446 . . . . 71.219999999999999 111.169 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.57 98.25 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.133 0.492 . . . . 73.349999999999994 111.037 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -87.1 4.98 39.97 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.066 -0.516 . . . . 62.420000000000002 112.298 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 90.5 m-85 -84.85 -178.92 6.97 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.8 0.333 . . . . 63.140000000000001 110.985 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t -111.74 147.07 36.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 112.153 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 95.93 0.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.021 -0.536 . . . . 75.099999999999994 111.917 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.21 -22.74 0.87 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.955 -0.566 . . . . 52.149999999999999 112.679 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -80.31 146.89 31.37 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 111.713 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.6 m -57.87 -38.52 75.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.56 0.695 . . . . 64.340000000000003 110.448 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.9 p -62.7 -24.33 67.6 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.487 -0.779 . . . . 72.409999999999997 112.274 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -62.59 -65.28 0.71 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.334 0.494 . . . . 65.140000000000001 112.334 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -66.97 -29.08 68.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.537 0.569 . . . . 73.230000000000004 112.537 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 57' ' ' CYS . 61.1 t -61.37 -37.63 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 111.426 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -57.97 -47.82 81.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.978 0.418 . . . . 75.319999999999993 110.845 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.14 -38.69 72.25 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.944 0.35 . . . . 62.32 111.944 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -56.07 -38.39 70.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.998 0.428 . . . . 72.319999999999993 111.855 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' ILE . 8.8 p -88.39 9.37 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 121.388 0.613 . . . . 51.329999999999998 111.456 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.68 -2.87 77.3 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.336 -0.393 . . . . 33.439999999999998 113.703 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.31 14.56 66.06 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.998 -0.62 . . . . 63.229999999999997 113.143 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.82 10.38 6.4 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.199 0.444 . . . . 73.129999999999995 112.199 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 pt -110.5 174.1 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.799 0.333 . . . . 53.409999999999997 111.118 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.6 124.31 6.76 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.93 -0.652 . . . . 54.329999999999998 114.013 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.3 p -65.5 -19.39 65.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.026 0.441 . . . . 75.400000000000006 111.13 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 t -78.58 -6.94 56.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.809 0.67 . . . . 64.140000000000001 112.809 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -61.33 -43.51 98.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.153 -0.342 . . . . 74.519999999999996 111.684 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 71.89 -116.29 5.92 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 114.246 0.458 . . . . 71.540000000000006 114.246 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -57.66 132.47 53.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.197 0.444 . . . . 72.0 112.197 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.96 -40.55 80.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.178 0.513 . . . . 41.399999999999999 111.885 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -66.91 -19.3 65.7 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.394 0.616 . . . . 72.530000000000001 110.767 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.9 -17.51 23.92 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.055 -0.521 . . . . 74.109999999999999 112.387 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.401 ' CZ3' HG21 ' A' ' 99' ' ' ILE . 10.7 m0 -47.56 -47.07 28.4 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.345 0.868 . . . . 73.530000000000001 113.345 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.415 ' H ' ' NE2' ' A' ' 101' ' ' GLN . . . -59.22 -46.48 88.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.83 0.348 . . . . 50.509999999999998 111.701 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.6 t -59.43 -38.91 81.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.004 0.43 . . . . 41.310000000000002 111.439 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.45 -59.51 2.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 111.277 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -50.47 -52.65 36.26 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.685 0.624 . . . . 73.150000000000006 112.685 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 p -55.64 -53.52 55.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 111.998 0.37 . . . . 71.030000000000001 111.998 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -72.14 -22.1 61.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.233 0.457 . . . . 74.310000000000002 112.233 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.64 -17.55 50.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.197 0.443 . . . . 63.509999999999998 112.197 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 25.39 5.46 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.003 -0.617 . . . . 73.540000000000006 113.803 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.412 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 65.6 m-85 -100.72 -176.38 3.17 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.446 -0.444 . . . . 70.310000000000002 110.732 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 63.8 m -109.19 93.0 4.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.741 0.305 . . . . 73.040000000000006 111.772 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 152' ' ' ILE . 46.8 t -97.02 91.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.22 0.533 . . . . 73.219999999999999 111.018 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -122.58 163.94 19.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.004 -0.544 . . . . 62.340000000000003 110.531 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.87 -7.47 57.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.11 -0.369 . . . . 74.549999999999997 111.166 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -51.45 106.05 0.6 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 116.382 -0.372 . . . . 64.209999999999994 110.86 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -84.25 13.24 2.78 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.832 2.355 . . . . 63.520000000000003 114.796 -168.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.24 151.46 36.21 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.929 0.714 . . . . 74.010000000000005 112.929 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.58 160.3 11.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.44 -0.8 . . . . 73.019999999999996 112.892 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.4 32.97 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.192 -0.528 . . . . 63.25 112.273 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -145.55 164.91 30.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.822 0.344 . . . . 53.409999999999997 110.715 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -100.86 117.42 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.059 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD13 HG11 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -79.35 136.87 37.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 72.5 110.601 174.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' NE2' ' H ' ' A' ' 80' ' ' ALA . 31.0 tt0 -120.06 104.54 10.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.835 0.35 . . . . 74.400000000000006 111.335 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 50.8 m -84.51 85.03 7.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.939 0.399 . . . . 74.340000000000003 110.811 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.4 p -65.97 -40.09 90.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.219 0.533 . . . . 75.439999999999998 110.853 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.17 102.42 4.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.874 -0.603 . . . . 74.109999999999999 111.362 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.61 -143.6 9.67 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.874 -0.679 . . . . 74.319999999999993 113.105 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.66 71.93 1.56 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.558 -0.354 . . . . 65.150000000000006 113.711 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 62.86 8.92 3.35 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.564 0.95 . . . . 73.329999999999998 113.564 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.31 129.44 3.57 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.99 -0.624 . . . . 72.25 113.929 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 46.7 t60 -138.42 149.73 45.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.819 0.447 . . . . 75.010000000000005 110.747 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.504 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.0 m -141.17 143.95 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.439 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.67 23.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 111.681 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -80.64 133.68 35.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.246 -0.284 . . . . 75.430000000000007 110.989 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.46 114.34 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.025 0.441 . . . . 53.340000000000003 111.91 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -79.28 -41.49 27.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.912 -0.586 . . . . 75.319999999999993 111.686 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -167.85 151.95 6.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.909 0.385 . . . . 72.109999999999999 111.809 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.25 122.21 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.638 0.256 . . . . 71.239999999999995 110.685 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -83.05 160.97 21.84 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.15 0.426 . . . . 73.310000000000002 112.15 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -56.07 -22.5 28.05 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.029 0.443 . . . . 75.319999999999993 111.545 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.76 -9.11 17.9 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.135 -0.484 . . . . 71.25 112.0 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.54 89.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.338 -0.458 . . . . 74.340000000000003 112.272 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 m -88.45 131.48 34.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.147 0.498 . . . . 75.239999999999995 111.663 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.07 119.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.349 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.59 107.91 20.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.687 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 100' ' ' LEU . 34.4 m -105.2 161.87 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.551 0.574 . . . . 63.420000000000002 112.551 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.2 t -95.81 123.73 39.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.037 -0.529 . . . . 72.329999999999998 111.874 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -126.51 150.0 49.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.129 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.7 ttm -100.06 131.59 45.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.747 0.308 . . . . 72.109999999999999 110.234 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -97.45 -68.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.747 0.647 . . . . 74.439999999999998 112.747 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.54 125.85 32.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.179 0.437 . . . . 72.439999999999998 112.179 -170.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.01 -46.15 78.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.241 0.46 . . . . 71.349999999999994 112.241 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -86.62 17.99 36.67 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.092 -0.575 . . . . 63.240000000000002 113.169 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -132.58 80.87 0.32 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.55 -0.357 . . . . 64.019999999999996 112.654 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.52 -2.15 6.88 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 122.726 2.284 . . . . 75.209999999999994 113.055 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -112.63 3.32 16.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.997 0.427 . . . . 73.430000000000007 111.186 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -87.98 86.79 7.18 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.28 0.562 . . . . 61.210000000000001 110.977 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 75.7 t -109.18 148.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.139 -0.482 . . . . 62.43 111.605 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.3 m -143.35 136.58 28.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.044 0.449 . . . . 74.150000000000006 111.253 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -83.65 120.11 25.59 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.116 0.484 . . . . 72.150000000000006 111.715 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.43 118.57 31.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.306 -0.407 . . . . 75.549999999999997 110.841 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.4 m -90.69 105.27 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.134 0.493 . . . . 75.019999999999996 111.866 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.51 133.54 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.073 0.549 . . . . 72.349999999999994 111.102 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -72.85 157.95 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.157 0.428 . . . . 75.099999999999994 112.157 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.46 72.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.688 0.625 . . . . 53.109999999999999 112.688 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.06 -45.88 86.2 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.305 -0.474 . . . . 60.039999999999999 112.997 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.61 -40.56 95.72 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.416 0.627 . . . . 71.430000000000007 110.878 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.93 -21.11 64.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.641 -0.708 . . . . 71.540000000000006 112.689 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.4 p -65.73 -13.16 58.79 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.317 0.488 . . . . 61.439999999999998 112.317 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 39.0 t -102.49 2.21 36.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 111.865 0.32 . . . . 70.450000000000003 111.865 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -103.68 146.09 29.1 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.21 -0.306 . . . . 70.329999999999998 110.94 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -94.23 139.59 30.85 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.539 0.209 . . . . 51.210000000000001 110.943 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 100' ' ' LEU . 91.3 m-85 -117.22 116.98 28.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 73.450000000000003 111.797 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.3 mp -89.05 113.44 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.358 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 13.4 m-70 -99.97 136.06 40.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.082 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.12 -29.82 13.87 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.481 0.549 . . . . 72.140000000000001 112.481 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 121.079 0.466 . . . . 71.439999999999998 112.129 177.612 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 2' ' ' LYS . 24.7 ptm . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.955 0.354 . . . . 75.030000000000001 111.955 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 98.0 mttt -139.01 -156.76 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.408 0.283 . . . . 60.310000000000002 110.848 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 71.39 23.12 4.02 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.034 0.753 . . . . 63.350000000000001 113.034 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.34 157.51 33.85 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.153 0.502 . . . . 63.140000000000001 111.813 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.78 122.2 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.175 0.512 . . . . 50.539999999999999 111.978 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.9 p -85.76 150.58 24.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.942 0.401 . . . . 55.240000000000002 111.44 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.71 152.67 28.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.963 0.411 . . . . 64.329999999999998 111.733 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 159.81 42.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.953 0.406 . . . . 74.510000000000005 111.594 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.6 m -151.31 124.69 8.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.203 -0.453 . . . . 52.140000000000001 111.415 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt -120.76 121.72 38.82 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.304 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -77.77 122.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.44 -0.345 . . . . 70.439999999999998 111.36 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.89 0.376 . . . . 73.109999999999999 111.975 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.27 84.14 1.59 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.306 -0.473 . . . . 62.43 112.934 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.6 pt -85.47 178.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.2 0.524 . . . . 62.140000000000001 112.038 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.42 161.23 10.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 51.439999999999998 112.779 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.33 153.23 31.3 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 122.508 -0.407 . . . . 73.230000000000004 111.822 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.91 104.51 4.0 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.141 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.93 129.01 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.203 0.525 . . . . 74.319999999999993 111.974 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.18 143.8 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.885 -0.598 . . . . 62.350000000000001 111.08 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.12 127.41 1.86 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.246 -0.502 . . . . 12.41 113.0 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.4 mt -133.83 157.73 45.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.498 -0.413 . . . . 73.209999999999994 111.356 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -90.43 136.76 32.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.307 0.575 . . . . 74.329999999999998 111.592 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -93.99 -25.44 17.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.862 -0.608 . . . . 74.409999999999997 111.526 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.16 73.41 0.56 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.918 -0.658 . . . . 50.539999999999999 112.722 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.84 129.63 34.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.885 0.374 . . . . 72.140000000000001 111.179 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -105.4 -175.79 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.915 0.709 . . . . 62.130000000000003 112.915 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 49' ' ' ALA . . . 179.31 120.61 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.804 -1.089 . . . . 42.340000000000003 109.872 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.4 t70 -71.99 159.85 33.51 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.638 0.256 . . . . 43.020000000000003 110.829 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.27 32.44 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.79 0.293 . . . . 74.099999999999994 111.79 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.06 93.89 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.031 0.752 . . . . 71.150000000000006 113.031 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -81.55 105.53 12.78 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.345 0.593 . . . . 74.420000000000002 111.144 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.24 -73.73 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.165 -0.471 . . . . 72.340000000000003 112.213 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -160.72 172.4 17.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.678 0.275 . . . . 71.5 111.334 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 56.2 tt0 -120.0 109.77 37.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.593 -0.276 . . . . 74.439999999999998 111.516 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 34' ' ' GLN . 36.7 Cg_endo -65.92 99.54 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.432 2.088 . . . . 41.229999999999997 111.54 173.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.9 p -70.96 109.4 5.06 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 75.040000000000006 113.366 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.469 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -127.78 171.96 11.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.603 -0.726 . . . . 74.340000000000003 110.674 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.47 90.2 2.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.391 0.615 . . . . 74.099999999999994 111.393 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -97.05 158.2 15.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.844 -0.616 . . . . 75.019999999999996 111.758 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -78.64 154.55 30.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.365 -0.38 . . . . 70.299999999999997 111.28 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.25 66.77 4.79 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.699 0.629 . . . . 71.530000000000001 112.699 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.67 99.62 3.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.882 0.372 . . . . 74.209999999999994 110.814 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.9 m -79.77 146.72 32.17 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.21 0.528 . . . . 70.340000000000003 112.34 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 t -107.92 168.77 9.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.951 -0.568 . . . . 73.430000000000007 111.008 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -106.83 -30.68 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.863 0.363 . . . . 55.340000000000003 111.278 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 -150.94 42.22 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.058 -0.591 . . . . 55.32 112.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 t -174.86 116.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.575 0.35 . . . . 74.420000000000002 110.576 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.8 m -70.41 155.76 40.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.197 -0.314 . . . . 71.530000000000001 110.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 70.13 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.807 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.84 131.39 50.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.345 0.498 . . . . 64.299999999999997 112.345 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 71' ' ' SER . 84.2 mt -103.98 35.96 2.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.343 -0.389 . . . . 63.409999999999997 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -123.69 -86.54 0.64 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 111.627 0.232 . . . . 60.520000000000003 111.627 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -178.48 149.83 0.52 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 111.998 0.37 . . . . 51.140000000000001 111.998 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.72 124.3 28.92 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.852 0.358 . . . . 74.349999999999994 111.871 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.54 21.39 5.12 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.43 -0.414 . . . . 70.109999999999999 113.1 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -129.72 152.38 49.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.568 -0.372 . . . . 70.099999999999994 111.215 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.4 p -63.1 -35.76 81.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.945 0.403 . . . . 70.030000000000001 110.615 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -61.5 -26.59 68.01 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.059 0.456 . . . . 70.209999999999994 111.397 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -78.91 -55.69 4.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.049 -0.523 . . . . 65.430000000000007 110.869 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.05 -52.77 63.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.883 -0.599 . . . . 73.540000000000006 112.499 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.4 t -58.99 -31.99 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.301 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.41 -35.95 82.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.151 0.501 . . . . 65.329999999999998 110.667 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.96 -44.18 73.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.797 -0.638 . . . . 75.019999999999996 111.142 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.282 0.475 . . . . 74.209999999999994 112.282 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HG12 ' A' ' 69' ' ' ILE . 9.4 p -88.42 8.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 121.083 0.468 . . . . 71.030000000000001 111.563 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 28' ' ' ASP . . . 67.16 17.05 67.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.403 -0.427 . . . . 72.400000000000006 113.814 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.15 15.15 64.92 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.18 -0.533 . . . . 32.210000000000001 113.477 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.38 -5.88 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.218 0.451 . . . . 73.109999999999999 112.218 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.405 HG12 HG11 ' A' ' 65' ' ' VAL . 35.5 pt -98.79 140.93 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.559 -0.291 . . . . 72.049999999999997 110.495 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.16 125.14 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.9 -0.667 . . . . 71.239999999999995 113.586 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.525 ' HB2' HD12 ' A' ' 51' ' ' LEU . 57.7 m -66.36 78.31 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.182 0.515 . . . . 63.030000000000001 111.355 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -151.96 13.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.385 0.612 . . . . 74.200000000000003 110.905 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.66 -34.32 12.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.911 -0.586 . . . . 55.340000000000003 111.446 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.36 -130.92 10.02 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.184 -0.531 . . . . 53.140000000000001 113.344 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.11 151.25 47.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.3 0.572 . . . . 63.030000000000001 111.757 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.01 -33.92 67.65 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.863 1.06 . . . . 64.519999999999996 113.863 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.09 -28.08 69.2 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.848 -0.532 . . . . 72.040000000000006 112.032 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -84.63 -14.56 48.3 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.685 0.279 . . . . 62.210000000000001 111.604 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.409 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 8.2 m0 -51.02 -62.54 1.55 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.114 0.783 . . . . 72.430000000000007 113.114 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.57 -43.55 72.16 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.271 0.471 . . . . 73.409999999999997 112.271 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -60.91 -48.47 81.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.14 0.495 . . . . 73.439999999999998 111.508 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.12 60.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.148 -0.478 . . . . 71.200000000000003 111.455 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.65 7.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.355 -0.384 . . . . 74.530000000000001 111.025 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 p -62.14 -37.32 84.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.132 0.492 . . . . 55.240000000000002 110.941 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -64.25 -38.33 90.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.004 -0.543 . . . . 61.240000000000002 111.951 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.42 -6.01 58.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.676 0.621 . . . . 71.349999999999994 112.676 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.83 -2.3 25.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.938 -0.649 . . . . 74.319999999999993 113.574 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -76.36 170.32 16.58 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.305 0.574 . . . . 71.540000000000006 111.087 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.9 m -115.43 103.57 10.9 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.216 0.451 . . . . 73.340000000000003 112.216 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 152' ' ' ILE . 46.6 t -102.16 119.41 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 70.209999999999994 111.84 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -143.62 168.57 19.57 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.135 -0.484 . . . . 72.310000000000002 110.329 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.48 12.59 9.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.825 0.345 . . . . 70.420000000000002 111.53 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -65.73 108.99 2.54 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 110.624 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.68 14.0 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.042 2.495 . . . . 72.329999999999998 114.419 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -61.69 149.56 39.22 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.179 0.514 . . . . 74.329999999999998 111.985 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -60.51 152.47 25.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.953 0.723 . . . . 51.340000000000003 112.953 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.58 23.79 38.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.164 -0.471 . . . . 62.240000000000002 113.192 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.3 p -131.25 159.28 38.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 111.112 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.3 mp -103.42 119.69 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.327 -0.397 . . . . 63.25 110.521 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -96.07 130.22 43.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 30.1 tt0 -95.56 124.29 39.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.056 -0.52 . . . . 71.219999999999999 112.159 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -103.55 107.71 18.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.877 -0.601 . . . . 72.109999999999999 110.734 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.1 p -79.76 2.55 22.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.014 0.376 . . . . 74.25 112.014 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.81 -20.59 59.71 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.788 0.662 . . . . 63.32 112.788 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.24 159.69 19.96 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.95 -0.643 . . . . 55.43 113.65 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.71 129.02 38.69 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.271 -0.49 . . . . 63.329999999999998 112.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 70.6 5.16 5.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 111.117 -173.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.37 172.77 35.23 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.256 -0.429 . . . . 63.100000000000001 113.141 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -147.84 149.18 31.81 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.374 -0.486 . . . . 72.310000000000002 111.032 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.541 HG13 ' HB1' ' A' ' 76' ' ' ALA . 13.5 m -141.57 151.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.083 0.468 . . . . 73.519999999999996 111.779 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -149.26 167.79 25.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.992 -0.549 . . . . 71.109999999999999 110.996 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -102.94 129.76 49.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.25 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 96' ' ' ALA . 70.8 t -80.81 110.93 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 63.340000000000003 111.494 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -83.82 -45.58 13.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.08 0.4 . . . . 74.430000000000007 112.08 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -158.89 148.47 19.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.498 0.555 . . . . 73.25 112.498 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -109.71 134.7 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 63.310000000000002 110.638 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.96 160.87 14.38 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.297 0.48 . . . . 73.329999999999998 112.297 -176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -61.6 -22.4 65.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.103 -0.499 . . . . 62.439999999999998 111.413 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.64 -15.47 63.67 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.984 -0.553 . . . . 70.140000000000001 111.425 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.61 67.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.035 -0.426 . . . . 71.099999999999994 112.035 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 141.75 49.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.215 0.531 . . . . 74.430000000000007 111.894 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.32 128.32 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.857 -0.611 . . . . 72.129999999999995 111.981 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -93.28 117.27 29.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.941 0.4 . . . . 73.109999999999999 111.272 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.95 147.51 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 111.717 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.523 ' HB2' HG11 ' A' ' 136' ' ' VAL . 91.9 p -101.07 125.06 47.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.407 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 -179.68 5.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.384 0.611 . . . . 73.219999999999999 112.456 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.426 ' HB2' ' HE3' ' A' ' 127' ' ' MET . 47.3 ttm -137.59 118.41 14.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.896 -0.593 . . . . 74.409999999999997 110.822 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -123.98 -64.37 1.14 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.97 0.359 . . . . 60.399999999999999 111.97 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -156.76 -55.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.786 0.327 . . . . 73.450000000000003 111.223 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -52.16 117.18 2.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.246 -0.434 . . . . 75.140000000000001 111.499 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.72 -80.25 0.36 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.147 -0.549 . . . . 50.329999999999998 113.22 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.96 -163.56 31.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.984 -0.626 . . . . 41.100000000000001 113.666 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.14 -32.46 87.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.376 2.717 . . . . 52.219999999999999 114.2 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -134.09 22.05 3.8 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.592 0.59 . . . . 73.349999999999994 112.592 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -96.48 158.49 15.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.887 0.375 . . . . 73.209999999999994 110.957 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 125' ' ' SER . 25.0 t -120.78 158.36 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 113.206 0.817 . . . . 74.319999999999993 113.206 -169.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 136' ' ' VAL . 33.1 t -138.88 131.87 29.53 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.885 -0.598 . . . . 71.329999999999998 109.975 169.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -93.59 155.68 17.16 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 112.029 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.46 135.86 25.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.979 0.419 . . . . 73.439999999999998 111.526 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.3 m -95.05 99.76 11.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.075 0.464 . . . . 71.219999999999999 111.097 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.31 134.27 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.316 -0.402 . . . . 62.399999999999999 111.292 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 62.0 m -66.86 149.35 50.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.767 0.318 . . . . 61.219999999999999 111.562 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.85 66.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.582 0.586 . . . . 61.310000000000002 112.582 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.32 -38.47 86.77 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.408 -0.425 . . . . 54.240000000000002 113.564 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -83.09 -39.22 21.42 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.455 -0.438 . . . . 73.209999999999994 111.073 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -70.19 -42.51 72.29 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.802 0.667 . . . . 63.409999999999997 112.802 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.8 m -66.42 -14.41 62.13 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.918 0.389 . . . . 73.030000000000001 111.978 -171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -85.28 -10.84 55.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.428 -0.351 . . . . 61.130000000000003 111.551 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.428 ' CD2' HD12 ' A' ' 100' ' ' LEU . 25.4 m-85 -83.78 151.73 25.03 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.91 0.386 . . . . 72.140000000000001 111.175 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 81.5 m-20 -89.09 112.91 23.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.544 -0.298 . . . . 55.439999999999998 111.337 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.13 117.44 29.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.899 0.381 . . . . 60.140000000000001 111.646 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.7 mp -84.79 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.963 0.411 . . . . 63.32 111.022 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -119.71 147.53 44.47 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.751 0.42 . . . . 73.409999999999997 110.667 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.5 mt -101.52 135.39 43.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.709 0.633 . . . . 44.219999999999999 112.709 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 167.013 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 pmm? . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.31 0.1 . . . . 72.319999999999993 111.041 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 24.9 pttm -60.52 91.11 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.447 0.642 . . . . 44.340000000000003 111.798 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -74.24 -54.16 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.178 -0.465 . . . . 60.420000000000002 111.483 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.74 100.39 10.74 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.952 0.405 . . . . 60.340000000000003 110.922 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.31 99.8 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.119 0.485 . . . . 74.349999999999994 111.121 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t -105.26 169.15 8.61 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.109 -0.496 . . . . 64.319999999999993 111.371 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.41 162.37 16.97 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.926 0.393 . . . . 43.32 111.662 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -102.29 21.05 15.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.372 0.606 . . . . 75.310000000000002 110.935 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.521 HG22 ' HG ' ' A' ' 10' ' ' LEU . 43.9 m -113.19 120.86 42.68 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.128 -0.487 . . . . 74.040000000000006 111.784 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 9' ' ' THR . 88.6 mt 63.3 21.73 12.96 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.762 0.653 . . . . 72.510000000000005 112.762 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -104.03 160.56 14.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 111.778 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.86 8.71 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 112.379 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.45 -47.14 3.25 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.295 -0.479 . . . . 51.119999999999997 113.559 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 14' ' ' ILE . 14.0 tt -98.18 22.54 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.684 0.754 . . . . 72.099999999999994 111.442 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.83 75.05 1.3 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.98 -0.628 . . . . 73.430000000000007 113.317 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.65 113.04 25.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.566 -0.373 . . . . 45.420000000000002 111.7 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.72 154.4 20.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.855 0.359 . . . . 71.409999999999997 111.91 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.008 0.432 . . . . 62.219999999999999 111.578 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.49 126.16 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.475 -0.33 . . . . 74.140000000000001 111.081 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.81 112.47 0.69 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.087 -0.577 . . . . 64.230000000000004 112.661 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.1 mp -73.72 159.57 32.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.004 0.43 . . . . 74.010000000000005 111.498 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.67 167.65 11.33 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 111.752 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.09 105.8 11.77 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.069 0.461 . . . . 75.099999999999994 110.663 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.13 117.06 10.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.34 -0.457 . . . . 75.409999999999997 113.979 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -92.6 128.58 38.5 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.453 -0.439 . . . . 75.140000000000001 111.016 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -99.48 117.83 34.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.851 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.17 156.5 45.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.279 -0.419 . . . . 72.519999999999996 110.914 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -122.06 177.88 5.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.101 0.477 . . . . 74.430000000000007 111.668 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.65 132.3 52.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.094 0.474 . . . . 65.340000000000003 111.839 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.53 179.32 4.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 111.279 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.29 156.49 43.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.206 0.527 . . . . 73.109999999999999 111.654 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -132.92 -174.07 3.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.577 -0.738 . . . . 72.409999999999997 110.211 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -69.27 173.97 5.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.42 . . . . 73.120000000000005 111.027 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.9 102.45 35.51 Favored Pre-proline 0 CA--C 1.54 0.589 0 O-C-N 122.137 -0.352 . . . . 71.140000000000001 110.968 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.05 89.28 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.424 2.082 . . . . 74.329999999999998 112.917 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -78.8 70.8 5.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.584 . . . . 75.430000000000007 111.681 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.19 95.45 6.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.119 0.485 . . . . 62.350000000000001 110.446 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.96 -4.36 43.57 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.8 0.667 . . . . 60.520000000000003 112.8 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.7 p -83.78 97.9 9.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.349 0.595 . . . . 72.420000000000002 111.515 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.8 m -88.55 80.39 7.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.153 0.501 . . . . 75.010000000000005 110.811 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 p -89.93 140.36 29.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.338 -0.392 . . . . 71.349999999999994 111.144 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -91.3 22.66 3.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.554 0.692 . . . . 61.32 110.551 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.8 p -73.85 92.92 2.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.992 -0.549 . . . . 72.409999999999997 111.722 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -93.24 161.51 14.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.307 -0.406 . . . . 74.109999999999999 111.658 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -78.72 131.88 36.76 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.722 0.296 . . . . 70.109999999999999 111.092 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.66 9.49 76.87 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.953 -0.642 . . . . 73.219999999999999 113.432 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.7 t -154.56 106.64 2.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.198 0.499 . . . . 74.129999999999995 111.513 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -97.39 1.0 48.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.159 0.504 . . . . 72.519999999999996 111.381 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.36 18.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.256 -0.429 . . . . 44.32 110.95 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -100.8 134.9 43.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.764 0.316 . . . . 71.25 110.786 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.25 -11.59 20.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.072 0.768 . . . . 72.219999999999999 113.072 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -107.25 164.25 12.34 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.809 0.67 . . . . 75.219999999999999 112.809 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -80.69 165.22 22.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.547 -0.751 . . . . 71.120000000000005 112.995 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.73 37.72 0.24 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.607 0.595 . . . . 75.129999999999995 112.607 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.24 16.9 1.9 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.615 -0.326 . . . . 64.040000000000006 112.845 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -124.26 137.36 54.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.391 0.276 . . . . 74.030000000000001 110.682 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 m -60.97 -17.82 53.83 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.235 0.54 . . . . 53.509999999999998 111.688 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.5 p -78.53 -26.94 45.9 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.253 0.549 . . . . 73.140000000000001 111.734 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -56.87 -67.17 0.34 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 41.1 p90 -62.83 -28.19 69.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.092 0.405 . . . . 62.020000000000003 112.092 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -71.56 -36.18 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.875 0.369 . . . . 64.5 111.604 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.73 -35.47 63.73 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.5 111.747 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.64 -43.34 38.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.81 0.338 . . . . 75.219999999999999 111.263 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.01 -29.97 70.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.095 0.406 . . . . 60.310000000000002 112.095 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 2.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.289 0.566 . . . . 74.420000000000002 111.491 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.08 22.78 77.36 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.35 -0.387 . . . . 73.140000000000001 113.686 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.43 21.9 55.14 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.769 0.667 . . . . 32.549999999999997 114.769 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -82.23 3.9 25.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.571 0.685 . . . . 63.119999999999997 112.222 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -111.98 144.83 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.756 0.312 . . . . 60.100000000000001 111.601 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.55 112.07 4.1 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.272 -0.49 . . . . 74.030000000000001 112.797 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.2 p -68.46 -7.55 32.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.506 0.558 . . . . 72.040000000000006 112.506 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 t -65.12 -2.86 3.13 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.947 0.721 . . . . 64.010000000000005 112.947 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -64.83 -27.25 68.75 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.912 0.387 . . . . 73.109999999999999 111.838 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.3 -130.85 10.5 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.205 -0.522 . . . . 75.409999999999997 112.896 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 15.8 m120 -82.31 168.28 17.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.316 0.579 . . . . 64.450000000000003 111.717 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -73.28 16.55 0.17 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.861 1.06 . . . . 72.200000000000003 113.861 -170.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.45 -28.08 12.77 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.969 0.414 . . . . 63.219999999999999 111.632 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -95.82 -3.0 46.4 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.33 0.492 . . . . 71.140000000000001 112.33 -173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.408 ' HZ3' HD13 ' A' ' 99' ' ' ILE . 10.2 m0 -55.8 -56.48 20.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.842 0.682 . . . . 75.439999999999998 112.842 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.0 69.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.987 0.422 . . . . 75.319999999999993 112.016 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.1 t -66.86 -54.92 17.49 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.114 -0.494 . . . . 53.200000000000003 111.581 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.92 72.88 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.92 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -49.11 -57.22 7.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.609 0.364 . . . . 71.510000000000005 111.525 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.6 p -62.18 -39.67 93.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.973 0.416 . . . . 72.200000000000003 111.135 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -25.39 63.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.305 -0.407 . . . . 75.310000000000002 111.696 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.73 15.4 25.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.164 0.431 . . . . 61.219999999999999 112.164 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.55 -21.22 47.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.997 -0.621 . . . . 62.049999999999997 113.993 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.433 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.7 m-85 -63.6 154.98 31.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.476 0.638 . . . . 72.540000000000006 111.171 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 27.6 m -99.41 95.87 7.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.403 0.52 . . . . 72.430000000000007 112.403 -170.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.463 HG22 HG13 ' A' ' 152' ' ' ILE . 60.7 t -94.81 111.46 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.732 0.301 . . . . 72.049999999999997 111.383 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -133.29 174.77 10.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.603 -0.271 . . . . 72.019999999999996 111.161 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.64 0.52 52.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.968 0.413 . . . . 62.530000000000001 110.706 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.3 t -68.36 115.55 30.71 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.687 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -80.77 7.21 5.0 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.79 2.327 . . . . 73.310000000000002 113.276 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 137.74 5.41 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.171 0.434 . . . . 74.439999999999998 112.171 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.64 156.81 3.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.195 0.813 . . . . 42.520000000000003 113.195 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 26.01 57.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.93 -0.577 . . . . 71.420000000000002 113.016 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -129.38 175.99 8.32 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.272 0.558 . . . . 71.409999999999997 111.766 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 55.0 mt -129.92 128.13 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 62.409999999999997 110.57 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -101.63 138.47 38.58 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.906 -0.496 . . . . 71.200000000000003 111.523 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.457 HE21 HG22 ' A' ' 103' ' ' THR . 52.8 tt0 -103.41 110.83 22.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 111.193 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.59 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 56.1 m -84.13 -29.83 26.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.95 0.722 . . . . 63.109999999999999 112.95 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.457 HG22 HE21 ' A' ' 101' ' ' GLN . 19.0 p 67.12 -24.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.983 1.105 . . . . 73.319999999999993 113.983 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.09 84.89 0.24 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.521 0.934 . . . . 62.119999999999997 113.521 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.37 134.78 1.39 Allowed Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.974 0.75 . . . . 74.299999999999997 114.974 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.99 49.36 1.93 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.484 -0.389 . . . . 73.150000000000006 113.665 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.595 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 84.5 m-85 57.7 30.92 19.65 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.243 0.544 . . . . 74.439999999999998 110.67 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.71 -165.53 25.88 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.064 -0.814 . . . . 74.430000000000007 111.064 -170.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 59.4 t60 -168.2 134.87 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.651 0.725 . . . . 52.100000000000001 111.473 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG13 ' HB1' ' A' ' 76' ' ' ALA . 30.1 m -141.67 143.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.007 -0.542 . . . . 52.020000000000003 110.927 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.77 156.51 45.0 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.734 0.302 . . . . 61.219999999999999 111.005 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -89.58 129.19 36.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.868 0.366 . . . . 63.549999999999997 111.336 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -75.32 116.83 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.03 0.443 . . . . 63.43 111.529 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -75.74 -54.95 6.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.914 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -158.28 164.89 35.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.239 0.542 . . . . 73.340000000000003 111.778 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.45 129.88 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.06 -0.518 . . . . 64.319999999999993 110.835 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -85.24 145.62 27.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.295 -0.253 . . . . 74.549999999999997 110.596 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.1 m -59.71 -21.82 61.16 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.031 0.443 . . . . 70.340000000000003 111.212 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.46 -23.8 67.1 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.015 -0.539 . . . . 75.319999999999993 111.723 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.6 -20.31 29.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 112.1 -0.4 . . . . 24.52 112.1 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.0 m -68.66 135.72 51.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.862 0.363 . . . . 61.030000000000001 111.527 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.45 136.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.362 -0.381 . . . . 54.450000000000003 111.701 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.99 117.68 32.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.539 -0.3 . . . . 72.420000000000002 110.588 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.33 156.94 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.956 0.408 . . . . 73.450000000000003 111.933 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 p -110.96 123.89 51.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.965 0.412 . . . . 73.430000000000007 111.191 177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 38.6 mt-10 -128.86 151.65 49.38 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.244 -0.434 . . . . 71.450000000000003 111.65 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.4 tpp -74.57 109.51 8.11 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.926 0.393 . . . . 75.310000000000002 111.794 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -83.82 -35.41 24.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.274 -0.421 . . . . 71.530000000000001 110.65 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 63.9 t80 71.7 -18.37 0.3 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.889 0.7 . . . . 73.099999999999994 112.889 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -78.21 129.79 35.52 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.89 -0.506 . . . . 71.299999999999997 111.055 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.7 -106.44 3.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.124 -0.56 . . . . 64.120000000000005 112.548 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.73 164.7 53.31 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.379 -0.438 . . . . 75.340000000000003 113.504 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.81 -53.56 3.13 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.624 2.216 . . . . 72.019999999999996 112.857 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -98.43 45.28 1.01 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 73.319999999999993 110.709 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.2 t -68.25 84.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.227 0.537 . . . . 70.030000000000001 111.663 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.74 117.14 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.247 -0.433 . . . . 74.150000000000006 110.923 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.3 m -104.4 174.07 6.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.934 0.397 . . . . 71.049999999999997 111.652 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.46 156.03 19.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.241 0.543 . . . . 75.040000000000006 112.077 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -149.9 128.05 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.975 -0.557 . . . . 74.209999999999994 110.59 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.1 m -99.87 113.37 25.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.434 -0.348 . . . . 71.030000000000001 110.707 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.85 134.24 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.708 0.289 . . . . 75.430000000000007 111.243 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -63.13 151.73 39.29 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.068 0.396 . . . . 73.400000000000006 112.068 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.82 61.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.718 0.636 . . . . 43.310000000000002 112.718 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.47 -37.91 56.82 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.506 -0.378 . . . . 62.25 113.808 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -94.96 -51.32 4.72 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.526 -0.397 . . . . 61.229999999999997 111.106 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.23 67.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.778 0.658 . . . . 63.32 112.778 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -64.19 -14.33 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.591 0.589 . . . . 62.340000000000003 112.591 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.2 t -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.057 0.456 . . . . 72.420000000000002 111.015 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 23.9 m-85 -72.59 152.33 41.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.859 -0.609 . . . . 65.099999999999994 112.127 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -84.67 117.63 23.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.467 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 97.3 m-85 -96.48 113.98 25.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 111.969 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.8 mp -79.29 129.54 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.448 -0.342 . . . . 71.040000000000006 110.447 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 50.8 m-70 -119.46 152.03 37.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 110.865 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.49 -43.88 5.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 111.809 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.152 0.501 . . . . 73.129999999999995 111.453 -174.309 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.374 0.131 . . . . 73.420000000000002 110.801 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 3.7 mppt? -76.17 103.5 6.23 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.879 0.371 . . . . 73.129999999999995 111.398 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -112.8 30.88 6.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.248 0.547 . . . . 73.049999999999997 111.417 178.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.26 93.54 4.01 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 70.319999999999993 111.824 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.695 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.5 p -80.33 145.86 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.264 -0.425 . . . . 64.420000000000002 110.615 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.6 p -101.25 6.52 42.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.04 0.385 . . . . 74.439999999999998 112.04 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -67.11 106.26 1.93 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.9 0.704 . . . . 74.329999999999998 112.9 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -147.87 137.75 22.65 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.012 -0.54 . . . . 75.219999999999999 110.205 171.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.2 m -84.04 133.64 34.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.914 0.709 . . . . 74.400000000000006 112.914 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 10' ' ' LEU . 2.2 pt? -152.34 151.62 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.426 -0.807 . . . . 62.049999999999997 110.301 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 t -163.67 179.69 7.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 122.142 -0.349 . . . . 74.150000000000006 111.873 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.43 173.91 13.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.505 0.322 . . . . 72.430000000000007 111.096 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.61 97.22 2.45 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.164 -0.541 . . . . 65.010000000000005 113.452 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 14' ' ' ILE . 2.0 pp -87.84 128.82 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.174 0.511 . . . . 61.509999999999998 111.85 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.27 -157.44 23.81 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.273 -0.489 . . . . 51.109999999999999 113.621 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.89 129.19 17.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.612 -0.346 . . . . 70.230000000000004 111.184 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.82 157.09 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.163 0.506 . . . . 63.219999999999999 112.273 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.9 tt -77.19 143.9 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 116.096 -0.502 . . . . 51.299999999999997 111.551 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.8 p -106.45 120.96 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.174 0.512 . . . . 72.120000000000005 111.523 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.93 59.95 4.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 74.150000000000006 112.254 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 110.36 1.34 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.16 0.43 . . . . 73.209999999999994 112.16 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.33 155.03 24.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.315 -0.402 . . . . 73.329999999999998 111.74 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -134.17 15.52 3.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.186 0.81 . . . . 74.209999999999994 113.186 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.75 144.19 5.08 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.566 -0.826 . . . . 42.350000000000001 113.965 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 71.3 -15.45 0.42 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.014 0.746 . . . . 64.349999999999994 113.014 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -61.0 142.35 56.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.969 0.414 . . . . 75.219999999999999 112.04 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.97 167.59 20.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.273 0.559 . . . . 74.420000000000002 112.476 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.39 94.89 3.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.275 -0.42 . . . . 74.109999999999999 110.584 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.15 112.88 23.9 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.461 0.541 . . . . 65.219999999999999 112.461 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.71 114.63 12.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.29 -0.414 . . . . 62.020000000000003 110.777 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -14.58 54.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.298 0.481 . . . . 73.420000000000002 112.298 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.38 111.1 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.95 0.405 . . . . 51.329999999999998 111.311 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -153.27 161.19 42.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.99 0.424 . . . . 61.109999999999999 111.26 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -112.82 106.0 55.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.017 0.436 . . . . 74.299999999999997 110.173 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.7 92.15 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 62.310000000000002 114.316 -173.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -76.67 -28.13 55.86 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.616 0.722 . . . . 43.539999999999999 109.965 168.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB2' ' OD1' ' A' ' 155' ' ' ASN . 4.2 p-10 -89.89 150.0 22.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.398 -0.819 . . . . 73.129999999999995 110.821 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -72.43 143.86 48.34 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.01 0.433 . . . . 72.209999999999994 111.507 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.7 m -69.62 116.23 9.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.3 -0.409 . . . . 74.239999999999995 112.036 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.5 t -153.14 150.0 28.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.883 0.373 . . . . 75.219999999999999 111.563 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -139.56 137.47 35.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.288 -0.414 . . . . 72.299999999999997 110.124 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' HG3' HG23 ' A' ' 44' ' ' THR . 14.2 pt20 -160.93 -158.33 0.58 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.371 0.508 . . . . 74.430000000000007 112.371 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -80.16 31.11 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.186 0.81 . . . . 61.049999999999997 113.186 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 42' ' ' GLN . 41.4 p -69.41 99.54 1.24 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.115 -0.366 . . . . 54.109999999999999 111.557 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 m -130.23 71.14 1.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.935 0.398 . . . . 64.450000000000003 111.713 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.18 163.55 39.58 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.165 -0.54 . . . . 75.439999999999998 113.326 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.0 m -69.96 153.99 42.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.884 0.373 . . . . 51.530000000000001 111.597 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -94.54 -63.6 1.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.041 0.448 . . . . 52.049999999999997 111.766 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.06 172.63 12.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.107 0.78 . . . . 41.310000000000002 113.107 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -80.34 104.6 11.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.713 -0.676 . . . . 73.540000000000006 110.982 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.89 -17.41 50.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.085 0.402 . . . . 70.150000000000006 112.085 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -81.69 -170.29 2.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.126 0.488 . . . . 50.200000000000003 111.941 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -117.89 154.15 32.35 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.349 -0.387 . . . . 54.240000000000002 111.864 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.63 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.179 0.514 . . . . 63.219999999999999 112.004 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.72 -40.57 0.53 Allowed Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 112.763 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.57 144.54 56.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.754 0.311 . . . . 65.010000000000005 111.447 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 29.7 p -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.237 0.541 . . . . 73.450000000000003 110.974 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 p -66.01 -15.87 63.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.837 -0.619 . . . . 72.120000000000005 112.121 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -76.18 -60.83 2.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.007 0.373 . . . . 74.400000000000006 112.007 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 18.4 p90 -71.88 -30.6 65.57 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.75 0.648 . . . . 71.230000000000004 112.75 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.97 -32.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 110.469 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.2 -39.77 79.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.769 -0.651 . . . . 71.430000000000007 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.74 -37.51 76.5 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.341 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 125' ' ' SER . 30.4 mmmt -56.17 -33.58 65.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.913 0.387 . . . . 72.510000000000005 111.696 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.7 p -102.34 15.37 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.602 0.715 . . . . 61.0 111.163 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.9 -1.3 17.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.25 -0.432 . . . . 72.040000000000006 113.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.03 10.8 77.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.351 -0.452 . . . . 61.25 113.361 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -79.28 38.1 0.35 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.312 0.486 . . . . 73.439999999999998 112.312 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD21 ' A' ' 154' ' ' LEU . 20.5 pt -134.78 -41.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.21 100.24 2.49 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.911 -0.661 . . . . 65.5 113.353 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.0 p -80.24 43.57 0.64 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.199 0.444 . . . . 63.539999999999999 112.199 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 t -126.28 18.46 7.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.957 0.408 . . . . 71.329999999999998 112.084 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -91.17 11.67 22.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.849 0.685 . . . . 63.119999999999997 112.849 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.05 -143.44 28.69 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 113.596 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.08 152.42 45.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.521 -0.4 . . . . 61.119999999999997 111.104 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.53 -38.43 59.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.514 0.561 . . . . 52.240000000000002 112.514 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -61.31 -25.97 67.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.346 0.499 . . . . 62.340000000000003 112.346 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -94.56 -5.81 45.07 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.25 -0.281 . . . . 43.25 111.508 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.16 -56.26 21.88 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.373 0.509 . . . . 75.319999999999993 112.373 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.417 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -61.78 -40.92 96.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.861 0.363 . . . . 62.340000000000003 111.846 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -35.58 81.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.4 -0.363 . . . . 72.510000000000005 111.784 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.49 -45.9 24.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.615 0.228 . . . . 72.25 111.615 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.53 -55.42 25.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.936 0.398 . . . . 75.219999999999999 111.694 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 p -57.1 -49.41 75.97 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 111.283 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.7 t -65.7 -15.54 62.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.242 0.46 . . . . 51.409999999999997 112.242 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.84 3.47 54.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.924 0.392 . . . . 73.25 111.654 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.52 -4.44 73.03 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.3 -0.476 . . . . 75.109999999999999 113.657 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -75.15 170.4 16.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 111.565 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -99.88 97.21 8.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 112.353 -170.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.38 91.98 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.146 0.498 . . . . 64.409999999999997 110.692 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.77 138.42 53.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.677 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -76.71 13.33 1.03 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.48 0.918 . . . . 52.409999999999997 113.48 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -65.85 114.02 14.51 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 110.02 -0.363 . . . . 71.129999999999995 110.02 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.14 22.19 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.942 2.428 . . . . 55.25 114.543 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.5 mt-10 -74.44 159.81 31.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.529 0.681 . . . . 71.340000000000003 112.695 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.56 5.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.323 -0.853 . . . . 75.409999999999997 113.086 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.22 40.91 40.31 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.874 -0.603 . . . . 64.329999999999998 112.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.2 p -152.25 167.19 29.4 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.568 -0.372 . . . . 65.200000000000003 111.125 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.6 mp -112.78 122.95 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.602 -0.272 . . . . 72.5 110.351 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 149' ' ' TYR . 1.7 pt? -86.41 138.36 31.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 64.010000000000005 110.893 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -112.37 109.4 19.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.355 -0.384 . . . . 63.149999999999999 110.561 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.5 t -105.81 133.22 50.9 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.313 -0.403 . . . . 74.329999999999998 111.476 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.7 p -112.78 22.45 14.48 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.755 0.312 . . . . 71.439999999999998 111.787 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.52 -53.02 48.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.195 0.443 . . . . 72.299999999999997 112.195 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.5 -178.25 29.54 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.862 -0.685 . . . . 71.200000000000003 113.675 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.72 30.48 72.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.572 -0.347 . . . . 41.119999999999997 113.825 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 57.47 27.79 14.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.222 0.534 . . . . 75.140000000000001 111.775 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.7 151.85 23.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 116.004 -0.544 . . . . 74.099999999999994 112.94 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -148.98 143.55 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.511 -0.405 . . . . 74.109999999999999 111.421 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.77 153.92 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.048 0.451 . . . . 72.120000000000005 111.615 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.48 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.577 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -95.4 126.18 40.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.001 0.429 . . . . 64.109999999999999 111.627 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.403 HG22 HG12 ' A' ' 124' ' ' VAL . 42.6 t -74.99 108.21 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.068 -0.515 . . . . 74.239999999999995 111.682 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.75 -48.65 14.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.066 -0.515 . . . . 74.230000000000004 111.443 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -154.4 154.7 33.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.284 -0.417 . . . . 74.120000000000005 110.913 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 95' ' ' GLU . 45.2 t -123.65 111.0 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.874 0.368 . . . . 55.049999999999997 111.094 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -64.95 131.96 48.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.483 -0.326 . . . . 70.209999999999994 111.566 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.6 p -60.78 -19.01 58.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.835 0.35 . . . . 53.119999999999997 111.596 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 -16.72 64.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.882 0.372 . . . . 73.219999999999999 111.788 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.37 57.51 0.59 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.303 -0.475 . . . . 43.409999999999997 113.067 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -151.64 136.29 17.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.735 0.303 . . . . 74.030000000000001 111.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.93 116.1 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.269 -0.423 . . . . 61.210000000000001 110.912 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -90.22 104.85 17.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.874 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 113' ' ' VAL . 33.2 m -108.51 132.84 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.154 0.502 . . . . 55.439999999999998 111.907 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.505 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 32.0 t -89.28 114.23 25.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.425 -0.352 . . . . 64.519999999999996 111.17 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -131.05 147.31 52.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.532 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.593 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 40.8 ttm -81.02 107.73 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.093 0.473 . . . . 71.349999999999994 110.863 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.35 -21.41 24.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.918 -0.583 . . . . 75.439999999999998 110.983 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.564 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 9.0 t80 59.5 62.68 1.7 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.782 -0.644 . . . . 71.299999999999997 110.992 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -79.36 -64.26 1.23 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.888 -0.596 . . . . 74.319999999999993 110.828 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -126.23 -53.89 0.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.248 -0.501 . . . . 72.540000000000006 113.348 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.61 148.39 35.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.108 -0.568 . . . . 74.120000000000005 113.38 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.49 -14.87 37.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.953 2.436 . . . . 72.040000000000006 113.296 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -120.81 25.98 9.37 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.258 0.551 . . . . 74.120000000000005 110.604 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.564 ' HB3' ' HA ' ' A' ' 129' ' ' TYR . 43.2 t -59.45 97.56 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.983 0.734 . . . . 52.240000000000002 112.983 -175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 63.0 t -104.19 127.34 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.962 0.41 . . . . 73.349999999999994 110.866 175.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.4 t -112.62 136.54 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.352 -0.385 . . . . 72.340000000000003 111.257 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -82.63 97.0 8.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.331 0.586 . . . . 63.109999999999999 110.025 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -83.91 107.12 16.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.905 -0.589 . . . . 64.019999999999996 112.215 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.1 m -86.73 112.91 22.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 111.248 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.1 mt -111.87 139.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.391 -0.368 . . . . 75.430000000000007 111.568 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.5 m -58.45 133.81 56.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.621 0.248 . . . . 74.530000000000001 111.399 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.22 73.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.191 0.441 . . . . 52.009999999999998 112.191 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -52.25 40.04 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.203 -0.523 . . . . 71.109999999999999 112.965 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.48 -44.72 77.87 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.163 0.506 . . . . 55.43 110.859 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.438 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.84 -30.69 70.25 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.196 0.813 . . . . 34.149999999999999 113.196 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.9 t -58.49 -23.74 58.67 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.807 0.669 . . . . 63.530000000000001 112.807 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.5 t -76.17 -19.45 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.021 0.439 . . . . 71.25 111.79 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 11.0 m-85 -83.67 147.9 27.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.934 0.397 . . . . 75.219999999999999 110.965 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.8 121.41 33.4 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.333 -0.229 . . . . 75.340000000000003 111.274 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.438 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 54.4 m-85 -98.21 121.85 40.65 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.132 0.492 . . . . 74.120000000000005 112.005 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -83.68 121.74 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.354 -0.385 . . . . 65.420000000000002 110.423 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -115.38 147.35 40.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.548 0.339 . . . . 75.409999999999997 110.57 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 HG22 ' A' ' 69' ' ' ILE . 86.9 mt -110.64 116.89 32.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.321 0.489 . . . . 73.310000000000002 112.321 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 37' ' ' ASN . 36.6 m-80 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 109.895 -0.409 . . . . 71.540000000000006 109.895 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.474 0.178 . . . . 61.200000000000003 111.201 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.69 93.04 0.1 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.056 0.455 . . . . 75.340000000000003 111.39 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 9.7 mtmp? -121.15 120.67 35.93 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 111.784 -176.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.86 96.58 7.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.179 0.514 . . . . 72.209999999999994 110.566 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 m -74.05 104.65 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.54 0.686 . . . . 74.200000000000003 112.072 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 t -156.04 135.95 12.72 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.912 -0.585 . . . . 70.230000000000004 110.757 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.69 115.24 26.78 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.103 0.409 . . . . 55.109999999999999 112.103 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.7 m -63.01 88.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.352 0.596 . . . . 74.140000000000001 110.723 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 m -107.63 134.94 49.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.977 -0.556 . . . . 72.540000000000006 111.395 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.29 178.16 6.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.066 0.46 . . . . 64.319999999999993 111.724 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -158.1 150.13 21.87 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.085 -0.507 . . . . 72.310000000000002 111.064 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.28 179.54 4.22 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.261 0.467 . . . . 71.319999999999993 112.261 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.9 119.52 0.53 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.228 -0.51 . . . . 51.030000000000001 113.134 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 tt -166.13 -42.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.371 0.878 . . . . 71.420000000000002 113.371 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.86 166.17 13.48 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.684 -0.769 . . . . 33.310000000000002 114.632 -171.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 161.07 36.54 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.608 0.363 . . . . 40.530000000000001 111.275 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.69 162.9 13.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.83 0.678 . . . . 53.0 112.83 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -83.18 156.21 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.026 -0.533 . . . . 61.43 111.291 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.9 t -93.52 -66.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.822 0.675 . . . . 53.329999999999998 112.822 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 77.9 0.44 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.614 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 22' ' ' ASP . 3.6 tt -96.82 133.56 41.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 75.230000000000004 110.851 -174.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' N ' HD23 ' A' ' 21' ' ' LEU . 7.5 m-20 -81.22 88.55 6.03 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.947 0.403 . . . . 63.43 111.173 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -153.66 128.28 9.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.702 0.287 . . . . 64.400000000000006 111.683 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.68 -83.72 0.99 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.445 -0.407 . . . . 74.219999999999999 112.914 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -143.7 -69.66 0.32 Allowed 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.445 -0.444 . . . . 62.140000000000001 111.433 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.68 160.31 34.65 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.614 0.245 . . . . 75.019999999999996 111.595 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.67 105.26 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.153 0.427 . . . . 44.109999999999999 112.153 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.64 144.76 9.06 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.268 -0.424 . . . . 74.450000000000003 110.777 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -160.21 150.12 18.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.648 0.261 . . . . 71.319999999999993 111.373 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.42 -8.74 57.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.987 0.736 . . . . 43.509999999999998 112.987 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.38 -9.5 38.51 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.818 0.342 . . . . 55.43 111.865 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 29' ' ' ALA . 2.4 pt20 -85.54 176.58 8.14 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.384 0.611 . . . . 74.120000000000005 112.315 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.5 p -86.24 138.09 32.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.807 -0.633 . . . . 43.43 111.564 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.47 82.5 3.04 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 120.964 0.411 . . . . 54.039999999999999 111.175 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -97.48 172.83 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.387 2.725 . . . . 70.319999999999993 113.291 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 t -72.37 -25.36 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.096 0.474 . . . . 74.219999999999999 111.159 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.94 109.61 5.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.085 0.469 . . . . 72.230000000000004 111.798 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.32 82.67 2.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.103 0.478 . . . . 71.129999999999995 109.721 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.3 t -113.36 -179.12 3.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.42 0.526 . . . . 51.539999999999999 112.42 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.1 p -133.48 22.72 4.01 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.274 -0.421 . . . . 74.329999999999998 112.125 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.1 p -98.18 -175.64 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.859 0.361 . . . . 64.109999999999999 111.821 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -66.06 149.45 50.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 74.340000000000003 112.955 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.3 m -133.01 149.05 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.666 -0.697 . . . . 62.140000000000001 110.337 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.0 p -122.6 167.61 13.19 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.288 0.566 . . . . 72.030000000000001 112.523 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -96.79 126.26 41.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.965 -0.561 . . . . 74.219999999999999 110.196 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.93 -172.76 48.53 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.934 -0.65 . . . . 73.519999999999996 114.567 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -125.75 -177.93 4.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.763 0.425 . . . . 65.099999999999994 110.321 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -149.42 13.9 0.85 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.666 0.987 . . . . 73.140000000000001 113.666 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.42 117.53 23.12 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.56 0.578 . . . . 45.219999999999999 112.56 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' A' ' 63' ' ' ASP . 1.6 m-20 -76.73 86.92 3.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 72.129999999999995 110.848 176.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.85 50.32 1.97 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.016 0.436 . . . . 63.210000000000001 111.893 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.463 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 80.1 m-85 -116.25 -159.52 0.72 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.782 0.325 . . . . 72.409999999999997 111.371 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t -117.25 144.49 44.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 111.199 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.28 86.5 0.41 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 112.078 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 130' ' ' ASN . . . 160.29 -29.88 0.36 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.871 -0.681 . . . . 15.43 113.7 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.49 151.1 30.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 111.852 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.6 m -54.67 -40.95 69.59 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.834 -0.621 . . . . 71.209999999999994 112.248 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -62.82 -24.19 67.64 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 74.109999999999999 112.151 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -60.99 -47.89 84.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.222 0.453 . . . . 73.400000000000006 112.222 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 126' ' ' GLU . 25.0 p90 -80.63 -39.69 26.98 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.172 -0.33 . . . . 72.230000000000004 111.624 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 57' ' ' CYS . 45.6 t -57.23 -41.89 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.879 0.371 . . . . 74.319999999999993 111.74 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.01 -38.47 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.175 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' HB2' HD21 ' A' ' 50' ' ' ASN . 31.1 t70 -78.51 -39.58 37.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 111.003 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.2 mmmt -53.22 -44.81 68.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.928 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.95 -22.43 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 111.962 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.2 30.19 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.169 -0.538 . . . . 62.509999999999998 113.656 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.91 -14.89 35.09 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.321 -0.466 . . . . 75.030000000000001 114.144 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.41 68.81 4.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.303 -0.528 . . . . 74.310000000000002 112.118 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 70' ' ' GLY . 6.0 pt -146.96 -54.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.043 -0.526 . . . . 71.409999999999997 111.473 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG13 ' A' ' 69' ' ' ILE . . . 142.28 102.27 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.722 -0.752 . . . . 73.530000000000001 113.37 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 84.4 p -55.34 -28.09 51.47 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.023 0.379 . . . . 71.450000000000003 112.023 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -62.96 -16.64 60.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.087 0.773 . . . . 75.340000000000003 113.087 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -61.87 -43.15 99.42 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.908 0.385 . . . . 73.349999999999994 111.294 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 66.68 -92.99 0.2 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.323 -0.465 . . . . 74.319999999999993 114.122 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.91 139.74 38.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.01 0.433 . . . . 72.430000000000007 111.915 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -60.44 -28.58 68.4 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.366 0.506 . . . . 73.010000000000005 112.366 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -67.51 -17.76 64.79 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.943 0.401 . . . . 72.519999999999996 111.78 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.4 -34.16 12.87 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.197 0.443 . . . . 73.140000000000001 112.197 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -35.58 -64.62 0.28 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.625 1.343 . . . . 75.099999999999994 114.625 -171.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.48 79.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.632 0.604 . . . . 74.219999999999999 112.632 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -68.23 -44.55 75.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.085 0.469 . . . . 75.099999999999994 111.336 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.45 83.1 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.209 -0.451 . . . . 75.120000000000005 111.046 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -59.62 5.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.038 -0.528 . . . . 63.140000000000001 111.105 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.4 p -58.25 -32.41 68.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 111.56 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -72.85 -41.95 64.23 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.229 0.455 . . . . 44.119999999999997 112.229 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.75 -8.39 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.643 0.609 . . . . 54.009999999999998 112.643 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.38 7.48 26.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.942 -0.647 . . . . 43.350000000000001 113.447 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -80.4 168.18 19.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.629 . . . . 74.430000000000007 111.744 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 m -104.86 102.24 11.79 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.813 -0.631 . . . . 52.329999999999998 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.76 111.26 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 61.539999999999999 111.404 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 30.9 m120 -132.15 149.31 52.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.366 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.79 12.25 1.13 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.219 0.452 . . . . 62.310000000000002 112.219 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.5 t -73.54 116.85 55.55 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.733 -0.212 . . . . 52.340000000000003 111.24 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.76 104.24 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.39 2.06 . . . . 74.019999999999996 112.032 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -131.04 136.47 48.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.058 -0.519 . . . . 71.439999999999998 111.699 -174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.98 120.86 14.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.555 -0.293 . . . . 32.509999999999998 111.237 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.64 15.33 17.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.202 -0.523 . . . . 64.409999999999997 113.254 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -120.75 170.1 9.77 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.475 -0.426 . . . . 61.539999999999999 110.753 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.0 mp -113.24 123.04 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.617 -0.265 . . . . 75.230000000000004 110.71 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -93.71 133.29 37.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.073 0.463 . . . . 71.030000000000001 111.212 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.426 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.8 tt0 -94.25 112.18 23.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.294 -0.412 . . . . 72.209999999999994 111.153 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 37.5 m -93.9 -17.41 23.04 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.292 0.478 . . . . 74.209999999999994 112.292 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.4 p 47.41 21.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.476 0.917 . . . . 72.230000000000004 113.476 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.58 105.02 3.49 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.12 0.785 . . . . 74.439999999999998 113.12 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.75 97.34 0.6 Allowed Glycine 0 CA--C 1.531 1.044 0 N-CA-C 115.278 0.871 . . . . 13.32 115.278 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.04 -86.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.638 0.615 . . . . 62.200000000000003 114.638 171.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -69.39 -28.61 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.227 0.537 . . . . 75.400000000000006 110.859 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.02 176.54 33.44 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.874 -0.603 . . . . 73.010000000000005 113.322 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 39.6 t60 -136.0 142.78 44.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.709 0.29 . . . . 73.319999999999993 111.058 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.552 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -146.89 146.2 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.088 0.555 . . . . 64.340000000000003 110.397 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -143.84 161.7 37.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.961 0.41 . . . . 61.399999999999999 111.433 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.5 123.74 37.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.942 0.401 . . . . 72.230000000000004 111.054 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.86 106.04 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.966 0.412 . . . . 73.019999999999996 111.913 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.91 -51.59 53.47 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.121 0.486 . . . . 71.140000000000001 110.754 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -160.37 164.24 32.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.057 -0.52 . . . . 65.209999999999994 110.833 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.28 140.45 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.049 0.452 . . . . 64.219999999999999 111.198 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -89.54 147.91 23.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.728 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.0 t -62.54 -20.7 64.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.864 0.364 . . . . 44.240000000000002 111.908 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.82 -22.83 62.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.336 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.87 -17.87 10.72 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.302 -0.408 . . . . 64.25 113.073 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -64.07 126.25 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.951 0.405 . . . . 73.540000000000006 111.621 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.05 124.48 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.998 0.428 . . . . 73.409999999999997 111.967 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -93.23 113.85 26.18 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.939 0.4 . . . . 73.319999999999993 110.662 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.75 164.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.24 0.459 . . . . 74.540000000000006 112.24 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.518 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 48.6 p -117.17 140.61 49.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.462 -0.335 . . . . 71.409999999999997 111.715 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 59.8 mt-10 -138.65 159.06 43.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.05 0.54 . . . . 75.25 110.991 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.9 tpp -82.5 136.29 34.92 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.347 -0.221 . . . . 63.100000000000001 110.569 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.556 0.576 . . . . 71.0 112.556 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.94 164.95 37.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.395 0.617 . . . . 74.340000000000003 112.23 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.41 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 2.2 p-10 -62.06 116.03 4.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.552 -0.749 . . . . 63.520000000000003 111.578 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.6 30.6 26.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 43.210000000000001 112.558 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.08 -170.63 36.46 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.46 -0.4 . . . . 54.299999999999997 113.788 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.6 -178.59 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.978 2.452 . . . . 72.129999999999995 113.341 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.66 -19.51 65.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.07 0.462 . . . . 73.450000000000003 111.421 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.8 m -72.28 107.24 4.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.265 -0.425 . . . . 74.019999999999996 111.331 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.51 HG21 ' HD3' ' A' ' 64' ' ' LYS . 76.6 t -89.82 127.7 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.861 0.362 . . . . 65.349999999999994 111.535 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.5 t -68.24 174.61 3.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.086 0.469 . . . . 73.040000000000006 111.884 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 27.3 mt-10 -144.6 158.07 43.93 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.919 0.39 . . . . 65.340000000000003 111.755 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.2 ptp180 -157.73 173.15 17.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.477 -0.329 . . . . 54.439999999999998 111.118 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 72.8 m -127.73 123.51 35.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.963 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -94.73 137.42 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.876 0.37 . . . . 63.539999999999999 111.389 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -59.84 137.9 57.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.154 -0.476 . . . . 40.43 111.997 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.07 -42.62 60.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.545 0.572 . . . . 72.219999999999999 112.545 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.29 -27.99 61.15 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.316 -0.402 . . . . 34.340000000000003 113.637 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.82 -27.79 14.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.387 -0.478 . . . . 74.430000000000007 111.39 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.64 -29.02 61.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.087 0.773 . . . . 64.439999999999998 113.087 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t -78.19 -6.24 54.23 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.0 0.37 . . . . 73.400000000000006 112.0 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.5 m -85.88 -15.04 43.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.773 0.32 . . . . 72.349999999999994 111.797 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -93.69 144.92 24.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.053 0.454 . . . . 71.340000000000003 112.21 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -93.88 116.41 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.152 -0.476 . . . . 54.32 110.359 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 20.9 m-85 -95.49 122.91 38.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.933 0.397 . . . . 60.350000000000001 111.748 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -83.63 123.38 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.388 -0.369 . . . . 74.420000000000002 110.604 175.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.34 136.94 52.43 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.516 0.327 . . . . 63.439999999999998 110.547 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 69' ' ' ILE . 74.4 mt -97.92 102.94 14.83 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.348 0.499 . . . . 51.149999999999999 112.348 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.214 0.531 . . . . 64.349999999999994 110.813 173.264 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.547 0.213 . . . . 70.349999999999994 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.66 93.83 1.29 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.253 0.549 . . . . 73.019999999999996 110.204 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -124.46 124.52 42.49 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.288 -0.415 . . . . 75.030000000000001 111.092 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 4' ' ' LEU . 2.9 mm? -80.87 84.96 6.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.318 0.58 . . . . 73.140000000000001 110.81 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -102.06 94.79 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 115.869 -0.605 . . . . 63.350000000000001 111.098 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.5 m -133.83 97.16 3.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.49 -0.323 . . . . 73.329999999999998 110.871 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.13 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.869 0.322 . . . . 53.340000000000003 111.869 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -175.12 163.6 3.19 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.236 -0.438 . . . . 75.219999999999999 110.951 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -133.35 168.7 18.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.083 0.468 . . . . 43.32 111.988 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.7 mp -103.93 119.64 39.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.02 -0.536 . . . . 64.209999999999994 111.56 -173.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -78.17 121.46 24.37 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.495 -0.321 . . . . 73.010000000000005 111.694 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.22 -174.35 2.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.495 -0.32 . . . . 74.219999999999999 111.393 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.61 128.09 0.97 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.154 -0.546 . . . . 65.209999999999994 113.156 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -98.48 108.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.581 -0.364 . . . . 73.450000000000003 111.516 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.41 74.8 0.57 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.311 -0.471 . . . . 51.350000000000001 113.409 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.68 96.69 10.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.539 -0.389 . . . . 75.010000000000005 110.977 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.97 97.4 7.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.176 0.512 . . . . 75.129999999999995 112.348 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 pt -76.28 142.9 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.12 -0.491 . . . . 74.510000000000005 111.405 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.79 168.79 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.787 0.327 . . . . 74.319999999999993 111.374 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.49 -18.13 3.47 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.89 -0.671 . . . . 24.140000000000001 113.82 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.53 117.45 16.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.333 0.587 . . . . 71.010000000000005 111.638 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.6 123.53 35.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 111.426 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -141.38 164.57 29.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.972 0.415 . . . . 44.020000000000003 111.582 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.04 123.5 2.72 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.289 -0.482 . . . . 64.040000000000006 113.435 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -132.56 138.72 47.56 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.529 -0.395 . . . . 73.409999999999997 111.022 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.5 122.03 23.25 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.011 0.434 . . . . 74.239999999999995 111.642 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.27 124.46 3.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.048 0.451 . . . . 75.430000000000007 112.094 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.29 46.15 1.4 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.049 -0.523 . . . . 73.150000000000006 110.826 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.42 29.58 15.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.394 0.616 . . . . 72.109999999999999 111.042 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 19.56 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.883 0.697 . . . . 53.530000000000001 112.883 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -91.23 23.52 3.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.176 0.512 . . . . 74.540000000000006 110.677 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -75.37 159.06 31.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.421 0.629 . . . . 72.109999999999999 112.482 -176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 t -150.2 115.82 5.53 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.661 -0.7 . . . . 74.099999999999994 110.419 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -155.62 116.28 2.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.501 -0.318 . . . . 74.430000000000007 111.848 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.11 105.22 1.79 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.283 1.988 . . . . 73.310000000000002 112.131 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -60.58 128.33 36.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 64.409999999999997 111.342 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -53.36 140.88 25.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.97 0.414 . . . . 64.340000000000003 111.628 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -67.83 86.88 0.23 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.443 0.639 . . . . 72.549999999999997 111.858 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -75.73 114.24 14.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.697 -0.683 . . . . 60.240000000000002 111.204 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 p -68.97 -28.92 67.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.197 0.522 . . . . 71.540000000000006 110.976 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -152.04 137.77 17.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.969 -0.559 . . . . 74.400000000000006 111.523 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -96.72 8.87 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.14 0.495 . . . . 74.030000000000001 111.195 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -83.32 13.16 4.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 75.25 112.01 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 t -148.42 163.35 37.4 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.296 0.238 . . . . 74.319999999999993 111.16 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -153.86 -52.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.913 0.387 . . . . 65.420000000000002 111.932 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.67 88.16 1.7 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.114 -0.565 . . . . 71.349999999999994 112.792 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -84.54 116.46 23.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.604 -0.351 . . . . 73.239999999999995 110.928 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 69.9 m -145.33 142.02 29.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 73.420000000000002 112.651 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 51' ' ' LEU . . . -167.24 125.8 1.33 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.581 -0.736 . . . . 63.240000000000002 109.855 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -60.07 94.59 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.135 0.493 . . . . 55.450000000000003 111.725 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 49' ' ' ALA . 85.6 mt -95.94 20.86 9.39 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.775 -0.648 . . . . 71.109999999999999 111.242 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.89 -179.68 3.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.576 0.227 . . . . 73.420000000000002 111.111 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t -127.54 151.17 49.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 112.257 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 112.76 4.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.928 -0.578 . . . . 74.030000000000001 111.804 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.55 7.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.345 -0.455 . . . . 55.039999999999999 112.703 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -115.5 144.47 43.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.123 0.487 . . . . 73.200000000000003 111.584 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.1 p -58.03 -46.24 85.64 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.311 -0.404 . . . . 24.530000000000001 111.541 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -51.52 -45.35 62.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.093 0.405 . . . . 75.019999999999996 112.093 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -54.79 -48.66 72.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.96 -0.564 . . . . 75.549999999999997 111.744 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -68.79 -49.84 55.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 112.096 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 57' ' ' CYS . 58.0 t -58.18 -40.5 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.57 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' A' ' 48' ' ' SER . 92.4 t80 -55.97 -41.76 75.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.175 -0.466 . . . . 70.299999999999997 111.553 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.02 -43.0 68.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.372 -0.376 . . . . 71.019999999999996 111.447 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -61.32 -34.48 75.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.018 0.377 . . . . 70.25 112.018 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -86.22 6.55 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-O 121.358 0.599 . . . . 72.25 111.072 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.37 18.48 60.93 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 113.833 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 16.95 67.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.16 -0.543 . . . . 64.120000000000005 113.949 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -78.88 7.08 7.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 117.455 0.628 . . . . 72.430000000000007 112.463 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.29 -37.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.528 0.566 . . . . 72.400000000000006 112.528 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.17 102.56 2.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.967 -0.635 . . . . 71.109999999999999 112.013 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -61.34 -18.06 56.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.742 0.645 . . . . 74.310000000000002 112.742 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 t -57.24 -15.94 7.15 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.701 0.63 . . . . 62.119999999999997 112.701 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -57.97 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.255 0.55 . . . . 74.299999999999997 110.825 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.25 -103.21 0.56 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.805 -0.634 . . . . 63.350000000000001 114.613 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -57.37 134.91 56.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.112 0.412 . . . . 65.209999999999994 112.112 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.62 -11.78 47.54 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 51.200000000000003 113.04 -173.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.37 -10.97 36.21 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.957 174.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -93.35 -27.49 16.74 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.097 0.406 . . . . 75.120000000000005 112.097 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -41.34 -58.04 1.97 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.854 1.057 . . . . 74.530000000000001 113.854 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.9 91.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.917 -0.49 . . . . 52.32 111.975 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -57.69 -51.81 68.01 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.168 0.509 . . . . 54.310000000000002 111.618 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.93 97.69 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.37 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.48 -57.02 11.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.953 0.406 . . . . 35.520000000000003 111.26 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 t -57.5 -44.41 84.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.082 0.468 . . . . 33.32 111.39 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 t -70.85 -21.21 62.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 112.225 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.79 -10.06 32.64 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.205 0.446 . . . . 42.030000000000001 112.205 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.65 8.73 29.96 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.919 -0.657 . . . . 70.530000000000001 113.827 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HD2' ' HA ' ' A' ' 154' ' ' LEU . 71.3 m-85 -83.81 166.94 17.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.439 -0.447 . . . . 72.329999999999998 111.329 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 90.5 m -100.5 92.73 5.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.114 0.483 . . . . 62.039999999999999 111.923 -173.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.3 98.8 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 111.299 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -126.77 176.49 7.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.513 -0.312 . . . . 73.530000000000001 110.632 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -93.39 25.42 3.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.931 0.396 . . . . 62.520000000000003 111.275 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 t -81.89 108.14 10.44 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 111.458 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.5 19.11 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.04 2.494 . . . . 71.400000000000006 114.278 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -54.96 142.82 28.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 111.726 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.92 146.13 53.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.471 0.545 . . . . 71.140000000000001 112.471 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.98 10.09 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.17 -0.538 . . . . 73.430000000000007 113.031 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.4 p -136.62 169.08 18.29 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.5 -0.412 . . . . 73.310000000000002 111.167 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -110.14 134.6 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.626 -0.261 . . . . 71.140000000000001 110.302 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.5 pt? -112.99 131.24 55.84 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.247 0.546 . . . . 72.409999999999997 111.443 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.449 ' HG2' HG23 ' A' ' 103' ' ' THR . 29.7 tt0 -105.96 129.0 54.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.524 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -91.58 -37.82 12.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.773 0.656 . . . . 75.140000000000001 112.773 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 101' ' ' GLN . 26.3 p 60.58 10.35 2.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 113.128 0.788 . . . . 70.230000000000004 113.128 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.28 -67.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.147 0.795 . . . . 52.450000000000003 113.147 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.13 176.57 37.69 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.795 -0.717 . . . . 61.340000000000003 113.132 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.02 52.57 52.02 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.451 -0.404 . . . . 52.219999999999999 113.44 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 65.84 17.54 10.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.767 0.427 . . . . 74.120000000000005 112.113 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.69 -161.44 22.9 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.317 -0.468 . . . . 44.329999999999998 113.5 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -173.5 136.99 0.62 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.417 0.287 . . . . 71.299999999999997 110.92 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.9 151.52 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.33 -0.395 . . . . 51.340000000000003 111.408 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.78 167.37 25.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.466 -0.333 . . . . 72.430000000000007 110.99 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -102.88 131.44 49.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.894 0.378 . . . . 60.439999999999998 111.202 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 124' ' ' VAL . 60.9 t -81.89 112.29 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.297 -0.41 . . . . 74.450000000000003 111.539 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -80.13 -56.02 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.878 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.19 144.05 23.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.757 0.651 . . . . 63.310000000000002 112.757 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.47 136.25 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.745 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.17 147.33 24.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.399 -0.188 . . . . 41.340000000000003 110.925 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -57.71 -34.84 69.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.934 0.346 . . . . 65.109999999999999 111.934 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.59 -9.23 40.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.464 0.542 . . . . 64.209999999999994 112.464 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.56 0.41 46.47 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.367 -0.444 . . . . 74.230000000000004 113.757 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 m -77.53 142.07 39.26 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.747 0.308 . . . . 72.519999999999996 111.626 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.8 t -113.19 115.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 111.558 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.84 118.63 29.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.392 . . . . 63.119999999999997 111.326 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 113' ' ' VAL . 34.1 m -124.8 148.18 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.043 0.449 . . . . 62.409999999999997 111.924 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.0 m -102.89 116.04 31.78 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.068 0.461 . . . . 51.350000000000001 111.079 175.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.43 -168.24 1.29 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 111.246 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.0 ttm -144.48 114.41 7.33 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.948 0.404 . . . . 64.140000000000001 110.763 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -130.62 -79.35 0.54 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.384 -0.371 . . . . 63.329999999999998 111.122 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -152.28 116.67 5.0 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.198 0.444 . . . . 64.140000000000001 112.198 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 135' ' ' SER . 9.5 p30 171.96 151.23 0.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 71.230000000000004 110.213 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.46 -95.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.464 -0.398 . . . . 71.129999999999995 113.996 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.22 -169.53 14.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.626 -0.321 . . . . 74.099999999999994 112.968 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.88 0.36 5.1 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.962 2.441 . . . . 74.430000000000007 113.664 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -122.16 0.15 9.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.692 0.282 . . . . 70.400000000000006 111.42 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' ASN . 68.6 m -81.34 141.68 33.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.363 0.601 . . . . 64.510000000000005 111.799 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.91 146.16 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.941 -0.572 . . . . 73.209999999999994 112.27 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -118.42 117.49 29.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.317 -0.401 . . . . 64.299999999999997 109.972 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.95 156.35 18.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.206 0.527 . . . . 75.0 112.373 -172.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -152.1 130.85 12.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.466 . . . . 71.209999999999994 111.604 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 m -99.13 98.7 9.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.082 0.467 . . . . 71.310000000000002 110.209 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.72 134.76 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 112.231 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.8 m -67.99 148.59 50.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.598 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.87 -44.95 63.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.446 0.536 . . . . 50.140000000000001 112.446 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.75 76.56 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 73.519999999999996 113.017 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.97 -34.02 75.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.866 0.365 . . . . 70.430000000000007 111.557 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.82 66.79 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.174 0.511 . . . . 64.5 111.859 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 t -67.67 -3.64 9.72 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.403 0.52 . . . . 65.319999999999993 112.403 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -93.28 -0.3 56.78 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.965 0.412 . . . . 75.549999999999997 111.622 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -118.77 153.42 34.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.535 0.569 . . . . 75.409999999999997 112.535 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.2 m-80 -101.4 116.14 32.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.797 -0.638 . . . . 63.140000000000001 110.526 176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -94.85 112.68 24.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.230000000000004 111.91 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -81.06 127.23 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.076 0.465 . . . . 53.149999999999999 111.345 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 62.0 m-70 -111.1 133.15 53.7 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.548 -0.538 . . . . 73.349999999999994 109.548 174.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 88' ' ' TYR . 48.0 mt -84.29 -15.71 45.71 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.248 0.462 . . . . 65.439999999999998 112.248 -171.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 122.99 0.516 . . . . 33.340000000000003 111.929 -175.554 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.414 0.524 . . . . 65.010000000000005 112.414 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.58 148.45 46.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.996 0.427 . . . . 71.409999999999997 112.06 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.57 101.14 13.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.163 -0.471 . . . . 74.239999999999995 111.396 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.34 18.58 9.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.3 0.572 . . . . 71.040000000000006 110.583 175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.78 122.43 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.762 -0.653 . . . . 73.420000000000002 111.253 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -135.91 91.05 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.909 0.385 . . . . 65.109999999999999 110.866 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.58 106.04 16.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.057 0.456 . . . . 70.439999999999998 111.55 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.4 t -156.79 178.69 10.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.961 0.41 . . . . 73.129999999999995 111.679 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -142.77 146.65 34.46 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.234 -0.439 . . . . 72.310000000000002 111.666 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.33 170.68 5.64 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.25 -0.432 . . . . 71.049999999999997 111.348 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.2 m -72.93 91.92 1.58 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.889 0.376 . . . . 53.43 110.862 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 83.89 1.41 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.297 0.57 . . . . 73.129999999999995 111.69 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.55 83.97 1.21 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.088 -0.577 . . . . 74.219999999999999 112.878 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -61.59 110.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.384 0.612 . . . . 72.030000000000001 111.041 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 67.23 3.19 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.202 -0.523 . . . . 60.119999999999997 113.32 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.42 26.64 4.23 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.843 0.354 . . . . 75.540000000000006 111.757 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.4 100.08 10.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.028 0.381 . . . . 71.219999999999999 112.028 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.92 125.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.439 -0.346 . . . . 71.510000000000005 110.561 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.73 130.63 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.450000000000003 111.586 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.03 110.12 0.73 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.507 -0.377 . . . . 75.209999999999994 112.856 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pp -95.89 171.66 8.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.069 0.461 . . . . 71.109999999999999 111.97 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.56 164.27 30.68 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.236 0.541 . . . . 74.430000000000007 112.189 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -114.31 136.45 52.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.105 -0.498 . . . . 75.200000000000003 110.589 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.24 133.78 7.17 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.721 -0.752 . . . . 75.450000000000003 113.625 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 50.09 85.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.19 0.596 . . . . 75.239999999999995 112.558 176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.39 100.67 9.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 111.423 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.78 147.86 13.72 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.231 -0.441 . . . . 43.310000000000002 111.63 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -152.32 158.08 42.24 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.96 0.409 . . . . 75.340000000000003 111.336 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.92 109.15 4.47 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 110.543 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.54 107.54 7.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.57 0.582 . . . . 62.399999999999999 112.57 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -76.16 86.75 3.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.225 0.536 . . . . 75.25 109.805 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -171.28 -179.82 2.76 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.852 -0.613 . . . . 71.439999999999998 111.19 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.3 p -64.44 131.24 46.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.266 -0.424 . . . . 65.25 110.064 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.38 145.95 85.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.647 -0.251 . . . . 73.049999999999997 111.512 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.09 95.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.819 2.346 . . . . 71.400000000000006 113.203 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 p -86.88 77.2 9.3 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.332 0.587 . . . . 73.030000000000001 111.284 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -78.05 107.67 10.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 110.393 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -50.21 -42.31 51.31 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.205 0.446 . . . . 71.120000000000005 112.205 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -105.62 97.01 6.9 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.752 0.311 . . . . 64.140000000000001 110.884 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.1 m -60.5 90.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.159 0.504 . . . . 61.210000000000001 111.674 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -162.05 178.15 9.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.312 -0.404 . . . . 71.230000000000004 111.148 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -173.27 3.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.864 0.364 . . . . 75.239999999999995 111.536 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.0 p -157.49 -177.69 6.78 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.917 0.389 . . . . 74.040000000000006 111.426 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -78.94 104.13 9.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.917 0.389 . . . . 71.409999999999997 111.237 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.0 p -87.0 119.13 26.88 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.008 0.433 . . . . 72.25 111.777 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.21 -104.07 1.49 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.312 -0.471 . . . . 63.149999999999999 113.097 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -121.26 173.63 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.259 0.552 . . . . 71.200000000000003 111.698 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 p -100.52 -39.68 7.81 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.002 -0.544 . . . . 70.340000000000003 111.329 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.69 165.58 23.4 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.393 -0.367 . . . . 75.019999999999996 111.665 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -66.63 111.19 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.247 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.61 -13.58 59.76 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.293 0.479 . . . . 42.439999999999998 112.293 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -86.08 179.2 7.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.067 0.46 . . . . 72.140000000000001 111.909 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.4 t -129.35 151.66 49.74 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 73.219999999999999 111.934 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.68 138.18 42.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 72.349999999999994 111.738 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.79 -28.51 13.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.283 -0.484 . . . . 71.549999999999997 112.753 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -80.3 136.73 36.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.269 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.2 p -59.14 -41.28 87.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.073 171.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.5 p -52.57 -43.8 65.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.455 -0.793 . . . . 72.109999999999999 111.968 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -55.95 -52.31 64.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 112.022 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.63 -47.34 72.91 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.983 0.421 . . . . 72.010000000000005 111.702 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 57' ' ' CYS . 96.9 t -60.97 -34.52 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.555 -0.293 . . . . 65.219999999999999 111.706 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -54.69 -46.81 74.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 111.41 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 110.892 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 64' ' ' LYS . 29.3 mmmt -61.98 -31.73 72.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.155 -0.475 . . . . 63.509999999999998 112.202 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 154' ' ' LEU . 7.6 p -91.24 6.22 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.449 0.642 . . . . 55.350000000000001 111.164 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 10.26 72.04 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.299 -0.41 . . . . 64.120000000000005 113.959 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.14 15.75 72.43 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.002 -0.618 . . . . 64.200000000000003 114.032 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.43 ' HB2' HD13 ' A' ' 154' ' ' LEU . 40.2 m-80 -82.79 28.28 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.316 0.558 . . . . 72.120000000000005 111.99 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.76 161.78 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.131 0.491 . . . . 61.509999999999998 111.523 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.1 78.03 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.999 -0.619 . . . . 52.43 112.558 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -49.18 -28.18 4.24 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.571 0.582 . . . . 43.219999999999999 112.571 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -60.73 -18.03 52.08 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.873 0.694 . . . . 53.130000000000003 112.873 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -56.05 -32.95 64.53 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.942 0.401 . . . . 74.099999999999994 111.617 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.9 2.02 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.261 -0.427 . . . . 62.409999999999997 114.092 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.88 133.78 48.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 71.319999999999993 112.452 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.41 61.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.228 0.825 . . . . 65.230000000000004 113.228 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -67.05 -34.47 77.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.939 0.4 . . . . 73.409999999999997 112.047 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -71.26 -29.34 64.97 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.337 0.495 . . . . 60.130000000000003 112.337 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -43.38 -60.27 1.78 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.619 0.97 . . . . 73.310000000000002 113.619 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.43 86.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.45 0.537 . . . . 73.329999999999998 112.45 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 t -65.03 -55.02 21.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.941 0.401 . . . . 61.450000000000003 111.438 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.77 74.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.443 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.32 -49.02 77.44 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.629 -0.259 . . . . 62.509999999999998 111.291 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.7 p -66.51 -29.55 69.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.029 0.442 . . . . 74.319999999999993 111.119 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -76.79 -31.36 56.95 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.128 -0.487 . . . . 44.420000000000002 111.798 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.46 -24.48 24.12 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.156 0.428 . . . . 71.239999999999995 112.156 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.82 4.31 19.23 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.048 -0.596 . . . . 51.109999999999999 113.881 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.546 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 18.4 m-85 -69.23 168.49 14.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.467 . . . . 74.340000000000003 111.288 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.6 m -101.19 97.94 8.41 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.07 0.396 . . . . 75.120000000000005 112.07 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 152' ' ' ILE . 41.6 t -102.49 96.52 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.002 0.429 . . . . 73.150000000000006 111.316 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -122.66 172.31 8.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.891 0.377 . . . . 72.530000000000001 110.96 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -86.56 2.52 47.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.654 0.264 . . . . 71.530000000000001 111.305 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -62.8 113.75 10.1 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 116.52 -0.309 . . . . 72.420000000000002 110.761 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.415 ' HB2' HG22 ' A' ' 122' ' ' VAL . 90.0 Cg_endo -82.27 8.16 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.643 2.229 . . . . 72.519999999999996 113.973 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.32 138.62 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.328 0.492 . . . . 53.329999999999998 112.328 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.08 156.98 4.93 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.718 0.636 . . . . 70.430000000000007 112.718 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.46 33.38 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.111 -0.566 . . . . 74.349999999999994 112.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.2 p -138.31 176.64 8.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 73.010000000000005 111.115 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.71 121.78 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.36 -0.382 . . . . 53.32 110.889 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -100.62 136.66 40.15 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.692 -0.63 . . . . 71.129999999999995 111.636 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -101.99 124.99 48.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.868 -0.605 . . . . 75.230000000000004 111.46 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 31.2 t -90.09 -22.4 21.81 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.246 0.461 . . . . 52.549999999999997 112.246 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 p 66.82 -59.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.23 1.012 . . . . 74.420000000000002 113.639 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.89 10.81 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.555 1.317 . . . . 70.519999999999996 114.555 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.63 43.02 3.19 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.726 -0.609 . . . . 71.349999999999994 113.391 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 -77.7 0.4 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.527 -0.368 . . . . 55.32 113.127 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -97.24 20.45 11.44 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.293 0.568 . . . . 74.030000000000001 110.316 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.02 171.88 44.69 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.881 -0.6 . . . . 73.510000000000005 111.834 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 58.4 t60 -157.59 135.47 10.76 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.345 -0.503 . . . . 75.239999999999995 110.74 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.73 142.1 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.073 0.463 . . . . 44.100000000000001 111.389 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -139.44 156.69 46.79 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.243 -0.435 . . . . 43.450000000000003 110.837 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.71 133.14 38.7 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.832 0.349 . . . . 63.109999999999999 111.279 -176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.45 116.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.858 0.361 . . . . 44.439999999999998 111.836 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.72 -54.96 3.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.957 0.408 . . . . 71.319999999999993 112.01 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.76 145.2 30.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.265 0.555 . . . . 72.239999999999995 112.004 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.61 133.74 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.03 -0.532 . . . . 42.299999999999997 111.464 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' SER . 33.9 m-80 -76.87 152.25 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.406 -0.361 . . . . 63.240000000000002 110.556 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.1 m -47.22 -40.73 16.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.337 0.866 . . . . 72.310000000000002 113.337 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.55 -23.39 61.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.37 0.507 . . . . 70.549999999999997 112.37 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.44 -0.94 9.54 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.163 -0.541 . . . . 63.420000000000002 113.38 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 19.2 m -65.41 118.78 9.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.168 0.509 . . . . 72.239999999999995 110.952 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.42 HG21 ' OH ' ' A' ' 151' ' ' TYR . 40.4 t -96.35 121.97 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.805 -0.634 . . . . 51.509999999999998 112.392 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -96.35 105.25 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.342 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 m -97.08 163.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.423 0.527 . . . . 73.109999999999999 112.423 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -115.51 119.19 35.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.922 -0.581 . . . . 64.140000000000001 111.028 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.8 177.2 6.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.024 0.44 . . . . 63.549999999999997 111.512 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.5 ttm -138.23 149.72 46.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.497 -0.32 . . . . 63.399999999999999 110.45 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 74.39 -27.67 0.19 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.352 0.661 . . . . 72.439999999999998 112.172 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.73 -175.42 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.933 0.493 . . . . 74.209999999999994 110.154 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -44.96 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.173 0.511 . . . . 73.319999999999993 112.237 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 165.16 -52.36 0.27 Allowed Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.848 -0.614 . . . . 32.32 112.818 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.83 175.45 14.65 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.979 -0.629 . . . . 61.140000000000001 113.925 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 135' ' ' SER . 38.9 Cg_endo -65.58 128.69 20.65 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.982 2.455 . . . . 72.239999999999995 112.411 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.84 -23.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.758 0.651 . . . . 73.239999999999995 112.758 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 133' ' ' PRO . 67.2 m -69.46 141.28 54.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.293 0.568 . . . . 61.32 111.438 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.56 122.09 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.864 -0.607 . . . . 54.509999999999998 112.045 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.0 t -91.92 151.87 20.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.794 -0.639 . . . . 71.099999999999994 110.634 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -125.69 103.76 8.0 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.191 0.519 . . . . 70.5 111.695 -174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.06 105.07 16.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.168 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 88.2 m -79.17 104.14 9.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.041 0.448 . . . . 64.340000000000003 110.65 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 149' ' ' TYR . 73.2 mt -92.57 112.44 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.105 -0.498 . . . . 72.200000000000003 111.599 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.4 m -61.07 153.26 25.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.24 0.459 . . . . 75.109999999999999 112.24 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.79 -48.65 41.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.876 0.695 . . . . 74.430000000000007 112.876 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.14 -38.05 88.35 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.175 -0.536 . . . . 52.509999999999998 113.316 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -72.9 -37.35 67.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.963 0.411 . . . . 65.310000000000002 111.669 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.69 -23.91 67.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.911 0.708 . . . . 63.119999999999997 112.911 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 m -54.87 -17.29 3.42 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.845 1.054 . . . . 71.439999999999998 113.845 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.4 t -99.11 -13.94 19.6 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.155 0.798 . . . . 75.25 113.155 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 141' ' ' ILE . 31.4 m-85 -88.7 143.74 26.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.564 0.697 . . . . 75.239999999999995 112.866 -173.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 86.8 m-20 -100.09 116.35 31.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.613 -0.721 . . . . 72.040000000000006 111.071 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' A' ' 122' ' ' VAL . 64.0 m-85 -98.26 118.18 34.33 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.002 0.371 . . . . 64.299999999999997 112.002 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.573 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -84.66 131.99 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.432 -0.349 . . . . 74.150000000000006 110.595 174.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -121.58 148.65 44.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.703 0.401 . . . . 70.099999999999994 110.056 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.583 HD11 HG22 ' A' ' 65' ' ' VAL . 50.4 mt -93.17 132.08 37.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.406 0.622 . . . . 71.430000000000007 112.598 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 CA--C 1.545 0.78 0 CA-C-N 115.912 -0.585 . . . . 60.030000000000001 112.174 177.129 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.969 0.414 . . . . 72.109999999999999 111.209 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -145.25 134.96 23.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.848 0.356 . . . . 72.420000000000002 110.662 -178.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -114.54 98.99 7.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.309 0.576 . . . . 73.040000000000006 112.4 -174.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tt -104.59 101.0 10.66 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.112 -0.699 . . . . 54.0 109.112 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.08 115.01 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.29 0.567 . . . . 72.329999999999998 111.594 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -81.62 50.07 1.43 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.324 0.583 . . . . 64.109999999999999 111.483 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.87 67.02 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 62.329999999999998 111.739 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -105.23 93.56 4.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.044 0.449 . . . . 50.009999999999998 110.616 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -93.1 139.63 30.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.249 -0.432 . . . . 71.430000000000007 110.833 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.0 mp -92.61 38.11 1.01 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 111.808 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 m -66.26 94.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.459 -0.337 . . . . 62.240000000000002 111.59 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.48 125.24 0.5 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.386 -0.37 . . . . 72.310000000000002 111.397 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.5 101.87 0.17 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 113.035 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -86.6 123.21 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.847 0.356 . . . . 73.209999999999994 110.888 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.62 18.92 7.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.392 -0.432 . . . . 64.230000000000004 112.839 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.76 102.69 10.94 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.993 0.368 . . . . 51.340000000000003 111.993 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.58 90.69 0.95 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.986 0.422 . . . . 55.539999999999999 111.301 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -92.56 156.06 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 60.240000000000002 111.743 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.96 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.932 0.396 . . . . 72.340000000000003 111.107 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.45 93.17 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.267 -0.492 . . . . 52.200000000000003 112.969 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.76 82.9 2.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.215 0.531 . . . . 73.25 110.691 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -83.26 169.37 15.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.108 -0.497 . . . . 72.430000000000007 111.918 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.94 176.83 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.897 0.38 . . . . 74.010000000000005 111.9 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.03 78.97 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.899 -0.667 . . . . 64.430000000000007 113.321 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -94.27 95.38 8.88 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.481 -0.423 . . . . 65.010000000000005 110.561 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.66 113.73 13.94 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.233 0.457 . . . . 73.230000000000004 112.233 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.67 92.09 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.714 0.293 . . . . 62.409999999999997 111.781 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.75 138.92 39.01 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.87 0.366 . . . . 73.140000000000001 111.311 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 0.92 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.894 0.378 . . . . 62.25 111.859 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.84 88.75 2.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.995 0.426 . . . . 75.200000000000003 111.144 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -96.8 123.95 40.64 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.233 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -117.17 123.27 46.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.846 0.355 . . . . 53.439999999999998 111.477 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.0 m -157.15 114.27 3.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.751 0.31 . . . . 64.239999999999995 111.558 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 76.2 mt-30 -115.56 132.43 23.13 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 120.637 0.256 . . . . 63.140000000000001 111.583 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 17.0 Cg_exo -68.01 125.35 12.95 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.705 2.27 . . . . 60.509999999999998 111.847 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.2 p -51.53 -68.05 0.2 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.688 0.996 . . . . 65.430000000000007 113.688 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.7 125.91 29.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.247 0.546 . . . . 74.140000000000001 112.351 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.78 106.28 16.74 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.043 -0.526 . . . . 74.109999999999999 110.757 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m -102.56 32.12 3.76 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.843 0.312 . . . . 65.319999999999993 111.843 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.8 m -127.09 154.97 44.03 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.701 0.286 . . . . 72.329999999999998 111.37 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -56.7 126.43 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.805 0.442 . . . . 72.120000000000005 111.974 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -92.37 41.64 1.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.974 0.361 . . . . 72.219999999999999 111.974 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.3 m -76.88 89.66 3.48 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.417 0.627 . . . . 51.530000000000001 111.012 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -80.88 74.25 7.87 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.546 0.573 . . . . 61.310000000000002 112.546 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.9 p -134.51 8.83 3.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.508 0.559 . . . . 72.329999999999998 112.508 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.36 146.63 30.54 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.204 -0.522 . . . . 64.239999999999995 113.288 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.7 p -82.85 79.45 9.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.394 -0.474 . . . . 54.109999999999999 111.772 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -90.53 84.68 5.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.8 0.334 . . . . 75.200000000000003 110.45 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.02 137.71 8.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.174 0.512 . . . . 35.200000000000003 112.06 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -81.58 95.82 7.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.195 -0.457 . . . . 65.439999999999998 110.815 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.41 31.29 1.34 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.26 0.467 . . . . 74.109999999999999 112.26 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.509 ' HB3' ' OE1' ' A' ' 56' ' ' GLN . 20.0 m-85 -128.33 176.45 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.274 -0.266 . . . . 65.319999999999993 111.5 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.6 t -111.43 19.13 18.51 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.975 0.732 . . . . 73.420000000000002 112.975 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.99 152.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.175 0.512 . . . . 42.539999999999999 111.928 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' HA2' ' SD ' ' A' ' 127' ' ' MET . . . 82.82 -33.66 2.83 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.819 -0.705 . . . . 32.240000000000002 112.827 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 52' ' ' TYR . 95.5 mt-30 -62.5 139.83 58.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.382 0.273 . . . . 65.319999999999993 110.96 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.0 p -54.03 -45.88 71.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.072 0.463 . . . . 63.229999999999997 110.967 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.3 p -53.19 -43.47 67.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 112.022 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.422 ' HD1' ' HB2' ' A' ' 52' ' ' TYR . 89.1 t90 -56.94 -48.59 77.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.22 0.533 . . . . 72.019999999999996 111.188 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.66 -45.17 91.37 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.903 -0.59 . . . . 64.019999999999996 111.629 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 57' ' ' CYS . 64.3 t -60.46 -43.25 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.797 0.332 . . . . 71.299999999999997 111.415 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -55.04 -38.71 68.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.268 -0.423 . . . . 71.299999999999997 111.527 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.85 -48.81 34.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.834 0.35 . . . . 75.129999999999995 111.366 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -58.25 -36.52 73.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.362 0.505 . . . . 72.400000000000006 112.362 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 HD11 ' A' ' 154' ' ' LEU . 9.6 p -80.8 11.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.415 0.626 . . . . 72.120000000000005 111.42 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.13 19.44 66.04 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.294 -0.412 . . . . 73.420000000000002 113.581 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.53 24.14 61.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.26 -0.495 . . . . 71.140000000000001 113.716 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -86.8 9.94 17.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.301 -0.529 . . . . 72.430000000000007 111.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.82 148.85 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.979 0.419 . . . . 71.319999999999993 111.428 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.97 84.95 0.16 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 53.5 112.933 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.1 p -51.68 -21.12 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.447 0.536 . . . . 51.5 112.447 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.1 t -66.62 -2.13 4.5 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.787 0.662 . . . . 53.32 112.787 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -63.53 -22.83 67.11 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.07 0.396 . . . . 72.129999999999995 112.07 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.42 -131.73 10.87 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.173 -0.537 . . . . 70.049999999999997 113.729 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.82 154.98 40.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.415 0.626 . . . . 62.399999999999999 111.972 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -72.37 31.03 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 113.965 1.098 . . . . 52.310000000000002 113.965 -171.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -111.61 -18.25 12.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.249 0.547 . . . . 74.040000000000006 110.287 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -104.64 -0.17 27.85 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.935 -0.575 . . . . 60.450000000000003 112.067 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -66.96 -58.44 4.96 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.093 -0.379 . . . . 71.129999999999995 111.953 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 111.884 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.7 t -58.71 -51.37 70.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.945 0.402 . . . . 51.049999999999997 111.264 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.31 82.78 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.432 -0.349 . . . . 61.030000000000001 111.443 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -55.67 -52.88 62.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.519999999999996 111.273 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -62.78 -32.35 73.5 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.801 0.334 . . . . 65.109999999999999 111.602 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.9 t -76.48 -33.09 58.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.119 0.415 . . . . 74.510000000000005 112.119 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.88 -51.43 8.59 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.115 0.413 . . . . 72.129999999999995 112.115 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.29 24.7 0.08 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.831 -0.7 . . . . 63.109999999999999 113.818 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 28.5 m-85 -90.89 178.82 5.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.224 0.535 . . . . 75.430000000000007 111.293 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 91' ' ' ASN . 84.2 m -109.26 89.6 3.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.055 -0.52 . . . . 70.209999999999994 111.051 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.86 111.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.93 0.395 . . . . 63.32 111.648 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 89' ' ' THR . 6.0 m120 -135.61 177.14 8.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.99 0.424 . . . . 73.219999999999999 110.74 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.7 -0.05 57.29 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 110.815 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.5 m -67.86 114.24 19.16 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.802 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -85.75 12.35 3.07 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.074 2.516 . . . . 64.230000000000004 114.943 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.54 145.31 33.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.963 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.14 157.49 2.58 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.725 -0.67 . . . . 73.109999999999999 112.656 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.04 38.66 9.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.963 -0.637 . . . . 72.200000000000003 112.187 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.5 p -152.55 173.19 15.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.206 0.527 . . . . 51.130000000000003 111.79 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.16 124.38 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.636 -0.711 . . . . 71.439999999999998 110.786 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 1.6 pt? -91.81 137.38 32.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.932 -0.48 . . . . 52.020000000000003 111.244 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' OD1' ' A' ' 150' ' ' ASN . 27.3 tt0 -106.52 128.79 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.479 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 12.5 t -80.09 -56.87 3.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.979 0.733 . . . . 73.400000000000006 112.979 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 p 68.16 -53.46 0.53 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.221 1.008 . . . . 45.350000000000001 112.565 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.01 -28.91 26.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.973 0.731 . . . . 71.040000000000006 112.973 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.17 -2.27 13.17 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 114.413 0.525 . . . . 74.519999999999996 114.413 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.44 -65.63 3.82 Favored Glycine 0 CA--C 1.525 0.675 0 O-C-N 122.199 -0.589 . . . . 65.010000000000005 112.914 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.8 -0.4 13.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.994 0.426 . . . . 72.140000000000001 110.914 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.93 177.19 35.57 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.195 -0.526 . . . . 72.010000000000005 112.159 -170.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 19.6 t60 -175.0 138.32 0.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.748 0.309 . . . . 72.209999999999994 110.782 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.449 HG13 ' HB1' ' A' ' 76' ' ' ALA . 16.7 m -143.47 146.64 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 111.185 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.82 149.88 30.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.002 -0.545 . . . . 55.340000000000003 110.902 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -87.31 126.35 34.79 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.38 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 124' ' ' VAL . 54.4 t -70.44 111.7 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.059 0.392 . . . . 74.409999999999997 112.059 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.04 -44.98 36.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.944 0.402 . . . . 75.329999999999998 111.648 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.5 164.03 29.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 111.946 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.33 108.8 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.899 -0.591 . . . . 61.219999999999999 110.307 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.99 157.47 33.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.09 0.472 . . . . 63.219999999999999 111.959 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.8 m -61.29 -12.82 14.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.449 0.537 . . . . 70.439999999999998 112.449 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.97 -6.48 52.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.887 0.375 . . . . 63.240000000000002 111.705 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.14 -16.5 59.5 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.402 -0.428 . . . . 75.329999999999998 112.514 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -66.51 131.9 47.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.95 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.72 124.82 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.56 . . . . 72.010000000000005 111.475 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.89 111.43 23.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.928 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 113' ' ' VAL . 33.6 m -114.54 153.02 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.258 0.466 . . . . 74.109999999999999 112.258 -177.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -101.13 121.74 42.37 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.195 0.521 . . . . 53.520000000000003 111.437 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -127.68 124.16 37.24 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.896 -0.593 . . . . 72.219999999999999 111.329 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.486 ' SD ' ' HA2' ' A' ' 55' ' ' GLY . 44.5 ttm -65.82 112.41 3.73 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.943 -0.473 . . . . 72.129999999999995 110.457 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -138.24 -40.19 0.53 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.995 0.426 . . . . 64.319999999999993 111.765 -172.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.23 161.01 31.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.965 0.412 . . . . 45.450000000000003 111.579 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.87 116.79 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.442 -0.345 . . . . 73.25 111.034 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.85 -57.12 0.06 OUTLIER Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.831 -0.699 . . . . 75.329999999999998 113.086 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 164.56 -153.39 23.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.726 -0.75 . . . . 75.230000000000004 113.251 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.12 -21.31 21.6 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.039 2.493 . . . . 71.219999999999999 113.99 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.0 26.86 6.46 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.968 0.729 . . . . 72.219999999999999 112.968 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -86.74 72.36 10.19 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.162 0.982 . . . . 74.200000000000003 109.86 170.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 137' ' ' SER . 38.3 t -106.57 163.17 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.994 -1.003 . . . . 74.209999999999994 112.261 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 136' ' ' VAL . 88.5 p -122.38 140.43 52.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.833 -0.621 . . . . 74.329999999999998 110.288 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -96.14 103.88 15.8 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 74.209999999999994 110.161 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -103.57 105.8 16.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 111.626 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.2 m -87.71 104.93 17.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.794 0.33 . . . . 75.299999999999997 111.2 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.4 mt -93.38 140.28 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 122.494 0.317 . . . . 75.530000000000001 111.633 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.0 m -64.12 146.8 53.6 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.645 -0.252 . . . . 75.040000000000006 111.317 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.58 64.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.66 0.615 . . . . 74.430000000000007 112.66 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.61 -34.95 65.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.518 -0.372 . . . . 60.340000000000003 113.876 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.55 -35.29 17.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.964 0.412 . . . . 75.209999999999994 111.361 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.95 80.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.435 -0.348 . . . . 65.310000000000002 111.673 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.5 p -67.14 -8.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.863 0.363 . . . . 74.510000000000005 111.888 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.1 t -78.8 -11.82 60.0 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.093 0.473 . . . . 52.149999999999999 110.805 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 34.3 m-85 -106.16 135.11 48.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.054 -0.521 . . . . 72.400000000000006 110.316 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 101' ' ' GLN . 4.2 p-10 -82.11 129.69 34.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.995 0.426 . . . . 63.240000000000002 111.89 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -100.05 123.76 44.65 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.61 0.596 . . . . 73.030000000000001 112.61 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 80' ' ' ALA . 3.6 mp -86.5 123.95 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.135 -0.484 . . . . 72.120000000000005 110.576 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.2 149.64 35.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.547 0.339 . . . . 74.239999999999995 110.314 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 65' ' ' VAL . 24.7 mt -92.47 128.27 38.26 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.165 0.507 . . . . 72.340000000000003 111.427 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 111.834 -178.446 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 112.279 0.474 . . . . 74.420000000000002 112.279 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 56.17 83.63 0.09 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.307 0.575 . . . . 60.030000000000001 111.434 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -130.76 123.76 29.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.647 -0.706 . . . . 70.310000000000002 110.369 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -126.1 142.13 51.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.297 0.57 . . . . 70.310000000000002 112.173 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.41 -42.25 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 111.05 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.2 m 73.19 -55.01 0.69 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.269 0.627 . . . . 41.049999999999997 112.589 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.27 94.4 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.011 0.434 . . . . 72.430000000000007 111.368 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.5 p -87.85 124.51 33.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.007 0.432 . . . . 71.400000000000006 111.805 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 m -62.23 102.86 0.33 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.166 0.508 . . . . 53.140000000000001 111.457 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.88 174.86 6.74 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 111.956 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.4 m -136.4 128.22 29.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.565 -0.289 . . . . 63.240000000000002 111.41 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.49 143.41 32.55 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.934 0.397 . . . . 62.310000000000002 111.405 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.06 -109.6 0.41 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.169 -0.539 . . . . 74.129999999999995 113.027 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 pt 42.82 25.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 113.992 1.108 . . . . 60.25 113.992 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.82 98.23 1.97 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.069 -0.586 . . . . 72.450000000000003 112.86 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.29 135.86 8.22 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.591 -0.358 . . . . 75.420000000000002 111.818 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.19 147.91 13.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 72.340000000000003 111.937 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 pt -133.92 150.15 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.879 0.371 . . . . 72.439999999999998 111.699 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.27 163.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.109 0.48 . . . . 71.530000000000001 111.984 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.08 151.8 19.96 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 116.083 -0.508 . . . . 71.040000000000006 112.4 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.65 119.53 38.99 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.203 -0.586 . . . . 71.329999999999998 111.968 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.61 155.64 21.05 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 112.051 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -148.67 149.6 31.76 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.2 -0.455 . . . . 65.329999999999998 111.227 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.07 -132.97 1.42 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.257 -0.497 . . . . 31.010000000000002 112.844 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -163.26 -175.21 4.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.759 0.314 . . . . 55.310000000000002 111.436 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.68 -90.44 0.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 111.708 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.72 62.92 1.13 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.766 0.793 . . . . 54.409999999999997 109.998 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.14 9.12 2.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.342 -0.845 . . . . 75.040000000000006 112.817 -171.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 123.37 22.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.797 0.332 . . . . 73.540000000000006 111.022 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 92.72 2.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.134 0.492 . . . . 72.099999999999994 111.837 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.11 83.03 7.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.594 0.711 . . . . 62.119999999999997 111.517 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -86.03 3.67 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.528 -0.76 . . . . 51.039999999999999 110.784 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -95.51 156.48 16.31 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.08 0.467 . . . . 74.310000000000002 112.144 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.63 100.15 0.96 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.987 -0.551 . . . . 70.430000000000007 110.632 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.92 105.72 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.469 2.113 . . . . 41.219999999999999 113.063 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 t -86.74 -8.29 57.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.908 0.385 . . . . 51.030000000000001 111.478 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -70.72 141.46 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 70.239999999999995 111.501 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.04 -1.83 38.69 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.321 0.489 . . . . 63.450000000000003 112.321 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.6 p -68.36 90.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.029 0.442 . . . . 52.32 111.136 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.5 m 61.65 84.24 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.826 -0.625 . . . . 61.009999999999998 111.853 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 p -92.23 126.81 37.46 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.253 -0.431 . . . . 64.200000000000003 111.694 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -66.05 -48.8 69.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.726 0.298 . . . . 73.150000000000006 111.509 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.3 t -70.19 85.76 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.95 0.405 . . . . 72.209999999999994 111.077 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -90.69 121.26 32.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.324 -0.398 . . . . 74.019999999999996 110.972 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 98.9 p -66.44 140.46 58.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.999 0.428 . . . . 65.109999999999999 111.797 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.67 61.11 3.67 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.035 -0.603 . . . . 41.210000000000001 112.802 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -78.93 97.14 5.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.961 0.41 . . . . 55.109999999999999 110.746 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.8 t -108.0 110.18 21.83 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.113 0.482 . . . . 44.350000000000001 111.612 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.84 135.46 16.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.156 -0.475 . . . . 53.32 110.668 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -71.98 98.82 2.13 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.102 0.477 . . . . 54.25 110.603 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.89 18.74 1.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.619 0.599 . . . . 74.310000000000002 112.619 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.21 -174.72 2.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.268 0.556 . . . . 75.109999999999999 111.292 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -105.41 143.27 33.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.216 0.531 . . . . 52.310000000000002 112.148 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 140.67 45.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.986 -0.552 . . . . 63.399999999999999 112.062 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.54 -18.86 43.58 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.243 -0.503 . . . . 71.430000000000007 113.257 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.11 161.15 14.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.884 0.373 . . . . 75.430000000000007 111.754 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.452 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 59.6 m -63.22 -43.35 98.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.003 0.43 . . . . 73.219999999999999 111.878 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 74' ' ' GLY . 72.3 p -61.1 -25.51 67.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.573 0.583 . . . . 75.219999999999999 112.573 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.45 -63.88 1.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 38.9 p90 -66.52 -29.12 69.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.064 0.394 . . . . 71.549999999999997 112.064 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 57' ' ' CYS . 59.2 t -62.12 -45.05 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.95 0.405 . . . . 54.109999999999999 110.874 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -56.4 -34.1 66.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 111.086 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.35 -46.43 22.86 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.207 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HD3' HG11 ' A' ' 136' ' ' VAL . 28.9 mmmt -57.74 -32.64 67.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.079 0.4 . . . . 72.329999999999998 112.079 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 65' ' ' VAL . 8.0 p -91.52 13.18 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.3 0.571 . . . . 71.310000000000002 111.455 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.98 22.67 58.14 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 113.936 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.86 22.21 64.2 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.326 0.49 . . . . 73.519999999999996 114.326 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -83.35 12.0 6.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.488 0.644 . . . . 73.510000000000005 112.284 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.85 176.34 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.966 0.412 . . . . 70.019999999999996 111.744 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.17 115.75 8.44 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.164 -0.541 . . . . 73.099999999999994 113.621 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 p -75.41 0.87 15.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.592 0.59 . . . . 72.409999999999997 112.592 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 t -119.76 20.45 12.28 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.014 0.376 . . . . 73.209999999999994 112.014 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.83 -37.76 73.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.08 0.467 . . . . 75.129999999999995 111.386 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 58' ' ' THR . . . 67.29 -111.22 3.94 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.152 -0.477 . . . . 52.340000000000003 114.24 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.14 125.18 6.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.218 0.607 . . . . 71.519999999999996 112.522 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.12 60.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.287 0.477 . . . . 64.450000000000003 112.287 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -94.24 0.31 55.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.573 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.84 -12.9 16.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.545 0.338 . . . . 71.439999999999998 111.694 -176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -57.99 -33.69 69.18 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.463 0.912 . . . . 74.349999999999994 113.463 -172.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.79 64.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.898 0.38 . . . . 71.109999999999999 111.344 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -64.21 -43.72 94.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 111.128 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.11 96.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.413 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.76 -52.38 65.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.0 0.429 . . . . 75.349999999999994 110.633 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.0 t -58.8 -34.06 71.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 111.649 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 t -74.99 -25.71 59.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.819 0.342 . . . . 43.32 111.908 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.62 2.43 41.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.074 0.398 . . . . 65.349999999999994 112.074 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 41.55 14.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.325 -0.464 . . . . 74.239999999999995 113.943 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.448 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.5 m-85 -103.78 169.68 8.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.319 -0.518 . . . . 71.450000000000003 111.815 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.4 m -97.07 98.84 10.39 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.052 -0.522 . . . . 73.409999999999997 112.367 -171.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.43 103.19 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.151 0.501 . . . . 65.209999999999994 112.283 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -139.06 162.57 34.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.307 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -86.46 3.84 42.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.408 0.521 . . . . 75.340000000000003 112.408 -177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.0 m -57.25 113.13 5.59 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 110.542 -0.17 . . . . 73.430000000000007 110.542 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.94 -1.52 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.737 2.291 . . . . 75.129999999999995 114.577 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.71 139.57 9.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.874 0.694 . . . . 63.219999999999999 112.874 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.91 162.99 2.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.406 -0.816 . . . . 72.109999999999999 112.937 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.06 33.04 27.53 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.092 -0.575 . . . . 61.549999999999997 112.276 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.1 p -147.1 168.53 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.505 0.322 . . . . 71.430000000000007 110.834 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -115.7 124.44 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.345 -0.222 . . . . 74.310000000000002 110.659 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -96.95 134.97 39.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.326 0.584 . . . . 63.210000000000001 111.703 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -97.72 101.59 13.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 110.976 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 26.5 t -77.97 -30.07 50.08 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.851 -0.613 . . . . 64.409999999999997 111.923 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 30.2 p 67.54 -28.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.105 0.962 . . . . 72.209999999999994 113.444 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.47 102.8 1.51 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.815 -0.553 . . . . 61.539999999999999 111.872 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 155.05 45.99 0.02 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.936 -0.649 . . . . 62.229999999999997 113.613 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.56 -85.29 0.19 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.004 -0.617 . . . . 53.509999999999998 113.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -85.05 6.15 26.59 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.286 0.565 . . . . 74.409999999999997 110.973 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . 104.69 178.97 24.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.886 -0.597 . . . . 45.049999999999997 113.175 -178.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -149.1 131.34 15.51 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.591 -0.358 . . . . 64.510000000000005 110.86 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.79 149.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.171 -0.468 . . . . 71.510000000000005 110.392 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 61' ' ' VAL . . . -155.84 152.45 28.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.991 0.424 . . . . 62.530000000000001 111.984 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -80.8 129.08 34.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.272 -0.422 . . . . 63.149999999999999 110.811 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.24 102.68 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.216 0.531 . . . . 64.109999999999999 111.058 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.59 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 18.5 mm-40 -62.22 -58.1 9.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.459 -0.791 . . . . 71.420000000000002 111.289 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -161.67 148.47 14.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.846 -0.615 . . . . 75.310000000000002 111.361 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -115.15 137.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.309 . . . . 73.140000000000001 110.721 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -107.54 150.52 26.74 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.863 0.363 . . . . 61.43 111.762 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 m -61.53 -36.98 82.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.382 0.882 . . . . 61.219999999999999 113.382 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.19 -45.09 79.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.21 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.61 62.43 0.05 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.996 -0.621 . . . . 51.32 113.255 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.9 m -147.5 134.21 19.99 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.477 -0.425 . . . . 73.120000000000005 111.341 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 117.7 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.635 -0.711 . . . . 73.540000000000006 110.988 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.03 117.42 26.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.141 -0.481 . . . . 74.5 110.981 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.01 150.24 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.437 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.453 ' HB2' ' CG1' ' A' ' 136' ' ' VAL . 94.1 p -77.95 130.19 36.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.676 -0.693 . . . . 63.530000000000001 112.178 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -143.26 146.74 33.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.202 0.525 . . . . 75.239999999999995 112.306 174.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.411 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 57.3 tpp -99.54 156.48 17.03 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.077 -0.51 . . . . 72.540000000000006 110.264 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.411 ' OD1' ' HG3' ' A' ' 127' ' ' MET . 20.4 m120 59.31 40.63 21.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.447 0.642 . . . . 73.409999999999997 110.954 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 12.9 t80 -126.72 -171.23 2.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.06 -0.518 . . . . 74.329999999999998 110.563 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -43.86 100.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.951 0.723 . . . . 64.340000000000003 112.951 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 40.53 59.13 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 113.525 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.61 76.98 0.13 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.36 -0.924 . . . . 62.43 114.284 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.8 -42.49 0.32 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.414 2.076 . . . . 71.120000000000005 112.181 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -116.99 17.32 14.97 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.012 -0.54 . . . . 75.129999999999995 110.314 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.4 t -133.76 147.24 51.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.844 -0.616 . . . . 74.510000000000005 110.609 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 125' ' ' SER . 41.1 t -78.76 107.8 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.14 0.495 . . . . 63.130000000000003 111.95 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 129' ' ' TYR . 46.9 t -83.08 175.35 10.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.066 -0.515 . . . . 62.109999999999999 111.481 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 30.9 mt-10 -128.1 102.94 6.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.477 -0.329 . . . . 72.340000000000003 111.665 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -79.77 125.2 29.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.637 0.256 . . . . 64.530000000000001 110.631 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.9 m -91.33 99.54 12.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.99 0.424 . . . . 60.240000000000002 110.853 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.89 137.94 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.041 0.386 . . . . 73.120000000000005 112.041 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 52.5 m -61.6 151.5 33.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.941 0.4 . . . . 72.400000000000006 111.8 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.87 82.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.248 0.462 . . . . 72.439999999999998 112.248 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.13 74.79 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.418 -0.42 . . . . 51.530000000000001 113.426 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.96 -54.66 6.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.262 0.553 . . . . 71.150000000000006 111.129 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -61.48 -40.46 94.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.783 0.66 . . . . 54.240000000000002 112.783 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.3 p -62.07 -16.13 49.89 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.125 0.417 . . . . 43.210000000000001 112.125 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.8 t -76.69 -17.83 58.89 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.952 0.406 . . . . 73.319999999999993 111.317 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 16.8 m-85 -93.06 152.95 18.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.21 0.529 . . . . 71.120000000000005 111.847 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.04 132.17 35.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.035 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 94.5 m-85 -106.84 129.83 54.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.781 0.8 . . . . 74.129999999999995 112.807 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.76 112.08 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.294 -0.866 . . . . 62.049999999999997 110.798 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -106.2 141.38 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.954 0.407 . . . . 71.129999999999995 111.543 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.62 -40.61 8.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.088 -0.505 . . . . 54.100000000000001 111.181 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 . . . . . 0 N--CA 1.477 0.917 0 C-N-CA 123.031 0.532 . . . . 74.219999999999999 112.349 178.711 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.489 0.185 . . . . 52.420000000000002 111.464 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -76.1 104.99 6.89 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 72.409999999999997 110.856 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.517 ' HG3' ' HG ' ' A' ' 4' ' ' LEU . 5.2 tppp? -84.91 -61.73 1.71 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.345 -0.388 . . . . 54.409999999999997 111.678 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.517 ' HG ' ' HG3' ' A' ' 3' ' ' LYS . 93.2 mt -129.65 155.52 45.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.912 0.387 . . . . 55.229999999999997 111.331 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.46 131.03 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.993 0.425 . . . . 72.430000000000007 111.4 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.4 m -124.97 132.5 53.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 111.941 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.43 112.25 22.02 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.805 0.336 . . . . 62.009999999999998 110.684 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.0 p -108.53 -32.87 7.22 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.898 0.703 . . . . 72.219999999999999 112.898 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.41 ' C ' HD12 ' A' ' 10' ' ' LEU . 8.6 t -87.67 134.52 33.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.862 0.689 . . . . 62.130000000000003 112.862 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 9' ' ' THR . 7.2 mp -122.16 147.06 46.63 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.372 -0.376 . . . . 70.319999999999993 110.605 173.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.6 m -70.01 102.2 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 74.549999999999997 111.943 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.63 114.95 9.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.881 0.372 . . . . 34.030000000000001 111.164 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.83 -144.05 3.89 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.294 -0.479 . . . . 52.32 112.601 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 14' ' ' ILE . 20.6 pt -140.22 96.73 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.342 0.591 . . . . 63.32 111.707 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.19 54.65 1.56 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.002 -0.618 . . . . 62.420000000000002 113.316 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 119.61 19.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.903 0.334 . . . . 55.200000000000003 111.903 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.86 138.51 21.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.036 0.384 . . . . 73.510000000000005 112.036 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -129.95 128.17 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.543 0.337 . . . . 73.230000000000004 111.142 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.71 -78.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.896 0.702 . . . . 65.310000000000002 112.896 -174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.51 73.83 1.24 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.969 -0.634 . . . . 54.219999999999999 113.074 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -87.73 137.65 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.321 0.489 . . . . 72.299999999999997 112.321 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -169.7 132.67 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.081 -0.508 . . . . 61.140000000000001 110.933 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -171.07 136.31 1.07 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.826 0.346 . . . . 74.140000000000001 111.639 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 116.33 3.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.162 -0.542 . . . . 23.219999999999999 113.594 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -150.94 133.31 15.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.334 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -142.41 143.06 32.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.882 0.372 . . . . 55.329999999999998 111.315 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 90.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.945 0.402 . . . . 64.239999999999995 112.012 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -80.44 171.55 14.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 111.679 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.87 156.63 39.34 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.011 0.375 . . . . 61.130000000000003 112.011 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.84 86.8 0.05 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.873 0.368 . . . . 65.519999999999996 111.744 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.66 119.29 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.189 -0.319 . . . . 62.310000000000002 110.893 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -127.31 152.12 47.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.105 0.478 . . . . 61.240000000000002 111.804 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.3 p -111.72 150.96 29.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.082 -0.508 . . . . 71.140000000000001 110.87 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -130.68 159.79 69.39 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.486 -0.324 . . . . 73.310000000000002 111.249 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -72.8 30.47 0.29 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 122.752 2.301 . . . . 74.349999999999994 113.509 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.9 p -78.39 -171.66 2.53 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 72.319999999999993 110.975 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -73.42 -174.71 1.73 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 122.14 -0.35 . . . . 72.219999999999999 110.877 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -132.84 101.96 5.46 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.786 0.661 . . . . 73.420000000000002 112.786 -173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.8 m -79.58 160.73 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.202 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.6 t -87.76 143.83 26.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.397 -0.365 . . . . 60.32 110.048 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p 54.25 95.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.349 0.595 . . . . 62.520000000000003 111.37 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -81.47 165.4 21.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.966 0.412 . . . . 71.209999999999994 111.982 -173.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.7 m -60.94 123.52 17.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.331 -0.395 . . . . 75.319999999999993 110.691 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.8 p -57.62 -63.93 1.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.691 0.626 . . . . 74.120000000000005 112.691 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -161.33 135.92 7.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.912 0.387 . . . . 73.140000000000001 111.952 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.74 -178.27 50.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.264 -0.493 . . . . 62.109999999999999 112.207 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.0 m -143.12 148.46 36.65 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.151 -0.617 . . . . 74.25 111.641 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 m -90.33 -22.27 21.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.468 -0.333 . . . . 72.129999999999995 111.631 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 95.51 0.16 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.19 0.441 . . . . 73.430000000000007 112.19 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -88.36 142.06 28.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.902 0.382 . . . . 61.219999999999999 111.199 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.8 mt -94.76 15.79 17.46 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.307 0.484 . . . . 51.109999999999999 112.307 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.51 -174.21 2.44 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.067 0.46 . . . . 73.349999999999994 111.719 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 t -129.67 160.75 32.38 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.32 -0.4 . . . . 73.150000000000006 111.787 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 35.06 0.1 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.54 0.941 . . . . 63.149999999999999 113.54 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.68 4.72 1.27 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.221 -0.514 . . . . 63.229999999999997 113.556 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.69 147.04 42.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.997 0.399 . . . . 74.299999999999997 111.212 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 63.7 m -54.93 -31.52 60.44 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.209 0.528 . . . . 64.5 111.259 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.6 p -68.04 -18.15 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.039 0.755 . . . . 73.120000000000005 113.039 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -75.81 -71.22 0.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.942 0.719 . . . . 75.219999999999999 112.942 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.527 ' HB2' HG22 ' A' ' 136' ' ' VAL . 12.6 p90 -59.93 -18.42 45.08 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.384 0.883 . . . . 74.239999999999995 113.384 -171.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.13 -34.78 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.21 0.528 . . . . 73.209999999999994 110.749 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 72.7 t80 -56.94 -51.86 67.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.712 -0.676 . . . . 62.439999999999998 111.294 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.48 -42.77 92.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.324 -0.398 . . . . 71.340000000000003 111.602 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -66.33 -31.96 73.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.326 0.491 . . . . 55.119999999999997 112.326 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.86 9.69 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.475 0.655 . . . . 71.319999999999993 111.402 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.5 14.83 65.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.426 -0.416 . . . . 65.430000000000007 113.671 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.39 7.73 64.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.41 0.524 . . . . 72.140000000000001 114.41 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -78.45 35.05 0.22 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.263 0.532 . . . . 75.129999999999995 112.371 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.8 pt -121.44 -30.46 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.134 0.42 . . . . 73.219999999999999 112.134 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.31 9.44 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.07 -0.586 . . . . 53.039999999999999 113.289 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.526 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 53.2 p 59.6 4.8 0.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.287 0.847 . . . . 72.439999999999998 113.287 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -84.95 9.6 14.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.165 0.507 . . . . 55.219999999999999 111.571 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.4 m0 -79.36 -36.67 38.97 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.322 -0.399 . . . . 72.519999999999996 111.593 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.36 -122.63 6.02 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.023 -0.608 . . . . 64.439999999999998 113.964 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -51.6 141.44 16.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.421 0.526 . . . . 71.209999999999994 112.421 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -31.9 72.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.195 0.442 . . . . 63.439999999999998 112.195 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.38 1.93 20.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.807 0.337 . . . . 74.420000000000002 111.661 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.95 -6.97 12.58 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.132 0.419 . . . . 54.109999999999999 112.132 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.39 -56.47 21.62 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.682 0.623 . . . . 73.409999999999997 112.682 -176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.51 75.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 71.040000000000006 111.552 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.5 m -60.69 -52.53 64.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.977 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.21 78.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 111.196 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -58.38 8.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.512 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.6 p -58.89 -37.09 75.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.836 0.351 . . . . 70.030000000000001 111.735 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -71.52 -39.81 70.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.383 -0.371 . . . . 61.340000000000003 111.392 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.5 10.57 5.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.664 0.616 . . . . 54.450000000000003 112.664 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.94 66.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.012 -0.613 . . . . 64.329999999999998 114.334 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -76.79 164.3 25.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.514 0.657 . . . . 63.219999999999999 110.999 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.401 HG22 ' OD1' ' A' ' 91' ' ' ASN . 85.4 m -100.5 100.35 11.08 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 111.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 152' ' ' ILE . 48.1 t -108.83 119.88 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.773 0.32 . . . . 71.430000000000007 111.572 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 89' ' ' THR . 7.5 m120 -140.13 -176.15 4.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 111.19 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -97.57 4.07 50.37 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.182 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.6 m -67.71 114.1 18.06 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.274 -0.421 . . . . 65.450000000000003 110.439 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.69 22.9 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.968 2.445 . . . . 50.350000000000001 114.584 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.08 149.69 36.3 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.959 0.726 . . . . 71.329999999999998 112.959 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.38 163.06 4.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.71 -0.677 . . . . 53.140000000000001 112.467 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.63 34.53 73.09 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.947 -0.644 . . . . 71.109999999999999 112.626 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.1 m -139.01 165.83 26.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.654 0.264 . . . . 52.109999999999999 111.105 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -116.86 127.56 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 110.446 -0.205 . . . . 71.019999999999996 110.446 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.7 pt? -99.83 144.94 28.31 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.848 -0.533 . . . . 75.129999999999995 110.993 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -121.62 133.56 54.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.4 0.619 . . . . 63.020000000000003 112.536 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 29.7 t -112.36 115.58 28.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.35 -0.841 . . . . 65.310000000000002 110.657 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.7 p -91.99 13.9 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 52.329999999999998 111.593 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.39 -44.34 58.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.538 0.569 . . . . 65.030000000000001 112.538 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -96.34 72.11 0.83 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.184 -0.531 . . . . 74.219999999999999 114.295 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 48.31 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.736 0.654 . . . . 62.329999999999998 114.736 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.25 -23.75 65.88 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.095 0.558 . . . . 44.210000000000001 111.649 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.21 171.23 33.66 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.137 -0.554 . . . . 73.109999999999999 113.333 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 73.0 t60 -143.85 141.93 30.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.565 -0.374 . . . . 64.319999999999993 111.2 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 20.5 m -139.17 146.34 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.505 -0.316 . . . . 74.120000000000005 111.114 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.498 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -153.74 154.64 34.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.03 0.443 . . . . 71.099999999999994 112.125 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -91.18 121.21 32.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 111.535 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.65 114.33 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.03 0.381 . . . . 74.439999999999998 112.03 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 10.1 mm-40 -78.78 -56.69 4.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 111.635 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -149.46 141.66 24.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.411 0.523 . . . . 64.510000000000005 112.411 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.32 126.33 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 111.071 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -94.42 144.12 25.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.753 0.311 . . . . 72.519999999999996 111.093 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -60.91 -25.74 66.95 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.223 0.535 . . . . 75.340000000000003 111.549 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.49 -16.32 62.29 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.992 -0.549 . . . . 75.019999999999996 111.59 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.86 -14.98 37.67 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.28 -0.418 . . . . 42.219999999999999 112.952 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.1 m -66.68 120.99 14.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 64.409999999999997 111.499 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.57 116.93 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.306 0.574 . . . . 54.119999999999997 111.178 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.14 113.69 25.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 111.005 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.94 167.11 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.196 0.522 . . . . 65.109999999999999 112.146 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.1 t -108.01 105.59 15.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.096 -0.502 . . . . 44.329999999999998 111.088 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 137' ' ' SER . 5.8 pt-20 -141.69 118.58 11.16 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.27 -0.423 . . . . 53.130000000000003 111.382 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.1 ttm -67.4 117.19 9.04 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.218 -0.301 . . . . 53.530000000000001 110.703 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -114.69 -76.58 0.58 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 72.439999999999998 111.794 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -118.78 -52.3 2.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.408 -0.36 . . . . 74.129999999999995 111.535 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -124.11 148.9 46.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.624 -0.262 . . . . 51.210000000000001 110.72 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 163.26 -64.41 0.25 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.223 -0.513 . . . . 54.399999999999999 112.45 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.6 154.83 6.44 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.291 -0.48 . . . . 42.539999999999999 112.263 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.68 -36.37 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.749 2.299 . . . . 74.439999999999998 113.472 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -116.36 -5.84 11.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.906 0.384 . . . . 63.130000000000003 111.5 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -100.23 128.2 46.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.335 -0.393 . . . . 60.030000000000001 111.102 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 60' ' ' TYR . 14.7 t -95.11 139.53 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.839 0.352 . . . . 65.049999999999997 111.874 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 1.5 m -75.6 175.06 8.94 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.499 -0.318 . . . . 72.349999999999994 110.821 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 42.2 mt-10 -133.29 133.9 43.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 111.959 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -114.5 122.99 48.27 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.433 -0.348 . . . . 71.299999999999997 111.176 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.2 m -85.66 99.79 11.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.775 0.322 . . . . 64.019999999999996 110.505 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.9 mt -93.27 139.78 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.912 0.387 . . . . 73.530000000000001 111.925 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 m -69.17 150.78 47.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.338 -0.392 . . . . 71.409999999999997 111.734 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.93 -52.38 58.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.463 0.542 . . . . 74.310000000000002 112.463 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.28 -13.0 34.11 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.117 -0.492 . . . . 72.439999999999998 114.018 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -101.77 -49.81 3.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 110.959 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -56.88 -50.42 72.56 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.621 0.6 . . . . 74.530000000000001 112.621 -175.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 68.3 m -60.69 -9.52 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.064 0.764 . . . . 35.140000000000001 113.064 -177.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.0 t -83.37 -19.79 35.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.932 0.396 . . . . 64.230000000000004 111.548 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -85.91 161.58 18.98 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.155 0.502 . . . . 74.239999999999995 112.096 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.0 m-20 -89.29 117.76 28.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.493 -0.321 . . . . 73.430000000000007 111.265 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.417 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 93.7 m-85 -99.89 113.1 25.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.299 0.481 . . . . 74.129999999999995 112.299 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.7 mp -83.06 134.73 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.374 -0.376 . . . . 71.409999999999997 110.272 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -122.99 142.79 50.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.967 0.413 . . . . 63.130000000000003 111.354 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.7 mt -110.68 -37.69 5.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 111.796 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 63.530000000000001 111.579 -173.833 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HG3' ' HG3' ' A' ' 2' ' ' LYS . 14.0 ptp . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 112.352 0.501 . . . . 72.219999999999999 112.352 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 68.5 mttm -92.01 142.59 27.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.224 0.535 . . . . 63.350000000000001 112.257 -175.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -123.68 171.25 9.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.986 -0.552 . . . . 75.420000000000002 110.334 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.7 175.15 11.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 75.140000000000001 112.125 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.05 161.33 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.066 -0.516 . . . . 65.019999999999996 111.653 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.5 p -82.88 94.2 7.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.831 0.348 . . . . 60.549999999999997 111.165 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.33 117.35 32.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.503 0.557 . . . . 33.240000000000002 112.503 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -151.48 178.71 9.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.28 -0.418 . . . . 54.109999999999999 110.826 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -123.92 133.5 53.71 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 111.642 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 10' ' ' LEU . 2.6 pp -134.85 133.77 40.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.18 0.514 . . . . 63.219999999999999 110.696 173.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -107.01 123.71 48.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.372 0.508 . . . . 61.340000000000003 112.372 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 139.15 40.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.428 -0.351 . . . . 52.43 111.138 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 63.35 0.31 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.995 -0.621 . . . . 62.450000000000003 113.286 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.0 pt -96.74 155.03 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.506 -0.408 . . . . 75.510000000000005 111.531 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.3 92.23 0.09 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.868 -0.682 . . . . 71.340000000000003 113.24 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.99 107.31 19.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.973 0.416 . . . . 65.150000000000006 111.816 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.87 151.69 22.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 111.591 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.16 163.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.93 0.395 . . . . 73.450000000000003 111.583 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -97.39 100.14 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.892 0.377 . . . . 70.25 110.723 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.2 122.54 6.55 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.146 -0.55 . . . . 62.219999999999999 113.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.79 115.46 9.09 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.87 0.366 . . . . 71.420000000000002 110.157 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.15 136.9 32.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.903 0.382 . . . . 65.230000000000004 111.051 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -151.34 145.05 25.03 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.054 0.454 . . . . 71.120000000000005 112.086 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.61 167.1 26.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.056 -0.52 . . . . 63.509999999999998 112.515 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -151.73 112.91 4.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.396 0.517 . . . . 42.32 112.396 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -150.11 133.23 16.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.349 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.46 112.22 6.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 111.998 0.37 . . . . 64.010000000000005 111.998 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.86 112.64 24.31 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.913 0.387 . . . . 71.0 111.448 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.1 47.59 1.8 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.089 0.471 . . . . 54.109999999999999 110.553 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.62 109.1 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.836 -0.62 . . . . 62.520000000000003 112.408 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.59 87.06 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.01 -0.541 . . . . 72.329999999999998 111.32 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.57 95.64 10.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.1 -0.5 . . . . 63.350000000000001 111.103 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -89.65 1.36 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.266 0.555 . . . . 71.230000000000004 110.962 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 57.37 78.85 0.35 Allowed Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.336 -0.847 . . . . 74.230000000000004 112.238 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.72 100.21 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.638 2.225 . . . . 64.109999999999999 112.323 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.5 p -92.94 151.83 19.71 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 71.200000000000003 111.754 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.18 164.56 24.2 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.259 -0.428 . . . . 71.540000000000006 111.232 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -69.15 -40.02 78.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.863 0.363 . . . . 71.519999999999996 111.494 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -165.76 115.36 1.01 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.436 -0.347 . . . . 62.210000000000001 110.704 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -74.48 72.87 1.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.849 0.833 . . . . 64.230000000000004 111.712 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.5 m -143.41 90.86 2.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.691 -0.686 . . . . 73.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 111.8 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.0 m -74.85 75.39 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.06 0.457 . . . . 51.229999999999997 111.773 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -78.64 -52.3 8.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.552 0.692 . . . . 73.510000000000005 109.74 172.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 68' ' ' ASN . 33.9 t -106.12 86.4 2.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.215 -0.902 . . . . 72.120000000000005 110.445 171.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.64 -31.01 0.79 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.318 -0.468 . . . . 70.120000000000005 113.004 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -77.43 81.26 3.91 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.354 0.597 . . . . 54.299999999999997 111.677 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -71.86 85.73 0.96 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.881 -0.6 . . . . 63.200000000000003 111.198 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.37 119.18 30.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 34.140000000000001 111.55 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -82.71 94.27 7.56 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 73.200000000000003 111.179 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.442 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 3.4 mm? -68.67 -18.34 64.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.787 0.327 . . . . 71.310000000000002 111.443 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -73.48 174.23 8.51 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.454 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t -105.93 149.33 26.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.188 0.518 . . . . 71.329999999999998 111.945 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 115.2 9.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.915 -0.584 . . . . 65.209999999999994 111.273 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.92 -13.22 7.2 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.172 -0.537 . . . . 65.200000000000003 112.887 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -100.03 144.99 28.42 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.787 0.327 . . . . 74.099999999999994 111.144 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.6 m -56.01 -25.87 46.27 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.117 0.414 . . . . 74.140000000000001 112.117 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.2 p -67.21 -27.22 67.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.275 0.472 . . . . 51.409999999999997 112.275 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -65.64 -64.07 0.95 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.806 0.669 . . . . 74.510000000000005 112.806 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB3' ' SD ' ' A' ' 127' ' ' MET . 34.6 p90 -63.49 -32.48 73.94 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.048 0.388 . . . . 64.140000000000001 112.048 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 110' ' ' VAL . 66.1 t -62.62 -37.17 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.765 0.317 . . . . 72.319999999999993 111.442 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -59.15 -37.36 77.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.057 0.456 . . . . 74.540000000000006 110.84 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.11 -40.82 62.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.179 -0.464 . . . . 71.519999999999996 110.998 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.75 -44.88 86.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.093 0.473 . . . . 63.240000000000002 111.753 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.42 -3.14 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.106 0.479 . . . . 71.030000000000001 111.424 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.15 22.37 73.89 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.47 -0.395 . . . . 73.230000000000004 113.703 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.25 15.38 65.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 114.325 0.49 . . . . 25.039999999999999 114.325 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 45' ' ' SER . 49.6 m-80 -79.68 2.65 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.644 0.609 . . . . 61.310000000000002 112.644 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.7 pt -109.43 149.56 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.166 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.36 110.5 3.2 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.826 -0.702 . . . . 31.539999999999999 112.674 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 28.7 t -64.47 -3.24 2.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 122.413 -0.463 . . . . 63.32 112.24 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 t -64.12 -13.33 47.17 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.256 0.465 . . . . 70.439999999999998 112.256 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -59.11 -50.07 75.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.96 0.409 . . . . 65.319999999999993 111.424 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.58 -128.26 9.33 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.162 -0.542 . . . . 61.140000000000001 113.38 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.71 140.47 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 111.83 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.99 -41.28 64.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.118 0.784 . . . . 73.209999999999994 113.118 -173.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.62 -22.62 65.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -84.54 -24.2 29.41 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.748 0.277 . . . . 72.450000000000003 111.748 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -45.37 -46.98 13.48 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.996 0.739 . . . . 75.430000000000007 112.996 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.46 81.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 63.439999999999998 112.181 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 t -80.4 -47.5 14.3 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 74.049999999999997 111.617 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.94 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.359 -0.382 . . . . 73.409999999999997 111.602 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -60.55 -53.78 53.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 53.310000000000002 111.327 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.0 p -59.77 -42.47 93.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.89 0.376 . . . . 72.010000000000005 111.225 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 t -65.61 -29.77 70.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.374 -0.376 . . . . 75.030000000000001 111.543 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.18 -4.34 59.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.435 0.531 . . . . 74.25 112.435 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.45 3.18 56.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.262 -0.494 . . . . 72.25 113.853 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 81.7 m-85 -72.3 173.79 8.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 111.423 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 35.4 m -106.24 84.85 2.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.09 0.404 . . . . 73.400000000000006 112.09 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 152' ' ' ILE . 49.5 t -93.9 111.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.85 0.357 . . . . 74.549999999999997 111.562 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -149.06 159.96 43.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 110.779 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.2 24.36 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.447 0.536 . . . . 75.209999999999994 112.447 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -81.04 108.64 10.8 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.387 0.275 . . . . 75.209999999999994 110.83 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.45 7.9 4.72 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.833 2.355 . . . . 62.340000000000003 114.395 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -51.59 143.07 13.02 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.158 0.429 . . . . 70.120000000000005 112.158 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 152.7 11.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.52 13.78 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.133 -0.556 . . . . 64.010000000000005 113.114 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.3 p -144.86 178.4 8.04 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 71.129999999999995 111.06 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 62.7 mt -124.58 120.06 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.551 -0.295 . . . . 74.430000000000007 111.211 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.9 pt? -85.59 126.87 34.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 72.129999999999995 111.233 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.28 111.26 23.93 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.976 0.417 . . . . 73.310000000000002 109.927 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 21.4 t -66.02 -55.86 14.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.238 1.199 . . . . 61.039999999999999 114.238 -169.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.7 p 59.63 -1.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.639 0.977 . . . . 51.310000000000002 113.639 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.91 115.71 5.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.341 0.497 . . . . 73.319999999999993 112.341 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.41 -44.19 3.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.291 -0.48 . . . . 43.229999999999997 113.566 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 150.07 -45.97 0.65 Allowed Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 112.587 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -64.68 85.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.468 0.651 . . . . 71.209999999999994 110.811 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -51.02 113.38 2.15 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.215 -0.902 . . . . 50.450000000000003 113.938 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -111.91 143.31 43.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.542 0.337 . . . . 73.340000000000003 111.038 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.531 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.7 m -141.17 150.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.08 0.467 . . . . 70.140000000000001 111.824 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.415 ' H ' HD23 ' A' ' 100' ' ' LEU . . . -156.42 168.94 25.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.813 -0.63 . . . . 63.200000000000003 110.561 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -100.43 129.55 46.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 111.281 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.35 112.66 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.778 0.323 . . . . 60.25 111.689 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.29 -53.95 4.91 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.12 0.415 . . . . 70.329999999999998 112.12 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -143.18 150.43 39.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.993 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.19 131.98 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.886 -0.597 . . . . 70.239999999999995 110.757 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.57 156.3 16.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.475 -0.33 . . . . 53.299999999999997 111.302 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.8 p -64.66 -18.35 64.88 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.137 0.421 . . . . 55.049999999999997 112.137 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -69.47 -9.78 55.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.817 0.342 . . . . 73.519999999999996 111.443 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 93.5 0.07 67.57 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 112.214 -0.354 . . . . 70.439999999999998 112.214 -174.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 m -67.89 120.73 14.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 110.926 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.4 t -105.22 119.19 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.659 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.55 107.12 19.49 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.191 0.519 . . . . 74.400000000000006 110.929 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.58 144.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.013 -0.54 . . . . 55.219999999999999 111.771 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 t -90.98 112.83 24.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.333 -0.394 . . . . 74.010000000000005 111.379 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.39 -173.08 2.3 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.037 -0.529 . . . . 63.219999999999999 110.964 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' A' ' 60' ' ' TYR . 19.2 ptm -133.9 124.76 26.96 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.213 0.53 . . . . 64.409999999999997 110.77 173.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.86 42.66 0.87 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.139 -0.351 . . . . 71.530000000000001 111.748 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -53.11 -33.6 52.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.007 0.432 . . . . 63.549999999999997 111.759 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -66.91 -27.31 67.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.19 -0.459 . . . . 54.539999999999999 112.007 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.03 -58.07 0.76 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.484 -0.388 . . . . 64.230000000000004 112.788 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.41 172.46 14.22 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.585 -0.34 . . . . 73.209999999999994 113.493 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.25 96.94 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.843 2.362 . . . . 73.209999999999994 113.372 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.6 p90 43.37 24.45 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.943 1.09 . . . . 54.409999999999997 113.943 174.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.6 t -71.6 130.48 41.31 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.143 0.423 . . . . 74.540000000000006 112.143 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 77.1 t -95.43 125.4 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.772 0.32 . . . . 71.329999999999998 111.108 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -141.79 167.05 23.06 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.261 0.467 . . . . 72.019999999999996 112.261 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -99.12 137.06 38.19 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.163 -0.471 . . . . 71.150000000000006 111.945 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -111.94 125.41 54.03 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.025 -0.422 . . . . 60.030000000000001 110.77 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.1 m -91.54 105.12 17.51 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.964 0.411 . . . . 64.0 111.619 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.18 139.93 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.375 -0.375 . . . . 70.310000000000002 111.555 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.2 m -72.36 155.31 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.681 0.277 . . . . 70.420000000000002 111.679 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -54.99 -48.19 73.63 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.535 0.569 . . . . 72.099999999999994 112.535 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.33 -41.08 92.88 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.478 -0.392 . . . . 62.25 113.41 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.51 -45.3 39.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.249 0.547 . . . . 64.230000000000004 111.236 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -64.81 -38.1 89.85 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.837 0.68 . . . . 65.319999999999993 112.837 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -62.47 -15.63 50.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.615 0.598 . . . . 74.120000000000005 112.615 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -79.53 -28.35 41.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.904 0.383 . . . . 73.25 111.796 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 100' ' ' LEU . 22.9 m-85 -74.14 147.84 42.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.163 0.506 . . . . 64.25 111.969 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -91.99 108.12 19.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.233 -0.439 . . . . 75.510000000000005 110.781 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 71.3 m-85 -88.22 119.08 28.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.948 0.404 . . . . 71.25 111.803 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 90' ' ' VAL . 3.6 mp -82.21 130.18 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.731 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.46 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 46.4 m-70 -120.39 161.95 20.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.969 0.508 . . . . 74.129999999999995 109.87 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.87 141.67 36.89 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.754 0.65 . . . . 62.219999999999999 112.754 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 CA--C 1.544 0.713 0 CA-C-N 115.7 -0.682 . . . . 71.299999999999997 111.026 179.42 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.867 0.365 . . . . 72.400000000000006 111.155 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 9.2 mmpt? -142.36 149.71 39.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.79 0.436 . . . . 75.25 110.446 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -153.26 120.5 5.83 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.599 0.592 . . . . 75.310000000000002 112.599 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.89 148.72 43.66 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.724 -0.671 . . . . 72.340000000000003 110.011 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -162.32 144.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.389 0.514 . . . . 74.129999999999995 112.389 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 8' ' ' THR . 54.2 m -95.84 97.11 9.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.081 0.467 . . . . 60.009999999999998 110.348 173.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.02 2.66 38.02 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.034 1.124 . . . . 75.420000000000002 114.034 -169.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 6' ' ' THR . 11.8 t -71.16 162.42 29.45 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.661 0.615 . . . . 74.030000000000001 112.661 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.9 m -152.78 139.36 18.74 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.711 -0.677 . . . . 74.030000000000001 111.016 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -106.75 113.08 26.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.329 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.2 m -124.56 107.38 10.99 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.366 -0.209 . . . . 73.129999999999995 111.44 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.22 140.99 0.9 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.771 0.319 . . . . 53.409999999999997 111.641 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.16 111.01 0.26 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.377 -0.44 . . . . 63.420000000000002 112.873 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 tt -106.34 136.0 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.1 0.476 . . . . 72.040000000000006 112.265 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.04 83.02 0.34 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.388 -0.434 . . . . 65.209999999999994 112.577 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.92 135.65 33.23 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.415 -0.462 . . . . 72.5 112.051 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.6 103.56 0.71 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.697 0.284 . . . . 63.450000000000003 111.688 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.41 178.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.2 0.444 . . . . 53.520000000000003 112.2 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -116.11 140.07 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.861 0.363 . . . . 73.219999999999999 111.797 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.16 115.45 0.63 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.262 -0.426 . . . . 65.510000000000005 112.568 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.6 mm? -114.36 141.44 47.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.098 0.449 . . . . 74.340000000000003 111.902 -176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.5 146.45 38.47 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.93 0.395 . . . . 65.299999999999997 110.709 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -148.51 112.56 5.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.954 0.407 . . . . 53.240000000000002 111.742 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.5 23.25 12.4 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.128 -0.558 . . . . 54.549999999999997 113.29 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.32 166.41 12.31 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.51 -0.406 . . . . 63.32 111.856 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.52 177.81 7.16 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.352 -0.386 . . . . 71.310000000000002 111.348 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -172.6 168.45 5.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.902 0.382 . . . . 74.239999999999995 111.397 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.13 127.18 33.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.072 0.463 . . . . 63.409999999999997 110.542 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.88 138.84 33.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.977 0.418 . . . . 72.340000000000003 111.892 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.22 165.56 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.746 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -82.91 23.36 0.84 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.7 0.259 . . . . 64.209999999999994 111.7 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 54.56 42.64 31.17 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.362 0.601 . . . . 73.140000000000001 111.297 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -76.46 77.94 3.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.913 -0.585 . . . . 70.439999999999998 111.4 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 65.79 111.73 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 64.409999999999997 112.26 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.14 74.56 0.73 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.101 1.868 . . . . 64.030000000000001 112.125 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.3 m -71.49 109.23 5.32 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.178 -0.465 . . . . 71.019999999999996 112.064 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 t30 54.92 83.19 0.09 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.846 0.684 . . . . 75.340000000000003 112.846 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -125.49 -57.72 1.46 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.278 -0.419 . . . . 75.439999999999998 110.927 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -153.71 113.98 3.95 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.066 0.46 . . . . 73.430000000000007 111.565 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -110.96 -31.97 6.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.276 0.56 . . . . 74.439999999999998 111.003 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.3 p -83.42 73.67 10.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.281 0.562 . . . . 54.240000000000002 111.019 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.42 -15.93 53.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.222 -0.445 . . . . 61.149999999999999 111.601 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -82.57 160.07 22.63 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.222 -0.299 . . . . 72.430000000000007 110.467 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p 50.62 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.134 0.574 . . . . 64.430000000000007 111.762 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 93.0 p -159.53 152.88 22.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.026 -0.534 . . . . 71.510000000000005 110.863 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.39 -94.87 1.45 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.215 -0.517 . . . . 61.25 112.664 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -149.77 -167.28 2.78 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.843 0.321 . . . . 34.43 111.176 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.6 p -147.4 138.92 23.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.839 0.352 . . . . 32.210000000000001 110.799 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.17 164.81 4.85 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.46 -0.336 . . . . 71.25 110.891 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.38 105.31 14.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.96 0.409 . . . . 60.229999999999997 110.662 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.36 -0.95 11.36 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.566 0.58 . . . . 64.219999999999999 112.566 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 72.8 m-85 -99.27 -177.58 3.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 111.729 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.4 t -121.68 157.39 31.0 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.052 0.453 . . . . 72.209999999999994 111.854 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.08 149.88 26.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.834 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.18 -23.33 35.16 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.132 -0.556 . . . . 74.239999999999995 113.252 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -89.41 142.19 27.88 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.559 -0.377 . . . . 71.019999999999996 111.294 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.27 -27.05 65.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.213 0.53 . . . . 60.299999999999997 111.469 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.4 p -73.37 -16.37 61.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 112.203 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.98 -54.43 47.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.265 0.626 . . . . 72.340000000000003 112.397 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 39.4 p90 -77.89 -34.95 51.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.167 0.432 . . . . 73.129999999999995 112.167 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.14 -42.59 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 111.853 0.316 . . . . 75.329999999999998 111.853 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -58.01 -36.84 73.24 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.77 -41.82 43.27 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.868 0.366 . . . . 71.140000000000001 110.929 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.24 -27.2 68.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.107 0.41 . . . . 64.040000000000006 112.107 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.8 3.27 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 121.277 0.56 . . . . 60.350000000000001 111.422 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.28 12.77 66.56 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.163 -0.541 . . . . 72.150000000000006 113.933 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.41 16.91 71.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 114.43 0.532 . . . . 74.450000000000003 114.43 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.95 30.19 0.52 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.343 0.571 . . . . 63.229999999999997 112.123 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.81 150.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.923 0.392 . . . . 74.519999999999996 111.603 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.65 98.25 0.28 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.321 -0.466 . . . . 72.450000000000003 113.363 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.0 p -59.36 -8.76 1.88 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.086 0.773 . . . . 71.430000000000007 113.086 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -66.57 -12.5 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.59 0.589 . . . . 63.140000000000001 112.59 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -63.15 -59.45 4.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.807 0.337 . . . . 70.239999999999995 111.779 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.549 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 88.62 -110.43 3.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.11 -0.567 . . . . 32.130000000000003 113.699 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.52 140.2 58.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.985 0.393 . . . . 73.299999999999997 111.316 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.19 -43.68 64.31 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.573 0.582 . . . . 41.119999999999997 112.573 -176.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -56.96 -21.14 27.96 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.774 0.657 . . . . 61.130000000000003 112.774 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -90.94 -23.81 20.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.824 0.305 . . . . 72.030000000000001 111.824 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 101' ' ' GLN . 9.4 m0 -50.52 -40.26 51.11 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.264 0.839 . . . . 73.319999999999993 113.264 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.63 -64.58 0.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.171 0.434 . . . . 70.239999999999995 112.171 -175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -63.82 -35.44 80.62 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 71.030000000000001 111.691 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.39 87.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.773 0.32 . . . . 72.430000000000007 111.377 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.031 0.443 . . . . 34.210000000000001 111.347 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 p -64.22 -28.51 69.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.423 -0.353 . . . . 65.140000000000001 111.897 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -77.9 -36.34 49.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.9 0.381 . . . . 54.420000000000002 111.767 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -22.03 59.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.267 0.469 . . . . 72.129999999999995 112.267 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.58 10.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.047 -0.597 . . . . 23.23 113.587 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -76.67 -173.79 2.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.195 0.521 . . . . 54.329999999999998 111.286 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.9 m -121.23 97.47 5.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.436 -0.347 . . . . 63.149999999999999 111.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 152' ' ' ILE . 46.2 t -101.62 108.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.817 0.341 . . . . 74.430000000000007 111.847 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -140.65 147.74 39.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.51 -0.314 . . . . 74.219999999999999 110.932 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -72.76 -9.78 59.04 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.172 0.434 . . . . 72.319999999999993 112.172 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.9 m -56.53 119.79 31.48 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.519 0.2 . . . . 74.230000000000004 111.095 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.56 121.76 1.93 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.001 2.467 . . . . 73.140000000000001 113.78 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.49 156.87 35.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 111.099 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 151.66 46.04 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.077 0.465 . . . . 72.439999999999998 112.115 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.02 41.45 18.26 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.191 -0.528 . . . . 54.020000000000003 113.108 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.5 m -151.75 158.53 43.48 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.514 -0.404 . . . . 63.25 111.011 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -103.26 126.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.335 -0.246 . . . . 74.109999999999999 110.335 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 149' ' ' TYR . 1.2 pt? -98.85 124.36 43.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.399 0.619 . . . . 65.230000000000004 110.836 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -111.8 124.17 51.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 111.434 -172.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.585 ' HB2' ' CD1' ' A' ' 149' ' ' TYR . 47.5 t -109.13 112.84 25.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.877 0.37 . . . . 54.310000000000002 111.795 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -81.76 71.4 8.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.703 0.763 . . . . 73.239999999999995 111.531 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.39 -25.97 59.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.576 -0.738 . . . . 63.539999999999999 111.626 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.67 160.09 11.57 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.057 -0.519 . . . . 33.299999999999997 112.836 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.14 -77.05 0.24 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.546 -0.359 . . . . 72.25 113.344 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -106.25 -42.83 4.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.984 0.421 . . . . 75.409999999999997 111.629 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.1 -165.68 30.51 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 -169.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -159.52 142.25 13.93 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.494 0.647 . . . . 73.510000000000005 111.66 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' HB1' ' A' ' 76' ' ' ALA . 12.8 m -141.09 141.43 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 111.716 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.16 156.67 41.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.38 -0.373 . . . . 73.209999999999994 110.905 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -96.0 128.64 43.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.881 0.372 . . . . 70.109999999999999 111.209 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 124' ' ' VAL . 61.8 t -79.8 118.82 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.317 0.488 . . . . 63.530000000000001 112.317 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -83.92 -53.67 5.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.282 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.42 154.05 34.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.075 0.464 . . . . 64.519999999999996 111.605 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.28 129.09 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 111.009 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.46 160.0 29.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.869 0.366 . . . . 40.229999999999997 111.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.3 m -64.04 -20.42 65.91 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.784 0.326 . . . . 62.200000000000003 111.605 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.11 -22.92 66.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.071 0.463 . . . . 74.420000000000002 111.329 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.87 45.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.582 -0.607 . . . . 75.109999999999999 111.582 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -64.97 129.17 38.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.621 0.368 . . . . 74.239999999999995 110.909 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.469 HG21 ' OH ' ' A' ' 151' ' ' TYR . 61.0 t -106.7 111.36 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.201 0.524 . . . . 64.209999999999994 111.737 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 140' ' ' THR . 37.9 mt-10 -90.32 107.31 19.06 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 110.716 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 113' ' ' VAL . 30.6 m -108.91 173.87 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.004 -0.543 . . . . 73.310000000000002 112.14 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.496 ' HB2' HG11 ' A' ' 136' ' ' VAL . 54.8 p -117.87 126.09 51.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.026 -0.534 . . . . 74.340000000000003 111.488 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 136' ' ' VAL . 48.5 mt-10 -121.82 -172.68 2.49 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 111.268 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.1 tpp -130.88 133.24 45.72 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.904 -0.497 . . . . 45.32 111.338 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -89.4 -45.48 9.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.086 0.47 . . . . 75.329999999999998 111.488 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -89.21 110.79 21.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.913 0.387 . . . . 73.510000000000005 111.74 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -46.5 -38.97 10.0 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.353 0.871 . . . . 72.450000000000003 113.353 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -139.05 46.22 0.98 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.072 -0.585 . . . . 54.030000000000001 112.973 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -103.19 -153.31 24.0 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.268 -0.492 . . . . 73.049999999999997 113.509 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.902 2.402 . . . . 63.0 113.191 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -82.71 20.61 1.12 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.577 0.584 . . . . 72.430000000000007 112.577 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 m -71.44 83.56 0.8 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.194 0.521 . . . . 71.420000000000002 111.445 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 125' ' ' SER . 79.7 t -77.1 137.8 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.017 -0.538 . . . . 64.329999999999998 112.261 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.1 t -91.13 139.38 30.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.023 -0.535 . . . . 71.450000000000003 111.031 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.65 137.23 32.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.545 -0.298 . . . . 73.109999999999999 111.63 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.433 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 2.4 tpm_? -140.61 122.71 15.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.971 0.415 . . . . 50.229999999999997 111.923 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 123' ' ' GLU . 81.5 m -104.36 98.5 8.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.946 0.403 . . . . 60.399999999999999 110.739 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.66 128.88 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 54.43 111.775 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.1 m -67.29 147.25 53.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.549 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.72 -47.28 59.2 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.532 0.568 . . . . 52.219999999999999 112.532 -177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.66 64.55 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.225 -0.512 . . . . 71.200000000000003 113.246 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.32 -34.48 25.68 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.085 0.469 . . . . 73.439999999999998 111.06 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 149' ' ' TYR . . . -63.3 -10.93 18.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.707 0.632 . . . . 63.229999999999997 112.707 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -75.81 -21.6 57.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.328 0.492 . . . . 44.539999999999999 112.328 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 94.2 p -83.34 -33.28 25.91 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.355 0.502 . . . . 60.329999999999998 112.355 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 102' ' ' SER . 80.8 m-85 -70.8 145.82 50.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.251 0.548 . . . . 75.209999999999994 112.327 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -101.35 114.84 29.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.069 -0.514 . . . . 71.549999999999997 110.208 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.469 ' OH ' HG21 ' A' ' 122' ' ' VAL . 14.2 m-85 -90.91 114.96 27.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.283 0.475 . . . . 61.340000000000003 112.283 -174.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.558 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -82.02 107.75 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.752 -0.462 . . . . 74.510000000000005 109.752 173.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.81 125.36 40.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 52.539999999999999 111.239 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.94 95.74 10.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.986 0.422 . . . . 72.329999999999998 111.056 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.544 0.747 0 CA-C-O 120.876 0.37 . . . . 63.520000000000003 111.695 178.18 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.132 0.491 . . . . 75.140000000000001 111.916 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.46 110.03 13.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.176 -0.466 . . . . 54.399999999999999 111.758 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.72 -28.24 1.75 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.925 -0.655 . . . . 73.420000000000002 113.287 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.32 150.04 27.43 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.547 -0.384 . . . . 74.109999999999999 110.755 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 28.2 p -58.69 -34.18 70.99 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.143 0.497 . . . . 72.310000000000002 111.796 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.404 ' HB ' ' CZ2' ' A' ' 79' ' ' TRP . 49.8 p -64.44 -25.75 68.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.24 -60.33 3.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.519 0.563 . . . . 73.340000000000003 112.519 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 25.0 p90 -64.35 -30.53 71.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.097 -0.377 . . . . 64.430000000000007 111.892 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HG23 ' A' ' 110' ' ' VAL . 59.4 t -62.53 -43.67 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.105 0.479 . . . . 61.409999999999997 110.583 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -58.54 -36.61 74.15 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.043 -0.526 . . . . 63.229999999999997 110.944 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.73 -43.31 37.82 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.406 -0.361 . . . . 64.530000000000001 111.132 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -59.19 -34.4 72.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.146 0.498 . . . . 71.209999999999994 111.816 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 99' ' ' ILE . 7.1 p -85.03 9.38 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.309 0.576 . . . . 70.219999999999999 111.815 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.18 14.59 68.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.389 -0.434 . . . . 34.329999999999998 113.556 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.77 17.9 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.167 -0.539 . . . . 73.239999999999995 114.129 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -80.09 11.24 3.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.466 0.633 . . . . 64.219999999999999 112.375 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 pt -117.04 153.0 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.374 -0.376 . . . . 74.319999999999993 110.687 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.05 126.69 8.02 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.806 -0.711 . . . . 61.420000000000002 113.968 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -62.33 -19.27 63.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.189 0.518 . . . . 60.109999999999999 111.364 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -70.05 8.25 0.78 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.361 0.875 . . . . 73.430000000000007 113.361 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -78.15 -46.02 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.99 -0.444 . . . . 72.319999999999993 112.047 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.94 9.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.945 -0.645 . . . . 60.43 113.377 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -85.53 162.57 18.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.14 0.495 . . . . 55.43 111.881 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.32 -27.78 64.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.849 -0.614 . . . . 73.239999999999995 112.079 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -63.23 -35.34 79.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.985 0.422 . . . . 74.239999999999995 111.173 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.93 -21.26 19.32 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.508 0.558 . . . . 75.450000000000003 112.508 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.404 ' CZ2' ' HB ' ' A' ' 58' ' ' THR . 4.9 m0 -38.95 -55.43 1.55 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.447 1.277 . . . . 73.510000000000005 114.447 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -62.67 -37.63 87.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.941 -0.475 . . . . 62.32 112.235 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -68.94 -47.74 64.96 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.932 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.82 92.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.131 -0.486 . . . . 63.219999999999999 111.156 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.96 -51.98 62.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.078 0.466 . . . . 53.409999999999997 110.938 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 m -58.24 -45.27 88.07 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.176 0.512 . . . . 64.319999999999993 110.713 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 t -66.86 -24.6 66.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.072 -0.513 . . . . 64.299999999999997 111.97 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.3 -13.07 33.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.114 0.412 . . . . 64.140000000000001 112.114 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.34 41.84 3.86 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.253 -0.499 . . . . 62.439999999999998 113.434 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -107.61 -178.6 3.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 74.340000000000003 111.522 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.0 m -110.05 108.06 18.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.291 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 152' ' ' ILE . 39.0 t -116.81 110.99 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.082 0.467 . . . . 65.140000000000001 111.907 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 50.8 m-80 -139.17 155.6 47.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.385 -0.371 . . . . 72.319999999999993 110.369 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.64 13.71 1.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.008 0.373 . . . . 74.430000000000007 112.008 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.5 p -73.84 116.87 56.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.601 -0.272 . . . . 74.010000000000005 111.416 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 103.51 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.486 2.124 . . . . 53.539999999999999 112.241 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 36.9 tt0 -141.45 152.15 44.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.977 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.32 153.92 42.0 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.021 0.439 . . . . 71.319999999999993 111.905 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.54 34.05 63.53 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.074 -0.584 . . . . 63.020000000000003 112.691 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.5 m -136.78 158.8 43.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.299999999999997 111.067 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -107.95 127.53 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.597 -0.274 . . . . 64.530000000000001 110.448 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.7 pt? -95.63 130.37 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.937 -0.477 . . . . 42.329999999999998 111.127 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HA ' HG12 ' A' ' 110' ' ' VAL . 41.8 tt0 -98.29 129.32 45.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.402 -0.363 . . . . 64.140000000000001 111.685 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 112.752 0.649 . . . . 71.310000000000002 112.752 178.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.768 0 N-CA-C 113.584 0.193 . . . . 52.140000000000001 113.584 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -131.63 149.71 52.4 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.747 -0.267 . . . . 65.519999999999996 111.036 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.8 m -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.138 0.494 . . . . 65.530000000000001 111.663 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.86 163.03 40.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 73.129999999999995 110.651 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -96.68 127.4 42.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.752 0.31 . . . . 73.340000000000003 111.376 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 124' ' ' VAL . 60.9 t -76.1 108.05 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.948 0.404 . . . . 43.539999999999999 112.031 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 138' ' ' GLU . 11.3 mm-40 -71.95 -45.86 59.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.055 -0.52 . . . . 71.349999999999994 111.504 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -163.6 149.37 11.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 111.517 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 122' ' ' VAL . 57.9 t -120.65 128.91 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 52.119999999999997 110.535 177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -84.42 154.55 22.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.955 0.407 . . . . 70.400000000000006 111.925 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 t -57.61 -34.42 69.26 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.441 0.639 . . . . 75.019999999999996 110.078 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.2 -31.53 43.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.245 -0.889 . . . . 75.140000000000001 111.583 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 112.75 -19.35 21.4 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.369 -0.443 . . . . 54.509999999999998 112.669 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.3 p -61.62 125.7 24.72 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.329 0.585 . . . . 51.409999999999997 111.66 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 116' ' ' VAL . 48.9 t -103.44 117.85 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.716 -0.675 . . . . 74.109999999999999 111.347 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.85 102.52 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.218 0.532 . . . . 72.340000000000003 111.464 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.562 HG12 HG22 ' A' ' 113' ' ' VAL . 35.5 m -106.42 123.49 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.449 0.643 . . . . 60.340000000000003 111.876 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 39.5 t -81.03 122.19 26.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.054 0.455 . . . . 72.209999999999994 111.841 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -133.31 137.59 46.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.492 . . . . 63.200000000000003 111.18 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.5 ' HB3' ' CD2' ' A' ' 60' ' ' TYR . 50.2 ttm . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.016 0.436 . . . . 72.400000000000006 111.642 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 2.6 mp0 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.336 0.589 . . . . 64.140000000000001 111.366 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -70.04 109.3 4.48 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.504 -0.771 . . . . 64.420000000000002 111.895 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.8 m -85.33 98.26 10.44 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.95 0.405 . . . . 60.340000000000003 111.343 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.0 mt -88.52 144.34 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 111.549 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.8 m -68.85 148.32 50.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 111.293 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.404 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -49.36 -49.92 42.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.072 0.767 . . . . 65.230000000000004 113.072 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.03 -48.74 77.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.419 -0.419 . . . . 71.340000000000003 113.434 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.22 -39.03 75.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.042 0.449 . . . . 54.539999999999999 111.544 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.46 77.81 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.074 0.398 . . . . 73.400000000000006 112.074 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.9 m -61.55 -14.47 30.06 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.091 0.472 . . . . 62.520000000000003 111.74 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -73.67 -8.49 56.18 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.338 -0.392 . . . . 34.140000000000001 111.762 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 100' ' ' LEU . 53.1 m-85 -105.17 156.91 17.66 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.112 0.482 . . . . 74.329999999999998 112.064 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 91.7 m-20 -87.0 115.69 24.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.36 -0.382 . . . . 73.450000000000003 111.028 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 82.5 m-85 -93.29 121.32 34.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.053 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -89.89 111.08 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.347 -0.388 . . . . 64.310000000000002 110.316 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 33.2 m-70 -98.52 136.77 38.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.41 -0.359 . . . . 65.010000000000005 110.984 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 29.7 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.156 0.503 . . . . 53.130000000000003 112.236 -178.698 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 120.997 0.427 . . . . 63.310000000000002 111.784 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 103.84 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 112.35 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.75 -28.17 2.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 112.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 59' ' ' TRP . 96.3 mt-30 -73.88 143.87 45.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.007 0.432 . . . . 71.439999999999998 111.899 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.5 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.0 m -57.11 -46.28 82.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.569 174.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.3 p -55.13 -41.21 71.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.795 -0.639 . . . . 52.420000000000002 111.547 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 56' ' ' GLN . 59.3 t90 -55.23 -55.68 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.57 -0.741 . . . . 73.329999999999998 111.76 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.481 ' OH ' ' HD3' ' A' ' 64' ' ' LYS . 47.1 t80 -62.75 -42.18 99.55 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.294 0.479 . . . . 75.109999999999999 112.294 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 110' ' ' VAL . 82.4 t -60.44 -38.27 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 111.946 0.35 . . . . 73.530000000000001 111.946 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 44.2 t80 -62.22 -34.82 77.22 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 111.388 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.95 -46.78 56.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.167 0.508 . . . . 55.350000000000001 110.318 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HD3' ' OH ' ' A' ' 60' ' ' TYR . 25.5 mmmt -55.71 -40.58 72.6 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 112.3 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.51 9.5 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.077 0.465 . . . . 74.209999999999994 111.55 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.66 60.47 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.523 -0.37 . . . . 31.52 113.745 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA2' ' CE1' ' A' ' 62' ' ' TYR . . . 63.54 29.25 74.07 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.159 -0.543 . . . . 62.409999999999997 114.261 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -93.23 24.57 3.76 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.478 0.639 . . . . 71.430000000000007 112.214 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.82 155.5 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.03 0.443 . . . . 61.140000000000001 111.702 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.13 93.56 0.34 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.09 -0.576 . . . . 73.140000000000001 112.551 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 63.1 p -72.65 20.8 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.377 0.88 . . . . 35.329999999999998 113.377 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -90.0 -2.26 58.11 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.189 -0.319 . . . . 64.030000000000001 111.752 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -64.83 -38.18 90.12 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.56 0.578 . . . . 72.439999999999998 112.56 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.09 -111.09 3.24 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.071 -0.585 . . . . 60.229999999999997 113.445 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -53.63 134.05 41.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.926 0.393 . . . . 41.119999999999997 111.908 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.95 -39.31 85.14 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.507 0.558 . . . . 61.240000000000002 112.507 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -63.74 -9.82 16.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.48 0.548 . . . . 55.420000000000002 112.48 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -94.15 -16.65 23.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.497 0.319 . . . . 60.420000000000002 111.661 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 11.6 m0 -60.49 -42.26 95.95 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.129 0.789 . . . . 73.120000000000005 113.129 -170.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -66.1 -56.66 10.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.971 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -62.52 -44.51 96.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.91 0.386 . . . . 65.239999999999995 111.627 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.1 -47.94 83.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.566 -0.288 . . . . 54.009999999999998 111.728 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -56.38 -49.0 75.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 111.404 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -58.76 -40.81 84.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 111.999 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -75.49 -39.14 58.94 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.959 0.409 . . . . 62.299999999999997 111.897 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.99 82.61 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.113 0.412 . . . . 71.120000000000005 112.113 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.11 17.85 1.58 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.948 -0.644 . . . . 52.350000000000001 113.383 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 58.7 m-85 -89.19 176.61 6.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.26 0.552 . . . . 72.400000000000006 111.061 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -104.59 91.37 3.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.133 -0.485 . . . . 75.140000000000001 111.173 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 152' ' ' ILE . 62.1 t -103.69 117.52 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.029 0.442 . . . . 71.120000000000005 112.054 -176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -153.04 -179.46 7.7 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.902 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.15 10.1 30.8 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.083 0.401 . . . . 71.319999999999993 112.083 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -72.56 111.79 12.48 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 110.291 -0.263 . . . . 74.530000000000001 110.291 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.479 ' O ' HG21 ' A' ' 116' ' ' VAL . 91.8 Cg_endo -76.65 1.93 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.836 2.358 . . . . 62.520000000000003 115.065 -170.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.23 137.51 6.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.895 0.702 . . . . 60.43 112.895 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.51 174.16 1.84 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.396 0.888 . . . . 72.150000000000006 113.396 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.0 35.33 57.95 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.998 -0.547 . . . . 42.130000000000003 112.484 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.7 m -153.4 -176.96 6.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.571 0.348 . . . . 62.020000000000003 110.665 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mt -122.2 129.39 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.803 -0.18 . . . . 52.409999999999997 111.45 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.4 pt? -98.37 133.45 42.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.799 -0.563 . . . . 74.420000000000002 110.923 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -101.39 106.15 17.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.031 -0.531 . . . . 72.450000000000003 110.286 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 75.400000000000006 111.38 -176.945 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 CA-C-O 120.971 0.206 . . . . 72.409999999999997 113.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -142.44 110.55 5.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.456 -0.438 . . . . 64.0 111.095 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG13 ' HB1' ' A' ' 76' ' ' ALA . 31.4 m -111.81 145.15 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.921 0.391 . . . . 72.140000000000001 111.397 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.39 157.81 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.989 0.423 . . . . 73.530000000000001 111.366 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -90.7 130.91 36.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.827 0.346 . . . . 73.319999999999993 110.878 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' HA ' HG12 ' A' ' 124' ' ' VAL . 39.9 t -83.49 114.72 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 45.229999999999997 112.124 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.78 -50.96 10.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.907 -0.588 . . . . 73.409999999999997 111.536 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -158.08 150.71 22.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 111.84 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 94' ' ' PRO . 98.5 t -126.92 127.63 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.912 -0.585 . . . . 64.239999999999995 110.39 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -91.98 148.29 22.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.881 0.372 . . . . 74.549999999999997 111.852 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 75.8 m -64.0 -16.01 60.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.368 -0.378 . . . . 73.409999999999997 111.743 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.11 -6.46 39.43 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 111.379 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 60.05 1.59 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.316 -0.468 . . . . 54.219999999999999 112.985 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.0 p -145.78 133.6 21.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.294 -0.533 . . . . 64.109999999999999 111.668 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.46 113.62 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.213 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 31.2 mt-10 -99.49 118.85 36.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.502 -0.317 . . . . 75.109999999999999 110.928 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 113' ' ' VAL . 16.1 m -129.38 147.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.371 0.508 . . . . 64.340000000000003 112.371 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 65.9 m -79.4 122.91 26.98 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.928 0.394 . . . . 53.329999999999998 112.054 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.518 ' CD ' ' HD2' ' A' ' 139' ' ' ARG . 44.3 mt-10 -116.62 143.94 45.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.275 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 tpp . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.741 0.305 . . . . 52.299999999999997 110.227 171.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.729 0.299 . . . . 70.540000000000006 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HD2' ' CD ' ' A' ' 126' ' ' GLU . 11.3 ptm180 -87.46 151.59 22.92 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.117 -0.364 . . . . 71.510000000000005 110.633 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.422 HG23 ' HG2' ' A' ' 123' ' ' GLU . 52.4 m -114.8 102.59 10.14 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.123 0.487 . . . . 72.120000000000005 110.98 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 mt -86.43 131.0 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.854 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -71.26 149.11 46.52 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.814 -0.175 . . . . 72.140000000000001 110.94 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.99 61.53 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.701 0.63 . . . . 65.109999999999999 112.701 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.68 -23.63 55.66 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.459 -0.4 . . . . 71.510000000000005 113.809 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.24 -35.06 10.87 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.448 -0.442 . . . . 64.299999999999997 111.257 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.32 67.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.122 0.487 . . . . 61.409999999999997 111.8 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 148' ' ' SER . 69.1 m -60.83 143.79 54.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.221 -0.445 . . . . 24.050000000000001 110.859 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 147' ' ' SER . 31.3 t 83.56 -3.0 1.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.681 0.792 . . . . 65.010000000000005 112.241 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -93.61 127.99 39.55 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.972 -0.455 . . . . 75.439999999999998 110.272 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.89 118.48 30.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 111.707 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -92.17 113.22 25.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.951 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -80.22 114.92 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.501 -0.318 . . . . 73.120000000000005 110.35 174.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.57 146.93 28.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.667 0.27 . . . . 75.319999999999993 110.658 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 120.804 0.335 . . . . 75.049999999999997 111.414 -178.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 5.1 t . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 120.774 0.321 . . . . 61.119999999999997 111.61 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.37 156.73 25.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.715 0.635 . . . . 74.409999999999997 112.715 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.77 -33.9 3.23 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.284 -0.416 . . . . 53.450000000000003 113.795 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -75.64 150.74 37.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.229 0.537 . . . . 75.340000000000003 112.274 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.406 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.7 p -56.41 -39.53 73.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.025 -0.534 . . . . 75.25 111.638 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.7 p -54.99 -42.96 73.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.941 0.401 . . . . 63.219999999999999 111.649 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' THR . 86.7 t90 -62.82 -50.32 71.45 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.408 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.1 -54.15 50.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.787 -0.642 . . . . 63.310000000000002 111.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.8 t -60.5 -34.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.469 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -55.62 -47.69 76.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.519 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.19 -37.56 75.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.965 0.412 . . . . 74.439999999999998 110.884 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -61.24 -35.57 77.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.013 -0.539 . . . . 43.009999999999998 112.19 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.65 12.4 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.432 0.634 . . . . 63.399999999999999 110.997 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.67 18.38 59.05 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 114.179 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.02 67.14 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.115 -0.564 . . . . 51.119999999999997 113.792 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.01 37.76 0.44 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.231 -0.57 . . . . 62.420000000000002 111.89 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.3 pt -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.112 0.482 . . . . 64.310000000000002 111.455 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.8 1.26 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.071 -0.585 . . . . 44.520000000000003 112.315 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 m -52.82 -18.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.219 0.822 . . . . 64.420000000000002 113.219 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -94.43 18.93 10.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.576 0.584 . . . . 73.299999999999997 112.576 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -67.69 -37.0 81.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.074 0.398 . . . . 72.519999999999996 112.074 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.94 -134.62 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.072 -0.585 . . . . 63.149999999999999 113.715 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -63.17 151.02 41.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.312 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.65 -31.76 62.61 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.14 0.793 . . . . 73.099999999999994 113.14 -172.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -67.14 -21.62 65.82 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.494 0.553 . . . . 61.210000000000001 112.494 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.38 -14.21 29.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.109 0.411 . . . . 75.209999999999994 112.109 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -52.06 -65.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.202 0.816 . . . . 72.0 113.202 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.18 91.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.059 0.392 . . . . 44.329999999999998 112.059 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 m -54.97 -36.91 65.86 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.976 0.417 . . . . 73.340000000000003 111.613 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.2 -28.11 25.66 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.342 -0.39 . . . . 64.450000000000003 111.891 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.7 70.04 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.726 0.298 . . . . 70.450000000000003 111.372 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.4 p -58.88 -54.36 48.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.012 0.434 . . . . 65.530000000000001 111.106 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.8 t -55.56 -37.19 67.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.945 -0.571 . . . . 64.230000000000004 112.446 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.88 -10.46 59.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 111.999 0.37 . . . . 73.439999999999998 111.999 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 41.51 4.24 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.332 -0.461 . . . . 55.439999999999998 113.873 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -110.98 -179.07 3.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.005 0.431 . . . . 64.030000000000001 111.112 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.4 m -109.72 103.86 12.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.216 0.45 . . . . 63.130000000000003 112.216 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' C ' HD22 ' A' ' 91' ' ' ASN . 43.6 t -94.28 99.81 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 63.329999999999998 110.882 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -122.17 156.07 34.46 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 111.29 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.78 -4.06 58.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.443 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.2 m -66.35 111.71 7.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.323 -0.398 . . . . 74.239999999999995 110.806 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -78.12 20.29 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.471 2.781 . . . . 64.409999999999997 114.56 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -48.65 141.53 7.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.556 0.576 . . . . 73.400000000000006 112.556 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.74 144.68 47.55 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.987 -0.551 . . . . 44.299999999999997 112.36 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.54 45.89 5.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.916 -0.659 . . . . 73.140000000000001 112.584 -175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -149.53 177.68 9.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 70.319999999999993 111.121 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.8 mt -122.83 121.21 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 110.708 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.6 pt? -92.7 139.4 30.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.02 0.438 . . . . 70.329999999999998 110.867 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -105.06 103.7 13.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.92 0.39 . . . . 62.399999999999999 111.408 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 66.2 m . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 121.406 0.622 . . . . 70.329999999999998 111.165 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.649 0 CA-C-O 121.083 0.268 . . . . 73.299999999999997 113.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 26.8 t60 -141.32 148.09 39.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.687 -0.302 . . . . 74.230000000000004 110.457 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.493 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -139.43 144.2 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.146 0.498 . . . . 71.129999999999995 111.692 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.39 153.73 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.907 -0.588 . . . . 61.200000000000003 110.666 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -88.71 128.7 35.62 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.049 0.452 . . . . 71.200000000000003 111.129 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.74 106.38 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.27 -0.423 . . . . 62.25 111.665 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -74.81 -51.99 12.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.938 0.399 . . . . 64.239999999999995 111.384 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -148.88 145.78 27.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.293 0.568 . . . . 40.200000000000003 112.347 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.49 130.02 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.826 -0.625 . . . . 61.530000000000001 110.763 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -88.36 147.46 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.354 -0.385 . . . . 74.420000000000002 111.372 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -56.09 -37.33 69.21 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.908 0.385 . . . . 62.229999999999997 111.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -22.48 64.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 111.736 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.37 -20.66 8.34 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.412 -0.423 . . . . 63.509999999999998 113.587 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -58.63 126.25 26.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.131 0.419 . . . . 65.340000000000003 112.131 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.12 122.89 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.05 -0.523 . . . . 65.040000000000006 111.189 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -103.43 109.58 21.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.273 0.558 . . . . 73.519999999999996 110.978 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.62 160.43 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.961 -0.563 . . . . 54.43 111.534 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.8 p -107.83 124.8 50.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.214 0.531 . . . . 63.229999999999997 111.744 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -108.34 -176.58 3.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.819 -0.628 . . . . 75.219999999999999 111.207 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 39.0 tpp . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 116.381 -0.372 . . . . 54.32 111.48 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.327 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -108.45 121.04 44.13 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.856 -0.611 . . . . 72.349999999999994 111.432 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.4 m -94.98 103.72 15.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 111.458 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 111.309 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.4 m -67.02 144.77 55.99 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.494 -0.321 . . . . 72.120000000000005 111.419 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.69 -47.49 50.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.965 0.728 . . . . 64.510000000000005 112.965 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.85 -57.86 16.12 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.548 -0.358 . . . . 64.299999999999997 113.479 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.57 -41.66 98.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 71.519999999999996 110.971 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.31 69.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.892 -0.595 . . . . 54.329999999999998 112.176 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -64.08 -11.65 31.69 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.489 0.551 . . . . 73.140000000000001 112.489 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 44.4 t -83.0 -10.38 58.8 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.975 0.416 . . . . 73.340000000000003 111.178 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 26.2 m-85 -93.73 153.08 18.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.076 0.465 . . . . 71.310000000000002 111.285 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.27 112.58 20.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.286 -0.416 . . . . 75.530000000000001 111.335 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 89.6 m-85 -93.9 113.52 25.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.121 0.486 . . . . 62.420000000000002 111.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -80.12 128.38 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 54.219999999999999 110.933 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.09 144.82 48.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.436 -0.347 . . . . 71.25 110.568 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.175 0.512 . . . . 63.439999999999998 112.289 -173.685 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.413 HG22 ' OE1' ' A' ' 56' ' ' GLN . 8.8 t . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.971 0.36 . . . . 75.120000000000005 111.971 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 111.01 1.46 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.069 0.461 . . . . 55.130000000000003 111.124 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.65 -24.05 3.06 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.302 -0.475 . . . . 53.229999999999997 112.4 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 53' ' ' THR . 51.4 mt-30 -83.18 138.94 33.43 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.748 -0.266 . . . . 62.109999999999999 110.793 175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.1 p -61.54 -35.37 77.57 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.181 0.515 . . . . 72.019999999999996 109.994 174.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -54.87 -44.97 74.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.513 -0.767 . . . . 74.530000000000001 111.454 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -55.88 -50.09 71.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.903 -0.589 . . . . 72.329999999999998 111.77 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -63.04 -45.37 92.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.796 0.331 . . . . 73.150000000000006 111.667 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.6 t -60.99 -36.18 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.95 0.405 . . . . 42.32 111.053 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -56.14 -43.17 78.01 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 110.81 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.35 -47.55 70.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.153 -0.476 . . . . 63.119999999999997 110.977 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -56.76 -37.92 71.72 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.07 -3.6 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 111.483 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.98 8.43 84.07 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.441 -0.409 . . . . 23.32 113.713 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.55 84.62 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 113.554 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -78.6 36.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.177 0.436 . . . . 73.150000000000006 112.177 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.6 pt -140.02 -178.28 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.989 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.81 108.83 3.43 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.996 -0.621 . . . . 53.130000000000003 112.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.1 p -63.1 -14.66 51.16 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.415 -0.462 . . . . 53.109999999999999 112.203 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 t -85.85 5.4 32.91 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.674 0.62 . . . . 72.349999999999994 112.674 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -67.21 -34.74 78.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.092 -0.38 . . . . 75.340000000000003 111.889 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.25 -118.46 5.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.199 -0.524 . . . . 71.439999999999998 114.045 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -58.16 134.58 56.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.085 0.402 . . . . 55.520000000000003 112.085 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.08 -25.18 60.97 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.549 0.574 . . . . 72.030000000000001 112.549 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.33 -9.97 59.15 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.798 0.332 . . . . 73.129999999999995 111.881 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -102.53 -4.94 24.55 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 111.916 0.339 . . . . 54.020000000000003 111.916 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -64.7 -43.67 92.75 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.626 0.602 . . . . 73.340000000000003 112.626 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.61 95.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.088 0.47 . . . . 44.109999999999999 111.343 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -65.48 -48.11 73.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 64.329999999999998 111.315 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.42 95.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.866 0.365 . . . . 61.119999999999997 111.358 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.14 -56.23 24.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 111.393 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.6 t -64.06 -29.72 70.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 111.646 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 t -75.71 -33.46 60.31 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.941 0.401 . . . . 75.109999999999999 111.645 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.46 -25.0 36.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.902 0.382 . . . . 65.420000000000002 111.6 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 117.65 6.72 12.68 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.057 -0.592 . . . . 55.020000000000003 113.321 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 96.8 m-85 -74.3 158.2 34.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.242 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 92.88 6.91 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.272 0.558 . . . . 45.240000000000002 111.998 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 152' ' ' ILE . 46.7 t -95.3 124.37 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.83 -0.623 . . . . 74.0 111.365 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -146.42 166.97 24.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 111.203 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -82.49 -5.57 58.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.261 -0.427 . . . . 74.540000000000006 111.47 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 113.04 6.77 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 116.599 -0.273 . . . . 60.539999999999999 110.674 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.471 ' O ' HG21 ' A' ' 116' ' ' VAL . 94.1 Cg_endo -82.14 20.82 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.106 2.537 . . . . 72.140000000000001 114.625 -170.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.8 147.63 22.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.1 0.778 . . . . 73.340000000000003 113.1 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -64.75 159.82 21.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.366 -0.833 . . . . 64.519999999999996 112.329 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.7 44.65 12.08 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.405 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -156.48 179.66 9.04 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.975 0.417 . . . . 71.019999999999996 111.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.62 122.87 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.209 -0.45 . . . . 73.040000000000006 110.726 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -97.85 134.21 41.3 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.131 0.491 . . . . 54.009999999999998 111.078 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -101.62 116.66 33.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.013 0.435 . . . . 73.319999999999993 112.069 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 115.824 -0.626 . . . . 70.219999999999999 110.11 173.644 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 113.485 0.154 . . . . 33.340000000000003 113.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -141.17 130.92 24.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.427 0.291 . . . . 54.240000000000002 110.989 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.511 HG13 ' HB1' ' A' ' 76' ' ' ALA . 26.3 m -127.37 146.92 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.003 0.43 . . . . 74.420000000000002 111.441 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.53 156.47 45.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.095 -0.502 . . . . 43.409999999999997 111.088 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -87.15 127.13 35.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.86 0.362 . . . . 52.450000000000003 111.64 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 122' ' ' VAL . 60.1 t -77.85 105.17 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.303 -0.408 . . . . 53.049999999999997 111.151 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.12 -48.46 10.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.622 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -150.69 151.93 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.97 0.414 . . . . 74.340000000000003 111.585 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 94' ' ' PRO . 29.0 t -127.17 137.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.421 -0.354 . . . . 74.450000000000003 111.137 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.49 HD22 ' HB2' ' A' ' 121' ' ' SER . 87.2 m-20 -77.63 164.22 25.53 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.909 0.385 . . . . 54.229999999999997 111.41 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 m -63.09 -31.22 72.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.878 0.325 . . . . 72.319999999999993 111.878 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.66 -39.21 64.62 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 111.837 0.31 . . . . 61.520000000000003 111.837 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 142.13 -12.22 2.57 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 113.85 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.49 ' HB2' HD22 ' A' ' 117' ' ' ASN . 67.4 m -55.26 128.55 34.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.239 0.543 . . . . 55.020000000000003 111.835 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 113' ' ' VAL . 48.4 t -106.56 119.35 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.503 -0.771 . . . . 72.129999999999995 111.763 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.89 107.52 19.27 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.92 0.391 . . . . 72.510000000000005 110.577 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 122' ' ' VAL . 32.9 m -112.24 148.55 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.718 0.636 . . . . 65.040000000000006 112.718 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.8 p -99.21 112.45 24.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.795 -0.639 . . . . 74.120000000000005 111.376 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -123.44 -172.33 2.49 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.031 -0.531 . . . . 72.25 111.18 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.475 0.801 0 O-C-N 122.301 -0.25 . . . . 73.019999999999996 110.881 -179.506 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 121.018 0.437 . . . . 62.149999999999999 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -96.91 122.95 40.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 111.88 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 32.5 m -93.83 113.42 25.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.097 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.84 125.25 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.793 0.294 . . . . 71.140000000000001 111.793 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -62.23 145.14 54.42 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.684 0.278 . . . . 73.319999999999993 111.575 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.431 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -51.36 -43.03 61.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.775 0.657 . . . . 75.120000000000005 112.775 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.12 -22.25 28.11 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.252 -0.499 . . . . 74.340000000000003 113.707 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -101.69 -47.39 4.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 71.019999999999996 110.692 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.549 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.83 -40.78 94.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 113.192 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.6 m -60.59 -16.62 40.04 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.927 0.714 . . . . 75.310000000000002 112.927 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.4 t -79.16 -25.31 42.87 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.962 0.41 . . . . 63.439999999999998 111.55 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.71 148.49 34.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.06 0.457 . . . . 72.340000000000003 111.608 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.548 HD22 ' N ' ' A' ' 150' ' ' ASN . 0.8 OUTLIER -83.76 115.78 22.38 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.237 -0.289 . . . . 51.399999999999999 111.358 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 69.8 m-85 -94.2 110.83 22.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.847 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -81.37 113.38 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.293 -0.412 . . . . 75.510000000000005 110.695 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -104.29 135.98 44.73 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.691 0.281 . . . . 64.209999999999994 110.677 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.891 -175.793 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 120.984 0.421 . . . . 72.150000000000006 112.081 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.52 149.64 27.42 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.162 0.506 . . . . 64.400000000000006 112.338 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.64 -34.77 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.292 -0.413 . . . . 54.25 113.428 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.21 148.76 50.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.773 0.32 . . . . 71.510000000000005 111.545 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.3 p -56.8 -43.06 80.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.983 0.42 . . . . 70.319999999999993 111.12 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -55.73 -39.57 71.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.04 -0.527 . . . . 63.340000000000003 111.565 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.504 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 87.6 t90 -60.54 -52.29 65.8 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 111.44 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.06 -41.37 96.48 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.136 -0.353 . . . . 75.510000000000005 111.344 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 112' ' ' TYR . 65.7 t -63.23 -35.04 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.276 0.56 . . . . 75.400000000000006 110.69 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 59' ' ' TRP . 60.5 t80 -57.15 -46.51 82.67 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.589 -0.732 . . . . 63.329999999999998 111.136 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.6 -40.86 72.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.851 0.357 . . . . 55.009999999999998 111.726 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -61.33 -31.94 71.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.284 0.476 . . . . 71.329999999999998 112.284 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 65' ' ' VAL . 7.5 p -84.92 6.49 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.279 0.562 . . . . 72.239999999999995 111.193 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 21.63 73.96 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.425 -0.417 . . . . 74.230000000000004 113.527 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.55 27.16 71.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 121.227 -0.511 . . . . 55.049999999999997 113.456 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -89.95 25.45 2.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.216 -0.579 . . . . 75.129999999999995 111.674 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.4 pt -131.57 176.52 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.788 0.435 . . . . 74.230000000000004 110.643 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 129.22 9.81 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.8 -0.714 . . . . 54.439999999999998 113.124 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.6 m -62.35 -23.18 66.64 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.466 -0.432 . . . . 75.349999999999994 112.117 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -60.31 -15.74 28.18 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.599 0.592 . . . . 74.310000000000002 112.599 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -60.48 -36.18 77.67 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.045 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.44 -122.99 24.38 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.661 0.624 . . . . 71.209999999999994 114.661 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -60.23 141.84 55.42 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.25 0.548 . . . . 55.409999999999997 112.062 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.57 -23.11 62.64 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.993 0.738 . . . . 64.450000000000003 112.993 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.01 -11.4 60.32 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 122.046 -0.409 . . . . 72.109999999999999 111.864 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -101.54 -26.22 13.62 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.442 0.534 . . . . 73.519999999999996 112.442 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -41.08 -59.16 1.56 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.48 1.289 . . . . 72.129999999999995 114.48 -173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.85 85.01 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.046 -0.409 . . . . 53.299999999999997 112.013 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 m -63.78 -43.28 96.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 111.261 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.06 99.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.928 0.394 . . . . 52.32 111.365 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.1 82.9 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.042 0.448 . . . . 65.209999999999994 110.998 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 m -61.39 -40.68 95.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.133 -0.485 . . . . 65.230000000000004 111.489 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -73.16 -36.88 66.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.13 0.419 . . . . 74.540000000000006 112.13 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.02 66.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.231 0.456 . . . . 75.129999999999995 112.231 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.59 0.87 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.93 -0.652 . . . . 32.210000000000001 113.448 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.51 179.47 4.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 73.209999999999994 111.445 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.9 m -108.88 94.58 5.13 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.948 0.404 . . . . 64.530000000000001 111.815 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.85 111.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.893 0.377 . . . . 43.049999999999997 111.181 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.78 176.77 7.56 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.018 0.437 . . . . 75.400000000000006 111.09 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.26 -1.87 57.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.672 0.272 . . . . 44.210000000000001 110.818 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 t -55.8 118.28 19.33 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 116.304 -0.407 . . . . 75.120000000000005 111.425 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -86.23 11.8 3.2 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.008 2.472 . . . . 70.519999999999996 113.942 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -59.06 143.57 48.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 112.138 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.69 163.36 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.774 -0.648 . . . . 74.239999999999995 112.627 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.97 16.17 75.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.128 -0.558 . . . . 61.039999999999999 112.762 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -124.69 165.99 16.96 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.74 0.305 . . . . 52.329999999999998 111.153 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -112.96 128.73 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.25 -0.281 . . . . 72.530000000000001 110.553 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -101.26 133.06 46.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.332 0.587 . . . . 70.340000000000003 111.296 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.556 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.2 tt0 -92.83 108.83 20.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.046 -0.524 . . . . 63.100000000000001 110.934 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 46.6 m . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 N-CA-C 111.987 -0.445 . . . . 30.539999999999999 111.987 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -166.83 141.22 4.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.076 0.438 . . . . 65.329999999999998 111.521 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 101' ' ' GLN . 16.9 m -146.18 153.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.29 0.636 . . . . 60.350000000000001 110.697 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.22 160.55 42.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.926 0.394 . . . . 52.25 111.278 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' HB2' HG13 ' A' ' 61' ' ' VAL . 70.9 t80 -98.62 127.79 44.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.937 0.399 . . . . 74.040000000000006 111.445 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 116.21 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.391 -0.368 . . . . 74.519999999999996 111.888 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -88.03 -38.83 15.14 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.116 0.413 . . . . 73.409999999999997 112.116 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -161.88 145.91 12.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.796 0.665 . . . . 73.530000000000001 112.796 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.99 150.4 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.888 -0.596 . . . . 63.240000000000002 110.573 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.415 HD21 ' HG3' ' A' ' 123' ' ' GLU . 27.5 m-80 -113.11 168.73 9.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.479 0.548 . . . . 73.200000000000003 112.479 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.7 t -63.22 -31.84 73.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.086 0.47 . . . . 72.430000000000007 110.933 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.95 -12.36 54.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 111.723 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.62 -1.22 89.04 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.636 -0.585 . . . . 73.439999999999998 111.636 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 m -68.38 136.1 52.82 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.941 0.401 . . . . 61.340000000000003 111.608 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.92 122.03 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.056 -0.52 . . . . 73.120000000000005 111.884 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HG3' HD21 ' A' ' 117' ' ' ASN . 43.7 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 75.420000000000002 111.082 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.01 149.22 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.116 -0.493 . . . . 73.420000000000002 112.224 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.4 t -97.37 109.39 22.16 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.005 -0.543 . . . . 70.239999999999995 111.55 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.18 171.05 7.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.003 -0.544 . . . . 62.140000000000001 110.295 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 111.935 178.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 120.979 0.418 . . . . 60.229999999999997 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -99.64 119.39 38.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.098 0.475 . . . . 72.450000000000003 111.544 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.2 m -95.63 94.34 7.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.257 -0.429 . . . . 71.239999999999995 110.77 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.7 mt -83.22 131.83 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.582 -0.281 . . . . 72.420000000000002 111.311 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.5 m -62.63 150.11 41.63 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.483 0.182 . . . . 60.130000000000003 111.485 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.58 -51.06 39.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.736 0.643 . . . . 74.200000000000003 112.736 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.66 70.3 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.286 -0.415 . . . . 73.0 113.504 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.14 -38.53 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.124 0.487 . . . . 74.540000000000006 111.266 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -63.67 -38.69 92.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.073 -0.512 . . . . 75.019999999999996 112.173 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.1 t -61.36 -12.17 12.95 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.345 0.498 . . . . 75.140000000000001 112.345 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.1 t -82.02 -13.96 56.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.739 0.304 . . . . 45.140000000000001 111.784 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.44 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 36.2 m-85 -97.05 151.35 19.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 111.992 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -89.81 115.53 27.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.351 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.418 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 96.3 m-85 -94.87 112.06 23.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.419 . . . . 72.540000000000006 111.86 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.9 mp -79.36 121.25 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.706 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -112.6 136.12 52.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 109.971 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.6 mt . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.81 0.338 . . . . 72.109999999999999 111.697 -175.663 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 121.274 0.559 . . . . 71.019999999999996 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.69 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.678 -0.692 . . . . 61.140000000000001 111.051 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.83 -31.5 4.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.337 -0.459 . . . . 50.240000000000002 112.819 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -60.97 137.65 58.22 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.526 -0.396 . . . . 72.010000000000005 111.84 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.459 ' O ' HG23 ' A' ' 61' ' ' VAL . 57.2 m -50.59 -41.95 55.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 71.430000000000007 110.416 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -59.29 -39.19 82.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.267 -0.879 . . . . 71.049999999999997 112.182 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -60.81 -52.62 64.3 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.5 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.78 -49.21 78.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.949 0.404 . . . . 62.420000000000002 111.76 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' CYS . 67.5 t -59.87 -36.73 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.958 0.408 . . . . 61.009999999999998 111.348 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -58.46 -38.52 77.71 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.098 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.21 -46.68 69.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.378 -0.373 . . . . 71.230000000000004 111.174 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.65 -33.69 71.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.232 0.456 . . . . 73.5 112.232 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -88.98 12.12 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-O 121.31 0.576 . . . . 75.400000000000006 111.461 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.19 14.23 55.89 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.361 -0.381 . . . . 51.009999999999998 113.814 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.21 9.1 53.52 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 114.194 0.438 . . . . 72.019999999999996 114.194 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.4 -20.56 63.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.592 0.59 . . . . 74.299999999999997 112.592 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 154' ' ' LEU . 34.2 pt -80.23 -35.9 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.895 0.702 . . . . 72.340000000000003 112.895 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 119.34 2.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.097 -0.573 . . . . 63.530000000000001 112.231 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -81.72 20.39 0.94 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.771 0.656 . . . . 70.209999999999994 112.771 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 t -90.81 12.3 19.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 74.439999999999998 111.97 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -83.42 -30.03 27.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.683 0.277 . . . . 60.509999999999998 111.72 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.66 -126.31 7.48 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.373 -0.442 . . . . 50.43 113.925 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -58.8 139.47 56.29 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.893 0.377 . . . . 44.009999999999998 111.73 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -54.62 -40.29 68.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.839 0.681 . . . . 42.310000000000002 112.839 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -71.81 -9.59 58.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.689 0.626 . . . . 74.150000000000006 112.689 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -97.19 -15.98 20.62 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.759 0.314 . . . . 41.25 111.263 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -49.79 -58.74 4.74 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.726 0.639 . . . . 74.120000000000005 112.726 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.43 -39.71 70.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 75.439999999999998 111.769 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -40.41 89.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.325 -0.398 . . . . 70.400000000000006 111.766 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.44 -45.84 24.49 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.012 0.434 . . . . 74.140000000000001 111.37 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.89 -56.58 11.62 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.38 0.511 . . . . 71.409999999999997 112.38 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m -67.55 -1.01 4.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.621 0.6 . . . . 75.349999999999994 112.621 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.0 t -116.93 -12.18 10.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.973 0.416 . . . . 52.119999999999997 111.54 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.05 8.54 38.82 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.17 0.433 . . . . 72.239999999999995 112.17 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.82 35.82 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.967 -0.635 . . . . 61.200000000000003 113.543 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.01 162.63 12.98 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.141 0.496 . . . . 51.140000000000001 111.355 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -111.28 99.08 7.97 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.879 0.371 . . . . 74.049999999999997 111.905 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 152' ' ' ILE . 57.4 t -93.6 103.75 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.422 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 86.4 m-20 -134.8 137.92 43.79 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.061 -0.518 . . . . 75.209999999999994 109.956 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.58 -4.69 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.056 0.761 . . . . 74.25 113.056 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 m -55.71 112.81 4.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 122.597 0.359 . . . . 74.120000000000005 111.388 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.75 119.0 3.55 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.813 2.342 . . . . 71.200000000000003 113.166 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.9 145.16 30.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.703 -0.681 . . . . 73.019999999999996 111.146 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.43 133.11 54.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.917 0.389 . . . . 20.420000000000002 111.596 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.22 48.83 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.841 -0.695 . . . . 72.120000000000005 112.795 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.3 p -159.3 177.13 11.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.94 0.4 . . . . 63.420000000000002 110.657 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mt -123.7 122.75 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.872 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -98.59 123.52 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.547 0.689 . . . . 73.310000000000002 111.66 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 29.0 tt0 -82.37 106.45 14.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.94 -0.573 . . . . 73.030000000000001 111.45 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 44.2 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 110.734 173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 CA-C-O 120.838 0.132 . . . . 73.019999999999996 113.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 74.6 t60 -140.49 105.97 5.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.908 0.385 . . . . 65.049999999999997 110.652 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG13 ' HB1' ' A' ' 76' ' ' ALA . 27.7 m -103.65 136.38 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.111 0.481 . . . . 71.409999999999997 111.649 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.88 159.52 41.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.929 -0.578 . . . . 71.540000000000006 110.737 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -93.14 123.98 36.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.879 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.61 112.29 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.021 0.439 . . . . 73.230000000000004 111.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.23 -49.36 13.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.021 -0.536 . . . . 72.530000000000001 111.459 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -164.96 139.57 5.14 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.963 0.411 . . . . 64.239999999999995 112.091 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.42 123.64 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.247 -0.433 . . . . 52.229999999999997 109.922 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -78.17 166.84 22.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.372 0.508 . . . . 75.010000000000005 112.372 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -47.26 -48.51 24.57 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.465 0.543 . . . . 65.299999999999997 112.465 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.72 -45.28 87.22 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.002 0.429 . . . . 71.450000000000003 111.769 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.42 -21.89 2.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.889 -0.672 . . . . 70.430000000000007 113.661 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.1 m -56.78 129.74 42.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.419 0.61 . . . . 74.329999999999998 111.426 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.2 t -103.74 120.97 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.81 -0.632 . . . . 74.0 112.033 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.45 122.76 33.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.428 -0.351 . . . . 73.340000000000003 110.843 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.89 149.9 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.378 0.51 . . . . 73.5 112.378 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 90.1 p -94.35 126.57 39.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 111.171 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.85 179.75 4.4 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.413 0.625 . . . . 61.240000000000002 111.962 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.4 ttm . . . . . 0 CA--C 1.535 0.391 0 CA-C-N 115.53 -0.759 . . . . 65.25 109.851 171.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 110.842 -0.059 . . . . 73.0 110.842 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -127.91 133.21 49.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 111.782 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.9 m -97.49 100.22 11.63 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.846 0.355 . . . . 64.099999999999994 110.717 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.0 mt -81.57 136.91 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.681 0.277 . . . . 74.409999999999997 111.426 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -63.72 147.42 51.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.603 0.239 . . . . 73.319999999999993 111.538 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.84 -45.8 71.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.372 0.508 . . . . 63.0 112.372 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.35 -49.96 71.23 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.286 -0.483 . . . . 61.130000000000003 113.3 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -44.15 91.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 110.856 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.449 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.49 -44.3 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.777 -0.647 . . . . 70.400000000000006 112.112 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 t -63.9 -16.34 61.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.101 0.477 . . . . 74.140000000000001 111.577 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.2 t -82.08 -6.22 59.0 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.385 -0.37 . . . . 62.119999999999997 111.731 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 22.3 m-85 -102.11 153.16 20.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 73.030000000000001 111.821 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 15.9 m-80 -92.04 107.25 19.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.447 -0.342 . . . . 72.0 111.518 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.8 m-85 -85.9 114.66 22.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.28 0.474 . . . . 73.239999999999995 112.28 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -78.44 114.52 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.549 174.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -106.36 142.51 35.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.85 0.357 . . . . 64.430000000000007 110.961 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.485 HD21 HG22 ' A' ' 69' ' ' ILE . 41.7 mt . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 120.851 0.358 . . . . 72.150000000000006 111.749 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 112.797 0.666 . . . . 74.209999999999994 112.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.0 142.34 58.41 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.876 -0.602 . . . . 75.409999999999997 111.917 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.92 32.35 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.23 -0.51 . . . . 71.140000000000001 112.29 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.76 139.68 31.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.244 -0.28 . . . . 75.120000000000005 110.244 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 49.0 m -54.87 -29.23 55.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.984 0.421 . . . . 72.409999999999997 112.043 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 p -60.15 -35.67 75.83 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.909 0.707 . . . . 74.530000000000001 112.909 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 48.6 t90 -61.91 -62.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.278 0.844 . . . . 72.319999999999993 113.278 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 32.5 p90 -68.01 -28.86 67.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.875 0.694 . . . . 73.299999999999997 112.875 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.68 -36.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.06 0.457 . . . . 72.420000000000002 111.018 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -59.41 -34.93 73.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.276 0.56 . . . . 64.129999999999995 110.964 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.71 -50.56 34.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.94 -0.573 . . . . 75.209999999999994 110.405 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.0 mmmt -55.3 -36.82 66.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.774 0.657 . . . . 73.530000000000001 112.774 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.448 HG21 HG23 ' A' ' 69' ' ' ILE . 8.0 p -82.33 -5.22 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 121.059 0.457 . . . . 74.200000000000003 111.929 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.57 24.43 76.21 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.283 -0.484 . . . . 54.420000000000002 113.55 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.12 23.2 72.95 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.203 -0.522 . . . . 73.540000000000006 113.895 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -89.26 19.9 4.09 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.311 0.486 . . . . 61.119999999999997 112.311 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 65' ' ' VAL . 34.7 pt -126.73 178.49 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.921 0.391 . . . . 74.239999999999995 111.537 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.28 125.65 7.26 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.315 -0.469 . . . . 65.140000000000001 113.043 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.7 p -80.55 -13.35 59.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.742 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -94.55 13.92 22.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.204 0.446 . . . . 72.540000000000006 112.204 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.43 -32.37 58.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 73.409999999999997 111.824 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.48 -118.63 6.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.297 -0.477 . . . . 74.540000000000006 113.665 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.3 137.74 56.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.097 0.406 . . . . 75.439999999999998 112.097 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.36 -42.68 74.22 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.355 0.502 . . . . 62.25 112.355 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -68.64 -2.99 10.35 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.568 0.581 . . . . 74.310000000000002 112.568 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -100.96 -10.24 20.77 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.785 0.326 . . . . 60.109999999999999 111.537 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -61.19 -36.56 80.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.042 0.756 . . . . 70.349999999999994 113.042 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.21 -50.14 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.12 0.486 . . . . 75.140000000000001 111.2 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -61.23 -46.48 90.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.065 -0.516 . . . . 65.439999999999998 111.27 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.24 -52.54 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.085 -0.507 . . . . 62.109999999999999 111.614 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.46 -47.41 69.77 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.831 0.348 . . . . 64.420000000000002 111.665 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -59.58 -50.99 71.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.18 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.0 t -69.28 -19.85 63.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.205 0.446 . . . . 54.049999999999997 112.205 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.41 -36.03 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.081 0.401 . . . . 71.140000000000001 112.081 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.16 8.04 5.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.992 -0.623 . . . . 75.420000000000002 113.181 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -80.07 -171.34 2.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.186 0.517 . . . . 63.119999999999997 111.176 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.0 m -121.94 91.25 3.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.064 0.459 . . . . 63.109999999999999 111.359 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.27 105.17 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.0 0.428 . . . . 74.109999999999999 111.315 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -127.2 161.31 28.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 111.212 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.41 7.24 20.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.136 0.493 . . . . 71.219999999999999 110.969 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 m -72.76 112.49 15.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.318 -0.401 . . . . 41.219999999999999 110.995 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.58 22.72 0.51 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.052 2.501 . . . . 54.539999999999999 114.47 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 153' ' ' HIS . 36.4 tt0 -60.1 147.16 40.48 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.063 0.459 . . . . 62.109999999999999 111.851 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.34 166.55 21.39 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.22 0.822 . . . . 75.239999999999995 113.22 -173.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.06 31.02 44.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.703 -0.68 . . . . 71.230000000000004 112.93 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.1 m -146.75 170.63 16.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 111.273 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -107.68 133.83 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 110.254 -0.276 . . . . 75.319999999999993 110.254 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -98.89 107.82 20.35 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.986 0.898 . . . . 73.420000000000002 111.049 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -72.93 99.12 2.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 72.049999999999997 109.822 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 50.9 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.56 -0.746 . . . . 74.530000000000001 111.595 -173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 112.228 -0.349 . . . . 75.340000000000003 112.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -112.38 147.37 36.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 111.929 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 101' ' ' GLN . 10.1 m -142.69 141.49 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.143 -0.481 . . . . 64.439999999999998 110.667 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.03 159.63 43.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.76 0.314 . . . . 63.229999999999997 110.509 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -94.32 125.73 39.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.945 0.403 . . . . 51.149999999999999 111.667 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.42 109.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.893 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.84 -61.18 2.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.044 -0.525 . . . . 65.129999999999995 111.771 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -148.56 145.43 27.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 62.140000000000001 111.949 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.2 t -103.11 125.77 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.595 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -95.36 141.07 29.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.748 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -60.36 -21.25 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.394 -0.366 . . . . 53.420000000000002 111.852 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.23 -12.89 56.12 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.863 0.363 . . . . 74.239999999999995 111.956 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.83 45.56 4.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.93 -0.468 . . . . 64.319999999999993 111.93 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.7 p -137.17 138.6 40.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.086 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.17 119.45 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.223 -0.444 . . . . 62.43 111.57 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -88.44 112.27 22.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.86 0.362 . . . . 55.32 110.963 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.97 137.91 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.195 0.521 . . . . 64.519999999999996 112.02 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 34.5 p -86.61 115.61 24.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.07 0.462 . . . . 64.310000000000002 111.883 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.42 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 11.5 pt-20 -133.43 -179.27 5.41 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.596 . . . . 75.120000000000005 111.387 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.451 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 49.0 ttm . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.905 0.383 . . . . 53.539999999999999 111.54 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 120.819 0.342 . . . . 63.509999999999998 111.375 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -82.52 120.97 26.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.171 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 71.4 m -85.81 106.56 17.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.042 0.448 . . . . 75.140000000000001 110.923 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -97.71 139.65 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.192 -0.458 . . . . 72.510000000000005 111.658 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -69.71 154.54 41.84 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.783 0.325 . . . . 61.020000000000003 111.233 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.87 80.99 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.605 0.595 . . . . 64.129999999999995 112.605 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.26 -49.12 82.02 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.293 -0.479 . . . . 63.020000000000003 112.996 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.55 -40.98 93.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.127 0.489 . . . . 51.399999999999999 110.861 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.57 -42.57 78.83 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 111.8 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.3 t -60.96 -19.83 61.51 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.106 0.479 . . . . 64.209999999999994 111.744 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 47.4 t -77.42 -17.72 57.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.929 0.395 . . . . 71.319999999999993 111.674 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 17.0 m-85 -101.01 157.87 16.43 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.229 0.538 . . . . 72.409999999999997 111.817 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -99.74 111.04 23.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 111.333 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -87.98 106.2 17.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.063 0.459 . . . . 72.010000000000005 111.976 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.433 HD12 ' H ' ' A' ' 152' ' ' ILE . 4.1 mp -77.14 103.18 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.053 -0.521 . . . . 73.310000000000002 110.907 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' A' ' 95' ' ' GLU . 92.8 m-70 -85.16 143.09 29.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.364 . . . . 70.319999999999993 110.435 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 75.129999999999995 112.568 -166.424 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.404 0.52 . . . . 70.019999999999996 112.404 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.27 143.03 41.12 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.033 0.444 . . . . 43.219999999999999 111.946 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.95 58.19 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.086 -0.506 . . . . 45.210000000000001 113.295 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -83.52 141.59 31.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.904 0.352 . . . . 74.420000000000002 111.513 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 60' ' ' TYR . 56.6 m -59.97 -29.41 68.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.401 0.619 . . . . 45.240000000000002 111.075 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.1 p -76.08 -11.35 59.93 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.817 -0.629 . . . . 73.019999999999996 112.549 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -76.8 -62.71 1.55 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.657 0.614 . . . . 72.430000000000007 112.657 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HE2' ' HA ' ' A' ' 57' ' ' CYS . 50.5 p90 -63.72 -26.56 68.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.923 0.712 . . . . 73.109999999999999 112.923 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.465 HG21 HG23 ' A' ' 110' ' ' VAL . 46.4 t -60.68 -31.96 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.897 0.38 . . . . 74.230000000000004 111.974 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.79 -44.53 95.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.883 0.373 . . . . 72.439999999999998 111.295 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -64.63 -41.06 96.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.286 0.565 . . . . 74.510000000000005 110.565 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.9 mmmt -62.18 -32.91 73.59 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.693 -0.685 . . . . 70.140000000000001 112.28 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 HD11 ' A' ' 154' ' ' LEU . 9.2 p -96.52 6.82 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 121.334 0.588 . . . . 72.219999999999999 111.961 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.53 8.62 76.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 45.409999999999997 114.237 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.87 3.07 66.79 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.038 0.775 . . . . 34.25 115.038 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.01 17.64 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.904 -0.762 . . . . 74.420000000000002 112.705 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 pt -106.32 -29.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 111.954 0.353 . . . . 64.340000000000003 111.954 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.87 98.77 1.1 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.044 -0.598 . . . . 71.319999999999993 112.884 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 p -73.02 83.85 1.26 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.229 -0.571 . . . . 75.340000000000003 111.522 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.7 t -154.79 17.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.09 0.471 . . . . 64.239999999999995 111.318 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -89.47 -4.12 58.09 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.26 0.467 . . . . 74.299999999999997 112.26 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.63 -137.76 22.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.054 -0.593 . . . . 64.109999999999999 113.329 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -70.24 155.39 40.71 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.502 -0.411 . . . . 73.219999999999999 111.57 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -56.84 -32.12 65.45 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.828 0.677 . . . . 60.140000000000001 112.828 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.93 -28.61 57.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.328 0.492 . . . . 75.319999999999993 112.328 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.33 -16.53 24.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.286 0.476 . . . . 73.239999999999995 112.286 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 6.6 m0 -50.22 -66.02 0.46 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.964 1.098 . . . . 73.340000000000003 113.964 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.5 -33.71 68.31 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.298 0.481 . . . . 52.399999999999999 112.298 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -67.31 -48.02 68.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.057 0.456 . . . . 74.109999999999999 110.835 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.52 96.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.357 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.96 44.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.298 -0.41 . . . . 73.329999999999998 111.105 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -61.07 -40.0 92.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.892 0.377 . . . . 62.539999999999999 110.939 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -63.62 -27.58 69.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.301 -0.408 . . . . 62.240000000000002 111.379 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.27 -12.18 41.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.945 0.402 . . . . 63.329999999999998 111.898 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.51 52.69 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.261 -0.495 . . . . 72.319999999999993 113.693 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -70.51 175.52 4.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.333 0.587 . . . . 74.219999999999999 112.012 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -101.01 92.03 4.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.053 -0.521 . . . . 64.200000000000003 111.506 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 152' ' ' ILE . 22.0 t -99.8 93.48 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.916 0.389 . . . . 71.120000000000005 111.024 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -122.5 168.2 12.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.543 -0.299 . . . . 71.5 110.529 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.35 5.92 32.47 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.931 -0.481 . . . . 75.099999999999994 111.767 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 44.2 m -65.21 109.06 2.5 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 116.729 -0.214 . . . . 65.099999999999994 110.829 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 6.2 Cg_exo -79.14 8.85 3.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.302 2.668 . . . . 74.420000000000002 113.968 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.01 145.26 17.1 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.333 0.494 . . . . 75.120000000000005 112.333 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.72 46.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.877 -0.601 . . . . 54.149999999999999 112.587 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.28 55.5 1.69 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.001 -0.619 . . . . 70.420000000000002 111.803 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.6 t -163.01 165.35 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.305 0.574 . . . . 50.509999999999998 111.85 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 35.2 mt -116.58 125.38 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.644 -0.707 . . . . 65.400000000000006 110.479 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.8 pt? -99.43 133.14 44.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.928 0.394 . . . . 65.25 111.396 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -102.4 133.18 47.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.399 0.518 . . . . 73.140000000000001 112.399 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.473 0.684 0 CA-C-N 116.033 -0.53 . . . . 74.549999999999997 110.38 171.662 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.152 0.306 . . . . 63.229999999999997 113.038 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -140.73 137.27 33.33 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.857 -0.202 . . . . 65.150000000000006 110.817 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.3 m -138.68 141.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.923 0.392 . . . . 54.130000000000003 111.499 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.09 22.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.96 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -101.37 133.73 45.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.02 0.438 . . . . 71.019999999999996 111.44 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.41 110.1 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 111.646 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.43 -53.38 9.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.09 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -156.57 143.36 18.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.041 0.448 . . . . 61.450000000000003 112.135 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.71 135.0 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.386 -0.37 . . . . 63.25 110.926 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -92.17 154.7 18.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.369 -0.378 . . . . 63.43 111.304 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -59.18 -24.25 62.92 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.84 0.352 . . . . 65.430000000000007 111.688 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.17 -11.52 60.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.926 0.393 . . . . 71.329999999999998 111.717 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.65 56.47 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.385 -0.436 . . . . 42.219999999999999 112.968 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.1 m -64.84 126.43 27.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.11 0.481 . . . . 64.409999999999997 111.423 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.4 t -103.19 129.74 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.957 -0.565 . . . . 50.009999999999998 111.32 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.14 112.96 26.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.857 0.361 . . . . 75.099999999999994 111.415 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.0 162.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.964 0.412 . . . . 73.510000000000005 111.81 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.42 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 61.7 p -117.03 133.91 55.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.13 0.49 . . . . 72.230000000000004 111.614 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -129.51 152.09 49.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.12 -0.491 . . . . 53.119999999999997 111.047 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.0 ttm . . . . . 0 N--CA 1.466 0.336 0 O-C-N 121.902 -0.499 . . . . 61.450000000000003 109.96 172.11 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.605 0.24 . . . . 65.329999999999998 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.22 109.8 6.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 110.866 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 79.9 m -85.02 139.28 31.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.445 -0.343 . . . . 53.310000000000002 111.569 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.6 mt -123.52 149.08 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.758 0.423 . . . . 43.310000000000002 110.87 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 m -64.53 156.77 28.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.11 0.164 . . . . 61.039999999999999 110.838 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.67 -63.22 1.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.086 0.402 . . . . 64.439999999999998 112.086 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.66 -38.1 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.204 -0.522 . . . . 71.109999999999999 112.956 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.51 -36.26 80.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.006 0.522 . . . . 64.450000000000003 110.991 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.41 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -71.62 -43.63 65.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.106 -0.497 . . . . 61.399999999999999 111.529 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 t -59.23 -15.73 16.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 111.965 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.7 t -70.07 -25.28 63.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.925 0.393 . . . . 64.010000000000005 111.575 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -87.4 154.56 20.57 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.242 0.544 . . . . 72.430000000000007 111.895 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -89.3 119.76 30.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.952 -0.567 . . . . 64.409999999999997 110.828 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 95.5 m-85 -100.91 117.07 34.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.634 0.605 . . . . 55.549999999999997 112.634 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -91.35 121.03 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.127 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -113.76 157.31 22.41 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.901 0.481 . . . . 71.439999999999998 110.96 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.499 HD11 HG22 ' A' ' 65' ' ' VAL . 34.2 mt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.49 0.552 . . . . 73.310000000000002 112.49 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 112.153 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 95.93 0.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.021 -0.536 . . . . 75.099999999999994 111.917 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.21 -22.74 0.87 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.955 -0.566 . . . . 52.149999999999999 112.679 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -80.31 146.89 31.37 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 111.713 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.6 m -57.87 -38.52 75.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.56 0.695 . . . . 64.340000000000003 110.448 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.9 p -62.7 -24.33 67.6 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.487 -0.779 . . . . 72.409999999999997 112.274 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -62.59 -65.28 0.71 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.334 0.494 . . . . 65.140000000000001 112.334 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -66.97 -29.08 68.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.537 0.569 . . . . 73.230000000000004 112.537 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 57' ' ' CYS . 61.1 t -61.37 -37.63 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 111.426 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -57.97 -47.82 81.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.978 0.418 . . . . 75.319999999999993 110.845 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.14 -38.69 72.25 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.944 0.35 . . . . 62.32 111.944 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -56.07 -38.39 70.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.998 0.428 . . . . 72.319999999999993 111.855 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' ILE . 8.8 p -88.39 9.37 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 121.388 0.613 . . . . 51.329999999999998 111.456 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.68 -2.87 77.3 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.336 -0.393 . . . . 33.439999999999998 113.703 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.31 14.56 66.06 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.998 -0.62 . . . . 63.229999999999997 113.143 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.82 10.38 6.4 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.199 0.444 . . . . 73.129999999999995 112.199 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 pt -110.5 174.1 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.799 0.333 . . . . 53.409999999999997 111.118 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.6 124.31 6.76 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.93 -0.652 . . . . 54.329999999999998 114.013 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.3 p -65.5 -19.39 65.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.026 0.441 . . . . 75.400000000000006 111.13 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 t -78.58 -6.94 56.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.809 0.67 . . . . 64.140000000000001 112.809 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -61.33 -43.51 98.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.153 -0.342 . . . . 74.519999999999996 111.684 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.89 -116.29 5.92 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 114.246 0.458 . . . . 71.540000000000006 114.246 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -57.66 132.47 53.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.197 0.444 . . . . 72.0 112.197 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.96 -40.55 80.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.178 0.513 . . . . 41.399999999999999 111.885 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -66.91 -19.3 65.7 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.394 0.616 . . . . 72.530000000000001 110.767 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.9 -17.51 23.92 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.055 -0.521 . . . . 74.109999999999999 112.387 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.401 ' CZ3' HG21 ' A' ' 99' ' ' ILE . 10.7 m0 -47.56 -47.07 28.4 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.345 0.868 . . . . 73.530000000000001 113.345 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.415 ' H ' ' NE2' ' A' ' 101' ' ' GLN . . . -59.22 -46.48 88.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.83 0.348 . . . . 50.509999999999998 111.701 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.6 t -59.43 -38.91 81.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.004 0.43 . . . . 41.310000000000002 111.439 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.45 -59.51 2.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 111.277 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -50.47 -52.65 36.26 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.685 0.624 . . . . 73.150000000000006 112.685 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 p -55.64 -53.52 55.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 111.998 0.37 . . . . 71.030000000000001 111.998 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -72.14 -22.1 61.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.233 0.457 . . . . 74.310000000000002 112.233 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.64 -17.55 50.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.197 0.443 . . . . 63.509999999999998 112.197 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 25.39 5.46 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.003 -0.617 . . . . 73.540000000000006 113.803 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.412 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 65.6 m-85 -100.72 -176.38 3.17 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.446 -0.444 . . . . 70.310000000000002 110.732 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 63.8 m -109.19 93.0 4.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.741 0.305 . . . . 73.040000000000006 111.772 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 152' ' ' ILE . 46.8 t -97.02 91.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.22 0.533 . . . . 73.219999999999999 111.018 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -122.58 163.94 19.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.004 -0.544 . . . . 62.340000000000003 110.531 179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.87 -7.47 57.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.11 -0.369 . . . . 74.549999999999997 111.166 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -51.45 106.05 0.6 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 116.382 -0.372 . . . . 64.209999999999994 110.86 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -84.25 13.24 2.78 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.832 2.355 . . . . 63.520000000000003 114.796 -168.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.24 151.46 36.21 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.929 0.714 . . . . 74.010000000000005 112.929 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.58 160.3 11.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.44 -0.8 . . . . 73.019999999999996 112.892 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.4 32.97 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.192 -0.528 . . . . 63.25 112.273 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -145.55 164.91 30.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.822 0.344 . . . . 53.409999999999997 110.715 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -100.86 117.42 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.059 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD13 HG11 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -79.35 136.87 37.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 72.5 110.601 174.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' NE2' ' H ' ' A' ' 80' ' ' ALA . 31.0 tt0 -120.06 104.54 10.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.835 0.35 . . . . 74.400000000000006 111.335 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 50.8 m . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.939 0.399 . . . . 74.340000000000003 110.811 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 N-CA-C 113.929 0.332 . . . . 72.25 113.929 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 46.7 t60 -138.42 149.73 45.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.819 0.447 . . . . 75.010000000000005 110.747 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.504 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.0 m -141.17 143.95 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.439 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.67 23.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 111.681 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -80.64 133.68 35.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.246 -0.284 . . . . 75.430000000000007 110.989 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.46 114.34 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.025 0.441 . . . . 53.340000000000003 111.91 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -79.28 -41.49 27.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.912 -0.586 . . . . 75.319999999999993 111.686 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -167.85 151.95 6.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.909 0.385 . . . . 72.109999999999999 111.809 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.25 122.21 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.638 0.256 . . . . 71.239999999999995 110.685 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -83.05 160.97 21.84 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.15 0.426 . . . . 73.310000000000002 112.15 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -56.07 -22.5 28.05 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.029 0.443 . . . . 75.319999999999993 111.545 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.76 -9.11 17.9 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.135 -0.484 . . . . 71.25 112.0 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.54 89.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.338 -0.458 . . . . 74.340000000000003 112.272 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 m -88.45 131.48 34.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.147 0.498 . . . . 75.239999999999995 111.663 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.07 119.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.349 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.59 107.91 20.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.687 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 100' ' ' LEU . 34.4 m -105.2 161.87 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.551 0.574 . . . . 63.420000000000002 112.551 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.2 t -95.81 123.73 39.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.037 -0.529 . . . . 72.329999999999998 111.874 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -126.51 150.0 49.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.129 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.7 ttm . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.747 0.308 . . . . 72.109999999999999 110.234 175.431 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.116 0.484 . . . . 72.150000000000006 111.715 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.43 118.57 31.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.306 -0.407 . . . . 75.549999999999997 110.841 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.4 m -90.69 105.27 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.134 0.493 . . . . 75.019999999999996 111.866 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.51 133.54 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.073 0.549 . . . . 72.349999999999994 111.102 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -72.85 157.95 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.157 0.428 . . . . 75.099999999999994 112.157 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.46 72.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.688 0.625 . . . . 53.109999999999999 112.688 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.06 -45.88 86.2 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.305 -0.474 . . . . 60.039999999999999 112.997 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.61 -40.56 95.72 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.416 0.627 . . . . 71.430000000000007 110.878 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.93 -21.11 64.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.641 -0.708 . . . . 71.540000000000006 112.689 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.4 p -65.73 -13.16 58.79 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.317 0.488 . . . . 61.439999999999998 112.317 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 39.0 t -102.49 2.21 36.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 111.865 0.32 . . . . 70.450000000000003 111.865 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -103.68 146.09 29.1 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.21 -0.306 . . . . 70.329999999999998 110.94 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -94.23 139.59 30.85 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.539 0.209 . . . . 51.210000000000001 110.943 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 100' ' ' LEU . 91.3 m-85 -117.22 116.98 28.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 73.450000000000003 111.797 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.3 mp -89.05 113.44 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.358 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 13.4 m-70 -99.97 136.06 40.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.082 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 112.481 0.549 . . . . 72.140000000000001 112.481 -177.18 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 111.998 0.37 . . . . 51.140000000000001 111.998 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.72 124.3 28.92 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.852 0.358 . . . . 74.349999999999994 111.871 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.54 21.39 5.12 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.43 -0.414 . . . . 70.109999999999999 113.1 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -129.72 152.38 49.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.568 -0.372 . . . . 70.099999999999994 111.215 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.4 p -63.1 -35.76 81.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.945 0.403 . . . . 70.030000000000001 110.615 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -61.5 -26.59 68.01 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.059 0.456 . . . . 70.209999999999994 111.397 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -78.91 -55.69 4.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.049 -0.523 . . . . 65.430000000000007 110.869 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.05 -52.77 63.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.883 -0.599 . . . . 73.540000000000006 112.499 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.4 t -58.99 -31.99 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.301 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.41 -35.95 82.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.151 0.501 . . . . 65.329999999999998 110.667 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.96 -44.18 73.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.797 -0.638 . . . . 75.019999999999996 111.142 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.282 0.475 . . . . 74.209999999999994 112.282 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HG12 ' A' ' 69' ' ' ILE . 9.4 p -88.42 8.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 121.083 0.468 . . . . 71.030000000000001 111.563 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.05 67.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.403 -0.427 . . . . 72.400000000000006 113.814 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.15 15.15 64.92 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.18 -0.533 . . . . 32.210000000000001 113.477 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.38 -5.88 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.218 0.451 . . . . 73.109999999999999 112.218 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.405 HG12 HG11 ' A' ' 65' ' ' VAL . 35.5 pt -98.79 140.93 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.559 -0.291 . . . . 72.049999999999997 110.495 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.16 125.14 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.9 -0.667 . . . . 71.239999999999995 113.586 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -66.36 78.31 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.182 0.515 . . . . 63.030000000000001 111.355 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -151.96 13.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.385 0.612 . . . . 74.200000000000003 110.905 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.66 -34.32 12.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.911 -0.586 . . . . 55.340000000000003 111.446 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.36 -130.92 10.02 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.184 -0.531 . . . . 53.140000000000001 113.344 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -67.11 151.25 47.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.3 0.572 . . . . 63.030000000000001 111.757 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.01 -33.92 67.65 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.863 1.06 . . . . 64.519999999999996 113.863 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.09 -28.08 69.2 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.848 -0.532 . . . . 72.040000000000006 112.032 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -84.63 -14.56 48.3 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.685 0.279 . . . . 62.210000000000001 111.604 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.409 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 8.2 m0 -51.02 -62.54 1.55 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.114 0.783 . . . . 72.430000000000007 113.114 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.57 -43.55 72.16 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.271 0.471 . . . . 73.409999999999997 112.271 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -60.91 -48.47 81.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.14 0.495 . . . . 73.439999999999998 111.508 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.12 60.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.148 -0.478 . . . . 71.200000000000003 111.455 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.65 7.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.355 -0.384 . . . . 74.530000000000001 111.025 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 p -62.14 -37.32 84.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.132 0.492 . . . . 55.240000000000002 110.941 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -64.25 -38.33 90.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.004 -0.543 . . . . 61.240000000000002 111.951 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.42 -6.01 58.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.676 0.621 . . . . 71.349999999999994 112.676 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.83 -2.3 25.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.938 -0.649 . . . . 74.319999999999993 113.574 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -76.36 170.32 16.58 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.305 0.574 . . . . 71.540000000000006 111.087 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.9 m -115.43 103.57 10.9 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.216 0.451 . . . . 73.340000000000003 112.216 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 152' ' ' ILE . 46.6 t -102.16 119.41 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 70.209999999999994 111.84 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -143.62 168.57 19.57 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.135 -0.484 . . . . 72.310000000000002 110.329 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.48 12.59 9.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.825 0.345 . . . . 70.420000000000002 111.53 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -65.73 108.99 2.54 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 110.624 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.68 14.0 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.042 2.495 . . . . 72.329999999999998 114.419 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -61.69 149.56 39.22 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.179 0.514 . . . . 74.329999999999998 111.985 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -60.51 152.47 25.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.953 0.723 . . . . 51.340000000000003 112.953 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.58 23.79 38.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.164 -0.471 . . . . 62.240000000000002 113.192 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.3 p -131.25 159.28 38.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 111.112 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.3 mp -103.42 119.69 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.327 -0.397 . . . . 63.25 110.521 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -96.07 130.22 43.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 30.1 tt0 -95.56 124.29 39.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.056 -0.52 . . . . 71.219999999999999 112.159 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 115.877 -0.601 . . . . 72.109999999999999 110.734 171.011 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 CA-C-O 120.988 0.215 . . . . 63.100000000000001 113.141 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -147.84 149.18 31.81 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.374 -0.486 . . . . 72.310000000000002 111.032 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.541 HG13 ' HB1' ' A' ' 76' ' ' ALA . 13.5 m -141.57 151.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.083 0.468 . . . . 73.519999999999996 111.779 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -149.26 167.79 25.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.992 -0.549 . . . . 71.109999999999999 110.996 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -102.94 129.76 49.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.25 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 96' ' ' ALA . 70.8 t -80.81 110.93 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 63.340000000000003 111.494 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -83.82 -45.58 13.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.08 0.4 . . . . 74.430000000000007 112.08 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -158.89 148.47 19.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.498 0.555 . . . . 73.25 112.498 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -109.71 134.7 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 63.310000000000002 110.638 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.402 HD21 ' HG3' ' A' ' 123' ' ' GLU . 39.7 m-80 -94.96 160.87 14.38 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.297 0.48 . . . . 73.329999999999998 112.297 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -61.6 -22.4 65.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.103 -0.499 . . . . 62.439999999999998 111.413 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.64 -15.47 63.67 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.984 -0.553 . . . . 70.140000000000001 111.425 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.61 67.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.035 -0.426 . . . . 71.099999999999994 112.035 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 141.75 49.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.215 0.531 . . . . 74.430000000000007 111.894 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.32 128.32 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.857 -0.611 . . . . 72.129999999999995 111.981 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HG3' HD21 ' A' ' 117' ' ' ASN . 45.3 mt-10 -93.28 117.27 29.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.941 0.4 . . . . 73.109999999999999 111.272 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.95 147.51 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 111.717 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.9 p -101.07 125.06 47.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.407 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 -179.68 5.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.384 0.611 . . . . 73.219999999999999 112.456 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 CA--C 1.537 0.46 0 CA-C-N 115.896 -0.593 . . . . 74.409999999999997 110.822 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.471 0.614 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 112.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.46 135.86 25.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.979 0.419 . . . . 73.439999999999998 111.526 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.3 m -95.05 99.76 11.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.075 0.464 . . . . 71.219999999999999 111.097 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.31 134.27 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.316 -0.402 . . . . 62.399999999999999 111.292 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 62.0 m -66.86 149.35 50.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.767 0.318 . . . . 61.219999999999999 111.562 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.85 66.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.582 0.586 . . . . 61.310000000000002 112.582 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.32 -38.47 86.77 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.408 -0.425 . . . . 54.240000000000002 113.564 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -83.09 -39.22 21.42 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.455 -0.438 . . . . 73.209999999999994 111.073 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -70.19 -42.51 72.29 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.802 0.667 . . . . 63.409999999999997 112.802 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.8 m -66.42 -14.41 62.13 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.918 0.389 . . . . 73.030000000000001 111.978 -171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -85.28 -10.84 55.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.428 -0.351 . . . . 61.130000000000003 111.551 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.428 ' CD2' HD12 ' A' ' 100' ' ' LEU . 25.4 m-85 -83.78 151.73 25.03 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.91 0.386 . . . . 72.140000000000001 111.175 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 81.5 m-20 -89.09 112.91 23.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.544 -0.298 . . . . 55.439999999999998 111.337 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.13 117.44 29.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.899 0.381 . . . . 60.140000000000001 111.646 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.7 mp -84.79 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.963 0.411 . . . . 63.32 111.022 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -119.71 147.53 44.47 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.751 0.42 . . . . 73.409999999999997 110.667 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 112.709 0.633 . . . . 44.219999999999999 112.709 -174.518 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.995 0.739 . . . . 71.120000000000005 112.995 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.73 37.72 0.24 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.607 0.595 . . . . 75.129999999999995 112.607 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.24 16.9 1.9 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.615 -0.326 . . . . 64.040000000000006 112.845 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -124.26 137.36 54.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.391 0.276 . . . . 74.030000000000001 110.682 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 m -60.97 -17.82 53.83 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.235 0.54 . . . . 53.509999999999998 111.688 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.5 p -78.53 -26.94 45.9 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.253 0.549 . . . . 73.140000000000001 111.734 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -56.87 -67.17 0.34 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 41.1 p90 -62.83 -28.19 69.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.092 0.405 . . . . 62.020000000000003 112.092 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -71.56 -36.18 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.875 0.369 . . . . 64.5 111.604 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.73 -35.47 63.73 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.5 111.747 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.64 -43.34 38.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.81 0.338 . . . . 75.219999999999999 111.263 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.01 -29.97 70.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.095 0.406 . . . . 60.310000000000002 112.095 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 2.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.289 0.566 . . . . 74.420000000000002 111.491 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.08 22.78 77.36 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.35 -0.387 . . . . 73.140000000000001 113.686 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.43 21.9 55.14 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.769 0.667 . . . . 32.549999999999997 114.769 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -82.23 3.9 25.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.571 0.685 . . . . 63.119999999999997 112.222 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -111.98 144.83 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.756 0.312 . . . . 60.100000000000001 111.601 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.55 112.07 4.1 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.272 -0.49 . . . . 74.030000000000001 112.797 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.2 p -68.46 -7.55 32.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.506 0.558 . . . . 72.040000000000006 112.506 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 t -65.12 -2.86 3.13 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.947 0.721 . . . . 64.010000000000005 112.947 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -64.83 -27.25 68.75 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.912 0.387 . . . . 73.109999999999999 111.838 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.3 -130.85 10.5 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.205 -0.522 . . . . 75.409999999999997 112.896 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -82.31 168.28 17.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.316 0.579 . . . . 64.450000000000003 111.717 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -73.28 16.55 0.17 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.861 1.06 . . . . 72.200000000000003 113.861 -170.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.45 -28.08 12.77 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.969 0.414 . . . . 63.219999999999999 111.632 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.503 ' ND2' ' HB2' ' A' ' 82' ' ' ALA . 11.3 t30 -95.82 -3.0 46.4 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.33 0.492 . . . . 71.140000000000001 112.33 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.408 ' HZ3' HD13 ' A' ' 99' ' ' ILE . 10.2 m0 -55.8 -56.48 20.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.842 0.682 . . . . 75.439999999999998 112.842 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.0 69.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.987 0.422 . . . . 75.319999999999993 112.016 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.1 t -66.86 -54.92 17.49 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.114 -0.494 . . . . 53.200000000000003 111.581 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.503 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . . . -62.91 -49.92 72.88 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.92 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -49.11 -57.22 7.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.609 0.364 . . . . 71.510000000000005 111.525 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.6 p -62.18 -39.67 93.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.973 0.416 . . . . 72.200000000000003 111.135 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -25.39 63.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.305 -0.407 . . . . 75.310000000000002 111.696 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.73 15.4 25.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.164 0.431 . . . . 61.219999999999999 112.164 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.55 -21.22 47.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.997 -0.621 . . . . 62.049999999999997 113.993 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.433 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.7 m-85 -63.6 154.98 31.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.476 0.638 . . . . 72.540000000000006 111.171 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 27.6 m -99.41 95.87 7.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.403 0.52 . . . . 72.430000000000007 112.403 -170.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.463 HG22 HG13 ' A' ' 152' ' ' ILE . 60.7 t -94.81 111.46 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.732 0.301 . . . . 72.049999999999997 111.383 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -133.29 174.77 10.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.603 -0.271 . . . . 72.019999999999996 111.161 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.64 0.52 52.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.968 0.413 . . . . 62.530000000000001 110.706 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.3 t -68.36 115.55 30.71 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.687 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -80.77 7.21 5.0 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.79 2.327 . . . . 73.310000000000002 113.276 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 137.74 5.41 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.171 0.434 . . . . 74.439999999999998 112.171 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.64 156.81 3.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.195 0.813 . . . . 42.520000000000003 113.195 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 26.01 57.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.93 -0.577 . . . . 71.420000000000002 113.016 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -129.38 175.99 8.32 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.272 0.558 . . . . 71.409999999999997 111.766 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 55.0 mt -129.92 128.13 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 62.409999999999997 110.57 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -101.63 138.47 38.58 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.906 -0.496 . . . . 71.200000000000003 111.523 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -103.41 110.83 22.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 111.193 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.59 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 56.1 m . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 112.95 0.722 . . . . 63.109999999999999 112.95 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 111.064 -0.814 . . . . 74.430000000000007 111.064 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 59.4 t60 -168.2 134.87 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.651 0.725 . . . . 52.100000000000001 111.473 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG13 ' HB1' ' A' ' 76' ' ' ALA . 30.1 m -141.67 143.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.007 -0.542 . . . . 52.020000000000003 110.927 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.77 156.51 45.0 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.734 0.302 . . . . 61.219999999999999 111.005 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -89.58 129.19 36.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.868 0.366 . . . . 63.549999999999997 111.336 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -75.32 116.83 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.03 0.443 . . . . 63.43 111.529 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -75.74 -54.95 6.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.914 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -158.28 164.89 35.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.239 0.542 . . . . 73.340000000000003 111.778 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.45 129.88 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.06 -0.518 . . . . 64.319999999999993 110.835 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -85.24 145.62 27.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.295 -0.253 . . . . 74.549999999999997 110.596 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.1 m -59.71 -21.82 61.16 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.031 0.443 . . . . 70.340000000000003 111.212 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.46 -23.8 67.1 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.015 -0.539 . . . . 75.319999999999993 111.723 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.6 -20.31 29.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 112.1 -0.4 . . . . 24.52 112.1 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.0 m -68.66 135.72 51.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.862 0.363 . . . . 61.030000000000001 111.527 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.45 136.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.362 -0.381 . . . . 54.450000000000003 111.701 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.99 117.68 32.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.539 -0.3 . . . . 72.420000000000002 110.588 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.33 156.94 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.956 0.408 . . . . 73.450000000000003 111.933 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 p -110.96 123.89 51.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.965 0.412 . . . . 73.430000000000007 111.191 177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 38.6 mt-10 -128.86 151.65 49.38 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.244 -0.434 . . . . 71.450000000000003 111.65 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.4 tpp . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 120.926 0.393 . . . . 75.310000000000002 111.794 -178.155 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 121.241 0.543 . . . . 75.040000000000006 112.077 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -149.9 128.05 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.975 -0.557 . . . . 74.209999999999994 110.59 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.1 m -99.87 113.37 25.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.434 -0.348 . . . . 71.030000000000001 110.707 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.85 134.24 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.708 0.289 . . . . 75.430000000000007 111.243 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -63.13 151.73 39.29 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.068 0.396 . . . . 73.400000000000006 112.068 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.82 61.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.718 0.636 . . . . 43.310000000000002 112.718 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.47 -37.91 56.82 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.506 -0.378 . . . . 62.25 113.808 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -94.96 -51.32 4.72 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.526 -0.397 . . . . 61.229999999999997 111.106 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.23 67.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.778 0.658 . . . . 63.32 112.778 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -64.19 -14.33 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.591 0.589 . . . . 62.340000000000003 112.591 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.2 t -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.057 0.456 . . . . 72.420000000000002 111.015 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 23.9 m-85 -72.59 152.33 41.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.859 -0.609 . . . . 65.099999999999994 112.127 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -84.67 117.63 23.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.467 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 97.3 m-85 -96.48 113.98 25.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 111.969 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.8 mp -79.29 129.54 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.448 -0.342 . . . . 71.040000000000006 110.447 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 50.8 m-70 -119.46 152.03 37.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 110.865 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 57.1 mt . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 111.809 -177.625 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 111.864 0.32 . . . . 54.240000000000002 111.864 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.63 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.179 0.514 . . . . 63.219999999999999 112.004 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.72 -40.57 0.53 Allowed Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 112.763 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.57 144.54 56.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.754 0.311 . . . . 65.010000000000005 111.447 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 29.7 p -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.237 0.541 . . . . 73.450000000000003 110.974 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 p -66.01 -15.87 63.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.837 -0.619 . . . . 72.120000000000005 112.121 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -76.18 -60.83 2.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.007 0.373 . . . . 74.400000000000006 112.007 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 18.4 p90 -71.88 -30.6 65.57 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.75 0.648 . . . . 71.230000000000004 112.75 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.97 -32.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 110.469 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.2 -39.77 79.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.769 -0.651 . . . . 71.430000000000007 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.74 -37.51 76.5 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.341 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 125' ' ' SER . 30.4 mmmt -56.17 -33.58 65.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.913 0.387 . . . . 72.510000000000005 111.696 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.7 p -102.34 15.37 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.602 0.715 . . . . 61.0 111.163 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.9 -1.3 17.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.25 -0.432 . . . . 72.040000000000006 113.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.03 10.8 77.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.351 -0.452 . . . . 61.25 113.361 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -79.28 38.1 0.35 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.312 0.486 . . . . 73.439999999999998 112.312 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD21 ' A' ' 154' ' ' LEU . 20.5 pt -134.78 -41.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.21 100.24 2.49 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.911 -0.661 . . . . 65.5 113.353 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.0 p -80.24 43.57 0.64 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.199 0.444 . . . . 63.539999999999999 112.199 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 t -126.28 18.46 7.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.957 0.408 . . . . 71.329999999999998 112.084 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -91.17 11.67 22.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.849 0.685 . . . . 63.119999999999997 112.849 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.05 -143.44 28.69 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 113.596 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.08 152.42 45.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.521 -0.4 . . . . 61.119999999999997 111.104 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.53 -38.43 59.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.514 0.561 . . . . 52.240000000000002 112.514 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -61.31 -25.97 67.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.346 0.499 . . . . 62.340000000000003 112.346 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -94.56 -5.81 45.07 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.25 -0.281 . . . . 43.25 111.508 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.16 -56.26 21.88 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.373 0.509 . . . . 75.319999999999993 112.373 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.417 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -61.78 -40.92 96.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.861 0.363 . . . . 62.340000000000003 111.846 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -35.58 81.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.4 -0.363 . . . . 72.510000000000005 111.784 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.49 -45.9 24.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.615 0.228 . . . . 72.25 111.615 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.53 -55.42 25.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.936 0.398 . . . . 75.219999999999999 111.694 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 p -57.1 -49.41 75.97 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 111.283 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.7 t -65.7 -15.54 62.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.242 0.46 . . . . 51.409999999999997 112.242 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.84 3.47 54.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.924 0.392 . . . . 73.25 111.654 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.52 -4.44 73.03 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.3 -0.476 . . . . 75.109999999999999 113.657 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -75.15 170.4 16.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 111.565 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -99.88 97.21 8.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 112.353 -170.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.38 91.98 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.146 0.498 . . . . 64.409999999999997 110.692 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.77 138.42 53.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.677 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -76.71 13.33 1.03 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.48 0.918 . . . . 52.409999999999997 113.48 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -65.85 114.02 14.51 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 110.02 -0.363 . . . . 71.129999999999995 110.02 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.14 22.19 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.942 2.428 . . . . 55.25 114.543 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.5 mt-10 -74.44 159.81 31.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.529 0.681 . . . . 71.340000000000003 112.695 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.56 5.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.323 -0.853 . . . . 75.409999999999997 113.086 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.22 40.91 40.31 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.874 -0.603 . . . . 64.329999999999998 112.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.2 p -152.25 167.19 29.4 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.568 -0.372 . . . . 65.200000000000003 111.125 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.6 mp -112.78 122.95 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.602 -0.272 . . . . 72.5 110.351 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 149' ' ' TYR . 1.7 pt? -86.41 138.36 31.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 64.010000000000005 110.893 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -112.37 109.4 19.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.355 -0.384 . . . . 63.149999999999999 110.561 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.472 0.669 0 CA-C-N 116.313 -0.403 . . . . 74.329999999999998 111.476 -179.163 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 CA-C-O 121.052 0.251 . . . . 74.099999999999994 112.94 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -148.98 143.55 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.511 -0.405 . . . . 74.109999999999999 111.421 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.77 153.92 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.048 0.451 . . . . 72.120000000000005 111.615 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.48 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.577 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -95.4 126.18 40.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.001 0.429 . . . . 64.109999999999999 111.627 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.403 HG22 HG12 ' A' ' 124' ' ' VAL . 42.6 t -74.99 108.21 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.068 -0.515 . . . . 74.239999999999995 111.682 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.75 -48.65 14.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.066 -0.515 . . . . 74.230000000000004 111.443 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -154.4 154.7 33.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.284 -0.417 . . . . 74.120000000000005 110.913 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 95' ' ' GLU . 45.2 t -123.65 111.0 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.874 0.368 . . . . 55.049999999999997 111.094 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -64.95 131.96 48.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.483 -0.326 . . . . 70.209999999999994 111.566 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.6 p -60.78 -19.01 58.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.835 0.35 . . . . 53.119999999999997 111.596 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 -16.72 64.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.882 0.372 . . . . 73.219999999999999 111.788 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.37 57.51 0.59 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.303 -0.475 . . . . 43.409999999999997 113.067 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -151.64 136.29 17.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.735 0.303 . . . . 74.030000000000001 111.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.93 116.1 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.269 -0.423 . . . . 61.210000000000001 110.912 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -90.22 104.85 17.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.874 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 113' ' ' VAL . 33.2 m -108.51 132.84 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.154 0.502 . . . . 55.439999999999998 111.907 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.505 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 32.0 t -89.28 114.23 25.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.425 -0.352 . . . . 64.519999999999996 111.17 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -131.05 147.31 52.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.532 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.41 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 40.8 ttm . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 121.093 0.473 . . . . 71.349999999999994 110.863 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 121.331 0.586 . . . . 63.109999999999999 110.025 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -83.91 107.12 16.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.905 -0.589 . . . . 64.019999999999996 112.215 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.1 m -86.73 112.91 22.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 111.248 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.1 mt -111.87 139.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.391 -0.368 . . . . 75.430000000000007 111.568 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.5 m -58.45 133.81 56.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.621 0.248 . . . . 74.530000000000001 111.399 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.22 73.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.191 0.441 . . . . 52.009999999999998 112.191 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -52.25 40.04 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.203 -0.523 . . . . 71.109999999999999 112.965 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.48 -44.72 77.87 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.163 0.506 . . . . 55.43 110.859 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.438 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.84 -30.69 70.25 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.196 0.813 . . . . 34.149999999999999 113.196 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.9 t -58.49 -23.74 58.67 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.807 0.669 . . . . 63.530000000000001 112.807 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.5 t -76.17 -19.45 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.021 0.439 . . . . 71.25 111.79 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 11.0 m-85 -83.67 147.9 27.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.934 0.397 . . . . 75.219999999999999 110.965 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.8 121.41 33.4 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.333 -0.229 . . . . 75.340000000000003 111.274 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.438 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 54.4 m-85 -98.21 121.85 40.65 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.132 0.492 . . . . 74.120000000000005 112.005 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.68 121.74 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.354 -0.385 . . . . 65.420000000000002 110.423 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -115.38 147.35 40.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.548 0.339 . . . . 75.409999999999997 110.57 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 HG22 ' A' ' 69' ' ' ILE . 86.9 mt . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.321 0.489 . . . . 73.310000000000002 112.321 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 111.199 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.28 86.5 0.41 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 112.078 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.29 -29.88 0.36 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.871 -0.681 . . . . 15.43 113.7 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.49 151.1 30.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 111.852 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.6 m -54.67 -40.95 69.59 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.834 -0.621 . . . . 71.209999999999994 112.248 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -62.82 -24.19 67.64 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 74.109999999999999 112.151 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -60.99 -47.89 84.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.222 0.453 . . . . 73.400000000000006 112.222 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 126' ' ' GLU . 25.0 p90 -80.63 -39.69 26.98 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.172 -0.33 . . . . 72.230000000000004 111.624 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 57' ' ' CYS . 45.6 t -57.23 -41.89 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.879 0.371 . . . . 74.319999999999993 111.74 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.01 -38.47 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.175 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.51 -39.58 37.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 111.003 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.2 mmmt -53.22 -44.81 68.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.928 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.95 -22.43 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 111.962 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.2 30.19 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.169 -0.538 . . . . 62.509999999999998 113.656 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.91 -14.89 35.09 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.321 -0.466 . . . . 75.030000000000001 114.144 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.41 68.81 4.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.303 -0.528 . . . . 74.310000000000002 112.118 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 70' ' ' GLY . 6.0 pt -146.96 -54.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.043 -0.526 . . . . 71.409999999999997 111.473 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG13 ' A' ' 69' ' ' ILE . . . 142.28 102.27 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.722 -0.752 . . . . 73.530000000000001 113.37 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 84.4 p -55.34 -28.09 51.47 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.023 0.379 . . . . 71.450000000000003 112.023 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -62.96 -16.64 60.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.087 0.773 . . . . 75.340000000000003 113.087 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -61.87 -43.15 99.42 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.908 0.385 . . . . 73.349999999999994 111.294 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.68 -92.99 0.2 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.323 -0.465 . . . . 74.319999999999993 114.122 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.91 139.74 38.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.01 0.433 . . . . 72.430000000000007 111.915 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -60.44 -28.58 68.4 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.366 0.506 . . . . 73.010000000000005 112.366 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -67.51 -17.76 64.79 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.943 0.401 . . . . 72.519999999999996 111.78 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.4 -34.16 12.87 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.197 0.443 . . . . 73.140000000000001 112.197 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -35.58 -64.62 0.28 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.625 1.343 . . . . 75.099999999999994 114.625 -171.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.48 79.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.632 0.604 . . . . 74.219999999999999 112.632 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -68.23 -44.55 75.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.085 0.469 . . . . 75.099999999999994 111.336 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.45 83.1 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.209 -0.451 . . . . 75.120000000000005 111.046 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -59.62 5.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.038 -0.528 . . . . 63.140000000000001 111.105 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.4 p -58.25 -32.41 68.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 111.56 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -72.85 -41.95 64.23 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.229 0.455 . . . . 44.119999999999997 112.229 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.75 -8.39 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.643 0.609 . . . . 54.009999999999998 112.643 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.38 7.48 26.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.942 -0.647 . . . . 43.350000000000001 113.447 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -80.4 168.18 19.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.629 . . . . 74.430000000000007 111.744 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 m -104.86 102.24 11.79 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.813 -0.631 . . . . 52.329999999999998 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.76 111.26 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 61.539999999999999 111.404 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 58.6 m-80 -132.15 149.31 52.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.366 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.79 12.25 1.13 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.219 0.452 . . . . 62.310000000000002 112.219 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.5 t -73.54 116.85 55.55 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.733 -0.212 . . . . 52.340000000000003 111.24 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.76 104.24 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.39 2.06 . . . . 74.019999999999996 112.032 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -131.04 136.47 48.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.058 -0.519 . . . . 71.439999999999998 111.699 -174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.98 120.86 14.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.555 -0.293 . . . . 32.509999999999998 111.237 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.64 15.33 17.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.202 -0.523 . . . . 64.409999999999997 113.254 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -120.75 170.1 9.77 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.475 -0.426 . . . . 61.539999999999999 110.753 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.0 mp -113.24 123.04 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.617 -0.265 . . . . 75.230000000000004 110.71 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -93.71 133.29 37.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.073 0.463 . . . . 71.030000000000001 111.212 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.426 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.8 tt0 -94.25 112.18 23.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.294 -0.412 . . . . 72.209999999999994 111.153 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 37.5 m . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 112.292 0.478 . . . . 74.209999999999994 112.292 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 CA-C-O 120.965 0.203 . . . . 73.010000000000005 113.322 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 39.6 t60 -136.0 142.78 44.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.709 0.29 . . . . 73.319999999999993 111.058 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.552 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -146.89 146.2 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.088 0.555 . . . . 64.340000000000003 110.397 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -143.84 161.7 37.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.961 0.41 . . . . 61.399999999999999 111.433 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.5 123.74 37.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.942 0.401 . . . . 72.230000000000004 111.054 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.86 106.04 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.966 0.412 . . . . 73.019999999999996 111.913 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.91 -51.59 53.47 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.121 0.486 . . . . 71.140000000000001 110.754 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -160.37 164.24 32.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.057 -0.52 . . . . 65.209999999999994 110.833 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.28 140.45 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.049 0.452 . . . . 64.219999999999999 111.198 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -89.54 147.91 23.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.728 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.0 t -62.54 -20.7 64.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.864 0.364 . . . . 44.240000000000002 111.908 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.82 -22.83 62.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.336 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.87 -17.87 10.72 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.302 -0.408 . . . . 64.25 113.073 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -64.07 126.25 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.951 0.405 . . . . 73.540000000000006 111.621 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.05 124.48 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.998 0.428 . . . . 73.409999999999997 111.967 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -93.23 113.85 26.18 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.939 0.4 . . . . 73.319999999999993 110.662 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.75 164.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.24 0.459 . . . . 74.540000000000006 112.24 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.518 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 48.6 p -117.17 140.61 49.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.462 -0.335 . . . . 71.409999999999997 111.715 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 59.8 mt-10 -138.65 159.06 43.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.05 0.54 . . . . 75.25 110.991 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.9 tpp . . . . . 0 N--CA 1.472 0.656 0 O-C-N 122.347 -0.221 . . . . 63.100000000000001 110.569 175.615 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 27.3 mt-10 . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 120.919 0.39 . . . . 65.340000000000003 111.755 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.2 ptp180 -157.73 173.15 17.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.477 -0.329 . . . . 54.439999999999998 111.118 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 72.8 m -127.73 123.51 35.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.963 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -94.73 137.42 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.876 0.37 . . . . 63.539999999999999 111.389 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -59.84 137.9 57.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.154 -0.476 . . . . 40.43 111.997 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.07 -42.62 60.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.545 0.572 . . . . 72.219999999999999 112.545 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.29 -27.99 61.15 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.316 -0.402 . . . . 34.340000000000003 113.637 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.82 -27.79 14.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.387 -0.478 . . . . 74.430000000000007 111.39 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.64 -29.02 61.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.087 0.773 . . . . 64.439999999999998 113.087 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t -78.19 -6.24 54.23 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.0 0.37 . . . . 73.400000000000006 112.0 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.5 m -85.88 -15.04 43.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.773 0.32 . . . . 72.349999999999994 111.797 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -93.69 144.92 24.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.053 0.454 . . . . 71.340000000000003 112.21 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -93.88 116.41 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.152 -0.476 . . . . 54.32 110.359 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 20.9 m-85 -95.49 122.91 38.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.933 0.397 . . . . 60.350000000000001 111.748 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -83.63 123.38 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.388 -0.369 . . . . 74.420000000000002 110.604 175.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.34 136.94 52.43 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.516 0.327 . . . . 63.439999999999998 110.547 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 69' ' ' ILE . 74.4 mt . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 112.348 0.499 . . . . 51.149999999999999 112.348 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 112.257 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 112.76 4.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.928 -0.578 . . . . 74.030000000000001 111.804 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.55 7.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.345 -0.455 . . . . 55.039999999999999 112.703 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -115.5 144.47 43.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.123 0.487 . . . . 73.200000000000003 111.584 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.1 p -58.03 -46.24 85.64 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.311 -0.404 . . . . 24.530000000000001 111.541 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -51.52 -45.35 62.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.093 0.405 . . . . 75.019999999999996 112.093 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -54.79 -48.66 72.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.96 -0.564 . . . . 75.549999999999997 111.744 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -68.79 -49.84 55.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 112.096 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 57' ' ' CYS . 58.0 t -58.18 -40.5 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.57 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -55.97 -41.76 75.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.175 -0.466 . . . . 70.299999999999997 111.553 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.02 -43.0 68.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.372 -0.376 . . . . 71.019999999999996 111.447 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -61.32 -34.48 75.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.018 0.377 . . . . 70.25 112.018 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -86.22 6.55 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-O 121.358 0.599 . . . . 72.25 111.072 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.37 18.48 60.93 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 113.833 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 16.95 67.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.16 -0.543 . . . . 64.120000000000005 113.949 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -78.88 7.08 7.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 117.455 0.628 . . . . 72.430000000000007 112.463 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.29 -37.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.528 0.566 . . . . 72.400000000000006 112.528 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.17 102.56 2.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.967 -0.635 . . . . 71.109999999999999 112.013 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -61.34 -18.06 56.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.742 0.645 . . . . 74.310000000000002 112.742 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 t -57.24 -15.94 7.15 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.701 0.63 . . . . 62.119999999999997 112.701 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -57.97 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.255 0.55 . . . . 74.299999999999997 110.825 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.25 -103.21 0.56 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.805 -0.634 . . . . 63.350000000000001 114.613 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -57.37 134.91 56.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.112 0.412 . . . . 65.209999999999994 112.112 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.62 -11.78 47.54 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 51.200000000000003 113.04 -173.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.37 -10.97 36.21 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.957 174.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -93.35 -27.49 16.74 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.097 0.406 . . . . 75.120000000000005 112.097 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.473 ' N ' HE22 ' A' ' 101' ' ' GLN . 11.9 m0 -41.34 -58.04 1.97 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.854 1.057 . . . . 74.530000000000001 113.854 -175.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.9 91.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.917 -0.49 . . . . 52.32 111.975 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -57.69 -51.81 68.01 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.168 0.509 . . . . 54.310000000000002 111.618 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.93 97.69 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.37 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.48 -57.02 11.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.953 0.406 . . . . 35.520000000000003 111.26 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 t -57.5 -44.41 84.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.082 0.468 . . . . 33.32 111.39 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 t -70.85 -21.21 62.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 112.225 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.79 -10.06 32.64 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.205 0.446 . . . . 42.030000000000001 112.205 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.65 8.73 29.96 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.919 -0.657 . . . . 70.530000000000001 113.827 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HD2' ' HA ' ' A' ' 154' ' ' LEU . 71.3 m-85 -83.81 166.94 17.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.439 -0.447 . . . . 72.329999999999998 111.329 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 90.5 m -100.5 92.73 5.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.114 0.483 . . . . 62.039999999999999 111.923 -173.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.3 98.8 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 111.299 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -126.77 176.49 7.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.513 -0.312 . . . . 73.530000000000001 110.632 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -93.39 25.42 3.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.931 0.396 . . . . 62.520000000000003 111.275 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 t -81.89 108.14 10.44 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 111.458 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.5 19.11 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.04 2.494 . . . . 71.400000000000006 114.278 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -54.96 142.82 28.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 111.726 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.92 146.13 53.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.471 0.545 . . . . 71.140000000000001 112.471 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.98 10.09 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.17 -0.538 . . . . 73.430000000000007 113.031 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.4 p -136.62 169.08 18.29 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.5 -0.412 . . . . 73.310000000000002 111.167 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -110.14 134.6 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.626 -0.261 . . . . 71.140000000000001 110.302 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.5 pt? -112.99 131.24 55.84 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.247 0.546 . . . . 72.409999999999997 111.443 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.473 HE22 ' N ' ' A' ' 79' ' ' TRP . 36.0 tt0 -105.96 129.0 54.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.524 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 112.773 0.656 . . . . 75.140000000000001 112.773 -178.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.618 0 N-CA-C 113.5 0.16 . . . . 44.329999999999998 113.5 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -173.5 136.99 0.62 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.417 0.287 . . . . 71.299999999999997 110.92 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.9 151.52 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.33 -0.395 . . . . 51.340000000000003 111.408 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.78 167.37 25.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.466 -0.333 . . . . 72.430000000000007 110.99 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -102.88 131.44 49.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.894 0.378 . . . . 60.439999999999998 111.202 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 124' ' ' VAL . 60.9 t -81.89 112.29 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.297 -0.41 . . . . 74.450000000000003 111.539 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -80.13 -56.02 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.878 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.19 144.05 23.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.757 0.651 . . . . 63.310000000000002 112.757 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.47 136.25 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.745 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -98.17 147.33 24.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.399 -0.188 . . . . 41.340000000000003 110.925 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -57.71 -34.84 69.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.934 0.346 . . . . 65.109999999999999 111.934 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.59 -9.23 40.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.464 0.542 . . . . 64.209999999999994 112.464 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.56 0.41 46.47 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.367 -0.444 . . . . 74.230000000000004 113.757 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 m -77.53 142.07 39.26 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.747 0.308 . . . . 72.519999999999996 111.626 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.8 t -113.19 115.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 111.558 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.84 118.63 29.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.392 . . . . 63.119999999999997 111.326 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 113' ' ' VAL . 34.1 m -124.8 148.18 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.043 0.449 . . . . 62.409999999999997 111.924 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.0 m -102.89 116.04 31.78 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.068 0.461 . . . . 51.350000000000001 111.079 175.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.43 -168.24 1.29 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 111.246 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.948 0.404 . . . . 64.140000000000001 110.763 173.072 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 121.206 0.527 . . . . 75.0 112.373 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -152.1 130.85 12.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.466 . . . . 71.209999999999994 111.604 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 m -99.13 98.7 9.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.082 0.467 . . . . 71.310000000000002 110.209 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.72 134.76 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 112.231 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.8 m -67.99 148.59 50.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.598 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.87 -44.95 63.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.446 0.536 . . . . 50.140000000000001 112.446 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.75 76.56 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 73.519999999999996 113.017 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.97 -34.02 75.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.866 0.365 . . . . 70.430000000000007 111.557 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.82 66.79 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.174 0.511 . . . . 64.5 111.859 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 t -67.67 -3.64 9.72 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.403 0.52 . . . . 65.319999999999993 112.403 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -93.28 -0.3 56.78 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.965 0.412 . . . . 75.549999999999997 111.622 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -118.77 153.42 34.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.535 0.569 . . . . 75.409999999999997 112.535 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.2 m-80 -101.4 116.14 32.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.797 -0.638 . . . . 63.140000000000001 110.526 176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -94.85 112.68 24.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.230000000000004 111.91 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -81.06 127.23 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.076 0.465 . . . . 53.149999999999999 111.345 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 62.0 m-70 -111.1 133.15 53.7 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.548 -0.538 . . . . 73.349999999999994 109.548 174.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 88' ' ' TYR . 48.0 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 112.248 0.462 . . . . 65.439999999999998 112.248 -171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 73.219999999999999 111.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.68 138.18 42.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 72.349999999999994 111.738 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.79 -28.51 13.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.283 -0.484 . . . . 71.549999999999997 112.753 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -80.3 136.73 36.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.269 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.2 p -59.14 -41.28 87.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.073 171.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.5 p -52.57 -43.8 65.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.455 -0.793 . . . . 72.109999999999999 111.968 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -55.95 -52.31 64.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 112.022 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.63 -47.34 72.91 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.983 0.421 . . . . 72.010000000000005 111.702 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 57' ' ' CYS . 96.9 t -60.97 -34.52 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.555 -0.293 . . . . 65.219999999999999 111.706 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -54.69 -46.81 74.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 111.41 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 110.892 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 64' ' ' LYS . 29.3 mmmt -61.98 -31.73 72.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.155 -0.475 . . . . 63.509999999999998 112.202 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 154' ' ' LEU . 7.6 p -91.24 6.22 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.449 0.642 . . . . 55.350000000000001 111.164 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 10.26 72.04 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.299 -0.41 . . . . 64.120000000000005 113.959 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.14 15.75 72.43 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.002 -0.618 . . . . 64.200000000000003 114.032 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.43 ' HB2' HD13 ' A' ' 154' ' ' LEU . 40.2 m-80 -82.79 28.28 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.316 0.558 . . . . 72.120000000000005 111.99 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.76 161.78 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.131 0.491 . . . . 61.509999999999998 111.523 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.1 78.03 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.999 -0.619 . . . . 52.43 112.558 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -49.18 -28.18 4.24 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.571 0.582 . . . . 43.219999999999999 112.571 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -60.73 -18.03 52.08 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.873 0.694 . . . . 53.130000000000003 112.873 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -56.05 -32.95 64.53 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.942 0.401 . . . . 74.099999999999994 111.617 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.9 2.02 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.261 -0.427 . . . . 62.409999999999997 114.092 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.88 133.78 48.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 71.319999999999993 112.452 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.41 61.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.228 0.825 . . . . 65.230000000000004 113.228 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -67.05 -34.47 77.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.939 0.4 . . . . 73.409999999999997 112.047 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -71.26 -29.34 64.97 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.337 0.495 . . . . 60.130000000000003 112.337 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -43.38 -60.27 1.78 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.619 0.97 . . . . 73.310000000000002 113.619 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.43 86.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.45 0.537 . . . . 73.329999999999998 112.45 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 t -65.03 -55.02 21.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.941 0.401 . . . . 61.450000000000003 111.438 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.77 74.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.443 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.32 -49.02 77.44 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.629 -0.259 . . . . 62.509999999999998 111.291 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.7 p -66.51 -29.55 69.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.029 0.442 . . . . 74.319999999999993 111.119 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -76.79 -31.36 56.95 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.128 -0.487 . . . . 44.420000000000002 111.798 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.46 -24.48 24.12 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.156 0.428 . . . . 71.239999999999995 112.156 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.82 4.31 19.23 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.048 -0.596 . . . . 51.109999999999999 113.881 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.546 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 18.4 m-85 -69.23 168.49 14.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.467 . . . . 74.340000000000003 111.288 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.6 m -101.19 97.94 8.41 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.07 0.396 . . . . 75.120000000000005 112.07 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 152' ' ' ILE . 41.6 t -102.49 96.52 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.002 0.429 . . . . 73.150000000000006 111.316 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -122.66 172.31 8.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.891 0.377 . . . . 72.530000000000001 110.96 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -86.56 2.52 47.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.654 0.264 . . . . 71.530000000000001 111.305 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -62.8 113.75 10.1 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 116.52 -0.309 . . . . 72.420000000000002 110.761 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.415 ' HB2' HG22 ' A' ' 122' ' ' VAL . 90.0 Cg_endo -82.27 8.16 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.643 2.229 . . . . 72.519999999999996 113.973 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.32 138.62 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.328 0.492 . . . . 53.329999999999998 112.328 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.08 156.98 4.93 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.718 0.636 . . . . 70.430000000000007 112.718 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.46 33.38 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.111 -0.566 . . . . 74.349999999999994 112.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.2 p -138.31 176.64 8.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 73.010000000000005 111.115 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.71 121.78 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.36 -0.382 . . . . 53.32 110.889 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -100.62 136.66 40.15 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.692 -0.63 . . . . 71.129999999999995 111.636 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -101.99 124.99 48.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.868 -0.605 . . . . 75.230000000000004 111.46 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 31.2 t . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 112.246 0.461 . . . . 52.549999999999997 112.246 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 111.834 -0.506 . . . . 73.510000000000005 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 58.4 t60 -157.59 135.47 10.76 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.345 -0.503 . . . . 75.239999999999995 110.74 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.73 142.1 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.073 0.463 . . . . 44.100000000000001 111.389 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -139.44 156.69 46.79 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.243 -0.435 . . . . 43.450000000000003 110.837 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.71 133.14 38.7 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.832 0.349 . . . . 63.109999999999999 111.279 -176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.45 116.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.858 0.361 . . . . 44.439999999999998 111.836 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.72 -54.96 3.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.957 0.408 . . . . 71.319999999999993 112.01 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.76 145.2 30.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.265 0.555 . . . . 72.239999999999995 112.004 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.61 133.74 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.03 -0.532 . . . . 42.299999999999997 111.464 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' SER . 33.9 m-80 -76.87 152.25 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.406 -0.361 . . . . 63.240000000000002 110.556 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.1 m -47.22 -40.73 16.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.337 0.866 . . . . 72.310000000000002 113.337 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.55 -23.39 61.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.37 0.507 . . . . 70.549999999999997 112.37 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.44 -0.94 9.54 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.163 -0.541 . . . . 63.420000000000002 113.38 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 19.2 m -65.41 118.78 9.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.168 0.509 . . . . 72.239999999999995 110.952 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.42 HG21 ' OH ' ' A' ' 151' ' ' TYR . 40.4 t -96.35 121.97 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.805 -0.634 . . . . 51.509999999999998 112.392 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -96.35 105.25 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.342 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 m -97.08 163.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.423 0.527 . . . . 73.109999999999999 112.423 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -115.51 119.19 35.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.922 -0.581 . . . . 64.140000000000001 111.028 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.8 177.2 6.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.024 0.44 . . . . 63.549999999999997 111.512 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 N--CA 1.472 0.651 0 CA-C-N 116.497 -0.32 . . . . 63.399999999999999 110.45 176.733 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.191 0.519 . . . . 70.5 111.695 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.06 105.07 16.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.168 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 88.2 m -79.17 104.14 9.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.041 0.448 . . . . 64.340000000000003 110.65 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 149' ' ' TYR . 73.2 mt -92.57 112.44 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.105 -0.498 . . . . 72.200000000000003 111.599 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.4 m -61.07 153.26 25.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.24 0.459 . . . . 75.109999999999999 112.24 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.79 -48.65 41.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.876 0.695 . . . . 74.430000000000007 112.876 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.14 -38.05 88.35 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.175 -0.536 . . . . 52.509999999999998 113.316 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -72.9 -37.35 67.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.963 0.411 . . . . 65.310000000000002 111.669 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.69 -23.91 67.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.911 0.708 . . . . 63.119999999999997 112.911 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 m -54.87 -17.29 3.42 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.845 1.054 . . . . 71.439999999999998 113.845 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.4 t -99.11 -13.94 19.6 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.155 0.798 . . . . 75.25 113.155 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 141' ' ' ILE . 31.4 m-85 -88.7 143.74 26.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.564 0.697 . . . . 75.239999999999995 112.866 -173.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 86.8 m-20 -100.09 116.35 31.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.613 -0.721 . . . . 72.040000000000006 111.071 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' A' ' 122' ' ' VAL . 64.0 m-85 -98.26 118.18 34.33 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.002 0.371 . . . . 64.299999999999997 112.002 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.573 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -84.66 131.99 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.432 -0.349 . . . . 74.150000000000006 110.595 174.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -121.58 148.65 44.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.703 0.401 . . . . 70.099999999999994 110.056 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.583 HD11 HG22 ' A' ' 65' ' ' VAL . 50.4 mt . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.406 0.622 . . . . 71.430000000000007 112.598 -174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 112.975 0.732 . . . . 73.420000000000002 112.975 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.99 152.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.175 0.512 . . . . 42.539999999999999 111.928 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.486 ' HA2' ' SD ' ' A' ' 127' ' ' MET . . . 82.82 -33.66 2.83 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.819 -0.705 . . . . 32.240000000000002 112.827 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.5 139.83 58.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.382 0.273 . . . . 65.319999999999993 110.96 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.0 p -54.03 -45.88 71.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.072 0.463 . . . . 63.229999999999997 110.967 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.3 p -53.19 -43.47 67.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 112.022 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.94 -48.59 77.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.22 0.533 . . . . 72.019999999999996 111.188 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.66 -45.17 91.37 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.903 -0.59 . . . . 64.019999999999996 111.629 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 57' ' ' CYS . 64.3 t -60.46 -43.25 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.797 0.332 . . . . 71.299999999999997 111.415 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -55.04 -38.71 68.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.268 -0.423 . . . . 71.299999999999997 111.527 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.85 -48.81 34.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.834 0.35 . . . . 75.129999999999995 111.366 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -58.25 -36.52 73.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.362 0.505 . . . . 72.400000000000006 112.362 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 HD11 ' A' ' 154' ' ' LEU . 9.6 p -80.8 11.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.415 0.626 . . . . 72.120000000000005 111.42 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.13 19.44 66.04 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.294 -0.412 . . . . 73.420000000000002 113.581 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.53 24.14 61.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.26 -0.495 . . . . 71.140000000000001 113.716 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -86.8 9.94 17.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.301 -0.529 . . . . 72.430000000000007 111.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.82 148.85 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.979 0.419 . . . . 71.319999999999993 111.428 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.97 84.95 0.16 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 53.5 112.933 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.1 p -51.68 -21.12 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.447 0.536 . . . . 51.5 112.447 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.1 t -66.62 -2.13 4.5 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.787 0.662 . . . . 53.32 112.787 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -63.53 -22.83 67.11 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.07 0.396 . . . . 72.129999999999995 112.07 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.42 -131.73 10.87 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.173 -0.537 . . . . 70.049999999999997 113.729 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.82 154.98 40.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.415 0.626 . . . . 62.399999999999999 111.972 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -72.37 31.03 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 113.965 1.098 . . . . 52.310000000000002 113.965 -171.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -111.61 -18.25 12.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.249 0.547 . . . . 74.040000000000006 110.287 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.64 -0.17 27.85 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.935 -0.575 . . . . 60.450000000000003 112.067 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -66.96 -58.44 4.96 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.093 -0.379 . . . . 71.129999999999995 111.953 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 111.884 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.7 t -58.71 -51.37 70.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.945 0.402 . . . . 51.049999999999997 111.264 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.31 82.78 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.432 -0.349 . . . . 61.030000000000001 111.443 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -55.67 -52.88 62.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.519999999999996 111.273 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -62.78 -32.35 73.5 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.801 0.334 . . . . 65.109999999999999 111.602 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.9 t -76.48 -33.09 58.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.119 0.415 . . . . 74.510000000000005 112.119 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.88 -51.43 8.59 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.115 0.413 . . . . 72.129999999999995 112.115 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.29 24.7 0.08 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.831 -0.7 . . . . 63.109999999999999 113.818 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 28.5 m-85 -90.89 178.82 5.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.224 0.535 . . . . 75.430000000000007 111.293 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 91' ' ' ASN . 84.2 m -109.26 89.6 3.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.055 -0.52 . . . . 70.209999999999994 111.051 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.86 111.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.93 0.395 . . . . 63.32 111.648 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 89' ' ' THR . 6.0 m120 -135.61 177.14 8.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.99 0.424 . . . . 73.219999999999999 110.74 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.7 -0.05 57.29 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 110.815 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.5 m -67.86 114.24 19.16 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.802 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -85.75 12.35 3.07 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.074 2.516 . . . . 64.230000000000004 114.943 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.54 145.31 33.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.963 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.14 157.49 2.58 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.725 -0.67 . . . . 73.109999999999999 112.656 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.04 38.66 9.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.963 -0.637 . . . . 72.200000000000003 112.187 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.5 p -152.55 173.19 15.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.206 0.527 . . . . 51.130000000000003 111.79 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.16 124.38 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.636 -0.711 . . . . 71.439999999999998 110.786 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 1.6 pt? -91.81 137.38 32.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.932 -0.48 . . . . 52.020000000000003 111.244 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' OD1' ' A' ' 150' ' ' ASN . 27.3 tt0 -106.52 128.79 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.479 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 12.5 t . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 112.979 0.733 . . . . 73.400000000000006 112.979 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.388 0 N-CA-C 112.159 -0.377 . . . . 72.010000000000005 112.159 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 19.6 t60 -175.0 138.32 0.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.748 0.309 . . . . 72.209999999999994 110.782 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.449 HG13 ' HB1' ' A' ' 76' ' ' ALA . 16.7 m -143.47 146.64 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 111.185 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.82 149.88 30.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.002 -0.545 . . . . 55.340000000000003 110.902 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -87.31 126.35 34.79 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.38 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 124' ' ' VAL . 54.4 t -70.44 111.7 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.059 0.392 . . . . 74.409999999999997 112.059 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.04 -44.98 36.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.944 0.402 . . . . 75.329999999999998 111.648 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.5 164.03 29.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 111.946 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.33 108.8 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.899 -0.591 . . . . 61.219999999999999 110.307 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.99 157.47 33.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.09 0.472 . . . . 63.219999999999999 111.959 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.8 m -61.29 -12.82 14.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.449 0.537 . . . . 70.439999999999998 112.449 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.97 -6.48 52.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.887 0.375 . . . . 63.240000000000002 111.705 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.14 -16.5 59.5 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.402 -0.428 . . . . 75.329999999999998 112.514 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -66.51 131.9 47.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.95 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.72 124.82 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.56 . . . . 72.010000000000005 111.475 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.89 111.43 23.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.928 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 113' ' ' VAL . 33.6 m -114.54 153.02 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.258 0.466 . . . . 74.109999999999999 112.258 -177.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -101.13 121.74 42.37 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.195 0.521 . . . . 53.520000000000003 111.437 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -127.68 124.16 37.24 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.896 -0.593 . . . . 72.219999999999999 111.329 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.486 ' SD ' ' HA2' ' A' ' 55' ' ' GLY . 44.5 ttm . . . . . 0 N--CA 1.471 0.578 0 O-C-N 121.943 -0.473 . . . . 72.129999999999995 110.457 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 74.209999999999994 110.161 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -103.57 105.8 16.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 111.626 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.2 m -87.71 104.93 17.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.794 0.33 . . . . 75.299999999999997 111.2 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.4 mt -93.38 140.28 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 122.494 0.317 . . . . 75.530000000000001 111.633 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.0 m -64.12 146.8 53.6 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.645 -0.252 . . . . 75.040000000000006 111.317 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.58 64.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.66 0.615 . . . . 74.430000000000007 112.66 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.61 -34.95 65.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.518 -0.372 . . . . 60.340000000000003 113.876 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.55 -35.29 17.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.964 0.412 . . . . 75.209999999999994 111.361 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.95 80.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.435 -0.348 . . . . 65.310000000000002 111.673 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.5 p -67.14 -8.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.863 0.363 . . . . 74.510000000000005 111.888 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.1 t -78.8 -11.82 60.0 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.093 0.473 . . . . 52.149999999999999 110.805 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 34.3 m-85 -106.16 135.11 48.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.054 -0.521 . . . . 72.400000000000006 110.316 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 101' ' ' GLN . 4.2 p-10 -82.11 129.69 34.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.995 0.426 . . . . 63.240000000000002 111.89 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -100.05 123.76 44.65 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.61 0.596 . . . . 73.030000000000001 112.61 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 80' ' ' ALA . 3.6 mp -86.5 123.95 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.135 -0.484 . . . . 72.120000000000005 110.576 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.2 149.64 35.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.547 0.339 . . . . 74.239999999999995 110.314 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 65' ' ' VAL . 24.7 mt . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.165 0.507 . . . . 72.340000000000003 111.427 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.216 0.531 . . . . 52.310000000000002 112.148 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 140.67 45.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.986 -0.552 . . . . 63.399999999999999 112.062 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.54 -18.86 43.58 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.243 -0.503 . . . . 71.430000000000007 113.257 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.11 161.15 14.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.884 0.373 . . . . 75.430000000000007 111.754 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.452 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 59.6 m -63.22 -43.35 98.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.003 0.43 . . . . 73.219999999999999 111.878 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 74' ' ' GLY . 72.3 p -61.1 -25.51 67.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.573 0.583 . . . . 75.219999999999999 112.573 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.45 -63.88 1.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 38.9 p90 -66.52 -29.12 69.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.064 0.394 . . . . 71.549999999999997 112.064 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 57' ' ' CYS . 59.2 t -62.12 -45.05 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.95 0.405 . . . . 54.109999999999999 110.874 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -56.4 -34.1 66.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 111.086 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.35 -46.43 22.86 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.207 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -57.74 -32.64 67.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.079 0.4 . . . . 72.329999999999998 112.079 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 65' ' ' VAL . 8.0 p -91.52 13.18 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.3 0.571 . . . . 71.310000000000002 111.455 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.98 22.67 58.14 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 113.936 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.86 22.21 64.2 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.326 0.49 . . . . 73.519999999999996 114.326 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -83.35 12.0 6.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.488 0.644 . . . . 73.510000000000005 112.284 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.85 176.34 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.966 0.412 . . . . 70.019999999999996 111.744 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.17 115.75 8.44 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.164 -0.541 . . . . 73.099999999999994 113.621 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 p -75.41 0.87 15.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.592 0.59 . . . . 72.409999999999997 112.592 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 t -119.76 20.45 12.28 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.014 0.376 . . . . 73.209999999999994 112.014 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.83 -37.76 73.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.08 0.467 . . . . 75.129999999999995 111.386 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 58' ' ' THR . . . 67.29 -111.22 3.94 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.152 -0.477 . . . . 52.340000000000003 114.24 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.14 125.18 6.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.218 0.607 . . . . 71.519999999999996 112.522 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.12 60.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.287 0.477 . . . . 64.450000000000003 112.287 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -94.24 0.31 55.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.573 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.84 -12.9 16.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.545 0.338 . . . . 71.439999999999998 111.694 -176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -57.99 -33.69 69.18 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.463 0.912 . . . . 74.349999999999994 113.463 -172.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.79 64.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.898 0.38 . . . . 71.109999999999999 111.344 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -64.21 -43.72 94.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 111.128 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.11 96.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.413 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.76 -52.38 65.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.0 0.429 . . . . 75.349999999999994 110.633 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.0 t -58.8 -34.06 71.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 111.649 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 t -74.99 -25.71 59.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.819 0.342 . . . . 43.32 111.908 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.62 2.43 41.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.074 0.398 . . . . 65.349999999999994 112.074 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 41.55 14.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.325 -0.464 . . . . 74.239999999999995 113.943 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.448 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.5 m-85 -103.78 169.68 8.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.319 -0.518 . . . . 71.450000000000003 111.815 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.416 HG22 HD22 ' A' ' 91' ' ' ASN . 55.4 m -97.07 98.84 10.39 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.052 -0.522 . . . . 73.409999999999997 112.367 -171.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.43 103.19 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.151 0.501 . . . . 65.209999999999994 112.283 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.416 HD22 HG22 ' A' ' 89' ' ' THR . 44.7 m-80 -139.06 162.57 34.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.307 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -86.46 3.84 42.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.408 0.521 . . . . 75.340000000000003 112.408 -177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.0 m -57.25 113.13 5.59 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 110.542 -0.17 . . . . 73.430000000000007 110.542 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.94 -1.52 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.737 2.291 . . . . 75.129999999999995 114.577 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.71 139.57 9.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.874 0.694 . . . . 63.219999999999999 112.874 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.91 162.99 2.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.406 -0.816 . . . . 72.109999999999999 112.937 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.06 33.04 27.53 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.092 -0.575 . . . . 61.549999999999997 112.276 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.1 p -147.1 168.53 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.505 0.322 . . . . 71.430000000000007 110.834 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -115.7 124.44 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.345 -0.222 . . . . 74.310000000000002 110.659 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -96.95 134.97 39.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.326 0.584 . . . . 63.210000000000001 111.703 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -97.72 101.59 13.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 110.976 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 26.5 t . . . . . 0 N--CA 1.47 0.535 0 CA-C-N 115.851 -0.613 . . . . 64.409999999999997 111.923 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 CA-C-O 121.08 0.267 . . . . 45.049999999999997 113.175 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -149.1 131.34 15.51 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.591 -0.358 . . . . 64.510000000000005 110.86 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.79 149.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.171 -0.468 . . . . 71.510000000000005 110.392 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 61' ' ' VAL . . . -155.84 152.45 28.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.991 0.424 . . . . 62.530000000000001 111.984 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -80.8 129.08 34.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.272 -0.422 . . . . 63.149999999999999 110.811 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.24 102.68 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.216 0.531 . . . . 64.109999999999999 111.058 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.59 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 18.5 mm-40 -62.22 -58.1 9.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.459 -0.791 . . . . 71.420000000000002 111.289 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -161.67 148.47 14.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.846 -0.615 . . . . 75.310000000000002 111.361 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -115.15 137.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.309 . . . . 73.140000000000001 110.721 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -107.54 150.52 26.74 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.863 0.363 . . . . 61.43 111.762 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 m -61.53 -36.98 82.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.382 0.882 . . . . 61.219999999999999 113.382 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.19 -45.09 79.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.21 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.61 62.43 0.05 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.996 -0.621 . . . . 51.32 113.255 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.9 m -147.5 134.21 19.99 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.477 -0.425 . . . . 73.120000000000005 111.341 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 117.7 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.635 -0.711 . . . . 73.540000000000006 110.988 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.03 117.42 26.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.141 -0.481 . . . . 74.5 110.981 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.01 150.24 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.437 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 94.1 p -77.95 130.19 36.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.676 -0.693 . . . . 63.530000000000001 112.178 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -143.26 146.74 33.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.202 0.525 . . . . 75.239999999999995 112.306 174.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 57.3 tpp . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 116.077 -0.51 . . . . 72.540000000000006 110.264 175.121 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 30.9 mt-10 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.639 0.257 . . . . 72.340000000000003 111.665 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -79.77 125.2 29.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.637 0.256 . . . . 64.530000000000001 110.631 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.9 m -91.33 99.54 12.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.99 0.424 . . . . 60.240000000000002 110.853 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.89 137.94 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.041 0.386 . . . . 73.120000000000005 112.041 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 52.5 m -61.6 151.5 33.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.941 0.4 . . . . 72.400000000000006 111.8 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.87 82.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.248 0.462 . . . . 72.439999999999998 112.248 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.13 74.79 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.418 -0.42 . . . . 51.530000000000001 113.426 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.96 -54.66 6.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.262 0.553 . . . . 71.150000000000006 111.129 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -61.48 -40.46 94.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.783 0.66 . . . . 54.240000000000002 112.783 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.3 p -62.07 -16.13 49.89 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.125 0.417 . . . . 43.210000000000001 112.125 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.8 t -76.69 -17.83 58.89 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.952 0.406 . . . . 73.319999999999993 111.317 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 16.8 m-85 -93.06 152.95 18.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.21 0.529 . . . . 71.120000000000005 111.847 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.04 132.17 35.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.035 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 94.5 m-85 -106.84 129.83 54.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.781 0.8 . . . . 74.129999999999995 112.807 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.76 112.08 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.294 -0.866 . . . . 62.049999999999997 110.798 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -106.2 141.38 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.954 0.407 . . . . 71.129999999999995 111.543 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 CA--C 1.539 0.544 0 CA-C-N 116.088 -0.505 . . . . 54.100000000000001 111.181 179.591 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 111.787 0.292 . . . . 73.150000000000006 111.787 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 35.06 0.1 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.54 0.941 . . . . 63.149999999999999 113.54 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.68 4.72 1.27 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.221 -0.514 . . . . 63.229999999999997 113.556 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.69 147.04 42.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.997 0.399 . . . . 74.299999999999997 111.212 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 63.7 m -54.93 -31.52 60.44 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.209 0.528 . . . . 64.5 111.259 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.6 p -68.04 -18.15 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.039 0.755 . . . . 73.120000000000005 113.039 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -75.81 -71.22 0.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.942 0.719 . . . . 75.219999999999999 112.942 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.493 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 12.6 p90 -59.93 -18.42 45.08 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.384 0.883 . . . . 74.239999999999995 113.384 -171.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.13 -34.78 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.21 0.528 . . . . 73.209999999999994 110.749 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 72.7 t80 -56.94 -51.86 67.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.712 -0.676 . . . . 62.439999999999998 111.294 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.48 -42.77 92.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.324 -0.398 . . . . 71.340000000000003 111.602 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -66.33 -31.96 73.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.326 0.491 . . . . 55.119999999999997 112.326 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.86 9.69 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.475 0.655 . . . . 71.319999999999993 111.402 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.5 14.83 65.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.426 -0.416 . . . . 65.430000000000007 113.671 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.39 7.73 64.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.41 0.524 . . . . 72.140000000000001 114.41 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -78.45 35.05 0.22 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.263 0.532 . . . . 75.129999999999995 112.371 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.8 pt -121.44 -30.46 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.134 0.42 . . . . 73.219999999999999 112.134 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.31 9.44 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.07 -0.586 . . . . 53.039999999999999 113.289 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.526 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 53.2 p 59.6 4.8 0.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.287 0.847 . . . . 72.439999999999998 113.287 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -84.95 9.6 14.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.165 0.507 . . . . 55.219999999999999 111.571 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.4 m0 -79.36 -36.67 38.97 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.322 -0.399 . . . . 72.519999999999996 111.593 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.36 -122.63 6.02 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.023 -0.608 . . . . 64.439999999999998 113.964 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -51.6 141.44 16.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.421 0.526 . . . . 71.209999999999994 112.421 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -31.9 72.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.195 0.442 . . . . 63.439999999999998 112.195 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.38 1.93 20.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.807 0.337 . . . . 74.420000000000002 111.661 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.95 -6.97 12.58 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.132 0.419 . . . . 54.109999999999999 112.132 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.39 -56.47 21.62 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.682 0.623 . . . . 73.409999999999997 112.682 -176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.51 75.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 71.040000000000006 111.552 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.5 m -60.69 -52.53 64.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.977 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.21 78.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 111.196 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -58.38 8.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.512 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.6 p -58.89 -37.09 75.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.836 0.351 . . . . 70.030000000000001 111.735 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -71.52 -39.81 70.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.383 -0.371 . . . . 61.340000000000003 111.392 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.5 10.57 5.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.664 0.616 . . . . 54.450000000000003 112.664 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.94 66.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.012 -0.613 . . . . 64.329999999999998 114.334 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -76.79 164.3 25.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.514 0.657 . . . . 63.219999999999999 110.999 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.401 HG22 ' OD1' ' A' ' 91' ' ' ASN . 85.4 m -100.5 100.35 11.08 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 111.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 152' ' ' ILE . 48.1 t -108.83 119.88 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.773 0.32 . . . . 71.430000000000007 111.572 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 89' ' ' THR . 7.5 m120 -140.13 -176.15 4.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 111.19 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -97.57 4.07 50.37 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.182 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.6 m -67.71 114.1 18.06 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.274 -0.421 . . . . 65.450000000000003 110.439 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.69 22.9 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.968 2.445 . . . . 50.350000000000001 114.584 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.08 149.69 36.3 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.959 0.726 . . . . 71.329999999999998 112.959 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.38 163.06 4.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.71 -0.677 . . . . 53.140000000000001 112.467 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.63 34.53 73.09 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.947 -0.644 . . . . 71.109999999999999 112.626 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.1 m -139.01 165.83 26.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.654 0.264 . . . . 52.109999999999999 111.105 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -116.86 127.56 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 110.446 -0.205 . . . . 71.019999999999996 110.446 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.7 pt? -99.83 144.94 28.31 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.848 -0.533 . . . . 75.129999999999995 110.993 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -121.62 133.56 54.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.4 0.619 . . . . 63.020000000000003 112.536 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 29.7 t . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 115.35 -0.841 . . . . 65.310000000000002 110.657 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 CA-C-O 121.003 0.224 . . . . 73.109999999999999 113.333 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 73.0 t60 -143.85 141.93 30.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.565 -0.374 . . . . 64.319999999999993 111.2 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 20.5 m -139.17 146.34 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.505 -0.316 . . . . 74.120000000000005 111.114 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.498 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -153.74 154.64 34.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.03 0.443 . . . . 71.099999999999994 112.125 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -91.18 121.21 32.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 111.535 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.65 114.33 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.03 0.381 . . . . 74.439999999999998 112.03 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 10.1 mm-40 -78.78 -56.69 4.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 111.635 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -149.46 141.66 24.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.411 0.523 . . . . 64.510000000000005 112.411 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.32 126.33 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 111.071 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -94.42 144.12 25.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.753 0.311 . . . . 72.519999999999996 111.093 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -60.91 -25.74 66.95 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.223 0.535 . . . . 75.340000000000003 111.549 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.49 -16.32 62.29 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.992 -0.549 . . . . 75.019999999999996 111.59 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.86 -14.98 37.67 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.28 -0.418 . . . . 42.219999999999999 112.952 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.1 m -66.68 120.99 14.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 64.409999999999997 111.499 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.57 116.93 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.306 0.574 . . . . 54.119999999999997 111.178 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.14 113.69 25.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 111.005 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.94 167.11 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.196 0.522 . . . . 65.109999999999999 112.146 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.1 t -108.01 105.59 15.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.096 -0.502 . . . . 44.329999999999998 111.088 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -141.69 118.58 11.16 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.27 -0.423 . . . . 53.130000000000003 111.382 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.1 ttm . . . . . 0 CA--C 1.534 0.361 0 O-C-N 122.218 -0.301 . . . . 53.530000000000001 110.703 174.786 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 42.2 mt-10 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 111.959 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -114.5 122.99 48.27 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.433 -0.348 . . . . 71.299999999999997 111.176 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.2 m -85.66 99.79 11.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.775 0.322 . . . . 64.019999999999996 110.505 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.9 mt -93.27 139.78 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.912 0.387 . . . . 73.530000000000001 111.925 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 m -69.17 150.78 47.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.338 -0.392 . . . . 71.409999999999997 111.734 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.93 -52.38 58.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.463 0.542 . . . . 74.310000000000002 112.463 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.28 -13.0 34.11 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.117 -0.492 . . . . 72.439999999999998 114.018 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -101.77 -49.81 3.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 110.959 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -56.88 -50.42 72.56 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.621 0.6 . . . . 74.530000000000001 112.621 -175.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 68.3 m -60.69 -9.52 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.064 0.764 . . . . 35.140000000000001 113.064 -177.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.0 t -83.37 -19.79 35.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.932 0.396 . . . . 64.230000000000004 111.548 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -85.91 161.58 18.98 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.155 0.502 . . . . 74.239999999999995 112.096 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.0 m-20 -89.29 117.76 28.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.493 -0.321 . . . . 73.430000000000007 111.265 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.417 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 93.7 m-85 -99.89 113.1 25.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.299 0.481 . . . . 74.129999999999995 112.299 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.7 mp -83.06 134.73 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.374 -0.376 . . . . 71.409999999999997 110.272 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -122.99 142.79 50.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.967 0.413 . . . . 63.130000000000003 111.354 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 111.796 -179.908 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.188 0.518 . . . . 71.329999999999998 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 115.2 9.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.915 -0.584 . . . . 65.209999999999994 111.273 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.92 -13.22 7.2 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.172 -0.537 . . . . 65.200000000000003 112.887 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -100.03 144.99 28.42 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.787 0.327 . . . . 74.099999999999994 111.144 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.6 m -56.01 -25.87 46.27 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.117 0.414 . . . . 74.140000000000001 112.117 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.2 p -67.21 -27.22 67.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.275 0.472 . . . . 51.409999999999997 112.275 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -65.64 -64.07 0.95 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.806 0.669 . . . . 74.510000000000005 112.806 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB3' ' SD ' ' A' ' 127' ' ' MET . 34.6 p90 -63.49 -32.48 73.94 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.048 0.388 . . . . 64.140000000000001 112.048 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 110' ' ' VAL . 66.1 t -62.62 -37.17 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.765 0.317 . . . . 72.319999999999993 111.442 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -59.15 -37.36 77.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.057 0.456 . . . . 74.540000000000006 110.84 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.11 -40.82 62.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.179 -0.464 . . . . 71.519999999999996 110.998 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.75 -44.88 86.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.093 0.473 . . . . 63.240000000000002 111.753 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.42 -3.14 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.106 0.479 . . . . 71.030000000000001 111.424 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.15 22.37 73.89 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.47 -0.395 . . . . 73.230000000000004 113.703 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.25 15.38 65.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 114.325 0.49 . . . . 25.039999999999999 114.325 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -79.68 2.65 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.644 0.609 . . . . 61.310000000000002 112.644 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.7 pt -109.43 149.56 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.166 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.36 110.5 3.2 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.826 -0.702 . . . . 31.539999999999999 112.674 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -64.47 -3.24 2.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 122.413 -0.463 . . . . 63.32 112.24 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 t -64.12 -13.33 47.17 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.256 0.465 . . . . 70.439999999999998 112.256 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -59.11 -50.07 75.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.96 0.409 . . . . 65.319999999999993 111.424 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.58 -128.26 9.33 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.162 -0.542 . . . . 61.140000000000001 113.38 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.71 140.47 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 111.83 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.99 -41.28 64.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.118 0.784 . . . . 73.209999999999994 113.118 -173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.62 -22.62 65.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -84.54 -24.2 29.41 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.748 0.277 . . . . 72.450000000000003 111.748 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -45.37 -46.98 13.48 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.996 0.739 . . . . 75.430000000000007 112.996 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.46 81.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 63.439999999999998 112.181 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 t -80.4 -47.5 14.3 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 74.049999999999997 111.617 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.94 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.359 -0.382 . . . . 73.409999999999997 111.602 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -60.55 -53.78 53.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 53.310000000000002 111.327 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.0 p -59.77 -42.47 93.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.89 0.376 . . . . 72.010000000000005 111.225 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 t -65.61 -29.77 70.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.374 -0.376 . . . . 75.030000000000001 111.543 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.18 -4.34 59.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.435 0.531 . . . . 74.25 112.435 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.45 3.18 56.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.262 -0.494 . . . . 72.25 113.853 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 81.7 m-85 -72.3 173.79 8.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 111.423 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 35.4 m -106.24 84.85 2.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.09 0.404 . . . . 73.400000000000006 112.09 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 152' ' ' ILE . 49.5 t -93.9 111.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.85 0.357 . . . . 74.549999999999997 111.562 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -149.06 159.96 43.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 110.779 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.2 24.36 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.447 0.536 . . . . 75.209999999999994 112.447 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -81.04 108.64 10.8 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.387 0.275 . . . . 75.209999999999994 110.83 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.45 7.9 4.72 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.833 2.355 . . . . 62.340000000000003 114.395 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -51.59 143.07 13.02 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.158 0.429 . . . . 70.120000000000005 112.158 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 152.7 11.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.52 13.78 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.133 -0.556 . . . . 64.010000000000005 113.114 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.3 p -144.86 178.4 8.04 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 71.129999999999995 111.06 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 62.7 mt -124.58 120.06 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.551 -0.295 . . . . 74.430000000000007 111.211 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.469 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.9 pt? -85.59 126.87 34.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 72.129999999999995 111.233 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 111.26 23.93 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.976 0.417 . . . . 73.310000000000002 109.927 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 21.4 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 114.238 1.199 . . . . 61.039999999999999 114.238 -169.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 113.938 0.335 . . . . 50.450000000000003 113.938 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -111.91 143.31 43.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.542 0.337 . . . . 73.340000000000003 111.038 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.531 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.7 m -141.17 150.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.08 0.467 . . . . 70.140000000000001 111.824 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.415 ' H ' HD23 ' A' ' 100' ' ' LEU . . . -156.42 168.94 25.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.813 -0.63 . . . . 63.200000000000003 110.561 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -100.43 129.55 46.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 111.281 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.35 112.66 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.778 0.323 . . . . 60.25 111.689 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.29 -53.95 4.91 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.12 0.415 . . . . 70.329999999999998 112.12 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -143.18 150.43 39.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.993 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.19 131.98 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.886 -0.597 . . . . 70.239999999999995 110.757 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.57 156.3 16.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.475 -0.33 . . . . 53.299999999999997 111.302 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.8 p -64.66 -18.35 64.88 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.137 0.421 . . . . 55.049999999999997 112.137 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -69.47 -9.78 55.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.817 0.342 . . . . 73.519999999999996 111.443 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 93.5 0.07 67.57 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 112.214 -0.354 . . . . 70.439999999999998 112.214 -174.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 m -67.89 120.73 14.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 110.926 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.4 t -105.22 119.19 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.659 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.55 107.12 19.49 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.191 0.519 . . . . 74.400000000000006 110.929 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.58 144.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.013 -0.54 . . . . 55.219999999999999 111.771 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 t -90.98 112.83 24.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.333 -0.394 . . . . 74.010000000000005 111.379 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.39 -173.08 2.3 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.037 -0.529 . . . . 63.219999999999999 110.964 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' A' ' 60' ' ' TYR . 19.2 ptm . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.213 0.53 . . . . 64.409999999999997 110.77 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 111.945 0.35 . . . . 71.150000000000006 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -111.94 125.41 54.03 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.025 -0.422 . . . . 60.030000000000001 110.77 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.1 m -91.54 105.12 17.51 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.964 0.411 . . . . 64.0 111.619 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.18 139.93 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.375 -0.375 . . . . 70.310000000000002 111.555 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.2 m -72.36 155.31 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.681 0.277 . . . . 70.420000000000002 111.679 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -54.99 -48.19 73.63 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.535 0.569 . . . . 72.099999999999994 112.535 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.33 -41.08 92.88 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.478 -0.392 . . . . 62.25 113.41 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.51 -45.3 39.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.249 0.547 . . . . 64.230000000000004 111.236 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -64.81 -38.1 89.85 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.837 0.68 . . . . 65.319999999999993 112.837 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -62.47 -15.63 50.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.615 0.598 . . . . 74.120000000000005 112.615 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -79.53 -28.35 41.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.904 0.383 . . . . 73.25 111.796 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 100' ' ' LEU . 22.9 m-85 -74.14 147.84 42.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.163 0.506 . . . . 64.25 111.969 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -91.99 108.12 19.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.233 -0.439 . . . . 75.510000000000005 110.781 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 71.3 m-85 -88.22 119.08 28.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.948 0.404 . . . . 71.25 111.803 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 90' ' ' VAL . 3.6 mp -82.21 130.18 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.731 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.46 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 46.4 m-70 -120.39 161.95 20.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.969 0.508 . . . . 74.129999999999995 109.87 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.754 0.65 . . . . 62.219999999999999 112.754 -172.275 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 121.052 0.453 . . . . 72.209999999999994 111.854 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.08 149.88 26.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.834 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.18 -23.33 35.16 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.132 -0.556 . . . . 74.239999999999995 113.252 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -89.41 142.19 27.88 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.559 -0.377 . . . . 71.019999999999996 111.294 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.27 -27.05 65.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.213 0.53 . . . . 60.299999999999997 111.469 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.4 p -73.37 -16.37 61.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 112.203 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.98 -54.43 47.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.265 0.626 . . . . 72.340000000000003 112.397 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 39.4 p90 -77.89 -34.95 51.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.167 0.432 . . . . 73.129999999999995 112.167 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.14 -42.59 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 111.853 0.316 . . . . 75.329999999999998 111.853 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -58.01 -36.84 73.24 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.77 -41.82 43.27 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.868 0.366 . . . . 71.140000000000001 110.929 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.24 -27.2 68.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.107 0.41 . . . . 64.040000000000006 112.107 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.8 3.27 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 121.277 0.56 . . . . 60.350000000000001 111.422 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.28 12.77 66.56 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.163 -0.541 . . . . 72.150000000000006 113.933 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.41 16.91 71.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 114.43 0.532 . . . . 74.450000000000003 114.43 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.95 30.19 0.52 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.343 0.571 . . . . 63.229999999999997 112.123 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.81 150.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.923 0.392 . . . . 74.519999999999996 111.603 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.65 98.25 0.28 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.321 -0.466 . . . . 72.450000000000003 113.363 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.0 p -59.36 -8.76 1.88 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.086 0.773 . . . . 71.430000000000007 113.086 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -66.57 -12.5 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.59 0.589 . . . . 63.140000000000001 112.59 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -63.15 -59.45 4.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.807 0.337 . . . . 70.239999999999995 111.779 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.62 -110.43 3.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.11 -0.567 . . . . 32.130000000000003 113.699 176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.52 140.2 58.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.985 0.393 . . . . 73.299999999999997 111.316 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.19 -43.68 64.31 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.573 0.582 . . . . 41.119999999999997 112.573 -176.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -56.96 -21.14 27.96 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.774 0.657 . . . . 61.130000000000003 112.774 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -90.94 -23.81 20.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.824 0.305 . . . . 72.030000000000001 111.824 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 101' ' ' GLN . 9.4 m0 -50.52 -40.26 51.11 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.264 0.839 . . . . 73.319999999999993 113.264 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.63 -64.58 0.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.171 0.434 . . . . 70.239999999999995 112.171 -175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -63.82 -35.44 80.62 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 71.030000000000001 111.691 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.39 87.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.773 0.32 . . . . 72.430000000000007 111.377 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.031 0.443 . . . . 34.210000000000001 111.347 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 p -64.22 -28.51 69.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.423 -0.353 . . . . 65.140000000000001 111.897 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -77.9 -36.34 49.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.9 0.381 . . . . 54.420000000000002 111.767 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -22.03 59.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.267 0.469 . . . . 72.129999999999995 112.267 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.58 10.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.047 -0.597 . . . . 23.23 113.587 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -76.67 -173.79 2.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.195 0.521 . . . . 54.329999999999998 111.286 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.9 m -121.23 97.47 5.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.436 -0.347 . . . . 63.149999999999999 111.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 152' ' ' ILE . 46.2 t -101.62 108.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.817 0.341 . . . . 74.430000000000007 111.847 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.65 147.74 39.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.51 -0.314 . . . . 74.219999999999999 110.932 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -72.76 -9.78 59.04 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.172 0.434 . . . . 72.319999999999993 112.172 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.9 m -56.53 119.79 31.48 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.519 0.2 . . . . 74.230000000000004 111.095 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.56 121.76 1.93 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.001 2.467 . . . . 73.140000000000001 113.78 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.49 156.87 35.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 111.099 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 151.66 46.04 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.077 0.465 . . . . 72.439999999999998 112.115 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.02 41.45 18.26 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.191 -0.528 . . . . 54.020000000000003 113.108 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.5 m -151.75 158.53 43.48 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.514 -0.404 . . . . 63.25 111.011 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -103.26 126.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.335 -0.246 . . . . 74.109999999999999 110.335 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 149' ' ' TYR . 1.2 pt? -98.85 124.36 43.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.399 0.619 . . . . 65.230000000000004 110.836 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -111.8 124.17 51.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 111.434 -172.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.585 ' HB2' ' CD1' ' A' ' 149' ' ' TYR . 47.5 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.877 0.37 . . . . 54.310000000000002 111.795 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -159.52 142.25 13.93 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.494 0.647 . . . . 73.510000000000005 111.66 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' HB1' ' A' ' 76' ' ' ALA . 12.8 m -141.09 141.43 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 111.716 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.16 156.67 41.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.38 -0.373 . . . . 73.209999999999994 110.905 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -96.0 128.64 43.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.881 0.372 . . . . 70.109999999999999 111.209 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 124' ' ' VAL . 61.8 t -79.8 118.82 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.317 0.488 . . . . 63.530000000000001 112.317 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -83.92 -53.67 5.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.282 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.42 154.05 34.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.075 0.464 . . . . 64.519999999999996 111.605 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.28 129.09 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 111.009 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.8 OUTLIER -77.46 160.0 29.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.869 0.366 . . . . 40.229999999999997 111.5 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.3 m -64.04 -20.42 65.91 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.784 0.326 . . . . 62.200000000000003 111.605 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.11 -22.92 66.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.071 0.463 . . . . 74.420000000000002 111.329 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.87 45.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.582 -0.607 . . . . 75.109999999999999 111.582 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -64.97 129.17 38.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.621 0.368 . . . . 74.239999999999995 110.909 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.469 HG21 ' OH ' ' A' ' 151' ' ' TYR . 61.0 t -106.7 111.36 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.201 0.524 . . . . 64.209999999999994 111.737 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 140' ' ' THR . 37.9 mt-10 -90.32 107.31 19.06 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 110.716 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 113' ' ' VAL . 30.6 m -108.91 173.87 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.004 -0.543 . . . . 73.310000000000002 112.14 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.8 p -117.87 126.09 51.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.026 -0.534 . . . . 74.340000000000003 111.488 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 48.5 mt-10 -121.82 -172.68 2.49 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 111.268 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.1 tpp . . . . . 0 N--CA 1.471 0.619 0 O-C-N 121.904 -0.497 . . . . 45.32 111.338 177.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.634 0.254 . . . . 73.109999999999999 111.63 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 2.4 tpm_? -140.61 122.71 15.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.971 0.415 . . . . 50.229999999999997 111.923 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 123' ' ' GLU . 81.5 m -104.36 98.5 8.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.946 0.403 . . . . 60.399999999999999 110.739 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.66 128.88 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 54.43 111.775 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.1 m -67.29 147.25 53.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.549 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.72 -47.28 59.2 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.532 0.568 . . . . 52.219999999999999 112.532 -177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.66 64.55 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.225 -0.512 . . . . 71.200000000000003 113.246 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.32 -34.48 25.68 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.085 0.469 . . . . 73.439999999999998 111.06 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 149' ' ' TYR . . . -63.3 -10.93 18.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.707 0.632 . . . . 63.229999999999997 112.707 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -75.81 -21.6 57.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.328 0.492 . . . . 44.539999999999999 112.328 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 94.2 p -83.34 -33.28 25.91 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.355 0.502 . . . . 60.329999999999998 112.355 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 102' ' ' SER . 80.8 m-85 -70.8 145.82 50.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.251 0.548 . . . . 75.209999999999994 112.327 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -101.35 114.84 29.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.069 -0.514 . . . . 71.549999999999997 110.208 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.469 ' OH ' HG21 ' A' ' 122' ' ' VAL . 14.2 m-85 -90.91 114.96 27.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.283 0.475 . . . . 61.340000000000003 112.283 -174.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.558 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -82.02 107.75 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.752 -0.462 . . . . 74.510000000000005 109.752 173.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.81 125.36 40.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 52.539999999999999 111.239 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.986 0.422 . . . . 72.329999999999998 111.056 178.338 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 20.5 ptp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 111.939 0.348 . . . . 62.240000000000002 111.939 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.1 mptp? 73.33 -50.65 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 112.971 0.73 . . . . 74.409999999999997 112.971 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -53.83 110.8 0.63 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.005 0.431 . . . . 74.319999999999993 111.809 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 tt -92.2 122.87 35.09 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.073 -0.512 . . . . 75.099999999999994 110.799 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -75.56 95.31 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.973 0.416 . . . . 54.310000000000002 111.156 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.6 m -82.74 129.03 34.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 72.230000000000004 111.683 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.35 113.31 24.59 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.922 0.392 . . . . 63.130000000000003 111.39 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 75.5 p -84.9 18.43 2.45 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.465 0.543 . . . . 73.209999999999994 112.465 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 m -62.48 137.56 58.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.319 0.488 . . . . 75.510000000000005 112.319 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 10' ' ' LEU . 2.1 pt? -146.56 116.34 7.22 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.213 0.53 . . . . 75.409999999999997 110.841 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -79.66 119.75 23.02 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.303 -0.408 . . . . 71.430000000000007 111.17 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.17 114.91 19.62 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.949 0.404 . . . . 45.310000000000002 111.67 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.19 145.28 17.59 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.214 -0.517 . . . . 74.409999999999997 112.567 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.8 129.54 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 117.088 0.444 . . . . 72.409999999999997 111.784 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.03 -179.3 47.27 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 113.207 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.06 131.88 45.96 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.205 0.526 . . . . 72.329999999999998 112.282 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.24 84.62 7.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.098 0.475 . . . . 70.430000000000007 111.466 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -89.36 147.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.868 0.366 . . . . 72.299999999999997 111.443 178.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.7 t -123.16 143.73 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.024 0.379 . . . . 51.100000000000001 112.024 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.92 135.56 12.96 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.536 -0.364 . . . . 75.120000000000005 112.78 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.7 mm? -90.1 163.59 14.81 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.061 0.458 . . . . 74.219999999999999 111.724 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.38 130.33 47.56 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.013 0.435 . . . . 64.340000000000003 111.814 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -162.12 111.49 1.49 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.167 -0.47 . . . . 70.340000000000003 111.089 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -127.34 3.89 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.998 -0.62 . . . . 60.539999999999999 114.178 -175.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -87.79 152.65 21.95 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.2 0.524 . . . . 71.140000000000001 112.222 -174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.6 pm0 -93.35 177.75 5.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.118 -0.492 . . . . 73.299999999999997 111.904 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.59 165.41 12.03 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.803 0.668 . . . . 75.129999999999995 112.803 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -103.55 137.8 41.12 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 111.621 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.62 151.97 20.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.987 0.422 . . . . 75.420000000000002 111.943 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -104.03 -172.35 2.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.486 0.315 . . . . 41.100000000000001 111.301 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.9 128.65 12.44 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.242 0.544 . . . . 72.319999999999993 112.09 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -173.75 151.91 1.93 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.939 -0.573 . . . . 65.150000000000006 110.964 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 48.1 p -85.1 102.49 13.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.043 0.449 . . . . 65.030000000000001 110.708 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -150.41 99.5 3.2 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.313 -0.403 . . . . 74.420000000000002 111.131 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.36 90.96 0.39 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.749 2.299 . . . . 71.230000000000004 113.022 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.3 p -94.46 131.84 39.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.824 0.345 . . . . 52.450000000000003 111.316 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -89.86 -20.64 23.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.473 -0.33 . . . . 72.430000000000007 111.689 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -92.54 165.23 13.12 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.35 0.595 . . . . 72.200000000000003 112.296 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -78.92 101.53 7.77 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.197 0.522 . . . . 63.240000000000002 110.096 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.8 p -83.11 119.5 24.58 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.422 0.897 . . . . 54.43 113.422 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.8 m -67.61 133.09 48.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.872 -0.604 . . . . 74.209999999999994 109.957 169.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -52.55 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.566 0.58 . . . . 73.239999999999995 112.566 -174.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 155' ' ' ASN . 22.5 m -133.12 152.8 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.795 0.331 . . . . 71.200000000000003 111.399 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.8 p -78.61 176.43 9.47 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.048 0.452 . . . . 74.230000000000004 111.554 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.4 p -135.27 93.98 3.06 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.287 0.477 . . . . 62.530000000000001 112.287 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.91 64.73 1.73 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.141 -0.552 . . . . 70.209999999999994 111.999 173.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 68' ' ' ASN . 34.2 t -88.89 110.84 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.178 0.436 . . . . 62.350000000000001 112.178 -173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -149.49 158.03 43.81 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.25 -0.432 . . . . 72.329999999999998 111.321 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 160.12 5.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.695 0.283 . . . . 74.230000000000004 111.566 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 63' ' ' ASP . 38.9 t-20 -59.7 106.4 0.47 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.025 0.44 . . . . 71.219999999999999 111.765 -176.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.32 9.52 42.57 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.074 -0.512 . . . . 72.430000000000007 111.928 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -94.85 159.48 15.03 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.084 -0.385 . . . . 72.150000000000006 111.128 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t -70.91 139.64 50.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.132 0.491 . . . . 75.140000000000001 111.916 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.46 110.03 13.16 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.176 -0.466 . . . . 54.399999999999999 111.758 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.72 -28.24 1.75 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.925 -0.655 . . . . 73.420000000000002 113.287 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -82.32 150.04 27.43 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 122.547 -0.384 . . . . 74.109999999999999 110.755 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 28.2 p -58.69 -34.18 70.99 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.143 0.497 . . . . 72.310000000000002 111.796 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.404 ' HB ' ' CZ2' ' A' ' 79' ' ' TRP . 49.8 p -64.44 -25.75 68.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 68.3 t90 -61.24 -60.33 3.92 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.519 0.563 . . . . 73.340000000000003 112.519 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 25.0 p90 -64.35 -30.53 71.58 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.097 -0.377 . . . . 64.430000000000007 111.892 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HG23 ' A' ' 110' ' ' VAL . 59.4 t -62.53 -43.67 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.105 0.479 . . . . 61.409999999999997 110.583 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -58.54 -36.61 74.15 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.043 -0.526 . . . . 63.229999999999997 110.944 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB2' HD22 ' A' ' 50' ' ' ASN . 23.5 t70 -76.73 -43.31 37.82 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.406 -0.361 . . . . 64.530000000000001 111.132 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -59.19 -34.4 72.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.146 0.498 . . . . 71.209999999999994 111.816 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 99' ' ' ILE . 7.1 p -85.03 9.38 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.309 0.576 . . . . 70.219999999999999 111.815 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.18 14.59 68.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.389 -0.434 . . . . 34.329999999999998 113.556 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.77 17.9 69.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.167 -0.539 . . . . 73.239999999999995 114.129 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 59.8 m-80 -80.09 11.24 3.55 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.466 0.633 . . . . 64.219999999999999 112.375 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 pt -117.04 153.0 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.374 -0.376 . . . . 74.319999999999993 110.687 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.05 126.69 8.02 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.806 -0.711 . . . . 61.420000000000002 113.968 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.5 m -62.33 -19.27 63.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.189 0.518 . . . . 60.109999999999999 111.364 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 t -70.05 8.25 0.78 Allowed 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 113.361 0.875 . . . . 73.430000000000007 113.361 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -78.15 -46.02 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.99 -0.444 . . . . 72.319999999999993 112.047 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.58 -129.94 9.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.945 -0.645 . . . . 60.43 113.377 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -85.53 162.57 18.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.14 0.495 . . . . 55.43 111.881 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.32 -27.78 64.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.849 -0.614 . . . . 73.239999999999995 112.079 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -63.23 -35.34 79.99 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.985 0.422 . . . . 74.239999999999995 111.173 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.93 -21.26 19.32 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.508 0.558 . . . . 75.450000000000003 112.508 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.404 ' CZ2' ' HB ' ' A' ' 58' ' ' THR . 4.9 m0 -38.95 -55.43 1.55 Allowed 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.447 1.277 . . . . 73.510000000000005 114.447 -172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -62.67 -37.63 87.16 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.941 -0.475 . . . . 62.32 112.235 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -68.94 -47.74 64.96 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 110.932 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.82 92.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.131 -0.486 . . . . 63.219999999999999 111.156 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.96 -51.98 62.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.078 0.466 . . . . 53.409999999999997 110.938 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 m -58.24 -45.27 88.07 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.176 0.512 . . . . 64.319999999999993 110.713 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 t -66.86 -24.6 66.15 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.072 -0.513 . . . . 64.299999999999997 111.97 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.3 -13.07 33.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.114 0.412 . . . . 64.140000000000001 112.114 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.34 41.84 3.86 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.253 -0.499 . . . . 62.439999999999998 113.434 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -107.61 -178.6 3.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 74.340000000000003 111.522 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.0 m -110.05 108.06 18.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.291 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 152' ' ' ILE . 39.0 t -116.81 110.99 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.082 0.467 . . . . 65.140000000000001 111.907 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 50.8 m-80 -139.17 155.6 47.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.385 -0.371 . . . . 72.319999999999993 110.369 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -79.64 13.71 1.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.008 0.373 . . . . 74.430000000000007 112.008 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.5 p -73.84 116.87 56.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.601 -0.272 . . . . 74.010000000000005 111.416 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.2 103.51 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.486 2.124 . . . . 53.539999999999999 112.241 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 36.9 tt0 -141.45 152.15 44.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.977 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.32 153.92 42.0 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.021 0.439 . . . . 71.319999999999993 111.905 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.54 34.05 63.53 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.074 -0.584 . . . . 63.020000000000003 112.691 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.5 m -136.78 158.8 43.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.299999999999997 111.067 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -107.95 127.53 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.597 -0.274 . . . . 64.530000000000001 110.448 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.422 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.7 pt? -95.63 130.37 42.52 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.937 -0.477 . . . . 42.329999999999998 111.127 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HA ' HG12 ' A' ' 110' ' ' VAL . 41.8 tt0 -98.29 129.32 45.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.402 -0.363 . . . . 64.140000000000001 111.685 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.5 t -95.38 -40.62 9.41 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.752 0.649 . . . . 71.310000000000002 112.752 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.3 p 66.59 -42.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.419 1.087 . . . . 75.200000000000003 113.47 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.63 160.17 9.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.212 0.529 . . . . 33.219999999999999 112.075 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.52 -8.51 64.19 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.162 -0.542 . . . . 55.32 113.349 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.97 -84.14 0.36 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.398 -0.43 . . . . 65.140000000000001 113.038 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -87.7 1.85 52.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.955 0.407 . . . . 54.030000000000001 111.767 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.06 155.32 23.92 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.288 -0.482 . . . . 52.140000000000001 113.584 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -131.63 149.71 52.4 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.747 -0.267 . . . . 65.519999999999996 111.036 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.8 m -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.138 0.494 . . . . 65.530000000000001 111.663 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.86 163.03 40.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.006 -0.543 . . . . 73.129999999999995 110.651 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -96.68 127.4 42.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.752 0.31 . . . . 73.340000000000003 111.376 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.562 HG22 HG12 ' A' ' 124' ' ' VAL . 60.9 t -76.1 108.05 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.948 0.404 . . . . 43.539999999999999 112.031 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 138' ' ' GLU . 11.3 mm-40 -71.95 -45.86 59.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.055 -0.52 . . . . 71.349999999999994 111.504 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -163.6 149.37 11.37 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.043 -0.526 . . . . 73.129999999999995 111.517 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 122' ' ' VAL . 57.9 t -120.65 128.91 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.252 -0.431 . . . . 52.119999999999997 110.535 177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -84.42 154.55 22.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.955 0.407 . . . . 70.400000000000006 111.925 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.0 t -57.61 -34.42 69.26 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.441 0.639 . . . . 75.019999999999996 110.078 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.2 -31.53 43.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.245 -0.889 . . . . 75.140000000000001 111.583 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 112.75 -19.35 21.4 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 121.369 -0.443 . . . . 54.509999999999998 112.669 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.3 p -61.62 125.7 24.72 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.329 0.585 . . . . 51.409999999999997 111.66 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.473 HG13 HG22 ' A' ' 116' ' ' VAL . 48.9 t -103.44 117.85 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.716 -0.675 . . . . 74.109999999999999 111.347 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.85 102.52 15.28 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.218 0.532 . . . . 72.340000000000003 111.464 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.562 HG12 HG22 ' A' ' 113' ' ' VAL . 35.5 m -106.42 123.49 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.449 0.643 . . . . 60.340000000000003 111.876 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 39.5 t -81.03 122.19 26.99 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.054 0.455 . . . . 72.209999999999994 111.841 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -133.31 137.59 46.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.134 0.492 . . . . 63.200000000000003 111.18 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.579 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 50.2 ttm -80.58 122.14 26.68 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.016 0.436 . . . . 72.400000000000006 111.642 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.469 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.9 OUTLIER -83.23 -29.46 28.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.15 -0.477 . . . . 64.319999999999993 110.592 176.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.4 t80 71.38 -55.74 0.65 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.91 0.707 . . . . 60.299999999999997 112.91 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -50.38 93.6 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.066 0.46 . . . . 72.409999999999997 111.529 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.62 -38.05 1.48 Allowed Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.99 -0.55 . . . . 54.130000000000003 112.683 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -172.02 167.17 40.14 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.597 -0.335 . . . . 33.149999999999999 112.834 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.06 -28.2 65.73 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.763 2.309 . . . . 64.340000000000003 113.169 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.29 28.07 8.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.668 0.271 . . . . 73.329999999999998 111.684 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.2 m -66.56 83.17 0.1 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.417 0.627 . . . . 52.229999999999997 111.044 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 22.0 t -109.29 155.25 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.832 -0.622 . . . . 54.149999999999999 110.821 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.7 m -145.21 136.85 25.36 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.072 0.463 . . . . 54.210000000000001 111.737 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' A' ' 114' ' ' GLU . 2.6 mp0 -84.35 94.08 8.39 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.336 0.589 . . . . 64.140000000000001 111.366 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -70.04 109.3 4.48 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.504 -0.771 . . . . 64.420000000000002 111.895 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.8 m -85.33 98.26 10.44 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.95 0.405 . . . . 60.340000000000003 111.343 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.0 mt -88.52 144.34 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 111.549 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.8 m -68.85 148.32 50.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 111.293 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.404 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -49.36 -49.92 42.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.072 0.767 . . . . 65.230000000000004 113.072 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.03 -48.74 77.06 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.419 -0.419 . . . . 71.340000000000003 113.434 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.22 -39.03 75.34 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.042 0.449 . . . . 54.539999999999999 111.544 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.37 -48.46 77.81 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.074 0.398 . . . . 73.400000000000006 112.074 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.9 m -61.55 -14.47 30.06 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.091 0.472 . . . . 62.520000000000003 111.74 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -73.67 -8.49 56.18 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.338 -0.392 . . . . 34.140000000000001 111.762 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 100' ' ' LEU . 53.1 m-85 -105.17 156.91 17.66 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.112 0.482 . . . . 74.329999999999998 112.064 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 91.7 m-20 -87.0 115.69 24.55 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.36 -0.382 . . . . 73.450000000000003 111.028 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 82.5 m-85 -93.29 121.32 34.54 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.135 0.493 . . . . 72.319999999999993 112.053 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -89.89 111.08 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.347 -0.388 . . . . 64.310000000000002 110.316 173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 95' ' ' GLU . 33.2 m-70 -98.52 136.77 38.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.41 -0.359 . . . . 65.010000000000005 110.984 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.04 93.21 7.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.156 0.503 . . . . 53.130000000000003 112.236 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 155' ' ' ASN . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.107 0.479 . . . . 74.319999999999993 110.269 173.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.798 0.333 . . . . 64.439999999999998 111.19 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -94.1 150.04 20.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.25 0.547 . . . . 75.310000000000002 111.723 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -108.25 123.38 48.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.265 -0.425 . . . . 70.099999999999994 110.974 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.34 103.59 5.55 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.001 0.429 . . . . 72.409999999999997 111.997 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 m -87.29 38.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.45 0.643 . . . . 73.329999999999998 111.196 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.1 m -86.58 144.69 27.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.629 0.603 . . . . 74.400000000000006 112.629 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.21 126.91 38.54 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.7 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.0 m -136.92 105.16 5.7 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.668 0.271 . . . . 62.109999999999999 111.357 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 10' ' ' LEU . 25.4 m -88.3 157.38 18.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.983 0.42 . . . . 75.120000000000005 111.959 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.9 mm? -102.83 22.8 13.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.688 0.395 . . . . 73.129999999999995 111.242 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 t -61.58 152.48 30.36 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.608 0.596 . . . . 71.400000000000006 112.608 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.53 168.61 8.98 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.194 -0.457 . . . . 50.119999999999997 112.202 -176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.76 96.1 1.76 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.443 -0.408 . . . . 74.310000000000002 113.021 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.1 mt -94.92 120.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 122.61 -0.347 . . . . 71.019999999999996 111.503 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.98 -139.62 10.77 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.304 -0.475 . . . . 62.109999999999999 113.331 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.65 119.67 3.37 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.61 -0.347 . . . . 71.319999999999993 111.357 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.33 101.66 4.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.993 0.425 . . . . 63.32 111.689 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.671 HD13 ' HB2' ' A' ' 49' ' ' ALA . 35.1 mm -79.49 79.84 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.289 0.566 . . . . 62.210000000000001 110.918 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.97 124.62 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.196 -0.457 . . . . 64.340000000000003 110.967 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.73 84.85 0.08 OUTLIER Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 112.439 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -170.61 122.91 0.63 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.81 0.338 . . . . 73.230000000000004 111.1 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.57 95.21 2.88 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.847 0.356 . . . . 74.209999999999994 110.498 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 66.64 -4.25 0.77 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 112.66 0.615 . . . . 63.399999999999999 112.66 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.9 -1.46 84.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.263 -0.494 . . . . 43.240000000000002 113.732 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -72.17 -19.97 61.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.895 0.379 . . . . 72.450000000000003 111.873 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -107.86 131.66 54.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.038 0.447 . . . . 73.200000000000003 111.294 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.82 23.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.978 -0.555 . . . . 75.030000000000001 110.665 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -62.06 162.54 9.2 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.309 0.485 . . . . 70.519999999999996 112.309 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.05 9.23 23.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.5 0.555 . . . . 74.420000000000002 112.5 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.14 107.53 0.9 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.032 0.444 . . . . 74.230000000000004 111.887 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.18 119.18 36.38 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.275 -0.42 . . . . 73.439999999999998 111.931 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.474 ' HB3' HE22 ' A' ' 34' ' ' GLN . 98.8 mt-30 -93.18 117.86 30.56 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.928 0.394 . . . . 70.329999999999998 111.064 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.5 p -113.52 96.1 5.7 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.613 0.597 . . . . 72.450000000000003 112.613 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.474 HE22 ' HB3' ' A' ' 32' ' ' GLN . 2.2 mp0 -118.63 112.79 36.8 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.394 -0.366 . . . . 64.310000000000002 110.939 173.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.57 100.45 0.41 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.772 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.7 p -118.89 157.41 27.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.186 0.517 . . . . 64.439999999999998 111.486 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -80.46 30.83 0.29 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.396 0.517 . . . . 75.340000000000003 112.396 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.32 7.68 15.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.924 0.342 . . . . 74.349999999999994 111.924 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -62.25 103.83 0.43 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.003 0.43 . . . . 43.210000000000001 111.491 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -139.5 158.21 44.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.37 -0.377 . . . . 45.109999999999999 111.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.6 m -84.15 92.16 7.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 52.020000000000003 110.198 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -104.83 146.59 28.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.096 0.474 . . . . 52.329999999999998 112.214 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.7 m -103.21 138.02 40.58 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.018 -0.537 . . . . 61.420000000000002 110.833 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.4 m -64.92 114.12 4.32 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.86 0.362 . . . . 75.219999999999999 111.908 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.5 p -114.17 -179.39 3.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.933 0.397 . . . . 62.25 111.375 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.5 -112.88 3.24 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.321 -0.466 . . . . 44.420000000000002 112.723 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.5 p 51.93 13.07 0.22 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 114.277 1.214 . . . . 75.209999999999994 114.277 174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.8 m -98.8 157.34 16.35 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.078 0.466 . . . . 73.510000000000005 111.701 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -74.61 -74.03 0.21 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.266 0.555 . . . . 65.439999999999998 111.898 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -165.12 90.32 0.5 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.94 -0.573 . . . . 72.530000000000001 110.055 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.43 31.53 0.58 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.138 0.494 . . . . 71.040000000000006 112.198 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -140.51 -177.93 5.27 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.607 0.363 . . . . 71.209999999999994 110.527 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -114.85 149.87 36.42 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.997 0.427 . . . . 63.310000000000002 111.784 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 103.84 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 112.35 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.75 -28.17 2.17 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 112.895 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 59' ' ' TRP . 96.3 mt-30 -73.88 143.87 45.65 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.007 0.432 . . . . 71.439999999999998 111.899 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.5 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.0 m -57.11 -46.28 82.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.569 174.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.3 p -55.13 -41.21 71.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.795 -0.639 . . . . 52.420000000000002 111.547 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 56' ' ' GLN . 59.3 t90 -55.23 -55.68 28.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.57 -0.741 . . . . 73.329999999999998 111.76 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.483 ' OH ' HG11 ' A' ' 136' ' ' VAL . 47.1 t80 -62.75 -42.18 99.55 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.294 0.479 . . . . 75.109999999999999 112.294 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 110' ' ' VAL . 82.4 t -60.44 -38.27 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 111.946 0.35 . . . . 73.530000000000001 111.946 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 44.2 t80 -62.22 -34.82 77.22 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 111.388 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.95 -46.78 56.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.167 0.508 . . . . 55.350000000000001 110.318 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HD3' ' OH ' ' A' ' 60' ' ' TYR . 25.5 mmmt -55.71 -40.58 72.6 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 112.3 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.51 9.5 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 121.077 0.465 . . . . 74.209999999999994 111.55 -177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.37 23.66 60.47 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.523 -0.37 . . . . 31.52 113.745 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' HA2' ' CE1' ' A' ' 62' ' ' TYR . . . 63.54 29.25 74.07 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.159 -0.543 . . . . 62.409999999999997 114.261 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -93.23 24.57 3.76 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.478 0.639 . . . . 71.430000000000007 112.214 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.82 155.5 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.03 0.443 . . . . 61.140000000000001 111.702 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.13 93.56 0.34 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.09 -0.576 . . . . 73.140000000000001 112.551 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.522 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 63.1 p -72.65 20.8 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.377 0.88 . . . . 35.329999999999998 113.377 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -90.0 -2.26 58.11 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.189 -0.319 . . . . 64.030000000000001 111.752 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -64.83 -38.18 90.12 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.56 0.578 . . . . 72.439999999999998 112.56 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.09 -111.09 3.24 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.071 -0.585 . . . . 60.229999999999997 113.445 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -53.63 134.05 41.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.926 0.393 . . . . 41.119999999999997 111.908 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.95 -39.31 85.14 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.507 0.558 . . . . 61.240000000000002 112.507 -175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -63.74 -9.82 16.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.48 0.548 . . . . 55.420000000000002 112.48 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -94.15 -16.65 23.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.497 0.319 . . . . 60.420000000000002 111.661 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 11.6 m0 -60.49 -42.26 95.95 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.129 0.789 . . . . 73.120000000000005 113.129 -170.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -66.1 -56.66 10.34 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.971 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.5 t -62.52 -44.51 96.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.91 0.386 . . . . 65.239999999999995 111.627 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.1 -47.94 83.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.566 -0.288 . . . . 54.009999999999998 111.728 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -56.38 -49.0 75.73 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.825 0.345 . . . . 71.430000000000007 111.404 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -58.76 -40.81 84.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 111.999 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -75.49 -39.14 58.94 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.959 0.409 . . . . 62.299999999999997 111.897 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.4 -35.99 82.61 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.113 0.412 . . . . 71.120000000000005 112.113 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.11 17.85 1.58 Allowed Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.948 -0.644 . . . . 52.350000000000001 113.383 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.523 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 58.7 m-85 -89.19 176.61 6.89 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.26 0.552 . . . . 72.400000000000006 111.061 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.6 m -104.59 91.37 3.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.133 -0.485 . . . . 75.140000000000001 111.173 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.419 HG22 HG13 ' A' ' 152' ' ' ILE . 62.1 t -103.69 117.52 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.029 0.442 . . . . 71.120000000000005 112.054 -176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -153.04 -179.46 7.7 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.157 -0.474 . . . . 65.340000000000003 110.902 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.15 10.1 30.8 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.083 0.401 . . . . 71.319999999999993 112.083 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -72.56 111.79 12.48 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 110.291 -0.263 . . . . 74.530000000000001 110.291 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.479 ' O ' HG21 ' A' ' 116' ' ' VAL . 91.8 Cg_endo -76.65 1.93 7.97 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.836 2.358 . . . . 62.520000000000003 115.065 -170.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.23 137.51 6.14 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.895 0.702 . . . . 60.43 112.895 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.51 174.16 1.84 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.396 0.888 . . . . 72.150000000000006 113.396 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.0 35.33 57.95 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.998 -0.547 . . . . 42.130000000000003 112.484 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.7 m -153.4 -176.96 6.04 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.571 0.348 . . . . 62.020000000000003 110.665 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mt -122.2 129.39 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.803 -0.18 . . . . 52.409999999999997 111.45 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.4 pt? -98.37 133.45 42.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.799 -0.563 . . . . 74.420000000000002 110.923 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -101.39 106.15 17.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.031 -0.531 . . . . 72.450000000000003 110.286 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 m -99.29 116.16 30.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.084 -0.507 . . . . 75.400000000000006 111.38 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 48.2 p -77.35 2.75 14.92 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.661 0.615 . . . . 63.439999999999998 112.661 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.48 58.41 1.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.087 0.47 . . . . 65.319999999999993 111.624 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.03 168.76 37.95 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.23 -0.51 . . . . 63.030000000000001 113.073 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.44 99.04 0.22 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.303 -0.475 . . . . 71.340000000000003 112.933 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 66.22 27.23 10.33 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.504 0.668 . . . . 75.420000000000002 110.833 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.26 162.01 30.55 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.411 -0.813 . . . . 72.409999999999997 113.021 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -142.44 110.55 5.97 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.456 -0.438 . . . . 64.0 111.095 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG13 ' HB1' ' A' ' 76' ' ' ALA . 31.4 m -111.81 145.15 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.921 0.391 . . . . 72.140000000000001 111.397 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.39 157.81 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.989 0.423 . . . . 73.530000000000001 111.366 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -90.7 130.91 36.65 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.827 0.346 . . . . 73.319999999999993 110.878 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' HA ' HG12 ' A' ' 124' ' ' VAL . 39.9 t -83.49 114.72 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 45.229999999999997 112.124 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.78 -50.96 10.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.907 -0.588 . . . . 73.409999999999997 111.536 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -158.08 150.71 22.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.285 0.564 . . . . 63.520000000000003 111.84 -176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 94' ' ' PRO . 98.5 t -126.92 127.63 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.912 -0.585 . . . . 64.239999999999995 110.39 176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -91.98 148.29 22.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.881 0.372 . . . . 74.549999999999997 111.852 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 75.8 m -64.0 -16.01 60.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.368 -0.378 . . . . 73.409999999999997 111.743 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.11 -6.46 39.43 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.864 0.364 . . . . 75.150000000000006 111.379 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 60.05 1.59 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.316 -0.468 . . . . 54.219999999999999 112.985 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.0 p -145.78 133.6 21.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.294 -0.533 . . . . 64.109999999999999 111.668 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.46 113.62 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 111.213 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 139' ' ' ARG . 31.2 mt-10 -99.49 118.85 36.98 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.502 -0.317 . . . . 75.109999999999999 110.928 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 113' ' ' VAL . 16.1 m -129.38 147.75 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 112.371 0.508 . . . . 64.340000000000003 112.371 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 65.9 m -79.4 122.91 26.98 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.928 0.394 . . . . 53.329999999999998 112.054 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' CD ' ' HD2' ' A' ' 139' ' ' ARG . 44.3 mt-10 -116.62 143.94 45.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.852 0.358 . . . . 71.010000000000005 111.275 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 tpp -93.77 103.99 16.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.741 0.305 . . . . 52.299999999999997 110.227 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 76.46 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.3 0.571 . . . . 63.409999999999997 111.896 -177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -60.01 -23.55 63.76 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.815 -0.629 . . . . 75.439999999999998 111.846 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.5 -29.66 68.01 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.126 0.489 . . . . 71.209999999999994 111.086 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.73 -50.44 1.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.835 -0.506 . . . . 53.140000000000001 111.835 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -165.69 120.81 0.95 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.357 -0.449 . . . . 73.239999999999995 112.517 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.41 5.46 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.015 2.477 . . . . 74.510000000000005 113.878 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -115.26 3.72 14.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.848 0.356 . . . . 72.049999999999997 111.118 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 m -115.93 132.55 56.61 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 111.365 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG11 ' OH ' ' A' ' 60' ' ' TYR . 43.2 t -113.48 140.24 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.528 0.566 . . . . 55.329999999999998 112.528 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.7 t -136.83 134.88 37.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.95 -0.568 . . . . 72.019999999999996 111.144 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -91.43 119.9 31.81 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.729 0.299 . . . . 70.540000000000006 111.413 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HD2' ' CD ' ' A' ' 126' ' ' GLU . 11.3 ptm180 -87.46 151.59 22.92 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.117 -0.364 . . . . 71.510000000000005 110.633 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.422 HG23 ' HG2' ' A' ' 123' ' ' GLU . 52.4 m -114.8 102.59 10.14 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.123 0.487 . . . . 72.120000000000005 110.98 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 mt -86.43 131.0 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.854 -175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -71.26 149.11 46.52 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.814 -0.175 . . . . 72.140000000000001 110.94 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.99 61.53 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.701 0.63 . . . . 65.109999999999999 112.701 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.68 -23.63 55.66 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.459 -0.4 . . . . 71.510000000000005 113.809 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -97.24 -35.06 10.87 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.448 -0.442 . . . . 64.299999999999997 111.257 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.32 67.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.122 0.487 . . . . 61.409999999999997 111.8 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 148' ' ' SER . 69.1 m -60.83 143.79 54.0 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.221 -0.445 . . . . 24.050000000000001 110.859 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 147' ' ' SER . 31.3 t 83.56 -3.0 1.17 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.681 0.792 . . . . 65.010000000000005 112.241 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -93.61 127.99 39.55 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.972 -0.455 . . . . 75.439999999999998 110.272 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.89 118.48 30.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.974 0.416 . . . . 72.409999999999997 111.707 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -92.17 113.22 25.43 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 111.951 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -80.22 114.92 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.501 -0.318 . . . . 73.120000000000005 110.35 174.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -104.57 146.93 28.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.667 0.27 . . . . 75.319999999999993 110.658 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 46.7 mt -102.47 127.81 49.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.804 0.335 . . . . 75.049999999999997 111.414 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 120.877 0.37 . . . . 61.219999999999999 111.012 178.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.009 0.374 . . . . 73.439999999999998 112.009 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -97.39 151.57 19.81 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.871 0.367 . . . . 64.129999999999995 110.518 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -87.33 94.01 9.56 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.937 0.398 . . . . 74.209999999999994 110.877 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -156.27 161.78 40.19 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.166 0.508 . . . . 74.129999999999995 112.257 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.07 141.86 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.962 -0.563 . . . . 73.109999999999999 110.474 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.3 m -83.71 106.4 15.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 110.902 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.9 150.06 34.14 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.328 0.492 . . . . 71.430000000000007 112.328 -175.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -162.18 167.42 24.14 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.246 -0.434 . . . . 54.340000000000003 111.187 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.9 m -150.35 126.19 10.42 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.747 0.308 . . . . 74.430000000000007 111.145 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.6 pt? -132.07 139.99 48.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.164 0.507 . . . . 65.25 111.667 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.1 t -164.53 104.49 0.83 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.731 -0.668 . . . . 71.420000000000002 110.798 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.13 112.56 24.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.188 0.44 . . . . 65.400000000000006 112.188 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.59 116.91 5.35 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 112.387 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 tt -110.2 144.2 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.026 0.441 . . . . 73.450000000000003 111.768 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.27 140.64 12.45 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.364 -0.446 . . . . 73.030000000000001 113.073 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.03 137.04 38.13 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.488 -0.419 . . . . 53.119999999999997 111.775 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.42 113.72 25.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.406 -0.361 . . . . 72.439999999999998 111.53 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -96.43 142.2 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.117 0.484 . . . . 74.329999999999998 112.037 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.1 153.66 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.355 -0.384 . . . . 62.100000000000001 111.406 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.23 118.0 0.84 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 120.877 -0.677 . . . . 64.319999999999993 113.873 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 22' ' ' ASP . 7.9 tt -144.63 138.62 27.49 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 21' ' ' LEU . 16.1 m-20 -121.83 161.19 23.16 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.862 0.69 . . . . 72.239999999999995 112.862 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -163.73 99.61 0.89 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.502 -0.772 . . . . 75.5 110.565 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.41 172.95 51.83 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.217 -0.516 . . . . 63.130000000000003 114.369 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -77.92 112.78 15.17 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.233 0.539 . . . . 73.329999999999998 111.321 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -83.1 143.38 30.59 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.219 0.822 . . . . 74.319999999999993 113.219 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -91.9 178.8 5.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 55.399999999999999 109.919 166.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -141.02 140.09 34.24 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 112.104 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.16 110.35 18.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.999 0.428 . . . . 70.230000000000004 110.486 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.82 89.7 6.34 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.247 0.832 . . . . 62.0 113.247 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.86 127.66 33.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.883 -0.784 . . . . 71.519999999999996 108.883 166.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.77 103.54 0.08 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.646 0.736 . . . . 71.310000000000002 111.553 -176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.7 t -68.14 86.18 0.26 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.428 -0.806 . . . . 40.020000000000003 112.424 -175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -129.11 140.34 38.35 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.038 -0.528 . . . . 62.299999999999997 110.747 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.54 104.82 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.45 2.1 . . . . 64.430000000000007 112.774 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -96.75 -41.48 8.46 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.353 0.501 . . . . 71.319999999999993 112.353 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -99.72 139.07 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.168 0.509 . . . . 64.510000000000005 111.951 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -93.05 -30.73 15.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.036 -0.529 . . . . 71.109999999999999 111.723 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.16 33.33 0.1 Allowed 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.589 0.589 . . . . 72.219999999999999 112.589 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.6 p -85.78 89.57 7.79 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.272 0.558 . . . . 61.520000000000003 112.004 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.5 p -115.45 131.19 57.01 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.237 -0.438 . . . . 63.210000000000001 110.561 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.08 103.08 2.2 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.104 0.478 . . . . 71.109999999999999 112.059 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.6 m -76.33 75.87 3.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.014 0.435 . . . . 44.520000000000003 110.216 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' THR . 7.1 t -66.36 81.06 0.09 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.847 0.832 . . . . 72.540000000000006 112.389 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.8 t -175.95 -48.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.343 -0.844 . . . . 34.439999999999998 110.691 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.66 -162.58 52.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.195 -0.526 . . . . 72.219999999999999 113.058 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.6 t -103.43 149.56 24.69 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.283 -0.539 . . . . 74.299999999999997 111.595 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.0 t -128.67 -0.53 5.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.826 -0.625 . . . . 74.439999999999998 111.412 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.86 175.2 14.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.183 0.516 . . . . 52.109999999999999 112.235 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -90.07 117.32 28.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.249 -0.432 . . . . 53.43 110.441 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 71' ' ' SER . 3.9 mm? -96.01 15.46 20.56 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.04 0.385 . . . . 74.329999999999998 112.04 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -110.32 178.8 4.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.936 0.398 . . . . 74.329999999999998 111.27 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 59' ' ' TRP . 5.1 t -116.8 150.1 38.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.403 -0.362 . . . . 61.119999999999997 111.61 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.37 156.73 25.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.715 0.635 . . . . 74.409999999999997 112.715 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.77 -33.9 3.23 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.284 -0.416 . . . . 53.450000000000003 113.795 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -75.64 150.74 37.91 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.229 0.537 . . . . 75.340000000000003 112.274 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.406 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.7 p -56.41 -39.53 73.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.025 -0.534 . . . . 75.25 111.638 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.7 p -54.99 -42.96 73.11 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.941 0.401 . . . . 63.219999999999999 111.649 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 53' ' ' THR . 86.7 t90 -62.82 -50.32 71.45 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.408 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -59.1 -54.15 50.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.787 -0.642 . . . . 63.310000000000002 111.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.8 t -60.5 -34.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.469 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -55.62 -47.69 76.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.519 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.19 -37.56 75.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.965 0.412 . . . . 74.439999999999998 110.884 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -61.24 -35.57 77.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.013 -0.539 . . . . 43.009999999999998 112.19 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.65 12.4 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.432 0.634 . . . . 63.399999999999999 110.997 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.67 18.38 59.05 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 114.179 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.02 67.14 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.115 -0.564 . . . . 51.119999999999997 113.792 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.01 37.76 0.44 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.231 -0.57 . . . . 62.420000000000002 111.89 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.3 pt -140.02 -176.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.112 0.482 . . . . 64.310000000000002 111.455 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.8 1.26 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.071 -0.585 . . . . 44.520000000000003 112.315 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 6.2 m -52.82 -18.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.219 0.822 . . . . 64.420000000000002 113.219 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 t -94.43 18.93 10.33 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.576 0.584 . . . . 73.299999999999997 112.576 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -67.69 -37.0 81.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.074 0.398 . . . . 72.519999999999996 112.074 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.94 -134.62 12.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.072 -0.585 . . . . 63.149999999999999 113.715 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -63.17 151.02 41.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.02 0.438 . . . . 74.299999999999997 111.312 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.65 -31.76 62.61 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.14 0.793 . . . . 73.099999999999994 113.14 -172.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -67.14 -21.62 65.82 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.494 0.553 . . . . 61.210000000000001 112.494 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -92.38 -14.21 29.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.109 0.411 . . . . 75.209999999999994 112.109 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -52.06 -65.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.202 0.816 . . . . 72.0 113.202 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.18 91.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.059 0.392 . . . . 44.329999999999998 112.059 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 m -54.97 -36.91 65.86 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.976 0.417 . . . . 73.340000000000003 111.613 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.2 -28.11 25.66 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.342 -0.39 . . . . 64.450000000000003 111.891 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.95 -50.7 70.04 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.726 0.298 . . . . 70.450000000000003 111.372 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 86.4 p -58.88 -54.36 48.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.012 0.434 . . . . 65.530000000000001 111.106 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.8 t -55.56 -37.19 67.7 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.945 -0.571 . . . . 64.230000000000004 112.446 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.88 -10.46 59.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 111.999 0.37 . . . . 73.439999999999998 111.999 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 41.51 4.24 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.332 -0.461 . . . . 55.439999999999998 113.873 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -110.98 -179.07 3.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.005 0.431 . . . . 64.030000000000001 111.112 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.4 m -109.72 103.86 12.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.216 0.45 . . . . 63.130000000000003 112.216 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' C ' HD22 ' A' ' 91' ' ' ASN . 43.6 t -94.28 99.81 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.022 0.439 . . . . 63.329999999999998 110.882 177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -122.17 156.07 34.46 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 111.29 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -84.78 -4.06 58.89 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.443 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.2 m -66.35 111.71 7.39 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.323 -0.398 . . . . 74.239999999999995 110.806 176.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -78.12 20.29 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.471 2.781 . . . . 64.409999999999997 114.56 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -48.65 141.53 7.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.556 0.576 . . . . 73.400000000000006 112.556 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.74 144.68 47.55 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.987 -0.551 . . . . 44.299999999999997 112.36 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.54 45.89 5.96 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.916 -0.659 . . . . 73.140000000000001 112.584 -175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -149.53 177.68 9.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 70.319999999999993 111.121 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 54.8 mt -122.83 121.21 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 74.430000000000007 110.708 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.6 pt? -92.7 139.4 30.6 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.02 0.438 . . . . 70.329999999999998 110.867 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -105.06 103.7 13.3 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.92 0.39 . . . . 62.399999999999999 111.408 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 66.2 m -74.6 97.27 3.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.406 0.622 . . . . 70.329999999999998 111.165 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 45.6 p -88.24 11.68 15.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.879 -0.601 . . . . 72.329999999999998 112.203 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.33 -27.59 68.7 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.466 0.543 . . . . 64.25 112.466 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 156.36 -174.47 34.17 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.911 -0.661 . . . . 63.140000000000001 113.599 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.41 41.54 94.34 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.324 -0.465 . . . . 64.109999999999999 113.407 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.39 17.39 8.32 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.026 0.531 . . . . 73.200000000000003 112.046 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.38 156.2 29.42 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.08 -0.581 . . . . 73.299999999999997 113.436 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 26.8 t60 -141.32 148.09 39.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.687 -0.302 . . . . 74.230000000000004 110.457 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.493 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -139.43 144.2 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.146 0.498 . . . . 71.129999999999995 111.692 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.39 153.73 40.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.907 -0.588 . . . . 61.200000000000003 110.666 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -88.71 128.7 35.62 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.049 0.452 . . . . 71.200000000000003 111.129 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.6 t -75.74 106.38 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.27 -0.423 . . . . 62.25 111.665 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -74.81 -51.99 12.59 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.938 0.399 . . . . 64.239999999999995 111.384 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -148.88 145.78 27.62 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.293 0.568 . . . . 40.200000000000003 112.347 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -117.49 130.02 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.826 -0.625 . . . . 61.530000000000001 110.763 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -88.36 147.46 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.354 -0.385 . . . . 74.420000000000002 111.372 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -56.09 -37.33 69.21 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.908 0.385 . . . . 62.229999999999997 111.46 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -22.48 64.93 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 111.736 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.37 -20.66 8.34 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.412 -0.423 . . . . 63.509999999999998 113.587 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -58.63 126.25 26.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.131 0.419 . . . . 65.340000000000003 112.131 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.12 122.89 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.05 -0.523 . . . . 65.040000000000006 111.189 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -103.43 109.58 21.27 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.273 0.558 . . . . 73.519999999999996 110.978 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.62 160.43 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.961 -0.563 . . . . 54.43 111.534 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 75.8 p -107.83 124.8 50.62 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.214 0.531 . . . . 63.229999999999997 111.744 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 48.4 mt-10 -108.34 -176.58 3.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.819 -0.628 . . . . 75.219999999999999 111.207 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 39.0 tpp -141.35 134.44 29.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.381 -0.372 . . . . 54.32 111.48 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 t30 60.22 29.17 18.78 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.313 0.578 . . . . 42.509999999999998 111.921 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -79.05 -168.53 1.5 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.791 -0.448 . . . . 54.399999999999999 109.791 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -62.64 96.09 0.08 Allowed 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.619 -0.676 . . . . 64.540000000000006 111.829 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.95 -63.01 0.13 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.039 -0.528 . . . . 71.109999999999999 112.82 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -174.64 154.66 19.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.796 -0.716 . . . . 64.109999999999999 113.469 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.26 140.91 41.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.633 2.222 . . . . 73.420000000000002 112.925 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 64.86 12.78 8.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.888 -0.596 . . . . 65.019999999999996 112.019 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.1 t -99.53 139.87 34.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.665 0.269 . . . . 75.310000000000002 111.032 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.8 t -83.58 118.36 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.16 0.505 . . . . 72.310000000000002 111.622 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 126' ' ' GLU . 49.4 m -98.65 107.28 19.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.063 0.459 . . . . 72.140000000000001 111.218 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.96 110.01 16.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 73.530000000000001 111.327 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -108.45 121.04 44.13 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.856 -0.611 . . . . 72.349999999999994 111.432 -173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.4 m -94.98 103.72 15.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 111.458 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.67 142.36 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.761 0.315 . . . . 73.140000000000001 111.309 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.4 m -67.02 144.77 55.99 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.494 -0.321 . . . . 72.120000000000005 111.419 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.69 -47.49 50.28 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.965 0.728 . . . . 64.510000000000005 112.965 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.85 -57.86 16.12 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.548 -0.358 . . . . 64.299999999999997 113.479 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.57 -41.66 98.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 71.519999999999996 110.971 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.31 69.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.892 -0.595 . . . . 54.329999999999998 112.176 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -64.08 -11.65 31.69 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.489 0.551 . . . . 73.140000000000001 112.489 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 44.4 t -83.0 -10.38 58.8 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.975 0.416 . . . . 73.340000000000003 111.178 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.523 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 26.2 m-85 -93.73 153.08 18.52 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.076 0.465 . . . . 71.310000000000002 111.285 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.27 112.58 20.9 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.286 -0.416 . . . . 75.530000000000001 111.335 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 89.6 m-85 -93.9 113.52 25.55 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.121 0.486 . . . . 62.420000000000002 111.57 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -80.12 128.38 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 54.219999999999999 110.933 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -121.09 144.82 48.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.436 -0.347 . . . . 71.25 110.568 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 59.8 mt -98.55 129.35 45.1 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.175 0.512 . . . . 63.439999999999998 112.289 -173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.787 0 CA-C-N 116.132 -0.486 . . . . 75.099999999999994 111.534 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.4 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.669 0.271 . . . . 73.5 111.136 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -89.54 103.41 16.05 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.985 0.421 . . . . 54.229999999999997 111.246 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.05 155.68 23.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.876 0.37 . . . . 72.409999999999997 111.292 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.6 mt -78.95 113.3 16.95 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 110.151 -0.314 . . . . 74.109999999999999 110.151 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.74 -38.32 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.96 0.356 . . . . 75.099999999999994 111.96 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.8 m 50.92 82.05 0.06 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.097 0.475 . . . . 62.020000000000003 111.159 -176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.08 158.15 43.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.746 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.548 HG23 ' HB ' ' A' ' 11' ' ' THR . 81.7 m -61.05 95.99 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.228 0.537 . . . . 63.130000000000003 111.365 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.8 m -111.68 114.34 27.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.128 -0.487 . . . . 50.299999999999997 111.299 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.61 28.67 17.81 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.535 0.683 . . . . 73.439999999999998 110.959 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.548 ' HB ' HG23 ' A' ' 8' ' ' THR . 79.2 m -120.38 128.74 53.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.667 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.94 -30.62 0.87 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.217 0.451 . . . . 74.0 112.217 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.08 65.85 1.76 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.971 -0.633 . . . . 51.32 112.759 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.4 mp -74.42 84.19 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.524 0.678 . . . . 73.519999999999996 110.997 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.06 139.43 3.95 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.665 -0.698 . . . . 61.530000000000001 112.623 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -162.7 106.9 1.11 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.923 0.392 . . . . 32.43 111.436 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.35 68.95 4.47 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.432 0.635 . . . . 52.399999999999999 111.81 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 tt -83.36 -20.56 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.01 -0.541 . . . . 62.5 111.471 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.77 102.42 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-O 121.523 0.677 . . . . 70.230000000000004 112.141 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -149.91 51.03 0.54 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.852 -0.613 . . . . 73.340000000000003 112.574 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.46 168.74 20.45 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.882 0.372 . . . . 62.439999999999998 111.752 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -101.87 -77.28 0.55 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.467 0.543 . . . . 64.030000000000001 112.467 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -179.63 -33.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.577 0.351 . . . . 71.409999999999997 111.568 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.04 -66.79 3.83 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.088 -0.577 . . . . 74.109999999999999 113.356 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.82 171.14 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.387 0.514 . . . . 62.399999999999999 112.387 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -138.23 144.32 40.53 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.09 -0.505 . . . . 64.439999999999998 111.907 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.65 92.92 9.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.967 0.413 . . . . 74.019999999999996 110.04 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -79.94 -148.52 0.05 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.054 0.761 . . . . 61.32 113.054 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 92.62 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.156 0.799 . . . . 73.200000000000003 113.156 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.47 134.31 53.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.064 -0.516 . . . . 64.230000000000004 110.244 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -34.52 35.14 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.007 0.432 . . . . 65.230000000000004 111.489 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.66 86.44 2.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.01 0.433 . . . . 74.030000000000001 110.092 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.3 t -152.66 115.56 4.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.604 . . . . 61.140000000000001 112.123 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -113.73 123.0 33.78 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.158 -0.474 . . . . 72.400000000000006 110.343 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.42 91.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.53 2.153 . . . . 74.519999999999996 112.782 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 38' ' ' GLN . 46.0 p -133.08 -19.72 2.22 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.683 -0.69 . . . . 71.409999999999997 111.566 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 38' ' ' GLN . 5.2 p30 48.79 -70.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.73 1.212 . . . . 72.340000000000003 113.941 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' THR . 36.0 tt0 72.68 -65.07 0.37 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.825 0.45 . . . . 63.439999999999998 111.816 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 93.7 p -86.75 170.71 11.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.004 0.431 . . . . 72.420000000000002 111.26 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -107.17 -17.52 14.13 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.063 0.458 . . . . 75.230000000000004 111.655 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.8 m -123.67 107.48 11.53 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.438 -0.346 . . . . 74.540000000000006 110.446 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -91.04 106.73 18.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.352 0.501 . . . . 73.409999999999997 112.352 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.638 ' HB2' ' HA3' ' A' ' 87' ' ' GLY . 73.0 m -123.5 117.17 24.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.056 -0.52 . . . . 75.329999999999998 110.087 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.2 m -139.27 144.59 38.44 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.124 0.487 . . . . 72.0 112.089 -174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.1 t -140.81 93.0 2.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.947 -0.57 . . . . 53.109999999999999 110.324 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.97 103.79 3.05 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.142 -0.551 . . . . 75.420000000000002 112.975 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.8 p -92.93 128.95 38.98 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.499 -0.412 . . . . 73.349999999999994 111.32 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -86.48 -16.21 37.76 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.944 0.402 . . . . 62.210000000000001 111.639 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.02 104.22 13.91 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 52.100000000000001 111.75 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -72.46 110.79 7.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.449 -0.342 . . . . 50.520000000000003 110.742 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' H ' ' HB2' ' A' ' 71' ' ' SER . 89.9 mt -93.67 17.38 11.92 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.191 0.441 . . . . 72.129999999999995 112.191 -176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -104.79 177.5 4.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.086 0.47 . . . . 74.340000000000003 111.177 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.413 HG22 ' OE1' ' A' ' 56' ' ' GLN . 8.8 t -124.18 148.99 46.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.404 -0.362 . . . . 75.120000000000005 111.971 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 111.01 1.46 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.069 0.461 . . . . 55.130000000000003 111.124 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.65 -24.05 3.06 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.302 -0.475 . . . . 53.229999999999997 112.4 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 53' ' ' THR . 51.4 mt-30 -83.18 138.94 33.43 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.748 -0.266 . . . . 62.109999999999999 110.793 175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.1 p -61.54 -35.37 77.57 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.181 0.515 . . . . 72.019999999999996 109.994 174.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -54.87 -44.97 74.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.513 -0.767 . . . . 74.530000000000001 111.454 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -55.88 -50.09 71.59 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.903 -0.589 . . . . 72.329999999999998 111.77 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -63.04 -45.37 92.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.796 0.331 . . . . 73.150000000000006 111.667 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 57' ' ' CYS . 60.6 t -60.99 -36.18 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.95 0.405 . . . . 42.32 111.053 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -56.14 -43.17 78.01 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.011 -0.54 . . . . 63.020000000000003 110.81 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.35 -47.55 70.1 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.153 -0.476 . . . . 63.119999999999997 110.977 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -56.76 -37.92 71.72 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.427 0.529 . . . . 65.200000000000003 112.427 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.07 -3.6 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 111.483 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.98 8.43 84.07 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.441 -0.409 . . . . 23.32 113.713 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.93 11.55 84.62 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.105 -0.569 . . . . 41.219999999999999 113.554 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -78.6 36.19 0.25 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.177 0.436 . . . . 73.150000000000006 112.177 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 31.6 pt -140.02 -178.28 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.989 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.81 108.83 3.43 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.996 -0.621 . . . . 53.130000000000003 112.945 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.527 ' HB2' ' H ' ' A' ' 51' ' ' LEU . 80.1 p -63.1 -14.66 51.16 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.415 -0.462 . . . . 53.109999999999999 112.203 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.6 t -85.85 5.4 32.91 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.674 0.62 . . . . 72.349999999999994 112.674 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -67.21 -34.74 78.14 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.092 -0.38 . . . . 75.340000000000003 111.889 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.25 -118.46 5.58 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.199 -0.524 . . . . 71.439999999999998 114.045 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -58.16 134.58 56.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.085 0.402 . . . . 55.520000000000003 112.085 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -58.08 -25.18 60.97 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.549 0.574 . . . . 72.030000000000001 112.549 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.33 -9.97 59.15 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.798 0.332 . . . . 73.129999999999995 111.881 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -102.53 -4.94 24.55 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 111.916 0.339 . . . . 54.020000000000003 111.916 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -64.7 -43.67 92.75 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.626 0.602 . . . . 73.340000000000003 112.626 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.61 95.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.088 0.47 . . . . 44.109999999999999 111.343 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.0 t -65.48 -48.11 73.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 64.329999999999998 111.315 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.42 95.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.866 0.365 . . . . 61.119999999999997 111.358 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.14 -56.23 24.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 111.393 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.6 t -64.06 -29.72 70.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 111.646 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.5 t -75.71 -33.46 60.31 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.941 0.401 . . . . 75.109999999999999 111.645 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.46 -25.0 36.43 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.902 0.382 . . . . 65.420000000000002 111.6 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.638 ' HA3' ' HB2' ' A' ' 43' ' ' SER . . . 117.65 6.72 12.68 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.057 -0.592 . . . . 55.020000000000003 113.321 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 96.8 m-85 -74.3 158.2 34.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.339 0.59 . . . . 73.430000000000007 111.242 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.9 m -95.42 92.88 6.91 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.272 0.558 . . . . 45.240000000000002 111.998 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.476 HG22 HG13 ' A' ' 152' ' ' ILE . 46.7 t -95.3 124.37 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.83 -0.623 . . . . 74.0 111.365 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -146.42 166.97 24.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 111.203 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -82.49 -5.57 58.79 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.261 -0.427 . . . . 74.540000000000006 111.47 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 113.04 6.77 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 116.599 -0.273 . . . . 60.539999999999999 110.674 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.471 ' O ' HG21 ' A' ' 116' ' ' VAL . 94.1 Cg_endo -82.14 20.82 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.106 2.537 . . . . 72.140000000000001 114.625 -170.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.8 147.63 22.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.1 0.778 . . . . 73.340000000000003 113.1 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -64.75 159.82 21.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.366 -0.833 . . . . 64.519999999999996 112.329 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.7 44.65 12.08 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.405 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -156.48 179.66 9.04 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.975 0.417 . . . . 71.019999999999996 111.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.4 mt -123.62 122.87 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.209 -0.45 . . . . 73.040000000000006 110.726 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -97.85 134.21 41.3 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.131 0.491 . . . . 54.009999999999998 111.078 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -101.62 116.66 33.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.013 0.435 . . . . 73.319999999999993 112.069 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -101.98 115.68 31.06 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.824 -0.626 . . . . 70.219999999999999 110.11 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.7 p -76.23 66.93 2.42 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.396 0.617 . . . . 62.420000000000002 111.747 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.28 168.84 18.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.735 -0.666 . . . . 42.520000000000003 112.042 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.16 -26.66 67.89 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.002 -0.545 . . . . 60.539999999999999 114.001 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.02 49.25 3.17 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.092 -0.575 . . . . 74.109999999999999 113.771 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 59.03 27.83 16.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.022 0.439 . . . . 73.239999999999995 111.967 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.52 152.36 29.25 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.152 -0.476 . . . . 33.340000000000003 113.485 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -141.17 130.92 24.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.427 0.291 . . . . 54.240000000000002 110.989 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.511 HG13 ' HB1' ' A' ' 76' ' ' ALA . 26.3 m -127.37 146.92 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.003 0.43 . . . . 74.420000000000002 111.441 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.53 156.47 45.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.095 -0.502 . . . . 43.409999999999997 111.088 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -87.15 127.13 35.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.86 0.362 . . . . 52.450000000000003 111.64 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 122' ' ' VAL . 60.1 t -77.85 105.17 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.303 -0.408 . . . . 53.049999999999997 111.151 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -83.12 -48.46 10.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.622 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -150.69 151.93 33.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.97 0.414 . . . . 74.340000000000003 111.585 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 94' ' ' PRO . 29.0 t -127.17 137.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.421 -0.354 . . . . 74.450000000000003 111.137 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.49 HD22 ' HB2' ' A' ' 121' ' ' SER . 87.2 m-20 -77.63 164.22 25.53 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.909 0.385 . . . . 54.229999999999997 111.41 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 m -63.09 -31.22 72.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.878 0.325 . . . . 72.319999999999993 111.878 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.66 -39.21 64.62 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 111.837 0.31 . . . . 61.520000000000003 111.837 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 142.13 -12.22 2.57 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 113.85 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.49 ' HB2' HD22 ' A' ' 117' ' ' ASN . 67.4 m -55.26 128.55 34.57 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.239 0.543 . . . . 55.020000000000003 111.835 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.535 HG13 HG13 ' A' ' 113' ' ' VAL . 48.4 t -106.56 119.35 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.503 -0.771 . . . . 72.129999999999995 111.763 -176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.89 107.52 19.27 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.92 0.391 . . . . 72.510000000000005 110.577 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.408 HG13 HG12 ' A' ' 122' ' ' VAL . 32.9 m -112.24 148.55 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.718 0.636 . . . . 65.040000000000006 112.718 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 91.8 p -99.21 112.45 24.6 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.795 -0.639 . . . . 74.120000000000005 111.376 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.562 ' HG3' ' HB3' ' A' ' 137' ' ' SER . 5.3 pt-20 -123.44 -172.33 2.49 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.031 -0.531 . . . . 72.25 111.18 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.8 ttm -138.48 141.54 39.42 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.301 -0.25 . . . . 73.019999999999996 110.881 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -129.71 -71.49 0.61 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.234 0.457 . . . . 65.010000000000005 112.234 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.485 ' HB3' ' OG ' ' A' ' 135' ' ' SER . 36.5 t80 -72.46 97.6 2.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.426 0.631 . . . . 74.439999999999998 112.626 -171.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -68.99 88.29 0.39 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.518 0.675 . . . . 74.239999999999995 110.658 173.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.14 -42.31 0.07 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.744 . . . . 63.439999999999998 111.827 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.66 160.34 47.04 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.971 -0.633 . . . . 34.0 111.942 173.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.2 -28.94 81.7 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.742 2.295 . . . . 71.540000000000006 113.531 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.486 ' HD2' HG23 ' A' ' 136' ' ' VAL . 29.2 p90 -135.78 -46.92 0.67 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.876 0.324 . . . . 70.25 111.876 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 129' ' ' TYR . 43.0 t 46.67 63.66 1.82 Allowed 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.297 0.57 . . . . 72.409999999999997 111.966 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG23 ' HD2' ' A' ' 134' ' ' PHE . 58.5 t -88.9 128.33 41.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 70.010000000000005 111.7 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.562 ' HB3' ' HG3' ' A' ' 126' ' ' GLU . 15.3 t -101.69 127.17 48.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.139 -0.482 . . . . 64.310000000000002 110.939 176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -102.11 92.53 4.8 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.018 0.437 . . . . 62.149999999999999 109.935 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -96.91 122.95 40.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.037 0.446 . . . . 71.099999999999994 111.88 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 32.5 m -93.83 113.42 25.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 110.097 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.84 125.25 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.793 0.294 . . . . 71.140000000000001 111.793 -177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -62.23 145.14 54.42 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.684 0.278 . . . . 73.319999999999993 111.575 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.431 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -51.36 -43.03 61.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.775 0.657 . . . . 75.120000000000005 112.775 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.12 -22.25 28.11 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.252 -0.499 . . . . 74.340000000000003 113.707 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -101.69 -47.39 4.64 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.521 0.677 . . . . 71.019999999999996 110.692 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.549 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.83 -40.78 94.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 113.192 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.6 m -60.59 -16.62 40.04 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.927 0.714 . . . . 75.310000000000002 112.927 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.4 t -79.16 -25.31 42.87 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.962 0.41 . . . . 63.439999999999998 111.55 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -77.71 148.49 34.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.06 0.457 . . . . 72.340000000000003 111.608 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 150' ' ' ASN . 0.8 OUTLIER -83.76 115.78 22.38 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.237 -0.289 . . . . 51.399999999999999 111.358 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.549 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 69.8 m-85 -94.2 110.83 22.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.847 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.476 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -81.37 113.38 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.293 -0.412 . . . . 75.510000000000005 110.695 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -104.29 135.98 44.73 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.691 0.281 . . . . 64.209999999999994 110.677 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.6 mt -99.83 123.36 44.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.891 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.263 0.554 . . . . 74.439999999999998 110.573 176.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.687 0.254 . . . . 75.230000000000004 111.687 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.94 116.01 29.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.059 0.392 . . . . 74.230000000000004 112.059 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.96 101.26 1.93 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.181 0.515 . . . . 65.549999999999997 111.4 175.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.6 mt -121.17 91.88 3.63 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.75 0.31 . . . . 62.109999999999999 111.294 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.58 150.48 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 111.616 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -158.69 140.4 13.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.806 0.336 . . . . 72.420000000000002 111.531 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.7 104.74 8.25 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.055 0.455 . . . . 70.409999999999997 111.691 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.3 p -99.69 136.51 39.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.259 -0.428 . . . . 43.530000000000001 111.345 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -129.62 23.17 5.45 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.554 0.576 . . . . 74.340000000000003 112.554 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.9 mp -75.63 86.44 2.69 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.091 0.472 . . . . 62.240000000000002 110.606 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -123.36 17.14 9.79 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.217 0.451 . . . . 52.439999999999998 112.217 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 122.17 17.06 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.395 0.517 . . . . 73.019999999999996 112.395 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.41 59.72 0.47 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-N 116.358 -0.383 . . . . 64.25 112.506 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 14' ' ' ILE . 2.1 mp -77.3 141.4 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 111.893 0.331 . . . . 73.540000000000006 111.893 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 177.31 117.69 0.52 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 116.357 -0.383 . . . . 33.399999999999999 112.469 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.95 165.64 27.58 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.069 0.461 . . . . 42.399999999999999 112.038 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.98 148.83 32.11 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.377 0.51 . . . . 72.25 112.377 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.6 pt -133.37 156.77 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.091 -0.504 . . . . 72.129999999999995 111.108 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.9 141.34 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 120.897 0.379 . . . . 72.109999999999999 111.164 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.16 96.12 0.5 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.001 -0.618 . . . . 74.310000000000002 113.92 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 21' ' ' LEU . 6.9 mp -83.3 91.01 7.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.855 0.36 . . . . 73.120000000000005 110.957 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.3 113.02 19.13 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.074 0.464 . . . . 74.019999999999996 111.523 -177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -143.31 173.13 11.87 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.371 -0.377 . . . . 64.409999999999997 110.82 177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.67 114.89 3.56 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.918 -0.658 . . . . 73.019999999999996 113.541 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -110.79 -164.91 0.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 122.51 0.324 . . . . 73.239999999999995 111.037 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.79 178.43 9.14 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.007 0.432 . . . . 70.549999999999997 111.287 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.48 -178.84 3.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.22 -0.445 . . . . 64.430000000000007 110.832 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -81.32 -3.76 53.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.742 0.306 . . . . 73.409999999999997 111.727 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.48 109.61 10.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.258 0.466 . . . . 65.140000000000001 112.258 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.31 168.2 24.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.138 -0.483 . . . . 55.32 111.29 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -131.93 141.97 49.5 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.98 0.419 . . . . 74.530000000000001 111.764 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -72.56 83.65 1.13 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.996 0.427 . . . . 70.540000000000006 111.542 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -170.92 172.34 5.59 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.237 -0.438 . . . . 61.310000000000002 111.171 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.83 94.62 17.67 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.609 -0.269 . . . . 73.140000000000001 111.351 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -65.14 145.51 84.75 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.664 2.243 . . . . 71.430000000000007 112.429 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 t -63.19 108.92 1.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.536 0.684 . . . . 74.409999999999997 112.315 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -85.38 68.5 10.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.099 0.476 . . . . 70.319999999999993 110.983 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -65.2 -63.71 1.04 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.967 0.413 . . . . 74.310000000000002 111.327 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.8 m -88.14 135.28 33.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.358 -0.383 . . . . 61.119999999999997 111.228 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -80.91 27.63 0.38 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.019 0.438 . . . . 53.210000000000001 112.144 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.9 m -152.21 115.38 4.7 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.576 0.35 . . . . 72.430000000000007 110.793 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -179.59 3.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.997 0.427 . . . . 74.310000000000002 111.728 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -115.78 139.25 50.35 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.989 0.423 . . . . 72.5 111.453 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.7 p -138.91 29.34 2.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.071 0.462 . . . . 75.340000000000003 110.949 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.1 m -82.21 77.79 8.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.014 0.435 . . . . 52.100000000000001 111.398 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.21 109.63 2.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.289 -0.482 . . . . 54.109999999999999 112.832 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.3 p -80.84 103.11 10.46 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.048 0.451 . . . . 63.450000000000003 110.885 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . 21.3 m -74.25 -30.12 61.99 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.123 0.416 . . . . 74.420000000000002 112.123 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.93 161.01 29.89 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.824 0.345 . . . . 64.450000000000003 111.522 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.95 103.57 15.45 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.982 -0.449 . . . . 73.510000000000005 111.736 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.1 mm? -99.1 0.46 43.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.66 -0.245 . . . . 73.329999999999998 111.638 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.401 ' HE2' ' HA2' ' A' ' 74' ' ' GLY . 3.6 t80 -114.4 160.6 18.96 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.171 -0.33 . . . . 64.200000000000003 111.602 -173.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t -71.93 145.06 48.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.984 0.421 . . . . 72.150000000000006 112.081 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.52 149.64 27.42 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.162 0.506 . . . . 64.400000000000006 112.338 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.64 -34.77 5.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.292 -0.413 . . . . 54.25 113.428 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -68.21 148.76 50.39 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.773 0.32 . . . . 71.510000000000005 111.545 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.3 p -56.8 -43.06 80.58 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.983 0.42 . . . . 70.319999999999993 111.12 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -55.73 -39.57 71.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.04 -0.527 . . . . 63.340000000000003 111.565 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.504 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 87.6 t90 -60.54 -52.29 65.8 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.092 -0.504 . . . . 70.340000000000003 111.44 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.06 -41.37 96.48 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.136 -0.353 . . . . 75.510000000000005 111.344 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 112' ' ' TYR . 65.7 t -63.23 -35.04 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.276 0.56 . . . . 75.400000000000006 110.69 175.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 59' ' ' TRP . 60.5 t80 -57.15 -46.51 82.67 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.589 -0.732 . . . . 63.329999999999998 111.136 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.6 -40.86 72.97 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.851 0.357 . . . . 55.009999999999998 111.726 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -61.33 -31.94 71.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.284 0.476 . . . . 71.329999999999998 112.284 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 65' ' ' VAL . 7.5 p -84.92 6.49 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.279 0.562 . . . . 72.239999999999995 111.193 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.18 21.63 73.96 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.425 -0.417 . . . . 74.230000000000004 113.527 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 48' ' ' SER . . . 64.55 27.16 71.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 121.227 -0.511 . . . . 55.049999999999997 113.456 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -89.95 25.45 2.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.216 -0.579 . . . . 75.129999999999995 111.674 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.4 pt -131.57 176.52 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.788 0.435 . . . . 74.230000000000004 110.643 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.99 129.22 9.81 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.8 -0.714 . . . . 54.439999999999998 113.124 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 59.6 m -62.35 -23.18 66.64 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.466 -0.432 . . . . 75.349999999999994 112.117 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -60.31 -15.74 28.18 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.599 0.592 . . . . 74.310000000000002 112.599 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -60.48 -36.18 77.67 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.045 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.401 ' HA2' ' HE2' ' A' ' 52' ' ' TYR . . . 65.44 -122.99 24.38 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.661 0.624 . . . . 71.209999999999994 114.661 173.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -60.23 141.84 55.42 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.25 0.548 . . . . 55.409999999999997 112.062 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -59.57 -23.11 62.64 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.993 0.738 . . . . 64.450000000000003 112.993 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.01 -11.4 60.32 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 122.046 -0.409 . . . . 72.109999999999999 111.864 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -101.54 -26.22 13.62 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.442 0.534 . . . . 73.519999999999996 112.442 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -41.08 -59.16 1.56 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.48 1.289 . . . . 72.129999999999995 114.48 -173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.79 -42.85 85.01 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.046 -0.409 . . . . 53.299999999999997 112.013 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 m -63.78 -43.28 96.82 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 111.261 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.06 99.68 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.928 0.394 . . . . 52.32 111.365 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.27 -48.1 82.9 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.042 0.448 . . . . 65.209999999999994 110.998 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 m -61.39 -40.68 95.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.133 -0.485 . . . . 65.230000000000004 111.489 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -73.16 -36.88 66.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.13 0.419 . . . . 74.540000000000006 112.13 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.02 66.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.231 0.456 . . . . 75.129999999999995 112.231 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.59 0.87 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.93 -0.652 . . . . 32.210000000000001 113.448 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.51 179.47 4.43 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 73.209999999999994 111.445 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.9 m -108.88 94.58 5.13 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.948 0.404 . . . . 64.530000000000001 111.815 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.85 111.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.893 0.377 . . . . 43.049999999999997 111.181 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -128.78 176.77 7.56 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.018 0.437 . . . . 75.400000000000006 111.09 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.26 -1.87 57.97 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.672 0.272 . . . . 44.210000000000001 110.818 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.3 t -55.8 118.28 19.33 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 116.304 -0.407 . . . . 75.120000000000005 111.425 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -86.23 11.8 3.2 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.008 2.472 . . . . 70.519999999999996 113.942 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -59.06 143.57 48.11 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 112.138 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.69 163.36 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.774 -0.648 . . . . 74.239999999999995 112.627 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.97 16.17 75.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.128 -0.558 . . . . 61.039999999999999 112.762 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -124.69 165.99 16.96 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.74 0.305 . . . . 52.329999999999998 111.153 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -112.96 128.73 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.25 -0.281 . . . . 72.530000000000001 110.553 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -101.26 133.06 46.41 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.332 0.587 . . . . 70.340000000000003 111.296 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.556 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.2 tt0 -92.83 108.83 20.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.046 -0.524 . . . . 63.100000000000001 110.934 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 46.6 m -87.92 -34.74 18.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.048 0.388 . . . . 74.239999999999995 112.048 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.7 p 56.23 17.03 2.58 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.082 0.771 . . . . 51.149999999999999 113.082 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.63 86.52 2.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.995 0.426 . . . . 71.120000000000005 112.123 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 135.87 179.84 17.04 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.113 -0.565 . . . . 60.32 113.382 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.87 -48.59 74.98 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 72.019999999999996 113.515 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -78.7 -19.83 51.51 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.395 0.617 . . . . 71.129999999999995 110.48 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.57 -164.65 22.09 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.691 -0.686 . . . . 30.539999999999999 111.987 -174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -166.83 141.22 4.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 117.076 0.438 . . . . 65.329999999999998 111.521 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 101' ' ' GLN . 16.9 m -146.18 153.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.29 0.636 . . . . 60.350000000000001 110.697 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.22 160.55 42.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.926 0.394 . . . . 52.25 111.278 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' HB2' HG13 ' A' ' 61' ' ' VAL . 70.9 t80 -98.62 127.79 44.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.937 0.399 . . . . 74.040000000000006 111.445 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 116.21 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.391 -0.368 . . . . 74.519999999999996 111.888 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -88.03 -38.83 15.14 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.116 0.413 . . . . 73.409999999999997 112.116 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -161.88 145.91 12.51 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.796 0.665 . . . . 73.530000000000001 112.796 -174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.8 t -103.99 150.4 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.888 -0.596 . . . . 63.240000000000002 110.573 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.415 HD21 ' HG3' ' A' ' 123' ' ' GLU . 27.5 m-80 -113.11 168.73 9.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.479 0.548 . . . . 73.200000000000003 112.479 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.7 t -63.22 -31.84 73.09 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.086 0.47 . . . . 72.430000000000007 110.933 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.95 -12.36 54.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.033 -0.531 . . . . 73.129999999999995 111.723 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.62 -1.22 89.04 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.636 -0.585 . . . . 73.439999999999998 111.636 -170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.2 m -68.38 136.1 52.82 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.941 0.401 . . . . 61.340000000000003 111.608 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.92 122.03 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.056 -0.52 . . . . 73.120000000000005 111.884 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HG3' HD21 ' A' ' 117' ' ' ASN . 43.7 mt-10 -95.03 108.95 21.04 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.102 0.477 . . . . 75.420000000000002 111.082 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.01 149.22 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.116 -0.493 . . . . 73.420000000000002 112.224 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.4 t -97.37 109.39 22.16 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.005 -0.543 . . . . 70.239999999999995 111.55 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.18 171.05 7.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.003 -0.544 . . . . 62.140000000000001 110.295 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 34.7 ttm -110.26 124.55 51.82 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.398 0.618 . . . . 63.140000000000001 111.935 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.79 89.71 4.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.744 -0.662 . . . . 71.540000000000006 110.635 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -72.98 10.33 0.94 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.512 0.56 . . . . 75.420000000000002 112.512 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -94.0 85.12 4.64 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.082 0.468 . . . . 71.030000000000001 110.879 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.64 60.2 6.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.251 -0.499 . . . . 74.450000000000003 113.465 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 164.98 94.23 0.1 OUTLIER Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.083 -0.58 . . . . 52.240000000000002 113.445 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.19 -13.26 34.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.733 2.289 . . . . 75.340000000000003 113.414 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -118.9 1.58 11.51 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.819 0.342 . . . . 70.239999999999995 111.073 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.9 t -70.38 123.76 22.53 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.19 0.519 . . . . 72.450000000000003 111.164 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.27 147.61 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.43 -0.35 . . . . 65.109999999999999 111.349 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.9 t -130.87 120.19 23.28 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.107 0.48 . . . . 71.530000000000001 110.91 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.68 113.25 25.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.916 -0.584 . . . . 60.229999999999997 110.818 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -99.64 119.39 38.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.098 0.475 . . . . 72.450000000000003 111.544 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.2 m -95.63 94.34 7.67 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.257 -0.429 . . . . 71.239999999999995 110.77 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 51.7 mt -83.22 131.83 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.582 -0.281 . . . . 72.420000000000002 111.311 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.5 m -62.63 150.11 41.63 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 120.483 0.182 . . . . 60.130000000000003 111.485 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.58 -51.06 39.83 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.736 0.643 . . . . 74.200000000000003 112.736 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.11 -49.66 70.3 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.286 -0.415 . . . . 73.0 113.504 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.14 -38.53 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.124 0.487 . . . . 74.540000000000006 111.266 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -63.67 -38.69 92.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.073 -0.512 . . . . 75.019999999999996 112.173 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.1 t -61.36 -12.17 12.95 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.345 0.498 . . . . 75.140000000000001 112.345 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.1 t -82.02 -13.96 56.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.739 0.304 . . . . 45.140000000000001 111.784 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.44 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 36.2 m-85 -97.05 151.35 19.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 111.992 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -89.81 115.53 27.22 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.351 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.418 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 96.3 m-85 -94.87 112.06 23.81 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.979 0.419 . . . . 72.540000000000006 111.86 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.9 mp -79.36 121.25 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.706 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -112.6 136.12 52.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 109.971 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.98 129.38 34.86 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.81 0.338 . . . . 72.109999999999999 111.697 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.0 p30 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.188 0.518 . . . . 71.420000000000002 111.192 179.586 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 112.102 0.408 . . . . 70.439999999999998 112.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -79.12 76.75 5.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.75 0.786 . . . . 64.530000000000001 112.157 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -140.88 106.2 5.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 71.209999999999994 110.407 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 tt 56.31 87.8 0.05 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.232 0.539 . . . . 74.209999999999994 110.532 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.44 141.77 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.974 0.416 . . . . 52.310000000000002 111.633 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.0 m -76.17 98.84 4.51 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.004 0.43 . . . . 74.120000000000005 111.279 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.55 146.97 26.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.872 0.368 . . . . 52.219999999999999 111.813 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.5 p -123.5 112.95 18.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.394 -0.366 . . . . 63.340000000000003 111.431 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -89.0 126.68 35.52 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.85 0.357 . . . . 72.439999999999998 111.571 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.25 95.57 5.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.95 0.405 . . . . 50.329999999999998 111.295 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -105.69 110.51 22.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.507 -0.315 . . . . 55.420000000000002 110.974 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.24 150.07 51.0 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.363 0.505 . . . . 55.240000000000002 112.363 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 106.1 0.29 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.937 -0.574 . . . . 54.409999999999997 112.594 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 14' ' ' ILE . 2.8 pp -82.73 156.75 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.661 0.615 . . . . 64.329999999999998 112.661 -176.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -152.05 138.28 6.39 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 116.015 -0.539 . . . . 74.239999999999995 113.121 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.4 124.13 5.01 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.425 0.29 . . . . 74.239999999999995 111.317 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.74 116.97 32.22 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.836 0.351 . . . . 73.439999999999998 111.833 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 18' ' ' ILE . 3.3 mp -110.14 122.43 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.586 -0.279 . . . . 41.219999999999999 111.148 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 p -167.44 141.35 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.714 0.292 . . . . 72.230000000000004 111.559 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.245 -0.502 . . . . 71.439999999999998 113.039 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.4 mt -97.68 165.64 11.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.119 0.485 . . . . 75.319999999999993 112.129 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -145.57 152.1 39.17 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.224 -0.443 . . . . 74.129999999999995 111.952 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -176.12 147.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.764 0.426 . . . . 73.510000000000005 111.445 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.83 96.84 0.3 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 121.192 -0.528 . . . . 44.140000000000001 113.68 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.85 119.97 26.77 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 122.427 -0.455 . . . . 72.530000000000001 111.489 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.91 140.46 49.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.572 0.225 . . . . 71.299999999999997 111.002 175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.23 7.83 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.066 0.395 . . . . 70.140000000000001 112.066 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -163.16 147.59 11.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.672 0.272 . . . . 73.129999999999995 110.671 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.8 117.98 29.62 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.92 0.391 . . . . 61.409999999999997 111.889 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.18 145.08 23.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.904 0.383 . . . . 52.210000000000001 111.668 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -143.17 119.67 11.01 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.843 0.354 . . . . 74.019999999999996 110.552 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -150.71 141.08 22.37 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.915 0.388 . . . . 75.540000000000006 111.416 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.2 t -139.92 98.79 3.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.057 0.456 . . . . 65.219999999999999 111.457 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -83.36 115.06 57.27 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 122.262 -0.274 . . . . 62.340000000000003 111.315 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.98 98.05 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.343 2.028 . . . . 72.349999999999994 113.304 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.6 m -110.62 104.79 13.52 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.57 -0.286 . . . . 73.109999999999999 111.03 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -91.37 110.56 21.87 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.986 0.422 . . . . 73.510000000000005 110.818 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 80' ' ' ALA . 6.5 tp-100 -76.01 138.36 40.85 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.456 -0.338 . . . . 64.439999999999998 111.439 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.4 p -67.28 109.44 3.11 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.13 0.49 . . . . 32.32 110.767 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 84' ' ' SER . 30.5 p -74.4 156.7 36.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.845 0.683 . . . . 73.310000000000002 112.845 -173.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.6 t -116.23 136.27 53.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.944 -0.571 . . . . 70.299999999999997 111.359 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -7.92 57.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.147 0.425 . . . . 75.040000000000006 112.147 -177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -66.23 125.67 26.29 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.901 0.382 . . . . 51.030000000000001 111.663 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 t -114.33 175.08 5.63 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.028 0.442 . . . . 63.450000000000003 111.811 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB3' HG21 ' A' ' 72' ' ' THR . 30.0 t -170.95 168.67 6.96 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.319 -0.4 . . . . 74.420000000000002 111.385 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.08 32.48 2.34 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.181 -0.533 . . . . 45.140000000000001 113.319 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 t -90.24 122.61 33.32 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.551 -0.382 . . . . 63.520000000000003 111.627 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.4 m -97.84 -16.2 19.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 111.94 0.348 . . . . 74.129999999999995 111.94 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.28 148.29 41.58 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.785 0.326 . . . . 74.340000000000003 111.818 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.68 94.63 0.21 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.891 0.377 . . . . 74.010000000000005 111.497 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 72' ' ' THR . 69.3 mt -70.67 -18.06 62.84 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.079 0.4 . . . . 74.219999999999999 112.079 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -80.22 178.14 8.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.853 0.358 . . . . 72.010000000000005 111.45 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.4 p -111.11 154.15 24.7 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.274 0.559 . . . . 71.019999999999996 112.504 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.94 113.69 2.43 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.678 -0.692 . . . . 61.140000000000001 111.051 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.83 -31.5 4.53 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.337 -0.459 . . . . 50.240000000000002 112.819 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -60.97 137.65 58.22 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.526 -0.396 . . . . 72.010000000000005 111.84 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.459 ' O ' HG23 ' A' ' 61' ' ' VAL . 57.2 m -50.59 -41.95 55.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 71.430000000000007 110.416 173.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -59.29 -39.19 82.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.267 -0.879 . . . . 71.049999999999997 112.182 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 73.2 t90 -60.81 -52.62 64.3 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.5 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -60.78 -49.21 78.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.949 0.404 . . . . 62.420000000000002 111.76 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' CYS . 67.5 t -59.87 -36.73 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.958 0.408 . . . . 61.009999999999998 111.348 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -58.46 -38.52 77.71 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.098 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.21 -46.68 69.92 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.378 -0.373 . . . . 71.230000000000004 111.174 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.65 -33.69 71.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.232 0.456 . . . . 73.5 112.232 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -88.98 12.12 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-O 121.31 0.576 . . . . 75.400000000000006 111.461 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.19 14.23 55.89 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.361 -0.381 . . . . 51.009999999999998 113.814 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.21 9.1 53.52 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 114.194 0.438 . . . . 72.019999999999996 114.194 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.4 -20.56 63.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.592 0.59 . . . . 74.299999999999997 112.592 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 154' ' ' LEU . 34.2 pt -80.23 -35.9 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.895 0.702 . . . . 72.340000000000003 112.895 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.11 119.34 2.24 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.097 -0.573 . . . . 63.530000000000001 112.231 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.9 p -81.72 20.39 0.94 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.771 0.656 . . . . 70.209999999999994 112.771 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' HD12 ' A' ' 51' ' ' LEU . 11.5 t -90.81 12.3 19.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 74.439999999999998 111.97 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -83.42 -30.03 27.63 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.683 0.277 . . . . 60.509999999999998 111.72 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.66 -126.31 7.48 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.373 -0.442 . . . . 50.43 113.925 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -58.8 139.47 56.29 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.893 0.377 . . . . 44.009999999999998 111.73 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -54.62 -40.29 68.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.839 0.681 . . . . 42.310000000000002 112.839 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.546 ' OD1' ' HA ' ' A' ' 103' ' ' THR . 96.1 m-20 -71.81 -9.59 58.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.689 0.626 . . . . 74.150000000000006 112.689 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -97.19 -15.98 20.62 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.759 0.314 . . . . 41.25 111.263 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -49.79 -58.74 4.74 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.726 0.639 . . . . 74.120000000000005 112.726 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . . . -55.43 -39.71 70.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.827 0.346 . . . . 75.439999999999998 111.769 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -40.41 89.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.325 -0.398 . . . . 70.400000000000006 111.766 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.44 -45.84 24.49 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.012 0.434 . . . . 74.140000000000001 111.37 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.89 -56.58 11.62 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.38 0.511 . . . . 71.409999999999997 112.38 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB2' HG22 ' A' ' 40' ' ' THR . 68.9 m -67.55 -1.01 4.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.621 0.6 . . . . 75.349999999999994 112.621 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 40' ' ' THR . 38.0 t -116.93 -12.18 10.74 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.973 0.416 . . . . 52.119999999999997 111.54 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.05 8.54 38.82 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.17 0.433 . . . . 72.239999999999995 112.17 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.94 12.82 35.82 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.967 -0.635 . . . . 61.200000000000003 113.543 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.01 162.63 12.98 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.141 0.496 . . . . 51.140000000000001 111.355 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -111.28 99.08 7.97 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.879 0.371 . . . . 74.049999999999997 111.905 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 152' ' ' ILE . 57.4 t -93.6 103.75 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.037 0.446 . . . . 73.120000000000005 111.422 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 86.4 m-20 -134.8 137.92 43.79 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.061 -0.518 . . . . 75.209999999999994 109.956 176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -61.58 -4.69 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.056 0.761 . . . . 74.25 113.056 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 m -55.71 112.81 4.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 122.597 0.359 . . . . 74.120000000000005 111.388 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.75 119.0 3.55 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.813 2.342 . . . . 71.200000000000003 113.166 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.9 145.16 30.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.703 -0.681 . . . . 73.019999999999996 111.146 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.43 133.11 54.56 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.917 0.389 . . . . 20.420000000000002 111.596 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.22 48.83 2.97 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.841 -0.695 . . . . 72.120000000000005 112.795 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.3 p -159.3 177.13 11.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.94 0.4 . . . . 63.420000000000002 110.657 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.3 mt -123.7 122.75 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.872 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -98.59 123.52 42.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.547 0.689 . . . . 73.310000000000002 111.66 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 29.0 tt0 -82.37 106.45 14.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.94 -0.573 . . . . 73.030000000000001 111.45 177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 44.2 m -84.2 92.86 8.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 110.734 173.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.546 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 39.3 p -69.44 -8.86 50.53 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.112 0.482 . . . . 64.409999999999997 111.532 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.51 -35.14 71.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.001 -0.545 . . . . 75.200000000000003 112.022 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.77 38.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.356 -0.45 . . . . 74.329999999999998 112.865 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.49 -40.33 69.08 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.757 -0.258 . . . . 61.439999999999998 113.605 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -109.81 0.42 18.78 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.234 0.54 . . . . 62.32 110.636 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.68 155.26 28.27 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.788 -0.642 . . . . 73.019999999999996 113.065 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 74.6 t60 -140.49 105.97 5.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.908 0.385 . . . . 65.049999999999997 110.652 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG13 ' HB1' ' A' ' 76' ' ' ALA . 27.7 m -103.65 136.38 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.111 0.481 . . . . 71.409999999999997 111.649 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.88 159.52 41.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.929 -0.578 . . . . 71.540000000000006 110.737 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -93.14 123.98 36.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.89 0.376 . . . . 72.420000000000002 110.879 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.61 112.29 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.021 0.439 . . . . 73.230000000000004 111.762 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -78.23 -49.36 13.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.021 -0.536 . . . . 72.530000000000001 111.459 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -164.96 139.57 5.14 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.963 0.411 . . . . 64.239999999999995 112.091 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.6 t -102.42 123.64 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.247 -0.433 . . . . 52.229999999999997 109.922 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -78.17 166.84 22.27 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.372 0.508 . . . . 75.010000000000005 112.372 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -47.26 -48.51 24.57 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.465 0.543 . . . . 65.299999999999997 112.465 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.72 -45.28 87.22 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.002 0.429 . . . . 71.450000000000003 111.769 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.42 -21.89 2.05 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 120.889 -0.672 . . . . 70.430000000000007 113.661 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.1 m -56.78 129.74 42.6 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.419 0.61 . . . . 74.329999999999998 111.426 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.2 t -103.74 120.97 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.81 -0.632 . . . . 74.0 112.033 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.45 122.76 33.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.428 -0.351 . . . . 73.340000000000003 110.843 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.89 149.9 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.378 0.51 . . . . 73.5 112.378 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 90.1 p -94.35 126.57 39.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.142 -0.481 . . . . 64.230000000000004 111.171 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.85 179.75 4.4 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.413 0.625 . . . . 61.240000000000002 111.962 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.4 ttm -138.44 108.08 6.23 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.53 -0.759 . . . . 65.25 109.851 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.431 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.9 OUTLIER -98.13 -2.58 39.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.018 0.377 . . . . 73.209999999999994 112.018 -177.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.4 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 17.1 t80 56.44 37.97 29.28 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.417 0.627 . . . . 75.040000000000006 111.179 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -75.46 -67.47 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.136 -0.483 . . . . 70.329999999999998 111.285 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.86 -15.54 78.98 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.144 -0.55 . . . . 75.200000000000003 113.854 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 161.89 -158.94 30.93 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.035 -0.603 . . . . 60.140000000000001 113.147 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.68 -64.23 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.174 2.583 . . . . 72.019999999999996 113.702 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -86.75 37.24 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.069 0.461 . . . . 64.230000000000004 111.801 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 129' ' ' TYR . 47.9 t -75.27 93.64 2.89 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.266 0.555 . . . . 74.540000000000006 111.035 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 137' ' ' SER . 45.9 t -80.31 161.73 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.837 -0.619 . . . . 70.5 111.657 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.464 ' N ' HG12 ' A' ' 136' ' ' VAL . 75.0 m -143.4 156.47 44.68 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.382 -0.372 . . . . 53.229999999999997 110.433 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -130.86 121.07 24.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.901 -0.136 . . . . 73.0 110.842 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -127.91 133.21 49.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.922 0.391 . . . . 71.140000000000001 111.782 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.9 m -97.49 100.22 11.63 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.846 0.355 . . . . 64.099999999999994 110.717 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.0 mt -81.57 136.91 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.681 0.277 . . . . 74.409999999999997 111.426 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -63.72 147.42 51.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.603 0.239 . . . . 73.319999999999993 111.538 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.84 -45.8 71.03 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.372 0.508 . . . . 63.0 112.372 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.35 -49.96 71.23 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.286 -0.483 . . . . 61.130000000000003 113.3 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.49 -44.15 91.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 110.856 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.449 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.49 -44.3 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.777 -0.647 . . . . 70.400000000000006 112.112 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 t -63.9 -16.34 61.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.101 0.477 . . . . 74.140000000000001 111.577 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.2 t -82.08 -6.22 59.0 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.385 -0.37 . . . . 62.119999999999997 111.731 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 22.3 m-85 -102.11 153.16 20.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.032 0.444 . . . . 73.030000000000001 111.821 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 15.9 m-80 -92.04 107.25 19.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.447 -0.342 . . . . 72.0 111.518 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.8 m-85 -85.9 114.66 22.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.28 0.474 . . . . 73.239999999999995 112.28 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 90' ' ' VAL . 3.8 mp -78.44 114.52 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.549 174.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -106.36 142.51 35.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.85 0.357 . . . . 64.430000000000007 110.961 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.485 HD21 HG22 ' A' ' 69' ' ' ILE . 41.7 mt -104.2 91.5 3.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.851 0.358 . . . . 72.150000000000006 111.749 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.017 0.437 . . . . 72.530000000000001 111.23 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.538 0.209 . . . . 71.239999999999995 111.065 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -105.66 80.92 1.61 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.016 0.436 . . . . 75.409999999999997 110.831 177.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 5.0 mmmp? -145.67 117.96 8.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.183 -0.462 . . . . 63.509999999999998 110.872 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.32 168.46 25.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.005 0.431 . . . . 74.420000000000002 111.962 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.03 143.61 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.298 -0.41 . . . . 71.230000000000004 110.835 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -90.38 25.02 2.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.961 0.41 . . . . 75.200000000000003 112.03 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.37 126.37 21.03 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.56 0.578 . . . . 73.329999999999998 112.56 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -149.31 164.05 35.97 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.024 -0.534 . . . . 71.310000000000002 110.941 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -147.72 155.89 42.19 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.064 0.459 . . . . 64.5 112.095 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.1 mp -120.86 109.95 15.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.274 -0.421 . . . . 72.420000000000002 111.272 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 t -98.03 -176.93 3.58 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.772 -0.195 . . . . 43.240000000000002 111.342 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 75.1 -49.33 0.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.084 0.772 . . . . 73.319999999999993 113.084 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 32.11 1.98 Allowed Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.266 -0.492 . . . . 70.439999999999998 114.319 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -99.18 108.67 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.247 -0.56 . . . . 71.329999999999998 110.774 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.09 121.85 0.59 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.459 -0.401 . . . . 75.150000000000006 112.765 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.82 146.57 46.41 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.46 -0.436 . . . . 73.239999999999995 111.761 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.46 131.27 35.03 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.945 0.402 . . . . 62.310000000000002 111.908 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 65.9 mt -92.29 131.28 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.354 -0.385 . . . . 73.340000000000003 111.466 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.86 177.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.181 0.515 . . . . 73.540000000000006 112.05 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 103.72 2.54 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.301 -0.476 . . . . 41.539999999999999 113.744 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.2 pt? -164.64 132.16 3.21 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.985 0.422 . . . . 62.439999999999998 111.495 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -147.6 132.05 17.65 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.895 0.379 . . . . 64.420000000000002 111.437 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -144.2 151.66 39.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.69 0.281 . . . . 73.200000000000003 111.533 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.36 84.0 0.24 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.346 0.499 . . . . 52.210000000000001 114.346 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -126.1 134.0 51.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.967 0.413 . . . . 64.129999999999995 111.387 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -81.22 -174.26 4.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.637 0.606 . . . . 72.109999999999999 112.637 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.68 105.16 1.4 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.106 -0.497 . . . . 73.200000000000003 111.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.06 104.28 7.46 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.668 0.271 . . . . 71.200000000000003 111.301 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.55 95.92 10.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.787 0.327 . . . . 53.25 111.345 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.15 118.44 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.4 -0.364 . . . . 55.100000000000001 111.457 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -74.15 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.955 0.407 . . . . 53.509999999999998 111.963 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -126.16 153.88 43.99 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.87 0.366 . . . . 71.099999999999994 111.403 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.0 m -148.25 92.43 2.03 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.033 0.444 . . . . 62.299999999999997 111.5 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -155.05 75.39 5.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 121.249 0.547 . . . . 74.209999999999994 111.606 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.03 42.95 1.41 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.2 2.6 . . . . 73.430000000000007 112.447 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.9 m -116.27 91.11 3.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.819 0.342 . . . . 70.200000000000003 111.666 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.25 131.52 34.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.789 0.328 . . . . 72.140000000000001 111.23 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -90.8 100.76 13.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.059 0.457 . . . . 73.200000000000003 111.437 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 63.1 p -83.7 93.87 8.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.012 0.434 . . . . 73.030000000000001 111.739 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -165.26 151.88 10.27 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.21 0.448 . . . . 63.439999999999998 112.21 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 p -85.6 103.16 14.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.207 -0.451 . . . . 65.430000000000007 110.6 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -69.26 107.24 3.17 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.472 0.653 . . . . 75.530000000000001 112.022 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m -122.59 92.96 3.83 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.026 -0.534 . . . . 63.32 111.048 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 p -113.17 135.74 53.49 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.366 -0.208 . . . . 53.350000000000001 111.417 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' ' OH ' ' A' ' 88' ' ' TYR . 74.6 m -72.81 148.6 44.37 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.027 0.441 . . . . 63.450000000000003 111.253 176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.98 117.63 1.2 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.24 -0.505 . . . . 71.230000000000004 112.364 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 m -153.03 107.52 3.14 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.597 -0.355 . . . . 72.340000000000003 110.95 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.8 m -69.86 -21.76 63.32 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.287 0.477 . . . . 71.409999999999997 112.287 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.69 125.83 27.9 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.808 0.337 . . . . 54.030000000000001 111.559 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -91.9 105.99 18.12 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.879 0.371 . . . . 61.509999999999998 111.001 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 71' ' ' SER . 4.0 mm? -88.6 26.76 1.41 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 111.967 0.358 . . . . 62.229999999999997 111.967 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -119.72 -168.99 1.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.283 0.233 . . . . 75.209999999999994 110.564 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -136.6 148.25 47.38 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.797 0.666 . . . . 74.209999999999994 112.797 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.0 142.34 58.41 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.876 -0.602 . . . . 75.409999999999997 111.917 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.92 32.35 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.23 -0.51 . . . . 71.140000000000001 112.29 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -95.76 139.68 31.64 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 110.244 -0.28 . . . . 75.120000000000005 110.244 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 49.0 m -54.87 -29.23 55.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.984 0.421 . . . . 72.409999999999997 112.043 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 p -60.15 -35.67 75.83 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.909 0.707 . . . . 74.530000000000001 112.909 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 48.6 t90 -61.91 -62.85 1.5 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.278 0.844 . . . . 72.319999999999993 113.278 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 32.5 p90 -68.01 -28.86 67.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.875 0.694 . . . . 73.299999999999997 112.875 -173.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.68 -36.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.06 0.457 . . . . 72.420000000000002 111.018 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -59.41 -34.93 73.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.276 0.56 . . . . 64.129999999999995 110.964 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.71 -50.56 34.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.94 -0.573 . . . . 75.209999999999994 110.405 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.0 mmmt -55.3 -36.82 66.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.774 0.657 . . . . 73.530000000000001 112.774 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.448 HG21 HG23 ' A' ' 69' ' ' ILE . 8.0 p -82.33 -5.22 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 121.059 0.457 . . . . 74.200000000000003 111.929 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.57 24.43 76.21 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.283 -0.484 . . . . 54.420000000000002 113.55 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.12 23.2 72.95 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.203 -0.522 . . . . 73.540000000000006 113.895 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -89.26 19.9 4.09 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.311 0.486 . . . . 61.119999999999997 112.311 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 65' ' ' VAL . 34.7 pt -126.73 178.49 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.921 0.391 . . . . 74.239999999999995 111.537 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.28 125.65 7.26 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.315 -0.469 . . . . 65.140000000000001 113.043 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 51' ' ' LEU . 75.7 p -80.55 -13.35 59.15 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.742 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.8 t -94.55 13.92 22.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.204 0.446 . . . . 72.540000000000006 112.204 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.43 -32.37 58.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 73.409999999999997 111.824 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.48 -118.63 6.75 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 121.297 -0.477 . . . . 74.540000000000006 113.665 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.3 137.74 56.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.097 0.406 . . . . 75.439999999999998 112.097 -176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -55.36 -42.68 74.22 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.355 0.502 . . . . 62.25 112.355 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -68.64 -2.99 10.35 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.568 0.581 . . . . 74.310000000000002 112.568 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -100.96 -10.24 20.77 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.785 0.326 . . . . 60.109999999999999 111.537 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -61.19 -36.56 80.19 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.042 0.756 . . . . 70.349999999999994 113.042 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.21 -50.14 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.12 0.486 . . . . 75.140000000000001 111.2 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -61.23 -46.48 90.25 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.065 -0.516 . . . . 65.439999999999998 111.27 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.24 -52.54 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.085 -0.507 . . . . 62.109999999999999 111.614 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.46 -47.41 69.77 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.831 0.348 . . . . 64.420000000000002 111.665 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -59.58 -50.99 71.73 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.18 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.0 t -69.28 -19.85 63.91 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.205 0.446 . . . . 54.049999999999997 112.205 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.41 -36.03 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.081 0.401 . . . . 71.140000000000001 112.081 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.16 8.04 5.2 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 120.992 -0.623 . . . . 75.420000000000002 113.181 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.454 ' OH ' ' HB2' ' A' ' 45' ' ' SER . 14.2 m-85 -80.07 -171.34 2.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.186 0.517 . . . . 63.119999999999997 111.176 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.0 m -121.94 91.25 3.47 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.064 0.459 . . . . 63.109999999999999 111.359 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.27 105.17 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.0 0.428 . . . . 74.109999999999999 111.315 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -127.2 161.31 28.82 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 111.212 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -84.41 7.24 20.31 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.136 0.493 . . . . 71.219999999999999 110.969 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.8 m -72.76 112.49 15.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.318 -0.401 . . . . 41.219999999999999 110.995 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.58 22.72 0.51 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.052 2.501 . . . . 54.539999999999999 114.47 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 153' ' ' HIS . 36.4 tt0 -60.1 147.16 40.48 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.063 0.459 . . . . 62.109999999999999 111.851 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.34 166.55 21.39 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.22 0.822 . . . . 75.239999999999995 113.22 -173.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.06 31.02 44.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.703 -0.68 . . . . 71.230000000000004 112.93 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.1 m -146.75 170.63 16.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 111.273 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -107.68 133.83 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 110.254 -0.276 . . . . 75.319999999999993 110.254 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -98.89 107.82 20.35 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.986 0.898 . . . . 73.420000000000002 111.049 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HA ' HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -72.93 99.12 2.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.481 -0.781 . . . . 72.049999999999997 109.822 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 50.9 m -93.77 104.88 16.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.56 -0.746 . . . . 74.530000000000001 111.595 -173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.0 p -81.12 24.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.244 0.461 . . . . 72.230000000000004 112.244 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -106.16 96.96 6.84 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.154 0.428 . . . . 63.130000000000003 112.154 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.76 -176.2 29.33 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.151 0.42 . . . . 72.549999999999997 114.151 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.76 22.41 57.08 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 114.032 0.373 . . . . 23.43 114.032 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 57.77 19.6 5.76 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.91 0.386 . . . . 72.310000000000002 111.297 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.1 111.8 3.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.428 -0.415 . . . . 75.340000000000003 112.228 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -112.38 147.37 36.55 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 111.929 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 101' ' ' GLN . 10.1 m -142.69 141.49 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.143 -0.481 . . . . 64.439999999999998 110.667 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.03 159.63 43.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.76 0.314 . . . . 63.229999999999997 110.509 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -94.32 125.73 39.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.945 0.403 . . . . 51.149999999999999 111.667 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 74.2 t -70.42 109.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 71.540000000000006 111.893 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.84 -61.18 2.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.044 -0.525 . . . . 65.129999999999995 111.771 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -148.56 145.43 27.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 62.140000000000001 111.949 -175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.2 t -103.11 125.77 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.201 -0.454 . . . . 72.540000000000006 110.595 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -95.36 141.07 29.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.433 -0.349 . . . . 74.209999999999994 111.748 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -60.36 -21.25 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.394 -0.366 . . . . 53.420000000000002 111.852 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.23 -12.89 56.12 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.863 0.363 . . . . 74.239999999999995 111.956 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.83 45.56 4.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.93 -0.468 . . . . 64.319999999999993 111.93 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.7 p -137.17 138.6 40.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.086 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.17 119.45 59.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.223 -0.444 . . . . 62.43 111.57 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -88.44 112.27 22.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.86 0.362 . . . . 55.32 110.963 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.97 137.91 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.195 0.521 . . . . 64.519999999999996 112.02 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 34.5 p -86.61 115.61 24.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.07 0.462 . . . . 64.310000000000002 111.883 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.42 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 11.5 pt-20 -133.43 -179.27 5.41 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.596 . . . . 75.120000000000005 111.387 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.451 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . 49.0 ttm -135.18 128.54 32.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.905 0.383 . . . . 53.539999999999999 111.54 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -83.4 90.03 7.12 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.239 0.542 . . . . 75.129999999999995 111.046 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -62.94 152.27 37.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.782 -0.645 . . . . 63.439999999999998 111.85 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 70.88 -67.72 0.24 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.527 0.731 . . . . 64.019999999999996 111.993 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.23 7.78 50.37 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.146 -0.549 . . . . 71.430000000000007 113.718 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -155.82 159.84 29.57 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.136 -0.554 . . . . 63.32 112.873 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.91 -156.22 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.742 2.295 . . . . 74.010000000000005 112.525 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -68.58 13.33 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.882 0.697 . . . . 75.099999999999994 112.882 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.0 t -76.71 114.61 15.65 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.032 0.444 . . . . 54.119999999999997 111.75 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.5 t -81.0 124.42 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.958 0.409 . . . . 74.099999999999994 111.406 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.8 p -114.55 142.14 46.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.431 -0.35 . . . . 53.509999999999998 111.399 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -92.8 104.54 16.78 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.819 0.342 . . . . 63.509999999999998 111.375 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -82.52 120.97 26.18 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.171 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 71.4 m -85.81 106.56 17.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.042 0.448 . . . . 75.140000000000001 110.923 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -97.71 139.65 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.192 -0.458 . . . . 72.510000000000005 111.658 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 m -69.71 154.54 41.84 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.783 0.325 . . . . 61.020000000000003 111.233 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.87 80.99 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.605 0.595 . . . . 64.129999999999995 112.605 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.26 -49.12 82.02 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.293 -0.479 . . . . 63.020000000000003 112.996 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.55 -40.98 93.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.127 0.489 . . . . 51.399999999999999 110.861 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.57 -42.57 78.83 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 111.8 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 34.3 t -60.96 -19.83 61.51 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.106 0.479 . . . . 64.209999999999994 111.744 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 47.4 t -77.42 -17.72 57.88 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.929 0.395 . . . . 71.319999999999993 111.674 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.413 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 17.0 m-85 -101.01 157.87 16.43 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.229 0.538 . . . . 72.409999999999997 111.817 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -99.74 111.04 23.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 111.333 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -87.98 106.2 17.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.063 0.459 . . . . 72.010000000000005 111.976 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.433 ' H ' HD12 ' A' ' 152' ' ' ILE . 4.1 mp -77.14 103.18 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.053 -0.521 . . . . 73.310000000000002 110.907 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.548 ' HE1' ' HB3' ' A' ' 95' ' ' GLU . 92.8 m-70 -85.16 143.09 29.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.364 . . . . 70.319999999999993 110.435 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.92 9.76 38.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 75.129999999999995 112.568 -166.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 121.498 0.666 . . . . 53.299999999999997 110.644 -176.499 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.662 0.268 . . . . 71.209999999999994 111.252 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -119.57 130.15 55.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 112.009 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -127.4 113.12 15.8 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.788 -0.642 . . . . 72.540000000000006 109.767 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.55 159.43 26.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.122 0.487 . . . . 54.229999999999997 112.034 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.1 p -140.59 138.77 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.118 0.485 . . . . 64.340000000000003 111.293 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.6 p -107.98 27.14 9.55 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.864 0.364 . . . . 74.230000000000004 111.56 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.568 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -63.13 92.03 0.05 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.37 0.508 . . . . 54.409999999999997 112.37 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -141.21 154.01 45.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.888 -0.596 . . . . 75.25 110.606 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -120.39 113.89 21.01 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.444 0.535 . . . . 61.219999999999999 112.444 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -138.74 111.26 7.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.265 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.2 m -102.94 144.32 31.38 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.501 -0.318 . . . . 74.299999999999997 110.996 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.78 161.3 36.92 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.94 0.4 . . . . 62.329999999999998 111.887 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.49 145.95 4.58 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.35 -0.452 . . . . 75.450000000000003 113.043 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 14' ' ' ILE . 0.2 OUTLIER -136.26 127.97 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 121.255 0.55 . . . . 61.049999999999997 111.705 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.54 118.53 6.19 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.292 -0.48 . . . . 74.310000000000002 112.716 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.25 138.9 31.5 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.413 -0.463 . . . . 75.439999999999998 112.017 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.87 109.76 19.03 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.821 0.343 . . . . 75.430000000000007 110.913 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.07 141.08 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.272 0.471 . . . . 71.019999999999996 112.272 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.46 140.77 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.39 -0.368 . . . . 72.439999999999998 111.049 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.8 113.34 1.31 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.104 -0.569 . . . . 60.140000000000001 113.177 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.39 150.23 36.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.026 0.441 . . . . 63.409999999999997 111.594 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.82 146.48 27.32 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.244 -0.435 . . . . 73.349999999999994 111.295 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -129.48 163.64 25.44 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.933 0.397 . . . . 62.240000000000002 111.349 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.79 78.3 1.05 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.209 -0.45 . . . . 62.520000000000003 112.409 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -122.65 118.63 28.59 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.085 0.469 . . . . 72.450000000000003 111.688 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -65.74 160.48 22.83 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.845 0.683 . . . . 70.299999999999997 112.845 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.95 104.66 6.67 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.848 -0.614 . . . . 71.340000000000003 111.006 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.01 157.2 35.29 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.317 -0.401 . . . . 74.519999999999996 111.428 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.14 143.38 5.29 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.53 0.567 . . . . 61.530000000000001 112.53 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.9 17.07 6.22 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.085 1.143 . . . . 62.439999999999998 114.085 171.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.84 78.12 9.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.657 -0.652 . . . . 73.219999999999999 111.653 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -133.04 -4.9 3.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.622 0.725 . . . . 74.409999999999997 110.598 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.6 t -91.12 90.94 8.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.841 -0.618 . . . . 71.219999999999999 112.026 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -68.8 121.98 83.3 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.371 -0.377 . . . . 63.329999999999998 110.926 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.11 66.88 1.38 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.786 2.324 . . . . 74.200000000000003 113.071 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -71.78 90.53 1.09 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.03 0.443 . . . . 72.319999999999993 111.94 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -132.07 172.7 12.04 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.071 0.462 . . . . 72.129999999999995 111.329 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -108.4 -0.02 20.85 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.764 -0.653 . . . . 64.420000000000002 110.396 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 84.4 p -96.66 146.33 24.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.108 0.48 . . . . 74.450000000000003 111.997 -176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -143.75 116.0 8.48 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.982 -0.554 . . . . 60.119999999999997 110.748 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.2 p -115.24 114.72 25.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.441 0.534 . . . . 75.030000000000001 112.441 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -104.63 92.05 4.12 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.35 0.595 . . . . 74.400000000000006 111.239 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.9 p -110.07 98.02 7.39 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.904 -0.589 . . . . 73.319999999999993 110.97 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -94.15 -26.0 16.88 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.806 0.336 . . . . 73.439999999999998 111.808 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -69.18 82.95 0.35 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.415 0.626 . . . . 60.420000000000002 111.206 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.86 -179.04 39.07 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.346 -0.843 . . . . 65.030000000000001 111.745 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.5 p -179.36 -179.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 117.219 0.51 . . . . 51.43 111.736 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.7 m -90.62 -7.19 53.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.219 -0.446 . . . . 44.409999999999997 110.685 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.37 86.31 1.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.049 0.452 . . . . 70.140000000000001 111.545 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -73.59 112.36 9.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.145 0.498 . . . . 55.539999999999999 111.33 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.81 -9.5 58.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.715 0.635 . . . . 71.120000000000005 112.715 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.71 176.35 9.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.051 -0.406 . . . . 74.129999999999995 110.882 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -121.92 152.28 39.82 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.404 0.52 . . . . 70.019999999999996 112.404 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.27 143.03 41.12 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.033 0.444 . . . . 43.219999999999999 111.946 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.95 58.19 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.086 -0.506 . . . . 45.210000000000001 113.295 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -83.52 141.59 31.51 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.904 0.352 . . . . 74.420000000000002 111.513 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 60' ' ' TYR . 56.6 m -59.97 -29.41 68.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.401 0.619 . . . . 45.240000000000002 111.075 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 46.1 p -76.08 -11.35 59.93 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.817 -0.629 . . . . 73.019999999999996 112.549 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -76.8 -62.71 1.55 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.657 0.614 . . . . 72.430000000000007 112.657 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' HE2' ' HA ' ' A' ' 57' ' ' CYS . 50.5 p90 -63.72 -26.56 68.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.923 0.712 . . . . 73.109999999999999 112.923 -174.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.465 HG21 HG23 ' A' ' 110' ' ' VAL . 46.4 t -60.68 -31.96 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.897 0.38 . . . . 74.230000000000004 111.974 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.79 -44.53 95.93 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.883 0.373 . . . . 72.439999999999998 111.295 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -64.63 -41.06 96.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.286 0.565 . . . . 74.510000000000005 110.565 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.9 mmmt -62.18 -32.91 73.59 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.693 -0.685 . . . . 70.140000000000001 112.28 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 HD11 ' A' ' 154' ' ' LEU . 9.2 p -96.52 6.82 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 121.334 0.588 . . . . 72.219999999999999 111.961 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.53 8.62 76.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 45.409999999999997 114.237 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.87 3.07 66.79 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.038 0.775 . . . . 34.25 115.038 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.01 17.64 1.18 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.904 -0.762 . . . . 74.420000000000002 112.705 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 pt -106.32 -29.09 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 111.954 0.353 . . . . 64.340000000000003 111.954 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.87 98.77 1.1 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.044 -0.598 . . . . 71.319999999999993 112.884 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.7 p -73.02 83.85 1.26 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.229 -0.571 . . . . 75.340000000000003 111.522 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.7 t -154.79 17.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.09 0.471 . . . . 64.239999999999995 111.318 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -89.47 -4.12 58.09 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.26 0.467 . . . . 74.299999999999997 112.26 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.63 -137.76 22.97 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.054 -0.593 . . . . 64.109999999999999 113.329 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -70.24 155.39 40.71 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.502 -0.411 . . . . 73.219999999999999 111.57 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -56.84 -32.12 65.45 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.828 0.677 . . . . 60.140000000000001 112.828 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 103' ' ' THR . 91.8 m-20 -55.93 -28.61 57.66 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.328 0.492 . . . . 75.319999999999993 112.328 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -93.33 -16.53 24.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.286 0.476 . . . . 73.239999999999995 112.286 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 6.6 m0 -50.22 -66.02 0.46 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.964 1.098 . . . . 73.340000000000003 113.964 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.5 -33.71 68.31 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.298 0.481 . . . . 52.399999999999999 112.298 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.6 t -67.31 -48.02 68.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.057 0.456 . . . . 74.109999999999999 110.835 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.52 96.87 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.357 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.77 -53.96 44.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.298 -0.41 . . . . 73.329999999999998 111.105 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -61.07 -40.0 92.04 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.892 0.377 . . . . 62.539999999999999 110.939 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.3 t -63.62 -27.58 69.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.301 -0.408 . . . . 62.240000000000002 111.379 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.27 -12.18 41.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.945 0.402 . . . . 63.329999999999998 111.898 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.51 52.69 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.261 -0.495 . . . . 72.319999999999993 113.693 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -70.51 175.52 4.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.333 0.587 . . . . 74.219999999999999 112.012 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -101.01 92.03 4.83 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.053 -0.521 . . . . 64.200000000000003 111.506 -173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG22 HG13 ' A' ' 152' ' ' ILE . 22.0 t -99.8 93.48 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.916 0.389 . . . . 71.120000000000005 111.024 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -122.5 168.2 12.42 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.543 -0.299 . . . . 71.5 110.529 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -86.35 5.92 32.47 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.931 -0.481 . . . . 75.099999999999994 111.767 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 44.2 m -65.21 109.06 2.5 Favored Pre-proline 0 N--CA 1.47 0.562 0 CA-C-N 116.729 -0.214 . . . . 65.099999999999994 110.829 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 6.2 Cg_exo -79.14 8.85 3.61 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.302 2.668 . . . . 74.420000000000002 113.968 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -54.01 145.26 17.1 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.333 0.494 . . . . 75.120000000000005 112.333 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.72 46.81 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.877 -0.601 . . . . 54.149999999999999 112.587 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.28 55.5 1.69 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.001 -0.619 . . . . 70.420000000000002 111.803 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.6 t -163.01 165.35 24.97 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.305 0.574 . . . . 50.509999999999998 111.85 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 35.2 mt -116.58 125.38 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.644 -0.707 . . . . 65.400000000000006 110.479 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.8 pt? -99.43 133.14 44.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.928 0.394 . . . . 65.25 111.396 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -102.4 133.18 47.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.399 0.518 . . . . 73.140000000000001 112.399 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -124.32 107.92 11.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.033 -0.53 . . . . 74.549999999999997 110.38 171.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.507 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 80.2 p -78.56 -14.61 59.25 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.357 0.503 . . . . 50.210000000000001 112.357 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.49 -27.83 68.09 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.845 0.684 . . . . 63.229999999999997 112.845 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.72 57.48 3.85 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 121.243 -0.503 . . . . 72.209999999999994 114.177 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.31 -86.68 0.02 OUTLIER Glycine 0 CA--C 1.529 0.939 0 CA-C-N 117.166 0.483 . . . . 60.140000000000001 113.819 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -91.83 11.06 26.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.51 0.671 . . . . 72.430000000000007 110.624 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 76' ' ' ALA . . . 86.84 163.13 38.32 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.339 -0.846 . . . . 63.229999999999997 113.038 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -140.73 137.27 33.33 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.857 -0.202 . . . . 65.150000000000006 110.817 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.53 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.3 m -138.68 141.96 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.923 0.392 . . . . 54.130000000000003 111.499 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.09 22.21 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.96 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -101.37 133.73 45.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.02 0.438 . . . . 71.019999999999996 111.44 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.41 110.1 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.212 -0.449 . . . . 73.150000000000006 111.646 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.43 -53.38 9.67 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 111.09 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -156.57 143.36 18.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.041 0.448 . . . . 61.450000000000003 112.135 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.71 135.0 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.386 -0.37 . . . . 63.25 110.926 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -92.17 154.7 18.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.369 -0.378 . . . . 63.43 111.304 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -59.18 -24.25 62.92 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.84 0.352 . . . . 65.430000000000007 111.688 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.17 -11.52 60.98 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.926 0.393 . . . . 71.329999999999998 111.717 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 -17.65 56.47 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 121.385 -0.436 . . . . 42.219999999999999 112.968 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.1 m -64.84 126.43 27.94 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.11 0.481 . . . . 64.409999999999997 111.423 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.4 t -103.19 129.74 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.957 -0.565 . . . . 50.009999999999998 111.32 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.14 112.96 26.22 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.857 0.361 . . . . 75.099999999999994 111.415 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.0 162.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.964 0.412 . . . . 73.510000000000005 111.81 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.42 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 61.7 p -117.03 133.91 55.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.13 0.49 . . . . 72.230000000000004 111.614 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -129.51 152.09 49.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.12 -0.491 . . . . 53.119999999999997 111.047 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.0 ttm -92.08 110.28 21.64 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.902 -0.499 . . . . 61.450000000000003 109.96 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -75.41 72.74 2.45 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 111.423 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 45.4 p90 -60.0 -20.16 56.3 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.679 0.622 . . . . 73.420000000000002 112.679 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -93.34 16.18 13.92 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.937 0.399 . . . . 73.510000000000005 111.924 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.77 -53.99 0.01 OUTLIER Glycine 0 CA--C 1.528 0.898 0 CA-C-N 116.407 -0.36 . . . . 71.340000000000003 112.238 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -121.25 87.26 0.4 Allowed Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.566 -0.613 . . . . 71.439999999999998 111.566 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 44.2 Cg_exo -56.44 -17.07 20.22 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.23 2.62 . . . . 64.230000000000004 114.644 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -123.93 16.73 9.34 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.183 -0.323 . . . . 65.340000000000003 111.478 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.3 t -123.27 150.02 44.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.349 0.595 . . . . 60.299999999999997 112.273 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.4 t -110.12 126.29 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.821 -0.627 . . . . 71.310000000000002 111.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.6 t -109.55 167.35 10.2 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.371 -0.377 . . . . 65.230000000000004 111.199 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -101.07 144.55 29.85 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.235 -0.439 . . . . 65.329999999999998 111.152 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.22 109.8 6.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.073 0.463 . . . . 75.409999999999997 110.866 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 79.9 m -85.02 139.28 31.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.445 -0.343 . . . . 53.310000000000002 111.569 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.6 mt -123.52 149.08 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.758 0.423 . . . . 43.310000000000002 110.87 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.2 m -64.53 156.77 28.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.11 0.164 . . . . 61.039999999999999 110.838 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.67 -63.22 1.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.086 0.402 . . . . 64.439999999999998 112.086 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.66 -38.1 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.204 -0.522 . . . . 71.109999999999999 112.956 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.51 -36.26 80.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.006 0.522 . . . . 64.450000000000003 110.991 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.41 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -71.62 -43.63 65.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.106 -0.497 . . . . 61.399999999999999 111.529 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 t -59.23 -15.73 16.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 111.965 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.7 t -70.07 -25.28 63.46 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.925 0.393 . . . . 64.010000000000005 111.575 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -87.4 154.56 20.57 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.242 0.544 . . . . 72.430000000000007 111.895 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -89.3 119.76 30.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.952 -0.567 . . . . 64.409999999999997 110.828 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 95.5 m-85 -100.91 117.07 34.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.634 0.605 . . . . 55.549999999999997 112.634 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.4 mp -91.35 121.03 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.127 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -113.76 157.31 22.41 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 122.901 0.481 . . . . 71.439999999999998 110.96 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.499 HD11 HG22 ' A' ' 65' ' ' VAL . 34.2 mt -102.26 -33.89 9.44 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.49 0.552 . . . . 73.310000000000002 112.49 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 N--CA 1.474 0.773 0 CA-C-O 121.413 0.625 . . . . 75.140000000000001 111.701 -177.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.6 mtp . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 112.059 0.392 . . . . 71.010000000000005 112.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -82.77 119.09 23.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.684 0.278 . . . . 72.239999999999995 111.23 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -119.63 123.84 44.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.722 0.296 . . . . 75.129999999999995 110.913 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 pp -158.03 160.07 37.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.24 0.543 . . . . 72.530000000000001 111.914 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.47 145.19 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 110.935 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.6 p -107.1 86.58 2.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 111.244 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.56 24.66 12.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.269 -0.423 . . . . 74.329999999999998 112.133 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -87.12 110.63 20.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 73.019999999999996 112.406 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -166.08 133.43 2.76 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.757 -0.656 . . . . 64.450000000000003 110.46 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -136.01 149.2 48.73 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.053 0.454 . . . . 72.040000000000006 112.169 -173.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -100.35 146.31 27.12 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.376 -0.375 . . . . 72.230000000000004 110.768 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 175.71 9.9 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.013 0.435 . . . . 64.219999999999999 111.93 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.05 72.58 1.28 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.187 -0.53 . . . . 40.520000000000003 113.987 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.2 pt -136.91 -178.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.724 0.297 . . . . 61.030000000000001 110.885 175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.93 161.76 37.05 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.049 -0.596 . . . . 74.450000000000003 114.087 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.51 153.97 5.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.963 0.505 . . . . 55.509999999999998 110.659 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.23 154.49 25.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.899 0.381 . . . . 75.150000000000006 111.604 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.1 pt -129.84 22.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 111.931 0.345 . . . . 74.430000000000007 111.931 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.85 94.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.197 0.523 . . . . 64.409999999999997 111.851 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.92 93.93 0.09 OUTLIER Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.823 -0.626 . . . . 73.099999999999994 112.173 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 pp -138.78 157.47 46.01 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.535 0.568 . . . . 73.299999999999997 112.535 -174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.14 106.72 1.36 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 111.281 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -150.51 13.87 0.75 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.002 0.43 . . . . 74.400000000000006 111.596 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.32 69.51 0.42 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.782 -0.723 . . . . 64.420000000000002 113.559 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -112.99 91.94 3.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.418 0.628 . . . . 70.519999999999996 111.564 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.12 149.84 32.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.884 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -170.46 154.87 4.84 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.448 . . . . 43.420000000000002 112.208 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -136.81 136.82 39.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 110.592 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.47 16.72 15.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.407 0.521 . . . . 21.34 112.407 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.48 132.47 43.9 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 33.450000000000003 111.47 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -70.82 127.76 33.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.571 -0.286 . . . . 72.310000000000002 110.664 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -134.99 115.75 13.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.044 0.45 . . . . 74.349999999999994 111.78 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -128.55 148.35 50.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.401 -0.363 . . . . 65.120000000000005 110.24 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -120.94 143.23 36.31 Favored Pre-proline 0 N--CA 1.467 0.421 0 O-C-N 122.341 -0.224 . . . . 72.25 111.493 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.75 125.46 15.87 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.41 2.073 . . . . 74.430000000000007 112.466 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.7 p -48.05 -73.2 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.078 0.77 . . . . 75.400000000000006 113.078 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -170.15 127.04 0.83 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.76 0.314 . . . . 71.519999999999996 111.413 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.35 125.42 6.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.2 0.524 . . . . 75.230000000000004 111.51 177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.9 p -66.12 105.61 1.42 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.999 -0.546 . . . . 51.340000000000003 111.487 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.0 p -133.09 124.75 28.16 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.287 -0.415 . . . . 62.409999999999997 111.427 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 88.5 m -76.83 96.17 4.23 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.194 0.521 . . . . 44.340000000000003 110.943 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.69 126.5 38.9 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.093 -0.503 . . . . 62.43 111.101 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 t -144.97 166.39 25.43 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.119 0.485 . . . . 60.210000000000001 111.716 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.7 p -91.62 16.58 10.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.91 -0.586 . . . . 74.150000000000006 111.337 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 m -64.2 100.19 0.32 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.069 -0.514 . . . . 75.319999999999993 112.011 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.4 118.8 1.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 116.481 -0.327 . . . . 63.420000000000002 112.582 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.2 t -101.41 104.02 14.97 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.318 -0.519 . . . . 72.519999999999996 111.84 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -88.51 91.95 9.0 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.809 0.338 . . . . 60.340000000000003 111.106 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.19 96.24 3.02 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.036 0.446 . . . . 71.219999999999999 111.169 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.57 98.25 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.133 0.492 . . . . 73.349999999999994 111.037 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -87.1 4.98 39.97 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.066 -0.516 . . . . 62.420000000000002 112.298 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 90.5 m-85 -84.85 -178.92 6.97 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.8 0.333 . . . . 63.140000000000001 110.985 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t -111.74 147.07 36.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 112.153 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 95.93 0.15 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.021 -0.536 . . . . 75.099999999999994 111.917 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.21 -22.74 0.87 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.955 -0.566 . . . . 52.149999999999999 112.679 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -80.31 146.89 31.37 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 111.713 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.438 ' O ' HG23 ' A' ' 61' ' ' VAL . 36.6 m -57.87 -38.52 75.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.56 0.695 . . . . 64.340000000000003 110.448 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.9 p -62.7 -24.33 67.6 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.487 -0.779 . . . . 72.409999999999997 112.274 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -62.59 -65.28 0.71 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.334 0.494 . . . . 65.140000000000001 112.334 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -66.97 -29.08 68.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.537 0.569 . . . . 73.230000000000004 112.537 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 57' ' ' CYS . 61.1 t -61.37 -37.63 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 111.426 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -57.97 -47.82 81.82 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.978 0.418 . . . . 75.319999999999993 110.845 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.14 -38.69 72.25 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 111.944 0.35 . . . . 62.32 111.944 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -56.07 -38.39 70.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.998 0.428 . . . . 72.319999999999993 111.855 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' ILE . 8.8 p -88.39 9.37 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-O 121.388 0.613 . . . . 51.329999999999998 111.456 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.68 -2.87 77.3 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.336 -0.393 . . . . 33.439999999999998 113.703 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.31 14.56 66.06 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.998 -0.62 . . . . 63.229999999999997 113.143 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.82 10.38 6.4 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.199 0.444 . . . . 73.129999999999995 112.199 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 pt -110.5 174.1 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.799 0.333 . . . . 53.409999999999997 111.118 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.6 124.31 6.76 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.93 -0.652 . . . . 54.329999999999998 114.013 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.3 p -65.5 -19.39 65.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.026 0.441 . . . . 75.400000000000006 111.13 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 t -78.58 -6.94 56.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.809 0.67 . . . . 64.140000000000001 112.809 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -61.33 -43.51 98.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.153 -0.342 . . . . 74.519999999999996 111.684 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 71.89 -116.29 5.92 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 114.246 0.458 . . . . 71.540000000000006 114.246 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -57.66 132.47 53.35 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.197 0.444 . . . . 72.0 112.197 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.96 -40.55 80.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.178 0.513 . . . . 41.399999999999999 111.885 -176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -66.91 -19.3 65.7 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.394 0.616 . . . . 72.530000000000001 110.767 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -92.9 -17.51 23.92 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.055 -0.521 . . . . 74.109999999999999 112.387 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.401 ' CZ3' HG21 ' A' ' 99' ' ' ILE . 10.7 m0 -47.56 -47.07 28.4 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.345 0.868 . . . . 73.530000000000001 113.345 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.415 ' H ' ' NE2' ' A' ' 101' ' ' GLN . . . -59.22 -46.48 88.35 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.83 0.348 . . . . 50.509999999999998 111.701 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.6 t -59.43 -38.91 81.9 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.004 0.43 . . . . 41.310000000000002 111.439 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.45 -59.51 2.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 111.277 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -50.47 -52.65 36.26 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.685 0.624 . . . . 73.150000000000006 112.685 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 p -55.64 -53.52 55.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 111.998 0.37 . . . . 71.030000000000001 111.998 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -72.14 -22.1 61.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.233 0.457 . . . . 74.310000000000002 112.233 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.64 -17.55 50.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.197 0.443 . . . . 63.509999999999998 112.197 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.69 25.39 5.46 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.003 -0.617 . . . . 73.540000000000006 113.803 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.412 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 65.6 m-85 -100.72 -176.38 3.17 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.446 -0.444 . . . . 70.310000000000002 110.732 176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 63.8 m -109.19 93.0 4.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.741 0.305 . . . . 73.040000000000006 111.772 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 152' ' ' ILE . 46.8 t -97.02 91.11 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.22 0.533 . . . . 73.219999999999999 111.018 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -122.58 163.94 19.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.004 -0.544 . . . . 62.340000000000003 110.531 179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.87 -7.47 57.95 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.11 -0.369 . . . . 74.549999999999997 111.166 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -51.45 106.05 0.6 Allowed Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 116.382 -0.372 . . . . 64.209999999999994 110.86 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -84.25 13.24 2.78 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.832 2.355 . . . . 63.520000000000003 114.796 -168.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.24 151.46 36.21 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.929 0.714 . . . . 74.010000000000005 112.929 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.58 160.3 11.59 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.44 -0.8 . . . . 73.019999999999996 112.892 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.85 32.4 32.97 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.192 -0.528 . . . . 63.25 112.273 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.4 m -145.55 164.91 30.2 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.822 0.344 . . . . 53.409999999999997 110.715 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -100.86 117.42 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.059 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD13 HG11 ' A' ' 124' ' ' VAL . 0.1 OUTLIER -79.35 136.87 37.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.675 -0.693 . . . . 72.5 110.601 174.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' NE2' ' H ' ' A' ' 80' ' ' ALA . 31.0 tt0 -120.06 104.54 10.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.835 0.35 . . . . 74.400000000000006 111.335 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 50.8 m -84.51 85.03 7.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.939 0.399 . . . . 74.340000000000003 110.811 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.4 p -65.97 -40.09 90.96 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.219 0.533 . . . . 75.439999999999998 110.853 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.17 102.42 4.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.874 -0.603 . . . . 74.109999999999999 111.362 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 157.61 -143.6 9.67 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.874 -0.679 . . . . 74.319999999999993 113.105 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.66 71.93 1.56 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.558 -0.354 . . . . 65.150000000000006 113.711 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 62.86 8.92 3.35 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.564 0.95 . . . . 73.329999999999998 113.564 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.31 129.44 3.57 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.99 -0.624 . . . . 72.25 113.929 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 46.7 t60 -138.42 149.73 45.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.819 0.447 . . . . 75.010000000000005 110.747 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.504 HG13 ' HB1' ' A' ' 76' ' ' ALA . 14.0 m -141.17 143.95 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.439 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.67 23.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.144 0.497 . . . . 73.040000000000006 111.681 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -80.64 133.68 35.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 122.246 -0.284 . . . . 75.430000000000007 110.989 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.46 114.34 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.025 0.441 . . . . 53.340000000000003 111.91 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -79.28 -41.49 27.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.912 -0.586 . . . . 75.319999999999993 111.686 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -167.85 151.95 6.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.909 0.385 . . . . 72.109999999999999 111.809 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.25 122.21 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.638 0.256 . . . . 71.239999999999995 110.685 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -83.05 160.97 21.84 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.15 0.426 . . . . 73.310000000000002 112.15 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -56.07 -22.5 28.05 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.029 0.443 . . . . 75.319999999999993 111.545 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.76 -9.11 17.9 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.135 -0.484 . . . . 71.25 112.0 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.54 89.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.338 -0.458 . . . . 74.340000000000003 112.272 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 m -88.45 131.48 34.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.147 0.498 . . . . 75.239999999999995 111.663 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.07 119.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 CA-C-N 115.647 -0.706 . . . . 73.349999999999994 111.349 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.59 107.91 20.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.687 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 100' ' ' LEU . 34.4 m -105.2 161.87 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.551 0.574 . . . . 63.420000000000002 112.551 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.2 t -95.81 123.73 39.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.037 -0.529 . . . . 72.329999999999998 111.874 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -126.51 150.0 49.02 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.129 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.7 ttm -100.06 131.59 45.92 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.747 0.308 . . . . 72.109999999999999 110.234 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -97.45 -68.0 0.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.747 0.647 . . . . 74.439999999999998 112.747 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -83.54 125.85 32.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.179 0.437 . . . . 72.439999999999998 112.179 -170.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -56.01 -46.15 78.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.241 0.46 . . . . 71.349999999999994 112.241 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -86.62 17.99 36.67 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.092 -0.575 . . . . 63.240000000000002 113.169 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -132.58 80.87 0.32 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.55 -0.357 . . . . 64.019999999999996 112.654 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.52 -2.15 6.88 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 122.726 2.284 . . . . 75.209999999999994 113.055 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -112.63 3.32 16.58 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.997 0.427 . . . . 73.430000000000007 111.186 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -87.98 86.79 7.18 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.28 0.562 . . . . 61.210000000000001 110.977 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 75.7 t -109.18 148.72 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.139 -0.482 . . . . 62.43 111.605 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.3 m -143.35 136.58 28.02 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.044 0.449 . . . . 74.150000000000006 111.253 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -83.65 120.11 25.59 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.116 0.484 . . . . 72.150000000000006 111.715 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.43 118.57 31.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.306 -0.407 . . . . 75.549999999999997 110.841 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.4 m -90.69 105.27 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.134 0.493 . . . . 75.019999999999996 111.866 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.3 mt -99.51 133.54 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.073 0.549 . . . . 72.349999999999994 111.102 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -72.85 157.95 36.47 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.157 0.428 . . . . 75.099999999999994 112.157 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.42 -49.46 72.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.688 0.625 . . . . 53.109999999999999 112.688 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.06 -45.88 86.2 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.305 -0.474 . . . . 60.039999999999999 112.997 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.61 -40.56 95.72 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.416 0.627 . . . . 71.430000000000007 110.878 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.93 -21.11 64.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.641 -0.708 . . . . 71.540000000000006 112.689 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.4 p -65.73 -13.16 58.79 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.317 0.488 . . . . 61.439999999999998 112.317 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 39.0 t -102.49 2.21 36.11 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 111.865 0.32 . . . . 70.450000000000003 111.865 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -103.68 146.09 29.1 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.21 -0.306 . . . . 70.329999999999998 110.94 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -94.23 139.59 30.85 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.539 0.209 . . . . 51.210000000000001 110.943 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 100' ' ' LEU . 91.3 m-85 -117.22 116.98 28.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 73.450000000000003 111.797 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.3 mp -89.05 113.44 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.358 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 13.4 m-70 -99.97 136.06 40.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.082 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.12 -29.82 13.87 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.481 0.549 . . . . 72.140000000000001 112.481 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 121.079 0.466 . . . . 71.439999999999998 112.129 177.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 2' ' ' LYS . 24.7 ptm . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.955 0.354 . . . . 75.030000000000001 111.955 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 98.0 mttt -139.01 -156.76 0.71 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.408 0.283 . . . . 60.310000000000002 110.848 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 71.39 23.12 4.02 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.034 0.753 . . . . 63.350000000000001 113.034 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.34 157.51 33.85 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.153 0.502 . . . . 63.140000000000001 111.813 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.78 122.2 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 121.175 0.512 . . . . 50.539999999999999 111.978 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.9 p -85.76 150.58 24.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.942 0.401 . . . . 55.240000000000002 111.44 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.71 152.67 28.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.963 0.411 . . . . 64.329999999999998 111.733 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -145.42 159.81 42.51 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.953 0.406 . . . . 74.510000000000005 111.594 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.6 m -151.31 124.69 8.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.203 -0.453 . . . . 52.140000000000001 111.415 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.2 mt -120.76 121.72 38.82 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.848 0.356 . . . . 74.209999999999994 111.304 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -77.77 122.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.44 -0.345 . . . . 70.439999999999998 111.36 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.89 0.376 . . . . 73.109999999999999 111.975 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.27 84.14 1.59 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.306 -0.473 . . . . 62.43 112.934 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.6 pt -85.47 178.35 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.2 0.524 . . . . 62.140000000000001 112.038 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.42 161.23 10.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.366 -0.445 . . . . 51.439999999999998 112.779 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.33 153.23 31.3 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 122.508 -0.407 . . . . 73.230000000000004 111.822 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.91 104.51 4.0 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.141 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.93 129.01 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.203 0.525 . . . . 74.319999999999993 111.974 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.18 143.8 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.885 -0.598 . . . . 62.350000000000001 111.08 177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.12 127.41 1.86 Allowed Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.246 -0.502 . . . . 12.41 113.0 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 97.4 mt -133.83 157.73 45.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.498 -0.413 . . . . 73.209999999999994 111.356 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -90.43 136.76 32.86 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.307 0.575 . . . . 74.329999999999998 111.592 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -93.99 -25.44 17.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.862 -0.608 . . . . 74.409999999999997 111.526 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.16 73.41 0.56 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.918 -0.658 . . . . 50.539999999999999 112.722 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.84 129.63 34.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.885 0.374 . . . . 72.140000000000001 111.179 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -105.4 -175.79 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.915 0.709 . . . . 62.130000000000003 112.915 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 49' ' ' ALA . . . 179.31 120.61 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.804 -1.089 . . . . 42.340000000000003 109.872 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.4 t70 -71.99 159.85 33.51 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.638 0.256 . . . . 43.020000000000003 110.829 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.27 32.44 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.79 0.293 . . . . 74.099999999999994 111.79 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.06 93.89 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.031 0.752 . . . . 71.150000000000006 113.031 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -81.55 105.53 12.78 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.345 0.593 . . . . 74.420000000000002 111.144 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.24 -73.73 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.165 -0.471 . . . . 72.340000000000003 112.213 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -160.72 172.4 17.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.678 0.275 . . . . 71.5 111.334 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 56.2 tt0 -120.0 109.77 37.13 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.593 -0.276 . . . . 74.439999999999998 111.516 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 34' ' ' GLN . 36.7 Cg_endo -65.92 99.54 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.432 2.088 . . . . 41.229999999999997 111.54 173.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.9 p -70.96 109.4 5.06 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.366 0.876 . . . . 75.040000000000006 113.366 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.469 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -127.78 171.96 11.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.603 -0.726 . . . . 74.340000000000003 110.674 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -75.47 90.2 2.71 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.391 0.615 . . . . 74.099999999999994 111.393 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -97.05 158.2 15.55 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.844 -0.616 . . . . 75.019999999999996 111.758 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -78.64 154.55 30.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.365 -0.38 . . . . 70.299999999999997 111.28 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.25 66.77 4.79 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.699 0.629 . . . . 71.530000000000001 112.699 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.67 99.62 3.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.882 0.372 . . . . 74.209999999999994 110.814 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.9 m -79.77 146.72 32.17 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.21 0.528 . . . . 70.340000000000003 112.34 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 t -107.92 168.77 9.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.951 -0.568 . . . . 73.430000000000007 111.008 175.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -106.83 -30.68 8.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.863 0.363 . . . . 55.340000000000003 111.278 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 -150.94 42.22 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.058 -0.591 . . . . 55.32 112.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 t -174.86 116.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.575 0.35 . . . . 74.420000000000002 110.576 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.8 m -70.41 155.76 40.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.197 -0.314 . . . . 71.530000000000001 110.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 70.13 113.19 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 111.807 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.84 131.39 50.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.345 0.498 . . . . 64.299999999999997 112.345 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 71' ' ' SER . 84.2 mt -103.98 35.96 2.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.343 -0.389 . . . . 63.409999999999997 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -123.69 -86.54 0.64 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 111.627 0.232 . . . . 60.520000000000003 111.627 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -178.48 149.83 0.52 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 111.998 0.37 . . . . 51.140000000000001 111.998 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.72 124.3 28.92 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.852 0.358 . . . . 74.349999999999994 111.871 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.54 21.39 5.12 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.43 -0.414 . . . . 70.109999999999999 113.1 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -129.72 152.38 49.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.568 -0.372 . . . . 70.099999999999994 111.215 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.4 p -63.1 -35.76 81.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.945 0.403 . . . . 70.030000000000001 110.615 175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -61.5 -26.59 68.01 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.059 0.456 . . . . 70.209999999999994 111.397 174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 86.8 t90 -78.91 -55.69 4.96 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.049 -0.523 . . . . 65.430000000000007 110.869 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.05 -52.77 63.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.883 -0.599 . . . . 73.540000000000006 112.499 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.4 t -58.99 -31.99 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.301 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -63.41 -35.95 82.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.151 0.501 . . . . 65.329999999999998 110.667 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.96 -44.18 73.48 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.797 -0.638 . . . . 75.019999999999996 111.142 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.282 0.475 . . . . 74.209999999999994 112.282 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG11 HG12 ' A' ' 69' ' ' ILE . 9.4 p -88.42 8.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-O 121.083 0.468 . . . . 71.030000000000001 111.563 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 28' ' ' ASP . . . 67.16 17.05 67.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.403 -0.427 . . . . 72.400000000000006 113.814 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.15 15.15 64.92 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.18 -0.533 . . . . 32.210000000000001 113.477 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.38 -5.88 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.218 0.451 . . . . 73.109999999999999 112.218 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.405 HG12 HG11 ' A' ' 65' ' ' VAL . 35.5 pt -98.79 140.93 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.559 -0.291 . . . . 72.049999999999997 110.495 173.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.16 125.14 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.9 -0.667 . . . . 71.239999999999995 113.586 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.525 ' HB2' HD12 ' A' ' 51' ' ' LEU . 57.7 m -66.36 78.31 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.182 0.515 . . . . 63.030000000000001 111.355 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -151.96 13.36 0.6 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.385 0.612 . . . . 74.200000000000003 110.905 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.66 -34.32 12.63 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.911 -0.586 . . . . 55.340000000000003 111.446 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.36 -130.92 10.02 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.184 -0.531 . . . . 53.140000000000001 113.344 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -67.11 151.25 47.93 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.3 0.572 . . . . 63.030000000000001 111.757 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -57.01 -33.92 67.65 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.863 1.06 . . . . 64.519999999999996 113.863 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -65.09 -28.08 69.2 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.848 -0.532 . . . . 72.040000000000006 112.032 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -84.63 -14.56 48.3 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.685 0.279 . . . . 62.210000000000001 111.604 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.409 ' CD1' ' HA ' ' A' ' 76' ' ' ALA . 8.2 m0 -51.02 -62.54 1.55 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.114 0.783 . . . . 72.430000000000007 113.114 -177.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.57 -43.55 72.16 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.271 0.471 . . . . 73.409999999999997 112.271 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.9 m -60.91 -48.47 81.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.14 0.495 . . . . 73.439999999999998 111.508 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.04 -30.12 60.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.148 -0.478 . . . . 71.200000000000003 111.455 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.65 7.38 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.355 -0.384 . . . . 74.530000000000001 111.025 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 p -62.14 -37.32 84.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.132 0.492 . . . . 55.240000000000002 110.941 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 t -64.25 -38.33 90.66 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.004 -0.543 . . . . 61.240000000000002 111.951 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.42 -6.01 58.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.676 0.621 . . . . 71.349999999999994 112.676 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.83 -2.3 25.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.938 -0.649 . . . . 74.319999999999993 113.574 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -76.36 170.32 16.58 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.305 0.574 . . . . 71.540000000000006 111.087 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.9 m -115.43 103.57 10.9 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.216 0.451 . . . . 73.340000000000003 112.216 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 152' ' ' ILE . 46.6 t -102.16 119.41 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.084 0.469 . . . . 70.209999999999994 111.84 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -143.62 168.57 19.57 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.135 -0.484 . . . . 72.310000000000002 110.329 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -86.48 12.59 9.99 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.825 0.345 . . . . 70.420000000000002 111.53 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -65.73 108.99 2.54 Favored Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 110.624 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.68 14.0 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.042 2.495 . . . . 72.329999999999998 114.419 -171.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -61.69 149.56 39.22 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.179 0.514 . . . . 74.329999999999998 111.985 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 113' ' ' VAL . . . -60.51 152.47 25.8 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.953 0.723 . . . . 51.340000000000003 112.953 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.58 23.79 38.33 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.164 -0.471 . . . . 62.240000000000002 113.192 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.3 p -131.25 159.28 38.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 111.112 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.3 mp -103.42 119.69 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.327 -0.397 . . . . 63.25 110.521 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -96.07 130.22 43.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 111.325 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 150' ' ' ASN . 30.1 tt0 -95.56 124.29 39.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.056 -0.52 . . . . 71.219999999999999 112.159 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -103.55 107.71 18.67 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.877 -0.601 . . . . 72.109999999999999 110.734 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.1 p -79.76 2.55 22.49 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.014 0.376 . . . . 74.25 112.014 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.81 -20.59 59.71 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.788 0.662 . . . . 63.32 112.788 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.24 159.69 19.96 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.95 -0.643 . . . . 55.43 113.65 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.71 129.02 38.69 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.271 -0.49 . . . . 63.329999999999998 112.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 70.6 5.16 5.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.962 0.505 . . . . 74.409999999999997 111.117 -173.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.37 172.77 35.23 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 116.256 -0.429 . . . . 63.100000000000001 113.141 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -147.84 149.18 31.81 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.374 -0.486 . . . . 72.310000000000002 111.032 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.541 HG13 ' HB1' ' A' ' 76' ' ' ALA . 13.5 m -141.57 151.88 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.083 0.468 . . . . 73.519999999999996 111.779 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -149.26 167.79 25.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.992 -0.549 . . . . 71.109999999999999 110.996 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -102.94 129.76 49.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.825 0.345 . . . . 71.439999999999998 111.25 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 96' ' ' ALA . 70.8 t -80.81 110.93 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 63.340000000000003 111.494 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -83.82 -45.58 13.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.08 0.4 . . . . 74.430000000000007 112.08 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -158.89 148.47 19.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.498 0.555 . . . . 73.25 112.498 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.4 t -109.71 134.7 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 63.310000000000002 110.638 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.402 HD21 ' HG3' ' A' ' 123' ' ' GLU . 39.7 m-80 -94.96 160.87 14.38 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.297 0.48 . . . . 73.329999999999998 112.297 -176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -61.6 -22.4 65.19 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.103 -0.499 . . . . 62.439999999999998 111.413 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -67.64 -15.47 63.67 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.984 -0.553 . . . . 70.140000000000001 111.425 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.61 67.17 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 112.035 -0.426 . . . . 71.099999999999994 112.035 -172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 141.75 49.26 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.215 0.531 . . . . 74.430000000000007 111.894 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.32 128.32 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.857 -0.611 . . . . 72.129999999999995 111.981 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' HG3' HD21 ' A' ' 117' ' ' ASN . 45.3 mt-10 -93.28 117.27 29.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.941 0.4 . . . . 73.109999999999999 111.272 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.95 147.51 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 111.717 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.523 ' HB2' HG11 ' A' ' 136' ' ' VAL . 91.9 p -101.07 125.06 47.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.156 -0.475 . . . . 72.209999999999994 110.407 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 -179.68 5.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.384 0.611 . . . . 73.219999999999999 112.456 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.426 ' HB2' ' HE3' ' A' ' 127' ' ' MET . 47.3 ttm -137.59 118.41 14.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.896 -0.593 . . . . 74.409999999999997 110.822 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -123.98 -64.37 1.14 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.97 0.359 . . . . 60.399999999999999 111.97 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -156.76 -55.02 0.08 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.786 0.327 . . . . 73.450000000000003 111.223 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -52.16 117.18 2.61 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.246 -0.434 . . . . 75.140000000000001 111.499 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.72 -80.25 0.36 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.147 -0.549 . . . . 50.329999999999998 113.22 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.96 -163.56 31.88 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.984 -0.626 . . . . 41.100000000000001 113.666 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.14 -32.46 87.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.376 2.717 . . . . 52.219999999999999 114.2 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -134.09 22.05 3.8 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.592 0.59 . . . . 73.349999999999994 112.592 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -96.48 158.49 15.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.887 0.375 . . . . 73.209999999999994 110.957 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 125' ' ' SER . 25.0 t -120.78 158.36 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 113.206 0.817 . . . . 74.319999999999993 113.206 -169.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 136' ' ' VAL . 33.1 t -138.88 131.87 29.53 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.885 -0.598 . . . . 71.329999999999998 109.975 169.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -93.59 155.68 17.16 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 112.029 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.46 135.86 25.52 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.979 0.419 . . . . 73.439999999999998 111.526 175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.3 m -95.05 99.76 11.71 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.075 0.464 . . . . 71.219999999999999 111.097 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.31 134.27 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.316 -0.402 . . . . 62.399999999999999 111.292 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 62.0 m -66.86 149.35 50.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.767 0.318 . . . . 61.219999999999999 111.562 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.99 -43.85 66.77 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.582 0.586 . . . . 61.310000000000002 112.582 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.32 -38.47 86.77 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.408 -0.425 . . . . 54.240000000000002 113.564 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -83.09 -39.22 21.42 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.455 -0.438 . . . . 73.209999999999994 111.073 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -70.19 -42.51 72.29 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.802 0.667 . . . . 63.409999999999997 112.802 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.8 m -66.42 -14.41 62.13 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.918 0.389 . . . . 73.030000000000001 111.978 -171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -85.28 -10.84 55.98 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.428 -0.351 . . . . 61.130000000000003 111.551 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.428 ' CD2' HD12 ' A' ' 100' ' ' LEU . 25.4 m-85 -83.78 151.73 25.03 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.91 0.386 . . . . 72.140000000000001 111.175 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 101' ' ' GLN . 81.5 m-20 -89.09 112.91 23.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.544 -0.298 . . . . 55.439999999999998 111.337 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.13 117.44 29.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.899 0.381 . . . . 60.140000000000001 111.646 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.7 mp -84.79 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.963 0.411 . . . . 63.32 111.022 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -119.71 147.53 44.47 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.751 0.42 . . . . 73.409999999999997 110.667 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.5 mt -101.52 135.39 43.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.709 0.633 . . . . 44.219999999999999 112.709 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.547 -0.538 . . . . 73.010000000000005 109.547 167.013 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 pmm? . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.31 0.1 . . . . 72.319999999999993 111.041 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 24.9 pttm -60.52 91.11 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.447 0.642 . . . . 44.340000000000003 111.798 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -74.24 -54.16 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.178 -0.465 . . . . 60.420000000000002 111.483 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.74 100.39 10.74 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.952 0.405 . . . . 60.340000000000003 110.922 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.31 99.8 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.119 0.485 . . . . 74.349999999999994 111.121 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.2 t -105.26 169.15 8.61 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.109 -0.496 . . . . 64.319999999999993 111.371 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.41 162.37 16.97 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.926 0.393 . . . . 43.32 111.662 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.3 t -102.29 21.05 15.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.372 0.606 . . . . 75.310000000000002 110.935 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.521 HG22 ' HG ' ' A' ' 10' ' ' LEU . 43.9 m -113.19 120.86 42.68 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.128 -0.487 . . . . 74.040000000000006 111.784 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.521 ' HG ' HG22 ' A' ' 9' ' ' THR . 88.6 mt 63.3 21.73 12.96 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.762 0.653 . . . . 72.510000000000005 112.762 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -104.03 160.56 14.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 111.778 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.86 8.71 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 112.379 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.45 -47.14 3.25 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.295 -0.479 . . . . 51.119999999999997 113.559 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 14' ' ' ILE . 14.0 tt -98.18 22.54 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.684 0.754 . . . . 72.099999999999994 111.442 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.83 75.05 1.3 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.98 -0.628 . . . . 73.430000000000007 113.317 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.65 113.04 25.2 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.566 -0.373 . . . . 45.420000000000002 111.7 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.72 154.4 20.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.855 0.359 . . . . 71.409999999999997 111.91 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.008 0.432 . . . . 62.219999999999999 111.578 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -106.49 126.16 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.475 -0.33 . . . . 74.140000000000001 111.081 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.81 112.47 0.69 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.087 -0.577 . . . . 64.230000000000004 112.661 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.1 mp -73.72 159.57 32.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.004 0.43 . . . . 74.010000000000005 111.498 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.67 167.65 11.33 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 111.752 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.09 105.8 11.77 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.069 0.461 . . . . 75.099999999999994 110.663 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.13 117.06 10.32 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.34 -0.457 . . . . 75.409999999999997 113.979 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -92.6 128.58 38.5 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.453 -0.439 . . . . 75.140000000000001 111.016 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -99.48 117.83 34.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.851 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.17 156.5 45.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.279 -0.419 . . . . 72.519999999999996 110.914 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -122.06 177.88 5.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.101 0.477 . . . . 74.430000000000007 111.668 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.65 132.3 52.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.094 0.474 . . . . 65.340000000000003 111.839 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -100.53 179.32 4.47 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 111.279 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.29 156.49 43.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.206 0.527 . . . . 73.109999999999999 111.654 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -132.92 -174.07 3.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.577 -0.738 . . . . 72.409999999999997 110.211 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.7 t -69.27 173.97 5.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.42 . . . . 73.120000000000005 111.027 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.9 102.45 35.51 Favored Pre-proline 0 CA--C 1.54 0.589 0 O-C-N 122.137 -0.352 . . . . 71.140000000000001 110.968 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.05 89.28 0.78 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.424 2.082 . . . . 74.329999999999998 112.917 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -78.8 70.8 5.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.584 . . . . 75.430000000000007 111.681 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -80.19 95.45 6.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.119 0.485 . . . . 62.350000000000001 110.446 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.96 -4.36 43.57 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.8 0.667 . . . . 60.520000000000003 112.8 -175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.7 p -83.78 97.9 9.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.349 0.595 . . . . 72.420000000000002 111.515 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.8 m -88.55 80.39 7.36 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.153 0.501 . . . . 75.010000000000005 110.811 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.8 p -89.93 140.36 29.69 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.338 -0.392 . . . . 71.349999999999994 111.144 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -91.3 22.66 3.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.554 0.692 . . . . 61.32 110.551 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.8 p -73.85 92.92 2.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.992 -0.549 . . . . 72.409999999999997 111.722 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -93.24 161.51 14.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.307 -0.406 . . . . 74.109999999999999 111.658 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -78.72 131.88 36.76 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.722 0.296 . . . . 70.109999999999999 111.092 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.66 9.49 76.87 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.953 -0.642 . . . . 73.219999999999999 113.432 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.7 t -154.56 106.64 2.74 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.198 0.499 . . . . 74.129999999999995 111.513 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -97.39 1.0 48.8 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.159 0.504 . . . . 72.519999999999996 111.381 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.55 167.36 18.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.256 -0.429 . . . . 44.32 110.95 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -100.8 134.9 43.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.764 0.316 . . . . 71.25 110.786 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.8 mt -100.25 -11.59 20.24 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.072 0.768 . . . . 72.219999999999999 113.072 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -107.25 164.25 12.34 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.809 0.67 . . . . 75.219999999999999 112.809 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -80.69 165.22 22.18 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.547 -0.751 . . . . 71.120000000000005 112.995 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.73 37.72 0.24 Allowed 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.607 0.595 . . . . 75.129999999999995 112.607 -178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.24 16.9 1.9 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.615 -0.326 . . . . 64.040000000000006 112.845 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -124.26 137.36 54.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.391 0.276 . . . . 74.030000000000001 110.682 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 m -60.97 -17.82 53.83 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.235 0.54 . . . . 53.509999999999998 111.688 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.5 p -78.53 -26.94 45.9 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.253 0.549 . . . . 73.140000000000001 111.734 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 33.7 t90 -56.87 -67.17 0.34 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.077 0.769 . . . . 74.420000000000002 113.077 -174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 41.1 p90 -62.83 -28.19 69.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.092 0.405 . . . . 62.020000000000003 112.092 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -71.56 -36.18 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.875 0.369 . . . . 64.5 111.604 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.73 -35.47 63.73 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.115 -0.493 . . . . 73.5 111.747 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.64 -43.34 38.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.81 0.338 . . . . 75.219999999999999 111.263 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -62.01 -29.97 70.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.095 0.406 . . . . 60.310000000000002 112.095 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -87.61 2.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.289 0.566 . . . . 74.420000000000002 111.491 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.08 22.78 77.36 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 116.35 -0.387 . . . . 73.140000000000001 113.686 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.43 21.9 55.14 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.769 0.667 . . . . 32.549999999999997 114.769 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -82.23 3.9 25.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.571 0.685 . . . . 63.119999999999997 112.222 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -111.98 144.83 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.756 0.312 . . . . 60.100000000000001 111.601 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.55 112.07 4.1 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.272 -0.49 . . . . 74.030000000000001 112.797 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.2 p -68.46 -7.55 32.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.506 0.558 . . . . 72.040000000000006 112.506 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 t -65.12 -2.86 3.13 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.947 0.721 . . . . 64.010000000000005 112.947 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -64.83 -27.25 68.75 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.912 0.387 . . . . 73.109999999999999 111.838 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.3 -130.85 10.5 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.205 -0.522 . . . . 75.409999999999997 112.896 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 15.8 m120 -82.31 168.28 17.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.316 0.579 . . . . 64.450000000000003 111.717 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -73.28 16.55 0.17 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.861 1.06 . . . . 72.200000000000003 113.861 -170.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.45 -28.08 12.77 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.969 0.414 . . . . 63.219999999999999 111.632 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.503 ' ND2' ' HB2' ' A' ' 82' ' ' ALA . 11.3 t30 -95.82 -3.0 46.4 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.33 0.492 . . . . 71.140000000000001 112.33 -173.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.408 ' HZ3' HD13 ' A' ' 99' ' ' ILE . 10.2 m0 -55.8 -56.48 20.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.842 0.682 . . . . 75.439999999999998 112.842 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.0 69.06 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.987 0.422 . . . . 75.319999999999993 112.016 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.1 t -66.86 -54.92 17.49 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.114 -0.494 . . . . 53.200000000000003 111.581 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.503 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . . . -62.91 -49.92 72.88 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 111.92 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -49.11 -57.22 7.0 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.609 0.364 . . . . 71.510000000000005 111.525 177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.6 p -62.18 -39.67 93.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.973 0.416 . . . . 72.200000000000003 111.135 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -70.64 -25.39 63.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.305 -0.407 . . . . 75.310000000000002 111.696 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.73 15.4 25.42 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.164 0.431 . . . . 61.219999999999999 112.164 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.55 -21.22 47.28 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.997 -0.621 . . . . 62.049999999999997 113.993 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.433 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.7 m-85 -63.6 154.98 31.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.476 0.638 . . . . 72.540000000000006 111.171 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 27.6 m -99.41 95.87 7.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.403 0.52 . . . . 72.430000000000007 112.403 -170.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.463 HG22 HG13 ' A' ' 152' ' ' ILE . 60.7 t -94.81 111.46 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.732 0.301 . . . . 72.049999999999997 111.383 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -133.29 174.77 10.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.603 -0.271 . . . . 72.019999999999996 111.161 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.64 0.52 52.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.968 0.413 . . . . 62.530000000000001 110.706 172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.3 t -68.36 115.55 30.71 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.687 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 93' ' ' SER . 5.1 Cg_exo -80.77 7.21 5.0 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.79 2.327 . . . . 73.310000000000002 113.276 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 137.74 5.41 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.171 0.434 . . . . 74.439999999999998 112.171 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.64 156.81 3.29 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.195 0.813 . . . . 42.520000000000003 113.195 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.6 26.01 57.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.93 -0.577 . . . . 71.420000000000002 113.016 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.8 p -129.38 175.99 8.32 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.272 0.558 . . . . 71.409999999999997 111.766 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 55.0 mt -129.92 128.13 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.933 -0.576 . . . . 62.409999999999997 110.57 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -101.63 138.47 38.58 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.906 -0.496 . . . . 71.200000000000003 111.523 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.457 HE21 HG22 ' A' ' 103' ' ' THR . 52.8 tt0 -103.41 110.83 22.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 111.193 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.59 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 56.1 m -84.13 -29.83 26.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.95 0.722 . . . . 63.109999999999999 112.95 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.457 HG22 HE21 ' A' ' 101' ' ' GLN . 19.0 p 67.12 -24.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.983 1.105 . . . . 73.319999999999993 113.983 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.09 84.89 0.24 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.521 0.934 . . . . 62.119999999999997 113.521 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.37 134.78 1.39 Allowed Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.974 0.75 . . . . 74.299999999999997 114.974 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.99 49.36 1.93 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.484 -0.389 . . . . 73.150000000000006 113.665 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.595 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 84.5 m-85 57.7 30.92 19.65 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.243 0.544 . . . . 74.439999999999998 110.67 -175.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 94.71 -165.53 25.88 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.064 -0.814 . . . . 74.430000000000007 111.064 -170.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 59.4 t60 -168.2 134.87 2.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.651 0.725 . . . . 52.100000000000001 111.473 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG13 ' HB1' ' A' ' 76' ' ' ALA . 30.1 m -141.67 143.92 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.007 -0.542 . . . . 52.020000000000003 110.927 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.77 156.51 45.0 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.734 0.302 . . . . 61.219999999999999 111.005 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -89.58 129.19 36.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.868 0.366 . . . . 63.549999999999997 111.336 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -75.32 116.83 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.03 0.443 . . . . 63.43 111.529 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -75.74 -54.95 6.15 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.164 -0.471 . . . . 71.319999999999993 110.914 177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -158.28 164.89 35.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.239 0.542 . . . . 73.340000000000003 111.778 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.45 129.88 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.06 -0.518 . . . . 64.319999999999993 110.835 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -85.24 145.62 27.47 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.295 -0.253 . . . . 74.549999999999997 110.596 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.1 m -59.71 -21.82 61.16 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.031 0.443 . . . . 70.340000000000003 111.212 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.46 -23.8 67.1 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.015 -0.539 . . . . 75.319999999999993 111.723 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.6 -20.31 29.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 112.1 -0.4 . . . . 24.52 112.1 -174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 65.0 m -68.66 135.72 51.83 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.862 0.363 . . . . 61.030000000000001 111.527 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.45 136.08 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.362 -0.381 . . . . 54.450000000000003 111.701 -176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -97.99 117.68 32.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.539 -0.3 . . . . 72.420000000000002 110.588 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.33 156.94 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.956 0.408 . . . . 73.450000000000003 111.933 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 p -110.96 123.89 51.06 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.965 0.412 . . . . 73.430000000000007 111.191 177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 38.6 mt-10 -128.86 151.65 49.38 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.244 -0.434 . . . . 71.450000000000003 111.65 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.4 tpp -74.57 109.51 8.11 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.926 0.393 . . . . 75.310000000000002 111.794 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.82 -35.41 24.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.274 -0.421 . . . . 71.530000000000001 110.65 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 63.9 t80 71.7 -18.37 0.3 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.889 0.7 . . . . 73.099999999999994 112.889 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -78.21 129.79 35.52 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.89 -0.506 . . . . 71.299999999999997 111.055 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.7 -106.44 3.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.124 -0.56 . . . . 64.120000000000005 112.548 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.73 164.7 53.31 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.379 -0.438 . . . . 75.340000000000003 113.504 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.81 -53.56 3.13 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.624 2.216 . . . . 72.019999999999996 112.857 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -98.43 45.28 1.01 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.235 0.54 . . . . 73.319999999999993 110.709 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.2 t -68.25 84.72 0.25 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.227 0.537 . . . . 70.030000000000001 111.663 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.74 117.14 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.247 -0.433 . . . . 74.150000000000006 110.923 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.3 m -104.4 174.07 6.03 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.934 0.397 . . . . 71.049999999999997 111.652 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -107.46 156.03 19.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.241 0.543 . . . . 75.040000000000006 112.077 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -149.9 128.05 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.975 -0.557 . . . . 74.209999999999994 110.59 171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.1 m -99.87 113.37 25.86 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.434 -0.348 . . . . 71.030000000000001 110.707 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.8 mt -103.85 134.24 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.708 0.289 . . . . 75.430000000000007 111.243 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -63.13 151.73 39.29 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.068 0.396 . . . . 73.400000000000006 112.068 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.79 -40.82 61.04 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.718 0.636 . . . . 43.310000000000002 112.718 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.47 -37.91 56.82 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.506 -0.378 . . . . 62.25 113.808 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -94.96 -51.32 4.72 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.526 -0.397 . . . . 61.229999999999997 111.106 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.29 -51.23 67.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.778 0.658 . . . . 63.32 112.778 -176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.6 t -64.19 -14.33 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.591 0.589 . . . . 62.340000000000003 112.591 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.2 t -71.35 -30.28 65.99 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.057 0.456 . . . . 72.420000000000002 111.015 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 23.9 m-85 -72.59 152.33 41.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.859 -0.609 . . . . 65.099999999999994 112.127 -176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -84.67 117.63 23.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.942 -0.572 . . . . 74.540000000000006 111.467 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 97.3 m-85 -96.48 113.98 25.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.954 0.407 . . . . 72.340000000000003 111.969 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.8 mp -79.29 129.54 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.448 -0.342 . . . . 71.040000000000006 110.447 174.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.559 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 50.8 m-70 -119.46 152.03 37.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 110.865 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.49 -43.88 5.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.226 -0.443 . . . . 71.200000000000003 111.809 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.152 0.501 . . . . 73.129999999999995 111.453 -174.309 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.374 0.131 . . . . 73.420000000000002 110.801 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 3.7 mppt? -76.17 103.5 6.23 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.879 0.371 . . . . 73.129999999999995 111.398 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -112.8 30.88 6.79 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.248 0.547 . . . . 73.049999999999997 111.417 178.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.26 93.54 4.01 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 70.319999999999993 111.824 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.695 HG22 ' H ' ' A' ' 7' ' ' ALA . 12.5 p -80.33 145.86 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.264 -0.425 . . . . 64.420000000000002 110.615 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.6 p -101.25 6.52 42.97 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.04 0.385 . . . . 74.439999999999998 112.04 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' H ' HG22 ' A' ' 5' ' ' VAL . . . -67.11 106.26 1.93 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.9 0.704 . . . . 74.329999999999998 112.9 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -147.87 137.75 22.65 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.012 -0.54 . . . . 75.219999999999999 110.205 171.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.2 m -84.04 133.64 34.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.914 0.709 . . . . 74.400000000000006 112.914 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 10' ' ' LEU . 2.2 pt? -152.34 151.62 31.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.426 -0.807 . . . . 62.049999999999997 110.301 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 t -163.67 179.69 7.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 122.142 -0.349 . . . . 74.150000000000006 111.873 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.43 173.91 13.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.505 0.322 . . . . 72.430000000000007 111.096 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.61 97.22 2.45 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.164 -0.541 . . . . 65.010000000000005 113.452 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.615 ' O ' HD12 ' A' ' 14' ' ' ILE . 2.0 pp -87.84 128.82 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.174 0.511 . . . . 61.509999999999998 111.85 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.27 -157.44 23.81 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.273 -0.489 . . . . 51.109999999999999 113.621 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.89 129.19 17.79 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.612 -0.346 . . . . 70.230000000000004 111.184 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.82 157.09 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.163 0.506 . . . . 63.219999999999999 112.273 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.9 tt -77.19 143.9 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 116.096 -0.502 . . . . 51.299999999999997 111.551 178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.8 p -106.45 120.96 58.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.174 0.512 . . . . 72.120000000000005 111.523 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.93 59.95 4.7 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.071 -0.585 . . . . 74.150000000000006 112.254 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -61.03 110.36 1.34 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.16 0.43 . . . . 73.209999999999994 112.16 -175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.33 155.03 24.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.315 -0.402 . . . . 73.329999999999998 111.74 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -134.17 15.52 3.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.186 0.81 . . . . 74.209999999999994 113.186 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.75 144.19 5.08 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.566 -0.826 . . . . 42.350000000000001 113.965 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 71.3 -15.45 0.42 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.014 0.746 . . . . 64.349999999999994 113.014 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -61.0 142.35 56.66 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.969 0.414 . . . . 75.219999999999999 112.04 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.97 167.59 20.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.273 0.559 . . . . 74.420000000000002 112.476 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.39 94.89 3.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.275 -0.42 . . . . 74.109999999999999 110.584 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.15 112.88 23.9 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.461 0.541 . . . . 65.219999999999999 112.461 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.71 114.63 12.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.29 -0.414 . . . . 62.020000000000003 110.777 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -14.58 54.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.298 0.481 . . . . 73.420000000000002 112.298 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.38 111.1 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.95 0.405 . . . . 51.329999999999998 111.311 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -153.27 161.19 42.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.99 0.424 . . . . 61.109999999999999 111.26 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -112.82 106.0 55.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.017 0.436 . . . . 74.299999999999997 110.173 176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.7 92.15 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.649 2.232 . . . . 62.310000000000002 114.316 -173.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 t -76.67 -28.13 55.86 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.616 0.722 . . . . 43.539999999999999 109.965 168.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB2' ' OD1' ' A' ' 155' ' ' ASN . 4.2 p-10 -89.89 150.0 22.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.398 -0.819 . . . . 73.129999999999995 110.821 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -72.43 143.86 48.34 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.01 0.433 . . . . 72.209999999999994 111.507 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.7 m -69.62 116.23 9.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.3 -0.409 . . . . 74.239999999999995 112.036 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.5 t -153.14 150.0 28.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.883 0.373 . . . . 75.219999999999999 111.563 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -139.56 137.47 35.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.288 -0.414 . . . . 72.299999999999997 110.124 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' HG3' HG23 ' A' ' 44' ' ' THR . 14.2 pt20 -160.93 -158.33 0.58 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.371 0.508 . . . . 74.430000000000007 112.371 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -80.16 31.11 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.186 0.81 . . . . 61.049999999999997 113.186 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 42' ' ' GLN . 41.4 p -69.41 99.54 1.24 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.115 -0.366 . . . . 54.109999999999999 111.557 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 m -130.23 71.14 1.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.935 0.398 . . . . 64.450000000000003 111.713 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.18 163.55 39.58 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.165 -0.54 . . . . 75.439999999999998 113.326 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.0 m -69.96 153.99 42.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.884 0.373 . . . . 51.530000000000001 111.597 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -94.54 -63.6 1.16 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.041 0.448 . . . . 52.049999999999997 111.766 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.06 172.63 12.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.107 0.78 . . . . 41.310000000000002 113.107 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -80.34 104.6 11.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.713 -0.676 . . . . 73.540000000000006 110.982 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.89 -17.41 50.73 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.085 0.402 . . . . 70.150000000000006 112.085 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -81.69 -170.29 2.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.126 0.488 . . . . 50.200000000000003 111.941 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -117.89 154.15 32.35 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.349 -0.387 . . . . 54.240000000000002 111.864 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.63 93.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.179 0.514 . . . . 63.219999999999999 112.004 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.72 -40.57 0.53 Allowed Glycine 0 CA--C 1.524 0.643 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 112.763 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.57 144.54 56.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.754 0.311 . . . . 65.010000000000005 111.447 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 29.7 p -62.12 -36.13 80.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.237 0.541 . . . . 73.450000000000003 110.974 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.8 p -66.01 -15.87 63.41 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.837 -0.619 . . . . 72.120000000000005 112.121 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -76.18 -60.83 2.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.007 0.373 . . . . 74.400000000000006 112.007 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 57' ' ' CYS . 18.4 p90 -71.88 -30.6 65.57 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.75 0.648 . . . . 71.230000000000004 112.75 -176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.97 -32.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 110.469 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -58.2 -39.77 79.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.769 -0.651 . . . . 71.430000000000007 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.74 -37.51 76.5 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.291 -0.413 . . . . 71.420000000000002 111.341 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 125' ' ' SER . 30.4 mmmt -56.17 -33.58 65.38 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.913 0.387 . . . . 72.510000000000005 111.696 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.7 p -102.34 15.37 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.602 0.715 . . . . 61.0 111.163 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.9 -1.3 17.28 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 116.25 -0.432 . . . . 72.040000000000006 113.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.03 10.8 77.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.351 -0.452 . . . . 61.25 113.361 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -79.28 38.1 0.35 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.312 0.486 . . . . 73.439999999999998 112.312 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 HD21 ' A' ' 154' ' ' LEU . 20.5 pt -134.78 -41.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.21 100.24 2.49 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.911 -0.661 . . . . 65.5 113.353 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.0 p -80.24 43.57 0.64 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.199 0.444 . . . . 63.539999999999999 112.199 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 t -126.28 18.46 7.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.957 0.408 . . . . 71.329999999999998 112.084 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -91.17 11.67 22.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.849 0.685 . . . . 63.119999999999997 112.849 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.05 -143.44 28.69 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 113.596 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -67.08 152.42 45.8 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.521 -0.4 . . . . 61.119999999999997 111.104 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.53 -38.43 59.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.514 0.561 . . . . 52.240000000000002 112.514 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -61.31 -25.97 67.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.346 0.499 . . . . 62.340000000000003 112.346 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -94.56 -5.81 45.07 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.25 -0.281 . . . . 43.25 111.508 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.8 m0 -55.16 -56.26 21.88 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.373 0.509 . . . . 75.319999999999993 112.373 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.417 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -61.78 -40.92 96.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.861 0.363 . . . . 62.340000000000003 111.846 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.2 m -65.34 -35.58 81.42 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.4 -0.363 . . . . 72.510000000000005 111.784 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.49 -45.9 24.14 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.615 0.228 . . . . 72.25 111.615 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.53 -55.42 25.65 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.936 0.398 . . . . 75.219999999999999 111.694 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 p -57.1 -49.41 75.97 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 111.283 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.7 t -65.7 -15.54 62.9 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.242 0.46 . . . . 51.409999999999997 112.242 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.84 3.47 54.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.924 0.392 . . . . 73.25 111.654 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.52 -4.44 73.03 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.3 -0.476 . . . . 75.109999999999999 113.657 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -75.15 170.4 16.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 111.565 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -99.88 97.21 8.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 112.353 -170.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.38 91.98 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.146 0.498 . . . . 64.409999999999997 110.692 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -119.77 138.42 53.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.677 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -76.71 13.33 1.03 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.48 0.918 . . . . 52.409999999999997 113.48 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -65.85 114.02 14.51 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 110.02 -0.363 . . . . 71.129999999999995 110.02 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.14 22.19 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.942 2.428 . . . . 55.25 114.543 -172.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HA ' HG21 ' A' ' 116' ' ' VAL . 44.5 mt-10 -74.44 159.81 31.8 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.529 0.681 . . . . 71.340000000000003 112.695 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.56 5.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.323 -0.853 . . . . 75.409999999999997 113.086 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.22 40.91 40.31 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.874 -0.603 . . . . 64.329999999999998 112.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.2 p -152.25 167.19 29.4 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.568 -0.372 . . . . 65.200000000000003 111.125 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.6 mp -112.78 122.95 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.602 -0.272 . . . . 72.5 110.351 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 149' ' ' TYR . 1.7 pt? -86.41 138.36 31.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.121 0.486 . . . . 64.010000000000005 110.893 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -112.37 109.4 19.01 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.355 -0.384 . . . . 63.149999999999999 110.561 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.5 t -105.81 133.22 50.9 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.313 -0.403 . . . . 74.329999999999998 111.476 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.7 p -112.78 22.45 14.48 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.755 0.312 . . . . 71.439999999999998 111.787 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.52 -53.02 48.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.195 0.443 . . . . 72.299999999999997 112.195 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.5 -178.25 29.54 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.862 -0.685 . . . . 71.200000000000003 113.675 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.72 30.48 72.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.572 -0.347 . . . . 41.119999999999997 113.825 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 57.47 27.79 14.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.222 0.534 . . . . 75.140000000000001 111.775 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.7 151.85 23.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 116.004 -0.544 . . . . 74.099999999999994 112.94 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -148.98 143.55 26.2 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.511 -0.405 . . . . 74.109999999999999 111.421 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.77 153.92 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.048 0.451 . . . . 72.120000000000005 111.615 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -155.98 159.48 39.24 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.577 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -95.4 126.18 40.52 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.001 0.429 . . . . 64.109999999999999 111.627 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.403 HG22 HG12 ' A' ' 124' ' ' VAL . 42.6 t -74.99 108.21 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.068 -0.515 . . . . 74.239999999999995 111.682 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -78.75 -48.65 14.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.066 -0.515 . . . . 74.230000000000004 111.443 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -154.4 154.7 33.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.284 -0.417 . . . . 74.120000000000005 110.913 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 95' ' ' GLU . 45.2 t -123.65 111.0 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.874 0.368 . . . . 55.049999999999997 111.094 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -64.95 131.96 48.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.483 -0.326 . . . . 70.209999999999994 111.566 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.6 p -60.78 -19.01 58.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.835 0.35 . . . . 53.119999999999997 111.596 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 -16.72 64.09 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.882 0.372 . . . . 73.219999999999999 111.788 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.37 57.51 0.59 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.303 -0.475 . . . . 43.409999999999997 113.067 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -151.64 136.29 17.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.735 0.303 . . . . 74.030000000000001 111.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.93 116.1 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 116.269 -0.423 . . . . 61.210000000000001 110.912 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -90.22 104.85 17.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.874 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 113' ' ' VAL . 33.2 m -108.51 132.84 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.154 0.502 . . . . 55.439999999999998 111.907 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.505 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 32.0 t -89.28 114.23 25.58 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.425 -0.352 . . . . 64.519999999999996 111.17 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -131.05 147.31 52.61 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.532 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.593 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . 40.8 ttm -81.02 107.73 14.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.093 0.473 . . . . 71.349999999999994 110.863 173.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -88.35 -21.41 24.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.918 -0.583 . . . . 75.439999999999998 110.983 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.564 ' HA ' ' HB3' ' A' ' 135' ' ' SER . 9.0 t80 59.5 62.68 1.7 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.782 -0.644 . . . . 71.299999999999997 110.992 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -79.36 -64.26 1.23 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.888 -0.596 . . . . 74.319999999999993 110.828 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -126.23 -53.89 0.16 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.248 -0.501 . . . . 72.540000000000006 113.348 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.61 148.39 35.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.108 -0.568 . . . . 74.120000000000005 113.38 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.49 -14.87 37.62 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.953 2.436 . . . . 72.040000000000006 113.296 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -120.81 25.98 9.37 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.258 0.551 . . . . 74.120000000000005 110.604 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.564 ' HB3' ' HA ' ' A' ' 129' ' ' TYR . 43.2 t -59.45 97.56 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.983 0.734 . . . . 52.240000000000002 112.983 -175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 63.0 t -104.19 127.34 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.962 0.41 . . . . 73.349999999999994 110.866 175.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.4 t -112.62 136.54 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.352 -0.385 . . . . 72.340000000000003 111.257 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -82.63 97.0 8.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.331 0.586 . . . . 63.109999999999999 110.025 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -83.91 107.12 16.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.905 -0.589 . . . . 64.019999999999996 112.215 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 89.1 m -86.73 112.91 22.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 111.248 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.1 mt -111.87 139.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.391 -0.368 . . . . 75.430000000000007 111.568 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.5 m -58.45 133.81 56.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.621 0.248 . . . . 74.530000000000001 111.399 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.73 -36.22 73.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.191 0.441 . . . . 52.009999999999998 112.191 -178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.82 -52.25 40.04 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.203 -0.523 . . . . 71.109999999999999 112.965 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.48 -44.72 77.87 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.163 0.506 . . . . 55.43 110.859 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.438 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -60.84 -30.69 70.25 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.196 0.813 . . . . 34.149999999999999 113.196 -176.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 43.9 t -58.49 -23.74 58.67 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.807 0.669 . . . . 63.530000000000001 112.807 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 43.5 t -76.17 -19.45 58.44 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.021 0.439 . . . . 71.25 111.79 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 146' ' ' ALA . 11.0 m-85 -83.67 147.9 27.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.934 0.397 . . . . 75.219999999999999 110.965 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.8 121.41 33.4 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.333 -0.229 . . . . 75.340000000000003 111.274 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.438 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 54.4 m-85 -98.21 121.85 40.65 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.132 0.492 . . . . 74.120000000000005 112.005 -177.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -83.68 121.74 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.354 -0.385 . . . . 65.420000000000002 110.423 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -115.38 147.35 40.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.548 0.339 . . . . 75.409999999999997 110.57 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 HG22 ' A' ' 69' ' ' ILE . 86.9 mt -110.64 116.89 32.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.321 0.489 . . . . 73.310000000000002 112.321 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 37' ' ' ASN . 36.6 m-80 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 109.895 -0.409 . . . . 71.540000000000006 109.895 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.474 0.178 . . . . 61.200000000000003 111.201 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.69 93.04 0.1 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.056 0.455 . . . . 75.340000000000003 111.39 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 9.7 mtmp? -121.15 120.67 35.93 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 111.784 -176.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.86 96.58 7.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.179 0.514 . . . . 72.209999999999994 110.566 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 m -74.05 104.65 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.54 0.686 . . . . 74.200000000000003 112.072 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.1 t -156.04 135.95 12.72 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.912 -0.585 . . . . 70.230000000000004 110.757 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.69 115.24 26.78 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.103 0.409 . . . . 55.109999999999999 112.103 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.7 m -63.01 88.17 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.352 0.596 . . . . 74.140000000000001 110.723 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 m -107.63 134.94 49.89 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.977 -0.556 . . . . 72.540000000000006 111.395 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.29 178.16 6.79 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.066 0.46 . . . . 64.319999999999993 111.724 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -158.1 150.13 21.87 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.085 -0.507 . . . . 72.310000000000002 111.064 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -107.28 179.54 4.22 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.261 0.467 . . . . 71.319999999999993 112.261 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.9 119.52 0.53 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.228 -0.51 . . . . 51.030000000000001 113.134 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 tt -166.13 -42.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.371 0.878 . . . . 71.420000000000002 113.371 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.86 166.17 13.48 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.684 -0.769 . . . . 33.310000000000002 114.632 -171.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 161.07 36.54 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.608 0.363 . . . . 40.530000000000001 111.275 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.69 162.9 13.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.83 0.678 . . . . 53.0 112.83 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 tt -83.18 156.21 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 116.026 -0.533 . . . . 61.43 111.291 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.9 t -93.52 -66.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 112.822 0.675 . . . . 53.329999999999998 112.822 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.33 77.9 0.44 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.731 -0.747 . . . . 71.310000000000002 112.614 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 22' ' ' ASP . 3.6 tt -96.82 133.56 41.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 75.230000000000004 110.851 -174.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' N ' HD23 ' A' ' 21' ' ' LEU . 7.5 m-20 -81.22 88.55 6.03 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.947 0.403 . . . . 63.43 111.173 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -153.66 128.28 9.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.702 0.287 . . . . 64.400000000000006 111.683 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.68 -83.72 0.99 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.445 -0.407 . . . . 74.219999999999999 112.914 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -143.7 -69.66 0.32 Allowed 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.445 -0.444 . . . . 62.140000000000001 111.433 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.68 160.31 34.65 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.614 0.245 . . . . 75.019999999999996 111.595 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.67 105.26 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.153 0.427 . . . . 44.109999999999999 112.153 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -163.64 144.76 9.06 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.268 -0.424 . . . . 74.450000000000003 110.777 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.545 ' H ' ' NE2' ' A' ' 32' ' ' GLN . . . -160.21 150.12 18.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.648 0.261 . . . . 71.319999999999993 111.373 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.42 -8.74 57.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.987 0.736 . . . . 43.509999999999998 112.987 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.38 -9.5 38.51 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.818 0.342 . . . . 55.43 111.865 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.545 ' NE2' ' H ' ' A' ' 29' ' ' ALA . 21.2 pt20 -85.54 176.58 8.14 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.384 0.611 . . . . 74.120000000000005 112.315 -171.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.5 p -86.24 138.09 32.13 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.807 -0.633 . . . . 43.43 111.564 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.47 82.5 3.04 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-O 120.964 0.411 . . . . 54.039999999999999 111.175 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -97.48 172.83 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.387 2.725 . . . . 70.319999999999993 113.291 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 t -72.37 -25.36 61.49 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.096 0.474 . . . . 74.219999999999999 111.159 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -70.94 109.61 5.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.085 0.469 . . . . 72.230000000000004 111.798 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -99.32 82.67 2.72 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.103 0.478 . . . . 71.129999999999995 109.721 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.3 t -113.36 -179.12 3.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.42 0.526 . . . . 51.539999999999999 112.42 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.1 p -133.48 22.72 4.01 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.274 -0.421 . . . . 74.329999999999998 112.125 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.1 p -98.18 -175.64 3.18 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.859 0.361 . . . . 64.109999999999999 111.821 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.06 149.45 50.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.955 0.724 . . . . 74.340000000000003 112.955 -178.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.3 m -133.01 149.05 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.666 -0.697 . . . . 62.140000000000001 110.337 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.0 p -122.6 167.61 13.19 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.288 0.566 . . . . 72.030000000000001 112.523 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -96.79 126.26 41.82 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.965 -0.561 . . . . 74.219999999999999 110.196 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.93 -172.76 48.53 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.934 -0.65 . . . . 73.519999999999996 114.567 -174.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -125.75 -177.93 4.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.763 0.425 . . . . 65.099999999999994 110.321 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -149.42 13.9 0.85 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.666 0.987 . . . . 73.140000000000001 113.666 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.42 117.53 23.12 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.56 0.578 . . . . 45.219999999999999 112.56 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' A' ' 63' ' ' ASP . 1.6 m-20 -76.73 86.92 3.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 72.129999999999995 110.848 176.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.85 50.32 1.97 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.016 0.436 . . . . 63.210000000000001 111.893 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.463 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 80.1 m-85 -116.25 -159.52 0.72 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.782 0.325 . . . . 72.409999999999997 111.371 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.5 t -117.25 144.49 44.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 111.199 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.28 86.5 0.41 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 112.078 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 130' ' ' ASN . . . 160.29 -29.88 0.36 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.871 -0.681 . . . . 15.43 113.7 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.49 151.1 30.98 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 111.852 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.452 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.6 m -54.67 -40.95 69.59 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.834 -0.621 . . . . 71.209999999999994 112.248 -176.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.0 p -62.82 -24.19 67.64 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.151 0.426 . . . . 74.109999999999999 112.151 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -60.99 -47.89 84.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.222 0.453 . . . . 73.400000000000006 112.222 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.51 ' CZ ' ' HA ' ' A' ' 126' ' ' GLU . 25.0 p90 -80.63 -39.69 26.98 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 122.172 -0.33 . . . . 72.230000000000004 111.624 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 57' ' ' CYS . 45.6 t -57.23 -41.89 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.879 0.371 . . . . 74.319999999999993 111.74 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.01 -38.47 70.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.061 -0.518 . . . . 74.219999999999999 111.175 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' HB2' HD21 ' A' ' 50' ' ' ASN . 31.1 t70 -78.51 -39.58 37.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 111.003 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.518 ' HE2' ' OG ' ' A' ' 125' ' ' SER . 30.2 mmmt -53.22 -44.81 68.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.928 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 p -79.95 -22.43 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 111.962 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.24 10.2 30.19 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 121.169 -0.538 . . . . 62.509999999999998 113.656 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.91 -14.89 35.09 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.321 -0.466 . . . . 75.030000000000001 114.144 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.41 68.81 4.5 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.303 -0.528 . . . . 74.310000000000002 112.118 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 70' ' ' GLY . 6.0 pt -146.96 -54.74 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.043 -0.526 . . . . 71.409999999999997 111.473 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.459 ' H ' HG13 ' A' ' 69' ' ' ILE . . . 142.28 102.27 0.44 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.722 -0.752 . . . . 73.530000000000001 113.37 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 84.4 p -55.34 -28.09 51.47 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.023 0.379 . . . . 71.450000000000003 112.023 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 t -62.96 -16.64 60.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.087 0.773 . . . . 75.340000000000003 113.087 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -61.87 -43.15 99.42 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.908 0.385 . . . . 73.349999999999994 111.294 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 66.68 -92.99 0.2 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.323 -0.465 . . . . 74.319999999999993 114.122 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.91 139.74 38.22 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.01 0.433 . . . . 72.430000000000007 111.915 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -60.44 -28.58 68.4 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.366 0.506 . . . . 73.010000000000005 112.366 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -67.51 -17.76 64.79 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.943 0.401 . . . . 72.519999999999996 111.78 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -94.4 -34.16 12.87 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.197 0.443 . . . . 73.140000000000001 112.197 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -35.58 -64.62 0.28 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.625 1.343 . . . . 75.099999999999994 114.625 -171.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.48 79.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.632 0.604 . . . . 74.219999999999999 112.632 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.8 m -68.23 -44.55 75.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.085 0.469 . . . . 75.099999999999994 111.336 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.45 83.1 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.209 -0.451 . . . . 75.120000000000005 111.046 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -59.62 5.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.038 -0.528 . . . . 63.140000000000001 111.105 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.4 p -58.25 -32.41 68.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 111.56 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -72.85 -41.95 64.23 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.229 0.455 . . . . 44.119999999999997 112.229 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.75 -8.39 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.643 0.609 . . . . 54.009999999999998 112.643 -176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.38 7.48 26.29 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.942 -0.647 . . . . 43.350000000000001 113.447 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -80.4 168.18 19.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.629 . . . . 74.430000000000007 111.744 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 m -104.86 102.24 11.79 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.813 -0.631 . . . . 52.329999999999998 111.575 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.76 111.26 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.048 0.451 . . . . 61.539999999999999 111.404 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 151' ' ' TYR . 58.6 m-80 -132.15 149.31 52.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.366 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.79 12.25 1.13 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.219 0.452 . . . . 62.310000000000002 112.219 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.5 t -73.54 116.85 55.55 Favored Pre-proline 0 C--O 1.238 0.499 0 CA-C-N 116.733 -0.212 . . . . 52.340000000000003 111.24 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.76 104.24 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.39 2.06 . . . . 74.019999999999996 112.032 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -131.04 136.47 48.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.058 -0.519 . . . . 71.439999999999998 111.699 -174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.98 120.86 14.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.555 -0.293 . . . . 32.509999999999998 111.237 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.64 15.33 17.27 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.202 -0.523 . . . . 64.409999999999997 113.254 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.4 p -120.75 170.1 9.77 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.475 -0.426 . . . . 61.539999999999999 110.753 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 99' ' ' ILE . 4.0 mp -113.24 123.04 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.617 -0.265 . . . . 75.230000000000004 110.71 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -93.71 133.29 37.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.073 0.463 . . . . 71.030000000000001 111.212 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.426 ' HA ' HG12 ' A' ' 110' ' ' VAL . 43.8 tt0 -94.25 112.18 23.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.294 -0.412 . . . . 72.209999999999994 111.153 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 109' ' ' HIS . 37.5 m -93.9 -17.41 23.04 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.292 0.478 . . . . 74.209999999999994 112.292 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 75.4 p 47.41 21.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.476 0.917 . . . . 72.230000000000004 113.476 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.58 105.02 3.49 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.12 0.785 . . . . 74.439999999999998 113.12 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.75 97.34 0.6 Allowed Glycine 0 CA--C 1.531 1.044 0 N-CA-C 115.278 0.871 . . . . 13.32 115.278 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.04 -86.09 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 114.638 0.615 . . . . 62.200000000000003 114.638 171.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -69.39 -28.61 66.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.227 0.537 . . . . 75.400000000000006 110.859 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.02 176.54 33.44 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.874 -0.603 . . . . 73.010000000000005 113.322 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 39.6 t60 -136.0 142.78 44.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.709 0.29 . . . . 73.319999999999993 111.058 178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.552 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.9 m -146.89 146.2 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.088 0.555 . . . . 64.340000000000003 110.397 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -143.84 161.7 37.99 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.961 0.41 . . . . 61.399999999999999 111.433 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.5 123.74 37.02 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.942 0.401 . . . . 72.230000000000004 111.054 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.9 t -71.86 106.04 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.966 0.412 . . . . 73.019999999999996 111.913 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -66.91 -51.59 53.47 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.121 0.486 . . . . 71.140000000000001 110.754 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -160.37 164.24 32.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.057 -0.52 . . . . 65.209999999999994 110.833 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -128.28 140.45 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.049 0.452 . . . . 64.219999999999999 111.198 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -89.54 147.91 23.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.728 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.0 t -62.54 -20.7 64.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.864 0.364 . . . . 44.240000000000002 111.908 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.82 -22.83 62.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.759 0.314 . . . . 73.239999999999995 111.336 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.87 -17.87 10.72 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.302 -0.408 . . . . 64.25 113.073 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.0 m -64.07 126.25 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.951 0.405 . . . . 73.540000000000006 111.621 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.05 124.48 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.998 0.428 . . . . 73.409999999999997 111.967 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -93.23 113.85 26.18 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.939 0.4 . . . . 73.319999999999993 110.662 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.4 m -118.75 164.43 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.24 0.459 . . . . 74.540000000000006 112.24 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.518 ' OG ' ' HE2' ' A' ' 64' ' ' LYS . 48.6 p -117.17 140.61 49.31 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.462 -0.335 . . . . 71.409999999999997 111.715 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 59.8 mt-10 -138.65 159.06 43.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.05 0.54 . . . . 75.25 110.991 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.9 tpp -82.5 136.29 34.92 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.347 -0.221 . . . . 63.100000000000001 110.569 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.556 0.576 . . . . 71.0 112.556 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -155.94 164.95 37.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.395 0.617 . . . . 74.340000000000003 112.23 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.41 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 2.8 p30 -62.06 116.03 4.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.552 -0.749 . . . . 63.520000000000003 111.578 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.6 30.6 26.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 43.210000000000001 112.558 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -78.08 -170.63 36.46 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.46 -0.4 . . . . 54.299999999999997 113.788 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.6 -178.59 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.978 2.452 . . . . 72.129999999999995 113.341 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.66 -19.51 65.78 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.07 0.462 . . . . 73.450000000000003 111.421 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.8 m -72.28 107.24 4.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.265 -0.425 . . . . 74.019999999999996 111.331 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.51 HG21 ' HD3' ' A' ' 64' ' ' LYS . 76.6 t -89.82 127.7 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 120.861 0.362 . . . . 65.349999999999994 111.535 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 41.5 t -68.24 174.61 3.81 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.086 0.469 . . . . 73.040000000000006 111.884 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 27.3 mt-10 -144.6 158.07 43.93 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.919 0.39 . . . . 65.340000000000003 111.755 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 139' ' ' ARG . 7.2 ptp180 -157.73 173.15 17.26 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.477 -0.329 . . . . 54.439999999999998 111.118 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 72.8 m -127.73 123.51 35.56 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.963 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 57.3 mt -94.73 137.42 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.876 0.37 . . . . 63.539999999999999 111.389 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.5 m -59.84 137.9 57.94 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.154 -0.476 . . . . 40.43 111.997 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.07 -42.62 60.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.545 0.572 . . . . 72.219999999999999 112.545 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.29 -27.99 61.15 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.316 -0.402 . . . . 34.340000000000003 113.637 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.82 -27.79 14.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.387 -0.478 . . . . 74.430000000000007 111.39 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.64 -29.02 61.8 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.087 0.773 . . . . 64.439999999999998 113.087 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t -78.19 -6.24 54.23 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.0 0.37 . . . . 73.400000000000006 112.0 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.5 m -85.88 -15.04 43.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.773 0.32 . . . . 72.349999999999994 111.797 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -93.69 144.92 24.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.053 0.454 . . . . 71.340000000000003 112.21 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -93.88 116.41 28.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.152 -0.476 . . . . 54.32 110.359 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 20.9 m-85 -95.49 122.91 38.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.933 0.397 . . . . 60.350000000000001 111.748 -175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.4 mp -83.63 123.38 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.388 -0.369 . . . . 74.420000000000002 110.604 175.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -114.34 136.94 52.43 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.516 0.327 . . . . 63.439999999999998 110.547 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 69' ' ' ILE . 74.4 mt -97.92 102.94 14.83 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.348 0.499 . . . . 51.149999999999999 112.348 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.214 0.531 . . . . 64.349999999999994 110.813 173.264 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.547 0.213 . . . . 70.349999999999994 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.66 93.83 1.29 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.253 0.549 . . . . 73.019999999999996 110.204 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -124.46 124.52 42.49 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.288 -0.415 . . . . 75.030000000000001 111.092 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 4' ' ' LEU . 2.9 mm? -80.87 84.96 6.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.318 0.58 . . . . 73.140000000000001 110.81 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -102.06 94.79 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 115.869 -0.605 . . . . 63.350000000000001 111.098 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.5 m -133.83 97.16 3.83 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.49 -0.323 . . . . 73.329999999999998 110.871 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.13 34.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.869 0.322 . . . . 53.340000000000003 111.869 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -175.12 163.6 3.19 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.236 -0.438 . . . . 75.219999999999999 110.951 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -133.35 168.7 18.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.083 0.468 . . . . 43.32 111.988 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.7 mp -103.93 119.64 39.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.02 -0.536 . . . . 64.209999999999994 111.56 -173.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.8 m -78.17 121.46 24.37 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.495 -0.321 . . . . 73.010000000000005 111.694 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.22 -174.35 2.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.495 -0.32 . . . . 74.219999999999999 111.393 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.61 128.09 0.97 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.154 -0.546 . . . . 65.209999999999994 113.156 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -98.48 108.3 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.581 -0.364 . . . . 73.450000000000003 111.516 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.41 74.8 0.57 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.311 -0.471 . . . . 51.350000000000001 113.409 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.68 96.69 10.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.539 -0.389 . . . . 75.010000000000005 110.977 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.97 97.4 7.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.176 0.512 . . . . 75.129999999999995 112.348 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 pt -76.28 142.9 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.12 -0.491 . . . . 74.510000000000005 111.405 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.79 168.79 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.787 0.327 . . . . 74.319999999999993 111.374 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.49 -18.13 3.47 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.89 -0.671 . . . . 24.140000000000001 113.82 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.53 117.45 16.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.333 0.587 . . . . 71.010000000000005 111.638 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.6 123.53 35.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 111.426 -178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -141.38 164.57 29.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.972 0.415 . . . . 44.020000000000003 111.582 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.04 123.5 2.72 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.289 -0.482 . . . . 64.040000000000006 113.435 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -132.56 138.72 47.56 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.529 -0.395 . . . . 73.409999999999997 111.022 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.5 122.03 23.25 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.011 0.434 . . . . 74.239999999999995 111.642 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.27 124.46 3.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.048 0.451 . . . . 75.430000000000007 112.094 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.29 46.15 1.4 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.049 -0.523 . . . . 73.150000000000006 110.826 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.42 29.58 15.52 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.394 0.616 . . . . 72.109999999999999 111.042 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 19.56 0.14 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.883 0.697 . . . . 53.530000000000001 112.883 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -91.23 23.52 3.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.176 0.512 . . . . 74.540000000000006 110.677 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -75.37 159.06 31.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.421 0.629 . . . . 72.109999999999999 112.482 -176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.3 t -150.2 115.82 5.53 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.661 -0.7 . . . . 74.099999999999994 110.419 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -155.62 116.28 2.28 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.501 -0.318 . . . . 74.430000000000007 111.848 -176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.11 105.22 1.79 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.283 1.988 . . . . 73.310000000000002 112.131 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -60.58 128.33 36.11 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.469 -0.332 . . . . 64.409999999999997 111.342 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -53.36 140.88 25.98 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.97 0.414 . . . . 64.340000000000003 111.628 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -67.83 86.88 0.23 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.443 0.639 . . . . 72.549999999999997 111.858 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -75.73 114.24 14.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.697 -0.683 . . . . 60.240000000000002 111.204 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.0 p -68.97 -28.92 67.06 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.197 0.522 . . . . 71.540000000000006 110.976 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -152.04 137.77 17.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.969 -0.559 . . . . 74.400000000000006 111.523 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -96.72 8.87 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.14 0.495 . . . . 74.030000000000001 111.195 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -83.32 13.16 4.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.959 0.409 . . . . 75.25 112.01 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.9 t -148.42 163.35 37.4 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.296 0.238 . . . . 74.319999999999993 111.16 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -153.86 -52.04 0.1 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.913 0.387 . . . . 65.420000000000002 111.932 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.67 88.16 1.7 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.114 -0.565 . . . . 71.349999999999994 112.792 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.0 p -84.54 116.46 23.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.604 -0.351 . . . . 73.239999999999995 110.928 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 69.9 m -145.33 142.02 29.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.651 0.612 . . . . 73.420000000000002 112.651 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 51' ' ' LEU . . . -167.24 125.8 1.33 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.581 -0.736 . . . . 63.240000000000002 109.855 178.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -60.07 94.59 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.135 0.493 . . . . 55.450000000000003 111.725 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 49' ' ' ALA . 85.6 mt -95.94 20.86 9.39 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.775 -0.648 . . . . 71.109999999999999 111.242 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.89 -179.68 3.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.576 0.227 . . . . 73.420000000000002 111.111 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t -127.54 151.17 49.23 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 112.257 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 112.76 4.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.928 -0.578 . . . . 74.030000000000001 111.804 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.55 7.18 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.345 -0.455 . . . . 55.039999999999999 112.703 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -115.5 144.47 43.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.123 0.487 . . . . 73.200000000000003 111.584 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.1 p -58.03 -46.24 85.64 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.311 -0.404 . . . . 24.530000000000001 111.541 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.3 p -51.52 -45.35 62.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.093 0.405 . . . . 75.019999999999996 112.093 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -54.79 -48.66 72.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.96 -0.564 . . . . 75.549999999999997 111.744 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -68.79 -49.84 55.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.258 -0.428 . . . . 74.349999999999994 112.096 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 57' ' ' CYS . 58.0 t -58.18 -40.5 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.087 0.47 . . . . 75.219999999999999 111.57 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' A' ' 48' ' ' SER . 92.4 t80 -55.97 -41.76 75.26 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.175 -0.466 . . . . 70.299999999999997 111.553 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.02 -43.0 68.81 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.372 -0.376 . . . . 71.019999999999996 111.447 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -61.32 -34.48 75.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.018 0.377 . . . . 70.25 112.018 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -86.22 6.55 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-O 121.358 0.599 . . . . 72.25 111.072 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.37 18.48 60.93 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 113.833 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.96 16.95 67.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.16 -0.543 . . . . 64.120000000000005 113.949 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -78.88 7.08 7.7 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 117.455 0.628 . . . . 72.430000000000007 112.463 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.2 pt -97.29 -37.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.528 0.566 . . . . 72.400000000000006 112.528 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.17 102.56 2.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.967 -0.635 . . . . 71.109999999999999 112.013 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.2 p -61.34 -18.06 56.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.742 0.645 . . . . 74.310000000000002 112.742 -175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 t -57.24 -15.94 7.15 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.701 0.63 . . . . 62.119999999999997 112.701 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -57.97 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.255 0.55 . . . . 74.299999999999997 110.825 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.25 -103.21 0.56 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.805 -0.634 . . . . 63.350000000000001 114.613 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -57.37 134.91 56.42 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.112 0.412 . . . . 65.209999999999994 112.112 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.62 -11.78 47.54 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.04 0.755 . . . . 51.200000000000003 113.04 -173.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -92.37 -10.97 36.21 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.957 174.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -93.35 -27.49 16.74 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.097 0.406 . . . . 75.120000000000005 112.097 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.473 ' N ' HE22 ' A' ' 101' ' ' GLN . 11.9 m0 -41.34 -58.04 1.97 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.854 1.057 . . . . 74.530000000000001 113.854 -175.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.9 91.23 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.917 -0.49 . . . . 52.32 111.975 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.8 t -57.69 -51.81 68.01 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.168 0.509 . . . . 54.310000000000002 111.618 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.93 97.69 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.37 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.48 -57.02 11.21 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.953 0.406 . . . . 35.520000000000003 111.26 175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 t -57.5 -44.41 84.98 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.082 0.468 . . . . 33.32 111.39 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 t -70.85 -21.21 62.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 112.225 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.79 -10.06 32.64 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.205 0.446 . . . . 42.030000000000001 112.205 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.65 8.73 29.96 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.919 -0.657 . . . . 70.530000000000001 113.827 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HD2' ' HA ' ' A' ' 154' ' ' LEU . 71.3 m-85 -83.81 166.94 17.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.439 -0.447 . . . . 72.329999999999998 111.329 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 90.5 m -100.5 92.73 5.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.114 0.483 . . . . 62.039999999999999 111.923 -173.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.3 98.8 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 111.299 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -126.77 176.49 7.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.513 -0.312 . . . . 73.530000000000001 110.632 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -93.39 25.42 3.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.931 0.396 . . . . 62.520000000000003 111.275 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 t -81.89 108.14 10.44 Favored Pre-proline 0 N--CA 1.474 0.757 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 111.458 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.5 19.11 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.04 2.494 . . . . 71.400000000000006 114.278 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -54.96 142.82 28.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.012 0.434 . . . . 72.109999999999999 111.726 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.92 146.13 53.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.471 0.545 . . . . 71.140000000000001 112.471 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 32.98 10.09 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.17 -0.538 . . . . 73.430000000000007 113.031 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.4 p -136.62 169.08 18.29 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.5 -0.412 . . . . 73.310000000000002 111.167 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.8 mp -110.14 134.6 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.626 -0.261 . . . . 71.140000000000001 110.302 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.5 pt? -112.99 131.24 55.84 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.247 0.546 . . . . 72.409999999999997 111.443 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.473 HE22 ' N ' ' A' ' 79' ' ' TRP . 36.0 tt0 -105.96 129.0 54.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.524 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -91.58 -37.82 12.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.773 0.656 . . . . 75.140000000000001 112.773 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 101' ' ' GLN . 26.3 p 60.58 10.35 2.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 113.128 0.788 . . . . 70.230000000000004 113.128 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.28 -67.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.147 0.795 . . . . 52.450000000000003 113.147 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.13 176.57 37.69 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.795 -0.717 . . . . 61.340000000000003 113.132 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.02 52.57 52.02 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.451 -0.404 . . . . 52.219999999999999 113.44 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 65.84 17.54 10.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.767 0.427 . . . . 74.120000000000005 112.113 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.69 -161.44 22.9 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.317 -0.468 . . . . 44.329999999999998 113.5 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -173.5 136.99 0.62 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.417 0.287 . . . . 71.299999999999997 110.92 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.9 151.52 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.33 -0.395 . . . . 51.340000000000003 111.408 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -148.78 167.37 25.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.466 -0.333 . . . . 72.430000000000007 110.99 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -102.88 131.44 49.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.894 0.378 . . . . 60.439999999999998 111.202 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 124' ' ' VAL . 60.9 t -81.89 112.29 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.297 -0.41 . . . . 74.450000000000003 111.539 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -80.13 -56.02 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.878 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.19 144.05 23.68 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.757 0.651 . . . . 63.310000000000002 112.757 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.47 136.25 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.745 177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -98.17 147.33 24.69 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 122.399 -0.188 . . . . 41.340000000000003 110.925 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -57.71 -34.84 69.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 111.934 0.346 . . . . 65.109999999999999 111.934 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.59 -9.23 40.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.464 0.542 . . . . 64.209999999999994 112.464 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.56 0.41 46.47 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.367 -0.444 . . . . 74.230000000000004 113.757 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 m -77.53 142.07 39.26 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.747 0.308 . . . . 72.519999999999996 111.626 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.8 t -113.19 115.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.913 0.387 . . . . 74.430000000000007 111.558 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.84 118.63 29.56 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.924 0.392 . . . . 63.119999999999997 111.326 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 113' ' ' VAL . 34.1 m -124.8 148.18 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.043 0.449 . . . . 62.409999999999997 111.924 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.0 m -102.89 116.04 31.78 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.068 0.461 . . . . 51.350000000000001 111.079 175.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.43 -168.24 1.29 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 111.246 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.0 ttm -144.48 114.41 7.33 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.948 0.404 . . . . 64.140000000000001 110.763 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -130.62 -79.35 0.54 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.384 -0.371 . . . . 63.329999999999998 111.122 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -152.28 116.67 5.0 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.198 0.444 . . . . 64.140000000000001 112.198 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 135' ' ' SER . 9.5 p30 171.96 151.23 0.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.659 0.784 . . . . 71.230000000000004 110.213 171.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.46 -95.08 0.05 OUTLIER Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.464 -0.398 . . . . 71.129999999999995 113.996 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -147.22 -169.53 14.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.626 -0.321 . . . . 74.099999999999994 112.968 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.88 0.36 5.1 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.962 2.441 . . . . 74.430000000000007 113.664 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -122.16 0.15 9.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.692 0.282 . . . . 70.400000000000006 111.42 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' ASN . 68.6 m -81.34 141.68 33.79 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.363 0.601 . . . . 64.510000000000005 111.799 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.91 146.16 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.941 -0.572 . . . . 73.209999999999994 112.27 -173.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 t -118.42 117.49 29.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.317 -0.401 . . . . 64.299999999999997 109.972 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.95 156.35 18.95 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.206 0.527 . . . . 75.0 112.373 -172.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -152.1 130.85 12.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.08 0.466 . . . . 71.209999999999994 111.604 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 m -99.13 98.7 9.67 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.082 0.467 . . . . 71.310000000000002 110.209 175.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -72.72 134.76 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 112.231 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.8 m -67.99 148.59 50.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.908 -0.587 . . . . 73.150000000000006 111.598 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.87 -44.95 63.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.446 0.536 . . . . 50.140000000000001 112.446 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.75 76.56 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.048 -0.596 . . . . 73.519999999999996 113.017 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.97 -34.02 75.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.866 0.365 . . . . 70.430000000000007 111.557 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.82 66.79 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.174 0.511 . . . . 64.5 111.859 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 t -67.67 -3.64 9.72 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.403 0.52 . . . . 65.319999999999993 112.403 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -93.28 -0.3 56.78 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.965 0.412 . . . . 75.549999999999997 111.622 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -118.77 153.42 34.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.535 0.569 . . . . 75.409999999999997 112.535 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 21.2 m-80 -101.4 116.14 32.1 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.797 -0.638 . . . . 63.140000000000001 110.526 176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -94.85 112.68 24.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.230000000000004 111.91 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 152' ' ' ILE . 3.6 mp -81.06 127.23 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.076 0.465 . . . . 53.149999999999999 111.345 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 62.0 m-70 -111.1 133.15 53.7 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.548 -0.538 . . . . 73.349999999999994 109.548 174.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 88' ' ' TYR . 48.0 mt -84.29 -15.71 45.71 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.248 0.462 . . . . 65.439999999999998 112.248 -171.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 122.99 0.516 . . . . 33.340000000000003 111.929 -175.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.414 0.524 . . . . 65.010000000000005 112.414 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.58 148.45 46.62 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.996 0.427 . . . . 71.409999999999997 112.06 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -89.57 101.14 13.82 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.163 -0.471 . . . . 74.239999999999995 111.396 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.34 18.58 9.43 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.3 0.572 . . . . 71.040000000000006 110.583 175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -109.78 122.43 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.762 -0.653 . . . . 73.420000000000002 111.253 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.1 m -135.91 91.05 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.909 0.385 . . . . 65.109999999999999 110.866 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.58 106.04 16.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.057 0.456 . . . . 70.439999999999998 111.55 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.4 t -156.79 178.69 10.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.961 0.41 . . . . 73.129999999999995 111.679 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -142.77 146.65 34.46 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.234 -0.439 . . . . 72.310000000000002 111.666 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.33 170.68 5.64 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.25 -0.432 . . . . 71.049999999999997 111.348 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.2 m -72.93 91.92 1.58 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.889 0.376 . . . . 53.43 110.862 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 83.89 1.41 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.297 0.57 . . . . 73.129999999999995 111.69 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.55 83.97 1.21 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.088 -0.577 . . . . 74.219999999999999 112.878 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -61.59 110.31 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.384 0.612 . . . . 72.030000000000001 111.041 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 67.23 3.19 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.202 -0.523 . . . . 60.119999999999997 113.32 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.42 26.64 4.23 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.843 0.354 . . . . 75.540000000000006 111.757 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.4 100.08 10.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.028 0.381 . . . . 71.219999999999999 112.028 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.92 125.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.439 -0.346 . . . . 71.510000000000005 110.561 174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.73 130.63 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.450000000000003 111.586 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.03 110.12 0.73 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.507 -0.377 . . . . 75.209999999999994 112.856 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pp -95.89 171.66 8.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.069 0.461 . . . . 71.109999999999999 111.97 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -141.56 164.27 30.68 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.236 0.541 . . . . 74.430000000000007 112.189 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -114.31 136.45 52.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.105 -0.498 . . . . 75.200000000000003 110.589 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.24 133.78 7.17 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.721 -0.752 . . . . 75.450000000000003 113.625 -177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 50.09 85.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.19 0.596 . . . . 75.239999999999995 112.558 176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.39 100.67 9.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.061 0.458 . . . . 74.329999999999998 111.423 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.78 147.86 13.72 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.231 -0.441 . . . . 43.310000000000002 111.63 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -152.32 158.08 42.24 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.96 0.409 . . . . 75.340000000000003 111.336 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.92 109.15 4.47 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 110.543 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.54 107.54 7.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.57 0.582 . . . . 62.399999999999999 112.57 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -76.16 86.75 3.02 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.225 0.536 . . . . 75.25 109.805 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -171.28 -179.82 2.76 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.852 -0.613 . . . . 71.439999999999998 111.19 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 65.3 p -64.44 131.24 46.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.266 -0.424 . . . . 65.25 110.064 168.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -60.38 145.95 85.41 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.647 -0.251 . . . . 73.049999999999997 111.512 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.09 95.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.819 2.346 . . . . 71.400000000000006 113.203 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 p -86.88 77.2 9.3 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.332 0.587 . . . . 73.030000000000001 111.284 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -78.05 107.67 10.78 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.966 -0.561 . . . . 70.340000000000003 110.393 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.574 ' NE2' ' H ' ' A' ' 38' ' ' GLN . 1.9 mp0 -50.21 -42.31 51.31 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.205 0.446 . . . . 71.120000000000005 112.205 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m -105.62 97.01 6.9 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.752 0.311 . . . . 64.140000000000001 110.884 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.1 m -60.5 90.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.159 0.504 . . . . 61.210000000000001 111.674 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -162.05 178.15 9.09 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.312 -0.404 . . . . 71.230000000000004 111.148 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -173.27 3.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.864 0.364 . . . . 75.239999999999995 111.536 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.0 p -157.49 -177.69 6.78 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.917 0.389 . . . . 74.040000000000006 111.426 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.2 p -78.94 104.13 9.36 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.917 0.389 . . . . 71.409999999999997 111.237 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.0 p -87.0 119.13 26.88 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.008 0.433 . . . . 72.25 111.777 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.21 -104.07 1.49 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.312 -0.471 . . . . 63.149999999999999 113.097 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -121.26 173.63 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.259 0.552 . . . . 71.200000000000003 111.698 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.6 p -100.52 -39.68 7.81 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.002 -0.544 . . . . 70.340000000000003 111.329 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.69 165.58 23.4 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.393 -0.367 . . . . 75.019999999999996 111.665 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -66.63 111.19 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.247 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.61 -13.58 59.76 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.293 0.479 . . . . 42.439999999999998 112.293 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -86.08 179.2 7.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.067 0.46 . . . . 72.140000000000001 111.909 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.4 t -129.35 151.66 49.74 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.957 0.408 . . . . 73.219999999999999 111.934 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.68 138.18 42.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 72.349999999999994 111.738 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.79 -28.51 13.79 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.283 -0.484 . . . . 71.549999999999997 112.753 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -80.3 136.73 36.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.269 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.432 ' O ' HG23 ' A' ' 61' ' ' VAL . 25.2 p -59.14 -41.28 87.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.073 171.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.5 p -52.57 -43.8 65.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.455 -0.793 . . . . 72.109999999999999 111.968 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -55.95 -52.31 64.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 112.022 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.63 -47.34 72.91 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.983 0.421 . . . . 72.010000000000005 111.702 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 57' ' ' CYS . 96.9 t -60.97 -34.52 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.555 -0.293 . . . . 65.219999999999999 111.706 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -54.69 -46.81 74.18 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 111.41 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.36 -41.2 73.43 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.094 0.473 . . . . 74.310000000000002 110.892 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 64' ' ' LYS . 29.3 mmmt -61.98 -31.73 72.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.155 -0.475 . . . . 63.509999999999998 112.202 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 154' ' ' LEU . 7.6 p -91.24 6.22 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 121.449 0.642 . . . . 55.350000000000001 111.164 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.86 10.26 72.04 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.299 -0.41 . . . . 64.120000000000005 113.959 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.14 15.75 72.43 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 121.002 -0.618 . . . . 64.200000000000003 114.032 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.43 ' HB2' HD13 ' A' ' 154' ' ' LEU . 40.2 m-80 -82.79 28.28 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.316 0.558 . . . . 72.120000000000005 111.99 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 pt -125.76 161.78 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.131 0.491 . . . . 61.509999999999998 111.523 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.1 78.03 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.999 -0.619 . . . . 52.43 112.558 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.4 t -49.18 -28.18 4.24 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.571 0.582 . . . . 43.219999999999999 112.571 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 t -60.73 -18.03 52.08 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.873 0.694 . . . . 53.130000000000003 112.873 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -56.05 -32.95 64.53 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.942 0.401 . . . . 74.099999999999994 111.617 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.67 -106.9 2.02 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.261 -0.427 . . . . 62.409999999999997 114.092 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.88 133.78 48.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.452 0.538 . . . . 71.319999999999993 112.452 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.06 -27.41 61.68 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.228 0.825 . . . . 65.230000000000004 113.228 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -67.05 -34.47 77.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.939 0.4 . . . . 73.409999999999997 112.047 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -71.26 -29.34 64.97 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.337 0.495 . . . . 60.130000000000003 112.337 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -43.38 -60.27 1.78 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.619 0.97 . . . . 73.310000000000002 113.619 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.43 86.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.45 0.537 . . . . 73.329999999999998 112.45 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 t -65.03 -55.02 21.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.941 0.401 . . . . 61.450000000000003 111.438 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.77 74.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.389 -0.369 . . . . 73.340000000000003 111.443 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.32 -49.02 77.44 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.629 -0.259 . . . . 62.509999999999998 111.291 176.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.7 p -66.51 -29.55 69.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.029 0.442 . . . . 74.319999999999993 111.119 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -76.79 -31.36 56.95 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.128 -0.487 . . . . 44.420000000000002 111.798 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.46 -24.48 24.12 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.156 0.428 . . . . 71.239999999999995 112.156 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.82 4.31 19.23 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.048 -0.596 . . . . 51.109999999999999 113.881 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.546 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 18.4 m-85 -69.23 168.49 14.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.082 0.467 . . . . 74.340000000000003 111.288 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.6 m -101.19 97.94 8.41 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.07 0.396 . . . . 75.120000000000005 112.07 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.573 HG22 HG13 ' A' ' 152' ' ' ILE . 41.6 t -102.49 96.52 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.002 0.429 . . . . 73.150000000000006 111.316 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -122.66 172.31 8.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.891 0.377 . . . . 72.530000000000001 110.96 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -86.56 2.52 47.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.654 0.264 . . . . 71.530000000000001 111.305 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -62.8 113.75 10.1 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 116.52 -0.309 . . . . 72.420000000000002 110.761 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.415 ' HB2' HG22 ' A' ' 122' ' ' VAL . 90.0 Cg_endo -82.27 8.16 4.68 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.643 2.229 . . . . 72.519999999999996 113.973 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.32 138.62 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.328 0.492 . . . . 53.329999999999998 112.328 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.08 156.98 4.93 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.718 0.636 . . . . 70.430000000000007 112.718 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.46 33.38 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.111 -0.566 . . . . 74.349999999999994 112.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 94.2 p -138.31 176.64 8.52 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.931 0.396 . . . . 73.010000000000005 111.115 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.71 121.78 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.36 -0.382 . . . . 53.32 110.889 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.9 pt? -100.62 136.66 40.15 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.692 -0.63 . . . . 71.129999999999995 111.636 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -101.99 124.99 48.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.868 -0.605 . . . . 75.230000000000004 111.46 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 31.2 t -90.09 -22.4 21.81 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.246 0.461 . . . . 52.549999999999997 112.246 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 p 66.82 -59.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.23 1.012 . . . . 74.420000000000002 113.639 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.89 10.81 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.555 1.317 . . . . 70.519999999999996 114.555 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.63 43.02 3.19 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.726 -0.609 . . . . 71.349999999999994 113.391 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 -77.7 0.4 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.527 -0.368 . . . . 55.32 113.127 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -97.24 20.45 11.44 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.293 0.568 . . . . 74.030000000000001 110.316 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.02 171.88 44.69 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.881 -0.6 . . . . 73.510000000000005 111.834 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 58.4 t60 -157.59 135.47 10.76 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.345 -0.503 . . . . 75.239999999999995 110.74 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.73 142.1 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.073 0.463 . . . . 44.100000000000001 111.389 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -139.44 156.69 46.79 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.243 -0.435 . . . . 43.450000000000003 110.837 177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.71 133.14 38.7 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.832 0.349 . . . . 63.109999999999999 111.279 -176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.45 116.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.858 0.361 . . . . 44.439999999999998 111.836 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.72 -54.96 3.99 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.957 0.408 . . . . 71.319999999999993 112.01 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -145.76 145.2 30.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.265 0.555 . . . . 72.239999999999995 112.004 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.61 133.74 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.03 -0.532 . . . . 42.299999999999997 111.464 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' SER . 33.9 m-80 -76.87 152.25 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.406 -0.361 . . . . 63.240000000000002 110.556 175.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.1 m -47.22 -40.73 16.91 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.337 0.866 . . . . 72.310000000000002 113.337 -174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.55 -23.39 61.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.37 0.507 . . . . 70.549999999999997 112.37 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 123.44 -0.94 9.54 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.163 -0.541 . . . . 63.420000000000002 113.38 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 19.2 m -65.41 118.78 9.89 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.168 0.509 . . . . 72.239999999999995 110.952 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.42 HG21 ' OH ' ' A' ' 151' ' ' TYR . 40.4 t -96.35 121.97 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.805 -0.634 . . . . 51.509999999999998 112.392 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -96.35 105.25 17.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.342 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 m -97.08 163.99 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.423 0.527 . . . . 73.109999999999999 112.423 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 t -115.51 119.19 35.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.922 -0.581 . . . . 64.140000000000001 111.028 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.8 177.2 6.42 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.024 0.44 . . . . 63.549999999999997 111.512 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.5 ttm -138.23 149.72 46.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.497 -0.32 . . . . 63.399999999999999 110.45 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 74.39 -27.67 0.19 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.352 0.661 . . . . 72.439999999999998 112.172 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -59.73 -175.42 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.933 0.493 . . . . 74.209999999999994 110.154 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -44.96 98.84 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.173 0.511 . . . . 73.319999999999993 112.237 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 165.16 -52.36 0.27 Allowed Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.848 -0.614 . . . . 32.32 112.818 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.83 175.45 14.65 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.979 -0.629 . . . . 61.140000000000001 113.925 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 135' ' ' SER . 38.9 Cg_endo -65.58 128.69 20.65 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.982 2.455 . . . . 72.239999999999995 112.411 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 67.84 -23.37 0.12 Allowed 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.758 0.651 . . . . 73.239999999999995 112.758 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 133' ' ' PRO . 67.2 m -69.46 141.28 54.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.293 0.568 . . . . 61.32 111.438 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t -83.56 122.09 37.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.864 -0.607 . . . . 54.509999999999998 112.045 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.0 t -91.92 151.87 20.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.794 -0.639 . . . . 71.099999999999994 110.634 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -125.69 103.76 8.0 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.191 0.519 . . . . 70.5 111.695 -174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -95.06 105.07 16.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.168 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 88.2 m -79.17 104.14 9.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.041 0.448 . . . . 64.340000000000003 110.65 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.409 HD13 ' CE2' ' A' ' 149' ' ' TYR . 73.2 mt -92.57 112.44 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.105 -0.498 . . . . 72.200000000000003 111.599 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.4 m -61.07 153.26 25.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.24 0.459 . . . . 75.109999999999999 112.24 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.79 -48.65 41.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.876 0.695 . . . . 74.430000000000007 112.876 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.14 -38.05 88.35 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.175 -0.536 . . . . 52.509999999999998 113.316 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -72.9 -37.35 67.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.963 0.411 . . . . 65.310000000000002 111.669 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.69 -23.91 67.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.911 0.708 . . . . 63.119999999999997 112.911 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 m -54.87 -17.29 3.42 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.845 1.054 . . . . 71.439999999999998 113.845 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.4 t -99.11 -13.94 19.6 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.155 0.798 . . . . 75.25 113.155 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' A' ' 141' ' ' ILE . 31.4 m-85 -88.7 143.74 26.73 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.564 0.697 . . . . 75.239999999999995 112.866 -173.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 86.8 m-20 -100.09 116.35 31.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.613 -0.721 . . . . 72.040000000000006 111.071 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' A' ' 122' ' ' VAL . 64.0 m-85 -98.26 118.18 34.33 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.002 0.371 . . . . 64.299999999999997 112.002 -177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.573 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -84.66 131.99 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.432 -0.349 . . . . 74.150000000000006 110.595 174.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -121.58 148.65 44.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.703 0.401 . . . . 70.099999999999994 110.056 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.583 HD11 HG22 ' A' ' 65' ' ' VAL . 50.4 mt -93.17 132.08 37.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.406 0.622 . . . . 71.430000000000007 112.598 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 CA--C 1.545 0.78 0 CA-C-N 115.912 -0.585 . . . . 60.030000000000001 112.174 177.129 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.969 0.414 . . . . 72.109999999999999 111.209 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -145.25 134.96 23.46 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.848 0.356 . . . . 72.420000000000002 110.662 -178.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -114.54 98.99 7.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.309 0.576 . . . . 73.040000000000006 112.4 -174.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tt -104.59 101.0 10.66 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.112 -0.699 . . . . 54.0 109.112 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.08 115.01 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.29 0.567 . . . . 72.329999999999998 111.594 -176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -81.62 50.07 1.43 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.324 0.583 . . . . 64.109999999999999 111.483 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.87 67.02 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.132 0.491 . . . . 62.329999999999998 111.739 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.6 m -105.23 93.56 4.75 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.044 0.449 . . . . 50.009999999999998 110.616 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -93.1 139.63 30.36 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.249 -0.432 . . . . 71.430000000000007 110.833 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.0 mp -92.61 38.11 1.01 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 111.808 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 m -66.26 94.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.459 -0.337 . . . . 62.240000000000002 111.59 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.48 125.24 0.5 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.386 -0.37 . . . . 72.310000000000002 111.397 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.5 101.87 0.17 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.896 -0.669 . . . . 62.130000000000003 113.035 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -86.6 123.21 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.847 0.356 . . . . 73.209999999999994 110.888 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.62 18.92 7.14 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.392 -0.432 . . . . 64.230000000000004 112.839 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.76 102.69 10.94 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.993 0.368 . . . . 51.340000000000003 111.993 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.58 90.69 0.95 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.986 0.422 . . . . 55.539999999999999 111.301 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 pt -92.56 156.06 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.944 0.402 . . . . 60.240000000000002 111.743 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.96 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.932 0.396 . . . . 72.340000000000003 111.107 178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.45 93.17 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.267 -0.492 . . . . 52.200000000000003 112.969 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.76 82.9 2.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.215 0.531 . . . . 73.25 110.691 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -83.26 169.37 15.79 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.108 -0.497 . . . . 72.430000000000007 111.918 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -128.94 176.83 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.897 0.38 . . . . 74.010000000000005 111.9 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.03 78.97 0.04 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.899 -0.667 . . . . 64.430000000000007 113.321 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -94.27 95.38 8.88 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.481 -0.423 . . . . 65.010000000000005 110.561 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.66 113.73 13.94 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.233 0.457 . . . . 73.230000000000004 112.233 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.67 92.09 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.714 0.293 . . . . 62.409999999999997 111.781 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -102.75 138.92 39.01 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.87 0.366 . . . . 73.140000000000001 111.311 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.17 97.74 0.92 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.894 0.378 . . . . 62.25 111.859 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.84 88.75 2.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.995 0.426 . . . . 75.200000000000003 111.144 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -96.8 123.95 40.64 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.448 -0.342 . . . . 72.129999999999995 111.233 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -117.17 123.27 46.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.846 0.355 . . . . 53.439999999999998 111.477 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.0 m -157.15 114.27 3.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 120.751 0.31 . . . . 64.239999999999995 111.558 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 35' ' ' PRO . 76.2 mt-30 -115.56 132.43 23.13 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 120.637 0.256 . . . . 63.140000000000001 111.583 176.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 17.0 Cg_exo -68.01 125.35 12.95 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.705 2.27 . . . . 60.509999999999998 111.847 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.2 p -51.53 -68.05 0.2 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.688 0.996 . . . . 65.430000000000007 113.688 -172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.7 125.91 29.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.247 0.546 . . . . 74.140000000000001 112.351 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.78 106.28 16.74 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.043 -0.526 . . . . 74.109999999999999 110.757 176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m -102.56 32.12 3.76 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.843 0.312 . . . . 65.319999999999993 111.843 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.8 m -127.09 154.97 44.03 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.701 0.286 . . . . 72.329999999999998 111.37 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.3 m -56.7 126.43 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.805 0.442 . . . . 72.120000000000005 111.974 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -92.37 41.64 1.08 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 111.974 0.361 . . . . 72.219999999999999 111.974 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 75.3 m -76.88 89.66 3.48 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.417 0.627 . . . . 51.530000000000001 111.012 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -80.88 74.25 7.87 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.546 0.573 . . . . 61.310000000000002 112.546 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.9 p -134.51 8.83 3.65 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.508 0.559 . . . . 72.329999999999998 112.508 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.36 146.63 30.54 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.204 -0.522 . . . . 64.239999999999995 113.288 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.7 p -82.85 79.45 9.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.394 -0.474 . . . . 54.109999999999999 111.772 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -90.53 84.68 5.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.8 0.334 . . . . 75.200000000000003 110.45 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.02 137.71 8.66 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.174 0.512 . . . . 35.200000000000003 112.06 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -81.58 95.82 7.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.195 -0.457 . . . . 65.439999999999998 110.815 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.41 31.29 1.34 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.26 0.467 . . . . 74.109999999999999 112.26 -176.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.509 ' HB3' ' OE1' ' A' ' 56' ' ' GLN . 20.0 m-85 -128.33 176.45 7.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.274 -0.266 . . . . 65.319999999999993 111.5 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.6 t -111.43 19.13 18.51 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.975 0.732 . . . . 73.420000000000002 112.975 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 65.99 152.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.175 0.512 . . . . 42.539999999999999 111.928 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' HA2' ' SD ' ' A' ' 127' ' ' MET . . . 82.82 -33.66 2.83 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.819 -0.705 . . . . 32.240000000000002 112.827 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 52' ' ' TYR . 95.5 mt-30 -62.5 139.83 58.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.382 0.273 . . . . 65.319999999999993 110.96 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.505 ' O ' HG23 ' A' ' 61' ' ' VAL . 29.0 p -54.03 -45.88 71.71 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.072 0.463 . . . . 63.229999999999997 110.967 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.3 p -53.19 -43.47 67.18 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 112.022 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.422 ' HD1' ' HB2' ' A' ' 52' ' ' TYR . 89.1 t90 -56.94 -48.59 77.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.22 0.533 . . . . 72.019999999999996 111.188 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -63.66 -45.17 91.37 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.903 -0.59 . . . . 64.019999999999996 111.629 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 57' ' ' CYS . 64.3 t -60.46 -43.25 93.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.797 0.332 . . . . 71.299999999999997 111.415 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -55.04 -38.71 68.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.268 -0.423 . . . . 71.299999999999997 111.527 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.85 -48.81 34.44 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.834 0.35 . . . . 75.129999999999995 111.366 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -58.25 -36.52 73.35 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.362 0.505 . . . . 72.400000000000006 112.362 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 HD11 ' A' ' 154' ' ' LEU . 9.6 p -80.8 11.46 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.415 0.626 . . . . 72.120000000000005 111.42 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.13 19.44 66.04 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 116.294 -0.412 . . . . 73.420000000000002 113.581 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.53 24.14 61.43 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.26 -0.495 . . . . 71.140000000000001 113.716 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -86.8 9.94 17.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.301 -0.529 . . . . 72.430000000000007 111.887 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.0 pt -110.82 148.85 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.979 0.419 . . . . 71.319999999999993 111.428 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.97 84.95 0.16 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.015 -0.612 . . . . 53.5 112.933 176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.1 p -51.68 -21.12 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.447 0.536 . . . . 51.5 112.447 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.1 t -66.62 -2.13 4.5 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.787 0.662 . . . . 53.32 112.787 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -63.53 -22.83 67.11 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.07 0.396 . . . . 72.129999999999995 112.07 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.42 -131.73 10.87 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.173 -0.537 . . . . 70.049999999999997 113.729 176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -72.82 154.98 40.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.415 0.626 . . . . 62.399999999999999 111.972 -176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -72.37 31.03 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 113.965 1.098 . . . . 52.310000000000002 113.965 -171.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -111.61 -18.25 12.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.249 0.547 . . . . 74.040000000000006 110.287 170.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -104.64 -0.17 27.85 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.935 -0.575 . . . . 60.450000000000003 112.067 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -66.96 -58.44 4.96 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 122.093 -0.379 . . . . 71.129999999999995 111.953 -171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.54 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.802 0.334 . . . . 73.439999999999998 111.884 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.7 t -58.71 -51.37 70.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.945 0.402 . . . . 51.049999999999997 111.264 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.31 82.78 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.432 -0.349 . . . . 61.030000000000001 111.443 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -55.67 -52.88 62.35 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.519999999999996 111.273 175.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -62.78 -32.35 73.5 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.801 0.334 . . . . 65.109999999999999 111.602 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.9 t -76.48 -33.09 58.69 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.119 0.415 . . . . 74.510000000000005 112.119 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.88 -51.43 8.59 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.115 0.413 . . . . 72.129999999999995 112.115 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.29 24.7 0.08 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.831 -0.7 . . . . 63.109999999999999 113.818 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 28.5 m-85 -90.89 178.82 5.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.224 0.535 . . . . 75.430000000000007 111.293 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 91' ' ' ASN . 84.2 m -109.26 89.6 3.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.055 -0.52 . . . . 70.209999999999994 111.051 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.86 111.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.93 0.395 . . . . 63.32 111.648 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 89' ' ' THR . 6.0 m120 -135.61 177.14 8.06 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.99 0.424 . . . . 73.219999999999999 110.74 -178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -89.7 -0.05 57.29 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 110.815 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.5 m -67.86 114.24 19.16 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.802 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -85.75 12.35 3.07 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.074 2.516 . . . . 64.230000000000004 114.943 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.54 145.31 33.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.963 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.14 157.49 2.58 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.725 -0.67 . . . . 73.109999999999999 112.656 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.04 38.66 9.99 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.963 -0.637 . . . . 72.200000000000003 112.187 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.5 p -152.55 173.19 15.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.206 0.527 . . . . 51.130000000000003 111.79 -177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 52.2 mt -127.16 124.38 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.636 -0.711 . . . . 71.439999999999998 110.786 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 1.6 pt? -91.81 137.38 32.42 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.932 -0.48 . . . . 52.020000000000003 111.244 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.408 ' HB3' ' OD1' ' A' ' 150' ' ' ASN . 27.3 tt0 -106.52 128.79 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 74.140000000000001 111.479 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 12.5 t -80.09 -56.87 3.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.979 0.733 . . . . 73.400000000000006 112.979 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 p 68.16 -53.46 0.53 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.221 1.008 . . . . 45.350000000000001 112.565 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.01 -28.91 26.4 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.973 0.731 . . . . 71.040000000000006 112.973 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -66.17 -2.27 13.17 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 114.413 0.525 . . . . 74.519999999999996 114.413 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.44 -65.63 3.82 Favored Glycine 0 CA--C 1.525 0.675 0 O-C-N 122.199 -0.589 . . . . 65.010000000000005 112.914 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.8 -0.4 13.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.994 0.426 . . . . 72.140000000000001 110.914 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.93 177.19 35.57 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.195 -0.526 . . . . 72.010000000000005 112.159 -170.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 19.6 t60 -175.0 138.32 0.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.748 0.309 . . . . 72.209999999999994 110.782 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.449 HG13 ' HB1' ' A' ' 76' ' ' ALA . 16.7 m -143.47 146.64 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.881 -0.599 . . . . 73.510000000000005 111.185 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.82 149.88 30.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.002 -0.545 . . . . 55.340000000000003 110.902 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -87.31 126.35 34.79 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.972 0.415 . . . . 73.120000000000005 111.38 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 124' ' ' VAL . 54.4 t -70.44 111.7 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.059 0.392 . . . . 74.409999999999997 112.059 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.04 -44.98 36.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.944 0.402 . . . . 75.329999999999998 111.648 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.5 164.03 29.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.06 0.457 . . . . 71.329999999999998 111.946 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.33 108.8 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.899 -0.591 . . . . 61.219999999999999 110.307 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.99 157.47 33.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.09 0.472 . . . . 63.219999999999999 111.959 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.8 m -61.29 -12.82 14.99 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.449 0.537 . . . . 70.439999999999998 112.449 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.97 -6.48 52.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.887 0.375 . . . . 63.240000000000002 111.705 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 92.14 -16.5 59.5 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 121.402 -0.428 . . . . 75.329999999999998 112.514 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.4 m -66.51 131.9 47.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.189 0.519 . . . . 74.209999999999994 111.95 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.1 t -99.72 124.82 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.969 -0.56 . . . . 72.010000000000005 111.475 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.89 111.43 23.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.928 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 113' ' ' VAL . 33.6 m -114.54 153.02 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.258 0.466 . . . . 74.109999999999999 112.258 -177.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -101.13 121.74 42.37 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.195 0.521 . . . . 53.520000000000003 111.437 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -127.68 124.16 37.24 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.896 -0.593 . . . . 72.219999999999999 111.329 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.486 ' SD ' ' HA2' ' A' ' 55' ' ' GLY . 44.5 ttm -65.82 112.41 3.73 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.943 -0.473 . . . . 72.129999999999995 110.457 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -138.24 -40.19 0.53 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.995 0.426 . . . . 64.319999999999993 111.765 -172.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.23 161.01 31.79 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.965 0.412 . . . . 45.450000000000003 111.579 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.87 116.79 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.442 -0.345 . . . . 73.25 111.034 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.85 -57.12 0.06 OUTLIER Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.831 -0.699 . . . . 75.329999999999998 113.086 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 164.56 -153.39 23.64 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.726 -0.75 . . . . 75.230000000000004 113.251 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.12 -21.31 21.6 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.039 2.493 . . . . 71.219999999999999 113.99 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.0 26.86 6.46 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.968 0.729 . . . . 72.219999999999999 112.968 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.4 p -86.74 72.36 10.19 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.162 0.982 . . . . 74.200000000000003 109.86 170.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 137' ' ' SER . 38.3 t -106.57 163.17 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 114.994 -1.003 . . . . 74.209999999999994 112.261 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 136' ' ' VAL . 88.5 p -122.38 140.43 52.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.833 -0.621 . . . . 74.329999999999998 110.288 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -96.14 103.88 15.8 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 74.209999999999994 110.161 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -103.57 105.8 16.14 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 111.626 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 40.2 m -87.71 104.93 17.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.794 0.33 . . . . 75.299999999999997 111.2 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.4 mt -93.38 140.28 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 122.494 0.317 . . . . 75.530000000000001 111.633 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.0 m -64.12 146.8 53.6 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.645 -0.252 . . . . 75.040000000000006 111.317 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.58 64.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.66 0.615 . . . . 74.430000000000007 112.66 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.61 -34.95 65.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.518 -0.372 . . . . 60.340000000000003 113.876 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.55 -35.29 17.01 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.964 0.412 . . . . 75.209999999999994 111.361 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.95 80.95 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.435 -0.348 . . . . 65.310000000000002 111.673 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.5 p -67.14 -8.71 33.05 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.863 0.363 . . . . 74.510000000000005 111.888 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.1 t -78.8 -11.82 60.0 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.093 0.473 . . . . 52.149999999999999 110.805 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 34.3 m-85 -106.16 135.11 48.21 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.054 -0.521 . . . . 72.400000000000006 110.316 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 101' ' ' GLN . 4.2 p-10 -82.11 129.69 34.88 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.995 0.426 . . . . 63.240000000000002 111.89 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -100.05 123.76 44.65 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.61 0.596 . . . . 73.030000000000001 112.61 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 80' ' ' ALA . 3.6 mp -86.5 123.95 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.135 -0.484 . . . . 72.120000000000005 110.576 173.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.2 149.64 35.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.547 0.339 . . . . 74.239999999999995 110.314 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 65' ' ' VAL . 24.7 mt -92.47 128.27 38.26 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.165 0.507 . . . . 72.340000000000003 111.427 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 111.834 -178.446 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 112.279 0.474 . . . . 74.420000000000002 112.279 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 56.17 83.63 0.09 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.307 0.575 . . . . 60.030000000000001 111.434 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -130.76 123.76 29.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.647 -0.706 . . . . 70.310000000000002 110.369 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -126.1 142.13 51.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.297 0.57 . . . . 70.310000000000002 112.173 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.41 -42.25 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.201 -0.454 . . . . 61.409999999999997 111.05 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.2 m 73.19 -55.01 0.69 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.269 0.627 . . . . 41.049999999999997 112.589 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.27 94.4 1.19 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.011 0.434 . . . . 72.430000000000007 111.368 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.5 p -87.85 124.51 33.73 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.007 0.432 . . . . 71.400000000000006 111.805 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 m -62.23 102.86 0.33 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.166 0.508 . . . . 53.140000000000001 111.457 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.88 174.86 6.74 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 111.956 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.4 m -136.4 128.22 29.18 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.565 -0.289 . . . . 63.240000000000002 111.41 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.49 143.41 32.55 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.934 0.397 . . . . 62.310000000000002 111.405 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.06 -109.6 0.41 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.169 -0.539 . . . . 74.129999999999995 113.027 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.5 pt 42.82 25.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 113.992 1.108 . . . . 60.25 113.992 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.82 98.23 1.97 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.069 -0.586 . . . . 72.450000000000003 112.86 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.29 135.86 8.22 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.591 -0.358 . . . . 75.420000000000002 111.818 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.19 147.91 13.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.912 0.387 . . . . 72.340000000000003 111.937 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.6 pt -133.92 150.15 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.879 0.371 . . . . 72.439999999999998 111.699 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -139.27 163.81 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-O 121.109 0.48 . . . . 71.530000000000001 111.984 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.08 151.8 19.96 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 116.083 -0.508 . . . . 71.040000000000006 112.4 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.65 119.53 38.99 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 122.203 -0.586 . . . . 71.329999999999998 111.968 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.61 155.64 21.05 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 112.051 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -148.67 149.6 31.76 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.2 -0.455 . . . . 65.329999999999998 111.227 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.07 -132.97 1.42 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.257 -0.497 . . . . 31.010000000000002 112.844 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -163.26 -175.21 4.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.759 0.314 . . . . 55.310000000000002 111.436 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.68 -90.44 0.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 120.828 0.347 . . . . 74.340000000000003 111.708 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.72 62.92 1.13 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.766 0.793 . . . . 54.409999999999997 109.998 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.14 9.12 2.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.342 -0.845 . . . . 75.040000000000006 112.817 -171.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 123.37 22.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.797 0.332 . . . . 73.540000000000006 111.022 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.4 92.72 2.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.134 0.492 . . . . 72.099999999999994 111.837 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.11 83.03 7.02 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.594 0.711 . . . . 62.119999999999997 111.517 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -86.03 3.67 41.31 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.528 -0.76 . . . . 51.039999999999999 110.784 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -95.51 156.48 16.31 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.08 0.467 . . . . 74.310000000000002 112.144 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.63 100.15 0.96 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.987 -0.551 . . . . 70.430000000000007 110.632 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.92 105.72 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.469 2.113 . . . . 41.219999999999999 113.063 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.3 t -86.74 -8.29 57.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.908 0.385 . . . . 51.030000000000001 111.478 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -70.72 141.46 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.377 -0.374 . . . . 70.239999999999995 111.501 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.04 -1.83 38.69 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.321 0.489 . . . . 63.450000000000003 112.321 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.6 p -68.36 90.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.029 0.442 . . . . 52.32 111.136 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.5 m 61.65 84.24 0.14 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.826 -0.625 . . . . 61.009999999999998 111.853 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 p -92.23 126.81 37.46 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.253 -0.431 . . . . 64.200000000000003 111.694 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -66.05 -48.8 69.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.726 0.298 . . . . 73.150000000000006 111.509 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.3 t -70.19 85.76 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.95 0.405 . . . . 72.209999999999994 111.077 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.6 m -90.69 121.26 32.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.324 -0.398 . . . . 74.019999999999996 110.972 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 98.9 p -66.44 140.46 58.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.999 0.428 . . . . 65.109999999999999 111.797 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.67 61.11 3.67 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.035 -0.603 . . . . 41.210000000000001 112.802 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -78.93 97.14 5.91 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.961 0.41 . . . . 55.109999999999999 110.746 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.8 t -108.0 110.18 21.83 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.113 0.482 . . . . 44.350000000000001 111.612 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.84 135.46 16.22 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.156 -0.475 . . . . 53.32 110.668 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -71.98 98.82 2.13 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.102 0.477 . . . . 54.25 110.603 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.8 mt -82.89 18.74 1.52 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.619 0.599 . . . . 74.310000000000002 112.619 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.21 -174.72 2.59 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.268 0.556 . . . . 75.109999999999999 111.292 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -105.41 143.27 33.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.216 0.531 . . . . 52.310000000000002 112.148 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 140.67 45.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.986 -0.552 . . . . 63.399999999999999 112.062 -176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.54 -18.86 43.58 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.243 -0.503 . . . . 71.430000000000007 113.257 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -96.11 161.15 14.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.884 0.373 . . . . 75.430000000000007 111.754 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.452 ' HA ' ' CE2' ' A' ' 60' ' ' TYR . 59.6 m -63.22 -43.35 98.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.003 0.43 . . . . 73.219999999999999 111.878 -177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 74' ' ' GLY . 72.3 p -61.1 -25.51 67.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.573 0.583 . . . . 75.219999999999999 112.573 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -60.45 -63.88 1.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.452 ' CE2' ' HA ' ' A' ' 57' ' ' CYS . 38.9 p90 -66.52 -29.12 69.14 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.064 0.394 . . . . 71.549999999999997 112.064 -175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 57' ' ' CYS . 59.2 t -62.12 -45.05 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.95 0.405 . . . . 54.109999999999999 110.874 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -56.4 -34.1 66.42 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.966 -0.561 . . . . 73.340000000000003 111.086 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.35 -46.43 22.86 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.207 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HD3' HG11 ' A' ' 136' ' ' VAL . 28.9 mmmt -57.74 -32.64 67.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.079 0.4 . . . . 72.329999999999998 112.079 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 65' ' ' VAL . 8.0 p -91.52 13.18 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.3 0.571 . . . . 71.310000000000002 111.455 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.98 22.67 58.14 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 116.396 -0.365 . . . . 71.129999999999995 113.936 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.86 22.21 64.2 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 114.326 0.49 . . . . 73.519999999999996 114.326 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -83.35 12.0 6.02 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.488 0.644 . . . . 73.510000000000005 112.284 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.85 176.34 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 120.966 0.412 . . . . 70.019999999999996 111.744 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.17 115.75 8.44 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.164 -0.541 . . . . 73.099999999999994 113.621 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 71.1 p -75.41 0.87 15.48 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.592 0.59 . . . . 72.409999999999997 112.592 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 t -119.76 20.45 12.28 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.014 0.376 . . . . 73.209999999999994 112.014 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -70.83 -37.76 73.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.08 0.467 . . . . 75.129999999999995 111.386 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' HG21 ' A' ' 58' ' ' THR . . . 67.29 -111.22 3.94 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.152 -0.477 . . . . 52.340000000000003 114.24 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.14 125.18 6.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.218 0.607 . . . . 71.519999999999996 112.522 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.12 60.85 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.287 0.477 . . . . 64.450000000000003 112.287 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -94.24 0.31 55.59 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.823 0.344 . . . . 74.319999999999993 111.573 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.84 -12.9 16.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.545 0.338 . . . . 71.439999999999998 111.694 -176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -57.99 -33.69 69.18 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.463 0.912 . . . . 74.349999999999994 113.463 -172.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.79 64.04 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.898 0.38 . . . . 71.109999999999999 111.344 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.8 t -64.21 -43.72 94.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.975 0.417 . . . . 75.540000000000006 111.128 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.11 96.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 73.25 111.413 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -57.76 -52.38 65.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.0 0.429 . . . . 75.349999999999994 110.633 175.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.0 t -58.8 -34.06 71.05 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.12 -0.491 . . . . 62.009999999999998 111.649 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 t -74.99 -25.71 59.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.819 0.342 . . . . 43.32 111.908 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.62 2.43 41.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.074 0.398 . . . . 65.349999999999994 112.074 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 41.55 14.17 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.325 -0.464 . . . . 74.239999999999995 113.943 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.448 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 66.5 m-85 -103.78 169.68 8.38 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.319 -0.518 . . . . 71.450000000000003 111.815 178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.416 HG22 HD22 ' A' ' 91' ' ' ASN . 55.4 m -97.07 98.84 10.39 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.052 -0.522 . . . . 73.409999999999997 112.367 -171.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.43 103.19 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.151 0.501 . . . . 65.209999999999994 112.283 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.416 HD22 HG22 ' A' ' 89' ' ' THR . 44.7 m-80 -139.06 162.57 34.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 110.307 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -86.46 3.84 42.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.408 0.521 . . . . 75.340000000000003 112.408 -177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.0 m -57.25 113.13 5.59 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 110.542 -0.17 . . . . 73.430000000000007 110.542 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.94 -1.52 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.737 2.291 . . . . 75.129999999999995 114.577 -172.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.71 139.57 9.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.874 0.694 . . . . 63.219999999999999 112.874 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.91 162.99 2.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.406 -0.816 . . . . 72.109999999999999 112.937 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.06 33.04 27.53 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.092 -0.575 . . . . 61.549999999999997 112.276 -176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 95.1 p -147.1 168.53 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.505 0.322 . . . . 71.430000000000007 110.834 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -115.7 124.44 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.345 -0.222 . . . . 74.310000000000002 110.659 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 151' ' ' TYR . 1.5 pt? -96.95 134.97 39.61 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.326 0.584 . . . . 63.210000000000001 111.703 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -97.72 101.59 13.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 110.976 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 26.5 t -77.97 -30.07 50.08 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.851 -0.613 . . . . 64.409999999999997 111.923 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 30.2 p 67.54 -28.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.105 0.962 . . . . 72.209999999999994 113.444 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.47 102.8 1.51 Allowed 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.815 -0.553 . . . . 61.539999999999999 111.872 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 155.05 45.99 0.02 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.936 -0.649 . . . . 62.229999999999997 113.613 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.56 -85.29 0.19 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.004 -0.617 . . . . 53.509999999999998 113.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -85.05 6.15 26.59 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.286 0.565 . . . . 74.409999999999997 110.973 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 103' ' ' THR . . . 104.69 178.97 24.68 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.886 -0.597 . . . . 45.049999999999997 113.175 -178.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -149.1 131.34 15.51 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.591 -0.358 . . . . 64.510000000000005 110.86 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.79 149.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.171 -0.468 . . . . 71.510000000000005 110.392 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 61' ' ' VAL . . . -155.84 152.45 28.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.991 0.424 . . . . 62.530000000000001 111.984 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -80.8 129.08 34.33 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.272 -0.422 . . . . 63.149999999999999 110.811 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.24 102.68 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.216 0.531 . . . . 64.109999999999999 111.058 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.59 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 18.5 mm-40 -62.22 -58.1 9.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.459 -0.791 . . . . 71.420000000000002 111.289 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -161.67 148.47 14.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.846 -0.615 . . . . 75.310000000000002 111.361 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.0 t -115.15 137.66 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.309 . . . . 73.140000000000001 110.721 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -107.54 150.52 26.74 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.863 0.363 . . . . 61.43 111.762 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 m -61.53 -36.98 82.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.382 0.882 . . . . 61.219999999999999 113.382 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.19 -45.09 79.94 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.21 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.61 62.43 0.05 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.996 -0.621 . . . . 51.32 113.255 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 62.9 m -147.5 134.21 19.99 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 122.477 -0.425 . . . . 73.120000000000005 111.341 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 117.7 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.635 -0.711 . . . . 73.540000000000006 110.988 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -88.03 117.42 26.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.141 -0.481 . . . . 74.5 110.981 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.01 150.24 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 121.312 0.577 . . . . 71.540000000000006 112.437 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.453 ' HB2' ' CG1' ' A' ' 136' ' ' VAL . 94.1 p -77.95 130.19 36.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.676 -0.693 . . . . 63.530000000000001 112.178 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -143.26 146.74 33.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.202 0.525 . . . . 75.239999999999995 112.306 174.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.411 ' HG3' ' OD1' ' A' ' 128' ' ' ASN . 57.3 tpp -99.54 156.48 17.03 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.077 -0.51 . . . . 72.540000000000006 110.264 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.411 ' OD1' ' HG3' ' A' ' 127' ' ' MET . 20.4 m120 59.31 40.63 21.0 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.447 0.642 . . . . 73.409999999999997 110.954 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 12.9 t80 -126.72 -171.23 2.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.06 -0.518 . . . . 74.329999999999998 110.563 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -43.86 100.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.951 0.723 . . . . 64.340000000000003 112.951 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 40.53 59.13 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 113.525 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.61 76.98 0.13 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.36 -0.924 . . . . 62.43 114.284 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.8 -42.49 0.32 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.414 2.076 . . . . 71.120000000000005 112.181 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -116.99 17.32 14.97 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.012 -0.54 . . . . 75.129999999999995 110.314 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.4 t -133.76 147.24 51.28 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.844 -0.616 . . . . 74.510000000000005 110.609 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 125' ' ' SER . 41.1 t -78.76 107.8 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.14 0.495 . . . . 63.130000000000003 111.95 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 129' ' ' TYR . 46.9 t -83.08 175.35 10.07 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.066 -0.515 . . . . 62.109999999999999 111.481 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 30.9 mt-10 -128.1 102.94 6.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.477 -0.329 . . . . 72.340000000000003 111.665 -175.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -79.77 125.2 29.38 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.637 0.256 . . . . 64.530000000000001 110.631 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 38.9 m -91.33 99.54 12.49 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.99 0.424 . . . . 60.240000000000002 110.853 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.89 137.94 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.041 0.386 . . . . 73.120000000000005 112.041 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 52.5 m -61.6 151.5 33.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.941 0.4 . . . . 72.400000000000006 111.8 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.87 82.69 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.248 0.462 . . . . 72.439999999999998 112.248 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.13 74.79 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.418 -0.42 . . . . 51.530000000000001 113.426 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -74.96 -54.66 6.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.262 0.553 . . . . 71.150000000000006 111.129 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -61.48 -40.46 94.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.783 0.66 . . . . 54.240000000000002 112.783 -176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 82.3 p -62.07 -16.13 49.89 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.125 0.417 . . . . 43.210000000000001 112.125 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.8 t -76.69 -17.83 58.89 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.952 0.406 . . . . 73.319999999999993 111.317 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 102' ' ' SER . 16.8 m-85 -93.06 152.95 18.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.21 0.529 . . . . 71.120000000000005 111.847 -175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.04 132.17 35.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.256 -0.429 . . . . 72.329999999999998 111.035 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 94.5 m-85 -106.84 129.83 54.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.781 0.8 . . . . 74.129999999999995 112.807 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 12.7 mt -92.76 112.08 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.294 -0.866 . . . . 62.049999999999997 110.798 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -106.2 141.38 37.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.954 0.407 . . . . 71.129999999999995 111.543 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.2 mt -96.62 -40.61 8.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.088 -0.505 . . . . 54.100000000000001 111.181 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 . . . . . 0 N--CA 1.477 0.917 0 C-N-CA 123.031 0.532 . . . . 74.219999999999999 112.349 178.711 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.489 0.185 . . . . 52.420000000000002 111.464 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -76.1 104.99 6.89 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 72.409999999999997 110.856 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.517 ' HG3' ' HG ' ' A' ' 4' ' ' LEU . 5.2 tppp? -84.91 -61.73 1.71 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.345 -0.388 . . . . 54.409999999999997 111.678 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.517 ' HG ' ' HG3' ' A' ' 3' ' ' LYS . 93.2 mt -129.65 155.52 45.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.912 0.387 . . . . 55.229999999999997 111.331 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -140.46 131.03 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.993 0.425 . . . . 72.430000000000007 111.4 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.4 m -124.97 132.5 53.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 111.941 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.43 112.25 22.02 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.805 0.336 . . . . 62.009999999999998 110.684 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.0 p -108.53 -32.87 7.22 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.898 0.703 . . . . 72.219999999999999 112.898 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.41 ' C ' HD12 ' A' ' 10' ' ' LEU . 8.6 t -87.67 134.52 33.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.862 0.689 . . . . 62.130000000000003 112.862 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.41 HD12 ' C ' ' A' ' 9' ' ' THR . 7.2 mp -122.16 147.06 46.63 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.372 -0.376 . . . . 70.319999999999993 110.605 173.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.6 m -70.01 102.2 1.97 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 74.549999999999997 111.943 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.63 114.95 9.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.881 0.372 . . . . 34.030000000000001 111.164 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.83 -144.05 3.89 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.294 -0.479 . . . . 52.32 112.601 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 14' ' ' ILE . 20.6 pt -140.22 96.73 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.342 0.591 . . . . 63.32 111.707 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.19 54.65 1.56 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.002 -0.618 . . . . 62.420000000000002 113.316 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 119.61 19.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.903 0.334 . . . . 55.200000000000003 111.903 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.86 138.51 21.92 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.036 0.384 . . . . 73.510000000000005 112.036 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -129.95 128.17 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.543 0.337 . . . . 73.230000000000004 111.142 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.71 -78.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.896 0.702 . . . . 65.310000000000002 112.896 -174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.51 73.83 1.24 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 120.969 -0.634 . . . . 54.219999999999999 113.074 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -87.73 137.65 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.321 0.489 . . . . 72.299999999999997 112.321 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -169.7 132.67 1.19 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.081 -0.508 . . . . 61.140000000000001 110.933 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -171.07 136.31 1.07 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.826 0.346 . . . . 74.140000000000001 111.639 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.51 116.33 3.04 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.162 -0.542 . . . . 23.219999999999999 113.594 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -150.94 133.31 15.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.334 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -142.41 143.06 32.49 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.882 0.372 . . . . 55.329999999999998 111.315 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 90.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.945 0.402 . . . . 64.239999999999995 112.012 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -80.44 171.55 14.9 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.826 0.346 . . . . 73.329999999999998 111.679 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.87 156.63 39.34 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.011 0.375 . . . . 61.130000000000003 112.011 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.84 86.8 0.05 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.873 0.368 . . . . 65.519999999999996 111.744 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.66 119.29 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.189 -0.319 . . . . 62.310000000000002 110.893 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -127.31 152.12 47.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.105 0.478 . . . . 61.240000000000002 111.804 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.3 p -111.72 150.96 29.48 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.082 -0.508 . . . . 71.140000000000001 110.87 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -130.68 159.79 69.39 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.486 -0.324 . . . . 73.310000000000002 111.249 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -72.8 30.47 0.29 Allowed 'Trans proline' 0 CA--C 1.548 1.196 0 C-N-CA 122.752 2.301 . . . . 74.349999999999994 113.509 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.9 p -78.39 -171.66 2.53 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 72.319999999999993 110.975 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -73.42 -174.71 1.73 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 122.14 -0.35 . . . . 72.219999999999999 110.877 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -132.84 101.96 5.46 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.786 0.661 . . . . 73.420000000000002 112.786 -173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.8 m -79.58 160.73 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.202 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.6 t -87.76 143.83 26.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.397 -0.365 . . . . 60.32 110.048 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p 54.25 95.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.349 0.595 . . . . 62.520000000000003 111.37 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 42' ' ' GLN . 1.2 mp0 -81.47 165.4 21.26 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.966 0.412 . . . . 71.209999999999994 111.982 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.7 m -60.94 123.52 17.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.331 -0.395 . . . . 75.319999999999993 110.691 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.8 p -57.62 -63.93 1.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.691 0.626 . . . . 74.120000000000005 112.691 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -161.33 135.92 7.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.912 0.387 . . . . 73.140000000000001 111.952 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.74 -178.27 50.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.264 -0.493 . . . . 62.109999999999999 112.207 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 64.0 m -143.12 148.46 36.65 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 122.151 -0.617 . . . . 74.25 111.641 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 m -90.33 -22.27 21.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.468 -0.333 . . . . 72.129999999999995 111.631 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.91 95.51 0.16 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.19 0.441 . . . . 73.430000000000007 112.19 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -88.36 142.06 28.04 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.902 0.382 . . . . 61.219999999999999 111.199 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.8 mt -94.76 15.79 17.46 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.307 0.484 . . . . 51.109999999999999 112.307 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -114.51 -174.21 2.44 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.067 0.46 . . . . 73.349999999999994 111.719 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 t -129.67 160.75 32.38 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.32 -0.4 . . . . 73.150000000000006 111.787 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 35.06 0.1 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.54 0.941 . . . . 63.149999999999999 113.54 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.68 4.72 1.27 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.221 -0.514 . . . . 63.229999999999997 113.556 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.69 147.04 42.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.997 0.399 . . . . 74.299999999999997 111.212 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 60' ' ' TYR . 63.7 m -54.93 -31.52 60.44 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.209 0.528 . . . . 64.5 111.259 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.6 p -68.04 -18.15 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.039 0.755 . . . . 73.120000000000005 113.039 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 43.4 t90 -75.81 -71.22 0.39 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.942 0.719 . . . . 75.219999999999999 112.942 -175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.527 ' HB2' HG22 ' A' ' 136' ' ' VAL . 12.6 p90 -59.93 -18.42 45.08 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.384 0.883 . . . . 74.239999999999995 113.384 -171.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.13 -34.78 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.21 0.528 . . . . 73.209999999999994 110.749 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 71' ' ' SER . 72.7 t80 -56.94 -51.86 67.48 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.712 -0.676 . . . . 62.439999999999998 111.294 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.48 -42.77 92.85 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.324 -0.398 . . . . 71.340000000000003 111.602 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -66.33 -31.96 73.07 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.326 0.491 . . . . 55.119999999999997 112.326 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.0 p -90.86 9.69 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.475 0.655 . . . . 71.319999999999993 111.402 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.5 14.83 65.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.426 -0.416 . . . . 65.430000000000007 113.671 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.39 7.73 64.63 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.41 0.524 . . . . 72.140000000000001 114.41 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -78.45 35.05 0.22 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.263 0.532 . . . . 75.129999999999995 112.371 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.8 pt -121.44 -30.46 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.134 0.42 . . . . 73.219999999999999 112.134 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.31 9.44 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.07 -0.586 . . . . 53.039999999999999 113.289 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.526 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . 53.2 p 59.6 4.8 0.57 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.287 0.847 . . . . 72.439999999999998 113.287 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -84.95 9.6 14.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.165 0.507 . . . . 55.219999999999999 111.571 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.4 m0 -79.36 -36.67 38.97 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.322 -0.399 . . . . 72.519999999999996 111.593 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.36 -122.63 6.02 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.023 -0.608 . . . . 64.439999999999998 113.964 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -51.6 141.44 16.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.421 0.526 . . . . 71.209999999999994 112.421 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -31.9 72.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.195 0.442 . . . . 63.439999999999998 112.195 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.38 1.93 20.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.807 0.337 . . . . 74.420000000000002 111.661 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.95 -6.97 12.58 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.132 0.419 . . . . 54.109999999999999 112.132 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.39 -56.47 21.62 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.682 0.623 . . . . 73.409999999999997 112.682 -176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.51 75.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 71.040000000000006 111.552 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.5 m -60.69 -52.53 64.74 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.162 0.506 . . . . 71.329999999999998 110.977 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.21 78.66 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.01 -0.541 . . . . 55.140000000000001 111.196 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -58.38 8.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.393 -0.367 . . . . 72.329999999999998 111.512 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.6 p -58.89 -37.09 75.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.836 0.351 . . . . 70.030000000000001 111.735 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -71.52 -39.81 70.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.383 -0.371 . . . . 61.340000000000003 111.392 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.5 10.57 5.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.664 0.616 . . . . 54.450000000000003 112.664 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.94 66.67 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.012 -0.613 . . . . 64.329999999999998 114.334 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -76.79 164.3 25.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.514 0.657 . . . . 63.219999999999999 110.999 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.401 HG22 ' OD1' ' A' ' 91' ' ' ASN . 85.4 m -100.5 100.35 11.08 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 111.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 152' ' ' ILE . 48.1 t -108.83 119.88 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.773 0.32 . . . . 71.430000000000007 111.572 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.401 ' OD1' HG22 ' A' ' 89' ' ' THR . 7.5 m120 -140.13 -176.15 4.5 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.987 0.422 . . . . 75.310000000000002 111.19 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -97.57 4.07 50.37 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.907 0.384 . . . . 75.420000000000002 111.182 173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.6 m -67.71 114.1 18.06 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.274 -0.421 . . . . 65.450000000000003 110.439 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.69 22.9 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.968 2.445 . . . . 50.350000000000001 114.584 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -61.08 149.69 36.3 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.959 0.726 . . . . 71.329999999999998 112.959 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.38 163.06 4.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.71 -0.677 . . . . 53.140000000000001 112.467 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.63 34.53 73.09 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.947 -0.644 . . . . 71.109999999999999 112.626 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.1 m -139.01 165.83 26.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.654 0.264 . . . . 52.109999999999999 111.105 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.7 mp -116.86 127.56 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 110.446 -0.205 . . . . 71.019999999999996 110.446 177.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.498 HD21 ' HB3' ' A' ' 111' ' ' ALA . 1.7 pt? -99.83 144.94 28.31 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.848 -0.533 . . . . 75.129999999999995 110.993 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -121.62 133.56 54.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.4 0.619 . . . . 63.020000000000003 112.536 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 109' ' ' HIS . 29.7 t -112.36 115.58 28.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.35 -0.841 . . . . 65.310000000000002 110.657 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.7 p -91.99 13.9 17.36 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.887 0.375 . . . . 52.329999999999998 111.593 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.39 -44.34 58.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.538 0.569 . . . . 65.030000000000001 112.538 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -96.34 72.11 0.83 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.184 -0.531 . . . . 74.219999999999999 114.295 -174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 48.31 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.736 0.654 . . . . 62.329999999999998 114.736 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.25 -23.75 65.88 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.095 0.558 . . . . 44.210000000000001 111.649 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.21 171.23 33.66 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.137 -0.554 . . . . 73.109999999999999 113.333 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 102' ' ' SER . 73.0 t60 -143.85 141.93 30.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.565 -0.374 . . . . 64.319999999999993 111.2 178.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 100' ' ' LEU . 20.5 m -139.17 146.34 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.505 -0.316 . . . . 74.120000000000005 111.114 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.498 ' HB3' HD21 ' A' ' 100' ' ' LEU . . . -153.74 154.64 34.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.03 0.443 . . . . 71.099999999999994 112.125 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -91.18 121.21 32.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 111.535 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.5 t -64.65 114.33 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 112.03 0.381 . . . . 74.439999999999998 112.03 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 138' ' ' GLU . 10.1 mm-40 -78.78 -56.69 4.21 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.295 -0.411 . . . . 73.420000000000002 111.635 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -149.46 141.66 24.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.411 0.523 . . . . 64.510000000000005 112.411 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.32 126.33 66.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 111.071 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -94.42 144.12 25.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.753 0.311 . . . . 72.519999999999996 111.093 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.6 t -60.91 -25.74 66.95 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.223 0.535 . . . . 75.340000000000003 111.549 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -64.49 -16.32 62.29 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.992 -0.549 . . . . 75.019999999999996 111.59 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.86 -14.98 37.67 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.28 -0.418 . . . . 42.219999999999999 112.952 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.1 m -66.68 120.99 14.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 64.409999999999997 111.499 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.4 t -107.57 116.93 52.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.306 0.574 . . . . 54.119999999999997 111.178 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.14 113.69 25.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 111.005 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.1 m -106.94 167.11 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.196 0.522 . . . . 65.109999999999999 112.146 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.1 t -108.01 105.59 15.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.096 -0.502 . . . . 44.329999999999998 111.088 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 137' ' ' SER . 5.8 pt-20 -141.69 118.58 11.16 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.27 -0.423 . . . . 53.130000000000003 111.382 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 42.1 ttm -67.4 117.19 9.04 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.218 -0.301 . . . . 53.530000000000001 110.703 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -114.69 -76.58 0.58 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 72.439999999999998 111.794 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -118.78 -52.3 2.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.408 -0.36 . . . . 74.129999999999995 111.535 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -124.11 148.9 46.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.624 -0.262 . . . . 51.210000000000001 110.72 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 163.26 -64.41 0.25 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.223 -0.513 . . . . 54.399999999999999 112.45 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 148.6 154.83 6.44 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.291 -0.48 . . . . 42.539999999999999 112.263 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.68 -36.37 72.06 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.749 2.299 . . . . 74.439999999999998 113.472 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -116.36 -5.84 11.78 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.906 0.384 . . . . 63.130000000000003 111.5 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -100.23 128.2 46.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.335 -0.393 . . . . 60.030000000000001 111.102 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 60' ' ' TYR . 14.7 t -95.11 139.53 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.839 0.352 . . . . 65.049999999999997 111.874 -174.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 1.5 m -75.6 175.06 8.94 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.499 -0.318 . . . . 72.349999999999994 110.821 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 114' ' ' GLU . 42.2 mt-10 -133.29 133.9 43.19 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.91 0.386 . . . . 74.030000000000001 111.959 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -114.5 122.99 48.27 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.433 -0.348 . . . . 71.299999999999997 111.176 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 56.2 m -85.66 99.79 11.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.775 0.322 . . . . 64.019999999999996 110.505 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.9 mt -93.27 139.78 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.912 0.387 . . . . 73.530000000000001 111.925 -175.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.3 m -69.17 150.78 47.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.338 -0.392 . . . . 71.409999999999997 111.734 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.93 -52.38 58.04 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.463 0.542 . . . . 74.310000000000002 112.463 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.28 -13.0 34.11 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 116.117 -0.492 . . . . 72.439999999999998 114.018 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -101.77 -49.81 3.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.093 0.473 . . . . 71.230000000000004 110.959 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' OH ' ' A' ' 151' ' ' TYR . . . -56.88 -50.42 72.56 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.621 0.6 . . . . 74.530000000000001 112.621 -175.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 68.3 m -60.69 -9.52 4.06 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.064 0.764 . . . . 35.140000000000001 113.064 -177.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 32.0 t -83.37 -19.79 35.44 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.932 0.396 . . . . 64.230000000000004 111.548 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -85.91 161.58 18.98 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.155 0.502 . . . . 74.239999999999995 112.096 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 54.0 m-20 -89.29 117.76 28.48 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.493 -0.321 . . . . 73.430000000000007 111.265 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.417 ' OH ' ' HB1' ' A' ' 146' ' ' ALA . 93.7 m-85 -99.89 113.1 25.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.299 0.481 . . . . 74.129999999999995 112.299 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 152' ' ' ILE . 3.7 mp -83.06 134.73 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.374 -0.376 . . . . 71.409999999999997 110.272 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -122.99 142.79 50.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.967 0.413 . . . . 63.130000000000003 111.354 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.7 mt -110.68 -37.69 5.37 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 111.796 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 123.038 0.535 . . . . 63.530000000000001 111.579 -173.833 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HG3' ' HG3' ' A' ' 2' ' ' LYS . 14.0 ptp . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 112.352 0.501 . . . . 72.219999999999999 112.352 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 1' ' ' MET . 68.5 mttm -92.01 142.59 27.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.224 0.535 . . . . 63.350000000000001 112.257 -175.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -123.68 171.25 9.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.986 -0.552 . . . . 75.420000000000002 110.334 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -148.7 175.15 11.46 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.073 0.463 . . . . 75.140000000000001 112.125 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.05 161.33 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.066 -0.516 . . . . 65.019999999999996 111.653 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.5 p -82.88 94.2 7.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.831 0.348 . . . . 60.549999999999997 111.165 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.33 117.35 32.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.503 0.557 . . . . 33.240000000000002 112.503 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -151.48 178.71 9.02 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.28 -0.418 . . . . 54.109999999999999 110.826 173.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -123.92 133.5 53.71 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.699 0.285 . . . . 74.129999999999995 111.642 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 10' ' ' LEU . 2.6 pp -134.85 133.77 40.07 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.18 0.514 . . . . 63.219999999999999 110.696 173.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -107.01 123.71 48.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.372 0.508 . . . . 61.340000000000003 112.372 -173.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 139.15 40.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.428 -0.351 . . . . 52.43 111.138 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 63.35 0.31 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.995 -0.621 . . . . 62.450000000000003 113.286 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.0 pt -96.74 155.03 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 122.506 -0.408 . . . . 75.510000000000005 111.531 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.3 92.23 0.09 OUTLIER Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.868 -0.682 . . . . 71.340000000000003 113.24 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.99 107.31 19.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.973 0.416 . . . . 65.150000000000006 111.816 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.87 151.69 22.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.954 0.407 . . . . 73.439999999999998 111.591 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.16 163.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.93 0.395 . . . . 73.450000000000003 111.583 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -97.39 100.14 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.892 0.377 . . . . 70.25 110.723 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.2 122.54 6.55 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.146 -0.55 . . . . 62.219999999999999 113.174 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -141.79 115.46 9.09 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.87 0.366 . . . . 71.420000000000002 110.157 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.15 136.9 32.75 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.903 0.382 . . . . 65.230000000000004 111.051 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -151.34 145.05 25.03 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.054 0.454 . . . . 71.120000000000005 112.086 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.61 167.1 26.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.056 -0.52 . . . . 63.509999999999998 112.515 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -151.73 112.91 4.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.396 0.517 . . . . 42.32 112.396 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -150.11 133.23 16.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.349 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.46 112.22 6.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 111.998 0.37 . . . . 64.010000000000005 111.998 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.86 112.64 24.31 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.913 0.387 . . . . 71.0 111.448 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.1 47.59 1.8 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.089 0.471 . . . . 54.109999999999999 110.553 177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.62 109.1 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.836 -0.62 . . . . 62.520000000000003 112.408 -175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.59 87.06 1.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.01 -0.541 . . . . 72.329999999999998 111.32 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.57 95.64 10.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.1 -0.5 . . . . 63.350000000000001 111.103 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 t -89.65 1.36 56.12 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.266 0.555 . . . . 71.230000000000004 110.962 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 57.37 78.85 0.35 Allowed Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 115.336 -0.847 . . . . 74.230000000000004 112.238 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.72 100.21 0.97 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.638 2.225 . . . . 64.109999999999999 112.323 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.5 p -92.94 151.83 19.71 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 71.200000000000003 111.754 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.18 164.56 24.2 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.259 -0.428 . . . . 71.540000000000006 111.232 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -69.15 -40.02 78.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.863 0.363 . . . . 71.519999999999996 111.494 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -165.76 115.36 1.01 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.436 -0.347 . . . . 62.210000000000001 110.704 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -74.48 72.87 1.9 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.849 0.833 . . . . 64.230000000000004 111.712 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.5 m -143.41 90.86 2.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.691 -0.686 . . . . 73.0 110.385 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 111.8 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.0 m -74.85 75.39 2.13 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.06 0.457 . . . . 51.229999999999997 111.773 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -78.64 -52.3 8.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.552 0.692 . . . . 73.510000000000005 109.74 172.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 68' ' ' ASN . 33.9 t -106.12 86.4 2.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.215 -0.902 . . . . 72.120000000000005 110.445 171.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.64 -31.01 0.79 Allowed Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.318 -0.468 . . . . 70.120000000000005 113.004 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.6 p -77.43 81.26 3.91 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.354 0.597 . . . . 54.299999999999997 111.677 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -71.86 85.73 0.96 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.881 -0.6 . . . . 63.200000000000003 111.198 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.37 119.18 30.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.153 -0.476 . . . . 34.140000000000001 111.55 -178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -82.71 94.27 7.56 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 73.200000000000003 111.179 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.442 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 3.4 mm? -68.67 -18.34 64.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.787 0.327 . . . . 71.310000000000002 111.443 177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -73.48 174.23 8.51 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.454 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t -105.93 149.33 26.69 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.188 0.518 . . . . 71.329999999999998 111.945 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 115.2 9.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.915 -0.584 . . . . 65.209999999999994 111.273 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.92 -13.22 7.2 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.172 -0.537 . . . . 65.200000000000003 112.887 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -100.03 144.99 28.42 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.787 0.327 . . . . 74.099999999999994 111.144 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.6 m -56.01 -25.87 46.27 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.117 0.414 . . . . 74.140000000000001 112.117 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.2 p -67.21 -27.22 67.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.275 0.472 . . . . 51.409999999999997 112.275 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -65.64 -64.07 0.95 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.806 0.669 . . . . 74.510000000000005 112.806 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' HB3' ' SD ' ' A' ' 127' ' ' MET . 34.6 p90 -63.49 -32.48 73.94 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.048 0.388 . . . . 64.140000000000001 112.048 -174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 110' ' ' VAL . 66.1 t -62.62 -37.17 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.765 0.317 . . . . 72.319999999999993 111.442 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -59.15 -37.36 77.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.057 0.456 . . . . 74.540000000000006 110.84 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.11 -40.82 62.42 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.179 -0.464 . . . . 71.519999999999996 110.998 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -57.75 -44.88 86.39 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.093 0.473 . . . . 63.240000000000002 111.753 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.42 -3.14 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.106 0.479 . . . . 71.030000000000001 111.424 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.15 22.37 73.89 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.47 -0.395 . . . . 73.230000000000004 113.703 177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.25 15.38 65.47 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 114.325 0.49 . . . . 25.039999999999999 114.325 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 45' ' ' SER . 49.6 m-80 -79.68 2.65 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.644 0.609 . . . . 61.310000000000002 112.644 -177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.7 pt -109.43 149.56 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.166 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.36 110.5 3.2 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.826 -0.702 . . . . 31.539999999999999 112.674 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 51' ' ' LEU . 28.7 t -64.47 -3.24 2.83 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 122.413 -0.463 . . . . 63.32 112.24 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 t -64.12 -13.33 47.17 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.256 0.465 . . . . 70.439999999999998 112.256 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -59.11 -50.07 75.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.96 0.409 . . . . 65.319999999999993 111.424 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.58 -128.26 9.33 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.162 -0.542 . . . . 61.140000000000001 113.38 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.71 140.47 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.068 0.461 . . . . 75.230000000000004 111.83 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.99 -41.28 64.46 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.118 0.784 . . . . 73.209999999999994 113.118 -173.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.62 -22.62 65.4 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -84.54 -24.2 29.41 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.748 0.277 . . . . 72.450000000000003 111.748 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -45.37 -46.98 13.48 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.996 0.739 . . . . 75.430000000000007 112.996 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.26 -40.46 81.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.125 0.488 . . . . 63.439999999999998 112.181 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.0 t -80.4 -47.5 14.3 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.881 0.372 . . . . 74.049999999999997 111.617 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.94 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.359 -0.382 . . . . 73.409999999999997 111.602 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 88' ' ' TYR . . . -60.55 -53.78 53.33 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.261 . . . . 53.310000000000002 111.327 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 81.0 p -59.77 -42.47 93.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.89 0.376 . . . . 72.010000000000005 111.225 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 t -65.61 -29.77 70.4 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.374 -0.376 . . . . 75.030000000000001 111.543 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.18 -4.34 59.15 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.435 0.531 . . . . 74.25 112.435 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 99.45 3.18 56.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.262 -0.494 . . . . 72.25 113.853 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.432 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 81.7 m-85 -72.3 173.79 8.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.301 0.572 . . . . 74.340000000000003 111.423 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 153' ' ' HIS . 35.4 m -106.24 84.85 2.1 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.09 0.404 . . . . 73.400000000000006 112.09 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 HG13 ' A' ' 152' ' ' ILE . 49.5 t -93.9 111.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.85 0.357 . . . . 74.549999999999997 111.562 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -149.06 159.96 43.76 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.348 -0.387 . . . . 74.450000000000003 110.779 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -75.2 24.36 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.447 0.536 . . . . 75.209999999999994 112.447 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.3 t -81.04 108.64 10.8 Favored Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.387 0.275 . . . . 75.209999999999994 110.83 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.45 7.9 4.72 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.833 2.355 . . . . 62.340000000000003 114.395 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -51.59 143.07 13.02 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.158 0.429 . . . . 70.120000000000005 112.158 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 152.7 11.41 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.655 0.613 . . . . 75.209999999999994 112.655 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.52 13.78 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.133 -0.556 . . . . 64.010000000000005 113.114 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.3 p -144.86 178.4 8.04 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 71.129999999999995 111.06 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 62.7 mt -124.58 120.06 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.551 -0.295 . . . . 74.430000000000007 111.211 -176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.469 HD12 ' CD2' ' A' ' 149' ' ' TYR . 1.9 pt? -85.59 126.87 34.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 72.129999999999995 111.233 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 111.26 23.93 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.976 0.417 . . . . 73.310000000000002 109.927 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . 21.4 t -66.02 -55.86 14.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.238 1.199 . . . . 61.039999999999999 114.238 -169.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 36.7 p 59.63 -1.29 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.639 0.977 . . . . 51.310000000000002 113.639 -172.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.91 115.71 5.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.341 0.497 . . . . 73.319999999999993 112.341 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.41 -44.19 3.16 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.291 -0.48 . . . . 43.229999999999997 113.566 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 150.07 -45.97 0.65 Allowed Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.304 -0.474 . . . . 61.140000000000001 112.587 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -64.68 85.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.468 0.651 . . . . 71.209999999999994 110.811 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 76' ' ' ALA . . . -51.02 113.38 2.15 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.215 -0.902 . . . . 50.450000000000003 113.938 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -111.91 143.31 43.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.542 0.337 . . . . 73.340000000000003 111.038 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.531 HG13 ' HB1' ' A' ' 76' ' ' ALA . 11.7 m -141.17 150.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.08 0.467 . . . . 70.140000000000001 111.824 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.415 ' H ' HD23 ' A' ' 100' ' ' LEU . . . -156.42 168.94 25.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.813 -0.63 . . . . 63.200000000000003 110.561 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -100.43 129.55 46.4 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 111.281 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.35 112.66 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.778 0.323 . . . . 60.25 111.689 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.29 -53.95 4.91 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.12 0.415 . . . . 70.329999999999998 112.12 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -143.18 150.43 39.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.993 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.19 131.98 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.886 -0.597 . . . . 70.239999999999995 110.757 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.57 156.3 16.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.475 -0.33 . . . . 53.299999999999997 111.302 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.8 p -64.66 -18.35 64.88 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.137 0.421 . . . . 55.049999999999997 112.137 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -69.47 -9.78 55.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.817 0.342 . . . . 73.519999999999996 111.443 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 143' ' ' ALA . . . 93.5 0.07 67.57 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 112.214 -0.354 . . . . 70.439999999999998 112.214 -174.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.1 m -67.89 120.73 14.66 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 110.926 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.4 t -105.22 119.19 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.967 0.413 . . . . 72.400000000000006 111.659 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.55 107.12 19.49 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.191 0.519 . . . . 74.400000000000006 110.929 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.58 144.45 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.013 -0.54 . . . . 55.219999999999999 111.771 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 t -90.98 112.83 24.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.333 -0.394 . . . . 74.010000000000005 111.379 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -116.39 -173.08 2.3 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.037 -0.529 . . . . 63.219999999999999 110.964 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' A' ' 60' ' ' TYR . 19.2 ptm -133.9 124.76 26.96 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.213 0.53 . . . . 64.409999999999997 110.77 173.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -83.86 42.66 0.87 Allowed 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.139 -0.351 . . . . 71.530000000000001 111.748 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -53.11 -33.6 52.97 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.007 0.432 . . . . 63.549999999999997 111.759 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -66.91 -27.31 67.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.19 -0.459 . . . . 54.539999999999999 112.007 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.03 -58.07 0.76 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.484 -0.388 . . . . 64.230000000000004 112.788 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.41 172.46 14.22 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.585 -0.34 . . . . 73.209999999999994 113.493 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.25 96.94 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.843 2.362 . . . . 73.209999999999994 113.372 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 45.6 p90 43.37 24.45 0.05 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.943 1.09 . . . . 54.409999999999997 113.943 174.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 28.6 t -71.6 130.48 41.31 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.143 0.423 . . . . 74.540000000000006 112.143 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 127' ' ' MET . 77.1 t -95.43 125.4 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.772 0.32 . . . . 71.329999999999998 111.108 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -141.79 167.05 23.06 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.261 0.467 . . . . 72.019999999999996 112.261 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -99.12 137.06 38.19 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.163 -0.471 . . . . 71.150000000000006 111.945 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -111.94 125.41 54.03 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.025 -0.422 . . . . 60.030000000000001 110.77 172.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.1 m -91.54 105.12 17.51 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.964 0.411 . . . . 64.0 111.619 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.18 139.93 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.375 -0.375 . . . . 70.310000000000002 111.555 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.2 m -72.36 155.31 40.29 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.681 0.277 . . . . 70.420000000000002 111.679 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HB2' ' HA3' ' A' ' 120' ' ' GLY . . . -54.99 -48.19 73.63 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.535 0.569 . . . . 72.099999999999994 112.535 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.33 -41.08 92.88 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.478 -0.392 . . . . 62.25 113.41 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -75.51 -45.3 39.0 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.249 0.547 . . . . 64.230000000000004 111.236 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 149' ' ' TYR . . . -64.81 -38.1 89.85 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.837 0.68 . . . . 65.319999999999993 112.837 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m -62.47 -15.63 50.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.615 0.598 . . . . 74.120000000000005 112.615 -175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -79.53 -28.35 41.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.904 0.383 . . . . 73.25 111.796 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 100' ' ' LEU . 22.9 m-85 -74.14 147.84 42.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.163 0.506 . . . . 64.25 111.969 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -91.99 108.12 19.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.233 -0.439 . . . . 75.510000000000005 110.781 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 71.3 m-85 -88.22 119.08 28.27 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.948 0.404 . . . . 71.25 111.803 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 90' ' ' VAL . 3.6 mp -82.21 130.18 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.959 0.409 . . . . 64.310000000000002 110.731 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.46 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 46.4 m-70 -120.39 161.95 20.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.969 0.508 . . . . 74.129999999999995 109.87 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.6 mt -105.87 141.67 36.89 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.754 0.65 . . . . 62.219999999999999 112.754 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 CA--C 1.544 0.713 0 CA-C-N 115.7 -0.682 . . . . 71.299999999999997 111.026 179.42 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.867 0.365 . . . . 72.400000000000006 111.155 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 9.2 mmpt? -142.36 149.71 39.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.79 0.436 . . . . 75.25 110.446 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -153.26 120.5 5.83 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.599 0.592 . . . . 75.310000000000002 112.599 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.89 148.72 43.66 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.724 -0.671 . . . . 72.340000000000003 110.011 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -162.32 144.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 112.389 0.514 . . . . 74.129999999999995 112.389 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 8' ' ' THR . 54.2 m -95.84 97.11 9.4 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.081 0.467 . . . . 60.009999999999998 110.348 173.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.02 2.66 38.02 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.034 1.124 . . . . 75.420000000000002 114.034 -169.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 6' ' ' THR . 11.8 t -71.16 162.42 29.45 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.661 0.615 . . . . 74.030000000000001 112.661 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.9 m -152.78 139.36 18.74 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.711 -0.677 . . . . 74.030000000000001 111.016 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 10' ' ' LEU . 5.4 mp -106.75 113.08 26.36 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.825 0.345 . . . . 71.510000000000005 111.329 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.2 m -124.56 107.38 10.99 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.366 -0.209 . . . . 73.129999999999995 111.44 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -173.22 140.99 0.9 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.771 0.319 . . . . 53.409999999999997 111.641 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.16 111.01 0.26 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.377 -0.44 . . . . 63.420000000000002 112.873 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.7 tt -106.34 136.0 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.1 0.476 . . . . 72.040000000000006 112.265 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.04 83.02 0.34 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.388 -0.434 . . . . 65.209999999999994 112.577 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.92 135.65 33.23 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.415 -0.462 . . . . 72.5 112.051 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.6 103.56 0.71 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.697 0.284 . . . . 63.450000000000003 111.688 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -93.41 178.53 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.2 0.444 . . . . 53.520000000000003 112.2 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.4 t -116.11 140.07 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.861 0.363 . . . . 73.219999999999999 111.797 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.16 115.45 0.63 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.262 -0.426 . . . . 65.510000000000005 112.568 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.6 mm? -114.36 141.44 47.62 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.098 0.449 . . . . 74.340000000000003 111.902 -176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.5 146.45 38.47 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.93 0.395 . . . . 65.299999999999997 110.709 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -148.51 112.56 5.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.954 0.407 . . . . 53.240000000000002 111.742 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.5 23.25 12.4 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.128 -0.558 . . . . 54.549999999999997 113.29 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.32 166.41 12.31 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 122.51 -0.406 . . . . 63.32 111.856 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -165.52 177.81 7.16 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.352 -0.386 . . . . 71.310000000000002 111.348 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -172.6 168.45 5.27 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.902 0.382 . . . . 74.239999999999995 111.397 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.13 127.18 33.75 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.072 0.463 . . . . 63.409999999999997 110.542 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.88 138.84 33.82 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.977 0.418 . . . . 72.340000000000003 111.892 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -164.22 165.56 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.746 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -82.91 23.36 0.84 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.7 0.259 . . . . 64.209999999999994 111.7 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 54.56 42.64 31.17 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.362 0.601 . . . . 73.140000000000001 111.297 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.4 p -76.46 77.94 3.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.913 -0.585 . . . . 70.439999999999998 111.4 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 65.79 111.73 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.617 -0.72 . . . . 64.409999999999997 112.26 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.14 74.56 0.73 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.101 1.868 . . . . 64.030000000000001 112.125 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.3 m -71.49 109.23 5.32 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.178 -0.465 . . . . 71.019999999999996 112.064 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 t30 54.92 83.19 0.09 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.846 0.684 . . . . 75.340000000000003 112.846 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -125.49 -57.72 1.46 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.278 -0.419 . . . . 75.439999999999998 110.927 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 t -153.71 113.98 3.95 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.066 0.46 . . . . 73.430000000000007 111.565 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -110.96 -31.97 6.97 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.276 0.56 . . . . 74.439999999999998 111.003 177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.3 p -83.42 73.67 10.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.281 0.562 . . . . 54.240000000000002 111.019 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -81.42 -15.93 53.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.222 -0.445 . . . . 61.149999999999999 111.601 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -82.57 160.07 22.63 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.222 -0.299 . . . . 72.430000000000007 110.467 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p 50.62 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.134 0.574 . . . . 64.430000000000007 111.762 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 93.0 p -159.53 152.88 22.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.026 -0.534 . . . . 71.510000000000005 110.863 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.39 -94.87 1.45 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.215 -0.517 . . . . 61.25 112.664 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -149.77 -167.28 2.78 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.843 0.321 . . . . 34.43 111.176 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.6 p -147.4 138.92 23.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.839 0.352 . . . . 32.210000000000001 110.799 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.17 164.81 4.85 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.46 -0.336 . . . . 71.25 110.891 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.38 105.31 14.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.96 0.409 . . . . 60.229999999999997 110.662 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.36 -0.95 11.36 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.566 0.58 . . . . 64.219999999999999 112.566 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HE1' ' HA2' ' A' ' 74' ' ' GLY . 72.8 m-85 -99.27 -177.58 3.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 74.310000000000002 111.729 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.4 t -121.68 157.39 31.0 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.052 0.453 . . . . 72.209999999999994 111.854 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.08 149.88 26.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.095 0.474 . . . . 71.540000000000006 111.834 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.18 -23.33 35.16 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 121.132 -0.556 . . . . 74.239999999999995 113.252 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -89.41 142.19 27.88 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 122.559 -0.377 . . . . 71.019999999999996 111.294 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 57.6 m -59.27 -27.05 65.45 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.213 0.53 . . . . 60.299999999999997 111.469 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 65.4 p -73.37 -16.37 61.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 112.203 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.98 -54.43 47.24 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.265 0.626 . . . . 72.340000000000003 112.397 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 126' ' ' GLU . 39.4 p90 -77.89 -34.95 51.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.167 0.432 . . . . 73.129999999999995 112.167 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.14 -42.59 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 111.853 0.316 . . . . 75.329999999999998 111.853 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -58.01 -36.84 73.24 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.77 -41.82 43.27 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.868 0.366 . . . . 71.140000000000001 110.929 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -64.24 -27.2 68.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.107 0.41 . . . . 64.040000000000006 112.107 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.8 3.27 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 CA-C-O 121.277 0.56 . . . . 60.350000000000001 111.422 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.28 12.77 66.56 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.163 -0.541 . . . . 72.150000000000006 113.933 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.41 16.91 71.96 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 114.43 0.532 . . . . 74.450000000000003 114.43 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.95 30.19 0.52 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 117.343 0.571 . . . . 63.229999999999997 112.123 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 pt -129.81 150.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.923 0.392 . . . . 74.519999999999996 111.603 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.65 98.25 0.28 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.321 -0.466 . . . . 72.450000000000003 113.363 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.0 p -59.36 -8.76 1.88 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.086 0.773 . . . . 71.430000000000007 113.086 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -66.57 -12.5 58.12 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.59 0.589 . . . . 63.140000000000001 112.59 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -63.15 -59.45 4.75 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.807 0.337 . . . . 70.239999999999995 111.779 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.549 ' HA2' ' HE1' ' A' ' 52' ' ' TYR . . . 88.62 -110.43 3.66 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.11 -0.567 . . . . 32.130000000000003 113.699 176.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -63.52 140.2 58.85 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.985 0.393 . . . . 73.299999999999997 111.316 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.442 ' HB1' HG13 ' A' ' 110' ' ' VAL . . . -52.19 -43.68 64.31 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.573 0.582 . . . . 41.119999999999997 112.573 -176.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -56.96 -21.14 27.96 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.774 0.657 . . . . 61.130000000000003 112.774 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -90.94 -23.81 20.35 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.824 0.305 . . . . 72.030000000000001 111.824 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 101' ' ' GLN . 9.4 m0 -50.52 -40.26 51.11 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.264 0.839 . . . . 73.319999999999993 113.264 -174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.63 -64.58 0.84 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.171 0.434 . . . . 70.239999999999995 112.171 -175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -63.82 -35.44 80.62 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.716 0.293 . . . . 71.030000000000001 111.691 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.39 87.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.773 0.32 . . . . 72.430000000000007 111.377 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.031 0.443 . . . . 34.210000000000001 111.347 177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.9 p -64.22 -28.51 69.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.423 -0.353 . . . . 65.140000000000001 111.897 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 t -77.9 -36.34 49.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.9 0.381 . . . . 54.420000000000002 111.767 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.99 -22.03 59.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.267 0.469 . . . . 72.129999999999995 112.267 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.58 10.2 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.047 -0.597 . . . . 23.23 113.587 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -76.67 -173.79 2.73 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.195 0.521 . . . . 54.329999999999998 111.286 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 55.9 m -121.23 97.47 5.53 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.436 -0.347 . . . . 63.149999999999999 111.501 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.558 HG22 HG13 ' A' ' 152' ' ' ILE . 46.2 t -101.62 108.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.817 0.341 . . . . 74.430000000000007 111.847 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.65 147.74 39.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.51 -0.314 . . . . 74.219999999999999 110.932 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -72.76 -9.78 59.04 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.172 0.434 . . . . 72.319999999999993 112.172 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.9 m -56.53 119.79 31.48 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.519 0.2 . . . . 74.230000000000004 111.095 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.56 121.76 1.93 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.001 2.467 . . . . 73.140000000000001 113.78 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.49 156.87 35.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 111.099 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.69 151.66 46.04 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.077 0.465 . . . . 72.439999999999998 112.115 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.02 41.45 18.26 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.191 -0.528 . . . . 54.020000000000003 113.108 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.5 m -151.75 158.53 43.48 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.514 -0.404 . . . . 63.25 111.011 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.4 mp -103.26 126.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.335 -0.246 . . . . 74.109999999999999 110.335 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 149' ' ' TYR . 1.2 pt? -98.85 124.36 43.71 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.399 0.619 . . . . 65.230000000000004 110.836 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -111.8 124.17 51.78 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 111.434 -172.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.585 ' HB2' ' CD1' ' A' ' 149' ' ' TYR . 47.5 t -109.13 112.84 25.23 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.877 0.37 . . . . 54.310000000000002 111.795 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 37.9 p -81.76 71.4 8.78 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.703 0.763 . . . . 73.239999999999995 111.531 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.39 -25.97 59.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.576 -0.738 . . . . 63.539999999999999 111.626 175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.67 160.09 11.57 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.057 -0.519 . . . . 33.299999999999997 112.836 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.14 -77.05 0.24 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.546 -0.359 . . . . 72.25 113.344 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -106.25 -42.83 4.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.984 0.421 . . . . 75.409999999999997 111.629 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.1 -165.68 30.51 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.5 -0.64 . . . . 71.219999999999999 111.5 -169.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -159.52 142.25 13.93 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.494 0.647 . . . . 73.510000000000005 111.66 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' HB1' ' A' ' 76' ' ' ALA . 12.8 m -141.09 141.43 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 111.716 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.16 156.67 41.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.38 -0.373 . . . . 73.209999999999994 110.905 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -96.0 128.64 43.07 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.881 0.372 . . . . 70.109999999999999 111.209 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 124' ' ' VAL . 61.8 t -79.8 118.82 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.317 0.488 . . . . 63.530000000000001 112.317 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -83.92 -53.67 5.42 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 111.282 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -152.42 154.05 34.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.075 0.464 . . . . 64.519999999999996 111.605 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.28 129.09 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 111.009 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.8 OUTLIER -77.46 160.0 29.0 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.869 0.366 . . . . 40.229999999999997 111.5 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.3 m -64.04 -20.42 65.91 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.784 0.326 . . . . 62.200000000000003 111.605 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.11 -22.92 66.42 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.071 0.463 . . . . 74.420000000000002 111.329 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.75 -3.87 45.96 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.582 -0.607 . . . . 75.109999999999999 111.582 -170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 m -64.97 129.17 38.74 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.621 0.368 . . . . 74.239999999999995 110.909 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.469 HG21 ' OH ' ' A' ' 151' ' ' TYR . 61.0 t -106.7 111.36 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.201 0.524 . . . . 64.209999999999994 111.737 -176.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 140' ' ' THR . 37.9 mt-10 -90.32 107.31 19.06 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 110.716 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 113' ' ' VAL . 30.6 m -108.91 173.87 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.004 -0.543 . . . . 73.310000000000002 112.14 -175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.496 ' HB2' HG11 ' A' ' 136' ' ' VAL . 54.8 p -117.87 126.09 51.73 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.026 -0.534 . . . . 74.340000000000003 111.488 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 136' ' ' VAL . 48.5 mt-10 -121.82 -172.68 2.49 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 111.268 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 48.1 tpp -130.88 133.24 45.72 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.904 -0.497 . . . . 45.32 111.338 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -89.4 -45.48 9.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.086 0.47 . . . . 75.329999999999998 111.488 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -89.21 110.79 21.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.913 0.387 . . . . 73.510000000000005 111.74 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -46.5 -38.97 10.0 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.353 0.871 . . . . 72.450000000000003 113.353 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -139.05 46.22 0.98 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.072 -0.585 . . . . 54.030000000000001 112.973 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -103.19 -153.31 24.0 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.268 -0.492 . . . . 73.049999999999997 113.509 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.23 -155.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.902 2.402 . . . . 63.0 113.191 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -82.71 20.61 1.12 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.577 0.584 . . . . 72.430000000000007 112.577 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 m -71.44 83.56 0.8 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.194 0.521 . . . . 71.420000000000002 111.445 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 125' ' ' SER . 79.7 t -77.1 137.8 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.017 -0.538 . . . . 64.329999999999998 112.261 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.1 t -91.13 139.38 30.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.023 -0.535 . . . . 71.450000000000003 111.031 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.65 137.23 32.55 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.545 -0.298 . . . . 73.109999999999999 111.63 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.433 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 2.4 tpm_? -140.61 122.71 15.68 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.971 0.415 . . . . 50.229999999999997 111.923 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 123' ' ' GLU . 81.5 m -104.36 98.5 8.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.946 0.403 . . . . 60.399999999999999 110.739 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.66 128.88 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 54.43 111.775 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.1 m -67.29 147.25 53.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.549 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.72 -47.28 59.2 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.532 0.568 . . . . 52.219999999999999 112.532 -177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.66 64.55 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.225 -0.512 . . . . 71.200000000000003 113.246 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.32 -34.48 25.68 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.085 0.469 . . . . 73.439999999999998 111.06 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 149' ' ' TYR . . . -63.3 -10.93 18.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.707 0.632 . . . . 63.229999999999997 112.707 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.2 t -75.81 -21.6 57.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.328 0.492 . . . . 44.539999999999999 112.328 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 94.2 p -83.34 -33.28 25.91 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.355 0.502 . . . . 60.329999999999998 112.355 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.585 ' CD1' ' HB2' ' A' ' 102' ' ' SER . 80.8 m-85 -70.8 145.82 50.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.251 0.548 . . . . 75.209999999999994 112.327 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -101.35 114.84 29.19 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.069 -0.514 . . . . 71.549999999999997 110.208 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.469 ' OH ' HG21 ' A' ' 122' ' ' VAL . 14.2 m-85 -90.91 114.96 27.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.283 0.475 . . . . 61.340000000000003 112.283 -174.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.558 HG13 HG22 ' A' ' 90' ' ' VAL . 3.7 mp -82.02 107.75 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.752 -0.462 . . . . 74.510000000000005 109.752 173.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -95.81 125.36 40.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.821 0.343 . . . . 52.539999999999999 111.239 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 47.4 mt -90.94 95.74 10.27 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.986 0.422 . . . . 72.329999999999998 111.056 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.544 0.747 0 CA-C-O 120.876 0.37 . . . . 63.520000000000003 111.695 178.18 . . . . . . . . 0 0 . 1 stop_ save_